<?xml version="1.0" encoding="UTF-8" ?><xml><records><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2044</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2044</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">A. Cuello, Mauricio</style></author><author><style face="normal" font="default" size="100%">E. Espinosa, María</style></author><author><style face="normal" font="default" size="100%">Orlandini, Elisa</style></author><author><style face="normal" font="default" size="100%">Y. Hwang, Du</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">El método CONO-UC: un protocolo integrado de toma de decisión y manejo de lesiones pre-invasoras del cuello uterino útil para especialistas jóvenes</style></title><secondary-title><style face="normal" font="default" size="100%">Rev. chil. obstet. ginecol. (En línea)</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Rev. chil. obstet. ginecol. (En línea)</style></full-title></periodical><pages><style face="normal" font="default" size="100%">539-553</style></pages><volume><style face="normal" font="default" size="100%">82</style></volume><number><style face="normal" font="default" size="100%">5</style></number><keywords><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Cervical Intraepithelial Neoplasia/surgery</style></keyword><keyword><style face="normal" font="default" size="100%">Cervical Intraepithelial Neoplasia/pathology</style></keyword><keyword><style face="normal" font="default" size="100%">Colposcopy/methods</style></keyword><keyword><style face="normal" font="default" size="100%">Electrosurgery/methods</style></keyword><keyword><style face="normal" font="default" size="100%">Biopsy</style></keyword><keyword><style face="normal" font="default" size="100%">Logistic Models</style></keyword><keyword><style face="normal" font="default" size="100%">Cervix Uteri/pathology</style></keyword><keyword><style face="normal" font="default" size="100%">Predictive Value of Tests</style></keyword><keyword><style face="normal" font="default" size="100%">Retrospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">ROC Curve</style></keyword><keyword><style face="normal" font="default" size="100%">Analysis of Variance</style></keyword><keyword><style face="normal" font="default" size="100%">Sensitivity and Specificity</style></keyword><keyword><style face="normal" font="default" size="100%">Cervical Intraepithelial Neoplasia/diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">Conization</style></keyword><keyword><style face="normal" font="default" size="100%">Decision Making</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style face="normal" font="default" size="100%">2017/11</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0717-7526</style></isbn><abstract><style face="normal" font="default" size="100%">OBJETIVOS: En la actualidad, existe una alta tasa de sobre-tratamiento de lesiones precursoras cervicales, la cual, en su causalidad, depende de la inexperiencia del operador que toma las decisiones. El objetivo del presente trabajo fue desarrollar un método estandarizado de ponderación/juicio de variables diagnósticas y tratamiento útiles de ser usadas por especialistas jóvenes a fin de minimizar el riesgo de manejo inadecuado. MATERIALES Y MÉTODOS: Se incluyeron 471 pacientes referidos por citología anormal y tratados mediante asa de LEEP. Se calcularon la sensibilidad, la especificidad, los valores predictivos y las relaciones de probabilidad para el diagnóstico de NIE2+ para cada uno de los métodos de diagnóstico. A cada residente se le enseñó un protocolo estandarizado de tratamiento mediante asa. Una vez identificados los mejores predictores, se construyó una escala de puntaje que ponderaba las variables y se definió mediante curva ROC el major punto de corte para la predicción de NIE2+. Las diferencias entre los grupos se compararon mediante Chi-cuadrado, ANOVA o t-test. Se construyó curva de fallas mediante el método de 1-Kaplan Meier. RESULTADOS: La prevalencia de NIE2+ en esta cohorte fue 66%. La concordancia entre las pruebas diagnósticas fue baja, teniendo la colposcopia el peor valor predictivo positivo y el mayor riesgo de sobre-tratamiento. Para la escala de puntaje se incluyeron la edad, la citología, la colposcopia (estratificación basada en la extensión de compromiso por cuadrantes), la biopsia por mascada y la concordancia entre pruebas diagnósticas. Un puntaje&amp;amp;#8805; 9 asociado al uso de un protocolo estandarizado, obtuvo tasas de sobre-tratamiento &amp;amp;lt;15%, de recurrencias de NIE2+ &amp;amp;lt;5% a 5 años y una baja tasa de procedimientos sub-óptimos o con complicaciones (&amp;amp;lt;2 %). CONCLUSIONES: El método CONO-UC al combinar un sistema de puntaje integrado (punto de corte) con un protocolo estandarizado de excisión, permite minimizar el riesgo de sobretratamiento o tratamiento inadecuado, por parte de especialistas jóvenes, de lesiones preinvasoras del cuello uterino, reduciendo además el número de procedimientos indicados innecesariamente y manteniendo una alta tasa de éxito terapéutico.&#xD;GOALS: Currently, there is a high rate of over-treatment of precursor cervical lesions, which, in their causality, depends on the inexperience of the decision-making operator. The objective of the present study was to develop a standardized method of weighting / judgment of diagnostic variables and treatment useful to be used by young specialists in order to minimize the risk of improper handling. MATERIAL AND METHODS: We included 471 patients referred by abnormal cytology and treated by LEEP. Sensitivity, specificity, predictive values and likelihood ratios for the diagnosis of CIN2+ were calculated for each of the diagnostic methods. Each resident was taught a standardized protocol to carry out a LEEP procedure. Once the best predictors were identified, a scoring scale was constructed that weighted the variables and the best cut-off point for the prediction of CIN2+ was defined by ROC curve. Differences between groups were compared using Chi-square, ANOVA or t-test. Failure curves were built up using the 1-Kaplan Meier method. RESULTS: The prevalence of CIN2+ in this cohort was 66%. The agreement between the diagnostic tests was low, with colposcopy having the worst positive predictive value and the highest risk of over-treatment. Age, cytology, colposcopy (stratification based on the extent of compromise by quadrants), punch biopsy, and agreement between diagnostic tests were included for building the scoring scale. A score &amp;amp;#8805; 9 in association with the use of a standardized protocol obtained rates of over-treatment &amp;amp;lt;15%, recurrences of CIN2+ &amp;amp;lt;5% at 5-year follow-up and a low rate of suboptimal procedures or complications (&amp;amp;lt;2%). CONCLUSIONS: The UC-CONE method, by combining an integrated scoring system with a standardized excision protocol, minimizes the risk of over-treatment or inadequate treatment of pre-invasive cervical lesions by young specialists, reducing the number of procedures indicated unnecessarily and maintaining a high rate of therapeutic success.</style></abstract><label><style face="normal" font="default" size="100%">Included by Hannah</style></label><urls><related-urls><url><style face="normal" font="default" size="100%">http://www.scielo.cl/scielo.php?script=sci_arttext&amp;amp;pid=S0717-75262017000500539</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2045</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2045</key></foreign-keys><ref-type name="Generic">13</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Aamir, Nazir</style></author><author><style face="normal" font="default" size="100%">Neelam, Raheel</style></author><author><style face="normal" font="default" size="100%">Jalees, Khan</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Use of mycobacterium culture in confirming diagnosis of tuberculosis in smear negative pulmonary tuberculosis suspects registered in dots implemented setting at Lahore</style></title></titles><pages><style face="normal" font="default" size="100%">11-13</style></pages><volume><style face="normal" font="default" size="100%">11</style></volume><dates><year><style face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style face="normal" font="default" size="100%">2015/00</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">2309-3080</style></isbn><abstract><style face="normal" font="default" size="100%">Objective: early diagnosis of disease and prompt initiation of treatment is essential for an effective tuberculosis control programme. There is concern that smear negative pulmonary tuberculosis may be over-diagnosed and treated in overburdened and resource poor countries. This study was conducted to determine what proportion of patients being registered for smear negative pulmonary tuberculosis treatment has microbiologically confirmed tuberculosis&#xD;Material and Methods: subjects of either sex above the age of 15 year with symptoms of and x-ray finding consistent with pulmonary tuberculosis were selected. Sputum specimens of 124 smear negative pulmonary tuberculosis suspects about to be registered for smear negative pulmonary tuberculosis treatment by the national tuberculosis programme were inoculated on LJ culture medium to isolate the organism. The result of smear and culture were then compared&#xD;Results: a total of 124 sputum smear negative cases were subjected to culture on LJ medium. Out of these 18[14.51 %] were confirmed positive by culture&#xD;Conclusion: sputum culture is gold standard the diagnosis of tuberculosis. Complementing smear negative cases with culture may help in reducing over diagnosis of pulmonary tuberculosis</style></abstract><label><style face="normal" font="default" size="100%">Included by Hannah</style></label><urls><related-urls><url><style face="normal" font="default" size="100%">https://pesquisa.bvsalud.org/gim/resource/en/emr-190902</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2046</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2046</key></foreign-keys><ref-type name="Generic">13</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Abdel Aziz Y, Hamza</style></author><author><style face="normal" font="default" size="100%">Jayant P, Bapat</style></author><author><style face="normal" font="default" size="100%">Rashid, Al Suwaidi</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Over-utilization of pathology services by accident and emergency department</style></title></titles><pages><style face="normal" font="default" size="100%">71-75</style></pages><volume><style face="normal" font="default" size="100%">6</style></volume><keywords><keyword><style face="normal" font="default" size="100%">Emergency Service, Hospital</style></keyword><keyword><style face="normal" font="default" size="100%">Clinical Laboratory Techniques/methods</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">1994</style></year><pub-dates><date><style face="normal" font="default" size="100%">1994/00</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1015-6321</style></isbn><abstract><style face="normal" font="default" size="100%">The over utilization of laboratory services by the accident and emergency [A/E] department at Salmaniya Medical Center is reported. 12583 test procedures ordered for the month of November 1992 for 14607 patients were analysed. BD. 488,484 estimated as yearly test expenditure. A proforma to curtail unnecessary tests is proposed which will reduce the expense by 6.1%</style></abstract><urls><related-urls><url><style face="normal" font="default" size="100%">https://pesquisa.bvsalud.org/gim/resource/en/emr-32660</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2047</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2047</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Abong, J.</style></author><author><style face="normal" font="default" size="100%">Dalay, V.</style></author><author><style face="normal" font="default" size="100%">Langley, I.</style></author><author><style face="normal" font="default" size="100%">Tomeny, E.</style></author><author><style face="normal" font="default" size="100%">Marcelo, D.</style></author><author><style face="normal" font="default" size="100%">Mendoza, V.</style></author><author><style face="normal" font="default" size="100%">Aquino, A. C.</style></author><author><style face="normal" font="default" size="100%">Garfin, A. M. C.</style></author><author><style face="normal" font="default" size="100%">Squire, B.</style></author><author><style face="normal" font="default" size="100%">Yu, C.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Research Division, De La Salle Medical and Health Sciences Institute, Dasmariñas City, Cavite, Philippines.&#xD;Collaboration for Applied Health Research &amp; Delivery, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.&#xD;National TB Control Program, Department of Health, Manila, Metro Manila, Philippines.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Use of GeneXpert and the role of an expert panel in improving clinical diagnosis of smear-negative tuberculosis cases</style></title><secondary-title><style face="normal" font="default" size="100%">PLoS One</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">PLoS ONE</style></full-title></periodical><pages><style face="normal" font="default" size="100%">e0227093</style></pages><volume><style face="normal" font="default" size="100%">14</style></volume><number><style face="normal" font="default" size="100%">12</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Aged, 80 and over</style></keyword><keyword><style face="normal" font="default" size="100%">Cross-Sectional Studies</style></keyword><keyword><style face="normal" font="default" size="100%">DNA, Bacterial/*isolation &amp; purification</style></keyword><keyword><style face="normal" font="default" size="100%">*Expert Testimony</style></keyword><keyword><style face="normal" font="default" size="100%">Feasibility Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Lung/diagnostic imaging/microbiology</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Mycobacterium tuberculosis/genetics/*isolation &amp; purification</style></keyword><keyword><style face="normal" font="default" size="100%">Nucleic Acid Amplification Techniques/*instrumentation/methods</style></keyword><keyword><style face="normal" font="default" size="100%">Philippines</style></keyword><keyword><style face="normal" font="default" size="100%">Pulmonologists</style></keyword><keyword><style face="normal" font="default" size="100%">Radiography</style></keyword><keyword><style face="normal" font="default" size="100%">Sputum/microbiology</style></keyword><keyword><style face="normal" font="default" size="100%">Tuberculosis, Pulmonary/*diagnosis/microbiology</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2019</style></year></dates><isbn><style face="normal" font="default" size="100%">1932-6203</style></isbn><abstract><style face="normal" font="default" size="100%">SETTING: A high proportion of notified tuberculosis cases in the Philippines are clinically diagnosed (63%) as opposed to bacteriologically confirmed. Better understanding of this phenomenon is required to improve tuberculosis control. OBJECTIVES: To determine the percentage of smear negative presumptive tuberculosis patients that would be diagnosed by GeneXpert; compare clinical characteristics of patients diagnosed as tuberculosis cases; and review the impact that the current single government physician and a reconstituted Tuberculosis Diagnostic committee (expert panel) may have on tuberculosis over-diagnosis. DESIGN: This a cross-sectional study of 152 patients 15-85 years old with two negative Direct Sputum Smear Microscopy results, with abnormal chest X-ray who underwent GeneXpert testing and review by an expert panel. RESULTS: Thirty-two percent (48/152) of the sample were Xpert positive and 93% (97/104) of GeneXpert negatives were clinically diagnosed by a single physician. Typical symptoms and X-ray findings were higher in bacteriologically confirmed tuberculosis. When compared to the GeneXpert results the Expert panel&apos;s sensitivity for active tuberculosis was high (97.5%, 39/40), specificity was low (40.2%, 35/87). CONCLUSION: Using the GeneXpert would increase the level of bacteriologically confirmed tuberculosis substantially among presumptive tuberculosis. An expert panel will greatly reduce over-diagnosis usually seen when a decision is made by a single physician.</style></abstract><notes><style face="normal" font="default" size="100%">1932-6203&#xD;Abong, Jovilia&#xD;Orcid: 0000-0003-4220-1495&#xD;Dalay, Victoria&#xD;Langley, Ivor&#xD;Tomeny, Ewan&#xD;Marcelo, Danaida&#xD;Mendoza, Victor&#xD;Aquino, Arvin Christian&#xD;Orcid: 0000-0002-4544-7821&#xD;Garfin, Anna Marie Celina&#xD;Squire, Bertie&#xD;Yu, Charles&#xD;Comparative Study&#xD;Journal Article&#xD;Multicenter Study&#xD;Observational Study&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;PLoS One. 2019 Dec 30;14(12):e0227093. doi: 10.1371/journal.pone.0227093. eCollection 2019.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6936841/pdf/pone.0227093.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC6936841</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1371/journal.pone.0227093</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2048</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2048</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Ahmadi, K.</style></author><author><style face="normal" font="default" size="100%">Hashemian, A. M.</style></author><author><style face="normal" font="default" size="100%">Pishbin, E.</style></author><author><style face="normal" font="default" size="100%">Sharif-Alhoseini, M.</style></author><author><style face="normal" font="default" size="100%">Rahimi-Movaghar, V.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Emergency Medicine, Alborz University of Medical Sciences, Karaj, Iran.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Impact of intravenous acetaminophen therapy on the necessity of cervical spine imaging in patients with cervical spine trauma</style></title><secondary-title><style face="normal" font="default" size="100%">Chin J Traumatol</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Chin J Traumatol</style></full-title></periodical><pages><style face="normal" font="default" size="100%">204-7</style></pages><volume><style face="normal" font="default" size="100%">17</style></volume><number><style face="normal" font="default" size="100%">4</style></number><keywords><keyword><style face="normal" font="default" size="100%">Acetaminophen/*administration &amp; dosage</style></keyword><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Analgesics, Non-Narcotic/*administration &amp; dosage</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Iran</style></keyword><keyword><style face="normal" font="default" size="100%">Longitudinal Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Neck Injuries/*diagnostic imaging/*drug therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Prospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Radiography</style></keyword><keyword><style face="normal" font="default" size="100%">Spinal Injuries/*diagnostic imaging/*drug therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Unnecessary Procedures</style></keyword><keyword><style face="normal" font="default" size="100%">Wounds, Nonpenetrating/*diagnostic imaging/*drug therapy</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2014</style></year></dates><isbn><style face="normal" font="default" size="100%">1008-1275 (Print)&#xD;1008-1275</style></isbn><abstract><style face="normal" font="default" size="100%">OBJECTIVE: We evaluated a new hypothesis of acetaminophen therapy to reduce the necessity of imaging in patients with probable traumatic cervical spine injury. METHODS: Patients with acute blunt trauma to the neck and just posterior midline cervical tenderness received acetaminophen (15 mg/kg) intravenously after cervical spine immobilization. Then, all the patients underwent plain radiography and computerized tomography of the cervical spine. The outcome measure was the presence of traumatic cervical spine injury. Sixty minutes after acetaminophen infusion, posterior midline cervical tenderness was reassessed. RESULTS: Of 1 309 patients, 41 had traumatic cervical spine injuries based on imaging. Sixty minutes after infusion, posterior midline cervical tenderness was eliminated in 1 041 patients, none of whom had abnormal imaging. CONCLUSION: Patients with cervical spine trauma do not need imaging if posterior midline cervical tenderness is eliminated after acetaminophen infusion. This analgesia could be considered as a diagnostic and therapeutic intervention.</style></abstract><label><style face="normal" font="default" size="100%">Included by Loai</style></label><notes><style face="normal" font="default" size="100%">Ahmadi, Koorosh&#xD;Hashemian, Amir-Masoud&#xD;Pishbin, Elham&#xD;Sharif-Alhoseini, Mahdi&#xD;Rahimi-Movaghar, Vafa&#xD;Journal Article&#xD;Observational Study&#xD;China&#xD;Chin J Traumatol. 2014;17(4):204-7.</style></notes><urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2049</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2049</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Al-Foheidi, M.</style></author><author><style face="normal" font="default" size="100%">Al-Mansour, M. M.</style></author><author><style face="normal" font="default" size="100%">Ibrahim, E. M.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Princess Noorah Oncology Center, King Abdulaziz Medical City, PO Box 9515, Jeddah 21423, Kingdom of Saudi Arabia.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Breast cancer screening: review of benefits and harms, and recommendations for developing and low-income countries</style></title><secondary-title><style face="normal" font="default" size="100%">Med Oncol</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Med Oncol</style></full-title></periodical><pages><style face="normal" font="default" size="100%">471</style></pages><volume><style face="normal" font="default" size="100%">30</style></volume><number><style face="normal" font="default" size="100%">2</style></number><keywords><keyword><style face="normal" font="default" size="100%">Breast Neoplasms/*diagnosis/*economics/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Cost-Benefit Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Developing Countries/*economics</style></keyword><keyword><style face="normal" font="default" size="100%">Early Detection of Cancer/adverse effects/*economics</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">*Health Planning Guidelines</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Mammography/adverse effects/economics</style></keyword><keyword><style face="normal" font="default" size="100%">Poverty/*economics</style></keyword><keyword><style face="normal" font="default" size="100%">Randomized Controlled Trials as Topic/economics/methods</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2013</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jun</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1357-0560</style></isbn><abstract><style face="normal" font="default" size="100%">Breast cancer is the most common cancer in women worldwide. The disease remains a public health concern as recent evidence indicates that the breast cancer burden has increased mainly in developing and low-income countries (DLICs). Despite the demonstrated benefits, the debate about the real benefits and harms of breast cancer screening is ongoing. Many experts believe that the benefits of screening, in terms of reduced breast cancer mortality, outweigh the harms, whereas others think the opposite. In this review, we assess the clinical utility of available screening modalities, present evidence, overdiagnosis, cost-effectiveness, and other pertinent issues. We also examine relevant data from DLICs to underscore the barriers and challenges that impede implementation of screening strategies in those populations. We also provide recommendations concerning rational preventive strategies for breast cancer control for women in DLICs.</style></abstract><notes><style face="normal" font="default" size="100%">1559-131x&#xD;Al-Foheidi, Meteb&#xD;Al-Mansour, Mubarak M&#xD;Ibrahim, Ezzeldin M&#xD;Journal Article&#xD;Review&#xD;United States&#xD;Med Oncol. 2013 Jun;30(2):471. doi: 10.1007/s12032-013-0471-5. Epub 2013 Feb 19.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://link.springer.com/content/pdf/10.1007/s12032-013-0471-5.pdf</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1007/s12032-013-0471-5</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2050</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2050</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Al-Selwi, K.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">K. Al-Selwi, Tropical Medicine Center, Hodiedah, Yemen</style></auth-address><titles><title><style face="normal" font="default" size="100%">Overdiagnosis of malaria among the health services providers in Hodeida-Yemen</style></title><secondary-title><style face="normal" font="default" size="100%">Giornale Italiano di Medicina Tropicale</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Giornale Italiano di Medicina Tropicale</style></full-title></periodical><pages><style face="normal" font="default" size="100%">3-5</style></pages><volume><style face="normal" font="default" size="100%">14</style></volume><number><style face="normal" font="default" size="100%">1-4</style></number><keywords><keyword><style face="normal" font="default" size="100%">article</style></keyword><keyword><style face="normal" font="default" size="100%">software</style></keyword><keyword><style face="normal" font="default" size="100%">diagnostic error</style></keyword><keyword><style face="normal" font="default" size="100%">health care personnel</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">interview</style></keyword><keyword><style face="normal" font="default" size="100%">laboratory personnel</style></keyword><keyword><style face="normal" font="default" size="100%">malaria</style></keyword><keyword><style face="normal" font="default" size="100%">medical assistant</style></keyword><keyword><style face="normal" font="default" size="100%">nurse</style></keyword><keyword><style face="normal" font="default" size="100%">pharmacist</style></keyword><keyword><style face="normal" font="default" size="100%">physician</style></keyword><keyword><style face="normal" font="default" size="100%">prescription</style></keyword><keyword><style face="normal" font="default" size="100%">registration</style></keyword><keyword><style face="normal" font="default" size="100%">responsibility</style></keyword><keyword><style face="normal" font="default" size="100%">rural area</style></keyword><keyword><style face="normal" font="default" size="100%">urban area</style></keyword><keyword><style face="normal" font="default" size="100%">Yemen</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2009</style></year></dates><isbn><style face="normal" font="default" size="100%">0394-3445</style></isbn><abstract><style face="normal" font="default" size="100%">Overdiagnosis or misdiagnosis of malaria has many negative consequences on society&apos;s health. This qualitative study about health service providers and malaria overdiagnosis performed in Hodeida, the most affected town in Yemen, aimed to determine if health service providers are aware of the problem. Health service providers included doctors working in hospitals, centers, or private clinics; medical assistants working in clinics, laboratories involved in diagnosing and treating malaria; and pharmacists prescribing and selling malaria treatment drugs, all of whom are officially registered in the health office. The study sample was obtained from the 2006 registration records by choosing every other person from the list. Half of the registered health service providers were from agencies in rural area and the other half was from urban areas. The stratified sample received an in depth interview by investigators and the data were analyzed using Epi Info software, version 6.3. The results indicated that 59% of physicians, 59% of laboratory technicians, 75% of pharmacists, and 50% of nurses think that malaria is misdiagnosed. Nurses were least concerned about misdiagnosis, followed by physicians and laboratory technicians, and pharmacists were the most concerned. On the other hand, 56% of physicians, 43% of nurses, 41% of laboratory technicians, and 58% of pharmacists think that malaria is overdiagnosed. All providers agreed that both laboratory technicians and physicians overdiagnosis malaria. A large proportion of laboratory technicians (39%) acknowledge primary responsibility for the problem, whereas only a small proportion of physicians (24%) acknowledge secondary responsibility.</style></abstract><label><style face="normal" font="default" size="100%">Included by Thanya</style></label><notes><style face="normal" font="default" size="100%">L361239965&#xD;2011-02-17&#xD;2011-02-23</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.embase.com/search/results?subaction=viewrecord&amp;id=L361239965&amp;from=export</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2051</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2051</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Alimoglu, O.</style></author><author><style face="normal" font="default" size="100%">Dilek, H. F.</style></author><author><style face="normal" font="default" size="100%">Tonyali, M.</style></author><author><style face="normal" font="default" size="100%">Eren, T.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of General Surgery, Faculty of Medicine, Istanbul, Turkey.&#xD;Faculty of Medicine, Istanbul Medeniyet University, Istanbul, Turkey.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Do all detected thyroid cancers correspond to &apos;real cancer&apos;?</style></title><secondary-title><style face="normal" font="default" size="100%">Br J Surg</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Br J Surg</style></full-title></periodical><pages><style face="normal" font="default" size="100%">e276</style></pages><volume><style face="normal" font="default" size="100%">107</style></volume><number><style face="normal" font="default" size="100%">8</style></number><keywords><keyword><style face="normal" font="default" size="100%">Carcinoma, Papillary/diagnosis/epidemiology/pathology/surgery</style></keyword><keyword><style face="normal" font="default" size="100%">Diagnosis, Differential</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Medical Overuse/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Retrospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Thyroid Neoplasms/*diagnosis/epidemiology/*pathology/surgery</style></keyword><keyword><style face="normal" font="default" size="100%">Thyroidectomy</style></keyword><keyword><style face="normal" font="default" size="100%">Turkey/epidemiology</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2020</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jul</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0007-1323</style></isbn><label><style face="normal" font="default" size="100%">Included by Ray</style></label><notes><style face="normal" font="default" size="100%">1365-2168&#xD;Alimoglu, O&#xD;Orcid: 0000-0003-2130-2529&#xD;Dilek, H F&#xD;Tonyali, M&#xD;Eren, T&#xD;Orcid: 0000-0001-7651-4321&#xD;Letter&#xD;England&#xD;Br J Surg. 2020 Jul;107(8):e276. doi: 10.1002/bjs.11658. Epub 2020 May 25.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://watermark.silverchair.com/bjs11658.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAqswggKnBgkqhkiG9w0BBwagggKYMIIClAIBADCCAo0GCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMcC9-tINeOrtvSgYvAgEQgIICXmgLznwmJfrw_WxJ_093jVUAR96GKRrmlg_pOPq7LiuToQz6qcBkE_BGsp_p5TdLonnNG2FDlzFnnx5q-nN2xHQOnh_Dwx6e9dSOY-fZNwbVoNCXd-rihKje_i6g7vXPrecuhnvTu2_RGTTeldRtUVTuIwQKC5BkP8zXbtk8YE91W00WdwyRrMPxNu_z3mmbNvMbJil0_R4CLOQRIHgzDS0DfwUe9W82K0n-6OoQ4I0xzMzeSxZbB9Te2h2yGI2WlUwcHB94vtr64MEKEEoX7kcBW9RXtBRi-qj2G3PPvE3s8sp49epVaMFDJT8pU-CW7eE2018gDWNRMxJx0Xi0s6jUJDcZPyK0A3z6HYdFMmrmPoncIpSuCEhzwdRiM9zLt1VoGPlk5MwjpKZSyCA9C5Yqq5yhJugKLaufvZPvVj6B2HYMG_X-fAw7TaNYr_IwOD1Rs3g1YFxUKuaYIl2EodZntWsSHWG_1AAQ52TVqI9tEM76Z9xJbNia9Y7Kkj4wcwsgrF9Va8BsxZzI5Vach0ZBNgZjTIRGmbpF41_Na7epcE6z-AIXw94M-BVJUFYWhdhoZtUb8V-LeMR6srIVp0UNqcM5zhORlwCXoWEbk_iam3wikhB3myHPDfLpGtmvc10z7-cWkbfUO8PuDerNoVQIjIcjfoiuPi7hkuJFS9D9RaoczkHn7IIKe0ZBDcKQMCM3YpNI7rTrSO3Zk0R6d2m830sFETFCk_cfwoX6vs8dtnvbOfB3A9U4jriCrrnXXJ_MErexfE6mXh7Im5hOLhLO-2Hj3maSQu0qcP5wCw</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1002/bjs.11658</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2052</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2052</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Almenas, Marina</style></author><author><style face="normal" font="default" size="100%">Hidalgo, Esteban Cordero</style></author><author><style face="normal" font="default" size="100%">Pineda, Carlos Andrés</style></author><author><style face="normal" font="default" size="100%">Muñoz, Eliasin</style></author><author><style face="normal" font="default" size="100%">Armadillo, María de Lourdes Rojas</style></author><author><style face="normal" font="default" size="100%">Salvatierra, Elizabeth</style></author><author><style face="normal" font="default" size="100%">Galindo, Gisela</style></author><author><style face="normal" font="default" size="100%">Cabezas, Carmen</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Prevención cuaternaria: como hacer, como ensiñar</style></title><secondary-title><style face="normal" font="default" size="100%">Rev. bras. med. fam. comunidade</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Rev. bras. med. fam. comunidade</style></full-title></periodical><pages><style face="normal" font="default" size="100%">69-83</style></pages><volume><style face="normal" font="default" size="100%">13</style></volume><number><style face="normal" font="default" size="100%">Suplemento 1 - VII CUMBRE Iberoamericana de Medicina Familiar</style></number><keywords><keyword><style face="normal" font="default" size="100%">Teaching</style></keyword><keyword><style face="normal" font="default" size="100%">Education, Continuing</style></keyword><keyword><style face="normal" font="default" size="100%">Professional Training</style></keyword><keyword><style face="normal" font="default" size="100%">Family Practice</style></keyword><keyword><style face="normal" font="default" size="100%">Quaternary Prevention</style></keyword><keyword><style face="normal" font="default" size="100%">Medical Overuse</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style face="normal" font="default" size="100%">2018/09</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1809-5909</style></isbn><abstract><style face="normal" font="default" size="100%">La prevención cuaternaria o P4 se define como las acciones que disminuyen los efectos de las intervenciones innecesarias, generadas por el contacto de las personas con los sistemas de salud. Se planteó como objetivo general desarrollar una estrategia para promover y difundir P4 em Iberoamérica; para cumplir dicha meta se realizó una investigación bibliográfica sobre los conceptos relacionados con P4; se aplicó una encuesta exploratoria para indagar sobre el conocimiento que tenían los participantes en la Cumbre y el Congreso respecto a P4. Existe múltiple literatura que define los términos relacionados con P4, lo que facilita su delimitación. Respecto a la encuesta, de las 309 personas que contestaron; 34% tenían entre 36 y 45 años; 88% eran profesionales en medicina; 69% conocía sobre P4 y más del 50% afirmó estar informado sobre los conceptos relacionados a P4; 92% consideró que P4 no es exclusiva de medicina familiar; 15% aseguró que después de la VI Cumbre se hicieron publicaciones sobre P4 en sus países; menos del 20% consideró que los políticos conocen sobre P4; 27% afirmó que los médicos de familia educan a los pacientes sobre P4. Se recomienda ampliar las campañas de educación sobre P4; facilitar el acceso a la información sobre P4 para profesionales del campo de la salud; incluir P4 en los programas académicos de pregrado y postgrado de las profesiones de la salud; crear alianzas con las entidades políticas de cada país para incluir P4 en políticas públicas.&#xD;Quaternary prevention or P4 is defined as any action taken to diminish the effects of unnecessary interventions generated when people interact with a health system. Methodology.The general objective was to develop a strategy to promote and spread P4 in Iberoamerica; to fulfill this goal a literature research was carried out, on the concepts related to P4; an exploratory survey was applied to inquire about the knowledge of the participates in the Summit and Congress, regarding P4 Results. There multiple literature sources that define the terms related to P4, which facilitated its delimitation. Regarding the survey, 69% knew about P4 and more that 50% declared that they where informed about the concepts related to P4; 92% considered that P4 is not only limited to family medicine; 15% assured that after the VI Summit publication regarding P4 where published in their countries; less than 20% stated that politicians knew about P4; 27% affirmed that family medicine doctors educate their patients about P4 Conclusions. It is recommended to expand the educational campaigns about P4; facilitate the access to information about P4 for professionals in the health field; include P4 in the academic programs of health professional for both graduate and post-graduate students; create alliances with political entities of each country to include P4 in public health policies.&#xD;A prevenção quaternária ou P4 é definida como ações que reduzem os efeitos de intervenções desnecessárias, geradas pelo contato das pessoas com os sistemas de saúde. O objetivo geral foi desenvolver uma estratégia para promover e disseminar o P4 na Ibero-América; Para atingir este objetivo, foi realizada uma pesquisa bibliográfica sobre os conceitos relacionados a P4; Uma pesquisa exploratória foi aplicada para indagar sobre o conhecimento que os participantes da Cúpula e do Congresso tinham sobre P4. Há uma diversidade de literatura que define os termos relacionados a P4, o que facilita sua delimitação. Em relação à pesquisa, das 309 pessoas que responderam; 34% tinham entre 36 e 45 anos; 88% eram profissionais de medicina; 69% conheciam o P4 e mais de 50% disseram que estavam informados sobre os conceitos relacionados ao P4; 92% consideraram que P4 não é exclusivo de medicina de família; 15% disseram que, após a VI Cúpula, foram feitas publicações sobre P4 em seus países; menos de 20% considerou que os políticos conhecem o P4; 27% disseram que os médicos de família educam os pacientes sobre o P4. Recomenda-se expandir as campanhas de educação sobre P4; facilitar o acesso à informação sobre P4 para profissionais da área da saúde; incluir P4 nos programas acadêmicos de graduação e pós-graduação das profissões de saúde; criar parceiras com as entidades políticas de cada país para incluir P4 nas políticas públicas</style></abstract><label><style face="normal" font="default" size="100%">Included by Ray</style></label><urls><related-urls><url><style face="normal" font="default" size="100%">https://rbmfc.org.br/rbmfc/article/view/1853/942</style></url><url><style face="normal" font="default" size="100%">http://fi-admin.bvsalud.org/document/view/rrcmk</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2053</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2053</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Alpay Ozbek, O.</style></author><author><style face="normal" font="default" size="100%">Oktem, M. A.</style></author><author><style face="normal" font="default" size="100%">Akyüz, E.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">alpay.ozbek@deu.edu.tr</style></auth-address><titles><title><style face="normal" font="default" size="100%">[Unnecessary test repeats in viral hepatitis serology]</style></title><secondary-title><style face="normal" font="default" size="100%">Mikrobiyol Bul</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Mikrobiyol Bul</style></full-title></periodical><pages><style face="normal" font="default" size="100%">279-83</style></pages><volume><style face="normal" font="default" size="100%">41</style></volume><number><style face="normal" font="default" size="100%">2</style></number><keywords><keyword><style face="normal" font="default" size="100%">Hepatitis A/*diagnosis/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Hepatitis A Antibodies/blood</style></keyword><keyword><style face="normal" font="default" size="100%">Hepatitis B/*diagnosis/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Hepatitis B Antibodies/blood</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Immunoglobulin G/blood</style></keyword><keyword><style face="normal" font="default" size="100%">Retrospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Seroepidemiologic Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Turkey/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Unnecessary Procedures/*economics/statistics &amp; numerical data</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2007</style></year><pub-dates><date><style face="normal" font="default" size="100%">Apr</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0374-9096 (Print)&#xD;0374-9096</style></isbn><abstract><style face="normal" font="default" size="100%">Inappropriate laboratory testing constitutes a vast burden regarding the cost and the workload for health care system. Unnecessary repetition of tests is one of the most common reasons accounting for inappropriate laboratory utilization. A wide spectrum of tests are utilized to diagnose hepatitis A and B infections in Turkey because of the high seroprevalence rates. The present research aimed to determine the rate of unnecessary repeat testing of anti-HAV total and anti-HBc used in serological diagnosis of hepatitis A and B infections and to discuss the possible solutions for this problem. Laboratory records of the serology laboratory of Dokuz Eylul University Hospital, dating between May 2002 - May 2005, were evaluated retrospectively. Unnecessary repeat testing was defined as the repetition of anti-HAV total and/or anti-HBc for the patients positive for one or both of the tests. During the study period of three years, a total of 10.658 anti-HAV total and 13.047 anti-HBc were tested of which 8.550 (80%) and 4.959 (38%) were found positive, respectively. Out of the positive results, 1.197 (14%) anti-HAV total and 904 (18%) anti-HBc tests were detected to be unnecessarily repeated tests. The estimated cost of a total of 2101 unnecessarily repeated tests was found approximately 17.000 US Dollars. Our data display that considerable amount of unnecessary testing takes place in serological testing of viral hepatitis. Prevention of inappropriate laboratory requests by clinicians would help to diminish the work load in serology laboratories and the cost both for the hospitals and the country.</style></abstract><notes><style face="normal" font="default" size="100%">Alpay Ozbek, Ozgen&#xD;Oktem, Mehmet Ali&#xD;Akyüz, Ebru&#xD;English Abstract&#xD;Journal Article&#xD;Turkey&#xD;Mikrobiyol Bul. 2007 Apr;41(2):279-83.</style></notes><urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2054</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2054</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Ameyaw, E.</style></author><author><style face="normal" font="default" size="100%">Nguah, S. B.</style></author><author><style face="normal" font="default" size="100%">Ansong, D.</style></author><author><style face="normal" font="default" size="100%">Page, I.</style></author><author><style face="normal" font="default" size="100%">Guillerm, M.</style></author><author><style face="normal" font="default" size="100%">Bates, I.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Child Health, Komfo Anokye Teaching Hospital, Kumasi, Ghana. ekameyaw@yahoo.com.</style></auth-address><titles><title><style face="normal" font="default" size="100%">The outcome of a test-treat package versus routine outpatient care for Ghanaian children with fever: a pragmatic randomized control trial</style></title><secondary-title><style face="normal" font="default" size="100%">Malar J</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Malar J</style></full-title></periodical><pages><style face="normal" font="default" size="100%">461</style></pages><volume><style face="normal" font="default" size="100%">13</style></volume><keywords><keyword><style face="normal" font="default" size="100%">Ambulatory Care/methods</style></keyword><keyword><style face="normal" font="default" size="100%">Anti-Bacterial Agents/*therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Antimalarials/*therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Child, Preschool</style></keyword><keyword><style face="normal" font="default" size="100%">Clinical Medicine/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Diagnostic Tests, Routine/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Fever of Unknown Origin/*diagnosis/*drug therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Ghana</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Infant</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">*Point-of-Care Systems</style></keyword><keyword><style face="normal" font="default" size="100%">Treatment Outcome</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style face="normal" font="default" size="100%">Nov 26</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1475-2875</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: Over-diagnosis of malaria among African children results in mismanagement of non-malaria infections. Limited laboratory capacity makes it difficult to implement policies that recommend pre-treatment confirmation of infections so a new approach with a package for on-the-spot management of fevers was evaluated. METHODS: Febrile children presenting to outpatient clinic were randomized to receive either a &apos;test-treat&apos; package (history with clinical examination; point-of-care tests; choice of artesunate-amodiaquine, co-amoxiclav and/or paracetamol) or routine outpatient care in a secondary health care facility in Kumasi, Ghana. A diagnosis of malaria, bacterial, viral or mixed malarial and bacterial infections was made using pre-defined criteria. Outcome was resolution of all symptoms including fever on day 7. RESULTS: The median age of the patients was 37.5 months (IQR: 19 to 66 months), with 56.7% being males. Compared to routine care the test-treat package resulted in less diagnoses of malaria, (37.2% vs 46.2%, p = 0.190) and mixed malaria and bacterial infections (14.0% vs 53.8%, p &lt; 0.001) but more diagnoses of viral (33.1% vs 0.0%, p &lt; 0.001) and bacterial infections only (15.7% vs 0.0%, p &lt; 0.001). Less anti-malarials (51.2% vs 100.0%, p &lt; 0.001) and antibiotics (29.7% vs 48.7%, p &lt; 0.001), were prescribed in the test-treat group on completion of study, more test-treat package patients were clinically well (99.2% vs 80.7%, p &lt; 0.001) and febrile (0.8% vs 10.1%, p = 0.001) and less were admitted for inpatient care (0.0% vs 8.4% p = 0.001) compared to the routine care group. CONCLUSION: Test-treat package improves the effectiveness of outpatient diagnosis and treatment of children with fever and reduces inappropriate prescribing of anti-malarials and antibiotics. The package provides clinicians with the option for immediate diagnosis and treatment of non-malaria fevers. The test-treat package now needs to be evaluated in other settings including primary health care facilities.</style></abstract><label><style face="normal" font="default" size="100%">Included by Ray</style></label><notes><style face="normal" font="default" size="100%">1475-2875&#xD;Ameyaw, Emmanuel&#xD;Nguah, Samuel B&#xD;Ansong, Daniel&#xD;Page, Iain&#xD;Guillerm, Martine&#xD;Bates, Imelda&#xD;Comparative Study&#xD;Journal Article&#xD;Randomized Controlled Trial&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Malar J. 2014 Nov 26;13:461. doi: 10.1186/1475-2875-13-461.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259007/pdf/12936_2014_Article_3621.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC4259007</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1186/1475-2875-13-461</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2055</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2055</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Aniebue, U. U.</style></author><author><style face="normal" font="default" size="100%">Nwankwo, T. O.</style></author><author><style face="normal" font="default" size="100%">Nwafor, M. I.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Obstetrics and Gynaecology, University of Nigeria Teaching Hospital, Enugu, Nigeria.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Vulvovaginal candidiasis in reproductive age women in Enugu Nigeria, clinical versus laboratory-assisted diagnosis</style></title><secondary-title><style face="normal" font="default" size="100%">Niger J Clin Pract</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Niger J Clin Pract</style></full-title></periodical><pages><style face="normal" font="default" size="100%">1017-1022</style></pages><volume><style face="normal" font="default" size="100%">21</style></volume><number><style face="normal" font="default" size="100%">8</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Candida/*isolation &amp; purification</style></keyword><keyword><style face="normal" font="default" size="100%">Candidiasis, Vulvovaginal/*diagnosis/epidemiology/microbiology</style></keyword><keyword><style face="normal" font="default" size="100%">Cross-Sectional Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Nigeria/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Pregnancy</style></keyword><keyword><style face="normal" font="default" size="100%">Prevalence</style></keyword><keyword><style face="normal" font="default" size="100%">Prospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Surveys and Questionnaires</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Candidiasis</style></keyword><keyword><style face="normal" font="default" size="100%">clinical laboratory diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">vulvovaginal</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style face="normal" font="default" size="100%">Aug</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1119-3077 (Print)</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: Clinical diagnosis of acute vulvovaginal candidiasis (VVC) depends on evidence of clinical symptoms, but symptomatic treatment widely practiced in low-resource area may lead to overdiagnosis and treatment. OBJECTIVE: The objective of the study is to determine the prevalence of VVC among women attending gynecological clinic in University of Nigeria Teaching Hospital (UNTH) Enugu and the accuracy of clinical-based diagnosis versus laboratory test supported diagnosis and patients&apos; characteristics that affect accuracy. MATERIALS AND METHODS: This study surveyed patients seen in a gynecologic clinic for VVC using a semi-structured, pretested, and interviewer-administered questionnaire. Vaginal examination was done on each patient and findings documented. A pair of swabs was taken from the vagina and cervical os and cultured for Candida species using Sabouraud Dexttose Agar. Data were analyzed using statistical software, SPSS version 15 (SPSS Inc., Chicago IL, USA). P ≤ 0.05 were considered to be statistically significant. RESULTS: The mean age of 209 women surveyed was 35.9 (standard deviation [SD] ±9.0) years. Their mean parity was 2 (SD ± 3). The prevalence of VVC was 17.7% based on symptoms and laboratory test. Clinically based diagnosis had a sensitivity of 70.3% and specificity of 83.7%. Forty-one (19.6%) of the study population had good knowledge of VVC. More than 44% of the women had self-reported and treated VVC within the year. Young women of 24 years or less (54.5%) and those who had reported other episodes of VVC within the past year (41.1%) were most commonly associated with inaccurate clinical diagnosis. CONCLUSION: Clinically based diagnosis of VVC has an unacceptably high false-positive rate which may encourage continued presumptive treatment with its attendant risks. Clinical evaluation and laboratory culture of vulvovaginal specimen should be the standard diagnostic method.</style></abstract><label><style face="normal" font="default" size="100%">Included by Hannah</style></label><notes><style face="normal" font="default" size="100%">Aniebue, U U&#xD;Nwankwo, T O&#xD;Nwafor, M I&#xD;Journal Article&#xD;Observational Study&#xD;India&#xD;Niger J Clin Pract. 2018 Aug;21(8):1017-1022. doi: 10.4103/njcp.njcp_25_16.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.njcponline.com/article.asp?issn=1119-3077;year=2018;volume=21;issue=8;spage=1017;epage=1022;aulast=Aniebue</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.4103/njcp.njcp_25_16</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2056</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2056</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Ansah, E. K.</style></author><author><style face="normal" font="default" size="100%">Narh-Bana, S.</style></author><author><style face="normal" font="default" size="100%">Affran-Bonful, H.</style></author><author><style face="normal" font="default" size="100%">Bart-Plange, C.</style></author><author><style face="normal" font="default" size="100%">Cundill, B.</style></author><author><style face="normal" font="default" size="100%">Gyapong, M.</style></author><author><style face="normal" font="default" size="100%">Whitty, C. J.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Research and Development Division, Ghana Health Service, PO Box MB-190, Accra, Ghana Ansahekdr@yahoo.co.uk.&#xD;Dodowa Health Research Center, Ghana Health Service.&#xD;Dangme West District Health Directorate, Ghana Health Service.&#xD;National Malaria Control Programme, Ghana Health Service.&#xD;London School of Hygiene &amp; Tropical Medicine, London, UK.</style></auth-address><titles><title><style face="normal" font="default" size="100%">The impact of providing rapid diagnostic malaria tests on fever management in the private retail sector in Ghana: a cluster randomized trial</style></title><secondary-title><style face="normal" font="default" size="100%">Bmj</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Bmj</style></full-title></periodical><pages><style face="normal" font="default" size="100%">h1019</style></pages><volume><style face="normal" font="default" size="100%">350</style></volume><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Child, Preschool</style></keyword><keyword><style face="normal" font="default" size="100%">*Community Pharmacy Services</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Fever/*drug therapy/etiology</style></keyword><keyword><style face="normal" font="default" size="100%">Ghana</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Inappropriate Prescribing/*prevention &amp; control</style></keyword><keyword><style face="normal" font="default" size="100%">Malaria/complications/*diagnosis/drug therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Pharmacies</style></keyword><keyword><style face="normal" font="default" size="100%">*Private Sector</style></keyword><keyword><style face="normal" font="default" size="100%">Rural Population</style></keyword><keyword><style face="normal" font="default" size="100%">Single-Blind Method</style></keyword><keyword><style face="normal" font="default" size="100%">Urban Population</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style face="normal" font="default" size="100%">Mar 4</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0959-8138 (Print)&#xD;0959-8138</style></isbn><abstract><style face="normal" font="default" size="100%">OBJECTIVE: To examine the impact of providing rapid diagnostic tests for malaria on fever management in private drug retail shops where most poor rural people with fever present, with the aim of reducing current massive overdiagnosis and overtreatment of malaria. DESIGN: Cluster randomized trial of 24 clusters of shops. SETTING: Dangme West, a poor rural district of Ghana. PARTICIPANTS: Shops and their clients, both adults and children. INTERVENTIONS: Providing rapid diagnostic tests with realistic training. MAIN OUTCOME MEASURES: The primary outcome was the proportion of clients testing negative for malaria by a double-read research blood slide who received an artemisinin combination therapy or other antimalarial. Secondary outcomes were use of antibiotics and antipyretics, and safety. RESULTS: Of 4603 clients, 3424 (74.4%) tested negative by double-read research slides. The proportion of slide-negative clients who received any antimalarial was 590/1854 (32%) in the intervention arm and 1378/1570 (88%) in the control arm (adjusted risk ratio 0.41 (95% CI 0.29 to 0.58), P&lt;0.0001). Treatment was in high agreement with rapid diagnostic test result. Of those who were slide-positive, 690/787 (87.8%) in the intervention arm and 347/392 (88.5%) in the control arm received an artemisinin combination therapy (adjusted risk ratio 0.96 (0.84 to 1.09)). There was no evidence of antibiotics being substituted for antimalarials. Overall, 1954/2641 (74%) clients in the intervention arm and 539/1962 (27%) in the control arm received appropriate treatment (adjusted risk ratio 2.39 (1.69 to 3.39), P&lt;0.0001). No safety concerns were identified. CONCLUSIONS: Most patients with fever in Africa present to the private sector. In this trial, providing rapid diagnostic tests for malaria in the private drug retail sector significantly reduced dispensing of antimalarials to patients without malaria, did not reduce prescribing of antimalarials to true malaria cases, and appeared safe. Rapid diagnostic tests should be considered for the informal private drug retail sector.Registration Clinicaltrials.gov NCT01907672.</style></abstract><notes><style face="normal" font="default" size="100%">1756-1833&#xD;Ansah, Evelyn K&#xD;Narh-Bana, Solomon&#xD;Affran-Bonful, Harriet&#xD;Bart-Plange, Constance&#xD;Cundill, Bonnie&#xD;Gyapong, Margaret&#xD;Whitty, Christopher J M&#xD;MR/K012126/1/Medical Research Council/United Kingdom&#xD;Journal Article&#xD;Randomized Controlled Trial&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;BMJ. 2015 Mar 4;350:h1019. doi: 10.1136/bmj.h1019.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.bmj.com/content/bmj/350/bmj.h1019.full.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC4353311 www.icmje.org/coi_disclosure.pdf and declare: no support from any organization for the submitted work; no financial relationships with any organizations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work”</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1136/bmj.h1019</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2057</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2057</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Arena, T. R.</style></author><author><style face="normal" font="default" size="100%">Jericó Mde, C.</style></author><author><style face="normal" font="default" size="100%">de Castro, L. C.</style></author><author><style face="normal" font="default" size="100%">Castilhod, V.</style></author><author><style face="normal" font="default" size="100%">Lima, A. F.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">[Spending with unnecessary complementary tests for hypertension and diabetes in health services]</style></title><secondary-title><style face="normal" font="default" size="100%">Rev Gaucha Enferm</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Rev Gaucha Enferm</style></full-title></periodical><pages><style face="normal" font="default" size="100%">86-93</style></pages><volume><style face="normal" font="default" size="100%">35</style></volume><number><style face="normal" font="default" size="100%">4</style></number><keywords><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Cross-Sectional Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Diabetes Mellitus/*diagnosis/*economics</style></keyword><keyword><style face="normal" font="default" size="100%">Family Health</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">*Health Expenditures</style></keyword><keyword><style face="normal" font="default" size="100%">Health Services</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Hypertension/*diagnosis/*economics</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Retrospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Unnecessary Procedures/*economics</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style face="normal" font="default" size="100%">Dec</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0102-6933 (Print)&#xD;0102-6933</style></isbn><abstract><style face="normal" font="default" size="100%">The aims of this study were to analyze unnecessary laboratory exams for patients with hypertension and diabetes and to check the expenditures involved.This is an exploratory-descriptive, cross-sectional study with a quantitative approach.We used data from medical records of 293 patients registered in primary units - the Family Health Center (NSF3); secondary: School Health Center (CSE); and tertiary: Hospital das Clinicas (HC) from 2006 to 2009 in a city in Southeastern Brazil. We identified a total of 9,522 laboratory tests, of which 5.97% were unnecessary. Of these, about 58% were requested by NSF3 and 42% by CSE. Results suggest there is a lack of integration among different levels of health care, which result in misallocation of resources and unnecessary spending. Descriptors: Health expenditures. Hypertension. Diabetes mellitus. Family health. Health services.</style></abstract><notes><style face="normal" font="default" size="100%">Arena, Thiago Roberto Castellane&#xD;Jericó, Marli de Carvalho&#xD;de Castro, Liliana Cristina&#xD;Castilhod, Valéria&#xD;Lima, Antonio Fernandes Costa&#xD;English Abstract&#xD;Journal Article&#xD;Brazil&#xD;Rev Gaucha Enferm. 2014 Dec;35(4):86-93. doi: 10.1590/1983-1447.2014.04.44793.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scielo.br/j/rgenf/a/qLzwjJwLyb3BpQzCCVswdLs/?lang=en&amp;format=pdf</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1590/1983-1447.2014.04.44793</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2058</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2058</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Arnold, M.</style></author><author><style face="normal" font="default" size="100%">Moore, S. W.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Faculty of Medicine, Stellenbosch University, Parow, Cape Town, South Africa . ma@sun.ac.za</style></auth-address><titles><title><style face="normal" font="default" size="100%">Paediatric blunt abdominal trauma - are we doing too many computed tomography scans?</style></title><secondary-title><style face="normal" font="default" size="100%">S Afr J Surg</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">S Afr J Surg</style></full-title></periodical><pages><style face="normal" font="default" size="100%">26-31</style></pages><volume><style face="normal" font="default" size="100%">51</style></volume><number><style face="normal" font="default" size="100%">1</style></number><keywords><keyword><style face="normal" font="default" size="100%">Abdominal Injuries/*diagnostic imaging</style></keyword><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Child, Preschool</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Infant</style></keyword><keyword><style face="normal" font="default" size="100%">Length of Stay</style></keyword><keyword><style face="normal" font="default" size="100%">Predictive Value of Tests</style></keyword><keyword><style face="normal" font="default" size="100%">Retrospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Tomography, X-Ray Computed/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Ultrasonography</style></keyword><keyword><style face="normal" font="default" size="100%">*Unnecessary Procedures</style></keyword><keyword><style face="normal" font="default" size="100%">Wounds, Nonpenetrating/*diagnostic imaging</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2013</style></year><pub-dates><date><style face="normal" font="default" size="100%">Feb 14</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0038-2361 (Print)&#xD;0038-2361</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: Blunt abdominal trauma in childhood contributes significantly to both morbidity and mortality. Selective non-operative management of blunt abdominal trauma in children depends on both diagnostic and clinical factors. Computed tomography (CT) scanning is widely used to facilitate better management. Increased availability of CT may, however, result in its overuse in the management of blunt abdominal trauma in children, which carries significant radiation exposure risks. AIM: To evaluate the use and value of CT scanning in the overall management and outcome of blunt abdominal trauma in children in the Tygerberg Academic Hospital trauma unit, Parow, Cape Town, South Africa, before and after improved access to CT as a result of installation of a new rapid CT scanner in the trauma management area (previously the scanner had been 4 floors away). METHODS: Patients aged 0 - 13 years who were referred with blunt abdominal trauma due to vehicle-related accidents before the introduction of the new CT scanner (group 1, n=66, November 2003 - March 2009) were compared with those seen in the 1-year period after the scanner was installed (group 2, n=37, April 2009 - April 2010). Details of clinical presentation, imaging results and their influence on management were retrospectively reviewed. A follow-up group was evaluated after stricter criteria for abdominal CT scanning (viz. prior evaluation by paediatric surgical personnel) were introduced (group 3, n=14, November 2011 - May 2012) to evaluate the impact of this clinical screening on the rate of negative scans. RESULTS: There were 66 patients in group 1 and 37 in group 2. An apparent increase in CT use with increased availability was accompanied by a marked increase in negative CT scans (38.9% compared with 6.2%; p&lt;0.006). Despite a slightly higher prevalence of associated injuries in group 2, as well as a slightly longer length of hospital stay, there was a similar prevalence of intra-abdominal injuries detected in positive scans in the two groups. In addition, rates of small-bowel perforation in the two groups were similar. The rate of negative scans in group 3 was 46.2% (6/13), but all except one of these patients had a severe brain injury preventing adequate clinical evaluation of intra-abdominal injury. CONCLUSION: CT scanning for blunt abdominal trauma in children is essential in the presence of appropriate clinical indications. Ease of access probably increases availability, but the rate of negative scans may increase. Management guidelines should be in place to direct CT scanning to cases in which clinical examination and/or other modalities indicate a likelihood of intra-abdominal injury. The principle of &apos;as low (radiation) dose as reasonably achievable&apos; (ALARA) should be adhered to because of the increased radiation exposure risks in children.</style></abstract><label><style face="normal" font="default" size="100%">Included by Loai</style></label><notes><style face="normal" font="default" size="100%">Arnold, M&#xD;Moore, S W&#xD;Journal Article&#xD;South Africa&#xD;S Afr J Surg. 2013 Feb 14;51(1):26-31. doi: 10.7196/sajs.1230.</style></notes><urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.7196/sajs.1230</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2059</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2059</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Aroonpruksakul, N.</style></author><author><style face="normal" font="default" size="100%">Stimanont, T.</style></author><author><style face="normal" font="default" size="100%">Pianchob, P.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">N. Aroonpruksakul, Department of Anesthesiology, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand</style></auth-address><titles><title><style face="normal" font="default" size="100%">The prevalence of inappropriate blood tests in pediatric patients scheduled for elective surgery in Thailand: A retrospective chart review</style></title><secondary-title><style face="normal" font="default" size="100%">Asian Biomedicine</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Asian Biomedicine</style></full-title></periodical><pages><style face="normal" font="default" size="100%">809-815</style></pages><volume><style face="normal" font="default" size="100%">9</style></volume><number><style face="normal" font="default" size="100%">6</style></number><keywords><keyword><style face="normal" font="default" size="100%">adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">blood cell count</style></keyword><keyword><style face="normal" font="default" size="100%">child</style></keyword><keyword><style face="normal" font="default" size="100%">elective surgery</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">laboratory test</style></keyword><keyword><style face="normal" font="default" size="100%">major clinical study</style></keyword><keyword><style face="normal" font="default" size="100%">medical record review</style></keyword><keyword><style face="normal" font="default" size="100%">minor surgery</style></keyword><keyword><style face="normal" font="default" size="100%">preoperative evaluation</style></keyword><keyword><style face="normal" font="default" size="100%">review</style></keyword><keyword><style face="normal" font="default" size="100%">risk factor</style></keyword><keyword><style face="normal" font="default" size="100%">Thailand</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2015</style></year></dates><isbn><style face="normal" font="default" size="100%">1875-855X&#xD;1905-7415</style></isbn><abstract><style face="normal" font="default" size="100%">Background: Laboratory blood tests rarely detect any abnormalities in apparently healthy patients. Moreover, unnecessary testing may not only upset pediatric patients and their parents, but may harm patients because of overtreatment of borderline or false-positive results. Objectives: To determine the prevalence and factors correlated with inappropriate preoperative testing of pediatric patients scheduled for elective surgery. Methods: We conducted a 6-month retrospective chart review of all children &lt;15 years of age who underwent elective surgery at Siriraj Hospital in Bangkok, Thailand. Demographic and clinical data were recorded, including age, sex, physical status class according to the American Society of Anesthesiologists (ASA), underlying diseases, diagnosis, operation, service unit, and grade of surgery. The requested preoperative laboratory tests were based on the surgeon&apos;s decision. We assessed whether each test was appropriate based on the recommendations for preoperative testing from our Department of Anesthesiology. Results: We included data from 130 patients. The overall prevalence of inappropriate preoperative testing was 55%. Grade of surgery and service unit significantly affected inappropriate testing (P = 0.01 and P = 0.001 respectively). The highest prevalence of inappropriate test requests was for a complete blood count (37%), and all the risk factors, including ASA class I (P = 0.015), minor operation (P &lt; 0.001), and nonpediatric surgery unit (P &lt; 0.001), were significantly associated with this test. Conclusions: The prevalence of inappropriate preoperative testing was high, especially for healthy patients who underwent minor operations. Therefore, we recommend that surgical staff be educated to request laboratory tests only when indicated.</style></abstract><label><style face="normal" font="default" size="100%">Included by Hannah</style></label><notes><style face="normal" font="default" size="100%">L609474011&#xD;2016-04-11&#xD;2016-04-25</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.embase.com/search/results?subaction=viewrecord&amp;id=L609474011&amp;from=export</style></url><url><style face="normal" font="default" size="100%">http://dx.doi.org/10.5372/1905-7415.0906.455</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.5372/1905-7415.0906.455</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2060</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2060</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Aske, H.</style></author><author><style face="normal" font="default" size="100%">Anong, S. A.</style></author><author><style face="normal" font="default" size="100%">Roald, B.</style></author><author><style face="normal" font="default" size="100%">Salpou, D.</style></author><author><style face="normal" font="default" size="100%">Jourdan, P. M.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Faculty of Medicine, University of Oslo, Norway.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Febrile Illness and Intravenous Antimalarial Treatment at a District Hospital in Cameroon</style></title><secondary-title><style face="normal" font="default" size="100%">West Afr J Med</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">West Afr J Med</style></full-title></periodical><pages><style face="normal" font="default" size="100%">55-61</style></pages><volume><style face="normal" font="default" size="100%">34</style></volume><number><style face="normal" font="default" size="100%">1</style></number><dates><year><style face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jan-Mar</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0189-160X (Print)&#xD;0189-160x</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: Malaria is one of the most common causes of mortality worldwide. The World Health Organization (WHO) has recently recommended that treatment should be guided by a laboratory diagnosis. The aim of this study is to explore patient and health care factors associated with intravenous antimalarial treatment of malaria test-negative patients at a district hospital in a malaria endemic area. STUDY DESIGN: A cross-sectional study of 91 patients admitted for intravenous antimalarial treatment was done at a district hospital in northern Cameroon in July and August 2010. Socio-cultural and clinical factors were studied in relation to quality blood smear results. RESULTS: Thirty-two per cent of all intravenous antimalarials were administered to patients with a negative malaria test. Test negative patients older than 40 years of age received significantly more often intravenous antimalarials than the youngest patients (OR = 7.9, 95% CI = 1.9-32.4, p = 0.004). Few differential diagnoses were identified in the study population, and patients older than 30 years of age had malaria less often than the youngest patients (OR = 0.3, 95% CI = 0.08-0.9 and OR = 0.09, 95% CI = 0.02-0.4). CONCLUSION: This study supports previous reports of over-diagnosis and treatment of malaria in endemic areas. The results suggest that differential diagnoses are important, especially in adults with febrile illnesses to ensure the correct diagnosis and treatment. Further studies are needed to explore the findings and to develop strategies to improve the management of malaria and its differential diagnoses.</style></abstract><label><style face="normal" font="default" size="100%">Included by Ray</style></label><notes><style face="normal" font="default" size="100%">Aske, H&#xD;Anong, S A&#xD;Roald, B&#xD;Salpou, D&#xD;Jourdan, P M&#xD;Journal Article&#xD;Nigeria&#xD;West Afr J Med. 2015 Jan-Mar;34(1):55-61.</style></notes><urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2061</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2061</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Attard, S. M.</style></author><author><style face="normal" font="default" size="100%">Herring, A. H.</style></author><author><style face="normal" font="default" size="100%">Wang, H.</style></author><author><style face="normal" font="default" size="100%">Howard, A. G.</style></author><author><style face="normal" font="default" size="100%">Thompson, A. L.</style></author><author><style face="normal" font="default" size="100%">Adair, L. S.</style></author><author><style face="normal" font="default" size="100%">Mayer-Davis, E. J.</style></author><author><style face="normal" font="default" size="100%">Gordon-Larsen, P.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Nutrition, Gillings School of Global Public Health, UNC-Chapel Hill, Chapel Hill, NC, USA.&#xD;1] Carolina Population Center, UNC-Chapel Hill, Chapel Hill, NC, USA [2] Department of Biostatistics, Gillings School of Global Public Health, UNC-Chapel Hill, Chapel Hill, NC, USA.&#xD;National Institute of Nutrition and Food Safety, Chinese Center for Disease Control and Prevention, Beijing, China.&#xD;1] Carolina Population Center, UNC-Chapel Hill, Chapel Hill, NC, USA [2] Department of Anthropology, UNC-Chapel Hill, Chapel Hill, NC, USA.&#xD;1] Department of Nutrition, Gillings School of Global Public Health, UNC-Chapel Hill, Chapel Hill, NC, USA [2] Carolina Population Center, UNC-Chapel Hill, Chapel Hill, NC, USA.&#xD;1] Department of Nutrition, Gillings School of Global Public Health, UNC-Chapel Hill, Chapel Hill, NC, USA [2] Department of Medicine, UNC-Chapel Hill, Chapel Hill, NC, USA.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Implications of iron deficiency/anemia on the classification of diabetes using HbA1c</style></title><secondary-title><style face="normal" font="default" size="100%">Nutr Diabetes</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Nutr Diabetes</style></full-title></periodical><pages><style face="normal" font="default" size="100%">e166</style></pages><volume><style face="normal" font="default" size="100%">5</style></volume><number><style face="normal" font="default" size="100%">6</style></number><dates><year><style face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jun 22</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">2044-4052 (Print)&#xD;2044-4052</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND/OBJECTIVES: Nonglycemic factors like iron deficiency (ID) or anemia may interfere with classification of diabetes and prediabetes using hemoglobin A1c (HbA1c). However, few population-based studies of diabetes in areas with endemic ID/anemia have been conducted. We aimed to determine how mutually exclusive categories of ID alone, anemia alone and iron-deficiency anemia (IDA) were each associated with prediabetes and diabetes prevalence using fasting blood glucose (FBG) versus HbA1c in a population-based study of adults with endemic ID/anemia. SUBJECTS/METHODS: We used data from the China Health and Nutrition Survey, a longitudinal, population-based study across 228 communities within nine provinces of China. This analysis included 7308 adults seen in the 2009 survey aged 18-75 years. We used descriptive and covariate-adjusted models to examine relative risk of prediabetes and diabetes using FBG alone, HbA1c alone, HbA1c and FBG, or neither (normoglycemia) by anemia alone, ID alone, IDA or normal iron/hemoglobin. RESULTS: Approximately 65% of individuals with diabetes in our sample were concordantly classified with diabetes using both FBG and HbA1c, while 35% had a discordant diabetes classification: they were classified using either FBG or HbA1c, but not both. Fewer participants with ID alone versus normal iron/hemoglobin were classified with diabetes using HbA1c only. From covariate-adjusted, multinomial regression analyses, the adjusted prevalence of prediabetes using HbA1c only was 22% for men with anemia alone, but 13% for men with normal iron/hemoglobin. In contrast, the predicted prevalence of prediabetes using HbA1c only was 8% for women with ID alone, compared with 13% for women with normal iron/hemoglobin. CONCLUSIONS: These findings suggest potential misclassification of diabetes using HbA1c in areas of endemic ID/anemia. Estimating diabetes prevalence using HbA1c may result in under-diagnosis in women with ID and over-diagnosis in men with anemia.</style></abstract><label><style face="normal" font="default" size="100%">Included by Morty</style></label><notes><style face="normal" font="default" size="100%">Estimating diabetes prevalence using HbA1c may result in under-diagnosis in women with ID and over-diagnosis in men with anemia. 2044-4052&#xD;Attard, S M&#xD;Herring, A H&#xD;Wang, H&#xD;Howard, A-G&#xD;Thompson, A L&#xD;Adair, L S&#xD;Mayer-Davis, E J&#xD;Gordon-Larsen, P&#xD;Orcid: 0000000153224188&#xD;R01 HD030880/HD/NICHD NIH HHS/United States&#xD;K01 HD071948/HD/NICHD NIH HHS/United States&#xD;R01 HL108427/HL/NHLBI NIH HHS/United States&#xD;R24 HD050924/HD/NICHD NIH HHS/United States&#xD;P2C HD050924/HD/NICHD NIH HHS/United States&#xD;Journal Article&#xD;Nutr Diabetes. 2015 Jun 22;5(6):e166. doi: 10.1038/nutd.2015.16.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.nature.com/articles/nutd201516.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC4491857</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1038/nutd.2015.16</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2062</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2062</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Aue-Aungkul, A.</style></author><author><style face="normal" font="default" size="100%">Punyawatanasin, S.</style></author><author><style face="normal" font="default" size="100%">Natprathan, A.</style></author><author><style face="normal" font="default" size="100%">Srisomboon, J.</style></author><author><style face="normal" font="default" size="100%">Kietpeerakool, C.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.</style></auth-address><titles><title><style face="normal" font="default" size="100%">&quot;See and treat&quot; approach is appropriate in women with high-grade lesions on either cervical cytology or colposcopy</style></title><secondary-title><style face="normal" font="default" size="100%">Asian Pac J Cancer Prev</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Asian Pac J Cancer Prev</style></full-title></periodical><pages><style face="normal" font="default" size="100%">1723-6</style></pages><volume><style face="normal" font="default" size="100%">12</style></volume><number><style face="normal" font="default" size="100%">7</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Aged, 80 and over</style></keyword><keyword><style face="normal" font="default" size="100%">Cervical Intraepithelial Neoplasia/*pathology/*surgery</style></keyword><keyword><style face="normal" font="default" size="100%">Cervix Uteri/*pathology</style></keyword><keyword><style face="normal" font="default" size="100%">Colposcopy</style></keyword><keyword><style face="normal" font="default" size="100%">Electrosurgery</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Papanicolaou Test</style></keyword><keyword><style face="normal" font="default" size="100%">Thailand</style></keyword><keyword><style face="normal" font="default" size="100%">Unnecessary Procedures</style></keyword><keyword><style face="normal" font="default" size="100%">Uterine Cervical Neoplasms/*pathology/*surgery</style></keyword><keyword><style face="normal" font="default" size="100%">Vaginal Smears</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2011</style></year></dates><isbn><style face="normal" font="default" size="100%">1513-7368</style></isbn><abstract><style face="normal" font="default" size="100%">This study was undertaken to evaluate the overtreatment rate of women with abnormal cervical cytology undergoing colposcopy followed by loop electrosurgical excision procedure (LEEP), the so-called &quot;see and treat&quot; approach. Overtreatment was defined as LEEP specimens containing cervical intraepithelial neoplasia (CIN) 1 or less. In this study, medical records of 192 women with abnormal Pap smears undergoing the &quot;see and treat&quot; approach in Chiang Mai University Hospital between October 2008 and October 2010 were reviewed. The preceding Pap smears were as follows: 124 (64.6%) with high-grade squamous intraepithelial lesion (HSIL); 35 (18.2%) with atypical squamous cells cannot exclude high-grade squamous intraepithelial lesion (ASC-H); 20 (10.4%) with low-grade squamous intraepithelial lesion (LSIL); 9 (4.7%) with squamous cell carcinoma (SCCA); and 4 (2.1%) with atypical squamous cells of undetermined significance (ASC-US). Histologic results obtained from loop electrosurgical excision procedure (LEEP) were as follows: CIN 2-3, 106 (55.2%); invasive cancer, 41 (21.4%); CIN 1, 15 (7.8%); adenocarcinoma in situ (AIS), 1 (0.5%); and no lesion, 29 (15.1%). Overall, 22.9% of LEEP specimens contained CIN 1 or less. Significant predictors for overtreatment were type of preceding smears and colposcopic impression. If the &quot;see and treat&quot; approach was strictly carried out in women who had either smears or colposcopic findings revealing high-grade disease, the overtreatment rate was only 7%. Hemorrhagic complication was 6.2% and all could be treated at an outpatient department. In conclusion, the overtreatment rate of the &quot;see and treat&quot; approach in women with various degree of abnormal Pap smears is 23% which would be diminished to the acceptable rate of lower that 10% if strictly performed in those with either smears or colposcopic impressions revealing high-grade abnormality. Peri-operative LEEP complications were mild and acceptable.</style></abstract><label><style face="normal" font="default" size="100%">Included by Loai</style></label><notes><style face="normal" font="default" size="100%">2476-762x&#xD;Aue-Aungkul, Apiwat&#xD;Punyawatanasin, Sitthisack&#xD;Natprathan, Apaporn&#xD;Srisomboon, Jatupol&#xD;Kietpeerakool, Chumnan&#xD;Journal Article&#xD;Thailand&#xD;Asian Pac J Cancer Prev. 2011;12(7):1723-6.</style></notes><urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2063</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2063</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Avci, S.</style></author><author><style face="normal" font="default" size="100%">Caglayan, V.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">S. Avci, Department of Urology, University of Health Sciences Bursa Yuksek Ihtisas Training and Research Hospital, Bursa, Turkey</style></auth-address><titles><title><style face="normal" font="default" size="100%">How can we predict the active surveillance candidates meeting all Epstein criteria prior to prostate biopsy to avoid overdiagnosis?</style></title><secondary-title><style face="normal" font="default" size="100%">Aging Male</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Aging Male</style></full-title></periodical><pages><style face="normal" font="default" size="100%">1289-1295</style></pages><volume><style face="normal" font="default" size="100%">23</style></volume><number><style face="normal" font="default" size="100%">5</style></number><keywords><keyword><style face="normal" font="default" size="100%">adult</style></keyword><keyword><style face="normal" font="default" size="100%">article</style></keyword><keyword><style face="normal" font="default" size="100%">cancer patient</style></keyword><keyword><style face="normal" font="default" size="100%">gene expression</style></keyword><keyword><style face="normal" font="default" size="100%">Gleason score</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">major clinical study</style></keyword><keyword><style face="normal" font="default" size="100%">male</style></keyword><keyword><style face="normal" font="default" size="100%">prediction</style></keyword><keyword><style face="normal" font="default" size="100%">prostate biopsy</style></keyword><keyword><style face="normal" font="default" size="100%">prostate cancer</style></keyword><keyword><style face="normal" font="default" size="100%">prostate volume</style></keyword><keyword><style face="normal" font="default" size="100%">protein expression</style></keyword><keyword><style face="normal" font="default" size="100%">retrospective study</style></keyword><keyword><style face="normal" font="default" size="100%">transrectal ultrasonography</style></keyword><keyword><style face="normal" font="default" size="100%">endogenous compound</style></keyword><keyword><style face="normal" font="default" size="100%">prostate specific antigen</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2021</style></year></dates><isbn><style face="normal" font="default" size="100%">1473-0790&#xD;1368-5538</style></isbn><abstract><style face="normal" font="default" size="100%">Objective: To investigate the effectiveness of PSA, prostate volume (PV) and free-to-total PSA ratio (fPSA%) in predicting patients meeting all active surveillance criteria, including Epstein criteria. Method: Retrospective analysis was made of the data of 1901 men who underwent transrectal ultrasound (TRUS)-guided prostate biopsy in our clinic between January 2015 and December 2019. The active surveillance criteria were determined as Gleason score ≤6, when specified ≤2 positive cores with &lt;50% cancer involvement in every positive core, a clinical T1c, a PSA &lt;10ng/mL and a PSA density &lt;0.15 ng/mL/cc. Patients who met all active surveillance criteria were included in Group 1, and other patients with prostate cancer were included in Group 2. Results: The study included 336 patients with available data of age, total-free PSA levels, PV calculated by TRUS. Group 1 consisted of 82 patients and Group 2 consisted of 254 patients. PV and fPSA% were significantly higher and PSA was significantly lower in Group 1 than in Group 2. On multivariate analysis, the independent predictors were determined to be PSA and PV while fPSA% was not. Conclusion: By using PSA and PV in predicting patients meeting all active surveillance criteria, unnecessary biopsies and ultimately overdiagnosis can be reduced.</style></abstract><label><style face="normal" font="default" size="100%">Included by Morty</style></label><notes><style face="normal" font="default" size="100%">L2005084252&#xD;2020-06-02</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.embase.com/search/results?subaction=viewrecord&amp;id=L2005084252&amp;from=export</style></url><url><style face="normal" font="default" size="100%">http://dx.doi.org/10.1080/13685538.2020.1764524</style></url><url><style face="normal" font="default" size="100%">https://www.tandfonline.com/doi/pdf/10.1080/13685538.2020.1764524?needAccess=true</style></url></related-urls></urls><custom5><style face="normal" font="default" size="100%">32406325</style></custom5><electronic-resource-num><style face="normal" font="default" size="100%">10.1080/13685538.2020.1764524</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2064</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2064</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Aydoǧdu, M.</style></author><author><style face="normal" font="default" size="100%">Topbaşi Sinanoǧlu, N.</style></author><author><style face="normal" font="default" size="100%">Doǧan, N. Ö</style></author><author><style face="normal" font="default" size="100%">Oǧuzülgen, I. K.</style></author><author><style face="normal" font="default" size="100%">Demircan, A.</style></author><author><style face="normal" font="default" size="100%">Bildik, F.</style></author><author><style face="normal" font="default" size="100%">Ekim, N. N.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">M. Aydoǧdu, Gazi Üniversitesi, Göǧüs Hastaliklari Anabilim Dali, Beşevler, ANKARA, Turkey</style></auth-address><titles><title><style face="normal" font="default" size="100%">Wells score and pulmonary embolism rule out criteria in preventing over investigation of pulmonary embolism in emergency departments</style></title><secondary-title><style face="normal" font="default" size="100%">Tuberkuloz ve Toraks</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Tuberkuloz ve Toraks</style></full-title></periodical><pages><style face="normal" font="default" size="100%">12-21</style></pages><volume><style face="normal" font="default" size="100%">62</style></volume><number><style face="normal" font="default" size="100%">1</style></number><keywords><keyword><style face="normal" font="default" size="100%">D dimer</style></keyword><keyword><style face="normal" font="default" size="100%">adult</style></keyword><keyword><style face="normal" font="default" size="100%">aged</style></keyword><keyword><style face="normal" font="default" size="100%">arterial gas</style></keyword><keyword><style face="normal" font="default" size="100%">article</style></keyword><keyword><style face="normal" font="default" size="100%">blood gas analysis</style></keyword><keyword><style face="normal" font="default" size="100%">cohort analysis</style></keyword><keyword><style face="normal" font="default" size="100%">comorbidity</style></keyword><keyword><style face="normal" font="default" size="100%">computed tomographic angiography</style></keyword><keyword><style face="normal" font="default" size="100%">controlled study</style></keyword><keyword><style face="normal" font="default" size="100%">coughing</style></keyword><keyword><style face="normal" font="default" size="100%">deep vein thrombosis</style></keyword><keyword><style face="normal" font="default" size="100%">diagnostic test accuracy study</style></keyword><keyword><style face="normal" font="default" size="100%">Doppler flowmetry</style></keyword><keyword><style face="normal" font="default" size="100%">dyspnea</style></keyword><keyword><style face="normal" font="default" size="100%">electrocardiography</style></keyword><keyword><style face="normal" font="default" size="100%">emergency ward</style></keyword><keyword><style face="normal" font="default" size="100%">faintness</style></keyword><keyword><style face="normal" font="default" size="100%">female</style></keyword><keyword><style face="normal" font="default" size="100%">fever</style></keyword><keyword><style face="normal" font="default" size="100%">heart rate</style></keyword><keyword><style face="normal" font="default" size="100%">hemoptysis</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">hypocapnia</style></keyword><keyword><style face="normal" font="default" size="100%">hypoxia</style></keyword><keyword><style face="normal" font="default" size="100%">immobilization</style></keyword><keyword><style face="normal" font="default" size="100%">leg swelling</style></keyword><keyword><style face="normal" font="default" size="100%">lung embolism</style></keyword><keyword><style face="normal" font="default" size="100%">lung ventilation perfusion ratio</style></keyword><keyword><style face="normal" font="default" size="100%">major clinical study</style></keyword><keyword><style face="normal" font="default" size="100%">male</style></keyword><keyword><style face="normal" font="default" size="100%">neoplasm</style></keyword><keyword><style face="normal" font="default" size="100%">observational study</style></keyword><keyword><style face="normal" font="default" size="100%">predictive value</style></keyword><keyword><style face="normal" font="default" size="100%">pulmonary embolism rule out criteria</style></keyword><keyword><style face="normal" font="default" size="100%">pulse oximetry</style></keyword><keyword><style face="normal" font="default" size="100%">pulse rate</style></keyword><keyword><style face="normal" font="default" size="100%">retrospective study</style></keyword><keyword><style face="normal" font="default" size="100%">scoring system</style></keyword><keyword><style face="normal" font="default" size="100%">sensitivity and specificity</style></keyword><keyword><style face="normal" font="default" size="100%">sputum</style></keyword><keyword><style face="normal" font="default" size="100%">thorax pain</style></keyword><keyword><style face="normal" font="default" size="100%">thorax radiography</style></keyword><keyword><style face="normal" font="default" size="100%">venous thromboembolism</style></keyword><keyword><style face="normal" font="default" size="100%">wells score</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2014</style></year></dates><isbn><style face="normal" font="default" size="100%">0494-1373</style></isbn><abstract><style face="normal" font="default" size="100%">Introduction: Unnecessary diagnostic tests are usually ordered to most of the patients with dyspnea or pleuritic chest pain, because of the worse outcomes of missed diagnosis of pulmonary embolism (PE). To identify rates and causes of over investigation for PE and to search whether it was possible to reduce this over investigation by using Wells score and Pulmonary Embolism Rule Out Criteria (PERC). Materials and Methods: A retrospective observational cohort study performed in an emergency department of a tertiary care university hospital. All patients who were ordered diagnostic with the suspicion of PE were included in the study. They were grouped into two as PE (+) and PE (-) and compared. Results: Among 108 patients, 53 (49%) were diagnosed as PE (+) and overdiagnosis was present in 55 (51%) patients i.e., PE (-). The sensitivity of high Wells score was 43%, specificity 78%, positive predictive value 66% and negative predictive value 59%. PERC criteria found to be negative (when all of the eight criteria were fulfilled) in only five patients. The sensitivity of the test was 98%, specificity 7%, positive predictive value 50%, negative pre- dictive value 80%. When individual parameters of PERC were evaluated solely for the exclusion of PE; no &quot;leg swelling&quot; and &quot;no previous deep venous thrombosis or PE history&quot; were found significantly negatively correlated with PE diagnosis (p= 0.001, r= -0.325 and p= 0.013, r= -0.214 respectively). Conclusion: Over investigation of PE in emergency departments still remains as an important problem. In order to prevent this, the clinical prediction rules must be developed further and their use in combination should be searched in future studies.</style></abstract><notes><style face="normal" font="default" size="100%">L373001897&#xD;2014-05-13&#xD;2019-12-06</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.embase.com/search/results?subaction=viewrecord&amp;id=L373001897&amp;from=export</style></url><url><style face="normal" font="default" size="100%">http://dx.doi.org/10.5578/tt.6493</style></url></related-urls></urls><custom5><style face="normal" font="default" size="100%">24814073</style></custom5><electronic-resource-num><style face="normal" font="default" size="100%">10.5578/tt.6493</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2065</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2065</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Belozerov Iu, M.</style></author><author><style face="normal" font="default" size="100%">Osmanov, I. M.</style></author><author><style face="normal" font="default" size="100%">Magomedova Sh, M.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">[Diagnosis and classification of mitral valve prolapse in children and adolescents]</style></title><secondary-title><style face="normal" font="default" size="100%">Kardiologiia</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Kardiologiia</style></full-title></periodical><pages><style face="normal" font="default" size="100%">63-7</style></pages><volume><style face="normal" font="default" size="100%">51</style></volume><number><style face="normal" font="default" size="100%">3</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Auscultation/*standards</style></keyword><keyword><style face="normal" font="default" size="100%">Body Constitution</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Echocardiography/*standards</style></keyword><keyword><style face="normal" font="default" size="100%">False Positive Reactions</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mitral Valve/pathology/physiopathology</style></keyword><keyword><style face="normal" font="default" size="100%">*Mitral Valve</style></keyword><keyword><style face="normal" font="default" size="100%">Prolapse/classification/diagnosis/epidemiology/etiology/pathology/physiopathology</style></keyword><keyword><style face="normal" font="default" size="100%">Pedigree</style></keyword><keyword><style face="normal" font="default" size="100%">Russia/epidemiology</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2011</style></year></dates><isbn><style face="normal" font="default" size="100%">0022-9040 (Print)&#xD;0022-9040</style></isbn><abstract><style face="normal" font="default" size="100%">We examined 1734 children and adolescents with admittance diagnosis mitral valve prolapse (MVP) and confirmed its presence using accepted Framingham criteria in 32.3% of cases. Reason for overdiagnosis in other cases was incorrect interpretation of auscultation or echocardiography data. Most often MVP was familial with recessive or dominant inheritance according to genealogical analysis. Contrary to MVP in adults children and adolescents commonly had no myxomatous transformation of valves. Taking into account constitutional and physiological peculiarities of the body in children and adolescents we distinguished two forms of MVP characteristic for this age: MVP as a variant of asthenic constitution and physiological MVP. Both forms are widely spread and represent normal states for juvenile population.</style></abstract><notes><style face="normal" font="default" size="100%">Belozerov, Iu M&#xD;Osmanov, I M&#xD;Magomedova, Sh M&#xD;English Abstract&#xD;Journal Article&#xD;Russia (Federation)&#xD;Kardiologiia. 2011;51(3):63-7.</style></notes><urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2066</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2066</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Beltramino, Juan Carlos</style></author><author><style face="normal" font="default" size="100%">Sosa, Horacio</style></author><author><style face="normal" font="default" size="100%">Gamba, Natalia</style></author><author><style face="normal" font="default" size="100%">Busquets, Natalia</style></author><author><style face="normal" font="default" size="100%">Navarro, Lucas</style></author><author><style face="normal" font="default" size="100%">Virgolini, Stella</style></author><author><style face="normal" font="default" size="100%">Ricardo, Omar</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Sobrediagnóstico de amebiasis en niños con disentería</style></title><secondary-title><style face="normal" font="default" size="100%">Arch. argent. pediatr</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Arch. argent. pediatr</style></full-title></periodical><pages><style face="normal" font="default" size="100%">510-514</style></pages><volume><style face="normal" font="default" size="100%">107</style></volume><number><style face="normal" font="default" size="100%">6</style></number><keywords><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Infant</style></keyword><keyword><style face="normal" font="default" size="100%">Child, Preschool</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Amebiasis</style></keyword><keyword><style face="normal" font="default" size="100%">Dysentery, Bacillary</style></keyword><keyword><style face="normal" font="default" size="100%">Dysentery, Amebic/diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">Entamoeba histolytica</style></keyword><keyword><style face="normal" font="default" size="100%">Intestinal Diseases, Parasitic</style></keyword><keyword><style face="normal" font="default" size="100%">Cross-Sectional Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Diagnosis, Differential</style></keyword><keyword><style face="normal" font="default" size="100%">Epidemiology, Descriptive</style></keyword><keyword><style face="normal" font="default" size="100%">Observational Studies as Topic</style></keyword><keyword><style face="normal" font="default" size="100%">Statistical Analysis</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2009</style></year><pub-dates><date><style face="normal" font="default" size="100%">2009/12</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0325-0075</style></isbn><abstract><style face="normal" font="default" size="100%">Existen dos amebas, morfológicamente idénticas, cuyas diferencias determinanque una de ellas, Entamoeba histolytica, pueda ser patógena. La otra, Entamoeba dispar, es inocua.Surgió la presunción de que casos tratados como amebiasis, no lo fueran. Objetivo. Identificar E. histolytica en niños con disenterías supuestamente amebianas. Métodos. Estudio transversal y observacional realizado en Santa Fe, entre marzo de 2005 y noviembre de 2007. En niños de 2 meses a 15 años con disentería y exámenes directos con E. histolytica/dispar, se realizó ELISA para detectar la adhesina de E. histolytica (adhesina Eh) en heces.Se efectuaron coloraciones para amebas, coprocultivos y se registraron datos clínicos.Resultados. De 75 casos estudiados, 35 fueron varones y 40 mujeres, con edad (mediana) de 3 años. Todos presentaron diarreas agudas con leucocitos;73 por ciento en sangre visible microcópicamente y 27 por ciento en el estudio microscópico. Tuvieron adhesina Eh positiva, 21. En 3 de ellos se detectaron trofozoítos hematófagos.Se realizaron 15 coprocultivos, en 5 desarrolló S. flexneri de tipo S2. Otros parásitos: 6 (Blastocystis homini 5).Tuvieron adhesina Eh negativa, 54. El 19 por ciento de las coloraciones demostró E. dispar.A 44 se les realizaron coprocultivos; desarrollaron bacterias invasivas 12 casos: S. flexneri de tipo S2 (13), Shigella sp (1), C. jejuni (5), otros (3). Otros parásitos: 12 (Blastocystis hominis 9).Conclusión. En este grupo de niños con disenterías amebianas, en la mitad de los casos seidentificaron bacterias invasivas y sólo en el 28 por ciento se detectó E. histolytica en heces, con lo cual cabría esperar una prevalencia de 18-38 por ciento de casos positivos en la población [IC 95 por ciento (0,179; 0,381)].</style></abstract><urls><related-urls><url><style face="normal" font="default" size="100%">http://www.sap.org.ar/docs/publicaciones/archivosarg/2009/v107n6a07.pdf</style></url><url><style face="normal" font="default" size="100%">http://www.scielo.org.ar/pdf/aap/v107n6/v107n6a07.pdf</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2067</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2067</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Benghanem Gharbi, M.</style></author><author><style face="normal" font="default" size="100%">Elseviers, M.</style></author><author><style face="normal" font="default" size="100%">Zamd, M.</style></author><author><style face="normal" font="default" size="100%">Belghiti Alaoui, A.</style></author><author><style face="normal" font="default" size="100%">Benahadi, N.</style></author><author><style face="normal" font="default" size="100%">Trabelssi el, H.</style></author><author><style face="normal" font="default" size="100%">Bayahia, R.</style></author><author><style face="normal" font="default" size="100%">Ramdani, B.</style></author><author><style face="normal" font="default" size="100%">De Broe, M. E.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Faculty of Medicine and Pharmacy, University Hassan II, Casablanca, Morocco.&#xD;Department of Biostatistics, Center for Research and Innovation in Care, University of Antwerp, Antwerp, Belgium.&#xD;Ministry of Health, Rabat, Morocco.&#xD;Faculty of Medicine and Pharmacy, University Mohammed V, Rabat, Morocco.&#xD;University of Antwerp, Antwerp, Belgium. Electronic address: marc.debroe@uantwerpen.be.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Chronic kidney disease, hypertension, diabetes, and obesity in the adult population of Morocco: how to avoid &quot;over&quot;- and &quot;under&quot;-diagnosis of CKD</style></title><secondary-title><style face="normal" font="default" size="100%">Kidney Int</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Kidney Int</style></full-title></periodical><pages><style face="normal" font="default" size="100%">1363-71</style></pages><volume><style face="normal" font="default" size="100%">89</style></volume><number><style face="normal" font="default" size="100%">6</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Age Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Arabs</style></keyword><keyword><style face="normal" font="default" size="100%">Blood Glucose/analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Creatinine/blood</style></keyword><keyword><style face="normal" font="default" size="100%">Cross-Sectional Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Diabetes Mellitus/blood/*epidemiology/urine</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">*Glomerular Filtration Rate</style></keyword><keyword><style face="normal" font="default" size="100%">Hematuria/diagnosis/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Hypertension/blood/*epidemiology/urine</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Morocco/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/blood/*epidemiology/urine</style></keyword><keyword><style face="normal" font="default" size="100%">Prevalence</style></keyword><keyword><style face="normal" font="default" size="100%">Proteinuria/diagnosis/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Random Allocation</style></keyword><keyword><style face="normal" font="default" size="100%">Renal Insufficiency, Chronic/blood/*diagnosis/*epidemiology/urine</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Sex Factors</style></keyword><keyword><style face="normal" font="default" size="100%">*Morocco</style></keyword><keyword><style face="normal" font="default" size="100%">*chronic kidney disease</style></keyword><keyword><style face="normal" font="default" size="100%">*diabetes</style></keyword><keyword><style face="normal" font="default" size="100%">*hypertension</style></keyword><keyword><style face="normal" font="default" size="100%">*obesity</style></keyword><keyword><style face="normal" font="default" size="100%">*overdiagnosis of CKD</style></keyword><keyword><style face="normal" font="default" size="100%">*underdiagnosis of CKD</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jun</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0085-2538</style></isbn><abstract><style face="normal" font="default" size="100%">The prevalence of hypertension, diabetes, obesity, and chronic kidney disease (CKD) in an adult Arabic-Berber population was investigated according to 2012 KDIGO guidelines. A stratified, randomized, representative sample of 10,524 participants was obtained. Weight, height, blood pressure, proteinuria (dipstick), plasma creatinine, estimated glomerular filtration rate, and fasting glycemia were measured. Abnormal results were controlled within 2 weeks; eGFR was retested at 3, 6, and 12 months. The population adjusted prevalences were 16.7% hypertension, 23.2% obesity, 13.8% glycemia, 1.6% for eGFR under 60 ml/min/1.73 m(2) and confirmed proteinuria 1.9% and hematuria 3.4%. Adjusted prevalence of CKD was 5.1%; distribution over KDIGO stages: CKD1: 17.8%; CKD2: 17.2%; CKD3: 52.5% (3A: 40.2%; 3B: 12.3%); CKD4: 4.4%; CKD5: 7.2%. An eGFR distribution within the sex and age categories was constructed using the third percentile as threshold for decreased eGFR. A single threshold (under 60 ml/min/1.73 m(2)) eGFR classifying CKD3-5 leads to &quot;overdiagnosis&quot; of CKD3A in the elderly, overt &quot;underdiagnosis&quot; in younger individuals with eGFR over 60 ml/min/1.73 m(2), below the third percentile, and no proteinuria. By using the KDIGO guidelines in a correct way, &quot;kidney damage&quot; (confirmed proteinuria, hematuria) and the demonstration of chronicity of decreased eGFR &lt;60 ml/min/1.73 m(2), combined with the third percentile as a cutoff for the normality of eGFR for age and sex, overcome false positives and negatives, substantially decrease CKD3A prevalence, and greatly increase the accuracy of identifying CKD.</style></abstract><label><style face="normal" font="default" size="100%">Included by Hannah</style></label><notes><style face="normal" font="default" size="100%">1523-1755&#xD;Benghanem Gharbi, Mohammed&#xD;Elseviers, Monique&#xD;Zamd, Mohamed&#xD;Belghiti Alaoui, Abdelali&#xD;Benahadi, Naïma&#xD;Trabelssi, El Hassane&#xD;Bayahia, Rabia&#xD;Ramdani, Benyounès&#xD;De Broe, Marc E&#xD;Journal Article&#xD;Observational Study&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Kidney Int. 2016 Jun;89(6):1363-71. doi: 10.1016/j.kint.2016.02.019. Epub 2016 Apr 13.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.kidney-international.org/article/S0085-2538(16)00369-0/pdf</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1016/j.kint.2016.02.019</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2068</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2068</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Bhattacharyya, A.</style></author><author><style face="normal" font="default" size="100%">Chatterjee, C.</style></author><author><style face="normal" font="default" size="100%">Chatterjee, S.</style></author><author><style face="normal" font="default" size="100%">Dasgupta, S.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Community Medicine, Calcutta National Medical College, Kolkata, India.</style></auth-address><titles><title><style face="normal" font="default" size="100%">A Comparative Study of the Management Decisions by IMNCI Algorithm and by Pediatricians of a Teaching Hospital for the Children Between 2 Months to 5 Years</style></title><secondary-title><style face="normal" font="default" size="100%">Indian J Community Med</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Indian J Community Med</style></full-title></periodical><pages><style face="normal" font="default" size="100%">174-9</style></pages><volume><style face="normal" font="default" size="100%">37</style></volume><number><style face="normal" font="default" size="100%">3</style></number><keywords><keyword><style face="normal" font="default" size="100%">Imnci</style></keyword><keyword><style face="normal" font="default" size="100%">Kappa</style></keyword><keyword><style face="normal" font="default" size="100%">validation study</style></keyword><keyword><style face="normal" font="default" size="100%">weighted kappa</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2012</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jul</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0970-0218 (Print)&#xD;0970-0218</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: Integrated management of neonatal and childhood illness (IMNCI) is already operational in many states of India, but there are very few studies in Indian scenario comparing its validity and reliability with the pediatricians&apos; decisions. OBJECTIVES: 1) To compare the IMNCI decision with the decision of pediatricians; 2) to assess the significance of multiple presenting symptoms in the IMNCI algorithm. MATERIALS AND METHODS: The study was conducted among the sick children between 2 months to 5 years presented in pediatric department from January to March 2009. The IMNCI decision was compared with pediatrician&apos;s decisions by percent agreement, Kappa and weighted Kappa with the aids of SPSS version 10. RESULTS: The overall diagnostic agreement between IMNCI algorithm and pediatrician&apos;s decisions was 36.64%, (Kappa 0.16 and weighted Kappa 0.29) with 51.15% over diagnosis and 12.21% under diagnosis. The importance given by IMNCI algorithm in cases of multiple presenting symptoms was also reflected as it was evident that 37.50% children presented with three symptoms were categorized as red, whereas it was 28.57% and 11.67% for those presented with two and one symptom, respectively, (P &lt; 0.0001). Pediatricians also gave importance for presence of multiple symptoms by considering 50% as admissible in the group presented with three symptoms, 30.16% in the group presented with two symptoms, and 16.67% in the group presented with only one symptom. The association was also statistically significant (P = 0.018). CONCLUSION: Diagnostic discordance is seen mainly due to over diagnosis of all fever cases as malaria. Importance of presence of comorbidities was also reflected.</style></abstract><label><style face="normal" font="default" size="100%">Included by Eman</style></label><notes><style face="normal" font="default" size="100%">1998-3581&#xD;Bhattacharyya, Agnihotri&#xD;Chatterjee, Chitra&#xD;Chatterjee, Sukanta&#xD;Dasgupta, Samir&#xD;Journal Article&#xD;Indian J Community Med. 2012 Jul;37(3):174-9. doi: 10.4103/0970-0218.99923.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ijcm.org.in/article.asp?issn=0970-0218;year=2012;volume=37;issue=3;spage=174;epage=179;aulast=Bhattacharyya</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC3483511</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.4103/0970-0218.99923</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2069</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2069</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Blinov, N. N.</style></author><author><style face="normal" font="default" size="100%">Anisimov, V. V.</style></author><author><style face="normal" font="default" size="100%">Leonchuk, A. D.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">[The under- and overdiagnosis of primary skin melanomas]</style></title><secondary-title><style face="normal" font="default" size="100%">Vopr Onkol</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Vopr Onkol</style></full-title></periodical><pages><style face="normal" font="default" size="100%">201-5</style></pages><volume><style face="normal" font="default" size="100%">36</style></volume><number><style face="normal" font="default" size="100%">2</style></number><keywords><keyword><style face="normal" font="default" size="100%">Cancer Care Facilities</style></keyword><keyword><style face="normal" font="default" size="100%">Diagnosis, Differential</style></keyword><keyword><style face="normal" font="default" size="100%">Diagnostic Errors</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Melanoma/*diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">Russia</style></keyword><keyword><style face="normal" font="default" size="100%">Skin Abnormalities</style></keyword><keyword><style face="normal" font="default" size="100%">Skin Neoplasms/*diagnosis</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">1990</style></year></dates><isbn><style face="normal" font="default" size="100%">0507-3758 (Print)&#xD;0507-3758</style></isbn><abstract><style face="normal" font="default" size="100%">The analysis of clinico-morphological data on 10123 cases of tumor and malformation of the skin seen at The N. N. Petrov Research Institute of Oncology of the USSR Ministry of Health showed primary skin melanoma to be underdiagnosed in 30.6% of cases and overdiagnosed in 60.1%. Complex pigmented nevus, pigmented basal-cell papilloma, basalioma, hemangioma and angiofibroma may simulate primary skin melanoma which accounts for misdiagnosis.</style></abstract><notes><style face="normal" font="default" size="100%">Blinov, N N&#xD;Anisimov, V V&#xD;Leonchuk, A D&#xD;English Abstract&#xD;Journal Article&#xD;Russia (Federation)&#xD;Vopr Onkol. 1990;36(2):201-5.</style></notes><urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2070</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2070</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Bohara, T. P.</style></author><author><style face="normal" font="default" size="100%">Laudari, U.</style></author><author><style face="normal" font="default" size="100%">Thapa, A.</style></author><author><style face="normal" font="default" size="100%">Rupakheti, S.</style></author><author><style face="normal" font="default" size="100%">Joshi, M. R.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Surgery, Kathmandu Medical College Teaching Hospital, Sinamangal, Kathmandu, Nepal.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Appropriateness of Indications of Upper Gastrointestinal Endoscopy and its Association With Positive Finding</style></title><secondary-title><style face="normal" font="default" size="100%">JNMA J Nepal Med Assoc</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">JNMA J Nepal Med Assoc</style></full-title></periodical><pages><style face="normal" font="default" size="100%">504-509</style></pages><volume><style face="normal" font="default" size="100%">56</style></volume><number><style face="normal" font="default" size="100%">209</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Cross-Sectional Studies</style></keyword><keyword><style face="normal" font="default" size="100%">*Endoscopy, Gastrointestinal/methods/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">*Gastrointestinal Diseases/diagnosis/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">*Medical Overuse/prevention &amp; control/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Nepal/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Practice Guidelines as Topic</style></keyword><keyword><style face="normal" font="default" size="100%">Referral and Consultation</style></keyword><keyword><style face="normal" font="default" size="100%">Unnecessary Procedures/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Upper Gastrointestinal Tract/diagnostic imaging</style></keyword><keyword><style face="normal" font="default" size="100%">appropriateness</style></keyword><keyword><style face="normal" font="default" size="100%">endoscopy</style></keyword><keyword><style face="normal" font="default" size="100%">guidelines</style></keyword><keyword><style face="normal" font="default" size="100%">indications.</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jan-Feb</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0028-2715 (Print)&#xD;0028-2715</style></isbn><abstract><style face="normal" font="default" size="100%">INTRODUCTION: Upper Gastrointestinal Endoscopy is a frequently advised investigation for upper abdominal symptoms. Studies have questioned the appropriateness of indications for upper gastrointestinal endoscopy and have shown that inappropriate indications range from 5% to 49%. The unnecessary upper gastrointestinal endoscopy expose patients to the risk. The number of upper gastrointestinal endoscopy is rising in our region and we assume so is the number of unnecessary upper gastrointestinal endoscopy. With an aim to find out the appropriateness of the indications of upper gastrointestinal endoscopy and compare its association with positive findings, we conducted a cross-sectional descriptive study. METHODS: All patients undergoing diagnostic upper gastrointestinal endoscopy during study period were included in the study. Appropriateness of indications for upper gastrointestinal endoscopy was defined as per American Society for Gastrointestinal Endoscopy criteria as &quot;appropriate&quot; and &quot;inappropriate&quot;. Upper gastrointestinal endoscopy findings were classified as &quot;significant&quot; and &quot;insignificant&quot; based on endoscopy findings. The extent of this association between appropriateness of indications and upper gastrointestinal endoscopy findings was expressed as the odds ratio of finding a relevant diagnosis in patients with an &apos;&apos;appropriate&apos;&apos; indication compared with those with an &apos;inappropriate&apos;&apos; indication. RESULTS: Seventy-nine patients were included in the study. Fifty- two (65.8%) of the indications were considered appropriate as per American Society for Gastrointestinal Endoscopy guidelines. Thirty-three (63.5%) of the appropriate indications has clinically significant finding as compared to seven (25.9%) of inappropriate indication with an odds ratio of 4.962 (95% CI:1.773 - 13.890, P=0.002) which is statistically significant. CONCLUSIONS: Appropriate indications have significantly higher rates of clinically significant findings. Use of guidelines may decrease the number of unnecessary procedures.</style></abstract><notes><style face="normal" font="default" size="100%">Bohara, Tanka Prasad&#xD;Laudari, Uttam&#xD;Thapa, Abhishek&#xD;Rupakheti, Shail&#xD;Joshi, Mukund Raj&#xD;Journal Article&#xD;Nepal&#xD;JNMA J Nepal Med Assoc. 2018 Jan-Feb;56(209):504-509.</style></notes><urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2071</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2071</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Borges, Akdm</style></author><author><style face="normal" font="default" size="100%">Miranda-Filho, A.</style></author><author><style face="normal" font="default" size="100%">Koifman, S.</style></author><author><style face="normal" font="default" size="100%">Koifman, R. J.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Anne Karin da Mota Borges, Sérgio Koifman,† and Rosalina Jorge Koifman, National Public Health School, Oswaldo Cruz Foundation; Anne Karin da Mota Borges, Brazilian National Cancer Institute, Rio de Janeiro, Brazil; and Adalberto Miranda-Filho, International Agency for Research on Cancer, Lyon, France.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Thyroid Cancer Incidences From Selected South America Population-Based Cancer Registries: An Age-Period-Cohort Study</style></title><secondary-title><style face="normal" font="default" size="100%">J Glob Oncol</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">J Glob Oncol</style></full-title></periodical><pages><style face="normal" font="default" size="100%">1-11</style></pages><volume><style face="normal" font="default" size="100%">4</style></volume><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Brazil/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Cohort Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Colombia/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Costa Rica/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Ecuador/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Incidence</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Registries</style></keyword><keyword><style face="normal" font="default" size="100%">Thyroid Neoplasms/*epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style face="normal" font="default" size="100%">Sep</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">2378-9506</style></isbn><abstract><style face="normal" font="default" size="100%">PURPOSE: The incidence of thyroid cancer (TC) has increased substantially worldwide. However, there is a lack of knowledge about age-period-cohort (APC) effects on incidence rates in South American countries. This study describes the TC incidence trends and analyzes APC effects in Cali, Colombia; Costa Rica; Goiânia, Brazil; and Quito, Ecuador. MATERIALS AND METHODS: Data were obtained from the Cancer Incidence in Five Continents series, and the crude and age-standardized incidence rates were calculated. Trends were assessed using the estimated annual percentage change, and APC models were estimated using Poisson regression for individuals between age 20 and 79 years. RESULTS: An increasing trend in age-standardized incidence rates was observed among women from Goiânia (9.2%), Costa Rica (5.7%), Quito (4.0%), and Cali (3.4%), and in men from Goiânia (10.0%) and Costa Rica (3.4%). The APC modeling showed that there was a period effect in all regions and for both sexes. Increasing rate ratios were observed among women over the periods. The best fit model was the APC model in women from all regions and in men from Quito, whereas the age-cohort model showed a better fit in men from Cali and Costa Rica, and the age-drift model showed a better fit among men from Goiânia. CONCLUSION: These findings suggest that overdiagnosis is a possible explanation for the observed increasing pattern of TC incidence. However, some environmental exposures may also have contributed to the observed increase.</style></abstract><label><style face="normal" font="default" size="100%">Included by Eman</style></label><notes><style face="normal" font="default" size="100%">2378-9506&#xD;Borges, Anne Karin da Mota&#xD;Miranda-Filho, Adalberto&#xD;Koifman, Sérgio&#xD;Koifman, Rosalina Jorge&#xD;Journal Article&#xD;J Glob Oncol. 2018 Sep;4:1-11. doi: 10.1200/JGO.17.00024. Epub 2017 Aug 21.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180755/pdf/JGO.17.00024.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC6180755</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1200/jgo.17.00024</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2072</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2072</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Borovkov, N. N.</style></author><author><style face="normal" font="default" size="100%">Matusova, A. P.</style></author><author><style face="normal" font="default" size="100%">Bubel, M. S.</style></author><author><style face="normal" font="default" size="100%">Velikovskaia, L. M.</style></author><author><style face="normal" font="default" size="100%">Ivanchenko, EIu</style></author><author><style face="normal" font="default" size="100%">Ivanova, I. M.</style></author><author><style face="normal" font="default" size="100%">Kravets, K. F.</style></author><author><style face="normal" font="default" size="100%">Utrobina, S. A.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">[The automated diagnosis of different forms of ischemic heart disease in the practice of a telecardiology diagnostic center]</style></title><secondary-title><style face="normal" font="default" size="100%">Ter Arkh</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Ter Arkh</style></full-title></periodical><pages><style face="normal" font="default" size="100%">37-40</style></pages><volume><style face="normal" font="default" size="100%">62</style></volume><number><style face="normal" font="default" size="100%">8</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">*Cardiac Care Facilities</style></keyword><keyword><style face="normal" font="default" size="100%">Coronary Disease/classification/*diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">Electrocardiography/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Mathematics</style></keyword><keyword><style face="normal" font="default" size="100%">Referral and Consultation</style></keyword><keyword><style face="normal" font="default" size="100%">Russia</style></keyword><keyword><style face="normal" font="default" size="100%">Telemetry/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Telephone</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">1990</style></year></dates><isbn><style face="normal" font="default" size="100%">0040-3660 (Print)&#xD;0040-3660</style></isbn><abstract><style face="normal" font="default" size="100%">The data of the authors&apos; work based on the experience gained with 36,500 telecardiological consultations provided within the framework of the counselling center point to the importance of taking into consideration, in addition to the ECG readings, of the clinical data on the patient to formulate the final diagnosis. In order to obtain formalized clinical information, a coding chart including 19 signs with regard to the gradation in the monotonously increasing extent of derangements has been elaborated. The mathematic maintenance of the work using algorithms of image recognition made it possible to derive a linear formula for computing the magnitude of the total diagnostic index. According to its magnitude the patient&apos;s pathology can be attributed to one of the three classes: 0--no coronary heart disease. I--steady angina pectoris, II--acute coronary heart disease. Judging from the examination sequence the percentage of errors does not exceed 8.3% with a tendency towards overdiagnosis of coronary heart disease.</style></abstract><label><style face="normal" font="default" size="100%">Included by Loai</style></label><notes><style face="normal" font="default" size="100%">Borovkov, N N&#xD;Matusova, A P&#xD;Bubel&apos;, M S&#xD;Velikovskaia, L M&#xD;Ivanchenko, E Iu&#xD;Ivanova, I M&#xD;Kravets, K F&#xD;Utrobina, S A&#xD;Case Reports&#xD;English Abstract&#xD;Journal Article&#xD;Russia (Federation)&#xD;Ter Arkh. 1990;62(8):37-40.</style></notes><urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2073</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2073</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Borrego, Luís Miguel</style></author><author><style face="normal" font="default" size="100%">Couto, Mariana</style></author><author><style face="normal" font="default" size="100%">Almeida, Isabel</style></author><author><style face="normal" font="default" size="100%">Pimenta, Lara</style></author><author><style face="normal" font="default" size="100%">Matos, Sara</style></author><author><style face="normal" font="default" size="100%">Almeida, Mário Morais</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Avaliação da função respiratória: comparação entre valores de referência percentuais fixos e o 5º percentil para diagnóstico de obstrução das vias aéreas</style></title><secondary-title><style face="normal" font="default" size="100%">Braz. j. allergy immunol</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Braz. j. allergy immunol</style></full-title></periodical><pages><style face="normal" font="default" size="100%">229-235</style></pages><volume><style face="normal" font="default" size="100%">1</style></volume><number><style face="normal" font="default" size="100%">4</style></number><keywords><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Aged, 80 and over</style></keyword><keyword><style face="normal" font="default" size="100%">Airway Obstruction</style></keyword><keyword><style face="normal" font="default" size="100%">Asthma</style></keyword><keyword><style face="normal" font="default" size="100%">Diagnostic Techniques and Procedures</style></keyword><keyword><style face="normal" font="default" size="100%">Respiratory Tract Diseases</style></keyword><keyword><style face="normal" font="default" size="100%">Methods</style></keyword><keyword><style face="normal" font="default" size="100%">Patients</style></keyword><keyword><style face="normal" font="default" size="100%">Retrospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Techniques</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2013</style></year><pub-dates><date><style face="normal" font="default" size="100%">2013/08</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">2318-5015</style></isbn><abstract><style face="normal" font="default" size="100%">Introdução: Têm sido utilizados critérios fixos para avaliação funcional de doentes com patologia respiratória. É atualmente recomendado pelas orientações internacionais a utilização preferencial do limite inferior do normal (LIN) e limite superior do normal (LSN) (inferior ou superior ao 5º percentil). Objetivo: Comparar os resultados das provas de função respiratória(PFR), utilizando os valores percentuais fixos versus 5º percentil (método de referência), como limites da normalidade, no diagnóstico funcional de obstrução das vias aéreas. Métodos: Análise retrospetiva dos registos de PFR (espirometria e pletismografia corporal) efetuados pelos autores em 2011. Foi avaliada a concordância entre os dois métodos na amostra global, sendoos doentes distribuídos por faixas etárias. Posteriormente foram selecionadas as PFR com razãoVEF1/CV &amp;lt; LIN. Nestas, foram analisados os parâmetros VEF1, CVF, CPT e VR quando considerados o 5º percentil versus valores percentuais fixos. A análise estatística for realizada utilizando-seo kappa de Cohen. Resultados: Em 2011, 1.358 indivíduos realizaram PFR. Foram excluídos 8por dados incompletos. De forma geral, o grau de concordância entre os dois critérios foi bom(valor de Kappa = 0,655±0,035). Entretanto, entre os 124 doentes que apresentavam obstrução pelo LIN, 32 (26%) tiveram um teste normal pelo cut-off de 0,70, pelo que seriam erroneamente sub diagnosticados. Este fato foi verificado apenas nas faixas etárias mais jovens, enquanto nos grupos etários mais idosos se observou uma elevada taxa de sobre diagnóstico (51 indivíduos,36%). Entre os doentes com obstrução, a concordância para os restantes parâmetros foi boa,exceto para a hiper insuflação diagnosticada por CPT. Conclusão: A utilização de valores percentuais fixos para diagnóstico de obstrução resulta em elevada taxa de subdiagnóstico em idades jovens e sobrediagnóstico em idade avançadas.&#xD;Introduction: Fixed criteria have been traditionally used in the functional characterization ofpatients with respiratory disease. International guidelines currently recommend the preferentialuse of the lower limit of normal (LLN) and the upper limit of normal (ULN) (below or above the5th percentile). Objective: To compare the results of lung function (LF) tests obtained in clinicalpractice for the diagnosis of airway obstruction using fixed percentage values vs. the 5th percentile(reference standard) as normality limit. Methods: LF tests (spirometry and body plethysmography)performed in 2011 by the authors were retrospectively analyzed. Concordance between bothmethods in the global sample was evaluated, and data were analyzed according to age group.Patients meeting criteria for airway obstruction (FEV1/VC ratio &amp;lt; LLN) were selected and had thefollowing variables analyzed considering the 5th percentile vs. fixed percentage values: FEV1/VC,FEV1, FVC, TLC, and RV. Statistical analysis was performed using Cohens kappa. Results: Over the year 2011, 1,358 subjects underwent LF tests; eight were excluded due to incomplete data.Overall, the concordance rate between the two criteria was good (kappa value = 0.655±0.035).However, of the 124 patients diagnosed with obstruction using the LLN, 32 (26%) showed a normaltest using the 0.70 cut-off, and would therefore be underdiagnosed. These results were foundonly in younger age groups, while in older patients a high rate of overdiagnosis was observed (51subjects, 36%). Among patients diagnosed with airway obstruction, concordance between the twocriteria was good for the remaining parameters, except for hyperinflation diagnosed with TLC.Conclusion: The use of fixed percentage values in the diagnosis of airway obstruction leads toa high rate of underdiagnosis in younger patients and overdiagnosis in older ones.</style></abstract><urls><related-urls><url><style face="normal" font="default" size="100%">http://www.bjai.org.br/audiencia_pdf.asp?aid2=647&amp;amp;nomeArquivo=v1n4a08.pdf</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2074</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2074</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Bostan, H.</style></author><author><style face="normal" font="default" size="100%">Sencar, M. E.</style></author><author><style face="normal" font="default" size="100%">Calapkulu, M.</style></author><author><style face="normal" font="default" size="100%">Hepsen, S.</style></author><author><style face="normal" font="default" size="100%">Duger, H.</style></author><author><style face="normal" font="default" size="100%">Ozturk Unsal, I.</style></author><author><style face="normal" font="default" size="100%">Ozbek, M.</style></author><author><style face="normal" font="default" size="100%">Cakal, E.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">H. Bostan, Department of Endocrinology and Metabolism, Diskapi Yildirim Beyazit Training and Research Hospital, Ziraat Mahallesi, Şht. Ömer Halisdemir Blv No. 1, Altlndaǧ/Ankara, Turkey</style></auth-address><titles><title><style face="normal" font="default" size="100%">Two Important Issues in Subacute Thyroiditis Management: Delayed Diagnosis and Inappropriate Use of Antibiotics</style></title><secondary-title><style face="normal" font="default" size="100%">European Thyroid Journal</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">European Thyroid Journal</style></full-title></periodical><keywords><keyword><style face="normal" font="default" size="100%">adult</style></keyword><keyword><style face="normal" font="default" size="100%">article</style></keyword><keyword><style face="normal" font="default" size="100%">awareness</style></keyword><keyword><style face="normal" font="default" size="100%">controlled study</style></keyword><keyword><style face="normal" font="default" size="100%">delayed diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">diagnostic error</style></keyword><keyword><style face="normal" font="default" size="100%">drug overdose</style></keyword><keyword><style face="normal" font="default" size="100%">drug therapy</style></keyword><keyword><style face="normal" font="default" size="100%">ear</style></keyword><keyword><style face="normal" font="default" size="100%">echography</style></keyword><keyword><style face="normal" font="default" size="100%">emergency physician</style></keyword><keyword><style face="normal" font="default" size="100%">female</style></keyword><keyword><style face="normal" font="default" size="100%">general practitioner</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">internal medicine</style></keyword><keyword><style face="normal" font="default" size="100%">jaw</style></keyword><keyword><style face="normal" font="default" size="100%">laboratory test</style></keyword><keyword><style face="normal" font="default" size="100%">major clinical study</style></keyword><keyword><style face="normal" font="default" size="100%">male</style></keyword><keyword><style face="normal" font="default" size="100%">neck pain</style></keyword><keyword><style face="normal" font="default" size="100%">prescription</style></keyword><keyword><style face="normal" font="default" size="100%">retrospective study</style></keyword><keyword><style face="normal" font="default" size="100%">subacute thyroiditis</style></keyword><keyword><style face="normal" font="default" size="100%">antibiotic agent</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2021</style></year></dates><isbn><style face="normal" font="default" size="100%">2235-0802&#xD;2235-0640</style></isbn><abstract><style face="normal" font="default" size="100%">Background: Subacute thyroiditis (SAT) is a rare inflammatory disease of the thyroid gland. It has been noticed that patients with a diagnosis of SAT visit more other clinics and receive antibiotics unnecessarily. Therefore, the aim of this study was to reveal the degree of delay in the diagnosis of SAT, prediagnosis antibiotic use rates, and the awareness of clinics for the diagnosis of SAT. Methods: A total of 121 patients with SAT were enrolled in the study. A retrospective analysis was made of the history of patient symptoms during the diagnosis, which physicians they visited, antibiotic use, laboratory test results, and ultrasonographic findings. Results: The median age of the patients was 41 years. Neck pain radiating to the jaw/ear was seen in most patients (71.1%). The median time from symptom onset to a diagnosis of SAT was 23 days (range, 6-70 days). Antibiotics were erroneously prescribed to 71 patients (58.7%) before the diagnosis. The median time to diagnosis was 28 days in patients using antibiotics and 20 days in the group not using antibiotics (p &lt; 0.001). Two or more physicians had been visited before SAT diagnosis by 89 (73.6%) patients, and more antibiotics were prescribed to these patients than the group who visited fewer physicians (p &lt; 0.05). The frequency of prescribing antibiotics by physicians was 73.7% by emergency physicians, 53.1% by family doctors, 51.1% by ENT specialists, and 35.4% by internal medicine specialists. Conclusion: The diagnosis of SAT is often delayed, and misdiagnosis leads to erroneous antibiotic overuse. Physicians should increase their awareness of the diagnosis of SAT in patients with neck pain.</style></abstract><notes><style face="normal" font="default" size="100%">L634641099&#xD;2021-04-07</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.embase.com/search/results?subaction=viewrecord&amp;id=L634641099&amp;from=export</style></url><url><style face="normal" font="default" size="100%">http://dx.doi.org/10.1159/000513745</style></url><url><style face="normal" font="default" size="100%">https://www.karger.com/Article/Abstract/513745</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1159/000513745</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2075</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2075</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Bozdag, H.</style></author><author><style face="normal" font="default" size="100%">Guzin, K.</style></author><author><style face="normal" font="default" size="100%">Gocmen, A.</style></author><author><style face="normal" font="default" size="100%">Kabaca, S.</style></author><author><style face="normal" font="default" size="100%">Usta, A.</style></author><author><style face="normal" font="default" size="100%">Akdeniz Duran, E.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">H. Bozdag, Department of Obstetrics and Gynecology, Göztepe Teaching and Research Hospital, İstanbul Medeniyet University Göztepe Teaching and Research Hospital, Doktor erkin caddesi. Kadıkoy, Istanbul, Turkey</style></auth-address><titles><title><style face="normal" font="default" size="100%">The diagnostic value of frozen section for borderline ovarian tumours</style></title><secondary-title><style face="normal" font="default" size="100%">Journal of Obstetrics and Gynaecology</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Journal of Obstetrics and Gynaecology</style></full-title></periodical><pages><style face="normal" font="default" size="100%">626-630</style></pages><volume><style face="normal" font="default" size="100%">36</style></volume><number><style face="normal" font="default" size="100%">5</style></number><keywords><keyword><style face="normal" font="default" size="100%">CA 125 antigen</style></keyword><keyword><style face="normal" font="default" size="100%">adult</style></keyword><keyword><style face="normal" font="default" size="100%">article</style></keyword><keyword><style face="normal" font="default" size="100%">borderline ovarian tumor</style></keyword><keyword><style face="normal" font="default" size="100%">cancer surgery</style></keyword><keyword><style face="normal" font="default" size="100%">clinical feature</style></keyword><keyword><style face="normal" font="default" size="100%">cohort analysis</style></keyword><keyword><style face="normal" font="default" size="100%">controlled study</style></keyword><keyword><style face="normal" font="default" size="100%">cystectomy</style></keyword><keyword><style face="normal" font="default" size="100%">diagnostic accuracy</style></keyword><keyword><style face="normal" font="default" size="100%">diagnostic test accuracy study</style></keyword><keyword><style face="normal" font="default" size="100%">diagnostic value</style></keyword><keyword><style face="normal" font="default" size="100%">female</style></keyword><keyword><style face="normal" font="default" size="100%">frozen section</style></keyword><keyword><style face="normal" font="default" size="100%">gold standard</style></keyword><keyword><style face="normal" font="default" size="100%">histology</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">major clinical study</style></keyword><keyword><style face="normal" font="default" size="100%">middle aged</style></keyword><keyword><style face="normal" font="default" size="100%">ovariectomy</style></keyword><keyword><style face="normal" font="default" size="100%">ovary tumor</style></keyword><keyword><style face="normal" font="default" size="100%">predictive value</style></keyword><keyword><style face="normal" font="default" size="100%">priority journal</style></keyword><keyword><style face="normal" font="default" size="100%">retrospective study</style></keyword><keyword><style face="normal" font="default" size="100%">sensitivity and specificity</style></keyword><keyword><style face="normal" font="default" size="100%">tumor volume</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2016</style></year></dates><isbn><style face="normal" font="default" size="100%">1364-6893&#xD;0144-3615</style></isbn><abstract><style face="normal" font="default" size="100%">Borderline ovarian tumours (BOTs) are characterised histologically by a low degree of cellular proliferation and nuclear atypia in the absence of infiltrative growth or stromal invasion. Surgical treatment has been a crucial component of BOT therapy. Surgical decisions are established intraoperatively via the frozen section. We evaluated the accuracy of frozen section diagnosis. The rate of correct diagnosis, underdiagnosis and overdiagnosis of BOTs with frozen sections was 78%, 17% and 5%, respectively. The sensitivity and positive predictive values for the diagnosis of BOTs with frozen sections were 82.3% and 93.3%, respectively. The positive likelihood ratio was 0.82 (95% CI: 0.85–0.96). The histological classification of BOTs had a significant effect on the accuracy of diagnosis (p = 0.001). Frozen section diagnosis is not suitable to be considered as the gold standard for a definitive diagnosis. Clinicians should be aware that using frozen sections is insufficient for the accurate staging of BOTs.</style></abstract><notes><style face="normal" font="default" size="100%">L607882323&#xD;2016-01-28&#xD;2016-07-05</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.embase.com/search/results?subaction=viewrecord&amp;id=L607882323&amp;from=export</style></url><url><style face="normal" font="default" size="100%">http://dx.doi.org/10.3109/01443615.2015.1133574</style></url><url><style face="normal" font="default" size="100%">https://www.tandfonline.com/doi/pdf/10.3109/01443615.2015.1133574?needAccess=true</style></url></related-urls></urls><custom5><style face="normal" font="default" size="100%">26790979</style></custom5><electronic-resource-num><style face="normal" font="default" size="100%">10.3109/01443615.2015.1133574</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2076</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2076</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Bruxvoort, K.</style></author><author><style face="normal" font="default" size="100%">Festo, C.</style></author><author><style face="normal" font="default" size="100%">Thwing, J.</style></author><author><style face="normal" font="default" size="100%">Thomson, R.</style></author><author><style face="normal" font="default" size="100%">Kalolella, A.</style></author><author><style face="normal" font="default" size="100%">Nchimbi, H.</style></author><author><style face="normal" font="default" size="100%">Taylor, M.</style></author><author><style face="normal" font="default" size="100%">Goodman, C.</style></author><author><style face="normal" font="default" size="100%">Patrick Kachur, S.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">K. Bruxvoort, London School of Hygiene and Tropical Medicine, London, United Kingdom</style></auth-address><titles><title><style face="normal" font="default" size="100%">Over and under-use of artemisinin based combination therapy at public health facilities in three regions of Tanzania</style></title><secondary-title><style face="normal" font="default" size="100%">American Journal of Tropical Medicine and Hygiene</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">American Journal of Tropical Medicine and Hygiene</style></full-title></periodical><pages><style face="normal" font="default" size="100%">194-195</style></pages><volume><style face="normal" font="default" size="100%">85</style></volume><number><style face="normal" font="default" size="100%">6</style></number><keywords><keyword><style face="normal" font="default" size="100%">artemisinin</style></keyword><keyword><style face="normal" font="default" size="100%">therapy</style></keyword><keyword><style face="normal" font="default" size="100%">public health</style></keyword><keyword><style face="normal" font="default" size="100%">health care facility</style></keyword><keyword><style face="normal" font="default" size="100%">Tanzania</style></keyword><keyword><style face="normal" font="default" size="100%">society</style></keyword><keyword><style face="normal" font="default" size="100%">tropical medicine</style></keyword><keyword><style face="normal" font="default" size="100%">hygiene</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">patient</style></keyword><keyword><style face="normal" font="default" size="100%">health care personnel</style></keyword><keyword><style face="normal" font="default" size="100%">scale up</style></keyword><keyword><style face="normal" font="default" size="100%">malaria</style></keyword><keyword><style face="normal" font="default" size="100%">diagnostic test</style></keyword><keyword><style face="normal" font="default" size="100%">consultation</style></keyword><keyword><style face="normal" font="default" size="100%">fever</style></keyword><keyword><style face="normal" font="default" size="100%">diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">parasite</style></keyword><keyword><style face="normal" font="default" size="100%">blood smear</style></keyword><keyword><style face="normal" font="default" size="100%">diseases</style></keyword><keyword><style face="normal" font="default" size="100%">weight</style></keyword><keyword><style face="normal" font="default" size="100%">parasitemia</style></keyword><keyword><style face="normal" font="default" size="100%">blood sampling</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2011</style></year></dates><isbn><style face="normal" font="default" size="100%">0002-9637</style></isbn><abstract><style face="normal" font="default" size="100%">Artemisinin based combination therapy (ACT) is the frst line drug in most malaria-endemic countries, but there are concerns that quality of care remains poor. Patients needing ACT often do not receive it, but there is also considerable over-treatment due to the lack of accurate diagnosis and inappropriate management. Tanzania is scaling up the use of rapid diagnostic tests (RDTs) to improve treatment of febrile illness. We conducted health facility surveys before RDT scale up to assess current treatment practices. We enrolled 1779 patients at 145 randomly selected health facilities in Mwanza, Mbeya, and Mtwara Regions between May and October 2010. Patients with fever in the previous 48 hours were enrolled on arrival and interviewed following their consultation. Data were collected on patient characteristics, previous treatment for fever, and care. Fingerprick blood samples were taken by study staff to test for malaria parasitemia. Overall, 66.6% of patients attended a facility with any ACT in stock and 28.6% a facility with all 4 weight-specifc doses of ACT available. 60.6% of patients had been seen by a health worker trained in ACTs. Only 6.3% of patients sought treatment at a facility that had RDTs in stock, and 5.7% saw a health worker who had been trained in RDTs. Overall, 9.8% of patients received a diagnostic test at the health facility; 82% of those tested received a blood smear and 18% an RDT. Of those tested, 54.8% were reported to have a positive test. ACTs were obtained by 58.5% of patients with a positive test, 11.4% of patients with a negative test, and 36.0% of patients who did not receive a diagnostic test during their consultation. Study RDTs conducted in all enrolled patients found that 24.5% of all patients had a positive RDT. ACTs had been obtained by 44.3% of patients with a positive RDT and 33.7% of patients with a negative RDT. Over-diagnosis of malaria remains common, with ACTs frequently prescribed to parasite-negative patients; it is anticipated that national scale up of RDTs should address this issue to some degree. However, under-treatment also remains a key problem, refecting both ACT stockouts and inappropriate health worker practices.</style></abstract><notes><style face="normal" font="default" size="100%">L71042804&#xD;2013-04-30</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.embase.com/search/results?subaction=viewrecord&amp;id=L71042804&amp;from=export</style></url><url><style face="normal" font="default" size="100%">http://www.ajtmh.org/content/85/6_Suppl/151.full.pdf+html</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2077</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2077</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Bruzzone, B.</style></author><author><style face="normal" font="default" size="100%">Bisio, F.</style></author><author><style face="normal" font="default" size="100%">Ventura, A.</style></author><author><style face="normal" font="default" size="100%">Nigro, N.</style></author><author><style face="normal" font="default" size="100%">Miguel, L. M.</style></author><author><style face="normal" font="default" size="100%">Mayinda Mboungou, F. A.</style></author><author><style face="normal" font="default" size="100%">Nzagou, A. C.</style></author><author><style face="normal" font="default" size="100%">Mayembo, P.</style></author><author><style face="normal" font="default" size="100%">Uberti, F.</style></author><author><style face="normal" font="default" size="100%">De Maria, A.</style></author><author><style face="normal" font="default" size="100%">Icardi, G.</style></author><author><style face="normal" font="default" size="100%">Viscoli, C.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Hygiene Unit, S. Martino Hospital, Genoa, Italy.</style></auth-address><titles><title><style face="normal" font="default" size="100%">HIV serological screening in a population of pregnant women in the Republic of Congo: suitability of different assays</style></title><secondary-title><style face="normal" font="default" size="100%">Trop Med Int Health</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Trop Med Int Health</style></full-title></periodical><pages><style face="normal" font="default" size="100%">900-3</style></pages><volume><style face="normal" font="default" size="100%">13</style></volume><number><style face="normal" font="default" size="100%">7</style></number><keywords><keyword><style face="normal" font="default" size="100%">AIDS Serodiagnosis/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Congo/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Enzyme-Linked Immunosorbent Assay/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">HIV/immunology/*isolation &amp; purification</style></keyword><keyword><style face="normal" font="default" size="100%">HIV Infections/*diagnosis/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Mass Screening/methods</style></keyword><keyword><style face="normal" font="default" size="100%">Pregnancy</style></keyword><keyword><style face="normal" font="default" size="100%">Pregnancy Complications, Infectious/*diagnosis/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Prevalence</style></keyword><keyword><style face="normal" font="default" size="100%">Prospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">World Health Organization</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2008</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jul</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1360-2276</style></isbn><abstract><style face="normal" font="default" size="100%">Different strategies can be applied for the screening of HIV infection, depending on the local seroprevalence. Within a WHO type III strategy, we compared the results of two different second-line methods for HIV screening of a population of pregnant women in the Republic of Congo. Sera from 3614 consecutive pregnant women were tested for HIV with Genescreen Plus Ag/Ab EIA assay; positive specimens were retested with two different second-line methods. (Determine HIV-1/2 rapid test and Vironostika HIV Ag/Ab specific EIA assay). Discordant samples were tested with HIV-1/2 Western Blot and, if necessary, HIV RNA molecular assay. Of the 3614 sera, 221 were positive with Genscreen. Among them, 21 and 10 tested negative with Vironostika and Determine, respectively. A 100% correspondence with 3rd line confirmation test results was found in Genscreen positive/Vironostika negative samples, whereas a 5.5% overestimation of HIV seroprevalence was observed when Determine, instead of Vironostika, was used as second-line test. The choice of appropriate assays in adequate sequence, within the correct WHO strategy, is pivotal to minimize the risk of overtreatment of HIV infection.</style></abstract><notes><style face="normal" font="default" size="100%">1365-3156&#xD;Bruzzone, Bianca&#xD;Bisio, Francesca&#xD;Ventura, Agostina&#xD;Nigro, Nicola&#xD;Miguel, Landry M&#xD;Mayinda Mboungou, Franck A&#xD;Nzagou, Abdon C&#xD;Mayembo, Patrice&#xD;Uberti, Filippo&#xD;De Maria, Andrea&#xD;Icardi, Giancarlo&#xD;Viscoli, Claudio&#xD;Journal Article&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Trop Med Int Health. 2008 Jul;13(7):900-3. doi: 10.1111/j.1365-3156.2008.02090.x. Epub 2008 May 13.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-3156.2008.02090.x?download=true</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1111/j.1365-3156.2008.02090.x</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2078</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2078</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Buendía, J. A.</style></author><author><style face="normal" font="default" size="100%">Rodríguez, C. A.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Grupo de Investigación en Farmacología y Toxicología (INFARTO), Universidad de Antioquia, Medellín, Colombia.&#xD;Department of Pharmacology and Toxicology, School of Medicine, University of Antioquia, Medellin, Colombia.&#xD;CIEMTO [drug and poison research and information center] at Integrated Laboratory of Specialized Medicine (LIME), Facultad de Medicina-IPS Universitaria, Universidad de Antioquia, Calle 64 #51-31, 050010, Medellin, Colombia.</style></auth-address><titles><title><style face="normal" font="default" size="100%">A predictive model of inappropriate use of medical tests and medications in Bronchiolitis</style></title><secondary-title><style face="normal" font="default" size="100%">Pan Afr Med J</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Pan Afr Med J</style></full-title></periodical><pages><style face="normal" font="default" size="100%">94</style></pages><volume><style face="normal" font="default" size="100%">37</style></volume><keywords><keyword><style face="normal" font="default" size="100%">Bronchiolitis/diagnosis/*therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Child, Preschool</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Hospitalization</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Infant</style></keyword><keyword><style face="normal" font="default" size="100%">Infant, Newborn</style></keyword><keyword><style face="normal" font="default" size="100%">Length of Stay/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">*Models, Theoretical</style></keyword><keyword><style face="normal" font="default" size="100%">Practice Patterns, Physicians&apos;/standards/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Retrospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Unnecessary Procedures/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Bronchiolitis</style></keyword><keyword><style face="normal" font="default" size="100%">Colombia</style></keyword><keyword><style face="normal" font="default" size="100%">cost</style></keyword><keyword><style face="normal" font="default" size="100%">resources</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2020</style></year></dates><abstract><style face="normal" font="default" size="100%">Few studies have identified predictors of inappropriate use of medications and medical tests in bronchiolitis. This study aimed to look for potential factors associated with the inappropriate use of medications and tests in bronchiolitis. A retrospective study that included all infants under two years of age in tertiary center admitted due to Bronchiolitis from January 2015 to December 2018. We defined a composite score as the main outcome variable. 1930 patients were included. The most prescribed medications were nebulized hypertonic saline in 1789 patients (92.6%), albuterol (56%), and β-lactam antibiotics (26.4%). The medical tests more commonly ordered were hemogram (95.9%), chest X-rays (92.2%) and C-reactive protein (79.8%). After controlling for potential confounders, it was found that the length of hospital stay increases the risk of the inappropriate use of medications and tests (OR 1.29; CI 95% 1.01-1.65), whereas fever (OR 0.22; CI 95% 0.06-0.71) and leukocytosis (&gt; 15,000/μL) (OR 0.09; CI 95% 0.03-0.32) at admission decrease the risk of the inappropriate use of medications and tests. Inappropriate use of diagnostic tests and drugs for bronchiolitis was a highly prevalent outcome in our population. Patients with longer hospitalizations, absence of fever and a normal white blood cell count at admission, were at increased risk of inappropriate use of medications and medical tests.</style></abstract><label><style face="normal" font="default" size="100%">Included by Eman</style></label><notes><style face="normal" font="default" size="100%">1937-8688&#xD;Buendía, Jefferson Antonio&#xD;Rodríguez, Carlos Andrés&#xD;Journal Article&#xD;Pan Afr Med J. 2020 Sep 25;37:94. doi: 10.11604/pamj.2020.37.94.22712. eCollection 2020.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757321/pdf/PAMJ-37-94.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC7757321</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.11604/pamj.2020.37.94.22712</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2079</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2079</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Cahoon, S.</style></author><author><style face="normal" font="default" size="100%">Cortessis, V.</style></author><author><style face="normal" font="default" size="100%">Najuna, S.</style></author><author><style face="normal" font="default" size="100%">Stumler, R.</style></author><author><style face="normal" font="default" size="100%">Jubilee, J.</style></author><author><style face="normal" font="default" size="100%">Ihenacho, U.</style></author><author><style face="normal" font="default" size="100%">Felix, J.</style></author><author><style face="normal" font="default" size="100%">Muderspach, L.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">S. Cahoon, University of Southern California, Los Angeles, CA, United States</style></auth-address><titles><title><style face="normal" font="default" size="100%">Pilot evaluation of cervical cancer screening modalities in a low resource Ugandan setting</style></title><secondary-title><style face="normal" font="default" size="100%">Gynecologic Oncology</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Gynecologic Oncology</style></full-title></periodical><pages><style face="normal" font="default" size="100%">192-193</style></pages><volume><style face="normal" font="default" size="100%">147</style></volume><number><style face="normal" font="default" size="100%">1</style></number><keywords><keyword><style face="normal" font="default" size="100%">acetic acid</style></keyword><keyword><style face="normal" font="default" size="100%">glass</style></keyword><keyword><style face="normal" font="default" size="100%">adult</style></keyword><keyword><style face="normal" font="default" size="100%">cancer screening</style></keyword><keyword><style face="normal" font="default" size="100%">cancer surgery</style></keyword><keyword><style face="normal" font="default" size="100%">conference abstract</style></keyword><keyword><style face="normal" font="default" size="100%">cryotherapy</style></keyword><keyword><style face="normal" font="default" size="100%">demography</style></keyword><keyword><style face="normal" font="default" size="100%">diagnostic test accuracy study</style></keyword><keyword><style face="normal" font="default" size="100%">electrode</style></keyword><keyword><style face="normal" font="default" size="100%">excision</style></keyword><keyword><style face="normal" font="default" size="100%">feasibility study</style></keyword><keyword><style face="normal" font="default" size="100%">female</style></keyword><keyword><style face="normal" font="default" size="100%">histology</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">Human immunodeficiency virus</style></keyword><keyword><style face="normal" font="default" size="100%">human tissue</style></keyword><keyword><style face="normal" font="default" size="100%">learning</style></keyword><keyword><style face="normal" font="default" size="100%">major clinical study</style></keyword><keyword><style face="normal" font="default" size="100%">medical history</style></keyword><keyword><style face="normal" font="default" size="100%">nonhuman</style></keyword><keyword><style face="normal" font="default" size="100%">pilot study</style></keyword><keyword><style face="normal" font="default" size="100%">predictive value</style></keyword><keyword><style face="normal" font="default" size="100%">prevalence</style></keyword><keyword><style face="normal" font="default" size="100%">squamous cell carcinoma</style></keyword><keyword><style face="normal" font="default" size="100%">Uganda</style></keyword><keyword><style face="normal" font="default" size="100%">uterine cervix cancer</style></keyword><keyword><style face="normal" font="default" size="100%">uterine cervix cytology</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2017</style></year></dates><isbn><style face="normal" font="default" size="100%">1095-6859</style></isbn><abstract><style face="normal" font="default" size="100%">Objectives: Cervical cancer incidence has declined steadily in areas of the world where most women have access to screening followed by treatment of pre-malignant lesions. Scarcity of these services has facilitated an epidemic in the developing world. We performed a pilot study of cervical cancer screening and lesion treatment in rural Uganda, where disease prevalence remains high, and few providers are trained in these techniques. Our goals were to compare performance of visual inspection with acetic acid (VIA) with and without HPV DNA testing to that of conventional cytology, and to assess both the feasibility of introducing these methods and the potential sustainability in this setting. Methods: Patients were screened for cervical lesions using VIA, glass slide cervical cytology, and high risk HPV DNA testing. Additional demographic data and medical history were collected. Proportions and accompanying 95% confidence intervals were calculated estimating the predictive values for VIA alone of abnormal cytology as well as predictive values of positive VIA plus positive HPV DNA. Results: We screened 392 women, of whom 326 were screened with each method: cytology, VIA, and HPV testing. 51 women (13.0%) reported being HIV positive. 70 women (17.9%) scored VIA positive, and 38 (9.7%) were positive for high risk HPV DNA. By comparison, 38 (9.7%) had abnormal cytology, 12 (3.1%) with low grade lesions, 15 (3.8%) with high grade lesions, and 11 (2.8%) concerning for squamous cell carcinoma on cytology. Histology was not available in this setting, so conventional cytology lesion grade was used for treatment decisions, with 17 women treated by loop electrode excision (LEEP) and 16 treated with cryotherapy. 6 women with visible tumor were referred for a higher level of care. VIA was useful in excluding premalignant lesions, with a 94.6% (95% confidence interval: 92.1-97.2) negative predictive value compared to cytology. The positive predictive value of VIA alone was only 14.5% (Cl 6.2-22.8). However, VIA positivity followed by a positive HPV test was a better predictor of premalignant lesions, with a positive predictive value of 70.0% (Cl 34.8-93.3). Among HIV positive women, positive VIA alone had a 42.9% (Cl 9.9-81.6) positive predictive value, while VIA positivity followed by positive high risk HPV DNA had a 100% (Cl 29.2-100) positive predictive value. Among HIV negative women, positive VIA alone had a positive predictive value of 10.2% (Cl 2.5-17.9), but VIA positivity followed by positive HPV DNA had a positive predictive value of 57.1% (Cl 18.4-90.1). Conclusions: These results indicate that screening by VIA followed by HPV testing of only VIA positive women would result in less overtreatment than by VIA alone, and incur less cost than universal screening with HPV DNA. This sequential screening approach increases accessibility in areas with limited resources to support cytology based cervical cancer screening. Learning objectives: Learners will be able to describe the utility of various cervical cancer screening methods as well as a management algorithm adapted for use in low resource settings.</style></abstract><label><style face="normal" font="default" size="100%">Included by Ray</style></label><notes><style face="normal" font="default" size="100%">L621287876&#xD;2018-03-22</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.embase.com/search/results?subaction=viewrecord&amp;id=L621287876&amp;from=export</style></url><url><style face="normal" font="default" size="100%">http://dx.doi.org/10.1016/j.ygyno.2017.07.018</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1016/j.ygyno.2017.07.018</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2080</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2080</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Caliskan, E.</style></author><author><style face="normal" font="default" size="100%">Kayikcioglu, F.</style></author><author><style face="normal" font="default" size="100%">Oztürk, N.</style></author><author><style face="normal" font="default" size="100%">Koc, S.</style></author><author><style face="normal" font="default" size="100%">Haberal, A.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">SSK Ankara Maternity and Women&apos;s Health Teaching Hospital, Etlik, Ankara, Turkey. eray68@hotmail.com</style></auth-address><titles><title><style face="normal" font="default" size="100%">A population-based risk factor scoring will decrease unnecessary testing for the diagnosis of gestational diabetes mellitus</style></title><secondary-title><style face="normal" font="default" size="100%">Acta Obstet Gynecol Scand</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Acta Obstet Gynecol Scand</style></full-title></periodical><pages><style face="normal" font="default" size="100%">524-30</style></pages><volume><style face="normal" font="default" size="100%">83</style></volume><number><style face="normal" font="default" size="100%">6</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Diabetes, Gestational/*epidemiology/*etiology</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Glucose Tolerance Test</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Population Surveillance/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Predictive Value of Tests</style></keyword><keyword><style face="normal" font="default" size="100%">Pregnancy</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Sensitivity and Specificity</style></keyword><keyword><style face="normal" font="default" size="100%">Turkey/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Unnecessary Procedures</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2004</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jun</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0001-6349 (Print)&#xD;0001-6349</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: To determine the effectiveness of a population-based risk factor scoring to decrease unnecessary testing for the diagnosis of gestational diabetes mellitus (GDM). METHODS: We formed a risk factor scoring over five, which questions maternal age, body mass index and first-degree relatives with a diagnosis of diabetes mellitus, a prior macrosomic fetus and adverse outcome during the previous pregnancies. All participants underwent a 50-g glucose challenge test (GCT) followed by a 100-g oral glucose tolerence test (OGTT). We opened the 50-g GCT envelope if the participant had a risk score &gt; or = 1 and opened the 100-g OGTT envelope if the 50-g GCT value was &gt; or = 7.2 mmol/l. After all patients delivered we also built other strategies and tested their detection rates. RESULTS: Fourteen patients (3.3%) were diagnosed as having gestational diabetes mellitus via a 100-g OGTT. None of the patients with a score of zero had gestational diabetes mellitus. Logistic regression analysis revealed that an increase in the score by one caused a three times increase in gestational diabetes mellitus risk (OR = 3, CI = 1.9-5). Compared with the universal screening, our strategy to screen if the risk score was &gt; or = 1, followed by a 50-g GCT with a 7.2-mmol/l cut-off value, decreased the number of women to be screened by 30% and diagnosed all cases with GDM. Screening the patients with a score &gt; or = 2 would have decreased the number of women to be screened by 63%, still diagnosing 85% of cases with GDM. Also, risk factor-based screening strategies cause a 50% and 53% reduction in the number of OGTT applied, respectively. CONCLUSION: A well integrated, population-based scoring will decrease the number of unnecessary testing but still diagnose 85-100% of GDM cases.</style></abstract><notes><style face="normal" font="default" size="100%">Caliskan, Eray&#xD;Kayikcioglu, Fulya&#xD;Oztürk, Nilgun&#xD;Koc, Sevgi&#xD;Haberal, Ali&#xD;Evaluation Study&#xD;Journal Article&#xD;United States&#xD;Acta Obstet Gynecol Scand. 2004 Jun;83(6):524-30. doi: 10.1111/j.0001-6349.2004.00389.x.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://obgyn.onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.0001-6349.2004.00389.x?download=true</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1111/j.0001-6349.2004.00389.x</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2081</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2081</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Campos, F.</style></author><author><style face="normal" font="default" size="100%">Dgegde, M. C.</style></author><author><style face="normal" font="default" size="100%">Parcally, L.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Sobre-diagnostico de tuberculose pulmonar infantil na Cidade de Maputo</style></title><secondary-title><style face="normal" font="default" size="100%">Revista medica de Mocambique</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Revista medica de Mocambique</style></full-title></periodical><keywords><keyword><style face="normal" font="default" size="100%">Tuberculosis</style></keyword><keyword><style face="normal" font="default" size="100%">Diagnosis</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">1994</style></year><pub-dates><date><style face="normal" font="default" size="100%">1994/00</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0254- 5705</style></isbn><abstract><style face="normal" font="default" size="100%">A retrospective descriptive study to determine the possibility of overdiagnosis of child pulmonary tuberculosis was carried out in 1990 in Maputo City. 186 children; from birth to seven years of age; diagnosed with pulmonary tuberculosis; in their third to sixth month of treatment in 14 health centers in Maputo City; were studied during the second half of 1989. The following information was collected in each health centre : syptoms; contact with a person with smear positive for pulmonary tuberculosis; smear chest x-ray results; tuberculin test results at the beginning of treatment and during the data collection period; and the number of patients with smear positive pulmonary tuberculosis. The existence of 1.01 cases of child pulmonary tuberculosis for one case of pulmonary tuberculosis BK+ was verified. On the basis of results obtained through the Basg system; readings of the children&amp;#039;s x-rays and of the annual risk of infection; the authors conclude that; in the Maputo City; there is 40 overdiagnosis of child pulmonary tuberculosis. The authors draw conclusions about the causes of overdiagnosis and make recommendations to improve the diagnosis of tuberculosis.</style></abstract><urls><related-urls><url><style face="normal" font="default" size="100%">https://pesquisa.bvsalud.org/gim/resource/en/afr-184954</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2082</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2082</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Casado Méndez, Pedro Rafael</style></author><author><style face="normal" font="default" size="100%">Peña Rosa, Yordanys</style></author><author><style face="normal" font="default" size="100%">Reyna Aguilar, Milton Michel</style></author><author><style face="normal" font="default" size="100%">Méndez López, Héctor Aurelio</style></author><author><style face="normal" font="default" size="100%">Remón Elías, Magdalena</style></author><author><style face="normal" font="default" size="100%">Méndez Jiménez, Onelia</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Evaluación de la calidad del diagnóstico de apendicitis aguda en la atención primaria y secundaria</style></title><secondary-title><style face="normal" font="default" size="100%">Arch. méd. Camaguey</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Arch. méd. Camaguey</style></full-title></periodical><pages><style face="normal" font="default" size="100%">25-35</style></pages><volume><style face="normal" font="default" size="100%">20</style></volume><number><style face="normal" font="default" size="100%">1</style></number><dates><year><style face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style face="normal" font="default" size="100%">2016/02</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1025-0255</style></isbn><abstract><style face="normal" font="default" size="100%">Fundamento: la apendicitis aguda es la enfermedad trazadora del abdomen agudo no traumático y su sobrediagnóstico es objeto de preocupación en medicina clínica. Objetivo: evaluar la calidad del diagnóstico de apendicitis aguda en los niveles primario y secundario de atención. Métodos: se realizó un estudio cuantitativo, prospectivo, observacional y descriptivo con fases analíticas donde se evaluaron los diagnósticos clínico, operatorio e histopatológico en un universo de 200 pacientes remitidos de la atención primaria de salud con diagnóstico de apendicitis aguda al servicio de cirugía general del Hospital Provincial Celia Sánchez Manduley, Manzanillo, Granma, en un periodo de cinco meses comprendidos entre noviembre de 2014 y marzo de 2015. Resultados: predominaron el sexo masculino (60, 5 %), el rango de edad 21-25 años y el estadio anatomopatológico catarral (28, 68 %). La correlación clínica entre los dos niveles de atención fue de 79 %. La correlación diagnóstica en la atención secundaria de salud fue de 81, 65 %; 68, 35 % y 83, 72 % entre los diagnósticos clínico y operatorio, clínico e histopatológico y operatorio e histopatológico respectivamente. La efectividad diagnóstica fue menor en los médicos generales (26, 03 %) y mayor en los especialistas en cirugía general (71, 93 %). Conclusiones: la calidad del diagnóstico de apendicitis aguda en el nivel primario de atención fue insatisfactoria y aunque este mejoró en el nivel secundario de atención, los parámetros de efectividad obtenidos no son satisfactorios. Aun cuando existe carencia de parámetros clínicos que otorguen certeza diagnóstica, la clínica aún es la base en la toma de decisiones.&#xD;Background: acute appendicitis is the tracer disease of non-traumatic acute abdomen. Its overdiagnosis is a matter of concern in clinical medicine. Objective: to evaluate the quality of the diagnosis of acute appendicitis in the primary and secondary care. Methods: a quantitative, prospective, observational and descriptive study with analytical facets was conducted. The clinical, operating and histopathological diagnoses were evaluated in a universe of 200 patients referred by the primary care to the general surgery department of Celia Sanchez Manduley Provincial Hospital, Manzanillo, Granma with the diagnosis of acute appendicitis in a period of five months, from November, 2014 to March, 2015. Results: male sex (60, 5 %), the 21 to 25 age group, and the catarrhal pathoanatomical stage (28, 68 %) predominated. The clinical correlation between both health care services was of 79 %. The diagnostic correlation between the clinical and the operating diagnoses, between the clinical and histopathological diagnoses and between the operating and the histopathological diagnoses was of 81, 65 %; 68, 35 % and 83, 72 % respectively in the secondary care. The diagnostic effectiveness was lower for general doctors (26, 03 %) and higher for specialists in general surgery (71, 93 %). Conclusion: the quality of the diagnosis of acute appendicitis in the primary care was unsatisfactory and although it improved in the secondary care, the parameters of effectiveness were not yet satisfactory. There is a lack of clinical parameters that provide diagnostic certainty; however, clinical medicine is still the base in decision-making.</style></abstract><label><style face="normal" font="default" size="100%">Included by Eman</style></label><urls><related-urls><url><style face="normal" font="default" size="100%">http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;amp;pid=S1025-02552016000100005</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2083</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2083</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Castro, Hugo Alexandre Sócrates de</style></author><author><style face="normal" font="default" size="100%">Iared, Wagner</style></author><author><style face="normal" font="default" size="100%">Shigueoka, David Carlos</style></author><author><style face="normal" font="default" size="100%">Mourão, José Eduardo</style></author><author><style face="normal" font="default" size="100%">Ajzen, Sérgio</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Contribuição da densidade do PSA para predizer o câncer da próstata em pacientes com valores de PSA entre 2, 6 e 10, 0 ng/ml</style></title><secondary-title><style face="normal" font="default" size="100%">Radiol. bras</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Radiol. bras</style></full-title></periodical><pages><style face="normal" font="default" size="100%">205-209</style></pages><volume><style face="normal" font="default" size="100%">44</style></volume><number><style face="normal" font="default" size="100%">4</style></number><keywords><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Aged, 80 and over</style></keyword><keyword><style face="normal" font="default" size="100%">Adenocarcinoma</style></keyword><keyword><style face="normal" font="default" size="100%">Prostatic Neoplasms/diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">Prostatic Neoplasms/physiopathology</style></keyword><keyword><style face="normal" font="default" size="100%">Prostate-Specific Antigen</style></keyword><keyword><style face="normal" font="default" size="100%">Prostate/pathology</style></keyword><keyword><style face="normal" font="default" size="100%">Biopsy</style></keyword><keyword><style face="normal" font="default" size="100%">Brazil</style></keyword><keyword><style face="normal" font="default" size="100%">Cross-Sectional Studies</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2011</style></year><pub-dates><date><style face="normal" font="default" size="100%">2011/08</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0100-3984</style></isbn><abstract><style face="normal" font="default" size="100%">OBJETIVO: Estudar o perfil dos pacientes submetidos a biópsia prostática, determinando possíveis padrões que, associados aos níveis de PSA entre 2,6 e 10,0 ng/ml, possam levar a uma diminuição de biópsias desnecessárias. MATERIAIS E MÉTODOS: De 2007 a 2009, foi realizado um estudo transversal com 1.282 indivíduos submetidos a biópsia prostática e que apresentavam níveis de PSA entre 2,6 e 10,0 ng/ml. RESULTADOS: A prevalência de câncer foi de 28,6 por cento. Pacientes com câncer eram, em média, mais idosos, com valores de PSA e densidade de PSA mais altos e menor volume da próstata. Na análise da densidade de PSA, os pacientes com câncer tiveram média de 0,31 ng/ml/cc, enquanto nos pacientes com resultado negativo a média foi de 0,10 ng/ml/cc. Utilizando como critério de positividade para câncer o ponto de corte de densidade de PSA de 0,15 ng/ml/cc, obtivemos especificidade de 74 por cento e sensibilidade de 70 por cento. Para aumentar a sensibilidade é preciso reduzir o ponto de corte. Com o valor 0,09 ng/ml/cc, obtivemos sensibilidade de 84 por cento (IC 95 por cento: 80-87 por cento) e especificidade de 75 por cento (IC 95 por cento: 72-78 por cento). CONCLUSÃO: O uso sistemático da densidade de PSA na indicação de prosseguimento da investigação do paciente com biópsia poderia reduzir a quantidade de procedimentos desnecessários.&#xD;OBJECTIVE: To study the profile of patients with PSA level between 2.6 and 10.0 ng/ml and submitted to prostate biopsy, determining possible patterns that might lead to a reduction of unnecessary biopsies. MATERIALS AND METHODS: In the period from 2007 to 2009, a cross-sectional study was developed with 1,282 patients with PSA levels between 2.6 and 10.0 ng/ml, and submitted to prostate biopsy. RESULTS: Cancer prevalence was 28.6 percent. On average, the patients with positive biopsies were older, with higher PSA levels and density, and smaller prostate volume as compared with the patients with negative biopsies. In the analysis of PSA density, the cancer patients averaged 0.31 ng/ml/cc, while patients with negative results averaged 0.10 ng/ml/cc. Utilizing a cutoff value of 0.15 ng/ml/cc for PSA density as a cancer positiveness criterion, the authors obtained sensitivity of 74 percent and specificity of 70 percent. The cutoff value should be reduced to increase the sensitivity. With a cutoff value of 0.09 ng/ml/cc, sensitivity reached 84 percent (CI 95 percent: 80-87 percent), and specificity, 75 percent (CI 95 percent: 72-78 percent). CONCLUSION: The systematic use of PSA density as an indicator to proceed with the investigation of a patient with biopsy could substantially reduce the amount of unnecessary procedures.</style></abstract><urls><related-urls><url><style face="normal" font="default" size="100%">http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S0100-39842011000400003</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2084</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2084</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Chan, T. H.</style></author><author><style face="normal" font="default" size="100%">Goh, K. L.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Division of Gastroenterology and Hepatology, Department of Medicine, University of Malaya, Kuala Lumpur, Malaysia.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Appropriateness of colonoscopy using the ASGE guidelines: experience in a large Asian hospital</style></title><secondary-title><style face="normal" font="default" size="100%">Chin J Dig Dis</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Chin J Dig Dis</style></full-title></periodical><pages><style face="normal" font="default" size="100%">24-32</style></pages><volume><style face="normal" font="default" size="100%">7</style></volume><number><style face="normal" font="default" size="100%">1</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Aged, 80 and over</style></keyword><keyword><style face="normal" font="default" size="100%">Colonoscopy/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Colorectal Neoplasms/*diagnosis/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Cross-Sectional Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Hospitals, University/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Malaysia/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">*Practice Guidelines as Topic</style></keyword><keyword><style face="normal" font="default" size="100%">Prospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Unnecessary Procedures</style></keyword><keyword><style face="normal" font="default" size="100%">*Utilization Review</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2006</style></year></dates><isbn><style face="normal" font="default" size="100%">1443-9611 (Print)&#xD;1443-9573</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: The is currently a heavy burden on endoscopy services worldwide and although guidelines for the appropriate use of esophagogastroduodenoscopy (EGD) have been well studied, there are few such studies with respect to colonoscopy and none for the Asia-Pacific region. This study aimed, firstly, to determine the &apos;appropriateness of colonoscopy&apos; for procedures performed in the endoscopy unit of a large Asian hospital using the American Society of Gastrointestinal Endoscopy (ASGE) 2000 guidelines, and secondly, to determine predictive factors including &apos;appropriateness of colonoscopy&apos; for positive findings and colorectal cancer (CRC). METHODS: A prospective cross-sectional study was carried out on consecutive colonoscopies performed in the University of Malaya Medical Center. The unit has an open-access endoscopy policy for doctors who work in the hospital. Referrals were from endoscopists (gastroenterologists and surgeon-endoscopists), primary care physicians and other specialists. The indication of a procedure referral was recorded and judged &apos;appropriate&apos; or &apos;inappropriate&apos; using the ASGE criteria. The colonoscopic findings were recorded and classified as positive (endoscopies showing any pathology that had direct therapeutic or prognostic consequences) or negative findings (endoscopies showing no pathology or minor pathologies). Predictive factors for positive findings and CRC were determined using multivariate analysis. RESULTS: Of 380 patients referred for colonoscopy, 220 (57.9%) were classified as appropriate according to the ASGE guidelines, and 49 (12.9%) as inappropriate. The remaining 111 patients (29.2%) presented with complaints and conditions that could not be categorized. The rate of appropriate referral was similar for all three categories of physician (endoscopists: 59.8%, primary care physicians: 48.1%, others: 51.1%). When referrals by endoscopists were substratified according to gastroenterologists and surgeon-endoscopists, the rate of appropriate referral among gastroenterologists (78.4%) was significantly higher than that of surgeon-endoscopists (56.1%) (P = 0.049), primary care physicians (P = 0.013) and &apos;others&apos; (P = 0.009). The most common appropriate indications were unexplained Rectalbleeding (79 cases, 20.8%) followed by CRC surveillance (45 cases, 11.8%). The most common inappropriate indication was inappropriately timed colonic cancer surveillance (32 cases, 8.4%). Chronic constipation in 36 cases (9.5%) was the most common &apos;unlisted&apos; indication. A positive colonoscopic finding was detected in 131 (34.5%) examinations and CRC was found in 36 patients (9.5%). Appropriateness of indication was not a predictive factor for positive findings or CRC and there was no difference in the proportion of cases with positive findings or CRC in the three &apos;appropriateness categories&apos;. Multivariate analysis revealed that only Rectalbleeding and smoking were significant independent positive predictive factors for positive findings and CRC. CONCLUSION: The appropriateness of colonoscopy was not high among the different sources of referrals except for the subgroup of &apos;gastroenterologist&apos;. Furthermore, the rates of positive findings and CRC among the cases with appropriate, inappropriate and unlisted indications did not differ. The ASGE guidelines will need to be modified for Asia to be of practical use.</style></abstract><notes><style face="normal" font="default" size="100%">Chan, T H&#xD;Goh, K L&#xD;Comparative Study&#xD;Journal Article&#xD;Australia&#xD;Chin J Dig Dis. 2006;7(1):24-32. doi: 10.1111/j.1443-9573.2006.00240.x.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1443-9573.2006.00240.x?download=true</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1111/j.1443-9573.2006.00240.x</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2085</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2085</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Chandhanayingyong, C.</style></author><author><style face="normal" font="default" size="100%">Tangtrakulwanich, B.</style></author><author><style face="normal" font="default" size="100%">Kiriratnikom, T.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">C. Chandhanayingyong, Department of Orthopaedic Surgery and Physical Medicine, Prince of Songkla University, Haadyai, Songkhla, Thailand.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Teleconsultation for emergency orthopaedic patients using the multimedia messaging service via mobile phones</style></title><secondary-title><style face="normal" font="default" size="100%">Journal of telemedicine and telecare</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Journal of telemedicine and telecare</style></full-title></periodical><pages><style face="normal" font="default" size="100%">193-196</style></pages><volume><style face="normal" font="default" size="100%">13</style></volume><number><style face="normal" font="default" size="100%">4</style></number><keywords><keyword><style face="normal" font="default" size="100%">article</style></keyword><keyword><style face="normal" font="default" size="100%">clinical competence</style></keyword><keyword><style face="normal" font="default" size="100%">emergency</style></keyword><keyword><style face="normal" font="default" size="100%">emergency health service</style></keyword><keyword><style face="normal" font="default" size="100%">fracture</style></keyword><keyword><style face="normal" font="default" size="100%">health care delivery</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">methodology</style></keyword><keyword><style face="normal" font="default" size="100%">mobile phone</style></keyword><keyword><style face="normal" font="default" size="100%">multimedia</style></keyword><keyword><style face="normal" font="default" size="100%">reproducibility</style></keyword><keyword><style face="normal" font="default" size="100%">sensitivity and specificity</style></keyword><keyword><style face="normal" font="default" size="100%">standard</style></keyword><keyword><style face="normal" font="default" size="100%">statistical analysis</style></keyword><keyword><style face="normal" font="default" size="100%">teleconsultation</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2007</style></year></dates><isbn><style face="normal" font="default" size="100%">1357-633X</style></isbn><abstract><style face="normal" font="default" size="100%">We investigated the accuracy and usefulness of teleconsultation using the mobile phone multimedia messaging service (MMS) in emergency orthopaedic patients. Pictures of radiographs were taken using a built-in 1.3 megapixel mobile phone camera from a digital display screen in the emergency room and then transmitted to the camera phones of four assessors. The cases comprised 59 emergency orthopaedic patients diagnosed with non- or minimally displaced fractures and 34 age-matched normal patients visiting the emergency department. Both clinical and radiographic follow up data were used as the gold standard. Inter- and intra-observer agreement were good (kappa&gt;0.60). The overall sensitivity, specificity and accuracy were 78%, 54% and 65%, respectively. The overall misdiagnosis rate was 40%, with over-diagnosis of 12% and under-diagnosis of 27%. The consequence of misdiagnosis would have resulted in mismanagement in up to 48% of the cases. No association was found between the experience of the assessors, the region of the fracture or the age group of the patients and the misdiagnosis rate. Teleconsultation via MMS demonstrated good reliability, but poor diagnostic accuracy which could have major consequences in emergency orthopaedic patients.</style></abstract><notes><style face="normal" font="default" size="100%">L350310029&#xD;2008-01-11</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.embase.com/search/results?subaction=viewrecord&amp;id=L350310029&amp;from=export</style></url><url><style face="normal" font="default" size="100%">https://journals.sagepub.com/doi/10.1258/135763307780908049?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%3dpubmed</style></url></related-urls></urls><custom5><style face="normal" font="default" size="100%">17565775</style></custom5></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2086</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2086</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Chandler, C. I.</style></author><author><style face="normal" font="default" size="100%">Jones, C.</style></author><author><style face="normal" font="default" size="100%">Boniface, G.</style></author><author><style face="normal" font="default" size="100%">Juma, K.</style></author><author><style face="normal" font="default" size="100%">Reyburn, H.</style></author><author><style face="normal" font="default" size="100%">Whitty, C. J.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">London School of Hygiene and Tropical Medicine, Keppel Street, WC1E 7HT, London, UK. clare.chandler@lshtm.ac.uk</style></auth-address><titles><title><style face="normal" font="default" size="100%">Guidelines and mindlines: why do clinical staff over-diagnose malaria in Tanzania? A qualitative study</style></title><secondary-title><style face="normal" font="default" size="100%">Malar J</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Malar J</style></full-title></periodical><pages><style face="normal" font="default" size="100%">53</style></pages><volume><style face="normal" font="default" size="100%">7</style></volume><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Attitude of Health Personnel</style></keyword><keyword><style face="normal" font="default" size="100%">Child, Preschool</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Health Personnel/education/*psychology</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Interviews as Topic</style></keyword><keyword><style face="normal" font="default" size="100%">Malaria/*diagnosis/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Patients/psychology</style></keyword><keyword><style face="normal" font="default" size="100%">Practice Guidelines as Topic</style></keyword><keyword><style face="normal" font="default" size="100%">Qualitative Research</style></keyword><keyword><style face="normal" font="default" size="100%">Tanzania/epidemiology</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2008</style></year><pub-dates><date><style face="normal" font="default" size="100%">Apr 2</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1475-2875</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: Malaria over-diagnosis in Africa is widespread and costly both financially and in terms of morbidity and mortality from missed diagnoses. An understanding of the reasons behind malaria over-diagnosis is urgently needed to inform strategies for better targeting of antimalarials. METHODS: In an ethnographic study of clinical practice in two hospitals in Tanzania, 2,082 patient consultations with 34 clinicians were observed over a period of three months at each hospital. All clinicians were also interviewed individually as well as being observed during routine working activities with colleagues. Interviews with five tutors and 10 clinical officer students at a nearby clinical officer training college were subsequently conducted. RESULTS: Four, primarily social, spheres of influence on malaria over-diagnosis were identified. Firstly, the influence of initial training within a context where the importance of malaria is strongly promoted. Secondly, the influence of peers, conforming to perceived expectations from colleagues. Thirdly, pressure to conform with perceived patient preferences. Lastly, quality of diagnostic support, involving resource management, motivation and supervision. Rather than following national guidelines for the diagnosis of febrile illness, clinician behaviour appeared to follow &apos;mindlines&apos;: shared rationales constructed from these different spheres of influence. Three mindlines were identified in this setting: malaria is easier to diagnose than alternative diseases; malaria is a more acceptable diagnosis; and missing malaria is indefensible. These mindlines were apparent during the training stages as well as throughout clinical careers. CONCLUSION: Clinicians were found to follow mindlines as well as or rather than guidelines, which incorporated multiple social influences operating in the immediate and the wider context of decision making. Interventions to move mindlines closer to guidelines need to take the variety of social influences into account.</style></abstract><notes><style face="normal" font="default" size="100%">1475-2875&#xD;Chandler, Clare I R&#xD;Jones, Caroline&#xD;Boniface, Gloria&#xD;Juma, Kaseem&#xD;Reyburn, Hugh&#xD;Whitty, Christopher J M&#xD;Journal Article&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Malar J. 2008 Apr 2;7:53. doi: 10.1186/1475-2875-7-53.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2323020/pdf/1475-2875-7-53.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC2323020</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1186/1475-2875-7-53</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2087</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2087</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Chandler, C. I.</style></author><author><style face="normal" font="default" size="100%">Meta, J.</style></author><author><style face="normal" font="default" size="100%">Ponzo, C.</style></author><author><style face="normal" font="default" size="100%">Nasuwa, F.</style></author><author><style face="normal" font="default" size="100%">Kessy, J.</style></author><author><style face="normal" font="default" size="100%">Mbakilwa, H.</style></author><author><style face="normal" font="default" size="100%">Haaland, A.</style></author><author><style face="normal" font="default" size="100%">Reyburn, H.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Global Health and Development, London School of Hygiene &amp; Tropical Medicine, 15-17 Tavistock Place, London WC1H 9SH, UK. clare.chandler@lshtm.ac.uk.</style></auth-address><titles><title><style face="normal" font="default" size="100%">The development of effective behaviour change interventions to support the use of malaria rapid diagnostic tests by Tanzanian clinicians</style></title><secondary-title><style face="normal" font="default" size="100%">Implement Sci</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Implement Sci</style></full-title></periodical><pages><style face="normal" font="default" size="100%">83</style></pages><volume><style face="normal" font="default" size="100%">9</style></volume><keywords><keyword><style face="normal" font="default" size="100%">Antimanic Agents/therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Education</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Malaria/*diagnosis/drug therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Practice Patterns, Physicians&apos;/*organization &amp; administration/standards</style></keyword><keyword><style face="normal" font="default" size="100%">Reagent Kits, Diagnostic/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Tanzania/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">*Technology Transfer</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jun 26</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1748-5908</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: Parasitological confirmation is now recommended for all cases of suspected malaria. The roll-out of rapid diagnostic tests (RDTs) is hoped to enable this goal in low resource settings through point of care testing. However, simply making RDTs available has not led to high uptake of the tests or adherence to results by clinicians, with malaria continuing to be overdiagnosed in many settings. We undertook to design an evidence-based intervention package that would be sufficient to support the introduction of RDTs at dispensaries in Tanzania, to be evaluated through the Targeting Artemisinin Combination Therapy (TACT) cluster randomised controlled trial. METHODS: We describe five steps in our intervention design: formative research, review of existing evidence and theory, a workshop to define the intervention approach and content and results of formative research, engagement with behaviour change theory and literature, detailed design of intervention materials and piloting and pretesting of intervention materials. This involved fieldwork with a total of 19 health workers and 212 community members in northeast Tanzania. RESULTS: The formative research suggested that RDTs were a potential source of conflict in the health worker-patient interaction, but that health workers used various techniques to resolve this, including provision of antimalarial drugs for RDT-negative patients. Our reviews showed that evidence was mixed regarding the effectiveness of different methods and theories to support change in prescribing practice. Our design process is presented, drawing from this collective evidence. We describe the final TACT intervention package (including interactive small group workshops, feedback text messages, motivational text messages and patient information leaflets and posters) in terms of its programme theory and implementation theory. CONCLUSIONS: Our study suggests that evidence-based design of complex interventions is possible. The use of formative research to understand malaria overdiagnosis in context was central to the design of the intervention as well as empirical research to test materials and methods prior to implementation. The TACT interventions may be appropriate for other settings where clinicians face similar challenges with malaria diagnostics. TRIAL REGISTRATION: NCT01292707.</style></abstract><label><style face="normal" font="default" size="100%">Included by Loai</style></label><notes><style face="normal" font="default" size="100%">1748-5908&#xD;Chandler, Clare I R&#xD;Meta, Judith&#xD;Ponzo, Célia&#xD;Nasuwa, Fortunata&#xD;Kessy, John&#xD;Mbakilwa, Hilda&#xD;Haaland, Ane&#xD;Reyburn, Hugh&#xD;Journal Article&#xD;Randomized Controlled Trial&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Implement Sci. 2014 Jun 26;9:83. doi: 10.1186/1748-5908-9-83.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4227094/pdf/1748-5908-9-83.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC4227094</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1186/1748-5908-9-83</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2088</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2088</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Chandler, C. I.</style></author><author><style face="normal" font="default" size="100%">Mwangi, R.</style></author><author><style face="normal" font="default" size="100%">Mbakilwa, H.</style></author><author><style face="normal" font="default" size="100%">Olomi, R.</style></author><author><style face="normal" font="default" size="100%">Whitty, C. J.</style></author><author><style face="normal" font="default" size="100%">Reyburn, H.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Infectious Diseases, London School of Hygiene and Tropical Medicine, 51 Bedford Square, London, WC1B 3DP, UK. clare.chandler@lshtm.ac.uk</style></auth-address><titles><title><style face="normal" font="default" size="100%">Malaria overdiagnosis: is patient pressure the problem?</style></title><secondary-title><style face="normal" font="default" size="100%">Health Policy Plan</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Health Policy Plan</style></full-title></periodical><pages><style face="normal" font="default" size="100%">170-8</style></pages><volume><style face="normal" font="default" size="100%">23</style></volume><number><style face="normal" font="default" size="100%">3</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Antimalarials/therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Child, Preschool</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Interviews as Topic</style></keyword><keyword><style face="normal" font="default" size="100%">Malaria/*diagnosis/*drug therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">*Patient Satisfaction</style></keyword><keyword><style face="normal" font="default" size="100%">Tanzania/epidemiology</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2008</style></year><pub-dates><date><style face="normal" font="default" size="100%">May</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0268-1080 (Print)&#xD;0268-1080</style></isbn><abstract><style face="normal" font="default" size="100%">OBJECTIVE: In Africa antimalarials are often prescribed when malaria is unlikely, a problem that is becoming critical as more expensive antimalarials replace established drugs. However, little is known about what drives the overuse of antimalarials. We conducted this study to explore to what extent current prescribing behaviour in hospitals is driven by patient demand. METHODS: Consultations were observed followed by exit interviews with patients or caretakers. Five district hospitals where microscopy was routinely available were selected in areas of low (n = 3) and high (n = 2) malaria transmission in north-eastern Tanzania. All outpatient consultations during the study period were observed (n = 669). Those sent for a malaria blood slide or treated with antimalarials presumptively were interviewed (n = 326). At the end of the study, clinicians were interviewed for their opinions on the use of antimalarials. FINDINGS: Patients were not observed to demand antimalarials from clinicians, but occasionally asked for a malaria slide. Patient satisfaction on exit was similar between those prescribed antimalarials and those not prescribed antimalarials, but more patients or carers expressed satisfaction when the patient had been tested than when not. Clinicians rarely reported perceiving patient demand for antimalarials and asserted that such demand for medication would not affect their prescribing behaviour. CONCLUSIONS: Patient demand was not found to be driving the over-prescription of antimalarials found in the hospitals in our setting. To the contrary, the involvement of patients may provide an opportunity to improve prescribing practice if their expectations for testing and treatment in line with test results can be effectively communicated to clinicians.</style></abstract><label><style face="normal" font="default" size="100%">Included by Eman</style></label><notes><style face="normal" font="default" size="100%">Chandler, Clare I R&#xD;Mwangi, Rose&#xD;Mbakilwa, Hilda&#xD;Olomi, Raimos&#xD;Whitty, Chris J M&#xD;Reyburn, Hugh&#xD;Journal Article&#xD;England&#xD;Health Policy Plan. 2008 May;23(3):170-8. doi: 10.1093/heapol/czm046. Epub 2008 Mar 4.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://watermark.silverchair.com/czm046.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAq4wggKqBgkqhkiG9w0BBwagggKbMIIClwIBADCCApAGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMwY59p9nPlmtTTp8tAgEQgIICYXIcXiXec3bTuXwpiilgjrxQJWkuvzYV0Ot9DabUcW68qxaAG-2s1m4NK2KDthdbU9kVsDZcKEIjiWgk6dNeCsVUUSfk_dLD_-5mfEO1M0ZdvcuSQceVSNef5qkW6paDi4qdffViztfQeza-Dnh5QOLiOsrc2AqEmjLBwPtmEv0QOg9E-Q-vpmxNoNjBtndT_cieDoi_7fKUZgMlDerI25M0hX9W8y5bgp898rDrzittKenWduqwopHPZW1vILk1CwXrui1mAE0faMTPQk4ftGcXrOYQX8QX1kebyHNqZcAqAhGhNl1itefEbVzq7EYVmMXCCu-5iCy8TbFxKbEdeY6WzRV6_9fa29ORnejjJI7b5EJLGlwrf1QzWuaV3QJt8hLS1FjcnmiR0KbI2wc2iY1DISE9g4xBUEByUliD2qyH9taiCoYhXEwxYHaupr89HPiqZpCe1g4k8ZN_rMczuI0oSLJNfQ0gkQm7-lkwgrz9L9tE9yZ3lx8nOjhqBTQZ2iuQzbRBwRt9pn4tvts3bid0kUFYwPtVQeR8l-G7IdSkPfxmrDDyUhc7hU4vvRVl4Nzmu0D-gTPNRJ8BHumzohfUav7j8_WpDpP7zlk0M7MsVf1CLRFo1Kh8EQMnay2tnkkhmHfXE3xUhG9Qe0PupM9Ylq_pedz2BK6wt_hzpRw3CmsweKDh1lyw1dT2T1OHLoeA275Acazibw-aiMG7W5s8sSBkPwUiZJuQZRQ8tRKbPlA1T1nuuPrVJbD0vHs6aVYDeIrHlbtbso5xj_QuT_8Bsc-yDEUR5_UdRpmGM1y18A</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1093/heapol/czm046</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2089</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2089</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Chipwaza, B.</style></author><author><style face="normal" font="default" size="100%">Mugasa, J. P.</style></author><author><style face="normal" font="default" size="100%">Mayumana, I.</style></author><author><style face="normal" font="default" size="100%">Amuri, M.</style></author><author><style face="normal" font="default" size="100%">Makungu, C.</style></author><author><style face="normal" font="default" size="100%">Gwakisa, P. S.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Nelson Mandela African Institute of Science and Technology, Arusha, Tanzania; Ifakara Health Institute, Ifakara, Tanzania.&#xD;National Institute for Medical Research, Amani Medical Research Centre, Muheza, Tanga, Tanzania.&#xD;Ifakara Health Institute, Ifakara, Tanzania.&#xD;Jhpiego, Dar-es-Salaam, Tanzania.&#xD;Nelson Mandela African Institute of Science and Technology, Arusha, Tanzania.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Community knowledge and attitudes and health workers&apos; practices regarding non-malaria febrile illnesses in eastern Tanzania</style></title><secondary-title><style face="normal" font="default" size="100%">PLoS Negl Trop Dis</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">PLoS Negl Trop Dis</style></full-title></periodical><pages><style face="normal" font="default" size="100%">e2896</style></pages><volume><style face="normal" font="default" size="100%">8</style></volume><number><style face="normal" font="default" size="100%">5</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">*Attitude of Health Personnel</style></keyword><keyword><style face="normal" font="default" size="100%">Communicable Diseases/*diagnosis/epidemiology/physiopathology</style></keyword><keyword><style face="normal" font="default" size="100%">Community Health Services/methods/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Cross-Sectional Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Fever/*diagnosis/epidemiology/etiology</style></keyword><keyword><style face="normal" font="default" size="100%">Focus Groups</style></keyword><keyword><style face="normal" font="default" size="100%">*Health Knowledge, Attitudes, Practice</style></keyword><keyword><style face="normal" font="default" size="100%">Health Personnel/*psychology/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Tanzania/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style face="normal" font="default" size="100%">May</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1935-2727 (Print)&#xD;1935-2727</style></isbn><abstract><style face="normal" font="default" size="100%">INTRODUCTION: Although malaria has been the leading cause of fever for many years, with improved control regimes malaria transmission, morbidity and mortality have decreased. Recent studies have increasingly demonstrated the importance of non-malaria fevers, which have significantly improved our understanding of etiologies of febrile illnesses. A number of non-malaria febrile illnesses including Rift Valley Fever, dengue fever, Chikungunya virus infection, leptospirosis, tick-borne relapsing fever and Q-fever have been reported in Tanzania. This study aimed at assessing the awareness of communities and practices of health workers on non-malaria febrile illnesses. METHODS: Twelve focus group discussions with members of communities and 14 in-depth interviews with health workers were conducted in Kilosa district, Tanzania. Transcripts were coded into different groups using MaxQDA software and analyzed through thematic content analysis. RESULTS: The study revealed that the awareness of the study participants on non-malaria febrile illnesses was low and many community members believed that most instances of fever are due to malaria. In addition, the majority had inappropriate beliefs about the possible causes of fever. In most cases, non-malaria febrile illnesses were considered following a negative Malaria Rapid Diagnostic Test (mRDT) result or persistent fevers after completion of anti-malaria dosage. Therefore, in the absence of mRDTs, there is over diagnosis of malaria and under diagnosis of non-malaria illnesses. Shortages of diagnostic facilities for febrile illnesses including mRDTs were repeatedly reported as a major barrier to proper diagnosis and treatment of febrile patients. CONCLUSION: Our results emphasize the need for creating community awareness on other causes of fever apart from malaria. Based on our study, appropriate treatment of febrile patients will require inputs geared towards strengthening of diagnostic facilities, drugs availability and optimal staffing of health facilities.</style></abstract><label><style face="normal" font="default" size="100%">Included by Eman</style></label><notes><style face="normal" font="default" size="100%">1935-2735&#xD;Chipwaza, Beatrice&#xD;Mugasa, Joseph P&#xD;Mayumana, Iddy&#xD;Amuri, Mbaraka&#xD;Makungu, Christina&#xD;Gwakisa, Paul S&#xD;Journal Article&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;PLoS Negl Trop Dis. 2014 May 22;8(5):e2896. doi: 10.1371/journal.pntd.0002896. eCollection 2014 May.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4031176/pdf/pntd.0002896.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC4031176</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1371/journal.pntd.0002896</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2090</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2090</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Choongki, K. I. M.</style></author><author><style face="normal" font="default" size="100%">Sung-Jin, Hong</style></author><author><style face="normal" font="default" size="100%">Chul-Min, A. H. N.</style></author><author><style face="normal" font="default" size="100%">Jung-Sun, K. I. M.</style></author><author><style face="normal" font="default" size="100%">Byeong-Keuk, K. I. M.</style></author><author><style face="normal" font="default" size="100%">Young-Guk, K. O.</style></author><author><style face="normal" font="default" size="100%">Byoung-Wook, Choi</style></author><author><style face="normal" font="default" size="100%">Donghoon, Choi</style></author><author><style face="normal" font="default" size="100%">Yangsoo, Jang</style></author><author><style face="normal" font="default" size="100%">Myeong-Ki, Hong</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Clinical Implications of Moderate Coronary Stenosis on Coronary Computed Tomography Angiography in Patients with Stable Angina</style></title><secondary-title><style face="normal" font="default" size="100%">Yonsei Medical Journal</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Yonsei Medical Journal</style></full-title></periodical><pages><style face="normal" font="default" size="100%">937-944</style></pages><keywords><keyword><style face="normal" font="default" size="100%">Angina, Stable</style></keyword><keyword><style face="normal" font="default" size="100%">Angiography</style></keyword><keyword><style face="normal" font="default" size="100%">Arteries</style></keyword><keyword><style face="normal" font="default" size="100%">Body Weight</style></keyword><keyword><style face="normal" font="default" size="100%">Cohort Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Constriction, Pathologic</style></keyword><keyword><style face="normal" font="default" size="100%">Coronary Angiography</style></keyword><keyword><style face="normal" font="default" size="100%">Coronary Artery Disease</style></keyword><keyword><style face="normal" font="default" size="100%">Coronary Stenosis</style></keyword><keyword><style face="normal" font="default" size="100%">Diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Incidence</style></keyword><keyword><style face="normal" font="default" size="100%">Information Systems</style></keyword><keyword><style face="normal" font="default" size="100%">Prospective Studies</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style face="normal" font="default" size="100%">2018/00</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0513-5796</style></isbn><abstract><style face="normal" font="default" size="100%">PURPOSE: The present study investigated the diagnostic accuracy and clinical implications of moderate stenosis (50–69%, Coronary Artery Disease Reporting and Data System, grade 3) on coronary computed tomography angiography (CCTA), compared with invasive coronary angiography (ICA). MATERIALS AND METHODS: Two hundred and seventy-six patients who underwent ICA due to moderate stenosis alone on CCTA were selected from our prospective registry cohort. RESULTS: Diagnostic concordance between CCTA and ICA was found in only 50 (18%) patients. Among the 396 vessels and 508 segments with moderate stenosis, diagnostic concordance was found in 132 vessels (33%) and 127 segments (25%). Segments with calcified plaque had lower diagnostic concordance than those with mixed or non-calcified plaque (22% vs. 28% vs. 27%, respectively, p=0.001). While calcified plaque burden did not have an influence on severe stenosis (≥70%) on ICA, higher burden of non-calcified plaque was correlated with a greater incidence of ICA-based severe stenosis, which was more frequent in patients with ≥3 segments of non-calcified plaque (75%) than those without non-calcified plaque (22%, p &amp;lt; 0.001). Typical angina and mixed or non-calcified plaque were correlated with a higher incidence of under-diagnosis, while the use of next-generation computed tomography scanners reduced the incidence of under-diagnosis. Increased body weight, left circumflex artery involvement, and calcified plaque were independent factors that increased the risk of over-diagnosis of CCTA. CONCLUSION: The diagnosis of moderate stenosis by CCTA may be limited in estimating the exact degree of ICA-based anatomical stenosis. Unlike calcific burden, non-calcific burden was positively correlated with the presence of severe stenosis on ICA.</style></abstract><urls><related-urls><url><style face="normal" font="default" size="100%">http://dx.doi.org/10.3349/ymj.2018.59.8.937</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2091</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2091</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Chuapai, Y.</style></author><author><style face="normal" font="default" size="100%">See, O.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Y. Chuapai, Ramathibodi Hospital, Bankok, Thailand</style></auth-address><titles><title><style face="normal" font="default" size="100%">Additional benefit of three-dimensional transesophageal echocardiography for detection of the left atrial and left atrial appendage thrombi</style></title><secondary-title><style face="normal" font="default" size="100%">European Heart Journal</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">European Heart Journal</style></full-title></periodical><pages><style face="normal" font="default" size="100%">632</style></pages><volume><style face="normal" font="default" size="100%">30</style></volume><keywords><keyword><style face="normal" font="default" size="100%">thrombus</style></keyword><keyword><style face="normal" font="default" size="100%">transesophageal echocardiography</style></keyword><keyword><style face="normal" font="default" size="100%">cardiology</style></keyword><keyword><style face="normal" font="default" size="100%">society</style></keyword><keyword><style face="normal" font="default" size="100%">heart atrium appendage</style></keyword><keyword><style face="normal" font="default" size="100%">patient</style></keyword><keyword><style face="normal" font="default" size="100%">decision making</style></keyword><keyword><style face="normal" font="default" size="100%">muscle</style></keyword><keyword><style face="normal" font="default" size="100%">diagnostic error</style></keyword><keyword><style face="normal" font="default" size="100%">transducer</style></keyword><keyword><style face="normal" font="default" size="100%">technology</style></keyword><keyword><style face="normal" font="default" size="100%">adult</style></keyword><keyword><style face="normal" font="default" size="100%">male</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2009</style></year></dates><isbn><style face="normal" font="default" size="100%">0195-668X</style></isbn><abstract><style face="normal" font="default" size="100%">Background: Two-dimensional transesophageal echocardiography (2D-TEE) is a well-established test of choice to evaluate left atrial and left atrial appendage (LA/LAA) thrombi. However, it is prone to misdiagnosis both over and underdiagnosis. Current 3-dimensional trans-esophageal echocardiography (3DTEE) using matrix array transducer technology might help overcome this. Objectives The aim of this study was to determine the feasibility and complimentary of Real Time 3D-TEE (RT3D) in determination of LA/LAA thrombi. Methods: Twenty five adult patients (age 55,44%male) referred for 2D-TEE were enrolled for the study. All cases underwent additional RT3D for detection of LA/LAA thrombi. Images of 2D-TEE and 3D-TEE were reviewed offline by 3 reviewers, blinded to each other&apos;s finding. Comparison of the presence of thrombus, possibility of judgment and score of confidence in rating between 2D-TEE and 3D-TEE were done. Results: All patients underwent 2D TEE and 3D matrix-array TEE and without complication. 76% of LAA was identified as unilobed by 2D-TEE and 52% by 3DTEE, 24% was multilobed by 2D-TEE and 48% by 3D-TEE. The kappa score for agreement of positive thrombus by 2D-TEE and 3D-TEE was 0.76. There was 12% (3/25 cases) disagreement of thrombus presence by 2D-TEE but not by 3DTEE, There was 100% agreement of no thrombus detected by both techniques. Conclusions: This study is the first to evaluate the feasibility of 3D-TEE and comparing the detection of LAA thrombus with 2D-TEE. The complex structure of LAA could be more thoroughly evaluated by 3D-TEE with good correlation with 2D-TEE for thrombus detection. 3D-TEE can help decrease the incidence of overdiagnosis in our study (false interpretation of pectinate muscles and spontaneous contrast echo as thrombus).</style></abstract><label><style face="normal" font="default" size="100%">Included by Morty</style></label><notes><style face="normal" font="default" size="100%">L70355567&#xD;2011-03-09</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.embase.com/search/results?subaction=viewrecord&amp;id=L70355567&amp;from=export</style></url><url><style face="normal" font="default" size="100%">http://dx.doi.org/10.1093/eurheartj/ehp415</style></url><url><style face="normal" font="default" size="100%">https://watermark.silverchair.com/ehp415.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAArQwggKwBgkqhkiG9w0BBwagggKhMIICnQIBADCCApYGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMSljRAGsFFsG33JxvAgEQgIICZxNLkGee-gTnjhihxGTnuVzoGO6mc6s8dsBCA5U-4_4olIHKg12WuVMunG4flwGeHxMiE1jOsvWHtZ8Ds1LhGXnFpRr3f9lrHv_5VvC7OvCDnqMmJHjVvRrFcGL9Dn_7U7FIGVg_pu8jZ8pUUEcrpcA-ce9F0FxjPfZsGvT9H3L1Vl14Kd6gikVYT5Adp_KW80-zoEiZy052Kb6O4SCNn7vucqaerJ1LaSZbOSvR160IURD55KSjr6pCsqDijNAb_VxIvqQGFkv9-UlRgR3dASsyoMxjwFLWJGQ0gqdaiWY8DcWQ4cF3BGxMoH88JTuAGe8c6g6Ud3cbrzUDQ13j03xfixI7HPFbNr4el_TuxSMcda8deUn7mOgaXVb6fB7xgs8-nMQtVNuMUkoDQdWLb6bn2aaYU9v0CS2i-vycPYBp-B9GtjdFRzGdoKReisjEUP6bAf5jtAXAzbX3tDLZnpWBWLw_6g9kUyVUFPgWvnE5Y_NEbW6WwhqHisZZBl6_POkvncSI4xPkmrJgf7FpL3u8hPNWXDqKYGvc9YRPX1yOHoMBXrvypfYSSENF_rpNxs0uY-F9mvLFXuMcRf89CaM2V9iXwRYoRfHVQf06xZCv6eCCTLIKN6s-5FHR-0nxoR_jm2TdEgnS5NVvFpK-ElSyRc9OIm7QqzRVonyf2kl5rpEtvgc2q1bPhWzLuTK5kaEKfVf2yGJjJma5AK6DfSCk2lZiCubJr4ulW1PQmNdGU9KWI4YjPHtT8mG5FJmB1lFEpSo7K4NHkQ3qFjaqjfyw5TK6j751R-cICqw0QokRes6Z_APDow</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1093/eurheartj/ehp415</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2092</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2092</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Çil, B.</style></author><author><style face="normal" font="default" size="100%">Kabak, M.</style></author><author><style face="normal" font="default" size="100%">Sezgi, C.</style></author><author><style face="normal" font="default" size="100%">Taylan, M.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">B. Çil, Mardin State Hospital, Mardin, Turkey</style></auth-address><titles><title><style face="normal" font="default" size="100%">Overdiagnosis of asthma in anxious and obes patients</style></title><secondary-title><style face="normal" font="default" size="100%">Turkish Thoracic Journal</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Turkish Thoracic Journal</style></full-title></periodical><pages><style face="normal" font="default" size="100%">S238</style></pages><volume><style face="normal" font="default" size="100%">20</style></volume><keywords><keyword><style face="normal" font="default" size="100%">endogenous compound</style></keyword><keyword><style face="normal" font="default" size="100%">immunoglobulin E</style></keyword><keyword><style face="normal" font="default" size="100%">adult</style></keyword><keyword><style face="normal" font="default" size="100%">anxiety</style></keyword><keyword><style face="normal" font="default" size="100%">asthma</style></keyword><keyword><style face="normal" font="default" size="100%">body mass</style></keyword><keyword><style face="normal" font="default" size="100%">conference abstract</style></keyword><keyword><style face="normal" font="default" size="100%">controlled study</style></keyword><keyword><style face="normal" font="default" size="100%">diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">dyspnea</style></keyword><keyword><style face="normal" font="default" size="100%">eosinophil count</style></keyword><keyword><style face="normal" font="default" size="100%">female</style></keyword><keyword><style face="normal" font="default" size="100%">forced expiratory volume</style></keyword><keyword><style face="normal" font="default" size="100%">forced vital capacity</style></keyword><keyword><style face="normal" font="default" size="100%">gene expression</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">human tissue</style></keyword><keyword><style face="normal" font="default" size="100%">immunoglobulin blood level</style></keyword><keyword><style face="normal" font="default" size="100%">major clinical study</style></keyword><keyword><style face="normal" font="default" size="100%">male</style></keyword><keyword><style face="normal" font="default" size="100%">mental disease</style></keyword><keyword><style face="normal" font="default" size="100%">obesity</style></keyword><keyword><style face="normal" font="default" size="100%">prick test</style></keyword><keyword><style face="normal" font="default" size="100%">protein expression</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2019</style></year></dates><isbn><style face="normal" font="default" size="100%">2149-2530</style></isbn><abstract><style face="normal" font="default" size="100%">Objectives: Shortness of breath is a subjective symptom and is one of the main symptoms of chronic obstructive pulmonary disease. Respiratory symptoms seen in obesity and anxiety may mimic asthma. Obese and anxious patients may be considered as false asthma. Therefore, these patients should be evaluated tests to support the diagnosis of asthma. The present study aims to assess the overdiagnosis of asthma due to obesity and anxiety among a group of asthma patients. Methods: One hundred and sixty six asthma patients over 18 years of age were included in the study. Patients without obesity or psychiatric disease were named Group A, those with obesity or psychiatric disease were named Group B. Demgraphic features, FVC, FEV1, FEV/FVC, PEF values, the presence of reversibility total serum IgE levels, blood eosinophil counts, prick test results and ACT of these two groups were compared Results: The mean age of Group B patients was higher than that of group A (p&lt;0.001).The BMI of the patients in Group B was statistically significantly higher (p&lt;0.001).ACT Score of Group A was significantly higher than that of Group B (p=0.02). Prick test positively rate was higher in Group A than Group B (p=0.001). Serum IgE levels of Group A was significantly higher than that of Group B (p=0.02). Conclusion: The presence of dyspnea on the basis of the diagnosis of asthma causes overdiagnosis in some patients, especially obesity and anxiety. Due to differences in pathogenesis of dyspnea symptoms in obese and psyciatric patients, asthma treatment will not be effective. These patients are considered as false asthma. In these patients, leading to unnecessary drug use and high costs.</style></abstract><notes><style face="normal" font="default" size="100%">L632344714&#xD;2020-07-23</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.embase.com/search/results?subaction=viewrecord&amp;id=L632344714&amp;from=export</style></url><url><style face="normal" font="default" size="100%">http://dx.doi.org/10.5152/TurkThoracJ.2019.238</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.5152/TurkThoracJ.2019.238</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2093</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2093</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Cingillioglu, B.</style></author><author><style face="normal" font="default" size="100%">Gokcu, M.</style></author><author><style face="normal" font="default" size="100%">Goklu, R.</style></author><author><style face="normal" font="default" size="100%">Dicle, N.</style></author><author><style face="normal" font="default" size="100%">Gultekin, E.</style></author><author><style face="normal" font="default" size="100%">Yildirim, Y.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">B. Cingillioglu, Gynecologic Oncology, Ege Maternity and Gynecology Training and Research Hospital, Izmir, Turkey</style></auth-address><titles><title><style face="normal" font="default" size="100%">Outcomes of intra-operative frozen section proven borderline ovarian tumors</style></title><secondary-title><style face="normal" font="default" size="100%">International Journal of Gynecological Cancer</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">International Journal of Gynecological Cancer</style></full-title></periodical><pages><style face="normal" font="default" size="100%">S552</style></pages><volume><style face="normal" font="default" size="100%">21</style></volume><number><style face="normal" font="default" size="100%">12</style></number><keywords><keyword><style face="normal" font="default" size="100%">paraffin</style></keyword><keyword><style face="normal" font="default" size="100%">CA 125 antigen</style></keyword><keyword><style face="normal" font="default" size="100%">frozen section</style></keyword><keyword><style face="normal" font="default" size="100%">oncology</style></keyword><keyword><style face="normal" font="default" size="100%">society</style></keyword><keyword><style face="normal" font="default" size="100%">ovary tumor</style></keyword><keyword><style face="normal" font="default" size="100%">diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">patient</style></keyword><keyword><style face="normal" font="default" size="100%">pathology</style></keyword><keyword><style face="normal" font="default" size="100%">gynecology</style></keyword><keyword><style face="normal" font="default" size="100%">hospital</style></keyword><keyword><style face="normal" font="default" size="100%">diagnostic error</style></keyword><keyword><style face="normal" font="default" size="100%">neoplasm</style></keyword><keyword><style face="normal" font="default" size="100%">diagnostic accuracy</style></keyword><keyword><style face="normal" font="default" size="100%">predictive value</style></keyword><keyword><style face="normal" font="default" size="100%">decision making</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2011</style></year></dates><isbn><style face="normal" font="default" size="100%">1048-891X</style></isbn><abstract><style face="normal" font="default" size="100%">Objective: We assesed the accuracy of frozen section diagnosis and the outcomes of misdiagnosis in borderline ovarian tumors (BOT) according to frozen section analysis. Methods: All pathology reports with BOT in both frozen section and permanent paraffin blocks were analysed between 2000-2011 at Ege Maternity and Gynecology Training and Research Hospital. Frozen section diagnosis and permanent paraffin blocks were compared. Patient and tumor characteristics analysed for diagnostic accuracy. Results: Agrement between frozen section and permanent diagnosis of BOT was observed in 50 of 103 patients. Mean age of patients frozen section result benign was 39,7,borderline 38, malign 50,4. The agreement, sensitivity and positive predictive values of frozen section diagnosis of BOT were 46%, 66% and 65%. Among the 77 patients with frozen section proven BOT, 50 (65%) patients were correctly diagnosed by frozen section analysis. Under diagnosis and over diagnosis occurred in 12 of 77 (16%) and 15 of 77 (20%) respectively. Conclusion: Although frozen section diagnosis agrees with permanent pathology of malignancy in 90-94% of cases over-diagnosis and underdiagnosis are relatively ferquent in frozen proven BOT. Surgical decision making for BOT based on frozen section diagnosis should be done carefully and the other clinical characteristics (age, radiologic findings,ca 125 level etc.) of the patient should be considered.</style></abstract><notes><style face="normal" font="default" size="100%">L70659878&#xD;2012-02-13</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.embase.com/search/results?subaction=viewrecord&amp;id=L70659878&amp;from=export</style></url><url><style face="normal" font="default" size="100%">http://dx.doi.org/10.1097/IGC.0b013e318235bd21</style></url><url><style face="normal" font="default" size="100%">https://ijgc.bmj.com/content/21/Suppl_3/S1</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1097/IGC.0b013e318235bd21</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2094</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2094</key></foreign-keys><ref-type name="Generic">13</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Closa, Cecilia</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Evaluación del uso de Resonancia Magnética Nuclear (RM), para diagnóstico de Cefaleas primarias y secundarias realizadas en el Hospital Oncológico de Córdoba a pacientes mayores de 18 años en el período enero-ciciembre de 211, con anáñisis costo-beneficio en los posibles resultados negativos de la mismas</style></title></titles><pages><style face="normal" font="default" size="100%">64-64</style></pages><keywords><keyword><style face="normal" font="default" size="100%">Cost-Benefit Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Headache Disorders, Primary</style></keyword><keyword><style face="normal" font="default" size="100%">Headache Disorders, Secondary</style></keyword><keyword><style face="normal" font="default" size="100%">Magnetic Resonance Imaging</style></keyword><keyword><style face="normal" font="default" size="100%">Argentina</style></keyword><keyword><style face="normal" font="default" size="100%">Diagnostic Imaging</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style face="normal" font="default" size="100%">2015/00</style></date></pub-dates></dates><label><style face="normal" font="default" size="100%">Included by Eman</style></label><urls><related-urls><url><style face="normal" font="default" size="100%">https://pesquisa.bvsalud.org/gim/resource/en/biblio-871386</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2095</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2095</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Cui, Y.</style></author><author><style face="normal" font="default" size="100%">Mubarik, S.</style></author><author><style face="normal" font="default" size="100%">Li, R.</style></author><author><style face="normal" font="default" size="100%">Nawsherwan,</style></author><author><style face="normal" font="default" size="100%">Yu, C.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Epidemiology and Biostatistics, School of Health Sciences, Wuhan University, 185 Donghu Road, Wuhan, 430071, China.&#xD;Global Health Institute, Wuhan University, Wuhan, 430071, China.&#xD;Department of Preventive Medicine, School of Health Sciences, Wuhan University, Wuhan, Hubei, China.&#xD;Department of Epidemiology and Biostatistics, School of Health Sciences, Wuhan University, 185 Donghu Road, Wuhan, 430071, China. YuCHua@whu.edu.cn.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Trend dynamics of thyroid cancer incidence among China and the U.S. adult population from 1990 to 2017: a joinpoint and age-period-cohort analysis</style></title><secondary-title><style face="normal" font="default" size="100%">BMC Public Health</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">BMC Public Health</style></full-title></periodical><pages><style face="normal" font="default" size="100%">624</style></pages><volume><style face="normal" font="default" size="100%">21</style></volume><number><style face="normal" font="default" size="100%">1</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">China/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Cohort Effect</style></keyword><keyword><style face="normal" font="default" size="100%">Cohort Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Incidence</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">*Thyroid Neoplasms/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">*Age-period-cohort effect</style></keyword><keyword><style face="normal" font="default" size="100%">*Incidence</style></keyword><keyword><style face="normal" font="default" size="100%">*Joinpoint regression analysis</style></keyword><keyword><style face="normal" font="default" size="100%">*Thyroid cancer</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2021</style></year><pub-dates><date><style face="normal" font="default" size="100%">Mar 31</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1471-2458</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: Thyroid cancer (TC) is the most common malignant disease of the endocrine system. Based on the previously published reports, the incidence of TC has been increasing in the past 25 years, and the reason for the increase is not yet clear. The present study aims to reveal the long-term trends and age-period-cohort effects for the incidence of TC in China and the U.S. from 1990 to 2017. METHODS: We examined the trends of TC incidence and the average annual percentage change (AAPC) of rate using the Joinpoint regression analysis in the two countries, for the different genders (men/women) in the Global Burden of Disease (GBD 2017). We further used an age-period-cohort model to analyze age-period-cohort effects on TC incidence. RESULTS: The ASIR of China increased markedly with AAPC of 4.5% (95% confidence interval (CI): 4.0, 5.0%) and 1.8% (1.6, 2.0%) for men and women during 1990-2017. The ASIR of the U. S increased by 1.4% (1.0, 1.8%) and 1.3% (0.9, 1.7%) for men and women from 1990 to 2017.TC increased with the age and period. Aging was one of the most influential factors of TC in China. The age effect increased markedly in the U.S. compared with China. The period effect showed an increase in China while that tended to grow steadily during 1990-2017 in the U.S. The cohort effect peaked in 1963-1967 birth cohorts for men and women in China and declined consistently in the birth cohort in the U.S. CONCLUSION: From 1990 to 2017, due to ionizing radiation and over-diagnosis, age-standardized TC incidence rates in both genders rose in China and the U.S. The standardized incidence rate of women is higher than that of men. It is necessary to provide women with reasonable prevention and protection measures for TC. We need to apply for health services and screening to reduce ionizing radiation.</style></abstract><label><style face="normal" font="default" size="100%">Included by Eman</style></label><notes><style face="normal" font="default" size="100%">1471-2458&#xD;Cui, Yiran&#xD;Mubarik, Sumaira&#xD;Li, Ruijia&#xD;Nawsherwan&#xD;Yu, Chuanhua&#xD;Orcid: 0000-0002-5467-2481&#xD;81773552/National Natural Science Foundation of China/&#xD;2017YFC1200502/the National Key R&amp;amp;D Program of China/&#xD;2018YFC1315302/the National Key R&amp;amp;D Program of China/&#xD;Journal Article&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;BMC Public Health. 2021 Mar 31;21(1):624. doi: 10.1186/s12889-021-10635-w.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010947/pdf/12889_2021_Article_10635.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC8010947</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1186/s12889-021-10635-w</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2096</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2096</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">D&apos;Acremont, V.</style></author><author><style face="normal" font="default" size="100%">Kahama-Maro, J.</style></author><author><style face="normal" font="default" size="100%">Swai, N.</style></author><author><style face="normal" font="default" size="100%">Mtasiwa, D.</style></author><author><style face="normal" font="default" size="100%">Genton, B.</style></author><author><style face="normal" font="default" size="100%">Lengeler, C.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Swiss Tropical and Public Health Institute, Socinstrasse 57, 4002 Basel, Switzerland. valerie.dacremont@unibas.ch</style></auth-address><titles><title><style face="normal" font="default" size="100%">Reduction of anti-malarial consumption after rapid diagnostic tests implementation in Dar es Salaam: a before-after and cluster randomized controlled study</style></title><secondary-title><style face="normal" font="default" size="100%">Malar J</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Malar J</style></full-title></periodical><pages><style face="normal" font="default" size="100%">107</style></pages><volume><style face="normal" font="default" size="100%">10</style></volume><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Aged, 80 and over</style></keyword><keyword><style face="normal" font="default" size="100%">Antimalarials/*administration &amp; dosage</style></keyword><keyword><style face="normal" font="default" size="100%">Chemoprevention/methods</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Child, Preschool</style></keyword><keyword><style face="normal" font="default" size="100%">Cross-Sectional Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Diagnostic Tests, Routine/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Drug Utilization/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Infant</style></keyword><keyword><style face="normal" font="default" size="100%">Infant, Newborn</style></keyword><keyword><style face="normal" font="default" size="100%">Malaria/*diagnosis/*drug therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Prescriptions/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Prospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Tanzania</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2011</style></year><pub-dates><date><style face="normal" font="default" size="100%">Apr 29</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1475-2875</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: Presumptive treatment of all febrile patients with anti-malarials leads to massive over-treatment. The aim was to assess the effect of implementing malaria rapid diagnostic tests (mRDTs) on prescription of anti-malarials in urban Tanzania. METHODS: The design was a prospective collection of routine statistics from ledger books and cross-sectional surveys before and after intervention in randomly selected health facilities (HF) in Dar es Salaam, Tanzania. The participants were all clinicians and their patients in the above health facilities. The intervention consisted of training and introduction of mRDTs in all three hospitals and in six HF. Three HF without mRDTs were selected as matched controls. The use of routine mRDT and treatment upon result was advised for all patients complaining of fever, including children under five years of age. The main outcome measures were: (1) anti-malarial consumption recorded from routine statistics in ledger books of all HF before and after intervention; (2) anti-malarial prescription recorded during observed consultations in cross-sectional surveys conducted in all HF before and 18 months after mRDT implementation. RESULTS: Based on routine statistics, the amount of artemether-lumefantrine blisters used post-intervention was reduced by 68% (95%CI 57-80) in intervention and 32% (9-54) in control HF. For quinine vials, the reduction was 63% (54-72) in intervention and an increase of 2.49 times (1.62-3.35) in control HF. Before-and-after cross-sectional surveys showed a similar decrease from 75% to 20% in the proportion of patients receiving anti-malarial treatment (Risk ratio 0.23, 95%CI 0.20-0.26). The cluster randomized analysis showed a considerable difference of anti-malarial prescription between intervention HF (22%) and control HF (60%) (Risk ratio 0.30, 95%CI 0.14-0.70). Adherence to test result was excellent since only 7% of negative patients received an anti-malarial. However, antibiotic prescription increased from 49% before to 72% after intervention (Risk ratio 1.47, 95%CI 1.37-1.59). CONCLUSIONS: Programmatic implementation of mRDTs in a moderately endemic area reduced drastically over-treatment with anti-malarials. Properly trained clinicians with adequate support complied with the recommendation of not treating patients with negative results. Implementation of mRDT should be integrated hand-in-hand with training on the management of other causes of fever to prevent irrational use of antibiotics.</style></abstract><notes><style face="normal" font="default" size="100%">1475-2875&#xD;D&apos;Acremont, Valérie&#xD;Kahama-Maro, Judith&#xD;Swai, Ndeniria&#xD;Mtasiwa, Deo&#xD;Genton, Blaise&#xD;Lengeler, Christian&#xD;Journal Article&#xD;Randomized Controlled Trial&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Malar J. 2011 Apr 29;10:107. doi: 10.1186/1475-2875-10-107.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108934/pdf/1475-2875-10-107.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC3108934</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1186/1475-2875-10-107</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2097</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2097</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Dağlar, B.</style></author><author><style face="normal" font="default" size="100%">Delialioğlu, O. M.</style></author><author><style face="normal" font="default" size="100%">Ceyhan, E.</style></author><author><style face="normal" font="default" size="100%">Ozdemir, G.</style></author><author><style face="normal" font="default" size="100%">Taşbaş, B. A.</style></author><author><style face="normal" font="default" size="100%">Bayrakci, K.</style></author><author><style face="normal" font="default" size="100%">Günel, U.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Orthopedics and Traumatology (4. Ortopedi ve Travmatoloji Kliniği), Ankara Numune Training and Research Hospital, Ankara, Turkey. budugul@yahoo.com</style></auth-address><titles><title><style face="normal" font="default" size="100%">[Superfluous computed tomography utilization for the evaluation of the pelvis and spinal column in an orthopedic emergency department]</style></title><secondary-title><style face="normal" font="default" size="100%">Acta Orthop Traumatol Turc</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Acta Orthop Traumatol Turc</style></full-title></periodical><pages><style face="normal" font="default" size="100%">59-63</style></pages><volume><style face="normal" font="default" size="100%">42</style></volume><number><style face="normal" font="default" size="100%">1</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Aged, 80 and over</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Emergency Treatment/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Medical Records</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Orthopedic Procedures/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">*Outcome Assessment, Health Care</style></keyword><keyword><style face="normal" font="default" size="100%">Pelvis/*diagnostic imaging/injuries</style></keyword><keyword><style face="normal" font="default" size="100%">Retrospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Spinal Injuries/*diagnostic imaging/*epidemiology/etiology</style></keyword><keyword><style face="normal" font="default" size="100%">Tomography, X-Ray Computed/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Turkey/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Unnecessary Procedures/statistics &amp; numerical data</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2008</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jan-Feb</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1017-995X (Print)&#xD;1017-995x</style></isbn><abstract><style face="normal" font="default" size="100%">OBJECTIVES: This study was designed to investigate the frequency of requests for computed tomography (CT) examination of the spinal column and pelvis in our emergency orthopedic department, the reasons of requests, and the rates of positive and negative CT examinations. METHODS: We retrospectively reviewed patients for whom a request for CT examination was made by the emergency orthopedic department within a year (September 2005- 2006). The reasons for CT requests, findings in CT reports, and age and sex of the patients were recorded. Findings unrelated and related to the original request denoted a negative and positive CT examination, respectively. RESULTS: Of 24,378 admissions to our emergency orthopedic department, a CT scan was requested in 1,295 patients (5.3%). In 817 patients (63.1%), CT examination involved the pelvis or the spinal column. Of these, 418 CT scans (51.2%) yielded a negative result. The mean age of the patients with a negative CT scan was significantly lower than those having a positive CT scan (40.7 vs 45.1 years; p=0.001). There was no significant difference with respect to sex between patients having negative and positive CT findings (p=0.670). Compared to pelvis CT scans, the frequency of negative CTs was significantly higher for spinal column examinations (p&lt;0.001). The incidence of negative CT scans for upper thoracic and cervical vertebrae was significantly higher than that found for lower thoracic and lumbar regions (p&lt;0.001). CONCLUSION: The high incidence of negative CT scans documented for pelvic and spinal column examinations underlines the need for measures to avoid superfluous CT requests in emergency departments.</style></abstract><label><style face="normal" font="default" size="100%">Included by Loai</style></label><notes><style face="normal" font="default" size="100%">Dağlar, Bülent&#xD;Delialioğlu, Onder Murat&#xD;Ceyhan, Erman&#xD;Ozdemir, Güzelali&#xD;Taşbaş, Bülent Adil&#xD;Bayrakci, Kenan&#xD;Günel, Uğur&#xD;Evaluation Study&#xD;Journal Article&#xD;Turkey&#xD;Acta Orthop Traumatol Turc. 2008 Jan-Feb;42(1):59-63. doi: 10.3944/aott.2008.059.</style></notes><urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.3944/aott.2008.059</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2098</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2098</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Dai, S.</style></author><author><style face="normal" font="default" size="100%">Huang, B.</style></author><author><style face="normal" font="default" size="100%">Zou, Y.</style></author><author><style face="normal" font="default" size="100%">Guo, J.</style></author><author><style face="normal" font="default" size="100%">Liu, Z.</style></author><author><style face="normal" font="default" size="100%">Pi, D.</style></author><author><style face="normal" font="default" size="100%">Qiu, Y.</style></author><author><style face="normal" font="default" size="100%">Xiao, C.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Emergency Department, The Third People&apos;s Hospital of Huizhou, Huizhou Department of Cardiology, the Third People&apos;s Hospital of Huizhou, Guangdong Province, China.</style></auth-address><titles><title><style face="normal" font="default" size="100%">The HEART score is useful to predict cardiovascular risks and reduces unnecessary cardiac imaging in low-risk patients with acute chest pain</style></title><secondary-title><style face="normal" font="default" size="100%">Medicine (Baltimore)</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Medicine (Baltimore)</style></full-title></periodical><pages><style face="normal" font="default" size="100%">e10844</style></pages><volume><style face="normal" font="default" size="100%">97</style></volume><number><style face="normal" font="default" size="100%">22</style></number><keywords><keyword><style face="normal" font="default" size="100%">Acute Disease</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Cardiac Imaging Techniques/methods/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Cardiovascular Diseases/complications/*diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">Chest Pain/*diagnosis/etiology</style></keyword><keyword><style face="normal" font="default" size="100%">China</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Heart/diagnostic imaging</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Predictive Value of Tests</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Assessment/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Sensitivity and Specificity</style></keyword><keyword><style face="normal" font="default" size="100%">*Severity of Illness Index</style></keyword><keyword><style face="normal" font="default" size="100%">Unnecessary Procedures/methods/statistics &amp; numerical data</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jun</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0025-7974 (Print)&#xD;0025-7974</style></isbn><abstract><style face="normal" font="default" size="100%">The present study was to investigate whether the HEART score can be used to evaluate cardiovascular risks and reduce unnecessary cardiac imaging in China.Acute coronary syndrome patients with the thrombosis in myocardial infarction risk score &lt; 2 were enrolled in the emergency department. Baseline data were collected and a HEART score was determined in each participant during the indexed emergency visit. Participants were follow-up for 30 days after discharge and the studied endpoints included acute myocardial infarction, cardiovascular mortality and all-cause mortality.A total of 244 patients were enrolled and 2 was loss of follow-up. The mean age was 50.4 years old and male patients accounted for 64.5%. Substernal pain and featured as pressure of the pain accounted for 34.3% and 39.3%, respectively. After 30 days&apos; follow-up, no patient in the low-risk HEART score group and 2 patients (1.5%) in the high risk HEART score group had cardiovascular events. The sensitivity of HEART score to predict cardiovascular events was 100% and the specificity was 46.7%. The potential unnecessary cardiac testing was 46.3%. Cox proportional hazards regression analysis showed that per one category increase of the HEART score was associated with nearly 1.3-fold risk of cardiovascular events.In the low-risk acute chest pain patients, the HEART score is useful to physicians in evaluating the risk of cardiovascular events within the first 30 days. In addition, the HEART score is also useful in reducing the unnecessary cardiac imaging.</style></abstract><notes><style face="normal" font="default" size="100%">1536-5964&#xD;Dai, Siping&#xD;Huang, Bo&#xD;Zou, Yunliang&#xD;Guo, Jianbin&#xD;Liu, Ziyong&#xD;Pi, Dangyu&#xD;Qiu, Yunhong&#xD;Xiao, Chun&#xD;Evaluation Study&#xD;Journal Article&#xD;Medicine (Baltimore). 2018 Jun;97(22):e10844. doi: 10.1097/MD.0000000000010844.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392761/pdf/medi-97-e10844.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC6392761 authors have no conflicts of interest to disclose.</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1097/md.0000000000010844</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2099</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2099</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">De Broe, M. E.</style></author><author><style face="normal" font="default" size="100%">Gharbi, M. B.</style></author><author><style face="normal" font="default" size="100%">Elseviers, M.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Laboratory of Pathophysiology, University of Antwerp, Universiteitsplein 1, B-2610, Wilrijk, Belgium. Electronic address: marc.debroe@uantwerpen.be.&#xD;Faculty of Medicine and Pharmacy, University Hassan II, Casablanca, Morocco.&#xD;Center for Research and Innovation in Care, University of Antwerp, Belgium.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Maremar, prevalence of chronic kidney disease, how to avoid over-diagnosis and under-diagnosis</style></title><secondary-title><style face="normal" font="default" size="100%">Nephrol Ther</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Nephrol Ther</style></full-title></periodical><pages><style face="normal" font="default" size="100%">S57-63</style></pages><volume><style face="normal" font="default" size="100%">12 Suppl 1</style></volume><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Diagnosis, Differential</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Follow-Up Studies</style></keyword><keyword><style face="normal" font="default" size="100%">*Glomerular Filtration Rate</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Morocco/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Prevalence</style></keyword><keyword><style face="normal" font="default" size="100%">Renal Insufficiency, Chronic/*diagnosis/*epidemiology/physiopathology</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Ckd</style></keyword><keyword><style face="normal" font="default" size="100%">Chronic kidney disease</style></keyword><keyword><style face="normal" font="default" size="100%">Diabetes</style></keyword><keyword><style face="normal" font="default" size="100%">Hypertension</style></keyword><keyword><style face="normal" font="default" size="100%">Morocco</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity</style></keyword><keyword><style face="normal" font="default" size="100%">Over-diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">Under-diagnosis</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style face="normal" font="default" size="100%">Apr</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1769-7255</style></isbn><abstract><style face="normal" font="default" size="100%">Chronic kidney disease is considered as a major public health problem. Recent studies mention a prevalence rate between 8%-12%. Several editorials, comments, short reviews described the weaknesses (lack of confirmation of proteinuria, and of chronicity of decreased estimated glomerular filtration rate) of a substantial number of studies and the irrational of using a single arbitrary set point, i.e. diagnosis of chronic kidney disease whenever the estimated glomerular filtration rate is less than 60mL/min/1.73m(2). Maremar (Maladies rénales chroniques au Maroc) is a prevalence study of chronic kidney disease, hypertension, diabetes and obesity in a randomized, representative, high response rate (85%), sample of the adult population of Morocco, strictly applying the Kidney Disease: Improving Global Outcomes (KDIGO) criteria. Compared to the vast majority of the available studies, Maremar has a low prevalence of chronic kidney disease (2.9% adjusted to the actual adult population of Morocco). The population pyramid, and particularly the confirmation of proteinuria and &quot;chronicity&quot; of the decreased estimated glomerular filtration rate are the main reasons for this low prevalence of chronic kidney disease. The choice of arbitrary single threshold of estimated glomerular filtration rate for classifying stage 3-5 chronic kidney disease inevitably leads to &quot;over-diagnosis&quot; (false positives) of the disease in the elderly, particularly those without proteinuria, hematuria or hypertension, and to &quot;under-diagnosed&quot; (false negatives) in younger individuals with an estimated glomerular filtration rate above 60mL/min/1.73m(2) and below the 3rd percentile of their age/gender category. There is an urgent need for quality studies using in a correct way the recent KDIGO guidelines when investigating the prevalence of chronic kidney disease, in order to avoid a 50 to 100% overestimation of a disease state with potential dramatic consequences. The combination of the general population screening encompassing four different major health problems in the same screening procedure, using the correct methodologies and procedures, combined with a prevention/follow-up program results in a clinically/scientifically relevant program.</style></abstract><notes><style face="normal" font="default" size="100%">1872-9177&#xD;De Broe, Marc E&#xD;Gharbi, Mohammed Benghanem&#xD;Elseviers, Monique&#xD;Comparative Study&#xD;Journal Article&#xD;France&#xD;Nephrol Ther. 2016 Apr;12 Suppl 1:S57-63. doi: 10.1016/j.nephro.2016.02.013. Epub 2016 Mar 11.</style></notes><urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1016/j.nephro.2016.02.013</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2100</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2100</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Dejsomritrutai, W.</style></author><author><style face="normal" font="default" size="100%">Chuaychoo, B.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">W. Dejsomritrutai, Division of Respiratory Disease and Tuberculosis, Department of Medicine, Siriraj Hospital, 2 Wanglang Road, Bangkoknoi, Bangkok, Thailand</style></auth-address><titles><title><style face="normal" font="default" size="100%">Impact of GLI-2012 spirometric references and lower limit of normal on prevalence of COPD in older urban Thai persons</style></title><secondary-title><style face="normal" font="default" size="100%">Journal of the Medical Association of Thailand</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Journal of the Medical Association of Thailand</style></full-title></periodical><pages><style face="normal" font="default" size="100%">276-281</style></pages><volume><style face="normal" font="default" size="100%">99</style></volume><number><style face="normal" font="default" size="100%">3</style></number><keywords><keyword><style face="normal" font="default" size="100%">aged</style></keyword><keyword><style face="normal" font="default" size="100%">airway obstruction</style></keyword><keyword><style face="normal" font="default" size="100%">article</style></keyword><keyword><style face="normal" font="default" size="100%">breathing</style></keyword><keyword><style face="normal" font="default" size="100%">chronic obstructive lung disease</style></keyword><keyword><style face="normal" font="default" size="100%">cross-sectional study</style></keyword><keyword><style face="normal" font="default" size="100%">data analysis</style></keyword><keyword><style face="normal" font="default" size="100%">demography</style></keyword><keyword><style face="normal" font="default" size="100%">diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">female</style></keyword><keyword><style face="normal" font="default" size="100%">forced expiratory volume</style></keyword><keyword><style face="normal" font="default" size="100%">forced vital capacity</style></keyword><keyword><style face="normal" font="default" size="100%">global initiative for obstructive lung disease</style></keyword><keyword><style face="normal" font="default" size="100%">health care planning</style></keyword><keyword><style face="normal" font="default" size="100%">health impact assessment</style></keyword><keyword><style face="normal" font="default" size="100%">health survey</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">lower limit of normal</style></keyword><keyword><style face="normal" font="default" size="100%">major clinical study</style></keyword><keyword><style face="normal" font="default" size="100%">male</style></keyword><keyword><style face="normal" font="default" size="100%">mathematical parameters</style></keyword><keyword><style face="normal" font="default" size="100%">pneumotachograph</style></keyword><keyword><style face="normal" font="default" size="100%">predictive value</style></keyword><keyword><style face="normal" font="default" size="100%">prevalence</style></keyword><keyword><style face="normal" font="default" size="100%">reference value</style></keyword><keyword><style face="normal" font="default" size="100%">Research Diagnostic Criteria</style></keyword><keyword><style face="normal" font="default" size="100%">smoking</style></keyword><keyword><style face="normal" font="default" size="100%">spirometry</style></keyword><keyword><style face="normal" font="default" size="100%">Thailand</style></keyword><keyword><style face="normal" font="default" size="100%">thorax radiography</style></keyword><keyword><style face="normal" font="default" size="100%">urban population</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2016</style></year></dates><isbn><style face="normal" font="default" size="100%">0125-2208</style></isbn><abstract><style face="normal" font="default" size="100%">Background: Previous analysis of survey data from a study in older urban Thai persons reported prevalence of chronic obstructive pulmonary disease (COPD) of 7.11% according to formerly recommended criteria that used fixed ratio (70%) of pre-bronchodilator FEV1/FVC as the cut-off value. In 2012, the Global Lung Initiative (GLI)-2012 equations for spirometric reference were established and the diagnostic criteria for COPD were changed. Objective: To reanalyze the data collected during the 2002 respiratory health survey to determine prevalence of COPD in older urban Thai persons according to the new GLI-2012 equations. Material and Method: Demographic and clinical data of 3,094 subjects aged ≥60 years from 124 urban communities were re-analyzed. Prevalence of COPD determined by post-bronchodilator FEV1/FVC and GLI-2012 equations using lower limit of normal by the Lambda-Mu-Sigma method (LMS-LLN) was compared to COPD prevalence findings based on criteria used in previous analysis. Results: Prevalence of COPD in the study population using post-bronchodilator FEV1/FVC and LMS-LLN was 6.50% (95% CI: 5.63-7.37), compared with 7.82% (95% CI: 6.87-8.77) when fixed ratio (70%) of FEV1/FVC was used as cut-off. Diagnostic agreement of COPD between LMS-LLN and fixed ratio was high (kappa 0.88, p&lt;0.0001). However, 45/242 (18.6%) subjects diagnosed as COPD by fixed ratio criteria were considered as “over-diagnosed” when LMS-LLN was used as the standard cut-off. The same comparison applied to subjects aged ≥80 years revealed an increased rate of over-diagnosis to 7/22 (31.8%) subjects. Higher agreement was observed (kappa 0.95, p&lt;0.0001) when comparing between cut-offs for diagnosis of “at least GOLD stage II” COPD. Conclusion: Prevalence of COPD in older urban Thai persons was lower when LMS-LLN was substituted for fixed ratio (70%) of FEV1/FVC. Agreement in COPD diagnosis between both criteria was high, but a substantial proportion of subjects may be over-diagnosed.</style></abstract><label><style face="normal" font="default" size="100%">Included by Loai</style></label><notes><style face="normal" font="default" size="100%">L609856364&#xD;2016-04-19&#xD;2016-05-03</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.embase.com/search/results?subaction=viewrecord&amp;id=L609856364&amp;from=export</style></url></related-urls></urls><custom5><style face="normal" font="default" size="100%">27276738</style></custom5></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2101</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2101</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Demir, S.</style></author><author><style face="normal" font="default" size="100%">Zorbozan, N.</style></author><author><style face="normal" font="default" size="100%">Basak, E.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">N. Zorbozan, Pamukkale University, Department of Medical Biochemistry, Denizli, Turkey</style></auth-address><titles><title><style face="normal" font="default" size="100%">Unnecessary repeated total cholesterol tests in biochemistry laboratory</style></title><secondary-title><style face="normal" font="default" size="100%">Biochemia Medica</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Biochemia Medica</style></full-title></periodical><pages><style face="normal" font="default" size="100%">77-81</style></pages><volume><style face="normal" font="default" size="100%">26</style></volume><number><style face="normal" font="default" size="100%">1</style></number><keywords><keyword><style face="normal" font="default" size="100%">article</style></keyword><keyword><style face="normal" font="default" size="100%">biochemistry</style></keyword><keyword><style face="normal" font="default" size="100%">cholesterol blood level</style></keyword><keyword><style face="normal" font="default" size="100%">health care cost</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">laboratory diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">major clinical study</style></keyword><keyword><style face="normal" font="default" size="100%">reference value</style></keyword><keyword><style face="normal" font="default" size="100%">unnecessary procedure</style></keyword><keyword><style face="normal" font="default" size="100%">unnecessary repeated cholesterol test</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2016</style></year></dates><isbn><style face="normal" font="default" size="100%">1330-0962</style></isbn><abstract><style face="normal" font="default" size="100%">Introduction: We aimed to determine the number of repeated cholesterol (RC) tests and the ratio of unnecessary-repeated cholesterol (URC) tests among patients admitted to Pamukkale University Hospital (Denizli, Turkey) and provide solutions to avoid URC testing. Materials and methods: Total cholesterol (T-cholesterol) tests (N=86,817) between June 2014 and May 2015 were evaluated. The tests performed more than once per patient were determined as RC test (N=28,811). RC test with an interval shorter than 4 weeks were determined as URC test (N=3968) according to the shortest retest interval stated in ACC/AHA blood cholesterol guideline. RC testing included internal medicine, surgery and paediatric outpatients and inpatients. Reference change value (RCV) of total cholesterol was calculated. Results: The 33.1% of the T-cholesterol tests were RC tests (N=28,811), 13.7% of them were URC tests (N=3968). Our RCV value was 25%. The percentage change between consecutive tests was less than RCV in 86.1% (N=3418) of URC tests. URC tests were performed more frequently in patients with desirable total cholesterol value (P&lt;0.001). Conclusion: There is a significant part of repeated T-cholesterol tests requested in our hospital. URC test requests can be evaluated by laboratories and the obtained data should be shared with clinicians. Laboratories can calculate RCV for the tests they performed and report this value with the test result. To prevent from URC tests, a warning plug-in can be added to hospital information software in accordance with guidelines to prevent from URC test requests.</style></abstract><label><style face="normal" font="default" size="100%">Included by Hannah</style></label><notes><style face="normal" font="default" size="100%">L608320295&#xD;2016-02-18&#xD;2016-02-23</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.embase.com/search/results?subaction=viewrecord&amp;id=L608320295&amp;from=export</style></url><url><style face="normal" font="default" size="100%">http://dx.doi.org/10.11613/BM.2016.007</style></url><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4783093/pdf/bm-26-77.pdf</style></url></related-urls></urls><custom5><style face="normal" font="default" size="100%">26981021</style></custom5><electronic-resource-num><style face="normal" font="default" size="100%">10.11613/BM.2016.007</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2102</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2102</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Diab, N.</style></author><author><style face="normal" font="default" size="100%">Gershon, A. S.</style></author><author><style face="normal" font="default" size="100%">Sin, D. D.</style></author><author><style face="normal" font="default" size="100%">Tan, W. C.</style></author><author><style face="normal" font="default" size="100%">Bourbeau, J.</style></author><author><style face="normal" font="default" size="100%">Boulet, L. P.</style></author><author><style face="normal" font="default" size="100%">Aaron, S. D.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">1 The Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada.&#xD;2 Department of Medicine, The University of Toronto, Toronto, Ontario, Canada.&#xD;3 Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.&#xD;4 Department of Medicine, McGill University, Montreal, Quebec, Canada; and.&#xD;5 Centre de Recherche, Hopital Laval, Universite Laval, Quebec City, Quebec, Canada.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Underdiagnosis and Overdiagnosis of Chronic Obstructive Pulmonary Disease</style></title><secondary-title><style face="normal" font="default" size="100%">Am J Respir Crit Care Med</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Am J Respir Crit Care Med</style></full-title></periodical><pages><style face="normal" font="default" size="100%">1130-1139</style></pages><volume><style face="normal" font="default" size="100%">198</style></volume><number><style face="normal" font="default" size="100%">9</style></number><keywords><keyword><style face="normal" font="default" size="100%">Asia</style></keyword><keyword><style face="normal" font="default" size="100%">Australia</style></keyword><keyword><style face="normal" font="default" size="100%">Diagnostic Errors/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Europe</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Internationality</style></keyword><keyword><style face="normal" font="default" size="100%">Medical Overuse/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">North America</style></keyword><keyword><style face="normal" font="default" size="100%">Pulmonary Disease, Chronic Obstructive/*diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">South America</style></keyword><keyword><style face="normal" font="default" size="100%">Spirometry</style></keyword><keyword><style face="normal" font="default" size="100%">*chronic obstructive pulmonary disease</style></keyword><keyword><style face="normal" font="default" size="100%">*misdiagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">*overdiagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">*underdiagnosis</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style face="normal" font="default" size="100%">Nov 1</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1073-449x</style></isbn><abstract><style face="normal" font="default" size="100%">Chronic obstructive pulmonary disease (COPD) is regarded as one of the leading causes of morbidity and mortality across the world, yet its proper diagnosis remains a challenge. Community-based population studies conducted in North and South America, Europe, Australia, and Asia have revealed that 10% to 12% of adults aged 40 years or older have evidence of persistent airflow limitation on spirometry, but only 20% to 30% of these subjects have been diagnosed with COPD. These studies collectively suggest that approximately 70% of COPD worldwide may be underdiagnosed. Conversely, other studies have shown that between 30% and 60% of patients with a previous physician diagnosis of COPD do not actually have the disease, and hence they have been overdiagnosed. In this review, we define under- and overdiagnosis and explore the prevalence and the burden of under- and overdiagnosis of COPD on both patients and healthcare systems. We further describe potential solutions to reduce the incidence of under- and overdiagnosis of COPD.</style></abstract><notes><style face="normal" font="default" size="100%">1535-4970&#xD;Diab, Nermin&#xD;Gershon, Andrea S&#xD;Orcid: 0000-0002-0246-594x&#xD;Sin, Don D&#xD;Tan, Wan C&#xD;Bourbeau, Jean&#xD;Boulet, Louis-Philippe&#xD;Aaron, Shawn D&#xD;Orcid: 0000-0002-4762-3542&#xD;Journal Article&#xD;Review&#xD;United States&#xD;Am J Respir Crit Care Med. 2018 Nov 1;198(9):1130-1139. doi: 10.1164/rccm.201804-0621CI.</style></notes><urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1164/rccm.201804-0621CI</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2103</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2103</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Diaconu, I. A.</style></author><author><style face="normal" font="default" size="100%">Stratan, L. M.</style></author><author><style face="normal" font="default" size="100%">Nichita, L.</style></author><author><style face="normal" font="default" size="100%">Aramă, V.</style></author><author><style face="normal" font="default" size="100%">Moroti Constantinescu, V. R.</style></author><author><style face="normal" font="default" size="100%">Diaconu, A. I.</style></author><author><style face="normal" font="default" size="100%">Ion, D. A.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Infectious Diseases Clinic III, &quot;Prof. Dr. Matei Bals&quot; National Institute for Infectious Diseases, Bucharest, Romania; diaconuia@yahoo.com.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Diagnosing HIV-associated cerebral diseases - the importance of Neuropathology in understanding HIV</style></title><secondary-title><style face="normal" font="default" size="100%">Rom J Morphol Embryol</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Rom J Morphol Embryol</style></full-title></periodical><pages><style face="normal" font="default" size="100%">745-750</style></pages><volume><style face="normal" font="default" size="100%">57</style></volume><number><style face="normal" font="default" size="100%">2 Suppl</style></number><keywords><keyword><style face="normal" font="default" size="100%">AIDS Dementia Complex/*diagnosis/*pathology/virology</style></keyword><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Child, Preschool</style></keyword><keyword><style face="normal" font="default" size="100%">Cytomegalovirus Infections/pathology</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Infant</style></keyword><keyword><style face="normal" font="default" size="100%">Leukoencephalopathy, Progressive Multifocal/pathology</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Neuropathology</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2016</style></year></dates><isbn><style face="normal" font="default" size="100%">1220-0522</style></isbn><abstract><style face="normal" font="default" size="100%">The study aims to compare two aspects concerning the diagnosis of acquired immune deficiency syndrome (AIDS)-associated central nervous system (CNS) pathology (neuroAIDS): clinical diagnoses issued ante mortem with pathology results issued post mortem. The group of 39 human immunodeficiency virus (HIV)-positive patients was created over 23 years and is limited by marked heterogeneity. The enrolled cases were treated at the &quot;Prof. Dr. Matei Bals&quot; National Institute for Infectious Diseases, Bucharest, Romania, deceased due to AIDS-related complications and underwent brain necropsies performed in the Pathology Laboratory at the &quot;Colentina&quot; Clinical Hospital, Bucharest. The level of superposition between clinical and the necroptic diagnoses of neurological AIDS-associated diseases was: 60% for progressive multifocal leukoencephalopathy (PML), 50% for cerebral cryptococcosis, 33% for cerebral toxoplasmosis, 20% for cerebral lymphoma, null for cerebral tuberculosis, HIV encephalopathy (HIVE), neurosyphilis and cytomegalovirus cerebral infection. Half of the cases without an AIDS-associated CNS lesion were previously clinically overdiagnosed. We observed that the rate of overdiagnosis concerning an AIDS-associated cerebral illness has risen from 36% in 1993 to 124% in 2015, an elevation with statistical relevance [p=0.037, confidence interval (CI) 95%]. The rate of underdiagnosis has slowly risen from 24% in 1993 to 40% in 2015, however, with no statistical relevance. The rate of clinical confirmation has been stagnant in linear regression from 1993 to 2015. The results of our study reveal a gap between ante mortem and post mortem diagnoses, with many instances of overdiagnosis and underdiagnosis of several major AIDS-associated CNS illnesses, highlighting the need for a more detailed, multidisciplinary approach of neuroAIDS.</style></abstract><notes><style face="normal" font="default" size="100%">2066-8279&#xD;Diaconu, Ioan Alexandru&#xD;Stratan, LaurenŢiu MihăiŢă&#xD;Nichita, Luciana&#xD;Aramă, Victoria&#xD;Moroti Constantinescu, Valentina Ruxandra&#xD;Diaconu, Alexandra Ioana&#xD;Ion, Daniela Adriana&#xD;Journal Article&#xD;Romania&#xD;Rom J Morphol Embryol. 2016;57(2 Suppl):745-750.</style></notes><urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2104</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2104</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Dimpe, M. W.</style></author><author><style face="normal" font="default" size="100%">Maphakisa, M. V.</style></author><author><style face="normal" font="default" size="100%">Matika, M. D.</style></author><author><style face="normal" font="default" size="100%">Prinsloo, E. A. M.</style></author><author><style face="normal" font="default" size="100%">Shabalala, S. L. N. B. joubert G.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Doctors&amp;#039; Use of Laboratory Tests in the Diagnosis and Treatment of Patients</style></title><secondary-title><style face="normal" font="default" size="100%">Southern African Journal of Infectious Diseases</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Southern African Journal of Infectious Diseases</style></full-title></periodical><keywords><keyword><style face="normal" font="default" size="100%">Laboratories</style></keyword><keyword><style face="normal" font="default" size="100%">Methods</style></keyword><keyword><style face="normal" font="default" size="100%">Therapeutics</style></keyword><keyword><style face="normal" font="default" size="100%">Inpatients</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2010</style></year><pub-dates><date><style face="normal" font="default" size="100%">2010/00</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">2220-1084</style></isbn><abstract><style face="normal" font="default" size="100%">The provincial health budgets in South Africa are under enormous pressure and; annually; budgets are exceeded by most hospitals and clinics. Laboratory tests requested by clinicians are contributing to the problem of over-expenditure. The aim of this study was to determine from patients&amp;#039; files whether doctors were using laboratory tests prudently during their treatment of patients in the outpatient department (OPD) of the National District Hospital in Bloemfontein. A descriptive study was carried out using all the files of patients who visited the OPD in a three-month period (1 July to 30 September 2005) for whom laboratory tests were requested by the attending physician. The majority (31.3) of patients for whom laboratory tests were requested presented to the OPD with cardiovascular complaints or diagnoses; followed by endocrine (27.8) and musculoskeletal (16.3) complaints or diagnoses. Between one and three tests were requested for most patients; i.e. 33and 15; respectively. The most frequently requested tests were erythrocyte sedimentation rate (8.1); urea and electrolytes (7.7); urine microscopy; culture and sensitivity (6.4); cholesterol (6.1); full blood count (5.7) and thyroid profile (TSH 4.6; T4 2.6and thyroid functions 2.3). In 70.4of cases; results were documented and; in 59.1; the physician&amp;#039;s management plans indicated the incorporation of laboratory test results into the patient&amp;#039;s treatment regimen. Our findings indicated inappropriate documentation and application of test results. Interventions to improve physician behaviour include education; guidelines; feedback; leadership and redesign of requisition forms.</style></abstract><urls><related-urls><url><style face="normal" font="default" size="100%">http://www.sajei.co.za/index.php/SAJEI/article/view/198/299.pdf</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2105</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2105</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Ding, T.</style></author><author><style face="normal" font="default" size="100%">Hardiman, P. J.</style></author><author><style face="normal" font="default" size="100%">Petersen, I.</style></author><author><style face="normal" font="default" size="100%">Wang, F. F.</style></author><author><style face="normal" font="default" size="100%">Qu, F.</style></author><author><style face="normal" font="default" size="100%">Baio, G.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">F. Qu, Women&apos;s Hospital, School of Medicine, Zhejiang University, Hangzhou, China</style></auth-address><titles><title><style face="normal" font="default" size="100%">The prevalence of polycystic ovary syndrome in reproductiveaged women of different ethnicity: A systematic review and meta-analysis</style></title><secondary-title><style face="normal" font="default" size="100%">Oncotarget</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Oncotarget</style></full-title></periodical><pages><style face="normal" font="default" size="100%">96351-96358</style></pages><volume><style face="normal" font="default" size="100%">8</style></volume><number><style face="normal" font="default" size="100%">56</style></number><keywords><keyword><style face="normal" font="default" size="100%">article</style></keyword><keyword><style face="normal" font="default" size="100%">Black person</style></keyword><keyword><style face="normal" font="default" size="100%">Caucasian</style></keyword><keyword><style face="normal" font="default" size="100%">Chinese</style></keyword><keyword><style face="normal" font="default" size="100%">ethnicity</style></keyword><keyword><style face="normal" font="default" size="100%">female</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">Iranian people</style></keyword><keyword><style face="normal" font="default" size="100%">Middle East</style></keyword><keyword><style face="normal" font="default" size="100%">ovary polycystic disease</style></keyword><keyword><style face="normal" font="default" size="100%">prevalence</style></keyword><keyword><style face="normal" font="default" size="100%">systematic review</style></keyword><keyword><style face="normal" font="default" size="100%">Turk (people)</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2017</style></year></dates><isbn><style face="normal" font="default" size="100%">1949-2553</style></isbn><abstract><style face="normal" font="default" size="100%">The prevalence of PCOS was investigated in many studies in different continents. However, there is no established prevalence of PCOS for distinct ethnic groups. In the current analysis, we conducted searches in PubMed, The Cochrane Library, EMBASE, CINAHL up to Jan. 2017 to identify studies reporting prevalence of PCOS in the general female population. Forty-two studies were identified, with 13 eligible for evidence synthesis. The prevalence among different ethnicity was estimated using random effect modelling. Our results suggested the lowest prevalence in Chinese women(2003 Rotterdam criterion: 5.6% 95% interval: 4.4-7.3%), and then in an ascending order for Caucasians (1990 NIH criterion: 5.5% 95% interval: 4.8-6.3%), Middle Eastern (1990 NIH 6.1% 95% interval: 5.3-7.1%; 2003 Rotterdam 16.0% 95% interval: 13.8-18.6%; 2006 AES 12.6% 95% interval: 11.3-14.2%), and Black women (1990 NIH: 6.1% 95% interval: 5.3-7.1%).There is variation in prevalence of PCOS under different diagnostic criteria and across ethnic groups. This emphasises the need for ethnicity-specific guidelines for PCOS to prevent under- or over-diagnosis of the condition given that under-diagnosis may lead to rapid conversion of metabolic disorders for patients whereas over-diagnosis may exert negative psychological effects on patients which worsens the major symptoms of PCOS.</style></abstract><label><style face="normal" font="default" size="100%">Included by Eman</style></label><notes><style face="normal" font="default" size="100%">L619195575&#xD;2017-11-15&#xD;2017-11-21</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.embase.com/search/results?subaction=viewrecord&amp;id=L619195575&amp;from=export</style></url><url><style face="normal" font="default" size="100%">http://dx.doi.org/10.18632/oncotarget.19180</style></url><url><style face="normal" font="default" size="100%">https://www.oncotarget.com/article/19180/pdf/</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.18632/oncotarget.19180</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2106</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2106</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Dorji, T.</style></author><author><style face="normal" font="default" size="100%">Wangmo, K.</style></author><author><style face="normal" font="default" size="100%">Dorjey, Y.</style></author><author><style face="normal" font="default" size="100%">Dorji, N.</style></author><author><style face="normal" font="default" size="100%">Kiran Chhetri, D.</style></author><author><style face="normal" font="default" size="100%">Tshering, S.</style></author><author><style face="normal" font="default" size="100%">Wangmo, P.</style></author><author><style face="normal" font="default" size="100%">Tshokey, T.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Kanglung Hospital, Trashigang, Bhutan.&#xD;Regional Livestock Development Center, Khangma, Bhutan.&#xD;Phuntsholing Hospital, Phuntsholing, Bhutan.&#xD;Central Regional Referral Hospital, Gelephu, Bhutan.&#xD;Trashigang Hospital, Trashigang, Bhutan.&#xD;Jigme Dorji Wangchuck National Referral Hospital, Thimphu, Bhutan.&#xD;Faculty of Nursing and Public Heath, Thimphu, Bhutan.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Indications and factors associated with cesarean section in Bhutan: A hospital-based study</style></title><secondary-title><style face="normal" font="default" size="100%">Int J Gynaecol Obstet</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Int J Gynaecol Obstet</style></full-title></periodical><pages><style face="normal" font="default" size="100%">520-526</style></pages><volume><style face="normal" font="default" size="100%">153</style></volume><number><style face="normal" font="default" size="100%">3</style></number><keywords><keyword><style face="normal" font="default" size="100%">Asia</style></keyword><keyword><style face="normal" font="default" size="100%">Bhutan</style></keyword><keyword><style face="normal" font="default" size="100%">Cesarean section</style></keyword><keyword><style face="normal" font="default" size="100%">Pregnancy</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2021</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jun</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0020-7292</style></isbn><abstract><style face="normal" font="default" size="100%">OBJECTIVE: To investigate the factors associated with cesarean section (CS) in Bhutan. METHODS: This was a cross-sectional study, using the retrospective data from the birth registers maintained in comprehensive emergency obstetric care centers for the year 2018. The data were entered in excel 2013 and analyzed using STATA 13. Multiple logistic regression was used to understand the factors associated with CS in Bhutan. RESULTS: The rate of CS in Bhutan was 18.7%. The indications for CS were previous CS, fetal distress, prolonged labor, and failed induction. The factors associated with CS were maternal age over 25 years, male child, women with smaller number of living children, multiple pregnancy, and gestation over 40 weeks. In addition, mothers delivering in Samtse Hospital and Central Regional Referral Hospital had higher odds of CS. CONCLUSION: In Bhutan, CS was commonly performed for mothers with previous CS, fetal distress, and prolonged labor. Increasing maternal age, multiple pregnancy, and postdated pregnancy and those with one child, or none, were more likely to undergo CS. To reduce the CS rate, Bhutan should focus on decreasing the primary CS rate as well as preventing over-diagnosis of prolonged labor by focusing on the partograph.</style></abstract><label><style face="normal" font="default" size="100%">Included by Ray</style></label><notes><style face="normal" font="default" size="100%">1879-3479&#xD;Dorji, Thinley&#xD;Wangmo, Karma&#xD;Dorjey, Yeshey&#xD;Dorji, Namkha&#xD;Kiran Chhetri, Deep&#xD;Tshering, Sangay&#xD;Wangmo, Passang&#xD;Tshokey, Tshokey&#xD;Journal Article&#xD;United States&#xD;Int J Gynaecol Obstet. 2021 Jun;153(3):520-526. doi: 10.1002/ijgo.13506. Epub 2020 Dec 31.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://obgyn.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ijgo.13506?download=true</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1002/ijgo.13506</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2107</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2107</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">El-Amin, E. O.</style></author><author><style face="normal" font="default" size="100%">Elamin, O. E.</style></author><author><style face="normal" font="default" size="100%">Haj El Bashir, M. I.</style></author><author><style face="normal" font="default" size="100%">Abdulrahman, I.</style></author><author><style face="normal" font="default" size="100%">El-Amin, M. E.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">E.O. El-Amin, Paediatrics, Faculty of Medicine, National Ribat University, Khartoum, Sudan</style></auth-address><titles><title><style face="normal" font="default" size="100%">Is cerebral malaria over diagnosed in children in Sudan?</style></title><secondary-title><style face="normal" font="default" size="100%">Archives of Disease in Childhood</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Archives of Disease in Childhood</style></full-title></periodical><pages><style face="normal" font="default" size="100%">A248</style></pages><volume><style face="normal" font="default" size="100%">97</style></volume><keywords><keyword><style face="normal" font="default" size="100%">cerebral malaria</style></keyword><keyword><style face="normal" font="default" size="100%">malaria</style></keyword><keyword><style face="normal" font="default" size="100%">child</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">Sudan</style></keyword><keyword><style face="normal" font="default" size="100%">organization</style></keyword><keyword><style face="normal" font="default" size="100%">patient</style></keyword><keyword><style face="normal" font="default" size="100%">virus</style></keyword><keyword><style face="normal" font="default" size="100%">laboratory</style></keyword><keyword><style face="normal" font="default" size="100%">diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">coma</style></keyword><keyword><style face="normal" font="default" size="100%">bacterial meningitis</style></keyword><keyword><style face="normal" font="default" size="100%">hospital</style></keyword><keyword><style face="normal" font="default" size="100%">malaria falciparum</style></keyword><keyword><style face="normal" font="default" size="100%">emergency ward</style></keyword><keyword><style face="normal" font="default" size="100%">blood</style></keyword><keyword><style face="normal" font="default" size="100%">herpes simplex</style></keyword><keyword><style face="normal" font="default" size="100%">encephalitis</style></keyword><keyword><style face="normal" font="default" size="100%">respiratory distress</style></keyword><keyword><style face="normal" font="default" size="100%">coinfection</style></keyword><keyword><style face="normal" font="default" size="100%">herpes simplex encephalitis</style></keyword><keyword><style face="normal" font="default" size="100%">anemia</style></keyword><keyword><style face="normal" font="default" size="100%">consciousness</style></keyword><keyword><style face="normal" font="default" size="100%">World Health Organization</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2012</style></year></dates><isbn><style face="normal" font="default" size="100%">0003-9888</style></isbn><abstract><style face="normal" font="default" size="100%">Background WHO defined cerebral malaria (CM) in 1990 as a clinical syndrome of Plasmodium falciparum infection with unrousable coma not attributable to another cause. This has been broaden by adding altered consciousness, severe anemia, and respiratory distress without laboratory confirmation in order to curtail mrtality in children. This has resulted in overdiagnosis and overlooking other serious alternatives plus overburdening the scarce resources. Aims To analyze the situation in Sudan by studying children admitted with clinical CM and do all the possible diagnostic work up in order to reach definitive diagnosis. Patients and methods Patients belonged t the main hospitals in the capital Khartoum admitting to well organized emergency departments. Clinical and laboratory data were collected from children over 1 month of age admitted with clinical CM between April and November 2011. Patients were investigated for CM, acute bacterial meningitis (ABM) and Herpes encephalitis (HE). Results One hundred and four children fulfilled the study criteria. CM was clinically diagnosed in 38 patients but only 5 were pure CM. Sixty three were suspected for ABM but 15 were confirmed cases. HE was defenitively diagnosed in only one case. There were 5 cases of mixed infection and the rest were unknown and presumed encephalitis due to viruses other than Herpes simplex. Conclusion CM was clinically over-diagnosed in our study. It is advisable to do all the necessary investigations, particularly a thoruogh blood film examinatiom, beforediagnosing CM. It is recommended to study cases that resemble CM for more detailed viruses disease.</style></abstract><notes><style face="normal" font="default" size="100%">L71062793&#xD;2013-05-24</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.embase.com/search/results?subaction=viewrecord&amp;id=L71062793&amp;from=export</style></url><url><style face="normal" font="default" size="100%">http://dx.doi.org/10.1136/archdischild-2012-302724.0863</style></url><url><style face="normal" font="default" size="100%">https://adc.bmj.com/content/archdischild/97/Suppl_2/A248.1.full.pdf</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1136/archdischild-2012-302724.0863</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2108</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2108</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Erika, H. Newton</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Addressing overuse in emergency medicine: evidence of a role for greater patient engagement</style></title><secondary-title><style face="normal" font="default" size="100%">Clinical and Experimental Emergency Medicine</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Clinical and Experimental Emergency Medicine</style></full-title></periodical><pages><style face="normal" font="default" size="100%">189-200</style></pages><number><style face="normal" font="default" size="100%">4</style></number><keywords><keyword><style face="normal" font="default" size="100%">Decision Making</style></keyword><keyword><style face="normal" font="default" size="100%">Delivery of Health Care</style></keyword><keyword><style face="normal" font="default" size="100%">Diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">Diagnostic Tests, Routine</style></keyword><keyword><style face="normal" font="default" size="100%">Emergencies</style></keyword><keyword><style face="normal" font="default" size="100%">Emergency Medicine</style></keyword><keyword><style face="normal" font="default" size="100%">Empathy</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Jurisprudence</style></keyword><keyword><style face="normal" font="default" size="100%">Medical Overuse</style></keyword><keyword><style face="normal" font="default" size="100%">Patient Participation</style></keyword><keyword><style face="normal" font="default" size="100%">Patient Safety</style></keyword><keyword><style face="normal" font="default" size="100%">Voice</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style face="normal" font="default" size="100%">2017/00</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">2383-4625</style></isbn><abstract><style face="normal" font="default" size="100%">Overuse of health care refers to tests, treatments, and even health care settings when used in circumstances where they are unlikely to help. Overuse is not only wasteful, it threatens patient safety by exposing patients to a greater chance of harm than benefit. It is a widespread problem and has proved resistant to change. Overuse of diagnostic testing is a particular problem in emergency medicine. Emergency physicians cite fear of missing a diagnosis, fear of law suits, and perceived patient expectations as key contributors. However, physicians’ assumptions about what patients expect are often wrong, and overlook two of patients’ most consistently voiced priorities: communication and empathy. Evidence indicates that patients who are more fully informed and engaged in their care often opt for less aggressive approaches. Shared decision making refers to (1) providing balanced information so that patients understand their options and the trade-offs involved, (2) encouraging them to voice their preferences and values, and (3) engaging them—to the extent appropriate or desired—in decision making. By adopting this approach to discretionary decision making, physicians are better positioned to address patients’ concerns without the use of tests and treatments patients neither need nor value.</style></abstract><urls><related-urls><url><style face="normal" font="default" size="100%">http://dx.doi.org/10.15441/ceem.17.233</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2109</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2109</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Esteban, S.</style></author><author><style face="normal" font="default" size="100%">Ricci, R.</style></author><author><style face="normal" font="default" size="100%">Terrasa, S.</style></author><author><style face="normal" font="default" size="100%">Kopitowski, K.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Family and Community Medicine Division, Hospital Italiano de Buenos Aires, Tte. Gral. Perón, 4272, Ciudad Autónoma de Buenos Aires, Argentina. santiago.esteban@hospitalitaliano.org.ar.&#xD;Research Department, Instituto Universitario Hospital Italiano de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina. santiago.esteban@hospitalitaliano.org.ar.&#xD;Family and Community Medicine Division, Hospital Italiano de Buenos Aires, Tte. Gral. Perón, 4272, Ciudad Autónoma de Buenos Aires, Argentina.&#xD;Plan de Salud, Hospital Italiano de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina.&#xD;Research Department, Hospital Italiano de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina.&#xD;Public Health Department, Instituto Universitario Hospital Italiano de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina.&#xD;Research Department, Instituto Universitario Hospital Italiano de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Colonoscopy overuse in colorectal cancer screening and associated factors in Argentina: a retrospective cohort study</style></title><secondary-title><style face="normal" font="default" size="100%">BMC Gastroenterol</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">BMC Gastroenterol</style></full-title></periodical><pages><style face="normal" font="default" size="100%">162</style></pages><volume><style face="normal" font="default" size="100%">17</style></volume><number><style face="normal" font="default" size="100%">1</style></number><keywords><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Argentina</style></keyword><keyword><style face="normal" font="default" size="100%">Colonic Polyps/diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">Colonoscopy/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Colorectal Neoplasms/*diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">Early Detection of Cancer/methods/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Follow-Up Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mass Screening/methods/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">*Medical Overuse</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Retrospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Colonoscopy</style></keyword><keyword><style face="normal" font="default" size="100%">Colorectal cancer</style></keyword><keyword><style face="normal" font="default" size="100%">Over screening</style></keyword><keyword><style face="normal" font="default" size="100%">Italiano de Buenos Aires (CEPI: Comité de Ética de protocolos de investigación del</style></keyword><keyword><style face="normal" font="default" size="100%">Hospital Italiano de Buenos Aires</style></keyword><keyword><style face="normal" font="default" size="100%">‘Ethics committee on research protocols at</style></keyword><keyword><style face="normal" font="default" size="100%">Hospital Italiano de Buenos Aires’) approved the full protocol (approval process</style></keyword><keyword><style face="normal" font="default" size="100%">#1885). The review board determined that, since data was collected from EMRs and</style></keyword><keyword><style face="normal" font="default" size="100%">deidentified, no new consent was required from the study subjects (all persons from</style></keyword><keyword><style face="normal" font="default" size="100%">the HP-HIBA sign a consent form that their data can be used for research purposes as</style></keyword><keyword><style face="normal" font="default" size="100%">long as it is deidentified). CONSENT FOR PUBLICATION: Not applicable. COMPETING</style></keyword><keyword><style face="normal" font="default" size="100%">INTERESTS: Santiago Esteban: No conflicts of interest. Ricardo I. Ricci: No</style></keyword><keyword><style face="normal" font="default" size="100%">conflicts of interest. Sergio A. Terrasa: No conflicts of interest. Karin S.</style></keyword><keyword><style face="normal" font="default" size="100%">Kopitowski: No conflicts of interest. PUBLISHER’S NOTE: Springer Nature remains</style></keyword><keyword><style face="normal" font="default" size="100%">neutral with regard to jurisdictional claims in published maps and institutional</style></keyword><keyword><style face="normal" font="default" size="100%">affiliations.</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style face="normal" font="default" size="100%">Dec 15</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1471-230x</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: In recent years, there has been growing concern about the overuse of colonoscopy (CC). Our objective was to evaluate the incidence rate and cumulative probability of having a potentially inadequate CC (PI-CC, e.g. a CC that was performed earlier that recommended) and the association between the report of a hyperplastic polyp in the baseline CC report and the probability of having a PI-CC. METHODS: A retrospective cohort of adults 50y/o or older with a complete baseline CC between January 1st and December 31st 2005, without reported lesions or with hyperplastic polyps, based on secondary data extracted from the electronic medical record of the Hospital Italiano of Buenos Aires. The outcome consisted of time until a PI-CC, defined as the time measured between basal colonoscopy and a colonoscopy performed earlier than the inter-screening interval recommended by the USPSTF and the USMSTF. RESULTS: 389 patients were included. The cumulative probability of receiving a PI-CC over 10 years was 0.29 (95% CI 0.241, 0.342). The incidence rate resulted in 30.91 PI-CC per 1000 person-years (95% CI 25.14, 38). The crude analysis of the association between the outcome and the presence of hyperplastic polyps in the baseline CC, showed a statistically significant difference between both groups (log rank, p 0.036). The multivariate analysis yielded a hazard ratio of 1.67 (95% CI 1.02-2.73). CONCLUSION: We observed that 3 in every 10 patients treated in our health system received a PI-CC during the first ten consecutive years after a normal complete CC. Furthermore, this could be in part attributed to the presence of a hyperplastic polyp in the baseline CC.</style></abstract><notes><style face="normal" font="default" size="100%">1471-230x&#xD;Esteban, Santiago&#xD;Orcid: 0000-0001-6940-9734&#xD;Ricci, Ricardo&#xD;Terrasa, Sergio&#xD;Kopitowski, Karin&#xD;Journal Article&#xD;BMC Gastroenterol. 2017 Dec 15;17(1):162. doi: 10.1186/s12876-017-0722-6.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732490/pdf/12876_2017_Article_722.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC5732490</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1186/s12876-017-0722-6</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2110</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2110</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Faust, C.</style></author><author><style face="normal" font="default" size="100%">Zelner, J.</style></author><author><style face="normal" font="default" size="100%">Brasseur, P.</style></author><author><style face="normal" font="default" size="100%">Vaillant, M.</style></author><author><style face="normal" font="default" size="100%">Badiane, M.</style></author><author><style face="normal" font="default" size="100%">Cisse, M.</style></author><author><style face="normal" font="default" size="100%">Grenfell, B.</style></author><author><style face="normal" font="default" size="100%">Olliaro, P.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Assessing drivers of full adoption of test and treat policy for malaria in Senegal</style></title><secondary-title><style face="normal" font="default" size="100%">Am J Trop Med Hyg</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Am J Trop Med Hyg</style></full-title></periodical><pages><style face="normal" font="default" size="100%">159-167</style></pages><volume><style face="normal" font="default" size="100%">93</style></volume><number><style face="normal" font="default" size="100%">1</style></number><keywords><keyword><style face="normal" font="default" size="100%">Antimalarials/*therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Artemisinins/*therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Fever/*diagnosis/etiology</style></keyword><keyword><style face="normal" font="default" size="100%">Guideline Adherence/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Logistic Models</style></keyword><keyword><style face="normal" font="default" size="100%">Malaria/complications/*diagnosis/drug therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Multivariate Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">*Practice Guidelines as Topic</style></keyword><keyword><style face="normal" font="default" size="100%">Senegal</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jul</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0002-9637 (Print)&#xD;0002-9637</style></isbn><abstract><style face="normal" font="default" size="100%">Malaria treatment policy has changed from presumptive treatment to targeted &quot;test and treat&quot; (T&amp;T) with malaria rapid diagnostic tests (RDTs) and artemisinin combination therapy (ACT). This transition involves changing behavior among health providers, meaning delays between introduction and full implementation are recorded in almost every instance. We investigated factors affecting successful transition, and suggest approaches for accelerating uptake of T&amp;T. Records from 2000 to 2011 from health clinics in Senegal where malaria is mesoendemic were examined (96,166 cases). The study period encompassed the implementation of national T&amp;T policy in 2006. Analysis showed that adherence to test results is the first indicator of T&amp;T adoption and is dependent on accumulation of experience with positive RDTs (odds ratio [OR]: 0.55 [P ≤ 0.001], 95% confidence interval [CI]: 0.53-0.58). Reliance on tests for malaria diagnosis (rather than presumptive diagnosis) followed after test adherence is achieved, and was also associated with increased experience with positive RDTs (OR: 0.60 [P ≤ 0.001], 95% CI: 0.58-0.62). Logistic models suggest that full adoption of T&amp;T clinical practices can occur within 2 years, that monitoring these behavioral responses rather than RDT or ACT consumption will improve evaluation of T&amp;T uptake, and that accelerating T&amp;T uptake by focusing training on adherence to test results will reduce overdiagnosis and associated health and economic costs in mesoendemic regions.</style></abstract><notes><style face="normal" font="default" size="100%">1476-1645&#xD;Faust, Christina&#xD;Zelner, Jonathan&#xD;Brasseur, Philippe&#xD;Vaillant, Michel&#xD;Badiane, Malick&#xD;Cisse, Moustafa&#xD;Grenfell, Bryan&#xD;Olliaro, Piero&#xD;001/World Health Organization/International&#xD;Journal Article&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Am J Trop Med Hyg. 2015 Jul;93(1):159-167. doi: 10.4269/ajtmh.14-0595. Epub 2015 May 11.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ajtmh.org/downloadpdf/journals/tpmd/93/1/article-p159.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC4497889</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.4269/ajtmh.14-0595</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2111</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2111</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Fehintola, F. A.</style></author><author><style face="normal" font="default" size="100%">Balogun, S. T.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Clinical Pharmacology, University College Hospital, Ibadan, Nigeria. fentolamine@yahoo.com</style></auth-address><titles><title><style face="normal" font="default" size="100%">Malaria: passive case detection and healthcare providers&apos; choices of chemotherapy</style></title><secondary-title><style face="normal" font="default" size="100%">Afr J Med Med Sci</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Afr J Med Med Sci</style></full-title></periodical><pages><style face="normal" font="default" size="100%">49-54</style></pages><volume><style face="normal" font="default" size="100%">39</style></volume><number><style face="normal" font="default" size="100%">1</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Age Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Antimalarials/therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Child, Preschool</style></keyword><keyword><style face="normal" font="default" size="100%">*Choice Behavior</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">*Guideline Adherence</style></keyword><keyword><style face="normal" font="default" size="100%">Health Personnel</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Infant</style></keyword><keyword><style face="normal" font="default" size="100%">Malaria, Falciparum/*diagnosis/drug therapy/parasitology</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Microscopy</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Nigeria</style></keyword><keyword><style face="normal" font="default" size="100%">Plasmodium falciparum/*isolation &amp; purification</style></keyword><keyword><style face="normal" font="default" size="100%">Population Surveillance</style></keyword><keyword><style face="normal" font="default" size="100%">Practice Guidelines as Topic</style></keyword><keyword><style face="normal" font="default" size="100%">*Practice Patterns, Physicians&apos;</style></keyword><keyword><style face="normal" font="default" size="100%">Referral and Consultation/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2010</style></year><pub-dates><date><style face="normal" font="default" size="100%">Mar</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0309-3913 (Print)&#xD;0309-3913</style></isbn><abstract><style face="normal" font="default" size="100%">Prompt diagnosis and treatment play a central role in the malaria control programme in sub Saharan Africa. However, in most cases the diagnoses are never confirmed either for lack of facility or disinterest of healthcare providers resulting in over-diagnosis. To determine the proportion of clinically diagnosed malaria cases who could be confirmed with microscopy and evaluate compliance of healthcare providers with the National treatment guidelines for malaria. Participants were patients referred for malaria microscopy after the attending physicians had made clinical diagnosis of malaria. Thick blood smears were made under strict asepsis, stained and thereafter examined under oil immersion objective lens. Of the 630 patients who were referred with clinical impression of malaria, only 224 or 35.6% were positive for malaria parasite. The slide positive patients were younger with a mean age of 10.6 +/- 13.0 years versus 17.2 +/- 18.5 years [P &lt; 0.005] for the slide negative individuals. There were only few instances of non-compliance with the National treatment guidelines for malaria. In conclusion, there appears to be over-diagnosis of malaria considering that only about a third of the clinical malaria cases were confirmed by microscopy. There is need for large epidemiological studies and possible policy review.</style></abstract><notes><style face="normal" font="default" size="100%">Fehintola, F A&#xD;Balogun, S T&#xD;Journal Article&#xD;Nigeria&#xD;Afr J Med Med Sci. 2010 Mar;39(1):49-54.</style></notes><urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2112</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2112</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Feio, Rita Guidotti</style></author><author><style face="normal" font="default" size="100%">Gonçalves, Marília Maia de</style></author><author><style face="normal" font="default" size="100%">Paes, Pedro</style></author><author><style face="normal" font="default" size="100%">Badalotti, Mariangela</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Amenorreia secundária: abordagem diagnóstica inicial</style></title><secondary-title><style face="normal" font="default" size="100%">Acta méd. (Porto Alegre)</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Acta méd. (Porto Alegre)</style></full-title></periodical><pages><style face="normal" font="default" size="100%">[5]-[5]</style></pages><volume><style face="normal" font="default" size="100%">36</style></volume><keywords><keyword><style face="normal" font="default" size="100%">Amenorrhea</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style face="normal" font="default" size="100%">2015/00</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0103-5037</style></isbn><abstract><style face="normal" font="default" size="100%">A amenorreia secundária é uma das causas frequentes de consulta médica feminina. Diante desse desafio diagnóstico, o médico deve realizar a investigação de forma sistematizada, seguindo ordem adequada de raciocínio lógico. O objetivo é definir corretamente a causa etiológica, evitando procedimentos desnecessários, a fim de tratar a patologia de base.&#xD;Secondary amenorrhea represents a frequent cause of female consultation. Considering the possible multifactorial etiology an objective as well as rational approach should be taking into consideration. The main purpose of this particular study is accurate diagnosis achievement, avoiding superfluous and unnecessary procedures.</style></abstract><label><style face="normal" font="default" size="100%">Included by Loai</style></label><urls><related-urls><url><style face="normal" font="default" size="100%">http://fi-admin.bvsalud.org/document/view/bdf65</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2113</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2113</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Fernández Ferrer, María de los Angeles</style></author><author><style face="normal" font="default" size="100%">Sánchez Valdés, Lizet</style></author><author><style face="normal" font="default" size="100%">Marín Iglesias, Humberto</style></author><author><style face="normal" font="default" size="100%">Montano Goodridge, Ivón</style></author><author><style face="normal" font="default" size="100%">Núñez Fernández, Fidel</style></author><author><style face="normal" font="default" size="100%">Núñez López, Yury</style></author><author><style face="normal" font="default" size="100%">Fonte Galindo, Luis</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Sobrediagnóstico microscópico de amebiasis intestinal: encuesta a técnicos de laboratorio</style></title><secondary-title><style face="normal" font="default" size="100%">Rev. cuba. invest. bioméd</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Rev. cuba. invest. bioméd</style></full-title></periodical><pages><style face="normal" font="default" size="100%">197-202</style></pages><volume><style face="normal" font="default" size="100%">18</style></volume><number><style face="normal" font="default" size="100%">3</style></number><keywords><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Child, Preschool</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Infant, Newborn</style></keyword><keyword><style face="normal" font="default" size="100%">Infant</style></keyword><keyword><style face="normal" font="default" size="100%">Data Collection</style></keyword><keyword><style face="normal" font="default" size="100%">Entamoeba histolytica</style></keyword><keyword><style face="normal" font="default" size="100%">Feces</style></keyword><keyword><style face="normal" font="default" size="100%">Laboratory Personnel</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">1999</style></year><pub-dates><date><style face="normal" font="default" size="100%">1999/12</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0864-0300</style></isbn><abstract><style face="normal" font="default" size="100%">Empleando ENZYMEBA, procedimiento diagnóstico de amebiasis intestinal desarrollado en el Instituto de Medicina Tropical &amp;quot;Pedro Kourí&amp;quot;, se demostró que en la provincia Cienfuegos el examen microscópico de heces se asocia con un marcado sobrediagnóstico de esta parasitosis (de 424 muestras positivas a Entamoeba histolytica, por examen microscópico, solo 61 lo fueron por ENZYMEBA). Para incursionar en los factores que podrían estar incidiendo en la calidad del trabajo de los técnicos de laboratorio de esta provincia se aplicó a la casi totalidad de ellos ( 96 de 102) un cuestionario (23 preguntas) sobre diversos aspectos relacionados con este tipo de diagnóstico. El conjunto de los resultados de esta encuesta sugiere que en la calidad del diagnóstico de amebiasis intestinal por examen microscópico podría estar incidiendo, además de deficiencias técnico-organizativas y materiales, una insuficiente preparación teórica de quienes la realizan</style></abstract><label><style face="normal" font="default" size="100%">Included by Morty</style></label><urls><related-urls><url><style face="normal" font="default" size="100%">http://bvs.sld.cu/revistas/ibi/vol18_3_99/ibi05399.htm</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2114</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2114</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Ferreira, Cristina Targa</style></author><author><style face="normal" font="default" size="100%">Carvalho, Elisa de</style></author><author><style face="normal" font="default" size="100%">Sdepanian, Vera Lucia</style></author><author><style face="normal" font="default" size="100%">Morais, Mauro Batista de</style></author><author><style face="normal" font="default" size="100%">Vieira, Mário César</style></author><author><style face="normal" font="default" size="100%">Silva, Luciana Rodrigues</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Gastroesophageal reflux disease: exaggerations, evidence and clinical practice</style></title><secondary-title><style face="normal" font="default" size="100%">J. pediatr. (Rio J.)</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">J. pediatr. (Rio J.)</style></full-title></periodical><pages><style face="normal" font="default" size="100%">105-117</style></pages><volume><style face="normal" font="default" size="100%">90</style></volume><number><style face="normal" font="default" size="100%">2</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Child, Preschool</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Infant</style></keyword><keyword><style face="normal" font="default" size="100%">Gastroesophageal Reflux/diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">/therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Milk Hypersensitivity/complications</style></keyword><keyword><style face="normal" font="default" size="100%">Milk Hypersensitivity/drug therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Proton Pump Inhibitors/therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Esophageal pH Monitoring</style></keyword><keyword><style face="normal" font="default" size="100%">Evidence-Based Practice</style></keyword><keyword><style face="normal" font="default" size="100%">Endoscopy, Gastrointestinal/methods</style></keyword><keyword><style face="normal" font="default" size="100%">Gastroesophageal Reflux/complications</style></keyword><keyword><style face="normal" font="default" size="100%">Milk Hypersensitivity/diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">Milk Proteins/adverse effects</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style face="normal" font="default" size="100%">2014/04</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0021-7557</style></isbn><abstract><style face="normal" font="default" size="100%">OBJECTIVE: there are many questions and little evidence regarding the diagnosis and treatment of gastroesophageal reflux disease (GERD) in children. The association between GERD and cow&amp;#039;s milk protein allergy (CMPA), overuse of abdominal ultrasonography for the diagnosis of GERD, and excessive pharmacological treatment, especially proton-pump inhibitors (PPIs) are some aspects that need clarification. This review aimed to establish the current scientific evidence for the diagnosis and treatment of GERD in children. DATA SOURCE: a search was conducted in the MEDLINE, PubMed, LILACS, SciELO, and Cochrane Library electronic databases, using the following keywords: gastroesophageal reflux; gastroesophageal reflux disease; proton-pump inhibitors; and prokinetics; in different age groups of the pediatric age range; up to May of 2013. DATA SYNTHESIS: abdominal ultrasonography should not be recommended to investigate gastroesophageal reflux (GER). Simultaneous treatment of GERD and CMPA often results in unnecessary use of medication or elimination diet. There is insufficient evidence for the prescription of prokinetics to all patients with GER/GERD. There is little evidence to support acid suppression in the first year of life, to treat nonspecific symptoms suggestive of GERD. Conservative treatment has many benefits and with low cost and no side-effects. CONCLUSIONS: there have been few randomized controlled trials that assessed the management of GERD in children and no examination can be considered the gold standard for GERD diagnosis. For these reasons, there are exaggerations in the diagnosis and treatment of this disease, which need to be corrected. .&#xD;OBJETIVO: há muitas dúvidas e poucas evidências para o diagnóstico e tratamento da doença do refluxo gastroesofágico (DRGE) na criança. A relação entre a DRGE e a alergia às proteínas do leite de vaca (APLV), o uso exagerado da ultrassonografia abdominal para diagnóstico da DRGE e o excesso de medicamentos, especialmente dos inibidores de bomba de prótons (IBP), são alguns aspectos que necessitam esclarecimentos. Esta revisão tem como objetivo estabelecer as evidências científicas atuais para o diagnóstico e tratamento da DRGE em pediatria. FONTES DOS DADOS: foram pesquisadas nas bases de dados eletrônicos do Medline, Pubmed, Lilacs, Cochrane Library e Scielo, nas diferentes faixas etárias da pediatria, até maio de 2013, as seguintes palavras-chave: refluxo gastroesofágico, doença do refluxo gastroesofágico, inibidores da bomba de prótons e procinéticos. SíNTESE DOS DADOS: a ultrassonografia de abdome não deve ser recomendada para pesquisa de refluxo gastroesofágico (RGE). O tratamento simultâneo da DRGE e da APLV induz, muitas vezes, ao uso desnecessário de medicação ou dieta de exclusão. Não existem evidências suficientes para prescrição de procinéticos em todos os portadores de RGE/DRGE. Poucas evidências fornecem suporte para a supressão ácida, no primeiro ano de vida, para tratamento de sintomas inespecíficos, sugestivos de DRGE. O tratamento conservador traz muitos benefícios e poucos gastos, sem efeitos colaterais. CONCLUSÕES: existem poucos estudos controlados e randomizados que avaliam a DRGE na criança e nenhum exame pode considerado padrão-ouro para o seu diagnóstico. Por esses motivos, ocorrem exageros no diagnóstico e no tratamento dessa doença, e que necessitam ...</style></abstract><label><style face="normal" font="default" size="100%">Included by Hannah</style></label><urls><related-urls><url><style face="normal" font="default" size="100%">http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S0021-75572014000200105</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2115</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2115</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Festo, C.</style></author><author><style face="normal" font="default" size="100%">Thwing, J.</style></author><author><style face="normal" font="default" size="100%">Thomson, R.</style></author><author><style face="normal" font="default" size="100%">Kalolella, A.</style></author><author><style face="normal" font="default" size="100%">Nchimbi, H.</style></author><author><style face="normal" font="default" size="100%">Taylor, M.</style></author><author><style face="normal" font="default" size="100%">Goodman, C.</style></author><author><style face="normal" font="default" size="100%">Patrick Kachur, S.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">C. Festo, London School of Hygiene and Tropical Medicine, London, United Kingdom</style></auth-address><titles><title><style face="normal" font="default" size="100%">Over and under-use of acts at public health facilities in threeregions of TanzaniaK. Bruxwoort</style></title><secondary-title><style face="normal" font="default" size="100%">Tropical Medicine and International Health</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Tropical Medicine and International Health</style></full-title></periodical><pages><style face="normal" font="default" size="100%">132</style></pages><volume><style face="normal" font="default" size="100%">16</style></volume><keywords><keyword><style face="normal" font="default" size="100%">artemisinin</style></keyword><keyword><style face="normal" font="default" size="100%">public health</style></keyword><keyword><style face="normal" font="default" size="100%">tropical medicine</style></keyword><keyword><style face="normal" font="default" size="100%">health care facility</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">patient</style></keyword><keyword><style face="normal" font="default" size="100%">diagnostic test</style></keyword><keyword><style face="normal" font="default" size="100%">malaria</style></keyword><keyword><style face="normal" font="default" size="100%">diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">scale up</style></keyword><keyword><style face="normal" font="default" size="100%">health</style></keyword><keyword><style face="normal" font="default" size="100%">fever</style></keyword><keyword><style face="normal" font="default" size="100%">blood sampling</style></keyword><keyword><style face="normal" font="default" size="100%">parasitemia</style></keyword><keyword><style face="normal" font="default" size="100%">weight</style></keyword><keyword><style face="normal" font="default" size="100%">blood smear</style></keyword><keyword><style face="normal" font="default" size="100%">parasite</style></keyword><keyword><style face="normal" font="default" size="100%">therapy</style></keyword><keyword><style face="normal" font="default" size="100%">worker</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2011</style></year></dates><isbn><style face="normal" font="default" size="100%">1360-2276</style></isbn><abstract><style face="normal" font="default" size="100%">INTRODUCTION: Artemisinin-based combination therapy (ACT) isthe first line drug in most malaria-endemic countries, but there areconcerns that quality of care remains poor. While patients needingACT may not receive it, there is considerable over-treatment dueto the lack of accurate diagnosis and inappropriate management.To assess current treatment practices, we conducted health facilitysurveys before scale up of rapid diagnostic tests (RDTs) inTanzania.METHODS We enrolled 1779 patients at 145 randomly selectedhealth facilities in Mwanza, Mbeya, and Mtwara Regions betweenMay and October 2010. Patients with fever in the previous 48 hwere enrolled on arrival and interviewed following their consultation.Data were collected on patient characteristics, previoustreatment, and care. Fingerprick blood samples were taken bystudy staff to test for malaria parasitemia. RESULTS: Overall, 66.6% of patients attended a facility with anyACT in stock and 28.6% a facility with all weight-specific doses ofACT available. Only 9.8% of patients received a diagnostic test atthe health facility; 82% of those tested received a blood smear and18% an RDT. Of those tested, 54.8% were reported to have apositive test. ACTs were obtained by 58.5% of patients with apositive test, 11.4% of patients with a negative test, and 36.0% ofpatients who did not receive a diagnostic test during theirconsultation. Study RDTs conducted in all enrolled patients foundthat 24.5% of all patients had a positive RDT. ACTs had beenobtained by 44.3% of patients with a positive RDT and 33.7% ofpatients with a negative RDT.CONCLUSION Over-diagnosis of malaria remains common, withACTs frequently prescribed to parasite-negative patients; it isanticipated that national scale up of RDTs should address thisissue to some degree. However, under-treatment also remains akey problem, reflecting both ACT stockouts and inappropriatehealth worker practices.</style></abstract><notes><style face="normal" font="default" size="100%">L70589250&#xD;2011-11-29</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.embase.com/search/results?subaction=viewrecord&amp;id=L70589250&amp;from=export</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2116</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2116</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Floriani, Isabela Dombeck</style></author><author><style face="normal" font="default" size="100%">Borgmann, Ariela Victoria</style></author><author><style face="normal" font="default" size="100%">Barreto, Marina Rachid</style></author><author><style face="normal" font="default" size="100%">Ribeiro, Elaine Rossi</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Exposure of pediatric emergency patients to imaging exams, nowadays and in times of covid-19: an integrative review</style></title><secondary-title><style face="normal" font="default" size="100%">Rev. Paul. Pediatr. (Ed. Port., Online)</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Rev. Paul. Pediatr. (Ed. Port., Online)</style></full-title></periodical><pages><style face="normal" font="default" size="100%">e2020302-e2020302</style></pages><volume><style face="normal" font="default" size="100%">40</style></volume><dates><year><style face="normal" font="default" size="100%">2022</style></year><pub-dates><date><style face="normal" font="default" size="100%">2022/00</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1984-0462</style></isbn><abstract><style face="normal" font="default" size="100%">ABSTRACT Objective: To analyze literature data about unnecessary exposure of pediatric emergency patients to ionizing agents from imaging examinations, nowadays and during times of COVID-19. Data sources: Between April and July 2020, articles were selected using the databases: Virtual Health Library, PubMed and Scientific Electronic Library Online. The following descriptors were used: [(pediatrics) AND (emergencies) AND (diagnostic imaging) AND (medical overuse)] and [(Coronavirus infections) OR (COVID-19) AND (pediatrics) AND (emergencies) AND (diagnostic imaging)]. Inclusion criteria were articles available in full, in Portuguese or English, published from 2016 to 2020 or from 2019 to 2020, and articles that covered the theme. Articles without adherence to the theme and duplicate texts in the databases were excluded. Data synthesis: 61 publications were identified, of which 17 were comprised in this review. Some imaging tests used in pediatric emergency departments increase the possibility of developing future malignancies in patients, since they emit ionizing radiation. There are clinical decision instruments that allow reducing unnecessary exam requests, avoiding over-medicalization, and hospital expenses. Moreover, with the COVID-19 pandemic, there was a growing concern about the overuse of imaging exams in the pediatric population, which highlights the problems pointed out by this review. Conclusions: It is necessary to improve hospital staff training, use clinical decision instruments and develop guidelines to reduce the number of exams required, allowing hospital cost savings; and reducing children&amp;#039;s exposure to ionizing agents.&#xD;RESUMO Objetivo: Analisar dados da literatura sobre exposição desnecessária de pacientes da emergência pediátrica a agentes ionizantes dos exames de imagem, na atualidade e em tempos de COVID-19. Fontes de dados: Entre abril e julho de 2020 ocorreu a seleção dos artigos, utilizando-se as bases de dados: Biblioteca Virtual em Saúde, PubMed e Scientific Electronic Library Online. Utilizaram-se os descritores: [(pediatrics) AND (emergencies) AND (diagnostic imaging) AND (medical overuse)] e [(Coronavirus infections) OR (COVID-19) AND (pediatrics) AND (emergencies) AND (diagnostic imaging)]. Incluíram-se artigos disponíveis na íntegra, em português ou inglês, publicados no período de 2016 a 2020 ou de 2019 a 2020, e artigos que contemplassem o tema. Excluiu-se artigos sem aderência com a temática e textos duplicados. Síntese dos dados: Identificaram-se 61 publicações, sendo 17 utilizadas para a elaboração desta revisão. Alguns exames de imagem utilizados nos Setores de Urgência e Emergência (SUEs) pediátricos, por emitirem radiação ionizante, aumentam a possibilidade de desenvolver malignidades futuras nas crianças. Destarte, há instrumentos de decisão clínica que possibilitam diminuir requisições de exames desnecessários, evitando a sobremedicalização e os gastos hospitalares. Ademais, com a pandemia da COVID-19, cresceu a preocupação com o uso excessivo de exames de imagem na população pediátrica, o que reafirma a problematização deste estudo. Conclusões: Veem-se como necessárias a capacitação da equipe hospitalar, a utilização de instrumentos de decisão clínica e a confecção de protocolos que possam avaliar a singularidade da criança. Isso permitirá reduzir o número de exames requeridos, possibilitando economia de custos hospitalares e redução da exposição de crianças a agentes ionizantes.</style></abstract><label><style face="normal" font="default" size="100%">Included by Hannah</style></label><urls><related-urls><url><style face="normal" font="default" size="100%">http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S0103-05822022000100501</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2117</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2117</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Fonte Galindo, Luis</style></author><author><style face="normal" font="default" size="100%">Sánchez Valdés, Lizet</style></author><author><style face="normal" font="default" size="100%">Fernández Ferrer, María de los Angeles</style></author><author><style face="normal" font="default" size="100%">Marín Iglesia, Humberto</style></author><author><style face="normal" font="default" size="100%">Montano Goodridge, Ivón</style></author><author><style face="normal" font="default" size="100%">Núñez Fernández, Fidel Angel</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Sobrediagnóstico microscópico de amebiasis intestinal: evaluación de una intervención en la provincia de Cienfuegos</style></title><secondary-title><style face="normal" font="default" size="100%">Rev. cuba. invest. bioméd</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Rev. cuba. invest. bioméd</style></full-title></periodical><volume><style face="normal" font="default" size="100%">22</style></volume><number><style face="normal" font="default" size="100%">3</style></number><keywords><keyword><style face="normal" font="default" size="100%">Clinical Laboratory Techniques</style></keyword><keyword><style face="normal" font="default" size="100%">Dysentery, Amebic</style></keyword><keyword><style face="normal" font="default" size="100%">Feces</style></keyword><keyword><style face="normal" font="default" size="100%">Intestinal Diseases, Parasitic</style></keyword><keyword><style face="normal" font="default" size="100%">Quality Control</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2003</style></year><pub-dates><date><style face="normal" font="default" size="100%">2003/09</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0864-0300</style></isbn><abstract><style face="normal" font="default" size="100%">Se realizó un estudio en la provincia Cienfuegos, el cual demostró que el examen microscópico de heces se asociaba a un marcado sobrediagnóstico de amebiasis intestinal. Los resultados de encuestas aplicadas a responsables y técnicos de laboratorio relacionados con el diagnóstico microscópico de esta parasitosis, evidenciaron que el sobrediagnóstico podía estar asociado a deficiencias cognoscitivas y técnico-organizativas. Para contribuir al mejoramiento del diagnóstico microscópico del parasitismo intestinal, en general, y de la amebiasis intestinal, en particular, se ejecutó un grupo de acciones en la citada provincia. A 1 año de completada la puesta en práctica de esas medidas, una segunda aplicación de las encuestas, permitió conocer de una significativa mejoría de los técnicos encuestados en la totalidad de los aspectos cognoscitivos evaluados. Sin embargo, tanto la encuesta aplicada a responsables de laboratorio como la aplicada a los técnicos, demostraron que subsisten la mayoría de las deficiencias técnico-organizativas detectadas antes de la intervención</style></abstract><label><style face="normal" font="default" size="100%">Included by Morty</style></label><urls><related-urls><url><style face="normal" font="default" size="100%">http://bvs.sld.cu/revistas/ibi/vol22_3_03/ibi05303.htm</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2118</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2118</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Ganiele, María de las Nieves</style></author><author><style face="normal" font="default" size="100%">Terrasa, Sergio Adrián</style></author><author><style face="normal" font="default" size="100%">Kopitowski, Karin Silvana</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Excesivo rastreo de osteoporosis en mujeres menores de 65 años: estudio de corte transversal</style></title><secondary-title><style face="normal" font="default" size="100%">Salud colect</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Salud colect</style></full-title></periodical><pages><style face="normal" font="default" size="100%">443-452</style></pages><volume><style face="normal" font="default" size="100%">12</style></volume><number><style face="normal" font="default" size="100%">3</style></number><dates><year><style face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style face="normal" font="default" size="100%">2016/09</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1669-2381</style></isbn><abstract><style face="normal" font="default" size="100%">RESUMEN El rastreo de osteoporosis en mujeres con bajo riesgo de fractura (sobreuso) puede conducir a sobrediagnóstico, tratamiento inapropiado y medicalización. El objetivo de este trabajo fue determinar la proporción de mujeres de 45 a 64 años afiliadas a un plan de medicina prepaga de Buenos Aires, Argentina, que realizaron al menos una densitometría ósea de cadera durante 2011 y no cumplían criterios para el rastreo. Se realizó un estudio observacional de corte transversal. Se identificaron 4.310 mujeres de este rango etario que se realizaron una densitometría ósea, entre las que se seleccionó una muestra aleatorizada de 401 mujeres y se obtuvieron datos completos para 178 mujeres. Para determinar si el rastreo era apropiado se utilizaron dos criterios: 1) tener un riesgo de fractura a 10 años mayor que una mujer de 65 años (regla FRAX®); 2) presentar al menos un factor de riesgo de fractura. Un 86,5% de las densitometrías óseas fueron realizadas en mujeres cuyo riesgo estimado por FRAX® no superaba el umbral mínimo recomendado, constatándose osteoporosis en el 5,8% y osteopenia en el 61,0%. En relación con el segundo criterio, el 49,4% no presentaba siquiera un factor de riesgo, documentándose osteoporosis en el 3,4%, y osteopenia en el 62,5%. Los resultados muestran que al menos la mitad de las mujeres no cumplía con los criterios de rastreo.&#xD;ABSTRACT Overuse of osteoporosis screening in women at low risk of fracture may lead to overdiagnosis, inappropriate treatment and medicalization. The objective of this work was to estimate the proportion of women aged 45 to 64 enrolled in a private health insurance plan in Buenos Aires undergoing hip dual-energy x-ray absorptiometry (DXA) in 2011 without meeting osteoporosis screening criteria. In this cross-sectional study, 4310 women of this age range that had undergone a hip DXA were identified. A randomly selected sub-group of 401 women was then assessed for the presence of risk factors for osteoporosis and complete data were retrieved for 178 women. Appropriate screening was defined by two criteria: 1) having a 10-year fracture risk higher than that of a 65-year old woman (estimated using the FRAX® tool); 2) having at least one risk factor for fracture. It was found that 86.5% of the women who underwent hip DXA did not exceed the minimum 10-year fracture risk threshold required for screening; 5.8% of them had osteoporosis and 61.0% osteopenia. According to the second criterion, 49.4% had no risk factors, 3.4% of these women had osteoporosis and 62.5% osteopenia. The results show that at least half the women screened did not meet osteoporosis screening criteria.</style></abstract><label><style face="normal" font="default" size="100%">Included by Hannah</style></label><urls><related-urls><url><style face="normal" font="default" size="100%">http://www.scielosp.org/scielo.php?script=sci_arttext&amp;amp;pid=S1851-82652016000300443</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2119</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2119</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Genç, O.</style></author><author><style face="normal" font="default" size="100%">Aksu, E.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Dumlupinar University Faculty of Medicine, Department of Medical Microbiology, Kutahya, Turkey. drozlemg@hotmail.com.</style></auth-address><titles><title><style face="normal" font="default" size="100%">[Inappropriate use of serological tests for hepatitis B virus in Evliya Celebi Education and Research Hospital of Dumlupinar University, Kütahya]</style></title><secondary-title><style face="normal" font="default" size="100%">Mikrobiyol Bul</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Mikrobiyol Bul</style></full-title></periodical><pages><style face="normal" font="default" size="100%">618-27</style></pages><volume><style face="normal" font="default" size="100%">48</style></volume><number><style face="normal" font="default" size="100%">4</style></number><keywords><keyword><style face="normal" font="default" size="100%">Algorithms</style></keyword><keyword><style face="normal" font="default" size="100%">Defensive Medicine</style></keyword><keyword><style face="normal" font="default" size="100%">Hepatitis B/*diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">Hepatitis B Antibodies/blood</style></keyword><keyword><style face="normal" font="default" size="100%">Hepatitis B Core Antigens/immunology</style></keyword><keyword><style face="normal" font="default" size="100%">Hepatitis B e Antigens/blood/immunology</style></keyword><keyword><style face="normal" font="default" size="100%">Hepatitis B virus/immunology/*isolation &amp; purification</style></keyword><keyword><style face="normal" font="default" size="100%">Hospital Information Systems</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Immunoglobulin M/blood</style></keyword><keyword><style face="normal" font="default" size="100%">Retrospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Turkey</style></keyword><keyword><style face="normal" font="default" size="100%">Unnecessary Procedures/economics/*statistics &amp; numerical data</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style face="normal" font="default" size="100%">Oct</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0374-9096 (Print)&#xD;0374-9096</style></isbn><abstract><style face="normal" font="default" size="100%">Since hepatitis B virus (HBV) infections may cause serious clinical symptoms and become chronic, the appropriate use and interpretation of laboratory tests in diagnosis is crucial. Implementation of serological tests for all HBV markers leads to high cost, labour force and time loss, so diagnostic algorithms are used for this purpose. The aims of this retrospective study were to detect the number of unnecessary test requests in HBV infection serology and financial burden as its consequence and to find out the reasons and ways of solutions. Three-years records of microbiology laboratory of Dumlupinar University Evliya Celebi Training and Research Hospital, Kutahya, Turkey, between 2011-2013 were analysed for the detection of unnecessary test requests and a total of 179.640 HBV serological test results were evaluated. Serological tests requested more than one on the same day and HBeAg, anti-HBe and anti-HBc IgM tests required from the patients with natural immunity or vaccinated ones were considered as unnecessary test requests. The main reasons of unnecessary test requests were detected as follows; unable to check the previous HBV test results in HIMS (Hospital Information Management System) owing to restricted of time, not being friendly user of HIMS, not trusting the test results, not knowing diagnostics algorithms, requiring of the tests by secretaries or other staff like nurses, not questioning HBV vaccination and requiring screening tests because of the defensive medicine. Survey questions prepared to search these reasons and awareness level of diagnostic algorithms were handed and asked to fill out 146 physicians working at clinics which made over 100 unnecessary requests in 3 years. Total numbers of unnecessary requested serological HBV tests were 5415 (3.01%) and total financial burden for our hospital in three years was 42.256 TL (18.373 USD) according to the notifications of Turkish Social Security Institution. It was determined that the most unnecessary test requests were HBeAg (44.86%), anti-HBe (37.75%) and anti-HBc IgM (37.41%). The most unnecessary test requests were made by internal medicine, obstetrics and gynaecology, general surgery and cardiology clinics, respectively. According to questionnaires filled by the 100 clinicians, the most common causes of unnecessary tests were hepatitis test requests from hospitalized patients for screening (96%), the tests required by secretary or nurse (62%), pre-surgical screening tests (53%) and lack of knowledge about diagnostic algorithms (42%). In conclusion, it is suggested that test requests should be restricted by using screening algorithms and in-service training should be provided, tests required by secretary or nurse should be stopped and previous test results should be conveyed to the clinicians actively through HIMS in order to prevent unnecessary test requests causing economic and workforce loss in HBV infection serology. These measures can provide early and true diagnosis for the patients and also will reduce the economic loss.</style></abstract><notes><style face="normal" font="default" size="100%">Genç, Ozlem&#xD;Aksu, Evrim&#xD;English Abstract&#xD;Journal Article&#xD;Turkey&#xD;Mikrobiyol Bul. 2014 Oct;48(4):618-27. doi: 10.5578/mb.8080.</style></notes><urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.5578/mb.8080</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2120</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2120</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Georgakis, M. K.</style></author><author><style face="normal" font="default" size="100%">Dessypris, N.</style></author><author><style face="normal" font="default" size="100%">Baka, M.</style></author><author><style face="normal" font="default" size="100%">Moschovi, M.</style></author><author><style face="normal" font="default" size="100%">Papadakis, V.</style></author><author><style face="normal" font="default" size="100%">Polychronopoulou, S.</style></author><author><style face="normal" font="default" size="100%">Kourti, M.</style></author><author><style face="normal" font="default" size="100%">Hatzipantelis, E.</style></author><author><style face="normal" font="default" size="100%">Stiakaki, E.</style></author><author><style face="normal" font="default" size="100%">Dana, H.</style></author><author><style face="normal" font="default" size="100%">Bouka, E.</style></author><author><style face="normal" font="default" size="100%">Antunes, L.</style></author><author><style face="normal" font="default" size="100%">Bastos, J.</style></author><author><style face="normal" font="default" size="100%">Coza, D.</style></author><author><style face="normal" font="default" size="100%">Demetriou, A.</style></author><author><style face="normal" font="default" size="100%">Agius, D.</style></author><author><style face="normal" font="default" size="100%">Eser, S.</style></author><author><style face="normal" font="default" size="100%">Gheorghiu, R.</style></author><author><style face="normal" font="default" size="100%">Sekerija, M.</style></author><author><style face="normal" font="default" size="100%">Trojanowski, M.</style></author><author><style face="normal" font="default" size="100%">Zagar, T.</style></author><author><style face="normal" font="default" size="100%">Zborovskaya, A.</style></author><author><style face="normal" font="default" size="100%">Ryzhov, A.</style></author><author><style face="normal" font="default" size="100%">Tragiannidis, A.</style></author><author><style face="normal" font="default" size="100%">Panagopoulou, P.</style></author><author><style face="normal" font="default" size="100%">Steliarova-Foucher, E.</style></author><author><style face="normal" font="default" size="100%">Petridou, E. T.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Hygiene, Epidemiology and Medical Statistics Medical School, National and Kapodistrian University of Athens, Athens, Greece.&#xD;Department of Pediatric Hematology-Oncology, &quot;Pan. &amp; Agl. Kyriakou&quot; Children&apos;s Hospital, Athens, Greece.&#xD;Pediatric Hematology/Oncology Unit, First Department of Pediatrics, University of Athens, &quot;Agia Sofia&quot; Children&apos;s Hospital, Athens, Greece.&#xD;Department of Pediatric Hematology-Oncology, &quot;Agia Sofia&quot; Children&apos;s Hospital, Athens, Greece.&#xD;Department of Pediatric Hematology and Oncology, Hippokration Hospital, Thessaloniki, Greece.&#xD;2nd Hematology Oncology Unit, 2nd Pediatric Department, Aristotle University of Thessaloniki, AHEPA Hospital, Thessaloniki, Greece.&#xD;Department of Pediatric Hematology-Oncology, University of Crete, Heraklion, Greece.&#xD;Department of Pediatric Hematology-Oncology, &quot;Mitera&quot; Children&apos;s Hospital, Athens, Greece.&#xD;North Region Cancer Registry of Portugal (RORENO), Portuguese Institute of Oncology, Porto, Portugal.&#xD;Registo Oncológico Regional do Centro (ROR-Centro), Instituto Português de Oncologia de Coimbra Francisco Gentil, E.P.E., Coimbra, Portugal.&#xD;The Oncology Institute &quot;Prof. Dr. Ion Chiricuţă&quot;, Cluj-Napoca, Romania.&#xD;Health Monitoring Unit, Ministry of Health, Nicosia, Cyprus.&#xD;Department for Policy in Health - Health Information and Research, Malta National Cancer Registry, Pieta, Malta.&#xD;Izmir Cancer Registry, Izmir Hub, Izmir and Hacettepe, University Institute of Public Health, Ankara, Turkey.&#xD;Regional Cancer Registry, National Institute of Public Health, Iasi, Romania.&#xD;Croatian Institute of Public Health, Croatian National Cancer Registry, Zagreb, Croatia.&#xD;Andrija Štampar School of Public Health, School of Medicine, University of Zagreb, Zagreb, Croatia.&#xD;Wielkopolskie Centrum Onkologii, Poznan University of Medical Sciences, Poznan, Poland.&#xD;Cancer Registry of Slovenia, Institute of Oncology Ljubljana, Ljubljana, Slovenia.&#xD;Belarusian Research Center for Paediatric Oncology, Haematology and Immunology, Childhood Cancer Subregistry of Belarus, Minsk, Belarus.&#xD;National Cancer Registry of Ukraine, National Institute of Cancer, Kiev, Ukraine.&#xD;Fourth Department of Pediatrics, Medical School, General Hospital &quot;Papageorgiou&quot;, Aristotle University of Thessaloniki, Thessaloniki, Greece.&#xD;International Agency for Research on Cancer, World Health Organization, Lyon, France.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Neuroblastoma among children in Southern and Eastern European cancer registries: Variations in incidence and temporal trends compared to US</style></title><secondary-title><style face="normal" font="default" size="100%">Int J Cancer</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Int J Cancer</style></full-title></periodical><pages><style face="normal" font="default" size="100%">1977-1985</style></pages><volume><style face="normal" font="default" size="100%">142</style></volume><number><style face="normal" font="default" size="100%">10</style></number><edition><style face="normal" font="default" size="100%">2017/12/19</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Child, Preschool</style></keyword><keyword><style face="normal" font="default" size="100%">Europe/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Europe, Eastern/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Incidence</style></keyword><keyword><style face="normal" font="default" size="100%">Infant</style></keyword><keyword><style face="normal" font="default" size="100%">Infant, Newborn</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Neuroblastoma/*epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Registries</style></keyword><keyword><style face="normal" font="default" size="100%">SEER Program</style></keyword><keyword><style face="normal" font="default" size="100%">United States/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">*children</style></keyword><keyword><style face="normal" font="default" size="100%">*incidence</style></keyword><keyword><style face="normal" font="default" size="100%">*neuroblastoma</style></keyword><keyword><style face="normal" font="default" size="100%">*overdiagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">*time trends</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style face="normal" font="default" size="100%">May 15</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0020-7136</style></isbn><accession-num><style face="normal" font="default" size="100%">29250786</style></accession-num><abstract><style face="normal" font="default" size="100%">Neuroblastoma comprises the most common neoplasm during infancy (first year of life). Our study describes incidence of neuroblastoma in Southern-Eastern Europe (SEE), including - for the first time - the Nationwide Registry for Childhood Hematological Malignancies and Solid Tumors (NARECHEM-ST)/Greece, compared to the US population, while controlling for human development index (HDI). Age-adjusted incidence rates (AIR) were calculated for 1,859 childhood (0-14 years) neuroblastoma cases, retrieved from 13 collaborating SEE registries (1990-2016), and were compared to those of SEER/US (N = 3,166; 1990-2012); temporal trends were assessed using Poisson regression and Joinpoint analyses. The overall AIR was significantly lower in SEE (10.1/million) compared to SEER (11.7 per million); the difference was maximum during infancy (43.7 vs. 53.3 per million, respectively), when approximately one-third of cases were diagnosed. Incidence rates of neuroblastoma at ages &lt;1 and 1-4 years were positively associated with HDI, whereas lower median age at diagnosis was correlated with higher overall AIR. Distribution of primary site and histology was similar in SEE and SEER. Neuroblastoma was slightly more common among males compared to females (male-to-female ratio: 1.1), mainly among SEE infants. Incidence trends decreased in infants in Slovenia, Cyprus and SEER and increased in Ukraine and Belarus. The lower incidence in SEE compared to SEER, especially in infants living in low HDI countries possibly indicates a lower level of overdiagnosis in SEE. Hence, increases in incidence rates in infancy noted in some subpopulations should be carefully monitored to avoid the unnecessary costs health impacts of tumors that could potentially spontaneously regress.</style></abstract><notes><style face="normal" font="default" size="100%">1097-0215&#xD;Georgakis, Marios K&#xD;Dessypris, Nick&#xD;Baka, Margarita&#xD;Moschovi, Maria&#xD;Papadakis, Vassilios&#xD;Polychronopoulou, Sophia&#xD;Kourti, Maria&#xD;Hatzipantelis, Emmanuel&#xD;Stiakaki, Eftichia&#xD;Dana, Helen&#xD;Bouka, Evdoxia&#xD;Antunes, Luis&#xD;Bastos, Joana&#xD;Coza, Daniela&#xD;Demetriou, Anna&#xD;Agius, Domenic&#xD;Eser, Sultan&#xD;Gheorghiu, Raluca&#xD;Sekerija, Mario&#xD;Trojanowski, Maciej&#xD;Zagar, Tina&#xD;Zborovskaya, Anna&#xD;Ryzhov, Anton&#xD;Tragiannidis, Athanassios&#xD;Panagopoulou, Paraskevi&#xD;Steliarova-Foucher, Eva&#xD;Petridou, Eleni Th&#xD;Orcid: 0000-0003-3695-3439&#xD;001/World Health Organization/International&#xD;Comparative Study&#xD;Journal Article&#xD;United States&#xD;Int J Cancer. 2018 May 15;142(10):1977-1985. doi: 10.1002/ijc.31222. Epub 2017 Dec 29.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ijc.31222?download=true</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1002/ijc.31222</style></electronic-resource-num><remote-database-provider><style face="normal" font="default" size="100%">NLM</style></remote-database-provider><language><style face="normal" font="default" size="100%">eng</style></language></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2121</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2121</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Gerhold, Jorge</style></author><author><style face="normal" font="default" size="100%">Poves, Victoria</style></author><author><style face="normal" font="default" size="100%">Calero, David</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Las consecuencias del sobrediagnóstico y el sobretratamiento en el câncer de próstata</style></title><secondary-title><style face="normal" font="default" size="100%">Brasília méd</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Brasília méd</style></full-title></periodical><volume><style face="normal" font="default" size="100%">48</style></volume><number><style face="normal" font="default" size="100%">2</style></number><dates><year><style face="normal" font="default" size="100%">2011</style></year><pub-dates><date><style face="normal" font="default" size="100%">2011/00</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0524-2053</style></isbn><abstract><style face="normal" font="default" size="100%">Introducción. El diagnóstico del cáncer de próstata ha cambiado radicalmente desde que se empezó a usar el antígeno prostático específico. Anteriormente la mayoría de los pacientes eran ancianos que acudían al médico con cánceres avanzados, mientras que en la actualidad la mayoría son varones asintomáticos alertados tras un análisis de sangre de rutina. Muchos de ellos no presentan tumores palpables en el tacto rectal ni visibles en las pruebas radiológicas (T1c), pero a menudo son sometidos a tratamientos agresivos, sin demostrarse mejoría en su supervivencia. Objetivo. Demostrar la existencia del sobrediagnóstico y sobretratamiento en el cáncer de próstata y cuantificar sus consecuencias. Método. Definir los motivos de alarma que justifican la sospecha del sobrediagnóstico y revisar la literatura parajustificarlos. Se presentan los datos que hacen sospechar la presencia de una elevada tasa de sobrediagnóstico entre dichos pacientes.Resultados. No se encuentra bibliografía que enfrente las ventajas de los tratamientos en los casos sospechosos de sobrediagnóstico (T1c). Se resumen las consecuencias manifestadas por los efectos secundarios de las pruebas diagnósticas y los tratamientos en grupos donde más del 80% de los casos son T2, enfrentándolas a los escasos beneficios:para prevenir un muerte hay que revisar como mínimo a 1410 varones y practicar 18,5 prostatectomías. Como efectos indeseables destaca entre los revisados una muerte por cada 9791, una impotencia por cada 58 o una incontinencia por cada 147. Conclusiones. El sobrediagnóstico en el cáncer de próstata en la actualidad es cuantitativamente importante y tienerepercusiones negativas importantes. Por su falta de soporte científico y su generalización más que un simple efecto secundario de una acción médica correcta, está convirtiéndose en un grave error del sistema sanitario en su conjunto.&#xD;Introdução. O diagnóstico de câncer de próstata mudou radicalmente desde que começou a ser utilizado o antígeno prostático específico. Antes, a maioria dos pacientes era composta de idosos que procuravam o médico com cânceres avançados, e atualmente a maior parte é constituída de homens assintomáticos alertados por exame de sangue de rotina. Em muitos deles, os tumores não são palpáveis ao toque retal nem visíveis nos exames radiológicos (T1c) e, apesar disso, são amiúde submetidos a tratamentos agressivos, sem demonstração de melhoria nas taxas de supervivência. Objetivo. Demonstrar a existência de sobrediagnóstico e sobretratamento no câncer de próstata e quantificar suasconsequências. Método. Estabelecer os motivos de alarme que justificam a suspeita do sobrediagnóstico do câncer de prostata e revisar a literatura para justificá-los. São apresentados dados que fazem suspeitar que ocorra elevada taxa de sobrediagnóstico nesses pacientes.Resultados. Não se encontram artigos que abordem as vantagens do tratamento nos casos suspeitos de sobrediagnóstico(T1c). São resumidas as conseqüências dos efeitos colaterais dos exames diagnósticos e do tratamento em grupos em que mais de 80% dos casos são T2, confrontando-as aos escassos benefícios: para prevenir uma morte é preciso submeter à biópsia no mínimo 1.410 homens e realizar 18,5 prostatectomias. Como efeitos indesejáveis destacam-se,entre os pacientes submetidos à biópsia, uma morte para cada 9.791, uma impotência para cada 58 ou uma incontinência para cada 147.Conclusões. O sobrediagnóstico no câncer de próstata é quantitativamente importante nos dias atuais e tem repercussõesnegativas importantes. Em virtude da sua generalização e da falta de suporte científico, vem se convertendo não apenas no simples efeito secundário de uma ação médica correta, mas num grave erro do sistema sanitário como um todo.&#xD;Introduction. Since the introduction of the specific antigen, the diagnosis of prostate cancer has radically changed. Previously, the majority of those seeking medical assistance were elderly patients with advanced cancers, whereas the current majority are asymptomatic men alerted by a routine blood test. Many tumors are not palpable on digital rectalexamination, nor visible on X-rays (T1c) and yet are often subjected to aggressive treatment, without showing improvement in survival rates.Objective. To demonstrate the existence of overdiagnosis and overtreatment for prostate cancer and to quantify their consequences.Method. Alarming conditions suggesting the occurrence of possible prostate cancer overdiagnosis are described and justified by proper literature review. Data presented give indications of a high rate of overdiagnosis among these patients. Results. No studies have been found that address the benefits of treatment in suspected cases of overdiagnosis (T1c). Summaries are made of consequences of the side effects of diagnostic and treatment groups where more than80% of cases are T2, comparing them to the limited benefits reaped: in order to prevent the death of one patient it is necessary to perform biopsy on at least 1,410 men and to carry out 18.5 prostatectomies. Undesirable effects include one death for every 9,791, one case of impotence for each 58 or one case of incontinence for every 147 patients whounderwent biopsy. Conclusions. The overdiagnosis in prostate cancer is quantitatively important at present and has significant negativeimpacts. Due to the generality of its impact and the lack of scientific support, it is becoming not just a simple side effect of proper medical action, but a serious error of the health system as a whole.</style></abstract><urls><related-urls><url><style face="normal" font="default" size="100%">http://www.ambr.org.br/portal/arquivos/cancer%20prostata.pdf</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2122</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2122</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Godaert, L.</style></author><author><style face="normal" font="default" size="100%">Bartholet, S.</style></author><author><style face="normal" font="default" size="100%">Gazeuse, Y.</style></author><author><style face="normal" font="default" size="100%">Brouste, Y.</style></author><author><style face="normal" font="default" size="100%">Najioullah, F.</style></author><author><style face="normal" font="default" size="100%">Kanagaratnam, L.</style></author><author><style face="normal" font="default" size="100%">Césaire, R.</style></author><author><style face="normal" font="default" size="100%">Fanon, J. L.</style></author><author><style face="normal" font="default" size="100%">Dramé, M.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Geriatrics, University Hospitals of Martinique, Martinique, France.&#xD;Department of Emergency Medicine, University Hospitals of Martinique, Martinique, France.&#xD;Department of Virology, University Hospitals of Martinique, Martinique, France.&#xD;Faculty of Medicine, University of Reims Champagne-Ardenne, Reims, France.&#xD;Department of Research and Public Health, University Hospital of Reims, Robert Debré Hospital, Reims, France.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Misdiagnosis of Chikungunya Virus Infection: Comparison of Old and Younger Adults</style></title><secondary-title><style face="normal" font="default" size="100%">J Am Geriatr Soc</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">J Am Geriatr Soc</style></full-title></periodical><pages><style face="normal" font="default" size="100%">1768-1772</style></pages><volume><style face="normal" font="default" size="100%">66</style></volume><number><style face="normal" font="default" size="100%">9</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">*Age Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Aged, 80 and over</style></keyword><keyword><style face="normal" font="default" size="100%">Chikungunya Fever/*diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">*Chikungunya virus</style></keyword><keyword><style face="normal" font="default" size="100%">Cross-Sectional Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Diagnostic Errors/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Emergency Service, Hospital/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Retrospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">*Chikungunya</style></keyword><keyword><style face="normal" font="default" size="100%">*French West Indies</style></keyword><keyword><style face="normal" font="default" size="100%">*emergency department</style></keyword><keyword><style face="normal" font="default" size="100%">*misdiagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">*older adults</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style face="normal" font="default" size="100%">Sep</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0002-8614</style></isbn><abstract><style face="normal" font="default" size="100%">OBJECTIVES: To assess the frequency of diagnostic errors in older adults presenting to the emergency department (ED) with symptoms suggestive of Chikungunya virus infection (CVI) and to compare the rates of misdiagnosis of older and younger adults. DESIGN: Cross-sectional study performed in the University Hospitals of Martinique from retrospective cases. SETTING: Emergency department. PARTICIPANTS: Individuals aged 65 and older who attended the ED and underwent reverse transcription polymerase chain reaction (RT-PCR) testing for CVI between January and December 2014 (n=333, mean age 80±8) were considered eligible and were compared with a randomly selected sample of younger adults (&lt; 65) (n=143, mean age 45±13). MEASUREMENTS: Misdiagnosis rates. RESULTS: The rate of misdiagnosis of CVI in the ED was 30.6% in individuals aged 65 and older and 6.3% in those younger than 65 (p&lt;.001). The overdiagnosis rate was 9.0% in individuals aged 65 and older and 3.5% in those younger than 65 (p=.04). The underdiagnosis rate was significantly higher (p&lt;.001) in individuals aged 65 and older (21.6%) than in those younger than 65 (2.8%). CONCLUSION: Misdiagnosis of CVI during an epidemic is statistically more frequent in older than younger adults because clinical presentation is often atypical in older adults. Specific diagnostic tools for older adults and better awareness of ED physicians of different presentations in different age groups could help to reduce the rate of misdiagnosis of CVI in the ED.</style></abstract><notes><style face="normal" font="default" size="100%">1532-5415&#xD;Godaert, Lidvine&#xD;Orcid: 0000-0003-4911-2217&#xD;Bartholet, Seendy&#xD;Gazeuse, Yannick&#xD;Brouste, Yannick&#xD;Najioullah, Fatiha&#xD;Kanagaratnam, Lukshe&#xD;Césaire, Raymond&#xD;Fanon, Jean-Luc&#xD;Dramé, Moustapha&#xD;Evaluation Study&#xD;Journal Article&#xD;United States&#xD;J Am Geriatr Soc. 2018 Sep;66(9):1768-1772. doi: 10.1111/jgs.15492. Epub 2018 Aug 6.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://agsjournals.onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jgs.15492?download=true</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1111/jgs.15492</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2123</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2123</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Gokcu, M.</style></author><author><style face="normal" font="default" size="100%">Cingillioglu, B.</style></author><author><style face="normal" font="default" size="100%">Goklu, R.</style></author><author><style face="normal" font="default" size="100%">Dicle, N.</style></author><author><style face="normal" font="default" size="100%">Adiyeke, M.</style></author><author><style face="normal" font="default" size="100%">Sanci, M.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">M. Gokcu, Gynecologic Oncology, Tepecik Research and Training Hospital, Izmir, Turkey</style></auth-address><titles><title><style face="normal" font="default" size="100%">Outcomes of intra-operative frozen section proven borderline ovarian tumors</style></title><secondary-title><style face="normal" font="default" size="100%">International Journal of Gynecological Cancer</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">International Journal of Gynecological Cancer</style></full-title></periodical><pages><style face="normal" font="default" size="100%">893</style></pages><volume><style face="normal" font="default" size="100%">23</style></volume><number><style face="normal" font="default" size="100%">8</style></number><keywords><keyword><style face="normal" font="default" size="100%">paraffin</style></keyword><keyword><style face="normal" font="default" size="100%">CA 125 antigen</style></keyword><keyword><style face="normal" font="default" size="100%">ovary tumor</style></keyword><keyword><style face="normal" font="default" size="100%">society</style></keyword><keyword><style face="normal" font="default" size="100%">oncology</style></keyword><keyword><style face="normal" font="default" size="100%">frozen section</style></keyword><keyword><style face="normal" font="default" size="100%">diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">female</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">patient</style></keyword><keyword><style face="normal" font="default" size="100%">pathology</style></keyword><keyword><style face="normal" font="default" size="100%">diagnostic accuracy</style></keyword><keyword><style face="normal" font="default" size="100%">neoplasm</style></keyword><keyword><style face="normal" font="default" size="100%">teaching hospital</style></keyword><keyword><style face="normal" font="default" size="100%">decision making</style></keyword><keyword><style face="normal" font="default" size="100%">predictive value</style></keyword><keyword><style face="normal" font="default" size="100%">diagnostic error</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2013</style></year></dates><isbn><style face="normal" font="default" size="100%">1048-891X</style></isbn><abstract><style face="normal" font="default" size="100%">Objectives We assesed the accuracy of frozen section diagnosis and the outcomes of misdiagnosis in borderline ovarian tumors (BOT) according to frozen section analysis. Methods All pathology reports with BOT in both frozen section and permanent paraffin blocks were analysed between 2000-2012 at Tepecik research &amp; teaching hospital. Frozen section diagnosis and permanent paraffin blocks were compared. Patient and tumor characteristics analysed for diagnostic accuracy. Results Agrement between frozen section and permanent diagnosis of BOT was observed in 58 of 113 patients. Mean age of patients with frozen section results were, benign 39.4, borderline 38.1, malign 50,6 years. The agreement, sensitivity and positive predictive values of frozen section diagnosis of BOT were 50%, 70% and 67%. Among the 87 patients with frozen section proven BOT, 58 (67%) patients were correctly diagnosed by frozen section analysis. Under diagnosis and over diagnosis occurred in 14 of 87 (16%) and 16 of 87 (18%) respectively. Conclusions Although frozen section diagnosis agrees with permanent pathology of malignancy in 90-94% of cases, over-diagnosis and underdiagnosis are relatively ferquent in frozen proven BOT. Surgical decision making for BOT based on frozen section diagnosis should be done carefully and the other clinical characteristics (age, radiologic findings,ca 125 level etc.) of the patient should be considered.</style></abstract><notes><style face="normal" font="default" size="100%">L71363496&#xD;2014-03-14</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.embase.com/search/results?subaction=viewrecord&amp;id=L71363496&amp;from=export</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2124</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2124</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Gómez Botero, Juliana</style></author><author><style face="normal" font="default" size="100%">Restrepo Jaramillo, Mónica</style></author><author><style face="normal" font="default" size="100%">Morales Uribe, Carlos Hernando</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Utilidad del examen físico para el diagnóstico de lesión intraabdominal en heridas por arma cortopunzante</style></title><secondary-title><style face="normal" font="default" size="100%">Rev. colomb. cir</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Rev. colomb. cir</style></full-title></periodical><pages><style face="normal" font="default" size="100%">52-61</style></pages><volume><style face="normal" font="default" size="100%">33</style></volume><number><style face="normal" font="default" size="100%">1</style></number><keywords><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Abdominal Injuries</style></keyword><keyword><style face="normal" font="default" size="100%">Physical Examination</style></keyword><keyword><style face="normal" font="default" size="100%">Tomography</style></keyword><keyword><style face="normal" font="default" size="100%">Wounds, Penetrating</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style face="normal" font="default" size="100%">2018/00</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">2011-7582</style></isbn><abstract><style face="normal" font="default" size="100%">Introducción. El propósito de este estudio fue evaluar el desempeño del examen físico, apoyado en ayudas imaginológicas, en los pacientes con herida penetrante abdominal, para diagnosticar la presencia de lesión intraabdominal y seleccionar los candidatos a manejo no operatorio. Materiales y métodos. Se analizó la base de datos de 559 pacientes mayores de 15 años con herida abdominal por arma cortopunzante que ingresaron a un centro hospitalario de cuarto nivel. Resultados. Se practicó laparotomía exploratoria de urgencia en 290/559 (51,4 %) pacientes, 38/290 (13,1 %) de las cuales fueron laparotomías no terapéuticas. La sensibilidad del examen físico para la decisión quirúrgica emergente fue de 99,6 % y, su especificidad, de 80,99 %. Al resto de los pacientes (47,7 %) se les realizó observación clínica estrecha con examen físico repetido. Durante el manejo no operatorio, 72/269 (26,8 %) pacientes fueron sometidos a cirugía por los hallazgos del examen físico. De este grupo, solo 8/72 (11 %) de las laparotomías fueron no terapéuticas. Se dieron de alta 197/269 (73,2 %) pacientes con un periodo de observación no inferior a 24 horas. En este grupo, la sensibilidad del examen físico fue de 98,46 % y, su especificidad, de 96,08 %. Conclusiones. La experiencia del manejo de pacientes con heridas abdominales penetrantes por arma cortopunzante apoya al examen físico como una prueba diagnóstica muy sensible y específica para el diagnóstico de lesión intraabdominal, lográndose que el tratamiento no operatorio sea una alternativa terapéutica, evitando laparotomías innecesarias y el aumento de la morbimortalidad&#xD;Introduction: The purpose of this study was to determine the value of the physical examination supported by imaging in patients with penetrating abdominal wounds in diagnosing intra-abdominal injury and to select candidates for nonoperative management.Materials and methods: Analysis of a database of 559 patients over 15 years of age presenting with penetrating abdominal trauma at a fourth level of care hospital. Results: Emergency exploratory laparotomy was performed in 290 patients (51.4%), of whom 38 (13.1%) were nontherapeutic laparotomies. The sensitivity and specificity of the physical examination for the emergent surgical decision was 99.6% and 80.99%, respectively. The remaining patients (47.7%) underwent clinical observation with repeated physical examination. During the nonoperative management, 72 patients (26.8%) were taken to surgery based on findings in the physical examination. Of this group, only 11% of laparotomies were non-therapeutic. One hundred and ninety-seven (73.2%) patients were discharged with an observation period of no less than 24 hours. In this group of patients, the sensitivity of the physical examination was 98.46% and specificity was 96.08%. Conclusions: Our experience in the management of patients with abdominal stab wounds supports physical examination as a highly sensitive and specific diagnostic method for the diagnosis of intra-abdominal injury. Nonoperative management is a therapeutic alternative, avoiding unnecessary laparotomies and increased morbidity and mortality</style></abstract><label><style face="normal" font="default" size="100%">Included by Hannah</style></label><urls><related-urls><url><style face="normal" font="default" size="100%">http://www.revistacirugia.org/media/k2/attachments/ExamenZfsicoZenZlesiones_GomezZJZetZal.pdf</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2125</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2125</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Gómez-Landeros, O.</style></author><author><style face="normal" font="default" size="100%">González-Pérez, S.</style></author><author><style face="normal" font="default" size="100%">Barrientos-Juárez, A.</style></author><author><style face="normal" font="default" size="100%">Granados-Cosme, J. A.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Universidad Autónoma Metropolitana Xochimilco, Licenciatura en Medicina. Ciudad de México, México.</style></auth-address><titles><title><style face="normal" font="default" size="100%">[Radio-diagnostic congruence improvement in a first-level unit]</style></title><secondary-title><style face="normal" font="default" size="100%">Rev Med Inst Mex Seguro Soc</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Rev Med Inst Mex Seguro Soc</style></full-title></periodical><pages><style face="normal" font="default" size="100%">4-10</style></pages><volume><style face="normal" font="default" size="100%">58</style></volume><number><style face="normal" font="default" size="100%">1</style></number><keywords><keyword><style face="normal" font="default" size="100%">Cost-Benefit Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Longitudinal Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Mexico</style></keyword><keyword><style face="normal" font="default" size="100%">*Radiography/economics</style></keyword><keyword><style face="normal" font="default" size="100%">Unnecessary Procedures</style></keyword><keyword><style face="normal" font="default" size="100%">Family Practice</style></keyword><keyword><style face="normal" font="default" size="100%">Health Services</style></keyword><keyword><style face="normal" font="default" size="100%">Radiology</style></keyword><keyword><style face="normal" font="default" size="100%">X-Rays</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2020</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jan 1</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0443-5117</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: Radiology is a fundamental tool on outpatient Family Medicine practice. Its adverse effects include its abuse, given that the patient is exposed to unnecessary radiation, and health care costs increase. OBJECTIVE: To evaluate the implementation of a radio-diagnostic congruence strategy (RDCS) in a first-level unit in Mexico City. MATERIAL AND METHODS: It was carried out an experimental, longitudinal study that covered both a previous period of time and another one after implementing the RDCS. It was evaluated the congruence between the diagnosis and the appropriateness of the imaging studies on the basis of the correspondent clinical practice guidelines. It was applied as well a bivariate statistical analysis that associated the diagnosis, the anatomical region and the patients&apos; sex. RESULTS: The number of imaging studies diminished substantially, while the congruence increased; this was associated to the anatomical region and the diagnosis; sex was not a decisive variable. CONCLUSIONS: Implementing the RDCS shows positive effects, since the number of requests for imaging diminished (in 43.7%), and the radio-diagnostic congruence increased (8.5%) after implementing the RDCS. The reduction of requests for imaging could have been influenced by the fact that the medical staff could have been inhibited after been monitored, which could have led them to dispatch only the necessary requests for imaging. Our findings concur with the literature in the number of imaging studies requested in the first level of care, and the necessity to check out its appropriateness in order to increase its effectivity.</style></abstract><notes><style face="normal" font="default" size="100%">2448-5667&#xD;Gómez-Landeros, Ofelia&#xD;González-Pérez, Silvia&#xD;Barrientos-Juárez, Arian&#xD;Granados-Cosme, José Arturo&#xD;English Abstract&#xD;Mexico&#xD;Rev Med Inst Mex Seguro Soc. 2020 Jan 1;58(1):4-10.</style></notes><urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2126</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2126</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Gonzaga, M. A.</style></author><author><style face="normal" font="default" size="100%">Kiguli-Malwadde, E.</style></author><author><style face="normal" font="default" size="100%">Businge, F.</style></author><author><style face="normal" font="default" size="100%">Byanyima, R. K.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Radiology department, School of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Utilisation of obstetric sonography at a peri-urban health centre in Uganda</style></title><secondary-title><style face="normal" font="default" size="100%">Pan Afr Med J</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Pan Afr Med J</style></full-title></periodical><pages><style face="normal" font="default" size="100%">24</style></pages><volume><style face="normal" font="default" size="100%">7</style></volume><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Delivery, Obstetric/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Gestational Age</style></keyword><keyword><style face="normal" font="default" size="100%">Hospitals, Rural</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Maternal Age</style></keyword><keyword><style face="normal" font="default" size="100%">Maternal Health Services</style></keyword><keyword><style face="normal" font="default" size="100%">Pregnancy</style></keyword><keyword><style face="normal" font="default" size="100%">Pregnancy Complications/*diagnostic imaging</style></keyword><keyword><style face="normal" font="default" size="100%">Pregnancy Outcome</style></keyword><keyword><style face="normal" font="default" size="100%">Pregnancy, High-Risk</style></keyword><keyword><style face="normal" font="default" size="100%">Prenatal Care/standards</style></keyword><keyword><style face="normal" font="default" size="100%">Retrospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Rural Population</style></keyword><keyword><style face="normal" font="default" size="100%">Uganda</style></keyword><keyword><style face="normal" font="default" size="100%">Ultrasonography, Prenatal/classification/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Unnecessary Procedures/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Obstetric</style></keyword><keyword><style face="normal" font="default" size="100%">sonography</style></keyword><keyword><style face="normal" font="default" size="100%">ultrasound</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2010</style></year></dates><isbn><style face="normal" font="default" size="100%">1937-8688 (Print)</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: Maternal mortality is related to obstetric complications in pregnancy some of which could be revealed by obstetric sonography. Obstetric sonography has become part of routine antenatal care in both urban and rural settings. The objective of the study was to assess the utilization of obstetric sonography in a rural hospital of Uganda, including the frequency and appropriateness of its usage as well as determine whether there was any relation between number of obstetric scans, patient management and obstetric outcomes. METHODS: It was a retrospective study in which review of all obstetric charts and obstetric scan requisition forms for all deliveries in Ndejje Health Centre (Uganda) was done. RESULTS: During the study period, there were 105 singleton deliveries, and these mothers underwent a total of 232 obstetric scans. More than half (53.4%) of the scans were classified as inappropriate. There were no significant differences in the number of scans between low- and high-risk pregnancies or between uncomplicated deliveries and those in which induction or instrumental or operative delivery occurred, nor was there any relation between number of scans and obstetric outcome. CONCLUSION: Obstetric sonography has become popular in rural health settings as part of antenatal care. However, it was over-used in the health centre. This overuse was not associated with any identifiable effect on obstetric outcome. Therefore, more appropriate use of obstetric sonography, in accordance with evidence-based guidelines, is recommended.</style></abstract><notes><style face="normal" font="default" size="100%">1937-8688&#xD;Gonzaga, Mubuuke Aloysius&#xD;Kiguli-Malwadde, Elsie&#xD;Businge, Francis&#xD;Byanyima, Rosemary Kusaba&#xD;Journal Article&#xD;Pan Afr Med J. 2010;7:24. Epub 2010 Dec 28.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3172624/pdf/pamj-7-24.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC3172624</style></custom2></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2127</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2127</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">González E, Patricio</style></author><author><style face="normal" font="default" size="100%">Jofre M, Josefina</style></author><author><style face="normal" font="default" size="100%">Massardo V, Teresa</style></author><author><style face="normal" font="default" size="100%">Humeres, Pamela</style></author><author><style face="normal" font="default" size="100%">Canessa G, José</style></author><author><style face="normal" font="default" size="100%">Sierralta C, Palunina</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Uso de la tomografía de emisión de positrones en el cáncer colorrectal</style></title><secondary-title><style face="normal" font="default" size="100%">Rev. chil. radiol</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Rev. chil. radiol</style></full-title></periodical><pages><style face="normal" font="default" size="100%">72-79</style></pages><volume><style face="normal" font="default" size="100%">8</style></volume><number><style face="normal" font="default" size="100%">2</style></number><keywords><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Colorectal Neoplasms/diagnostic imaging</style></keyword><keyword><style face="normal" font="default" size="100%">Computed Tomography Angiography/methods</style></keyword><keyword><style face="normal" font="default" size="100%">Colorectal Neoplasms/therapy</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2002</style></year><pub-dates><date><style face="normal" font="default" size="100%">2002/00</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0717-201X</style></isbn><abstract><style face="normal" font="default" size="100%">The value of PET (Positron Emission Tomography) in colorectal cancer is presented. PET is a novel technique that uses F-18-FDG (fluorodeoxiglucose) to assess glucose metabolism by whole body imaging. It has been demonstrated that malignant cells have both increase of glucose uptake and utilization. In colorectal cancer, PET is indicated for staging, assess recurrence, liver metastasis and treatment follow-up. PET is more sensitive and specific than CT (Computed Tomography) and is cost effective. In 30% of cases PET may change patient management, avoiding unnecessary procedures.&#xD;El valor de la tomografía de emisión de positrones (PET) en el cáncer colorrectal es revisado en esta corta comunicación. El PET es una nueva técnica que emplea F-18-FDG (Fluoro-deoxiglucosa) para evaluar el metabolismo glucídico de las células mediante imágenes de todo el cuerpo en un solo examen. Se ha demostrado que las células malignas tienen captación y utilización aumentada de la glucosa. En el cáncer colorrectal el PET esta indicado para el diagnóstico de extensión inicial, sospecha de recurrencia, evaluación de metástasis hepáticas, recidiva tumoral y control de terapias. El PET es más sensible y específico que la tomografía computada y es una técnica costo efectiva. En aproximadamente un 30% de los casos ayuda a cambiar el manejo terapéutico de los pacientes evitando procedimientos innecesarios. Este año entrará en funciones un ciclotrón en la Comisión Chilena de Energía Nuclear y la primera cámara PET multicristal de alta resolución de Chile y Sudamérica será instalada en el Hospital Militar de Santiago.</style></abstract><label><style face="normal" font="default" size="100%">Included by Eman</style></label><urls><related-urls><url><style face="normal" font="default" size="100%">http://www.scielo.cl/scielo.php?script=sci_arttext&amp;amp;pid=S0717-93082002000200006</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2128</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2128</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Goonetilleke, M. P. B.</style></author><author><style face="normal" font="default" size="100%">Jayarathna, U. A.</style></author><author><style face="normal" font="default" size="100%">Madanayake, P. M. W.</style></author><author><style face="normal" font="default" size="100%">Inthisar, H. A. M.</style></author><author><style face="normal" font="default" size="100%">Palangasinghe, D. R.</style></author><author><style face="normal" font="default" size="100%">Hettiarachchi, P. S.</style></author><author><style face="normal" font="default" size="100%">Egodage, U. K.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">An audit on the outcome of children referred to the paediatric cardiology unit with a previous echocardiographic diagnosis of mitral valve prolapse</style></title></titles><dates><year><style face="normal" font="default" size="100%">2013</style></year><pub-dates><date><style face="normal" font="default" size="100%">2013/07</style></date></pub-dates></dates><abstract><style face="normal" font="default" size="100%">Objective: To determine the outcome of children referred to the paediatric cardiology unit with a previous echocardiographic diagnosis of mitral valve prolapse (MVP). Method: This study was carried out at the paediatric cardiology clinic of Teaching Hospital Karapitiya from 1st January 2012 to 31st December 2012. All children (18 years or less) presenting with a previous echocardiographic diagnosis of MVP were included in study. An echocardiographic diagnosis of MVP was reached based on the standard diagnostic criteria using an IE 33 Phillips echocardiography machine. Results: There were 141 children presenting with a previous echocardiographic diagnosis of MVP of whom 50.4% were male. Seventeen percent were below 5 years, 45% 5-9 years, 36% 10-14 years and 2% above 14 years. Of the 141, 53.2% did not have a cardiac murmur, 41.8% had a grade 2 cardiac murmur and 5% had a grade 3 murmur. Only 7 (5%) were confirmed to have MVP using standard diagnostic criteria. Of these 7 cases, 3 did not have a murmur and the remaining 4 had a grade 3 murmur best heard in the mitral area. Out of 141 subjects 57.5% had undergone 2 previous echocardiographic evaluations and 40.4% had 3-6 previous echocardiographic evaluations. Conclusion: This study shows gross over diagnosis of MVP when the standard diagnostic criteria to diagnose MVP are applied.</style></abstract><urls><related-urls><url><style face="normal" font="default" size="100%">http://imsear.searo.who.int/handle/123456789/149743</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2129</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2129</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Gopi, P. G.</style></author><author><style face="normal" font="default" size="100%">Vasantha, M.</style></author><author><style face="normal" font="default" size="100%">Muniyandi, M.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Tuberculosis Research Centre (ICMR), Mayor V.R. Ramanathan Road Chetput, Chennai-600 031, India.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Assessment of X-ray readers in TB prevalence surveys</style></title><secondary-title><style face="normal" font="default" size="100%">J Commun Dis</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">J Commun Dis</style></full-title></periodical><pages><style face="normal" font="default" size="100%">191-9</style></pages><volume><style face="normal" font="default" size="100%">42</style></volume><number><style face="normal" font="default" size="100%">3</style></number><keywords><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">India/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Observer Variation</style></keyword><keyword><style face="normal" font="default" size="100%">Population Surveillance</style></keyword><keyword><style face="normal" font="default" size="100%">Prevalence</style></keyword><keyword><style face="normal" font="default" size="100%">Radiography, Thoracic/methods</style></keyword><keyword><style face="normal" font="default" size="100%">Rural Population</style></keyword><keyword><style face="normal" font="default" size="100%">Tuberculosis, Pulmonary/diagnosis/*diagnostic imaging/epidemiology</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2010</style></year><pub-dates><date><style face="normal" font="default" size="100%">Sep</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0019-5138 (Print)&#xD;0019-5138</style></isbn><abstract><style face="normal" font="default" size="100%">A prevalence study was carried out a rural community in Tiruvallur district in Tami Nadu to standardize the method of assessing an X-ray reader in tuberculosis (TB) prevalence surveys by means of different measures of agreement between the reader and a Standard Reader (SR). The exercise on assessing the X-ray readers was carried out on two occasions; one involving three trainee readers (R1, R2, and R3), and the other involving one trainee reader (R4). The extent of agreement was estimated using Kappa statistics (K), over-diagnosis, under-diagnosis, crude agreement and prevalence adjusted bias adjusted kappa (PABAK). The overall performance of readers R1, R2, and R3 was not satisfactory in terms of K (21, 34 and 14%) in the first assessment. The K, over-diagnosis and under-diagnosis were estimated to be 61, 28 and 4% for R1, 63, 18 and 4% for R2 and 58, 31 and 5% for R3 in the final assessment. This suggested that R2 performed well compared to the other two readers. The K was 68% for R4 in the first assessment. As the over-diagnosis was to the extent of 40%, the trainee reader underwent one more assessment. The K was 64% which was as good as before, but there was no improvement in the over-diagnosis (43.5%) in the second assessment. Based on the performance, only one reader (R2) was certified as qualified for X-ray reading in the first occasion while the reader (R4) assessed in the second occasion was not qualified. These findings were subject to the inherent variation in the SR&apos;s readings against which the readers were assessed.</style></abstract><label><style face="normal" font="default" size="100%">Included by Loai</style></label><notes><style face="normal" font="default" size="100%">Gopi, P G&#xD;Vasantha, M&#xD;Muniyandi, M&#xD;Journal Article&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;India&#xD;J Commun Dis. 2010 Sep;42(3):191-9.</style></notes><urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2130</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2130</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Graña-López, L.</style></author><author><style face="normal" font="default" size="100%">Herranz, M.</style></author><author><style face="normal" font="default" size="100%">Domínguez-Prado, I.</style></author><author><style face="normal" font="default" size="100%">Argibay, S.</style></author><author><style face="normal" font="default" size="100%">Villares, Á</style></author><author><style face="normal" font="default" size="100%">Vázquez-Caruncho, M.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Radiology Department, Hospital Universitario Lucus Augusti Lugo, Ulises Romero 1, 27003, Lugo, Spain. grana.lopez.lucia@gmail.com.&#xD;Breast Pathology Group, Hospital Universitario Lucus Augusti-IDIS, Ulises Romero 1, 27003, Lugo, Spain. grana.lopez.lucia@gmail.com.&#xD;Radiology Department, Hospital Universitario Lucus Augusti Lugo, Ulises Romero 1, 27003, Lugo, Spain.&#xD;Breast Pathology Group, Hospital Universitario Lucus Augusti-IDIS, Ulises Romero 1, 27003, Lugo, Spain.&#xD;Nuclear Medicine Department, Complexo Hospitalario Universitario de Santiago de Compostela Travesíca Choupana s/n, 15706, Santiago de Compostela, Spain.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Can dedicated breast PET help to reduce overdiagnosis and overtreatment by differentiating between indolent and potentially aggressive ductal carcinoma in situ?</style></title><secondary-title><style face="normal" font="default" size="100%">Eur Radiol</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Eur Radiol</style></full-title></periodical><pages><style face="normal" font="default" size="100%">514-522</style></pages><volume><style face="normal" font="default" size="100%">30</style></volume><number><style face="normal" font="default" size="100%">1</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Aged, 80 and over</style></keyword><keyword><style face="normal" font="default" size="100%">Breast/diagnostic imaging/pathology</style></keyword><keyword><style face="normal" font="default" size="100%">Breast Neoplasms/*diagnostic imaging/pathology</style></keyword><keyword><style face="normal" font="default" size="100%">Carcinoma, Intraductal, Noninfiltrating/*diagnostic imaging/pathology</style></keyword><keyword><style face="normal" font="default" size="100%">China</style></keyword><keyword><style face="normal" font="default" size="100%">Diagnosis, Differential</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Medical Overuse/*prevention &amp; control</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Positron-Emission Tomography/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Retrospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Sensitivity and Specificity</style></keyword><keyword><style face="normal" font="default" size="100%">Spain</style></keyword><keyword><style face="normal" font="default" size="100%">Ductal carcinoma in situ</style></keyword><keyword><style face="normal" font="default" size="100%">Molecular imaging</style></keyword><keyword><style face="normal" font="default" size="100%">Overdiagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">Overtreatment</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2020</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jan</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0938-7994</style></isbn><abstract><style face="normal" font="default" size="100%">OBJECTIVES: To analyze the utility of metabolic imaging, and specifically of dedicated breast positron emission tomography (dbPET) to differentiate between indolent and potentially aggressive ductal carcinoma in situ (DCIS). METHODS: After institutional review board approval, we retrospectively reviewed the cases of pure DCIS who underwent dbPET before biopsy and surgery in Lucus Augusti Universitary Hospital (Lugo, Spain) and in Fudan Cancer Institute (Shanghai, China) between January 2016 and May 2018. Grade 1 and &quot;non-comedo&quot; grade 2 DCIS were considered low-risk disease, while intermediate-grade with necrosis or grade 3 cases were included in the high-risk group. DbPET sensitivity and specificity to differentiate between indolent and potentially aggressive DCIS were determined along with their respective 95% confidence intervals. RESULTS: We enrolled 139 surgery-confirmed pure DCIS cases. Fifty were high-risk neoplasms and 89 low-risk DCIS. Only seven low-risk lesions were positive at dbPET and five of potentially aggressive neoplasms did not show FDG uptake, all included into the field of view (FOV). Sensitivity and specificity of dbPET to differentiate between indolent and potentially aggressive DCIS were 90% (95% CI, 77-96%) and 92% (95% CI, 84-97%), respectively. CONCLUSION: Metabolic imaging could help to identify the subgroup of indolent lesions from those potentially aggressive ones that may be managed by active surveillance. KEY POINTS: • Low- and high-grade DCIS likely arise from two distinct evolutionary paths and when low-grade lesions progress to invasive cancer, the tumor is frequently low grade and well differentiated. • Ongoing clinical trials evaluate whether patients with low-risk DCIS could be safely managed by an active surveillance approach, with avoidance of unnecessary treatments and without impact on ipsilateral invasive breast cancer free survival time. • Dedicated breast PET may differentiate harmless from potentially hazardous DCIS, supporting active surveillance for the management of those women with low-grade DCIS, decreasing the rate of the upgrade to invasive carcinoma at surgical excision.</style></abstract><label><style face="normal" font="default" size="100%">Included by Thanya</style></label><notes><style face="normal" font="default" size="100%">1432-1084&#xD;Graña-López, Lucía&#xD;Orcid: 0000-0002-4809-4208&#xD;Herranz, Michel&#xD;Domínguez-Prado, Inés&#xD;Argibay, Sonia&#xD;Villares, Ángeles&#xD;Vázquez-Caruncho, Manuel&#xD;Journal Article&#xD;Multicenter Study&#xD;Germany&#xD;Eur Radiol. 2020 Jan;30(1):514-522. doi: 10.1007/s00330-019-06356-9. Epub 2019 Aug 2.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://link.springer.com/content/pdf/10.1007/s00330-019-06356-9.pdf</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1007/s00330-019-06356-9</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2131</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2131</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Grant, K. A.</style></author><author><style face="normal" font="default" size="100%">Apffelstaedt, J. P.</style></author><author><style face="normal" font="default" size="100%">Wright, C. A.</style></author><author><style face="normal" font="default" size="100%">Myburgh, E.</style></author><author><style face="normal" font="default" size="100%">Pienaar, R.</style></author><author><style face="normal" font="default" size="100%">De Klerk, M.</style></author><author><style face="normal" font="default" size="100%">Kotze, M. J.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Biomedical Sciences, Cape Peninsula University of Technology, Cape Town, South Africa. grantk@cput.ac.za</style></auth-address><titles><title><style face="normal" font="default" size="100%">MammaPrint Pre-screen Algorithm (MPA) reduces chemotherapy in patients with early-stage breast cancer</style></title><secondary-title><style face="normal" font="default" size="100%">S Afr Med J</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">S Afr Med J</style></full-title></periodical><pages><style face="normal" font="default" size="100%">522-6</style></pages><volume><style face="normal" font="default" size="100%">103</style></volume><number><style face="normal" font="default" size="100%">8</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Algorithms</style></keyword><keyword><style face="normal" font="default" size="100%">Breast Neoplasms/chemistry/drug therapy/*genetics/pathology</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">*Genetic Testing</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Neoplasm Staging</style></keyword><keyword><style face="normal" font="default" size="100%">Receptor, ErbB-2/analysis</style></keyword><keyword><style face="normal" font="default" size="100%">South Africa</style></keyword><keyword><style face="normal" font="default" size="100%">Transcriptome</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2013</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jul 3</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0256-9574 (Print)</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: Clinical and pathological parameters may overestimate the need for chemotherapy in patients with early-stage breast cancer. More accurate determination of the risk of distant recurrence is now possible with use of genetic tests, such as the 70-gene MammaPrint profile. OBJECTIVES: A health technology assessment performed by a medical insurer in 2009 introduced a set of test eligibility criteria - the MammaPrint Pre-screen Algorithm (MPA) - applied in this study to determine the clinical usefulness of a pathology-supported genetic testing strategy, aimed at the reduction of healthcare costs.Methods. An implementation study was designed to take advantage of the fact that the 70-gene profile excludes analysis of hormone receptor and human epidermal growth factor receptor 2 (HER2) status, which form part of the MPA based partly on immunohistochemistry routinely performed in all breast cancer patients. The study population consisted of 104 South African women with early-stage breast carcinoma referred for MammaPrint. For the MammaPrint test, RNA was extracted from 60 fresh tumours (in 58 patients) and 46 formalin-fixed, paraffin-embedded (FFPE) tissue samples. RESULTS: When applying the MPA for selection of patients eligible for MammaPrint testing, 95 of the 104 patients qualified. In this subgroup 62% (59/95) were classified as low risk. Similar distribution patterns for risk classification were obtained for RNA extracted from fresh tumours v. FFPE tissue samples. CONCLUSIONS: The 70-gene profile classifies approximately 40% of early-stage breast cancer patients as low-risk compared with 15% using conventional criteria. In comparison, more than 60% were shown to be low risk with use of the MPA validated in this study as an appropriate strategy to prevent chemotherapy overtreatment in patients with early-stage breast cancer.</style></abstract><label><style face="normal" font="default" size="100%">Included by Hannah</style></label><notes><style face="normal" font="default" size="100%">Grant, Kathleen A&#xD;Apffelstaedt, Justus P&#xD;Wright, Colleen A&#xD;Myburgh, Ettienne&#xD;Pienaar, Rika&#xD;De Klerk, Manie&#xD;Kotze, Maritha J&#xD;Journal Article&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;South Africa&#xD;S Afr Med J. 2013 Jul 3;103(8):522-6. doi: 10.7196/samj.7223.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://core.ac.uk/download/190583674.pdf</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.7196/samj.7223</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2132</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2132</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Guimaraes, S.</style></author><author><style face="normal" font="default" size="100%">Soares, A.</style></author><author><style face="normal" font="default" size="100%">Freitas, C.</style></author><author><style face="normal" font="default" size="100%">Barros, P.</style></author><author><style face="normal" font="default" size="100%">Leite, R. D.</style></author><author><style face="normal" font="default" size="100%">Costa, P. S.</style></author><author><style face="normal" font="default" size="100%">Silva, E. D.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Ophthalmology, Hospital-Escola da Universidade Fernando Pessoa, Gondomar, Porto, Portugal.&#xD;Ophthalmology, Hospital de Braga, Braga, Portugal.&#xD;School Of Medicine - University Of Minho, Universidade do Minho Instituto de Investigacao em Ciencias da Vida e Saude, Braga, Braga, Portugal.&#xD;School Of Medicine - University Of Minho, ICVS 3B&apos;s Associate Laboratory, Braga, Braga, Portugal.&#xD;Ophthalmology, Centro Cirurgico de Coimbra, Coimbra, Portugal.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Amblyopia screening effectiveness at 3-4 years old: a cohort study</style></title><secondary-title><style face="normal" font="default" size="100%">BMJ Open Ophthalmol</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">BMJ Open Ophthalmol</style></full-title></periodical><pages><style face="normal" font="default" size="100%">e000599</style></pages><volume><style face="normal" font="default" size="100%">6</style></volume><number><style face="normal" font="default" size="100%">1</style></number><keywords><keyword><style face="normal" font="default" size="100%">epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">public health</style></keyword><keyword><style face="normal" font="default" size="100%">vision</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2021</style></year></dates><isbn><style face="normal" font="default" size="100%">2397-3269</style></isbn><abstract><style face="normal" font="default" size="100%">OBJECTIVE: To study the effectiveness of amblyopia screening at ages 3-4. METHODS AND ANALYSIS: From a population with no previous screening, a cohort of 2300 children with 3-4 years old attending school (91% of children this age attend school in Portugal), were submitted to a complete ophthalmological evaluation. Amblyopia was diagnosed, treated and followed. Amblyopia prevalence, treatment effectiveness, absolute risk reduction (ARR), number needed to screen (NNS) and relative risk reduction (RRR) were estimated. RESULTS: Past/present history of amblyopia was higher than 3.1%-4.2%, depending on amblyopia definition normatives. Screening at age 3-4, had estimated ARR=2.09% (95% CI 1.50% to 2.68%) with a reduced risk of amblyopia in adulthood of 87% (RRR). NNS was 47.8 (95% CI 37.3 to 66.7). Treatment effectiveness of new diagnosis was 88% (83% if we include children already followed). 91% of new amblyopia diagnoses were refractive (of which 100% surpassed amblyopia Multi-Ethnic Pediatric Eye Disease Study criteria after treatment), while most strabismic amblyopias were already treated or undertreatment. Only 30% of children with refractive amblyopia risk factors that were not followed by an ophthalmologist, ended up having amblyopia at age 3-4. Eye patch was needed equally in new-diagnosis versus treated-earlier refractive amblyopia. CONCLUSIONS: Screening amblyopia in a whole-population setting at age 3-4 is highly effective. For each 48 children screened at age 3-4, one amblyopia is estimated to be prevented in the future (NNS). Screening earlier may lead to overdiagnosis and overtreatments: Treating all new diagnosis before age 3-4 would have a maximal difference in ARR of 0.3%, with the possible burden of as much as 70% children being unnecessary treated before age 3-4.Involving primary care, with policies for timely referral of suspicious/high-risk preverbal children, plus whole screening at age 3-4 seems a rational/effective way of controlling amblyopia.</style></abstract><notes><style face="normal" font="default" size="100%">2397-3269&#xD;Guimaraes, Sandra&#xD;Orcid: 0000-0001-8143-641x&#xD;Soares, Andreia&#xD;Orcid: 0000-0002-4043-006x&#xD;Freitas, Cristina&#xD;Orcid: 0000-0002-0462-3366&#xD;Barros, Pedro&#xD;Leite, Ricardo Dourado&#xD;Orcid: 0000-0002-4090-8473&#xD;Costa, Patrício Soares&#xD;Orcid: 0000-0002-1201-9177&#xD;Silva, Eduardo D&#xD;Orcid: 0000-0002-2739-9854&#xD;Journal Article&#xD;BMJ Open Ophthalmol. 2021 Jan 4;6(1):e000599. doi: 10.1136/bmjophth-2020-000599. eCollection 2021.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783520/pdf/bmjophth-2020-000599.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC7783520</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1136/bmjophth-2020-000599</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2133</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2133</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Günaşti, S.</style></author><author><style face="normal" font="default" size="100%">Aksungur, V. L.</style></author><author><style face="normal" font="default" size="100%">Yücel, A.</style></author><author><style face="normal" font="default" size="100%">Denli, Y.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">S. Günaşti, Çukurova University Faculty of Medicine, Departments of Dermatology, Adana, Turkey</style></auth-address><titles><title><style face="normal" font="default" size="100%">Evaluation of a guideline for etiological diagnosis of chronic urticaria</style></title><secondary-title><style face="normal" font="default" size="100%">Turkiye Klinikleri Journal of Medical Sciences</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Turkiye Klinikleri Journal of Medical Sciences</style></full-title></periodical><pages><style face="normal" font="default" size="100%">1279-1286</style></pages><volume><style face="normal" font="default" size="100%">30</style></volume><number><style face="normal" font="default" size="100%">4</style></number><keywords><keyword><style face="normal" font="default" size="100%">adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">adult</style></keyword><keyword><style face="normal" font="default" size="100%">age</style></keyword><keyword><style face="normal" font="default" size="100%">aged</style></keyword><keyword><style face="normal" font="default" size="100%">article</style></keyword><keyword><style face="normal" font="default" size="100%">blood cell count</style></keyword><keyword><style face="normal" font="default" size="100%">child</style></keyword><keyword><style face="normal" font="default" size="100%">chronic urticaria</style></keyword><keyword><style face="normal" font="default" size="100%">clinical practice</style></keyword><keyword><style face="normal" font="default" size="100%">controlled study</style></keyword><keyword><style face="normal" font="default" size="100%">disease duration</style></keyword><keyword><style face="normal" font="default" size="100%">disease severity</style></keyword><keyword><style face="normal" font="default" size="100%">erythrocyte sedimentation rate</style></keyword><keyword><style face="normal" font="default" size="100%">feces analysis</style></keyword><keyword><style face="normal" font="default" size="100%">female</style></keyword><keyword><style face="normal" font="default" size="100%">gender</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">major clinical study</style></keyword><keyword><style face="normal" font="default" size="100%">male</style></keyword><keyword><style face="normal" font="default" size="100%">practice guideline</style></keyword><keyword><style face="normal" font="default" size="100%">questionnaire</style></keyword><keyword><style face="normal" font="default" size="100%">retrospective study</style></keyword><keyword><style face="normal" font="default" size="100%">school child</style></keyword><keyword><style face="normal" font="default" size="100%">urinalysis</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2010</style></year></dates><isbn><style face="normal" font="default" size="100%">1300-0292</style></isbn><abstract><style face="normal" font="default" size="100%">Background: Exhibiting potential causes of chronic urticaria in routine daily practice is a complex procedure. A guideline, developed by the researchers, investigating the etiology of chronic urticaria was evaluated in this study. In this guideline erythrocyte sedimentation rate, complete blood count, urine analysis and direct microscopic examination of stool for parasites were routine and other diagnostic procedures were requested according to clinical findings of potential causes. Objective: The purpose of the study was to determine the rate of implementation of the guideline considering a daily practice. Material and Methods: Following diagnosis of chronic urticaria, patients were interrogated with a standard questionnaire form, and were examined in order to determine the clinical findings of possible causes of the disease. The records of 903 patients in total were retrospectively evaluated. During the evaluation process, the necessary and unnecessary diagnostic procedures regarding the guideline were determined by using computerized algorithms. During evaluation some parameters such as age and gender of patients, duration and severity of the disease, and numbers and types of diagnostic procedures affecting the grade of the request and completion were also taken into account. Results: The total number of necessary procedures was 4070, less than one third of which were requested by the physicians. However, the patients completed more than three fourths of the requested procedures. Moreover, the physicians requested some unnecessary procedures in almost one third of the patients. Conclusion: According to clinical findings, lower threshold for necessity of investigation leads to more failure in implementation of a guideline. Guidelines developed for the etiological diagnosis of chronic urticaria should be evaluated retrospectively on data from daily practices to evaluate the utility of a guideline. © 2010 by Türkiye Klinikleri.</style></abstract><label><style face="normal" font="default" size="100%">Included by Eman</style></label><notes><style face="normal" font="default" size="100%">L359677584&#xD;2010-10-08&#xD;2010-10-12</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.embase.com/search/results?subaction=viewrecord&amp;id=L359677584&amp;from=export</style></url><url><style face="normal" font="default" size="100%">http://dx.doi.org/10.5336/medsci.2008-10157</style></url><url><style face="normal" font="default" size="100%">https://www.turkiyeklinikleri.com/article/en-evaluation-of-a-guideline-for-etiological-diagnosis-of-chronic-urticaria-58553.html</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.5336/medsci.2008-10157</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2134</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2134</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Gupta, R.</style></author><author><style face="normal" font="default" size="100%">Sachdev, H. P.</style></author><author><style face="normal" font="default" size="100%">Shah, D.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Pediatrics, Maulana Azad Medical College, New Delhi 110 002, India.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Evaluation of the WHO/UNICEF algorithm for integrated management of childhood illness between the ages of one week to two months</style></title><secondary-title><style face="normal" font="default" size="100%">Indian Pediatr</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Indian Pediatr</style></full-title></periodical><pages><style face="normal" font="default" size="100%">383-90</style></pages><volume><style face="normal" font="default" size="100%">37</style></volume><number><style face="normal" font="default" size="100%">4</style></number><keywords><keyword><style face="normal" font="default" size="100%">*Algorithms</style></keyword><keyword><style face="normal" font="default" size="100%">Bacterial Infections/mortality/therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Chi-Square Distribution</style></keyword><keyword><style face="normal" font="default" size="100%">Child Health Services/*standards/trends</style></keyword><keyword><style face="normal" font="default" size="100%">Congenital Abnormalities/mortality/therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Delivery of Health Care, Integrated/*standards/trends</style></keyword><keyword><style face="normal" font="default" size="100%">Diarrhea/mortality/therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">*Guidelines as Topic</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">India</style></keyword><keyword><style face="normal" font="default" size="100%">Infant</style></keyword><keyword><style face="normal" font="default" size="100%">Infant Mortality/*trends</style></keyword><keyword><style face="normal" font="default" size="100%">Infant, Newborn</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Odds Ratio</style></keyword><keyword><style face="normal" font="default" size="100%">Predictive Value of Tests</style></keyword><keyword><style face="normal" font="default" size="100%">Prospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Respiratory Tract Infections/mortality/therapy</style></keyword><keyword><style face="normal" font="default" size="100%">United Nations/*standards</style></keyword><keyword><style face="normal" font="default" size="100%">World Health Organization</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2000</style></year><pub-dates><date><style face="normal" font="default" size="100%">Apr</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0019-6061 (Print)&#xD;0019-6061</style></isbn><abstract><style face="normal" font="default" size="100%">OBJECTIVE: To evaluate the utility of the WHO/UNICEF algoritham for integrated management of childhood illness (IMCI) between the ages of 1 week to 2 months. DESIGN: Prospective observational. SETTING: The Outpatient Department and Emergency Room of a medical college hospital. METHODS: 129 infants presenting to Outpatient Department (n=70) or Emergency Room (n=59) were assessed and classified as per &apos;IMCI&apos; algorithm and treatment required was identified. A detailed evaluation with all relevant investigations was also done for these subjects. The final diagnoses made and therapies instituted on this basis served as &apos;gold standard&apos;. The diagnostic and therapeutic agreement between &apos;gold standard and the &apos;IMCI&apos; was computed. RESULTS: More than one illness was present in 97(75.2%) of subjects as per &apos;gold standard&apos; (mean 2.1). Subjects having any referral criteria as per &apos;IMCI&apos; algorithm had a greater (p=0.002) co-existence of illnesses (mean 2.3 vs. 1.8 illnesses per child, respectively. IMCI algorithm covered majority (81-84%) of the recorded diagnoses either partly (40-41%) or fully (40-44%). The referral criteria proved quite sensitive (86-87%) in predicting hospitalization but had a lower specificity (53-58%). a total agreement with IMCI was found in 60-66% cases. The mismatch (34-40%) was more commonly of overdiagnosis (21-23%) rather than underdiagnosis (15-21%). The sensitivity of the algorithm to identify serious bacterial infection was high (96.1-96.5%) while the specificity was relatively low (51. 8-59.7%). Upper respiratory infection (URI)emerged as an important cause resulting in unnecessary referrals (13 out of 21 cases). Of the 43 cases identified as diarrhea by the algorithm, 6 had breast fed stools, which do not require any therapy. The &apos;IMCI&apos; algorithm had a provision for preventive services of immunization and breastfeeding counseling (18% possibility of availing missed opportunities in both). CONCLUSION: There is a sound scientific basis for adopting IMCI approach even in young infants as there is a need to improve the specificity of referral criteria. Two important conditions identified for possible refinement are URI and breast fed stools</style></abstract><label><style face="normal" font="default" size="100%">Included by Eman</style></label><notes><style face="normal" font="default" size="100%">Gupta, R&#xD;Sachdev, H P&#xD;Shah, D&#xD;Evaluation Study&#xD;Journal Article&#xD;India&#xD;Indian Pediatr. 2000 Apr;37(4):383-90.</style></notes><urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2135</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2135</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Güzin, K.</style></author><author><style face="normal" font="default" size="100%">Bozag, H.</style></author><author><style face="normal" font="default" size="100%">Gökdagli, F.</style></author><author><style face="normal" font="default" size="100%">Kabaca, S.</style></author><author><style face="normal" font="default" size="100%">Yilmaz, B.</style></author><author><style face="normal" font="default" size="100%">Göcmen, A.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">K. Güzin, Division of Gynecological Oncology, Medeniyet University of Istanbul Goztepe Education and Research Hospital, Clinics of Gynecology and Obstetrics Istanbul, Istanbul, Turkey</style></auth-address><titles><title><style face="normal" font="default" size="100%">The accuracy of frozen section diagnosis of ovarian masses and the clinical properties of the borderline ovarian tumors (bots)</style></title><secondary-title><style face="normal" font="default" size="100%">International Journal of Gynecological Cancer</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">International Journal of Gynecological Cancer</style></full-title></periodical><pages><style face="normal" font="default" size="100%">907</style></pages><volume><style face="normal" font="default" size="100%">23</style></volume><number><style face="normal" font="default" size="100%">8</style></number><keywords><keyword><style face="normal" font="default" size="100%">diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">ovary tumor</style></keyword><keyword><style face="normal" font="default" size="100%">society</style></keyword><keyword><style face="normal" font="default" size="100%">oncology</style></keyword><keyword><style face="normal" font="default" size="100%">frozen section</style></keyword><keyword><style face="normal" font="default" size="100%">female</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">patient</style></keyword><keyword><style face="normal" font="default" size="100%">morbidity</style></keyword><keyword><style face="normal" font="default" size="100%">diagnostic error</style></keyword><keyword><style face="normal" font="default" size="100%">predictive value</style></keyword><keyword><style face="normal" font="default" size="100%">morphology</style></keyword><keyword><style face="normal" font="default" size="100%">cohort analysis</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2013</style></year></dates><isbn><style face="normal" font="default" size="100%">1048-891X</style></isbn><abstract><style face="normal" font="default" size="100%">Objectives To determine the accuracy of frozen section diagnosis of ovarian masses and the clinical properties of the borderline ovarian tumors (BOTs). Methods The study was designed as a retrospective cohort study. A total of 40 patients with histologically (frozen or permenant) proven BOTs, between -/2000 and 12/2000 were included in the study. The rate of accuracy with the frozen section in BOTs was analyzed. Results The average age of the patients in the study was 49.3 ± 18.7. Histological distribution of BOTs were as follows; 1 (3 %) brenner BOT, 1(3%) endometrioid BOT, 10 (30 %) mucinous BOTs, 23 (66 %) serous BOTs .The mean morphology index score of BOTs and malignant ovarian tumors were 5±2 and 7.5±2.3, respectively.The rate of correct diagnosis, under-diagnosis and over-diagnosis of BOTs with frozen section were 78%,17% and 5% respectively. The sensitivity and positive predictive values in diagnosis of BTOs with the frozen section were 93.3 % and 82.3%. Positive Likelihood Ratio is 0.93 (95% CI:0.85 to 1.03). Conclusions The frozen section diagnosis is an important and convenient tool in the clinical management of patients with ovarian tumors. As well as low sensitivity and PPV, overdiagnosis and underdiagnosis are frequent. Therefore a more careful approach is needed in order to reduce the false diagnosis and surgical morbidity.</style></abstract><notes><style face="normal" font="default" size="100%">L71363509&#xD;2014-03-14</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.embase.com/search/results?subaction=viewrecord&amp;id=L71363509&amp;from=export</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2136</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2136</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Hajeer, M. H.</style></author><author><style face="normal" font="default" size="100%">Awad, H. A.</style></author><author><style face="normal" font="default" size="100%">Abdullah, N. I.</style></author><author><style face="normal" font="default" size="100%">Almuhaisen, G. H.</style></author><author><style face="normal" font="default" size="100%">Abudalu, L. E.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Histopathology, Microbiology and Forensic Medicine, University of Jordan, Amman, Jordan. E-mail. m.hajeer83@hotmail.com.</style></auth-address><titles><title><style face="normal" font="default" size="100%">The rising trend in papillary thyroid carcinoma. True increase or over diagnosis?</style></title><secondary-title><style face="normal" font="default" size="100%">Saudi Med J</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Saudi Med J</style></full-title></periodical><pages><style face="normal" font="default" size="100%">147-153</style></pages><volume><style face="normal" font="default" size="100%">39</style></volume><number><style face="normal" font="default" size="100%">2</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Age Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Carcinoma, Papillary/*diagnosis/*epidemiology/pathology</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Incidence</style></keyword><keyword><style face="normal" font="default" size="100%">Jordan/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Medical Overuse/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Neoplasm Staging</style></keyword><keyword><style face="normal" font="default" size="100%">Retrospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Sex Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Thyroid Cancer, Papillary</style></keyword><keyword><style face="normal" font="default" size="100%">Thyroid Neoplasms/*diagnosis/*epidemiology/pathology</style></keyword><keyword><style face="normal" font="default" size="100%">Tumor Burden</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style face="normal" font="default" size="100%">Feb</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0379-5284 (Print)&#xD;0379-5284</style></isbn><abstract><style face="normal" font="default" size="100%">To assess the changes in parameters of thyroid carcinoma, particularly papillary type, in the era of widespread use of sensitive diagnostic methods. We aim to investigate whether the increased frequency of thyroid cancer is true or resulted from over diagnosis. Methods: We conducted a retrospective study of 313 cases of thyroid carcinoma diagnosed at Jordan University Hospital and King Hussein Cancer Center from 2007-2015. Papillary carcinoma accounted for 290 (92.7%) of all cases. Cases were sub classified according to demographic features, histological type, size, stage, and other variables. For comparison of data, cases were subdivided into 2 study periods: Group I included patients diagnosed in the period 2007-2010, and Group II in the period 2011-2015. Results: The frequency of thyroid carcinoma has increased across the study period. Papillary carcinoma was the major type accounting for this increase. Papillary micro carcinomas ≤1cm accounted for 34.8% of cases of PTC. Most cases (52.4%) of papillary thyroid carcinoma (PTC) were localized stage tumors. Group II of the study witnessed a more than doubled number of cases of PTC compared to group I, with increased frequency of tumors of all sizes as well as tumors of both localized and regional stages. Conclusions: Our observed trend cannot be totally explained by over diagnosis and increased diagnostic scrutiny. This increase could be of true nature and cannot be explained by single cause.</style></abstract><label><style face="normal" font="default" size="100%">Included by Loai</style></label><notes><style face="normal" font="default" size="100%">Hajeer, Manar H&#xD;Awad, Heyam A&#xD;Abdullah, Niveen I&#xD;Almuhaisen, Ghadeer H&#xD;Abudalu, Loay E&#xD;Journal Article&#xD;Saudi Med J. 2018 Feb;39(2):147-153. doi: 10.15537/smj.2018.2.21211.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5885091/pdf/SaudiMedJ-39-147.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC5885091</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.15537/smj.2018.2.21211</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2137</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2137</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Hamer, D. H.</style></author><author><style face="normal" font="default" size="100%">Ndhlovu, M.</style></author><author><style face="normal" font="default" size="100%">Zurovac, D.</style></author><author><style face="normal" font="default" size="100%">Fox, M.</style></author><author><style face="normal" font="default" size="100%">Yeboah-Antwi, K.</style></author><author><style face="normal" font="default" size="100%">Chanda, P.</style></author><author><style face="normal" font="default" size="100%">Sipilinyambe, N.</style></author><author><style face="normal" font="default" size="100%">Simon, J. L.</style></author><author><style face="normal" font="default" size="100%">Snow, R. W.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Center for International Health and Development, Boston University School of Public Health, Boston, Mass 02118, USA. dhamer@bu.edu</style></auth-address><titles><title><style face="normal" font="default" size="100%">Improved diagnostic testing and malaria treatment practices in Zambia</style></title><secondary-title><style face="normal" font="default" size="100%">Jama</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Jama</style></full-title></periodical><pages><style face="normal" font="default" size="100%">2227-31</style></pages><volume><style face="normal" font="default" size="100%">297</style></volume><number><style face="normal" font="default" size="100%">20</style></number><keywords><keyword><style face="normal" font="default" size="100%">Animals</style></keyword><keyword><style face="normal" font="default" size="100%">Antigens, Protozoan/*analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Antimalarials/*therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Artemether, Lumefantrine Drug Combination</style></keyword><keyword><style face="normal" font="default" size="100%">Artemisinins/therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Child, Preschool</style></keyword><keyword><style face="normal" font="default" size="100%">Cluster Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Cross-Sectional Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Drug Combinations</style></keyword><keyword><style face="normal" font="default" size="100%">Drug Utilization</style></keyword><keyword><style face="normal" font="default" size="100%">Ethanolamines/therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Fluorenes/therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Malaria/*diagnosis/*drug therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Microscopy</style></keyword><keyword><style face="normal" font="default" size="100%">Parasitemia/diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">Plasmodium falciparum/*isolation &amp; purification</style></keyword><keyword><style face="normal" font="default" size="100%">Protozoan Proteins/analysis</style></keyword><keyword><style face="normal" font="default" size="100%">*Reagent Kits, Diagnostic</style></keyword><keyword><style face="normal" font="default" size="100%">Unnecessary Procedures</style></keyword><keyword><style face="normal" font="default" size="100%">Zambia</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2007</style></year><pub-dates><date><style face="normal" font="default" size="100%">May 23</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0098-7484 (Print)&#xD;0098-7484</style></isbn><abstract><style face="normal" font="default" size="100%">CONTEXT: Improving the accuracy of malaria diagnosis with rapid antigen-detection diagnostic tests (RDTs) has been proposed as an approach for reducing overtreatment of malaria in the current era of widespread implementation of artemisinin-based combination therapy in sub-Saharan Africa. OBJECTIVE: To assess the association between use of microscopy and RDT and the prescription of antimalarials. DESIGN, SETTING, AND PARTICIPANTS: Cross-sectional, cluster sample survey, carried out between March and May 2006, of all outpatients treated during 1 working day at government and mission health facilities in 4 sentinel districts in Zambia. MAIN OUTCOME MEASURE: Proportions of patients undergoing malaria diagnostic procedures and receiving antimalarial treatment. RESULTS: Seventeen percent of the 104 health facilities surveyed had functional microscopy, 63% had RDTs available, and 73% had 1 or more diagnostics available. Of patients with fever (suspected malaria), 27.8% (95% confidence interval [CI], 13.1%-42.5%) treated in health facilities with malaria diagnostics were tested and 44.6% had positive test results. Of patients with negative blood smear results, 58.4% (95% CI, 36.7%-80.2%) were prescribed an antimalaria drug, as were 35.5% (95% CI, 16.0%-55.0%) of those with a negative RDT result. Of patients with fever who did not have diagnostic tests done, 65.9% were also prescribed antimalarials. In facilities with artemether-lumefantrine in stock, this antimalarial was prescribed to a large proportion of febrile patients with a positive diagnostic test result (blood smear, 75.0% [95% CI, 51.7%-98.3%]; RDT, 70.4% [95% CI, 39.3%-100.0%]), but also to some of those with a negative diagnostic test result (blood smear, 30.4% [95% CI, 8.0%-52. 9%]; RDT, 26.7% [95% CI, 5.7%-47.7%]). CONCLUSIONS: Despite efforts to expand the provision of malaria diagnostics in Zambia, they continue to be underused and patients with negative test results frequently receive antimalarials. Provision of new tools to reduce inappropriate use of new expensive antimalarial treatments must be accompanied by a major change in clinical treatment of patients presenting with fever but lacking evidence of malaria infection.</style></abstract><label><style face="normal" font="default" size="100%">Included by Loai</style></label><notes><style face="normal" font="default" size="100%">1538-3598&#xD;Hamer, Davidson H&#xD;Ndhlovu, Micky&#xD;Zurovac, Dejan&#xD;Fox, Matthew&#xD;Yeboah-Antwi, Kojo&#xD;Chanda, Pascalina&#xD;Sipilinyambe, Naawa&#xD;Simon, Jonathon L&#xD;Snow, Robert W&#xD;058992/Wellcome Trust/United Kingdom&#xD;079080/Wellcome Trust/United Kingdom&#xD;Journal Article&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;JAMA. 2007 May 23;297(20):2227-31. doi: 10.1001/jama.297.20.2227.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://jamanetwork.com/journals/jama/articlepdf/207244/joc70054_2227_2231.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC2674546</style></custom2><custom6><style face="normal" font="default" size="100%">UKMS4137</style></custom6><electronic-resource-num><style face="normal" font="default" size="100%">10.1001/jama.297.20.2227</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2138</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2138</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Harchut, K.</style></author><author><style face="normal" font="default" size="100%">Standley, C.</style></author><author><style face="normal" font="default" size="100%">Dobson, A.</style></author><author><style face="normal" font="default" size="100%">Klaassen, B.</style></author><author><style face="normal" font="default" size="100%">Rambaud-Althaus, C.</style></author><author><style face="normal" font="default" size="100%">Althaus, F.</style></author><author><style face="normal" font="default" size="100%">Nowak, K.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Princeton University, 106A Guyot Hall, Princeton, NJ 08544, USA. kellyharchut@gmail.com</style></auth-address><titles><title><style face="normal" font="default" size="100%">Over-diagnosis of malaria by microscopy in the Kilombero Valley, Southern Tanzania: an evaluation of the utility and cost-effectiveness of rapid diagnostic tests</style></title><secondary-title><style face="normal" font="default" size="100%">Malar J</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Malar J</style></full-title></periodical><pages><style face="normal" font="default" size="100%">159</style></pages><volume><style face="normal" font="default" size="100%">12</style></volume><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Aged, 80 and over</style></keyword><keyword><style face="normal" font="default" size="100%">Antimalarials/*economics/*therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Child, Preschool</style></keyword><keyword><style face="normal" font="default" size="100%">Cost-Benefit Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Diagnostic Errors/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Infant</style></keyword><keyword><style face="normal" font="default" size="100%">Infant, Newborn</style></keyword><keyword><style face="normal" font="default" size="100%">Malaria/*diagnosis/*drug therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Microscopy/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">*Reagent Kits, Diagnostic</style></keyword><keyword><style face="normal" font="default" size="100%">Rural Population</style></keyword><keyword><style face="normal" font="default" size="100%">Tanzania</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2013</style></year><pub-dates><date><style face="normal" font="default" size="100%">May 10</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1475-2875</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: Early and accurate diagnosis of febrile patients is essential to treat uncomplicated malaria cases properly, prevent severe malaria, and avert unnecessary anti-malarial treatments. Improper use of anti-malarials increases the risk of adverse drug reaction and the evolution of drug/parasite resistance. While microscopy is the most common form of malaria diagnosis, concerns over its accuracy have prompted the incorporation of malaria rapid diagnostic tests (RDTs) into many national malaria control programmes. METHODS: Over a three-month period, a direct comparison between microscopy and RDTs was made in a rural, private dispensary in the Kilombero Valley, Morogoro District, southern Tanzania, with the aim of estimating the extent of malaria over-diagnosis and over-treatment with anti-malarials. The study cohort was made up of patients referred by the dispensary&apos;s clinician for malaria testing. One hundred percent of patients approached agreed to participate in this study and were then tested using both microscopy and RDTs. Using the results from the comparison of the two tests at this dispensary, the potential cost effectiveness of introducing RDTs to a neighbouring public health centre was estimated on the basis of this centre&apos;s past malaria records spanning December 2007 to August 2011. RESULTS: At the private dispensary, the apparent prevalence of malaria was 78% based on microscopy whereas the true prevalence, calculated using RDTs as the gold standard, was estimated at 14%. This discrepancy indicates that when using microscopy as the sole diagnostic test, malaria is being over-diagnosed by approximately a factor of five in this setting. At the public clinic, apparent malaria prevalence based on microscopy was 74%. If similar rates of over-diagnosis are assumed, 5,285 patients of the 6,769 patients positively diagnosed with malaria using microscopy were likely given unnecessary anti-malarials, and their true cause of illness was not addressed. The introduction of RDTs to the public clinic would be highly cost-efficient, with an estimated net saving of over 96 USD/month. CONCLUSIONS: Compared with RDTs, microscopy led to almost four out of five patients being over-diagnosed with malaria in this rural part of Tanzania. A policy that encompasses both the private and public sectors of health care is needed to ensure quality diagnostic testing for febrile patients. With estimated prevalence at 14%, RDT introduction is recommended given WHO findings that RDTs are predicted to be cost-effective in prevalence areas of less than 20%. The use of RDTs in malaria diagnosis would not only reduce government spending but would prove beneficial to ensuring appropriate care and treatment of febrile illness.</style></abstract><notes><style face="normal" font="default" size="100%">1475-2875&#xD;Harchut, Kelly&#xD;Standley, Claire&#xD;Dobson, Andrew&#xD;Klaassen, Belia&#xD;Rambaud-Althaus, Clotilde&#xD;Althaus, Fabrice&#xD;Nowak, Katarzyna&#xD;Comparative Study&#xD;Journal Article&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Malar J. 2013 May 10;12:159. doi: 10.1186/1475-2875-12-159.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3689637/pdf/1475-2875-12-159.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC3689637</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1186/1475-2875-12-159</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2139</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2139</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Harutyunyan, V.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">V. Harutyunyan, Malaria Consortium, Kampala, Uganda</style></auth-address><titles><title><style face="normal" font="default" size="100%">Quality assurance of malaria rapid diagnostic tests (RDT) and its implication for clinical management of malaria</style></title><secondary-title><style face="normal" font="default" size="100%">American Journal of Tropical Medicine and Hygiene</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">American Journal of Tropical Medicine and Hygiene</style></full-title></periodical><pages><style face="normal" font="default" size="100%">284</style></pages><volume><style face="normal" font="default" size="100%">83</style></volume><number><style face="normal" font="default" size="100%">5</style></number><keywords><keyword><style face="normal" font="default" size="100%">malaria</style></keyword><keyword><style face="normal" font="default" size="100%">society</style></keyword><keyword><style face="normal" font="default" size="100%">diagnostic test</style></keyword><keyword><style face="normal" font="default" size="100%">quality control</style></keyword><keyword><style face="normal" font="default" size="100%">hygiene</style></keyword><keyword><style face="normal" font="default" size="100%">tropical medicine</style></keyword><keyword><style face="normal" font="default" size="100%">diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">patient</style></keyword><keyword><style face="normal" font="default" size="100%">hospital</style></keyword><keyword><style face="normal" font="default" size="100%">laboratory</style></keyword><keyword><style face="normal" font="default" size="100%">outpatient department</style></keyword><keyword><style face="normal" font="default" size="100%">sensitivity and specificity</style></keyword><keyword><style face="normal" font="default" size="100%">health care personnel</style></keyword><keyword><style face="normal" font="default" size="100%">Tanzania</style></keyword><keyword><style face="normal" font="default" size="100%">monitoring</style></keyword><keyword><style face="normal" font="default" size="100%">microscopy</style></keyword><keyword><style face="normal" font="default" size="100%">reliability</style></keyword><keyword><style face="normal" font="default" size="100%">clinical practice</style></keyword><keyword><style face="normal" font="default" size="100%">child</style></keyword><keyword><style face="normal" font="default" size="100%">prescription</style></keyword><keyword><style face="normal" font="default" size="100%">habit</style></keyword><keyword><style face="normal" font="default" size="100%">World Health Organization</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2010</style></year></dates><isbn><style face="normal" font="default" size="100%">0002-9637</style></isbn><abstract><style face="normal" font="default" size="100%">In 2010 WHO changed its guidelines for the treatment of malaria to recommend parasitological confirmation in all patients suspected of malaria before treatment is started. However perceptions of reliability of malaria diagnostic tests among the frontline health care workers in resource limited settings present considerable obstacles for the effective rollout of parasitologically confirmed malaria treatment. We assessed the implications of simple measures for monitoring accuracy of malaria RDT-s in the field settings on malaria treatment practices at the outpatient clinics in Kibondo district, Tanzania. We determined the sensitivity and specificity of the malaria RDT in patients diagnosed with suspected malaria at the outpatient clinics, by comparing the results of the RDT at the clinics with microscopy done by an independent blinded laboratory technologist. Results of this investigation were shared with the clinical staff and confirmation of all patients with suspected malaria by RDT was recommended. Clinical practice was monitored by comparing the proportion of laboratory confirmed versus presumptive malaria diagnoses during the period from June to December 2007. Malaria slides and RDT&apos;s from 513 patients diagnosed in September and October 2007 in the clinics were compared. Specificity and sensitivity of RDTs used were 92.2% and 93.7% respectively. Over-diagnosis of malaria at the clinics was common and 68.8% (95% CI: 61.8% - 75.8%) of children under five years old diagnosed with malaria had a negative malaria slide. After sharing these results with the clinicians, malaria diagnoses based on laboratory confirmation in the clinics rose within two months from 38% of total malaria diagnoses to 64%. Implementing field based malaria RDT quality control measures has important implications for the clinical performance of the frontline health care providers in resource limited settings. Clinicians in rural African settings need to be convinced by disseminating and discussing evidence about RDT&apos;s from their own and similar settings in order to improve diagnostic and prescription habits.</style></abstract><label><style face="normal" font="default" size="100%">Included by Ray</style></label><notes><style face="normal" font="default" size="100%">L70442959&#xD;2011-09-13</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.embase.com/search/results?subaction=viewrecord&amp;id=L70442959&amp;from=export</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2140</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2140</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Hawkes, S.</style></author><author><style face="normal" font="default" size="100%">Morison, L.</style></author><author><style face="normal" font="default" size="100%">Foster, S.</style></author><author><style face="normal" font="default" size="100%">Gausia, K.</style></author><author><style face="normal" font="default" size="100%">Chakraborty, J.</style></author><author><style face="normal" font="default" size="100%">Peeling, R. W.</style></author><author><style face="normal" font="default" size="100%">Mabey, D.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">International Centre for Diarrhoeal Disease Research, and Centre for Health and Population Research, Bangladesh. s.hawkes@lshtm.ac.uk</style></auth-address><titles><title><style face="normal" font="default" size="100%">Reproductive-tract infections in women in low-income, low-prevalence situations: assessment of syndromic management in Matlab, Bangladesh</style></title><secondary-title><style face="normal" font="default" size="100%">Lancet</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Lancet</style></full-title></periodical><pages><style face="normal" font="default" size="100%">1776-81</style></pages><volume><style face="normal" font="default" size="100%">354</style></volume><number><style face="normal" font="default" size="100%">9192</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Algorithms</style></keyword><keyword><style face="normal" font="default" size="100%">Bangladesh/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Costs and Cost Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genital Diseases, Female/diagnosis/drug therapy/*epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Poverty</style></keyword><keyword><style face="normal" font="default" size="100%">Prevalence</style></keyword><keyword><style face="normal" font="default" size="100%">Primary Health Care/economics</style></keyword><keyword><style face="normal" font="default" size="100%">Asia</style></keyword><keyword><style face="normal" font="default" size="100%">Bangladesh</style></keyword><keyword><style face="normal" font="default" size="100%">*Cost Benefit Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Delivery Of Health Care</style></keyword><keyword><style face="normal" font="default" size="100%">Developing Countries</style></keyword><keyword><style face="normal" font="default" size="100%">Diseases</style></keyword><keyword><style face="normal" font="default" size="100%">Economic Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Evaluation</style></keyword><keyword><style face="normal" font="default" size="100%">Examinations And Diagnoses</style></keyword><keyword><style face="normal" font="default" size="100%">Health</style></keyword><keyword><style face="normal" font="default" size="100%">*Health Services</style></keyword><keyword><style face="normal" font="default" size="100%">Infections</style></keyword><keyword><style face="normal" font="default" size="100%">*Laboratory Examinations And Diagnoses</style></keyword><keyword><style face="normal" font="default" size="100%">*Low Income Population--women</style></keyword><keyword><style face="normal" font="default" size="100%">Quantitative Evaluation</style></keyword><keyword><style face="normal" font="default" size="100%">*Reproductive Tract Infections</style></keyword><keyword><style face="normal" font="default" size="100%">*Research Report</style></keyword><keyword><style face="normal" font="default" size="100%">*Sexually Transmitted Diseases</style></keyword><keyword><style face="normal" font="default" size="100%">Social Class</style></keyword><keyword><style face="normal" font="default" size="100%">Socioeconomic Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Socioeconomic Status</style></keyword><keyword><style face="normal" font="default" size="100%">Southern Asia</style></keyword><keyword><style face="normal" font="default" size="100%">*Treatment</style></keyword><keyword><style face="normal" font="default" size="100%">*Women</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">1999</style></year><pub-dates><date><style face="normal" font="default" size="100%">Nov 20</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0140-6736 (Print)&#xD;0140-6736</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: In the control of reproductive-tract infections, including sexually transmitted infections (STIs), in low-income and middle-income countries, WHO recommends syndromic management for individuals with symptoms. This intervention was initially developed in areas where prevalence of such infections is high. We investigated the clinical effectiveness and cost of this approach among a group of women with a low prevalence of infection. METHODS: During a 5-month period, we investigated all women complaining of abnormal vaginal discharge and seeking care at maternal and child health/family-planning centres in Matlab, Bangladesh, for the presence of laboratory-diagnosed reproductive-tract infections and STIs. Syndromic diagnoses made by trained health-care workers were compared with laboratory diagnosis of infection. We then calculated the costs of treating women by means of the recommended WHO algorithm and an adapted algorithm incorporating use of a speculum and simple diagnostic tests. FINDINGS: The prevalence of endogenous infections among 320 women seen was 30%. Cervical infections (Neisseria gonorrhoeae and Chlamydia trachomatis) were found in only three women. The WHO algorithm had a high sensitivity (100%) but a low specificity (zero for bacterial vaginosis, candida, and Trichomonas vaginalis). The speculum-based algorithm had a low sensitivity (between zero and 59%) but a higher specificity (79-97%). Between 36% and 87% of costs would have been spent on uninfected women. INTERPRETATION: The high rate of overtreatment in the population studied carries both financial and social costs--the latter in potentially exposing women misdiagnosed as having an STI to threats of domestic disruption or even violence. We make recommendations for management programmes in areas of low STI prevalence and low income.&#xD;This paper presents a study on the syndromic management of reproductive tract infections among women in low-income and low-prevalence situations. Women complaining of abnormal vaginal discharge and seeking care at health centers in Matlab, Bangladesh, were examined for the presence of laboratory-diagnosed reproductive tract infections and sexually transmitted infections. In the results, 30% of 320 women were diagnosed as having endogenous infections. Overall result of the study revealed a low prevalence of sexually transmitted infections among these women. The WHO algorithm had 100% sensitivity but a low specificity, while the speculum-based algorithm had a low sensitivity (0-59%) but a higher specificity (79-97%). Cost analysis indicated that 87% of expenditure was wasted on overtreatment under the WHO algorithm, while only 36% of expenditure was wasted on overtreatment using the speculum-based algorithm. In conclusion, the development of simple, affordable and effective diagnostic tests should be prioritized by policymakers and public health specialists to ensure the provision of adequate services among the higher risk groups in society.&#xD;eng</style></abstract><label><style face="normal" font="default" size="100%">Included by Loai</style></label><notes><style face="normal" font="default" size="100%">Hawkes, S&#xD;Morison, L&#xD;Foster, S&#xD;Gausia, K&#xD;Chakraborty, J&#xD;Peeling, R W&#xD;Mabey, D&#xD;Comparative Study&#xD;Journal Article&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Research Support, U.S. Gov&apos;t, P.H.S.&#xD;England&#xD;Lancet. 1999 Nov 20;354(9192):1776-81. doi: 10.1016/s0140-6736(99)02463-0.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(99)02463-0/fulltext</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1016/s0140-6736(99)02463-0</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2141</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2141</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">He, A. J.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Asian and Policy Studies, The Hong Kong Institute of Education, Hong Kong. Electronic address: jwhe@ied.edu.hk.</style></auth-address><titles><title><style face="normal" font="default" size="100%">The doctor-patient relationship, defensive medicine and overprescription in Chinese public hospitals: evidence from a cross-sectional survey in Shenzhen city</style></title><secondary-title><style face="normal" font="default" size="100%">Soc Sci Med</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Soc Sci Med</style></full-title></periodical><pages><style face="normal" font="default" size="100%">64-71</style></pages><volume><style face="normal" font="default" size="100%">123</style></volume><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">China</style></keyword><keyword><style face="normal" font="default" size="100%">Cost Control</style></keyword><keyword><style face="normal" font="default" size="100%">Cross-Sectional Studies</style></keyword><keyword><style face="normal" font="default" size="100%">*Defensive Medicine</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Hospitals, Public</style></keyword><keyword><style face="normal" font="default" size="100%">Hospitals, Urban</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">*Physician-Patient Relations</style></keyword><keyword><style face="normal" font="default" size="100%">Prescription Drug Misuse/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Unnecessary Procedures/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Cost containment</style></keyword><keyword><style face="normal" font="default" size="100%">Defensive medicine</style></keyword><keyword><style face="normal" font="default" size="100%">Doctor–patient relationship</style></keyword><keyword><style face="normal" font="default" size="100%">Health policy</style></keyword><keyword><style face="normal" font="default" size="100%">Overprescription</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style face="normal" font="default" size="100%">Dec</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0277-9536</style></isbn><abstract><style face="normal" font="default" size="100%">Defensive medicine describes physicians&apos; behavioral response to threats from medical malpractice litigation. Previous studies have found widespread practice of defensive medicine that is responsible for the global escalation of health care costs. Defying the traditional explanations, this study, with a case of a Chinese city, reveals that in a country where medical malpractice lawsuits are rare, physicians&apos; self-perceived threats from patients may constitute a major reason for defensive practices. Defensive behaviors in the Chinese context mainly take the form of overprescribing diagnostic tests, procedures and drugs. The existing literature tends to explain this in terms of Chinese doctors&apos; desire to supplement their low incomes. Behind this is a series of misaligned incentives deeply embedded in the Chinese health system. Using a cross-sectional survey of physicians, this study shows that overprescription in Chinese hospitals is driven not only by hard economic incentives, but also by doctors&apos; motive of avoiding disputes with patients. The survey was carried out in Shenzhen City, in December 2013. A sample containing 504 licensed physicians was drawn by random sampling. Descriptive analyses identified significant dissatisfaction with income and workload as well as severe tensions between doctors and patients. Drawing from the literature on defensive medicine, multivariate analysis revealed that physicians&apos; previous experience of medical disputes is significantly associated with defensive behaviors, particularly overprescription. Low income continued to be a critical predictor, reinforcing the target income hypothesis and suggesting the resilience of perverse economic incentives. This study sheds fresh light on China&apos;s recent health policy reforms by highlighting the critical impact of the doctor-patient relationship. The effort to contain health care costs must progress on two fronts, mitigating the tensions between doctors and patients while still reforming the remuneration scheme cautiously to enable physicians to respond to right incentives.</style></abstract><label><style face="normal" font="default" size="100%">Included by Thanya</style></label><notes><style face="normal" font="default" size="100%">1873-5347&#xD;He, Alex Jingwei&#xD;Journal Article&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Soc Sci Med. 2014 Dec;123:64-71. doi: 10.1016/j.socscimed.2014.10.055. Epub 2014 Oct 29.</style></notes><urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1016/j.socscimed.2014.10.055</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2142</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2142</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Henao-Villada, R.</style></author><author><style face="normal" font="default" size="100%">Sossa-Briceño, M. P.</style></author><author><style face="normal" font="default" size="100%">Rodríguez-Martínez, C. E.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Pediatrics, Fundacion Hospital de la Misericordia, Bogota, Colombia.&#xD;Department of Internal Medicine, School of Medicine, Universidad Nacional de Colombia, Bogota, Colombia.&#xD;Department of Pediatrics, School of Medicine, Universidad Nacional de Colombia, Bogota, Colombia, Avenida Calle 127 No. 20-78, Bogota, Colombia carerodriguezmar@unal.edu.co.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Impact of the implementation of an evidence-based guideline on diagnostic testing, management, and clinical outcomes for infants with bronchiolitis</style></title><secondary-title><style face="normal" font="default" size="100%">Ther Adv Respir Dis</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Ther Adv Respir Dis</style></full-title></periodical><pages><style face="normal" font="default" size="100%">425-34</style></pages><volume><style face="normal" font="default" size="100%">10</style></volume><number><style face="normal" font="default" size="100%">5</style></number><keywords><keyword><style face="normal" font="default" size="100%">Bronchiolitis/diagnosis/*therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Child, Preschool</style></keyword><keyword><style face="normal" font="default" size="100%">Colombia</style></keyword><keyword><style face="normal" font="default" size="100%">Developing Countries</style></keyword><keyword><style face="normal" font="default" size="100%">Electronic Health Records</style></keyword><keyword><style face="normal" font="default" size="100%">Evidence-Based Medicine/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Guideline Adherence</style></keyword><keyword><style face="normal" font="default" size="100%">Hospitalization/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Hospitals, University</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Infant</style></keyword><keyword><style face="normal" font="default" size="100%">Length of Stay</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Patient Readmission/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">*Practice Guidelines as Topic</style></keyword><keyword><style face="normal" font="default" size="100%">Practice Patterns, Physicians&apos;/standards</style></keyword><keyword><style face="normal" font="default" size="100%">Quality of Health Care</style></keyword><keyword><style face="normal" font="default" size="100%">Unnecessary Procedures</style></keyword><keyword><style face="normal" font="default" size="100%">*bronchiolitis</style></keyword><keyword><style face="normal" font="default" size="100%">*clinical practice guidelines</style></keyword><keyword><style face="normal" font="default" size="100%">*clinical practice variation</style></keyword><keyword><style face="normal" font="default" size="100%">*diagnostic tests</style></keyword><keyword><style face="normal" font="default" size="100%">*health resources</style></keyword><keyword><style face="normal" font="default" size="100%">*implementation</style></keyword><keyword><style face="normal" font="default" size="100%">*quality of care</style></keyword><keyword><style face="normal" font="default" size="100%">interest in preparing this article.</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style face="normal" font="default" size="100%">Oct</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1753-4658 (Print)&#xD;1753-4658</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: Although bronchiolitis poses a significant health problem in low- and middle-income countries (LMICs), to the best of our knowledge, to date it has not been determined whether evidence-based bronchiolitis clinical practice guidelines (CPGs) complemented by standardized educational strategies reduce the use of unnecessary diagnostic tests and medications and improve clinically important outcomes in LMICs. METHODS: In an uncontrolled before and after study, we assessed the impact of the implementation of an evidence-based bronchiolitis CPG on physician behavior and the care of infants with bronchiolitis by comparing pre-guideline (March to August 2014) and post-guideline (March to August 2015) use of diagnostic tests and medications through an electronic medical record review in a children&apos;s hospital in Bogota, Colombia. We also sought to assess the impact of the implementation of the CPG on clinically important outcomes such as lengths of stay, hospital admissions, intensive care admissions, and hospital readmissions. RESULTS: Data from 662 cases of bronchiolitis (pre-guideline period) were compared with the data from 703 cases (post-guideline period). On comparing the pre- and post-guideline periods, it was seen that there was a significant increase in the proportion of patients with an appropriate diagnosis and treatment of bronchiolitis (36.4% versus 44.5%, p = 0.003), and there were statistically significant decreases in the use of a hemogram (33.2% versus 26.6%, p=0.010), procalcitonin (3.9% versus 1.6%, p=0.018), nebulized beta-2 agonists (45.6% versus 3.4%, p &lt; 0.001), nebulized anticholinergics (3.3% versus 1.4%, p= 0.029), and nebulized epinephrine (16.2% versus 7.8%, p &lt; 0.001). Likewise, a significant increase in the use of nebulized hypertonic saline was seen (79.6% versus 91.7%, p &lt; 0.001). However, implementation of the CPG for bronchiolitis was not associated with significant changes in clinically important outcomes. CONCLUSIONS: The development and implementation of a good quality bronchiolitis CPG is associated with a significant increase in the proportion of cases with an appropriate diagnosis and treatment of the disease in the context of a university-based hospital located in the capital of an LMIC. However, we could not demonstrate an improvement in clinically important outcomes such as any of the bronchiolitis severity parameters.</style></abstract><notes><style face="normal" font="default" size="100%">1753-4666&#xD;Henao-Villada, Ricardo&#xD;Sossa-Briceño, Monica P&#xD;Rodríguez-Martínez, Carlos E&#xD;Journal Article&#xD;Ther Adv Respir Dis. 2016 Oct;10(5):425-34. doi: 10.1177/1753465816662159. Epub 2016 Aug 4.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://journals.sagepub.com/doi/pdf/10.1177/1753465816662159</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC5933622</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1177/1753465816662159</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2143</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2143</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Ho, T.</style></author><author><style face="normal" font="default" size="100%">Cusack, R. P.</style></author><author><style face="normal" font="default" size="100%">Chaudhary, N.</style></author><author><style face="normal" font="default" size="100%">Satia, I.</style></author><author><style face="normal" font="default" size="100%">Kurmi, O. P.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Firestone Institute of Respiratory Health, Division of Respirology, Dept of Medicine, McMaster University, Hamilton, ON, Canada.&#xD;All authors contributed equally.&#xD;Division of Respirology, Dept of Medicine, McMaster University, Hamilton, ON, Canada.&#xD;Dept of Paediatrics, Universal College of Medical Sciences, Bhairahawa, Nepal.&#xD;Population Health Research Institute, Division of Respirology, Dept of Medicine, McMaster University, Hamilton, ON, Canada.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Under- and over-diagnosis of COPD: a global perspective</style></title><secondary-title><style face="normal" font="default" size="100%">Breathe (Sheff)</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Breathe (Sheff)</style></full-title></periodical><pages><style face="normal" font="default" size="100%">24-35</style></pages><volume><style face="normal" font="default" size="100%">15</style></volume><number><style face="normal" font="default" size="100%">1</style></number><dates><year><style face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style face="normal" font="default" size="100%">Mar</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1810-6838 (Print)&#xD;1810-6838</style></isbn><abstract><style face="normal" font="default" size="100%">Globally, chronic obstructive pulmonary disease (COPD) is the fourth major cause of mortality and morbidity and projected to rise to third within a decade as our efforts to prevent, identify, diagnose and treat patients at a global population level have been insufficient. The European Respiratory Society and American Thoracic Society, along with the Global Initiative for Chronic Obstructive Lung Disease (GOLD) strategy document, have highlighted key pathological risk factors and suggested clinical treatment strategies in order to reduce the mortality and morbidity associated with COPD. This review focuses solely on issues related to the under- and over-diagnosis of COPD across the main geographical regions of the world and highlights some of the associated risk factors. Prevalence of COPD obtained mainly from epidemiological studies varies greatly depending on the clinical and spirometric criteria used to diagnose COPD, i.e. forced expiratory volume in 1 s to forced vital capacity ratio &lt;0.7 or 5% below the lower limit of normal, and this subsequently affects the rates of under- and over-diagnosis. Although under-utilisation of spirometry is the major reason, additional factors such as exposure to airborne pollutants, educational level, age of patients and language barriers have been widely identified as other potential risk factors. Co-existent diseases, such as asthma, bronchiectasis, heart failure and previously treated tuberculosis, are reported to be the other determinants of under- and over-diagnosis of COPD. KEY POINTS: Globally, there is large variation in the prevalence of COPD, with 10-95% under-diagnosis and 5-60% over-diagnosis (table 1) due to differences in the definition of diagnosis used, and the unavailability of spirometry in rural areas of low- and middle-income countries where the prevalence of COPD is likely to be high.In order to be diagnosed with COPD, patients must have a combination of symptoms with irreversible airflow obstruction defined by a post-bronchodilator FEV(1)/FVC ratio of &lt;0.7 or below the fifth centile of the lower limit of normal (LLN), and with a history of significant exposure to a risk factor. Repeat spirometry is recommended if the ratio is between 0.6 and 0.8.Not performing spirometry is the strongest predictor for an incorrect diagnosis of COPD; however, additional factors, such as age, gender, ethnicity, self-perception of symptoms, co-existent asthma, and educational awareness of risk factor by patients and their physician, are also important.COPD can be associated with inhalation of noxious particles other than smoking tobacco. EDUCATIONAL AIMS: To summarise the global prevalence of over- and under-diagnosis of COPD.To highlight the risk factors associated with the under- and over-diagnosis of COPD.To update readers on the key changes in the recent progress made regarding the correct diagnosis of COPD.</style></abstract><notes><style face="normal" font="default" size="100%">2073-4735&#xD;Ho, Terence&#xD;Cusack, Ruth P&#xD;Chaudhary, Nagendra&#xD;Orcid: 0000-0002-3216-8671&#xD;Satia, Imran&#xD;Kurmi, Om P&#xD;Journal Article&#xD;Review&#xD;Breathe (Sheff). 2019 Mar;15(1):24-35. doi: 10.1183/20734735.0346-2018.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395975/pdf/EDU-0346-2018.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC6395975 has nothing to disclose. Conflict of interest: N. Chaudhary has nothing to disclose. Conflict of interest: I. Satia has nothing to disclose. Conflict of interest: O.P. Kurmi has nothing to disclose.</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1183/20734735.0346-2018</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2144</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2144</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Honnekeri, B.</style></author><author><style face="normal" font="default" size="100%">Vyas, A.</style></author><author><style face="normal" font="default" size="100%">Lokhandwala, D.</style></author><author><style face="normal" font="default" size="100%">Vaishnav, A.</style></author><author><style face="normal" font="default" size="100%">Vaishnav, A.</style></author><author><style face="normal" font="default" size="100%">Singhal, M.</style></author><author><style face="normal" font="default" size="100%">Barwad, P.</style></author><author><style face="normal" font="default" size="100%">Panicker, G. K.</style></author><author><style face="normal" font="default" size="100%">Lokhandwala, Y.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Grant Medical College and Sir J.J. Group of Hospitals, Mumbai, Maharashtra, India.&#xD;Cardiologist, Indore, Madhya Pradesh, India.&#xD;K.J. Somaiya Medical College and Research Centre, Mumbai, Maharashtra, India.&#xD;D.Y. Patil Medical College, Navi Mumbai, Maharashtra, India.&#xD;Postgraduate Institute of Medical Education and Research, Sector 12, Chandigarh 160012, India.&#xD;Quintiles Cardiac Safety Services, Mumbai, Maharashtra, India.&#xD;Arrhythmia Associates, Mumbai, Maharashtra, India.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Routine health check-ups: A boon or a burden?</style></title><secondary-title><style face="normal" font="default" size="100%">Natl Med J India</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Natl Med J India</style></full-title></periodical><pages><style face="normal" font="default" size="100%">18-21</style></pages><volume><style face="normal" font="default" size="100%">29</style></volume><number><style face="normal" font="default" size="100%">1</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Cardiovascular Diseases/diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">India</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">*Mass Screening/economics/methods</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Neoplasms/diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">Predictive Value of Tests</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Assessment</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jan-Feb</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0970-258X (Print)&#xD;0970-258x</style></isbn><abstract><style face="normal" font="default" size="100%">Healthcare provider institutions in India now offer structured health check-up &apos;packages&apos; for routine screening of common diseases. While some tests included within their ambit are in keeping with international and Indian recommendations, some are entirely unwarranted. Unnecessary and inappropriate screening tests may cause more harm than benefit. Besides financial and resource burden, there may be over-diagnosis and over-treatment, psychological distress due to false-positive test results, harm from invasive follow-up tests, and false reassurance due to false-negative test results. Clinicians must ensure a net benefit from tests and interventions in order to efficiently deliver preventive services. We reviewed current screening guidelines for cardiovascular disease and common cancers, and surveyed multiple &apos;packages&apos; provided at 8 centres in Mumbai, India. We put forth our recommendations for routine health screening in asymptomatic adults in India.</style></abstract><label><style face="normal" font="default" size="100%">Included by Loai</style></label><notes><style face="normal" font="default" size="100%">Honnekeri, Bianca&#xD;Vyas, Aniruddha&#xD;Lokhandwala, Disha&#xD;Vaishnav, Avani&#xD;Vaishnav, Aditi&#xD;Singhal, Mayank&#xD;Barwad, Parag&#xD;Panicker, Gopi Krishna&#xD;Lokhandwala, Yash&#xD;Journal Article&#xD;Review&#xD;India&#xD;Natl Med J India. 2016 Jan-Feb;29(1):18-21. doi: 10.4103/0970-258x.186908.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.nmji.in/article.asp?issn=0970-258X;year=2016;volume=29;issue=1;spage=18;epage=21;aulast=Honnekeri;type=0</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.4103/0970-258x.186908</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2145</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2145</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Horvath, Eleonora</style></author><author><style face="normal" font="default" size="100%">Majlis D, Sergio</style></author><author><style face="normal" font="default" size="100%">Franco S, Carmen</style></author><author><style face="normal" font="default" size="100%">Soto N, Eduardo</style></author><author><style face="normal" font="default" size="100%">Niedmann E, Juan P.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">¿Existen nódulos coloidos tiroideos que no requieren punción diagnóstica?</style></title><secondary-title><style face="normal" font="default" size="100%">Rev. chil. radiol</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Rev. chil. radiol</style></full-title></periodical><pages><style face="normal" font="default" size="100%">5-10</style></pages><volume><style face="normal" font="default" size="100%">14</style></volume><number><style face="normal" font="default" size="100%">1</style></number><keywords><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Aged, 80 and over</style></keyword><keyword><style face="normal" font="default" size="100%">Biopsy, Fine-Needle/methods</style></keyword><keyword><style face="normal" font="default" size="100%">Thyroid Neoplasms/pathology</style></keyword><keyword><style face="normal" font="default" size="100%">Thyroid Neoplasms</style></keyword><keyword><style face="normal" font="default" size="100%">Ultrasonography</style></keyword><keyword><style face="normal" font="default" size="100%">Thyroid Gland/pathology</style></keyword><keyword><style face="normal" font="default" size="100%">Thyroid Gland</style></keyword><keyword><style face="normal" font="default" size="100%">Prospective Studies</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2008</style></year><pub-dates><date><style face="normal" font="default" size="100%">2008/00</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0717-201X</style></isbn><abstract><style face="normal" font="default" size="100%">Depending on age, sex, and geographic area, 19 to 67% of the general population is found to have thyroid nodules when submitted to ultrasonica-lly-guided diagnostic puncture. Being benign in more than a 80%, most of them corresponds to colloid nodules. Indiscriminate fine-needle aspiration not only increases health costs but also generates anxiety in patients. The echographic-histological correlation of thyroid nodules made it possible to define five typical patterns (colloid patterns 1, 2, 3; neoplastic type, and malignant pattern). Thirty three percent of colloid nodules may appear as follicular neoplasms or malign nodules, being puncture the only means for recognizing and establishing the difference between them. Nevertheless, 67% of nodules presents a typical appearance that corresponds to colloid patterns 1, 2, and 3, which show a weak association to cancer risk(0%, 0% and 1,5%, respectively). On this basis, ultrasound follow-up is advised to recognize them in order to significantly diminish unnecessary diagnostic histological punctures.&#xD;En el 19 al 67%&amp;gt; de la población general se diagnostican nodulos tiroideos mediante ultra-sonografía, dependiendo de la edad, sexo y área geográfica. En más del 80% su naturaleza es benigna y la gran mayoría corresponde a nodulos coloideos. Su punción indiscriminada aumenta costos y genera ansiedad. La correlación ultrasonográfica-histológica de los nodulos tiroideos permitió definir cinco patrones característicos (patrón coloideo típico tipos 1 a 3, patrón neoplásico y patrón maligno). El 33%&amp;gt; de los nodulos coloideos simula la apariencia de nodulos de tipo neoplasia folicular o de aspecto maligno y sólo con punción se puede diferenciar entre ellos. No obstante, el 67%&amp;gt; de los nodulos tiene aspecto típico y corresponden a patrones coloideos Tipo 1, 2 y 3, con una baja asociación con cáncer (0%, 0%y 1,5% en los tres grupos respectivamente), lo que autoriza su seguimiento ultrasonográfico. Al reconocerlos como tal, se puede disminuir en forma significativa las punciones diagnósticas innecesarias.</style></abstract><label><style face="normal" font="default" size="100%">Included by Hannah</style></label><urls><related-urls><url><style face="normal" font="default" size="100%">http://www.scielo.cl/scielo.php?script=sci_arttext&amp;amp;pid=S0717-93082008000100003</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2146</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2146</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Hu, X. F.</style></author><author><style face="normal" font="default" size="100%">Han, X. R.</style></author><author><style face="normal" font="default" size="100%">Yang, Z. Y.</style></author><author><style face="normal" font="default" size="100%">Hu, Y. H.</style></author><author><style face="normal" font="default" size="100%">Tang, J. L.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Division of Epidemiology, JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong 999077, China.</style></auth-address><titles><title><style face="normal" font="default" size="100%">[The impact of broadened diagnostic criteria on the prevalence of hypertension, hyperlipidemia and diabetes mellitus in China]</style></title><secondary-title><style face="normal" font="default" size="100%">Zhonghua Yu Fang Yi Xue Za Zhi</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Zhonghua Yu Fang Yi Xue Za Zhi</style></full-title></periodical><pages><style face="normal" font="default" size="100%">369-377</style></pages><volume><style face="normal" font="default" size="100%">51</style></volume><number><style face="normal" font="default" size="100%">5</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Asian Continental Ancestry Group/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">China/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Diabetes Mellitus/*diagnosis/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Hyperglycemia</style></keyword><keyword><style face="normal" font="default" size="100%">Hyperlipidemias/*diagnosis/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Hypertension/*diagnosis/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Prevalence</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Rural Population</style></keyword><keyword><style face="normal" font="default" size="100%">Surveys and Questionnaires</style></keyword><keyword><style face="normal" font="default" size="100%">Dyslipidemias</style></keyword><keyword><style face="normal" font="default" size="100%">Hypertension</style></keyword><keyword><style face="normal" font="default" size="100%">Over-diagnosis</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style face="normal" font="default" size="100%">May 6</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0253-9624 (Print)&#xD;0253-9624</style></isbn><abstract><style face="normal" font="default" size="100%">Objective: The burden of chronic disease has been continuously increasing in China since the early 1980s. Besides the worsening of risk factors, the change in diagnostic criteria is very likely an important explanation for the increase in the prevalence of hypertension, hyperlipidemia and diabetes mellitus, three commonest, major chronic conditions that can lead to major vascular events and deaths. This study aims to estimate the contribution of changes in diagnostic criteria to the increase in the prevalence of the three conditions in China. Methods: The data from two representative nation-wide surveys in China in 2002 and 2009, with 145 254 and 8 813 adults included respectively, were used to estimate the prevalence rate of the three conditions and the proportion attributable to the change in diagnostic criteria around year 2000. The new and old cutoff values for hypertension, hyperlipidemia, and hyperglycemia were 140/90 and 160/95 mmHg (1 mmHg=0.133 kPa), 5.7 and 6.2 mmol/L, and 7.0 and 7.8 mmol/L, respectively. The prevalence was standardized according to the distribution of age, sex and rural-urban residence of the 2000 national census of the country so as to compare between the old and new diagnostic criteria and project the situation for the entire country. Results: The standardized prevalence of hypertension, hyperlipidemia, and diabetes mellitus for the entire Chinese adult population in 2002 was 8.21%, 1.71% and 1.43% according to the immediate previous diagnostic criteria, and 19.18%, 3.53% and 2.66% according to the new criteria. In 2009, the prevalence was 11.89%, 9.34% and 4.29% according to the old criteria, and 24.78%, 18.36% and 6.55% according to the new criteria. The total cumulative prevalence of the three conditions was increased by 124% in 2002 and 95% in 2009 as a result of change in diagnostic criteria. Put it differently, the change in diagnostic criteria increased the number of the three conditions from 2002 to 2009 by approximately 359 million and could increase the annual drug costs by some 271 billion RMB if all the conditions are treated. The drug costs alone of treating all the three conditions could consume 56% of the total health budget of the Government in 2010. Conclusion: About half of the number of the three conditions is a result of the change in diagnostic criteria. These criteria were adopted from western populations, which are designed to meet the population need and suit healthcare resources available in these countries. It is important for China to consider the resources available and needs and values of the population in addition to the benefits, harms and costs of treatment in determining the cutoff values for defining these conditions for drug interventions.</style></abstract><label><style face="normal" font="default" size="100%">Included by Loai</style></label><notes><style face="normal" font="default" size="100%">Hu, X F&#xD;Han, X R&#xD;Yang, Z Y&#xD;Hu, Y H&#xD;Tang, J L&#xD;Journal Article&#xD;China&#xD;Zhonghua Yu Fang Yi Xue Za Zhi. 2017 May 6;51(5):369-377. doi: 10.3760/cma.j.issn.0253-9624.2017.05.001.</style></notes><urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.3760/cma.j.issn.0253-9624.2017.05.001</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2147</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2147</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Huangfu, P.</style></author><author><style face="normal" font="default" size="100%">Laurence, Y. V.</style></author><author><style face="normal" font="default" size="100%">Alisjahbana, B.</style></author><author><style face="normal" font="default" size="100%">Ugarte-Gil, C.</style></author><author><style face="normal" font="default" size="100%">Riza, A. L.</style></author><author><style face="normal" font="default" size="100%">Walzl, G.</style></author><author><style face="normal" font="default" size="100%">Ruslami, R.</style></author><author><style face="normal" font="default" size="100%">Moore, D. A. J.</style></author><author><style face="normal" font="default" size="100%">Ioana, M.</style></author><author><style face="normal" font="default" size="100%">McAllister, S.</style></author><author><style face="normal" font="default" size="100%">Ronacher, K.</style></author><author><style face="normal" font="default" size="100%">Koesoemadinata, R. C.</style></author><author><style face="normal" font="default" size="100%">Grint, D.</style></author><author><style face="normal" font="default" size="100%">Kerry, S.</style></author><author><style face="normal" font="default" size="100%">Coronel, J.</style></author><author><style face="normal" font="default" size="100%">Malherbe, S. T.</style></author><author><style face="normal" font="default" size="100%">Griffiths, U.</style></author><author><style face="normal" font="default" size="100%">Dockrell, H. M.</style></author><author><style face="normal" font="default" size="100%">Hill, P. C.</style></author><author><style face="normal" font="default" size="100%">van Crevel, R.</style></author><author><style face="normal" font="default" size="100%">Pearson, F.</style></author><author><style face="normal" font="default" size="100%">Critchley, J. A.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Population Health Research Institute, St George&apos;s University of London, London.&#xD;Department of Global Health and Development, Faculty of Public Health and Policy, TB Centre, London School of Hygiene &amp; Tropical Medicine, London, UK.&#xD;Infectious Disease Research Centre, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia.&#xD;Facultad de Medicina Alberto Hurtado and Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru, Department of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA.&#xD;Human Genomics Laboratory, Universitatea de Medicina si Farmacie din Craiova, Romania, Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands.&#xD;Department of Science and Technology/National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research and South African Medical Research Council Centre for Tuberculosis Research, Tygerberg, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.&#xD;Facultad de Medicina Alberto Hurtado and Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru, TB Centre, London School of Hygiene &amp; Tropical Medicine, London, UK.&#xD;Human Genomics Laboratory, Universitatea de Medicina si Farmacie din Craiova, Romania, Dolj Regional Centre of Medical Genetics, Emergency County Clinical Hospital Craiova, Romania.&#xD;Centre for International Health, University of Otago, Dunedin, New Zealand.&#xD;Department of Science and Technology/National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research and South African Medical Research Council Centre for Tuberculosis Research, Tygerberg, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa, Mater Medical Research, The University of Queensland, Translational Research Institute, Brisbane, Queensland, Australia.&#xD;Laboratorio de Investigación y Desarrollo, Facultad de Ciencias y Filosofía, Universidad Peruana Cayetano Heredia Lima, Peru.&#xD;Department of Global Health and Development, Faculty of Public Health and Policy.&#xD;Department of Immunology &amp; Infection, London School of Hygiene &amp; Tropical Medicine, London, UK.&#xD;Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Point of care HbA(1c) level for diabetes mellitus management and its accuracy among tuberculosis patients: a study in four countries</style></title><secondary-title><style face="normal" font="default" size="100%">Int J Tuberc Lung Dis</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Int J Tuberc Lung Dis</style></full-title></periodical><pages><style face="normal" font="default" size="100%">283-292</style></pages><volume><style face="normal" font="default" size="100%">23</style></volume><number><style face="normal" font="default" size="100%">3</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Anemia/complications/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Diabetes Mellitus/*diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Glycated Hemoglobin A/*analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mass Screening/methods</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Point-of-Care Systems</style></keyword><keyword><style face="normal" font="default" size="100%">*Point-of-Care Testing</style></keyword><keyword><style face="normal" font="default" size="100%">Reproducibility of Results</style></keyword><keyword><style face="normal" font="default" size="100%">Tuberculosis/*epidemiology</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style face="normal" font="default" size="100%">Mar 1</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1027-3719</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: Diabetes mellitus (DM) is common among tuberculosis (TB) patients and often undiagnosed or poorly controlled. We compared point of care (POC) with laboratory glycated haemoglobin (HbA(1c)) testing among newly diagnosed TB patients to assess POC test accuracy, safety and acceptability in settings in which immediate access to DM services may be difficult. METHODS: We measured POC and accredited laboratory HbA(1c) (using high-performance liquid chromatography) in 1942 TB patients aged 18 years recruited from Peru, Romania, Indonesia and South Africa. We calculated overall agreement and individual variation (mean ± 2 standard deviations) stratified by country, age, sex, body mass index (BMI), HbA(1c) level and comorbidities (anaemia, human immunodeficiency virus [HIV]). We used an error grid approach to identify disagreement that could raise significant concerns. RESULTS: Overall mean POC HbA(1c) values were modestly higher than laboratory HbA(1c) levels by 0.1% units (95%CI 0.1-0.2); however, there was a substantial discrepancy for those with severe anaemia (1.1% HbA(1c), 95%CI 0.7-1.5). For 89.6% of 1942 patients, both values indicated the same DM status (no DM, HbA(1c) &lt;6.5%) or had acceptable deviation (relative difference &lt;6%). Individual agreement was variable, with POC values up to 1.8% units higher or 1.6% lower. For a minority, use of POC HbA(1c) alone could result in error leading to potential overtreatment (n = 40, 2.1%) or undertreatment (n = 1, 0.1%). The remainder had moderate disagreement, which was less likely to influence clinical decisions. CONCLUSION: POC HbA(1c) is pragmatic and sufficiently accurate to screen for hyperglycaemia and DM risk among TB patients.</style></abstract><notes><style face="normal" font="default" size="100%">1815-7920&#xD;Huangfu, P&#xD;Laurence, Y V&#xD;Alisjahbana, B&#xD;Ugarte-Gil, C&#xD;Riza, A-L&#xD;Walzl, G&#xD;Ruslami, R&#xD;Moore, D A J&#xD;Ioana, M&#xD;McAllister, S&#xD;Ronacher, K&#xD;Koesoemadinata, R C&#xD;Grint, D&#xD;Kerry, S&#xD;Coronel, J&#xD;Malherbe, S T&#xD;Griffiths, U&#xD;Dockrell, H M&#xD;Hill, P C&#xD;van Crevel, R&#xD;Pearson, F&#xD;Critchley, J A&#xD;MR/R010161/1/MRC_/Medical Research Council/United Kingdom&#xD;U01 AI115619/AI/NIAID NIH HHS/United States&#xD;Comparative Study&#xD;Journal Article&#xD;Multicenter Study&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;France&#xD;Int J Tuberc Lung Dis. 2019 Mar 1;23(3):283-292. doi: 10.5588/ijtld.18.0359.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">http://docserver.ingentaconnect.com/deliver/connect/iuatld/10273719/v23n3/s5.pdf?expires=1622598303&amp;id=0000&amp;titleid=3764&amp;checksum=E5B019B127A31AEB256203A2403FD92F</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.5588/ijtld.18.0359</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2148</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2148</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Huerga, H.</style></author><author><style face="normal" font="default" size="100%">Varaine, F.</style></author><author><style face="normal" font="default" size="100%">Okwaro, E.</style></author><author><style face="normal" font="default" size="100%">Bastard, M.</style></author><author><style face="normal" font="default" size="100%">Ardizzoni, E.</style></author><author><style face="normal" font="default" size="100%">Sitienei, J.</style></author><author><style face="normal" font="default" size="100%">Chakaya, J.</style></author><author><style face="normal" font="default" size="100%">Bonnet, M.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Clinical Research Department, Epicentre, Paris, France. helena.huerga@epicentre.msf.org</style></auth-address><titles><title><style face="normal" font="default" size="100%">Performance of the 2007 WHO algorithm to diagnose smear-negative pulmonary tuberculosis in a HIV prevalent setting</style></title><secondary-title><style face="normal" font="default" size="100%">PLoS One</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">PLoS ONE</style></full-title></periodical><pages><style face="normal" font="default" size="100%">e51336</style></pages><volume><style face="normal" font="default" size="100%">7</style></volume><number><style face="normal" font="default" size="100%">12</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">*Algorithms</style></keyword><keyword><style face="normal" font="default" size="100%">Ambulatory Care</style></keyword><keyword><style face="normal" font="default" size="100%">Anti-Bacterial Agents/therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">HIV Infections/*complications/*epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Image Interpretation, Computer-Assisted</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Mycobacterium tuberculosis/drug effects/growth &amp; development/physiology</style></keyword><keyword><style face="normal" font="default" size="100%">Prevalence</style></keyword><keyword><style face="normal" font="default" size="100%">Prospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Retrospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Sputum/*microbiology</style></keyword><keyword><style face="normal" font="default" size="100%">Tomography, X-Ray Computed</style></keyword><keyword><style face="normal" font="default" size="100%">Tuberculosis, Pulmonary/*complications/*diagnosis/diagnostic imaging/drug therapy</style></keyword><keyword><style face="normal" font="default" size="100%">*World Health Organization</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2012</style></year></dates><isbn><style face="normal" font="default" size="100%">1932-6203</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: The 2007 WHO algorithm for diagnosis of smear-negative pulmonary tuberculosis (PTB) including Mycobacterium tuberculosis (MTB) culture was evaluated in a HIV prevalent area of Kenya. METHODS: PTB smear-negative adult suspects were included in a prospective diagnostic study (2009-2011). In addition, program data (2008-2009) were retrospectively analysed. At the first consultation, clinical examination, chest X-ray, and sputum culture (Thin-Layer-Agar and Lowenstein-Jensen) were performed. Patients not started on TB treatment were clinically re-assessed after antibiotic course. The algorithm performance was calculated using culture as reference standard. RESULTS: 380 patients were included prospectively and 406 analyzed retrospectively. Culture was positive for MTB in 17.5% (61/348) and 21.8% (72/330) of cases. Sensitivity of the clinical-radiological algorithm was 55.0% and 31.9% in the prospective study and the program data analysis, respectively. Specificity, positive and negative predictive values were 72.9%, 29.7% and 88.6% in the prospective study and 79.8%, 30.7% and 80.8% in the program data analysis. Performing culture increased the number of confirmed TB patients started on treatment by 43.3% in the prospective study and by 44.4% in the program data analysis. Median time to treatment of confirmed TB patients was 6 days in the prospective study and 27 days in the retrospective study. Inter-reader agreement for X-ray interpretation between the study clinician and a radiologist was low (Kappa coefficient = 0.11, 95%CI: 0.09-0.12). In a multivariate logistic analysis, past TB history, number of symptoms and signs at the clinical exam were independently associated with risk of overtreatment. CONCLUSION: The clinical-radiological algorithm is suboptimal to diagnose smear-negative PTB. Culture increases significantly the proportion of confirmed TB cases started on treatment. Better access to rapid MTB culture and development of new diagnostic tests is necessary.</style></abstract><label><style face="normal" font="default" size="100%">Included by Loai</style></label><notes><style face="normal" font="default" size="100%">1932-6203&#xD;Huerga, Helena&#xD;Varaine, Francis&#xD;Okwaro, Eric&#xD;Bastard, Mathieu&#xD;Ardizzoni, Elisa&#xD;Sitienei, Joseph&#xD;Chakaya, Jeremiah&#xD;Bonnet, Maryline&#xD;Journal Article&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;PLoS One. 2012;7(12):e51336. doi: 10.1371/journal.pone.0051336. Epub 2012 Dec 19.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526594/pdf/pone.0051336.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC3526594</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1371/journal.pone.0051336</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2149</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2149</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Hume, J. C.</style></author><author><style face="normal" font="default" size="100%">Barnish, G.</style></author><author><style face="normal" font="default" size="100%">Mangal, T.</style></author><author><style face="normal" font="default" size="100%">Armázio, L.</style></author><author><style face="normal" font="default" size="100%">Streat, E.</style></author><author><style face="normal" font="default" size="100%">Bates, I.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Disease Control Strategy Group, Liverpool School of Tropical Medicine, Liverpool, UK. humej@niaid.nih.gov</style></auth-address><titles><title><style face="normal" font="default" size="100%">Household cost of malaria overdiagnosis in rural Mozambique</style></title><secondary-title><style face="normal" font="default" size="100%">Malar J</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Malar J</style></full-title></periodical><pages><style face="normal" font="default" size="100%">33</style></pages><volume><style face="normal" font="default" size="100%">7</style></volume><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Ambulatory Care/economics/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Antimalarials/economics/therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Child, Preschool</style></keyword><keyword><style face="normal" font="default" size="100%">Cohort Studies</style></keyword><keyword><style face="normal" font="default" size="100%">*Cost of Illness</style></keyword><keyword><style face="normal" font="default" size="100%">Family Characteristics</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Infant</style></keyword><keyword><style face="normal" font="default" size="100%">Malaria/*diagnosis/drug therapy/*economics</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Mozambique</style></keyword><keyword><style face="normal" font="default" size="100%">Rural Population</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2008</style></year><pub-dates><date><style face="normal" font="default" size="100%">Feb 18</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1475-2875</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: It is estimated that over 70% of patients with suspected malaria in sub-Saharan Africa, diagnose and manage their illness at home without referral to a formal health clinic. Of those patients who do attend a formal health clinic, malaria overdiagnosis rates are estimated to range between 30-70%. METHODS: This paper details an observational cohort study documenting the number and cost of repeat consultations as a result of malaria overdiagnosis at two health care providers in a rural district of Mozambique. 535 adults and children with a clinical diagnosis of malaria were enrolled and followed over a 21 day period to assess treatment regimen, symptoms, number and cost of repeat visits to health providers in patients misdiagnosed with malaria compared to those with confirmed malaria (determined by positive bloodfilm reading). RESULTS: Diagnosis based solely on clinical symptoms overdiagnosed 23% of children (&lt;16y) and 31% of adults with malaria. Symptoms persisted (p = 0.023) and new ones developed (p &lt; 0.001) in more adults than children in the three weeks following initial presentation. Adults overdiagnosed with malaria had more repeat visits (67% v 46%, p = 0.01-0.06) compared to those with true malaria. There was no difference in costs between patients correctly or incorrectly diagnosed with malaria. Median costs over three weeks were $0.28 for those who had one visit and $0.76 for &gt; or = 3 visits and were proportionally highest among the poorest (p &lt; 0.001) CONCLUSION: Overdiagnosis of malaria results in a greater number of healthcare visits and associated cost for adult patients. Additionally, it is clear that the poorest individuals pay significantly more proportionally for their healthcare making it imperative that the treatment they receive is correct in order to prevent wastage of limited economic resources. Thus, investment in accurate malaria diagnosis and appropriate management at primary level is critical for improving health outcomes and reducing poverty.</style></abstract><notes><style face="normal" font="default" size="100%">1475-2875&#xD;Hume, Jen C C&#xD;Barnish, Guy&#xD;Mangal, Tara&#xD;Armázio, Luiz&#xD;Streat, Elizabeth&#xD;Bates, Imelda&#xD;Journal Article&#xD;Malar J. 2008 Feb 18;7:33. doi: 10.1186/1475-2875-7-33.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2279141/pdf/1475-2875-7-33.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC2279141</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1186/1475-2875-7-33</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2150</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2150</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Ishengoma, D. S.</style></author><author><style face="normal" font="default" size="100%">Francis, F.</style></author><author><style face="normal" font="default" size="100%">Mmbando, B. P.</style></author><author><style face="normal" font="default" size="100%">Lusingu, J. P.</style></author><author><style face="normal" font="default" size="100%">Magistrado, P.</style></author><author><style face="normal" font="default" size="100%">Alifrangis, M.</style></author><author><style face="normal" font="default" size="100%">Theander, T. G.</style></author><author><style face="normal" font="default" size="100%">Bygbjerg, I. C.</style></author><author><style face="normal" font="default" size="100%">Lemnge, M. M.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">National Institute for Medical Research, Tanga Medical Research Centre, P.O. Box 5004, Tanga, Tanzania. dishengoma@tanga.mimcom.net</style></auth-address><titles><title><style face="normal" font="default" size="100%">Accuracy of malaria rapid diagnostic tests in community studies and their impact on treatment of malaria in an area with declining malaria burden in north-eastern Tanzania</style></title><secondary-title><style face="normal" font="default" size="100%">Malar J</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Malar J</style></full-title></periodical><pages><style face="normal" font="default" size="100%">176</style></pages><volume><style face="normal" font="default" size="100%">10</style></volume><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Antimalarials/*therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Child, Preschool</style></keyword><keyword><style face="normal" font="default" size="100%">Cross-Sectional Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Diagnostic Tests, Routine/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Drug Utilization/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Guideline Adherence/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Infant</style></keyword><keyword><style face="normal" font="default" size="100%">Infant, Newborn</style></keyword><keyword><style face="normal" font="default" size="100%">Longitudinal Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Malaria/*diagnosis/*drug therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Sensitivity and Specificity</style></keyword><keyword><style face="normal" font="default" size="100%">Tanzania</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2011</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jun 26</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1475-2875</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: Despite some problems related to accuracy and applicability of malaria rapid diagnostic tests (RDTs), they are currently the best option in areas with limited laboratory services for improving case management through parasitological diagnosis and reducing over-treatment. This study was conducted in areas with declining malaria burden to assess; 1) the accuracy of RDTs when used at different community settings, 2) the impact of using RDTs on anti-malarial dispensing by community-owned resource persons (CORPs) and 3) adherence of CORPs to treatment guidelines by providing treatment based on RDT results. METHODS: Data were obtained from: 1) a longitudinal study of passive case detection of fevers using CORPs in six villages in Korogwe; and 2) cross-sectional surveys (CSS) in six villages of Korogwe and Muheza districts, north-eastern, Tanzania. Performance of RDTs was compared with microscopy as a gold standard, and factors affecting their accuracy were explored using a multivariate logistic regression model. RESULTS: Overall sensitivity and specificity of RDTs in the longitudinal study (of 23,793 febrile cases; 18,154 with microscopy and RDTs results) were 88.6% and 88.2%, respectively. In the CSS, the sensitivity was significantly lower (63.4%; χ2=367.7, p&lt;0.001), while the specificity was significantly higher (94.3%; χ2=143.1, p&lt;0.001) when compared to the longitudinal study. As determinants of sensitivity of RDTs in both studies, parasite density of&lt;200 asexual parasites/μl was significantly associated with high risk of false negative RDTs (OR≥16.60, p&lt;0.001), while the risk of false negative test was significantly lower among cases with fever (axillary temperature ≥37.5 °C) (OR≤0.63, p≤0.027). The risk of false positive RDT (as a determinant of specificity) was significantly higher in cases with fever compared to afebrile cases (OR≥2.40, p&lt;0.001). Using RDTs reduced anti-malarials dispensing from 98.9% to 32.1% in cases aged ≥5 years. CONCLUSION: Although RDTs had low sensitivity and specificity, which varied widely depending on fever and parasite density, using RDTs reduced over-treatment with anti-malarials significantly. Thus, with declining malaria prevalence, RDTs will potentially identify majority of febrile cases with parasites and lead to improved management of malaria and non-malaria fevers.</style></abstract><label><style face="normal" font="default" size="100%">Included by Loai</style></label><notes><style face="normal" font="default" size="100%">1475-2875&#xD;Ishengoma, Deus S&#xD;Francis, Filbert&#xD;Mmbando, Bruno P&#xD;Lusingu, John P A&#xD;Magistrado, Pamela&#xD;Alifrangis, Michael&#xD;Theander, Thor G&#xD;Bygbjerg, Ib C&#xD;Lemnge, Martha M&#xD;Medical Research Council/United Kingdom&#xD;Evaluation Study&#xD;Journal Article&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Malar J. 2011 Jun 26;10:176. doi: 10.1186/1475-2875-10-176.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3145609/pdf/1475-2875-10-176.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC3145609</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1186/1475-2875-10-176</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2151</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2151</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Ishengoma, D. S.</style></author><author><style face="normal" font="default" size="100%">Mmbando, B. P.</style></author><author><style face="normal" font="default" size="100%">Segeja, M. D.</style></author><author><style face="normal" font="default" size="100%">Lemnge, M. M.</style></author><author><style face="normal" font="default" size="100%">Alifrangis, M.</style></author><author><style face="normal" font="default" size="100%">Bygbjerg, I. C.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">D.S. Ishengoma, National Institute for Medical Research, Tanga, Tanzania</style></auth-address><titles><title><style face="normal" font="default" size="100%">Declining burden of malaria in a rural community in Muheza district northeastern Tanzania over a period of 18 years (1992-2010) and its impact on antimalarial prescription</style></title><secondary-title><style face="normal" font="default" size="100%">American Journal of Tropical Medicine and Hygiene</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">American Journal of Tropical Medicine and Hygiene</style></full-title></periodical><pages><style face="normal" font="default" size="100%">120</style></pages><volume><style face="normal" font="default" size="100%">85</style></volume><number><style face="normal" font="default" size="100%">6</style></number><keywords><keyword><style face="normal" font="default" size="100%">antimalarial agent</style></keyword><keyword><style face="normal" font="default" size="100%">malaria</style></keyword><keyword><style face="normal" font="default" size="100%">rural population</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">Tanzania</style></keyword><keyword><style face="normal" font="default" size="100%">prescription</style></keyword><keyword><style face="normal" font="default" size="100%">society</style></keyword><keyword><style face="normal" font="default" size="100%">tropical medicine</style></keyword><keyword><style face="normal" font="default" size="100%">hygiene</style></keyword><keyword><style face="normal" font="default" size="100%">patient</style></keyword><keyword><style face="normal" font="default" size="100%">prevalence</style></keyword><keyword><style face="normal" font="default" size="100%">diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">microscopy</style></keyword><keyword><style face="normal" font="default" size="100%">malaria falciparum</style></keyword><keyword><style face="normal" font="default" size="100%">health care facility</style></keyword><keyword><style face="normal" font="default" size="100%">health center</style></keyword><keyword><style face="normal" font="default" size="100%">laboratory</style></keyword><keyword><style face="normal" font="default" size="100%">health</style></keyword><keyword><style face="normal" font="default" size="100%">health care</style></keyword><keyword><style face="normal" font="default" size="100%">Plasmodium</style></keyword><keyword><style face="normal" font="default" size="100%">blood</style></keyword><keyword><style face="normal" font="default" size="100%">blood smear</style></keyword><keyword><style face="normal" font="default" size="100%">gametocyte</style></keyword><keyword><style face="normal" font="default" size="100%">spleen</style></keyword><keyword><style face="normal" font="default" size="100%">anemia</style></keyword><keyword><style face="normal" font="default" size="100%">infection</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2011</style></year></dates><isbn><style face="normal" font="default" size="100%">0002-9637</style></isbn><abstract><style face="normal" font="default" size="100%">The declining burden of malaria in some endemic countries indicate that most of febrile cases may not necessarily be due to malaria; thus, over-diagnosis and -prescription of anti-malarials may pose an increasing challenge to the health system. This study was conducted to assess the changing burden of malaria and examine the effect of decreasing malaria prevalence on dispensing of anti-malarials. Blood smears were prepared from fnger prick/venous blood and examined for malaria parasites by microscopy during cross-section surveys conducted between September 1992 and June 2010 in two villages (Magoda and Mpapayu) in Muheza district, Tanzania. Prevalence of Plasmodium falciparum infections was compared across the years and study villages. Data from patients treated for malaria were obtained from health records at Magoda dispensary (without diagnostic laboratory facilities) and Mkuzi Health Centre (with capacity for malaria diagnosis by microscopy which serves as a referral centre for the study villages) and used to assess the level of antimalarials dispensing at the two health facilities. The prevalence of P. falciparum infections in Magoda village decreased signifcantly from 83.5% in 1992 to 15.0% in 2010 and in Mpapayu, the prevalence dropped from 83.3% in 1998 to 11.7% in 2010. Spleen rate (from &gt;40% to &lt;1%), anaemia prevalence (69% to &lt;25%) and gametocyte rates (23% to &lt;1%) also declined over the same period. From January 2008 to December 2010, a total of 5755 patients were attended and treated presumptively for malaria with Artemether/Lumefantrine at Magoda dispensary, and the number of patients increased from 114 in January 2008 to 289 patients in October 2010. At Mkuzi, over 50% of patients (n=564) with negative test results by microscopy were prescribed with anti-malarial drugs. Although a remarkable decline in the burden of malaria occurred between 1992 and 2010, the number of patients treated with antimalarial drugs in the same area did not decline, leading to over-prescription of anti-malarials. Accurate diagnosis and treatment of patients with positive malaria results is urgently needed to target anti-malarials to patients with malaria, reduce wastage of expensive drugs and improve management of other causes of febrile infections.</style></abstract><label><style face="normal" font="default" size="100%">Included by Ray</style></label><notes><style face="normal" font="default" size="100%">L71042558&#xD;2013-04-30</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.embase.com/search/results?subaction=viewrecord&amp;id=L71042558&amp;from=export</style></url><url><style face="normal" font="default" size="100%">http://www.ajtmh.org/content/85/6_Suppl/101.full.pdf+html</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2152</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2152</key></foreign-keys><ref-type name="Generic">13</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Jackson Filho, José Marçal</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Avaliaçäo da incidência de lesöes por esforço repetitivo nos setores de compensaçäo bancária e de processamento de dados na regiäo de Florianópolis do Banco do Estado de Santa Catarina: laudo pericial</style></title></titles><pages><style face="normal" font="default" size="100%">84-84</style></pages><keywords><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Cumulative Trauma Disorders/diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">Medical Examination</style></keyword><keyword><style face="normal" font="default" size="100%">Tendinopathy/diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">Tenosynovitis/diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">Hand Injuries/diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">Tendon Injuries/diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">Working Conditions</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">1993</style></year><pub-dates><date><style face="normal" font="default" size="100%">1993/11</style></date></pub-dates></dates><abstract><style face="normal" font="default" size="100%">Este relatório é o resultado de um laudo pericial realizado pela FUNDACENTRO/SC nos setores de Processamento de Dados e Compensaçäo Bancária do Banco do Estado de Santa Catarina, na regiäo da Grande Florianópolis, de setembro a novembro de 1993, após solicitaçäo do Ministério Público. Este laudo relaciona a incidência das L.E.R. com as condiçöes de trabalho e sua adequaçäo a Norma Regulamentadora 17 - ERGONOMIA</style></abstract><urls><related-urls><url><style face="normal" font="default" size="100%">https://pesquisa.bvsalud.org/gim/resource/en/lil-135879</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2153</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2153</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Janovsky, Ccps</style></author><author><style face="normal" font="default" size="100%">Bittencourt, M. S.</style></author><author><style face="normal" font="default" size="100%">Novais, M. A. P.</style></author><author><style face="normal" font="default" size="100%">Maciel, R. M. B.</style></author><author><style face="normal" font="default" size="100%">Biscolla, R. P. M.</style></author><author><style face="normal" font="default" size="100%">Zucchi, P.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Centro de Doenças da Tireoide e Laboratório de Endocrinologia Molecular e Translacional, Divisão de Endocrinologia, Departamento de Medicina, Escola Paulista de Medicina, Universidade Federal de São Paulo (EPM-Unifesp), São Paulo, SP Brasil.&#xD;Centro de Medicina Preventiva, Hospital Israelita Albert Einstein, São Paulo, SP, Brasil.&#xD;Núcleo de Pesquisa Clínica e Epidemiológica, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HCFMUSP), São Paulo, SP Brasil.&#xD;Divisão de Economia da Saúde, Departamento de Medicina, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brasil.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Thyroid cancer burden and economic impact on the Brazilian public health system</style></title><secondary-title><style face="normal" font="default" size="100%">Arch Endocrinol Metab</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Arch Endocrinol Metab</style></full-title></periodical><pages><style face="normal" font="default" size="100%">537-544</style></pages><volume><style face="normal" font="default" size="100%">62</style></volume><number><style face="normal" font="default" size="100%">5</style></number><keywords><keyword><style face="normal" font="default" size="100%">Brazil/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">*Cost of Illness</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Incidence</style></keyword><keyword><style face="normal" font="default" size="100%">National Health Programs/*economics</style></keyword><keyword><style face="normal" font="default" size="100%">Radiotherapy/economics/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Retrospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Thyroid Neoplasms/diagnosis/*economics/*epidemiology/therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Thyroidectomy/economics/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Time Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Ultrasonography/economics/statistics &amp; numerical data</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style face="normal" font="default" size="100%">Oct</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">2359-3997</style></isbn><abstract><style face="normal" font="default" size="100%">OBJECTIVE: Recent data indicates an increasing incidence of thyroid cancer not accompanied by a proportional increase in mortality, suggesting overdiagnosis, which may represent a big public health problem, particularly where resources are scarce. This article aims to describe and evaluate the procedures related to investigation of thyroid nodules and treatment and follow-up of thyroid cancer and the costs for the Brazilian public health system between 2008 and 2015. MATERIALS AND METHODS: Data on procedures related to investigation of thyroid nodules and treatment/follow-up of thyroid cancer between 2008 and 2015 in Brazil were collected from the Department of Informatics of the Brazilian Unified Health System (Datasus) website. RESULTS: A statistically significant increase in the use of procedures related to thyroid nodules investigation and thyroid cancer treatment and follow-up was observed in Brazil, though a reduction was noted for procedures related to the treatment of more aggressive thyroid cancer, such as total thyroidectomy with neck dissection and higher radioiodine activities such as 200 and 250 milicuries (mCi). The procedures related to thyroid nodules investigation costs increased by 91% for thyroid ultrasound (p = 0.0003) and 128% in thyroid nodule biopsy (p &lt; 0.001). Costs related to treatment and follow-up related-procedures increased by 120%. CONCLUSION: The increase in the incidence of thyroid cancer in Brazil is directly associated with an increased use of diagnostic tools for thyroid nodules, which leads to an upsurge in thyroid cancer treatment and followup-related procedures. These data suggest that substantial resources are being used for diagnosis, treatment and follow-up of a potentially indolent condition.</style></abstract><label><style face="normal" font="default" size="100%">Included by Hannah</style></label><notes><style face="normal" font="default" size="100%">2359-4292&#xD;Janovsky, Carolina Castro Porto Silva&#xD;Bittencourt, Marcio Sommer&#xD;Novais, Maykon Anderson Pires de&#xD;Maciel, Rui M B&#xD;Biscolla, Rosa Paula M&#xD;Zucchi, Paola&#xD;Journal Article&#xD;Brazil&#xD;Arch Endocrinol Metab. 2018 Oct;62(5):537-544. doi: 10.20945/2359-3997000000074.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scielo.br/j/aem/a/rdVBX3cLdGcWtFP8LtMwH4P/?lang=en&amp;format=pdf</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.20945/2359-3997000000074</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2154</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2154</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Javed, H.</style></author><author><style face="normal" font="default" size="100%">Imran, M.</style></author><author><style face="normal" font="default" size="100%">Nazir, Q. U.</style></author><author><style face="normal" font="default" size="100%">Fatima, I.</style></author><author><style face="normal" font="default" size="100%">Humayun, A.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Public Health and Community Medicine, Shaikh Khalifa Bin Zayed Al-Nahyan Medical College, Shaikh Zayed Postgraduate Medical Institute, Shaikh Zayed Medical Complex, Lahore, Pakistan.&#xD;Institute of Quality Management, University of the Punjab, Lahore, Pakistan.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Increased trend of unnecessary use of radiological diagnostic modalities in Pakistan: radiologists perspective</style></title><secondary-title><style face="normal" font="default" size="100%">Int J Qual Health Care</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Int J Qual Health Care</style></full-title></periodical><pages><style face="normal" font="default" size="100%">712-716</style></pages><volume><style face="normal" font="default" size="100%">31</style></volume><number><style face="normal" font="default" size="100%">9</style></number><keywords><keyword><style face="normal" font="default" size="100%">Attitude of Health Personnel</style></keyword><keyword><style face="normal" font="default" size="100%">Cross-Sectional Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Diagnostic Imaging/*trends</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Pakistan</style></keyword><keyword><style face="normal" font="default" size="100%">*Radiologists</style></keyword><keyword><style face="normal" font="default" size="100%">*Radiology</style></keyword><keyword><style face="normal" font="default" size="100%">Surveys and Questionnaires</style></keyword><keyword><style face="normal" font="default" size="100%">Tertiary Care Centers</style></keyword><keyword><style face="normal" font="default" size="100%">Unnecessary Procedures/*trends</style></keyword><keyword><style face="normal" font="default" size="100%">radiological investigations</style></keyword><keyword><style face="normal" font="default" size="100%">radiologists</style></keyword><keyword><style face="normal" font="default" size="100%">tertiary care hospitals</style></keyword><keyword><style face="normal" font="default" size="100%">unnecessary investigations</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style face="normal" font="default" size="100%">Nov 30</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1353-4505</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: Over the past few years, a significant overuse of radiological investigations influenced the quality and cost of healthcare of the country as it may lead to non-compliance of the patient due to non-affordability and also may harm the patient in terms of radiation hazards. Pakistan, being a low-income, resource-constraint country, is facing financial impact on families as well as health system due to multiple reasons. OBJECTIVES: The purpose of study is to identify reasons of unnecessary use of radiological diagnostic modalities in Pakistani hospitals as perceived by radiologists. METHODS: A cross-sectional study was conducted on a total of all 105 radiologists, having at least 1 year experience of working in radiology, working in five tertiary care hospitals in Lahore. A self-constructed, self-administered, pretested 5-point Likert scale opinion-based questionnaire was administered after taking informed consent. It includes questions about excessive radiological use that may be attributed to the physicians, investigations, patients and other non-categorized causes. Results were analyzed using SPSS version 23. RESULTS: Since the assessment forms were handed over and collected from the radiologists in person, the response rate was 100%. Of a total of 105 respondents, 78 (74.28%) respondentsagreed that there is an actual increase, 25 (23.80%) respondents disagreed and 2 (1.90%) respondents were unsure. Most important reasons for increased usage of radiological investigations are &apos;need of accuracy of diagnosis&apos; (P = 0.009), &apos;trend of physicians to repeat tests in order to confirm preset diagnoses&apos; (P-value = 0.03), &apos;lack of knowledge about proper usage of radiological advances&apos; (P-value = 0.005) and &apos;lack of proper clinical examination&apos; (P-value = 0.04). CONCLUSION: Unnecessary use of radiological investigations is actually there as perceived by radiologists, which is attributed to inadequate knowledge, attitude and training of physicians to refer patients to radiological resources. This research can be a stepping stone for future researchers as it can be used for elaborating these causes individually and finding ways as to how each of these causes can be controlled and minimized to bring about a decline in excessive usage of these modalities for the betterment of the patients.</style></abstract><notes><style face="normal" font="default" size="100%">1464-3677&#xD;Javed, Hassan&#xD;Imran, Mahum&#xD;Nazir, Qurrat-Ul-Ain&#xD;Fatima, Iram&#xD;Humayun, Ayesha&#xD;Journal Article&#xD;England&#xD;Int J Qual Health Care. 2019 Nov 30;31(9):712-716. doi: 10.1093/intqhc/mzy234.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://watermark.silverchair.com/mzy234.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAArAwggKsBgkqhkiG9w0BBwagggKdMIICmQIBADCCApIGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMyk0fXIjtAUuPE3jcAgEQgIICY8OTKfubfzDk2i9Rwc0adg_WC_EiOq8ByX9knUzUn4KJau25Z0JKPGw5V9U1PF8-PgENksUfM5wjZI0fJZYEZidzbQBxzBlXOzcuM6gzDO9kEg4iHXapkUSSrw8EjmCIPuSA_ABVVmPVQ3R3JsrcCwkJNCgQ5nfXv2H72rF2AZRixymRuXf44UdR04SNvjkzVKts_um-p0FAyhHkzQ6Vmuud8zUjNHQ1AzVsLhl8RhaQ-w1Y4ipIm95hE8paVC83n69a_xgu3befjgFrrJ6c9DRmrBrfVvN3cbwkTN4-9PV5m-oFTClIfJv3YIKOgXm8X0trn4XwkBQHYsIXVz4vcSHAYNN6RzIlWwuhaNcjeRi4cZ7NtX7DFP_K-2Ol6t1pyMg4fwl6wG3g8HLKhAbx_Tw4G-qMPqoCR3m9G9mWpEBXd0UT9SKR5Em5PPi9dmfHXR2Nxzgxo4UyiEnAvs8l4PGpzPYo2aU36jjA3sqDCCnzglroUFixfTOJ-AqytY_RQA7ub24bhO5WhDiv2T6Xsl12224aNRka1JH0uuCeCvdWWuksfAUr0knJkp4-2Tkgqk_fvdexOsB7Eje0h4DvRslN_hUnTKioNYnaNfdCHU3beMsZhDwAING1j4y5-0I3tv342_N9is2t0nwF5OUnxIhc0x7hv00tmfJDdgYw9GZY_14ZEPNP41IgKYnGp16T1U3Tn0sFpu_5LZjpe4oMiVG0nAAHmKp8saA_F0IkokyaNXpwwRDlub061f2o695DElWeZxqhGou1h5eGcztxLgVaJRPKbyFk2cHLuGbq5lgyYpo-</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1093/intqhc/mzy234</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2155</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2155</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Jiawei, L. I.</style></author><author><style face="normal" font="default" size="100%">En, Ouyang</style></author><author><style face="normal" font="default" size="100%">Zuofeng, L. I.</style></author><author><style face="normal" font="default" size="100%">Jin, Zhou</style></author><author><style face="normal" font="default" size="100%">Kai, Zhang</style></author><author><style face="normal" font="default" size="100%">Xiaoyan, Zhang</style></author><author><style face="normal" font="default" size="100%">Cai, Chang</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Preoperative ultrasonography of thyroid cancers:is it overdiagnosis or underdiagnosis?</style></title><secondary-title><style face="normal" font="default" size="100%">Chinese Journal of Ultrasonography</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Chinese Journal of Ultrasonography</style></full-title></periodical><pages><style face="normal" font="default" size="100%">308-313</style></pages><number><style face="normal" font="default" size="100%">12</style></number><dates><year><style face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style face="normal" font="default" size="100%">2018/00</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1004-4477</style></isbn><abstract><style face="normal" font="default" size="100%">Objective To investigate the accuracy and missed diagnosis rate of preoperative ultrasound in the diagnosis of thyroid carcinoma . Methods With the method of natural language recognition ,816 solitary thyroid nodules which received thyroidectomy were enrolled for the analysis of preoperative ultrasound examination and post-operative pathology results . The accuracy and the rate of missed diagnosis of ultrasonography for the diagnosis of thyroid carcinoma and lymph node metastasis were evaluated with the pathological results as the gold standard . Results There were 783 ( 96 .0&amp;amp;#65285; ) malignant thyroid tumors ,6 ( 0 .7&amp;amp;#65285; ) follicular tumor with uncertain malignant potential ,and 27 ( 3 .3&amp;amp;#65285; ) benign thyroid tumors . Ultrasonography yielded an accuracy of 96 .1&amp;amp;#65285; in the differential diagnosis between benign and malignant thyroid nodules and an accuracy of 94 .5&amp;amp;#65285; in the quantification of nodule numbers . 5 .5&amp;amp;#65285; of solitary nodules reported by ultrasound were proved to be 2 or more malignant nodules after the surgery . Regarding the diagnosis of central lymph node ,the preoperative ultrasound yielded an accuracy of 73 .0&amp;amp;#65285;and a misdiagnosis rate of 38 .7&amp;amp;#65285; . For the lateral neck lymph node ,the accuracy was 88 .3&amp;amp;#65285; ,and the misdiagnosis rate was 3 .4&amp;amp;#65285; . Conclusions Natural language recognition method can assist clinical research . Ultrasonography is valuable in the diagnosis of thyroid carcinomas and neck lymph nodes . However , ultrasonography has a certain rate of misdiagnosis for the quantification of nodule numbers ,and for the diagnosis of lymph nodes in central and lateral necks .</style></abstract><label><style face="normal" font="default" size="100%">Included by Eman</style></label><urls><related-urls><url><style face="normal" font="default" size="100%">http://dx.doi.org/10.3760/cma.j.issn.1004-4477.2018.04.009</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2156</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2156</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Johansson, E. W.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Women&apos;s and Children&apos;s Health, International Maternal and Child Health, Akademiska sjukhuset, Uppsala University, Uppsala, Sweden; emily.johansson@kbh.uu.se.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Beyond &apos;test and treat&apos; - malaria diagnosis for improved pediatric fever management in sub-Saharan Africa</style></title><secondary-title><style face="normal" font="default" size="100%">Glob Health Action</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Glob Health Action</style></full-title></periodical><pages><style face="normal" font="default" size="100%">31744</style></pages><volume><style face="normal" font="default" size="100%">9</style></volume><keywords><keyword><style face="normal" font="default" size="100%">Imci</style></keyword><keyword><style face="normal" font="default" size="100%">child health</style></keyword><keyword><style face="normal" font="default" size="100%">diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">fever case management</style></keyword><keyword><style face="normal" font="default" size="100%">malaria</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2016</style></year></dates><isbn><style face="normal" font="default" size="100%">1654-9716 (Print)&#xD;1654-9880</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: Malaria rapid diagnostic tests (RDTs) have great potential to improve quality care and rational drug use in malaria-endemic settings although studies have shown common RDT non-compliance. Yet, evidence has largely been derived from limited hospital settings in few countries. This article reviews a PhD thesis that analyzed national surveys from multiple sub-Saharan African countries to generate large-scale evidence of malaria diagnosis practices and its determinants across different contexts. DESIGN: A mixed-methods approach was used across four studies that included quantitative analysis of national household and facility surveys conducted in multiple sub-Saharan African countries at the outset of new guidelines (Demographic and Health Surveys and Service Provision Assessments). Qualitative methods were used to explore reasons for quantitative findings in select settings. RESULTS: There was low (17%) and inequitable test uptake across 13 countries in 2009-2011/12, with greater testing at hospitals than at peripheral clinics (odds ratio [OR]: 0.62, 95% confidence interval [CI]: 0.56-0.69) or community health workers (OR: 0.31, 95% CI: 0.23-0.43) (Study I). Significant variation was found in the effect of diagnosis on antimalarial use at the population level across countries (Uganda OR: 0.84, 95% CI: 0.66-1.06; Mozambique OR: 3.54, 95% CI: 2.33-5.39) (Study II). A Malawi national facility census indicated common compliance to malaria treatment guidelines (85% clients with RDT-confirmed malaria prescribed first-line treatment), although other fever assessments were not often conducted and there was poor antibiotic targeting (59% clients inappropriately prescribed antibiotics). RDT-negative patients had 16.8 (95% CI: 8.6-32.7) times higher odds of antibiotic overtreatment than RDT-positive patients conditioned by cough or difficult breathing complaints (Study III). In Mbarara (Uganda), health workers reportedly prescribed antimalarials to RDT-negative patients if no other fever cause was identified and non-compliance seemed further driven by RDT perceptions, system constraints, and client interactions (Study IV). CONCLUSIONS: A shift from malaria-focused test and treat strategies toward IMCI with testing is needed to improve quality care and rational use of both antimalarial and antibiotic medicines. Strengthened health systems are also needed to support quality clinical care, including adherence to malaria test results, and RDT deployment should be viewed as a unique opportunity to contribute to these important efforts.</style></abstract><label><style face="normal" font="default" size="100%">Included by Hannah</style></label><notes><style face="normal" font="default" size="100%">1654-9880&#xD;Johansson, Emily White&#xD;Journal Article&#xD;Glob Health Action. 2016 Dec 16;9:31744. doi: 10.3402/gha.v9.31744. eCollection 2016.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5165056/pdf/GHA-9-31744.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC5165056</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.3402/gha.v9.31744</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2157</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2157</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Johansson, E. W.</style></author><author><style face="normal" font="default" size="100%">Selling, K. E.</style></author><author><style face="normal" font="default" size="100%">Nsona, H.</style></author><author><style face="normal" font="default" size="100%">Mappin, B.</style></author><author><style face="normal" font="default" size="100%">Gething, P. W.</style></author><author><style face="normal" font="default" size="100%">Petzold, M.</style></author><author><style face="normal" font="default" size="100%">Peterson, S. S.</style></author><author><style face="normal" font="default" size="100%">Hildenwall, H.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Women&apos;s and Children&apos;s Health, International Maternal and Child Health, Uppsala University, Uppsala, Sweden. emily.johansson@kbh.uu.se.&#xD;Department of Women&apos;s and Children&apos;s Health, International Maternal and Child Health, Uppsala University, Uppsala, Sweden.&#xD;Integrated Management of Childhood Illness (IMCI) Unit, Ministry of Health, Lilongwe, Malawi.&#xD;Spatial Ecology and Epidemiology Group, Department of Zoology, University of Oxford, Oxford, UK.&#xD;The Sahlgrenska Academy, Center for Applied Biostatistics, University of Gothenburg, Gothenburg, Sweden.&#xD;Global Health-Health Systems and Policy Research Group, Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden.&#xD;School of Public Health, College of Health Sciences, Makerere University, Kampala, Uganda.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Integrated paediatric fever management and antibiotic over-treatment in Malawi health facilities: data mining a national facility census</style></title><secondary-title><style face="normal" font="default" size="100%">Malar J</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Malar J</style></full-title></periodical><pages><style face="normal" font="default" size="100%">396</style></pages><volume><style face="normal" font="default" size="100%">15</style></volume><number><style face="normal" font="default" size="100%">1</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Anti-Bacterial Agents/*therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Censuses</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Child, Preschool</style></keyword><keyword><style face="normal" font="default" size="100%">Data Mining</style></keyword><keyword><style face="normal" font="default" size="100%">*Delivery of Health Care, Integrated</style></keyword><keyword><style face="normal" font="default" size="100%">Diagnostic Tests, Routine/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">*Drug Utilization</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Fever/*diagnosis/*drug therapy</style></keyword><keyword><style face="normal" font="default" size="100%">*Health Services Research</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Infant</style></keyword><keyword><style face="normal" font="default" size="100%">Malaria/diagnosis/drug therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Malawi</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword><keyword><style face="normal" font="default" size="100%">*Antibiotic resistance</style></keyword><keyword><style face="normal" font="default" size="100%">*Child health</style></keyword><keyword><style face="normal" font="default" size="100%">*Diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">*Fever case management</style></keyword><keyword><style face="normal" font="default" size="100%">*imci</style></keyword><keyword><style face="normal" font="default" size="100%">*Malaria</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style face="normal" font="default" size="100%">Aug 4</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1475-2875</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: There are growing concerns about irrational antibiotic prescription practices in the era of test-based malaria case management. This study assessed integrated paediatric fever management using malaria rapid diagnostic tests (RDT) and Integrated Management of Childhood Illness (IMCI) guidelines, including the relationship between RDT-negative results and antibiotic over-treatment in Malawi health facilities in 2013-2014. METHODS: A Malawi national facility census included 1981 observed sick children aged 2-59 months with fever complaints. Weighted frequencies were tabulated for other complaints, assessments and prescriptions for RDT-confirmed malaria, IMCI-classified non-severe pneumonia, and clinical diarrhoea. Classification trees using model-based recursive partitioning estimated the association between RDT results and antibiotic over-treatment and learned the influence of 38 other input variables at patient-, provider- and facility-levels. RESULTS: Among 1981 clients, 72 % were tested or referred for malaria diagnosis and 85 % with RDT-confirmed malaria were prescribed first-line anti-malarials. Twenty-eight percent with IMCI-pneumonia were not prescribed antibiotics (under-treatment) and 59 % &apos;without antibiotic need&apos; were prescribed antibiotics (over-treatment). Few clients had respiratory rates counted to identify antibiotic need for IMCI-pneumonia (18 %). RDT-negative children had 16.8 (95 % CI 8.6-32.7) times higher antibiotic over-treatment odds compared to RDT-positive cases conditioned by cough or difficult breathing complaints. CONCLUSIONS: Integrated paediatric fever management was sub-optimal for completed assessments and antibiotic targeting despite common compliance to malaria treatment guidelines. RDT-negative results were strongly associated with antibiotic over-treatment conditioned by cough or difficult breathing complaints. A shift from malaria-focused &apos;test and treat&apos; strategies toward &apos;IMCI with testing&apos; is needed to improve quality fever care and rational use of both anti-malarials and antibiotics in line with recent global commitments to combat resistance.</style></abstract><notes><style face="normal" font="default" size="100%">1475-2875&#xD;Johansson, Emily White&#xD;Selling, Katarina Ekholm&#xD;Nsona, Humphreys&#xD;Mappin, Bonnie&#xD;Gething, Peter W&#xD;Petzold, Max&#xD;Peterson, Stefan Swartling&#xD;Hildenwall, Helena&#xD;Medical Research Council/United Kingdom&#xD;Journal Article&#xD;Malar J. 2016 Aug 4;15(1):396. doi: 10.1186/s12936-016-1439-7.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4972956/pdf/12936_2016_Article_1439.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC4972956</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1186/s12936-016-1439-7</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2158</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2158</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Kahama-Maro, J.</style></author><author><style face="normal" font="default" size="100%">D&apos;Acremont, V.</style></author><author><style face="normal" font="default" size="100%">Mtasiwa, D.</style></author><author><style face="normal" font="default" size="100%">Genton, B.</style></author><author><style face="normal" font="default" size="100%">Lengeler, C.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">City Medical Office of Health, Dar es Salaam City Council, P.O. Box 63320, Dar es Salaam, United Republic of Tanzania.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Low quality of routine microscopy for malaria at different levels of the health system in Dar es Salaam</style></title><secondary-title><style face="normal" font="default" size="100%">Malar J</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Malar J</style></full-title></periodical><pages><style face="normal" font="default" size="100%">332</style></pages><volume><style face="normal" font="default" size="100%">10</style></volume><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Aged, 80 and over</style></keyword><keyword><style face="normal" font="default" size="100%">Blood/*parasitology</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Child, Preschool</style></keyword><keyword><style face="normal" font="default" size="100%">Clinical Laboratory Techniques/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Cross-Sectional Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Health Facilities</style></keyword><keyword><style face="normal" font="default" size="100%">*Health Services Research</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Infant</style></keyword><keyword><style face="normal" font="default" size="100%">Infant, Newborn</style></keyword><keyword><style face="normal" font="default" size="100%">Malaria/*diagnosis/parasitology</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Microscopy/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Parasitology/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Sensitivity and Specificity</style></keyword><keyword><style face="normal" font="default" size="100%">Tanzania</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2011</style></year><pub-dates><date><style face="normal" font="default" size="100%">Nov 2</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1475-2875</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: Laboratory capacity to confirm malaria cases in Tanzania is low and presumptive treatment of malaria is being practiced widely. In malaria endemic areas WHO now recommends systematic laboratory testing when suspecting malaria. Currently, the use of Rapid Diagnostic Tests (RDTs) is recommended for the diagnosis of malaria in lower level peripheral facilities, but not in health centres and hospitals. In this study, the following parameters were evaluated: (1) the quality of routine microscopy, and (2) the effects of RDT implementation on the positivity rate of malaria test results at three levels of the health system in Dar es Salaam, Tanzania. METHODS: During a baseline cross-sectional survey, routine blood slides were randomly picked from 12 urban public health facilities in Dar es Salaam, Tanzania. Sensitivity and specificity of routine slides were assessed against expert microscopy. In March 2007, following training of health workers, RDTs were introduced in nine public health facilities (three hospitals, three health centres and three dispensaries) in a near-to-programmatic way, while three control health facilities continued using microscopy. The monthly malaria positivity rates (PR) recorded in health statistics registers were collected before (routine microscopy) and after (routine RDTs) the intervention in all facilities. RESULTS: At baseline, 53% of blood slides were reported as positive by the routine laboratories, whereas only 2% were positive by expert microscopy. Sensitivity of routine microscopy was 71.4% and specificity was 47.3%. Positive and negative predictive values were 2.8% and 98.7%, respectively. Median parasitaemia was only three parasites per 200 white blood cells (WBC) by routine microscopy compared to 1226 parasites per 200 WBC by expert microscopy. Before RDT implementation, the mean test positivity rates using routine microscopy were 43% in hospitals, 62% in health centres and 58% in dispensaries. After RDT implementation, mean positivity rates using routine RDTs were 6%, 7% and 8%, respectively. The sensitivity and specificity of RDTs using expert microscopy as reference were 97.0% and 96.8%. The positivity rate of routine microscopy remained the same in the three control facilities: 71% before versus 72% after. Two cross-sectional health facility surveys confirmed that the parasite rate in febrile patients was low in Dar es Salaam during both the rainy season (13.6%) and the dry season (3.3%). CONCLUSIONS: The quality of routine microscopy was poor in all health facilities, regardless of their level. Over-diagnosis was massive, with many false positive results reported as very low parasitaemia (1 to 5 parasites per 200 WBC). RDTs should replace microscopy as first-line diagnostic tool for malaria in all settings, especially in hospitals where the potential for saving lives is greatest.</style></abstract><label><style face="normal" font="default" size="100%">Included by Eman</style></label><notes><style face="normal" font="default" size="100%">1475-2875&#xD;Kahama-Maro, Judith&#xD;D&apos;Acremont, Valerie&#xD;Mtasiwa, Deo&#xD;Genton, Blaise&#xD;Lengeler, Christian&#xD;Evaluation Study&#xD;Journal Article&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Malar J. 2011 Nov 2;10:332. doi: 10.1186/1475-2875-10-332.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3217957/pdf/1475-2875-10-332.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC3217957</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1186/1475-2875-10-332</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2159</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2159</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Kamolratanapiboon, K.</style></author><author><style face="normal" font="default" size="100%">Tantanate, C.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Clinical Pathology, Faculty of Medicine Siriraj Hospital, Mahidol University , Bangkok , Thailand.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Inappropriate use of D-dimer and impact on the test characteristics for deep vein thrombosis exclusion</style></title><secondary-title><style face="normal" font="default" size="100%">Scand J Clin Lab Invest</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Scand J Clin Lab Invest</style></full-title></periodical><pages><style face="normal" font="default" size="100%">431-436</style></pages><volume><style face="normal" font="default" size="100%">79</style></volume><number><style face="normal" font="default" size="100%">6</style></number><keywords><keyword><style face="normal" font="default" size="100%">Diagnosis, Differential</style></keyword><keyword><style face="normal" font="default" size="100%">Diagnostic Tests, Routine/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Fibrin Fibrinogen Degradation Products/*metabolism</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Medical Overuse</style></keyword><keyword><style face="normal" font="default" size="100%">Predictive Value of Tests</style></keyword><keyword><style face="normal" font="default" size="100%">Retrospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Sensitivity and Specificity</style></keyword><keyword><style face="normal" font="default" size="100%">Thailand</style></keyword><keyword><style face="normal" font="default" size="100%">Venous Thrombosis/*diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">D-dimer</style></keyword><keyword><style face="normal" font="default" size="100%">Prevalence</style></keyword><keyword><style face="normal" font="default" size="100%">inappropriate use</style></keyword><keyword><style face="normal" font="default" size="100%">test performance</style></keyword><keyword><style face="normal" font="default" size="100%">thrombosis</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style face="normal" font="default" size="100%">Oct</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0036-5513</style></isbn><abstract><style face="normal" font="default" size="100%">This study aimed to investigate the prevalence of the inappropriate use of D-dimer testing for deep vein thrombosis (DVT) exclusion, and to evaluate the diagnostic value of D-dimer testing compared between testing in appropriate and inappropriate conditions. A retrospective chart review of patients with D-dimer requests at Siriraj Hospital, Bangkok, Thailand during January-September 2017 was performed. Data relating to D-dimer requests, Wells score, imaging investigations, and coexisting conditions that cause elevated D-dimer without correlation to DVT were analyzed. From 2196 cases, there were 300 D-dimer requests for DVT diagnosis. Of those, 5 (1.7%) and 158 (53.6%) requests were considered to be absolutely inappropriate D-dimer test requests due to the absence of pre-test Wells score evaluation and testing in DVT-likely patients, respectively. One-hundred and forty-eight (49.3%) requests were considered to be the relatively inappropriate D-dimer test requests due to testing in patients with coexisting conditions that included malignancies, sepsis, surgery, trauma, arterial thrombosis, and pregnancy. Three patients had more than one of these conditions. Comparatively higher negative predictive values (NPVs) of D-dimer assay for DVT exclusion were observed when used in DVT-unlikely (100% versus 80%), and in patients without coexisting conditions (100% versus 66.7%). The present study revealed the rate of inappropriate D-dimer testing for DVT exclusion to be high and this may lead to missed DVT diagnosis, overuse of imaging study, and unnecessary cost of D-dimer testing. Appropriate patient selection before test request can improve the NPV of D-dimer for DVT exclusion.</style></abstract><notes><style face="normal" font="default" size="100%">1502-7686&#xD;Kamolratanapiboon, Karnrawee&#xD;Tantanate, Chaicharoen&#xD;Orcid: 0000-0002-3078-6820&#xD;Journal Article&#xD;England&#xD;Scand J Clin Lab Invest. 2019 Oct;79(6):431-436. doi: 10.1080/00365513.2019.1658214. Epub 2019 Aug 23.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.tandfonline.com/doi/full/10.1080/00365513.2019.1658214</style></url><url><style face="normal" font="default" size="100%">https://www.tandfonline.com/doi/pdf/10.1080/00365513.2019.1658214?needAccess=true</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1080/00365513.2019.1658214</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2160</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2160</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Kaur, S.</style></author><author><style face="normal" font="default" size="100%">Singh, V.</style></author><author><style face="normal" font="default" size="100%">Dutta, A. K.</style></author><author><style face="normal" font="default" size="100%">Chandra, J.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Pediatrics, Kalawati Saran Childrens Hospital and Lady Hardinge Medical College, New Delhi, India.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Validation of IMNCI algorithm for young infants (0-2 months) in India</style></title><secondary-title><style face="normal" font="default" size="100%">Indian Pediatr</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Indian Pediatr</style></full-title></periodical><pages><style face="normal" font="default" size="100%">955-60</style></pages><volume><style face="normal" font="default" size="100%">48</style></volume><number><style face="normal" font="default" size="100%">12</style></number><keywords><keyword><style face="normal" font="default" size="100%">*Algorithms</style></keyword><keyword><style face="normal" font="default" size="100%">Case Management</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">India</style></keyword><keyword><style face="normal" font="default" size="100%">Infant</style></keyword><keyword><style face="normal" font="default" size="100%">Infant, Newborn</style></keyword><keyword><style face="normal" font="default" size="100%">Infant, Newborn, Diseases/*diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">Prospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Reproducibility of Results</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2011</style></year><pub-dates><date><style face="normal" font="default" size="100%">Dec</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0019-6061</style></isbn><abstract><style face="normal" font="default" size="100%">OBJECTIVE: To check the validity of Integrated Management of Neonatal and Childhood Illness (IMNCI) algorithm for young infants (0-2 months). DESIGN: Prospective observational study. SETTING: The outpatient department and emergency room of a medical college attached hospital. METHODS: 419 infants (176 between 0-7 days, 243 between 7 days to 2 months) underwent a detailed diagnostic assessment and treatment as per the standard protocol of treating unit. These infants also underwent assessment, classification and identification of treatment as per IMNCI algorithm. The diagnostic and therapeutic agreement between standard protocol and IMNCI was computed to assess the validity of IMNCI algorithm. RESULTS: The IMNCI algorithm performed well in identifying sick young infants with sensitivity of 97%, 94% and 95%, and specificity of 85%, 87% and 87% in 0-7 days, 7 days to 2 months and 0-2 months age groups, respectively. The algorithm covered majority (80%) of recorded diagnoses, and could identify bacterial infection with 88.5% sensitivity and 57.4% specificity. Complete diagnostic agreement with gold standard was seen in 50%; overdiagnosis and under diagnosis was seen in 13% and 19%, respectively. Low birthweight and upper respiratory infection were the main reasons for overdiagnosis whereas surgical conditions resulted in under diagnoses in majority. CONCLUSION: IMNCI algorithm for evaluation and management of young infants has good sensitivity and specificity for referring cases with severe illness.</style></abstract><label><style face="normal" font="default" size="100%">Included by Eman</style></label><notes><style face="normal" font="default" size="100%">0974-7559&#xD;Kaur, Satnam&#xD;Singh, V&#xD;Dutta, A K&#xD;Chandra, J&#xD;Journal Article&#xD;Validation Study&#xD;India&#xD;Indian Pediatr. 2011 Dec;48(12):955-60. doi: 10.1007/s13312-011-0155-1. Epub 2011 Mar 15.</style></notes><urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1007/s13312-011-0155-1</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2161</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2161</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Kavosi, Z.</style></author><author><style face="normal" font="default" size="100%">Sadeghi, A.</style></author><author><style face="normal" font="default" size="100%">Lotfi, F.</style></author><author><style face="normal" font="default" size="100%">Salari, H.</style></author><author><style face="normal" font="default" size="100%">Bayati, M.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Health Human Resources Research Center, School of Management and Information Sciences, Shiraz University of Medical Sciences, Almas Building, Alley 29, Qasrodasht Ave, Shiraz, Iran.&#xD;Health Policy and Management Department, Bushehr University of Medical Sciences, Bushehr, Iran.&#xD;Health Human Resources Research Center, School of Management and Information Sciences, Shiraz University of Medical Sciences, Almas Building, Alley 29, Qasrodasht Ave, Shiraz, Iran. bayatim66@gmail.com.</style></auth-address><titles><title><style face="normal" font="default" size="100%">The inappropriateness of brain MRI prescriptions: a study from Iran</style></title><secondary-title><style face="normal" font="default" size="100%">Cost Eff Resour Alloc</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Cost Eff Resour Alloc</style></full-title></periodical><pages><style face="normal" font="default" size="100%">14</style></pages><volume><style face="normal" font="default" size="100%">19</style></volume><number><style face="normal" font="default" size="100%">1</style></number><keywords><keyword><style face="normal" font="default" size="100%">Health Expenditures</style></keyword><keyword><style face="normal" font="default" size="100%">Magnetic Resonance Imaging</style></keyword><keyword><style face="normal" font="default" size="100%">Medical Overuse</style></keyword><keyword><style face="normal" font="default" size="100%">Neurology</style></keyword><keyword><style face="normal" font="default" size="100%">Prescriptions</style></keyword><keyword><style face="normal" font="default" size="100%">Unnecessary Procedures</style></keyword><keyword><style face="normal" font="default" size="100%">research, authorship, and publication of this article.</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2021</style></year><pub-dates><date><style face="normal" font="default" size="100%">Mar 5</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1478-7547 (Print)&#xD;1478-7547</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: Inappropriate prescriptions can lead to adverse consequences for patients. It also imposes excessive cost on the patients, payers and health systems. The current study aimed at estimating the rate of inappropriate brain Magnetic Resonance Imaging (MRI) prescriptions and their financial burden in Iran. METHODS: Using systematic stratified sampling method, this cross-sectional study recruited 385 participants from three public teaching hospitals in Shiraz, Iran. Demographic information, questions related to brain MRI prescription and its indications checklist were collected using study-specific data collection tools. The completed indications checklist was compared to the appropriateness status table of indications and scenarios to detect the percent of the appropriateness of prescriptions. RESULTS: About 21 percentage of total brain MRI prescriptions are inappropriate. Previous treatment, number of referrals to physician, having other diagnostic tests and the applicant of MRI (P &lt; 0.01) had significant relationships with prescription appropriateness. The estimated financial burden of inappropriate brain MRIs in Shiraz teaching hospitals was 99,988 US dollar in 2017. CONCLUSIONS: More than one-fifth of brains MRIs were inappropriate (i.e. prescriptions without medical indications). It caused 99,988 United States Dollar (USD) financial burden which is 17 times that of Iran&apos;s Gross Domestic Product (GDP) per capita. To better allocate resources for the provision of MRI services to health system, rationing policies for controlling moral hazard and reducing provider induced demand can be helpful.</style></abstract><notes><style face="normal" font="default" size="100%">1478-7547&#xD;Kavosi, Zahra&#xD;Sadeghi, Abouzar&#xD;Lotfi, Farhad&#xD;Salari, Hedayat&#xD;Bayati, Mohsen&#xD;Orcid: 0000-0002-9118-5447&#xD;13862/Shiraz University of Medical Sciences/&#xD;Journal Article&#xD;Cost Eff Resour Alloc. 2021 Mar 5;19(1):14. doi: 10.1186/s12962-021-00268-6.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934493/pdf/12962_2021_Article_268.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC7934493</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1186/s12962-021-00268-6</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2162</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2162</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Kebede, A.</style></author><author><style face="normal" font="default" size="100%">Verweij, J.</style></author><author><style face="normal" font="default" size="100%">Dorigo-Zetsma, W.</style></author><author><style face="normal" font="default" size="100%">Sanders, E.</style></author><author><style face="normal" font="default" size="100%">Messele, T.</style></author><author><style face="normal" font="default" size="100%">van Lieshout, L.</style></author><author><style face="normal" font="default" size="100%">Petros, B.</style></author><author><style face="normal" font="default" size="100%">Polderman, T.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Ethiopian Health and Nutrition Research &amp; Ethio-Netherlands AIDS Research Project, Addis Ababa, Ethiopia. amha@enarp.com</style></auth-address><titles><title><style face="normal" font="default" size="100%">Overdiagnosis of amoebiasis in the absence of Entamoeba histolytica among patients presenting with diarrhoea in Wonji and Akaki, Ethiopia</style></title><secondary-title><style face="normal" font="default" size="100%">Trans R Soc Trop Med Hyg</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Trans R Soc Trop Med Hyg</style></full-title></periodical><pages><style face="normal" font="default" size="100%">305-7</style></pages><volume><style face="normal" font="default" size="100%">97</style></volume><number><style face="normal" font="default" size="100%">3</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Animals</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Child, Preschool</style></keyword><keyword><style face="normal" font="default" size="100%">DNA, Protozoan/analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Diarrhea/*parasitology</style></keyword><keyword><style face="normal" font="default" size="100%">Dysentery, Amebic/*diagnosis/epidemiology/parasitology</style></keyword><keyword><style face="normal" font="default" size="100%">Entamoeba histolytica/*isolation &amp; purification</style></keyword><keyword><style face="normal" font="default" size="100%">Ethiopia/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Feces/parasitology</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Infant</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Polymerase Chain Reaction/methods</style></keyword><keyword><style face="normal" font="default" size="100%">Prospective Studies</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2003</style></year><pub-dates><date><style face="normal" font="default" size="100%">May-Jun</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0035-9203 (Print)&#xD;0035-9203</style></isbn><abstract><style face="normal" font="default" size="100%">To confirm the high reported incidence of intestinal amoebiasis among study participants at 2 cohort sites in Ethiopia where an HIV/AIDS study is taking place, stool samples of 232 patients with complaints of diarrhoea were examined for the presence of Entamoeba histolytica and E. dispar DNA between April and December 2001. By microscopy, 91 (39%) of the study participants were reported to harbour Entamoeba trophozoites and/or four-nucleated cysts. Using specific E. histolytica and E. dispar DNA amplification and detection, none of the study participants were found to be infected with E. histolytica and only 21 (9%) with E. dispar. The consequences of the overdiagnosis of E. histolytica are briefly discussed.</style></abstract><notes><style face="normal" font="default" size="100%">Kebede, Amha&#xD;Verweij, Jaco&#xD;Dorigo-Zetsma, Wendelien&#xD;Sanders, Eduard&#xD;Messele, Tsehaynesh&#xD;van Lieshout, Lisette&#xD;Petros, Beyene&#xD;Polderman, Ton&#xD;Journal Article&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Trans R Soc Trop Med Hyg. 2003 May-Jun;97(3):305-7. doi: 10.1016/s0035-9203(03)90153-2.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://academic.oup.com/trstmh/article-abstract/97/3/305/1940257?redirectedFrom=fulltext</style></url><url><style face="normal" font="default" size="100%">https://watermark.silverchair.com/97-3-305.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAArowggK2BgkqhkiG9w0BBwagggKnMIICowIBADCCApwGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMrXV10e7Udv_7fAMJAgEQgIICbf4SppxTPFcEz06ZRiMGF0BrFaxGAl7_rzNFsXVwcTjDJ6HuOwCh_MiTMhcYMCHwCokf5S70NttEqfcJ3AbTSk8Evm2X1ZEIgdzPHqRIufLHh9KXkeyZseww6SoCFlp_YUIMNBCV9sIeD6B4sYj3idm_AaqeQILDhUuhc_SThOdqsAecHCZI9xe2OKbzGeeAreZVL4_PQj8UbeG0JmuHde2bLjll8H1xrlKFTEFglkSbgEra_zyP2pLrxgVuRDevicZVyWelpOa-YuG1VtwLvLga2ndARe-lEljG3fjvco16gcB-5SUz3WAUma7GzLrBzcyPipj4n6WozfiUD5W1ub7-lbkc2Cp0FUwKS1qZricx4wj70PSq2OGbms0ZbjYc4sgzP2KXpL19SY1GRFtyD-gfb2WoOzUlgOAyb-V0AE2BCpBQTTgvjb8-P2DopUijfe9vg6YVK87xssOKZ1YQtGvWfkvhfauczVLBYAvzFst008J4xiqJCGHT4WQFST6C79PFaujIxAQbQlXm434_IxvJBFgGkkP7nniGYXeGMFZN1Vt6TTFFW4dwD34i9FMXtTvIMbxfhSt2ZjLGcUNJUQRkShrGsNGXmRagW7KgnaHd12ry-1Z7UTjn1xvyQB_JEXSfLFnsJhgjPIo_EyfzSSuXGIWXMEtb3ttCWeJVv9YhMBhn039mt5cnVhrUItNazZ5wNVDyeBptTJ6FV1VpQHqGGN0ZEcphP6WLKR1tdtLPdgTO4Bj8JCUp8O5NhT41Eb2umadEhdPManyB-B4as_-YNULcfAn6gfk3-hyCzjB8bw-VeKvn7whNVayt-g</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1016/s0035-9203(03)90153-2</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2163</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2163</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Khrouf, S.</style></author><author><style face="normal" font="default" size="100%">Letaief Ksontini, F.</style></author><author><style face="normal" font="default" size="100%">Ayadi, M.</style></author><author><style face="normal" font="default" size="100%">Belhaj Ali Rais, H.</style></author><author><style face="normal" font="default" size="100%">Mezlini, A.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Breast cancer screening: a dividing controversy</style></title><secondary-title><style face="normal" font="default" size="100%">Tunis Med</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Tunis Med</style></full-title></periodical><pages><style face="normal" font="default" size="100%">22-34</style></pages><volume><style face="normal" font="default" size="100%">98</style></volume><number><style face="normal" font="default" size="100%">1</style></number><keywords><keyword><style face="normal" font="default" size="100%">Breast Neoplasms/*diagnosis/epidemiology/mortality</style></keyword><keyword><style face="normal" font="default" size="100%">Early Detection of Cancer/*methods/standards/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Mammography</style></keyword><keyword><style face="normal" font="default" size="100%">Mass Screening/*methods/standards/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Randomized Controlled Trials as Topic/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Tunisia/epidemiology</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2020</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jan</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0041-4131 (Print)&#xD;0041-4131</style></isbn><abstract><style face="normal" font="default" size="100%">AIM: To report the conlcusions of articles and reviews assessing the benefit and harms of breast cancer screening in the world and in Tunisia. METHODS: This is a review of articles searched through specialized medical data bases (Pubmud, Science Direct) using the following key-words: Dépistage / Screening,Cancer du sein/ Breast Cancer, Surdiagnostic/ Overdiagnosis,Mammographie/ Mammography,Controverse/ controversy,Tumeur in Situ/ In Situ Tumour. RESULTS: We reviewed 36 articles published between 2001 and 2018 assessing the benefit of breast cancer screening. The mortality reduction due to breast cancer screening is estimated between 15-30% by the randomized trials. However, overdiagnosis is estimated between 0-50%. CONCLUSION: Breast cancer screening has been useful in the fight against cancer. In the era of innovative and efficient therapies, breast cancer screening remains controversial due to the potential overdiagnosis. However, this concept still need to be defined more precisely and estimated more accuratly.</style></abstract><notes><style face="normal" font="default" size="100%">Khrouf, Salim&#xD;Letaief Ksontini, Feryel&#xD;Ayadi, Mouna&#xD;Belhaj Ali Rais, Henda&#xD;Mezlini, Amel&#xD;Journal Article&#xD;Review&#xD;Tunisia&#xD;Tunis Med. 2020 Jan;98(1):22-34.</style></notes><urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2164</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2164</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Kirecci, S. L.</style></author><author><style face="normal" font="default" size="100%">Simsek, A.</style></author><author><style face="normal" font="default" size="100%">Dalkilic, A.</style></author><author><style face="normal" font="default" size="100%">Bayar, G.</style></author><author><style face="normal" font="default" size="100%">Horasanli, K.</style></author><author><style face="normal" font="default" size="100%">Gurbuz, G.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">S.L. Kirecci, Sisli Hamidiye Etfal Research and Training Hospital, Dept. of Urology, Istanbul, Turkey</style></auth-address><titles><title><style face="normal" font="default" size="100%">Evalution of perioperative cough stress test during transobturator mid-urethral sling surgery</style></title><secondary-title><style face="normal" font="default" size="100%">European Urology, Supplements</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">European Urology, Supplements</style></full-title></periodical><pages><style face="normal" font="default" size="100%">e355</style></pages><volume><style face="normal" font="default" size="100%">14</style></volume><number><style face="normal" font="default" size="100%">2</style></number><keywords><keyword><style face="normal" font="default" size="100%">exercise test</style></keyword><keyword><style face="normal" font="default" size="100%">suburethral sling</style></keyword><keyword><style face="normal" font="default" size="100%">surgery</style></keyword><keyword><style face="normal" font="default" size="100%">European</style></keyword><keyword><style face="normal" font="default" size="100%">urology</style></keyword><keyword><style face="normal" font="default" size="100%">coughing</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">patient</style></keyword><keyword><style face="normal" font="default" size="100%">pain</style></keyword><keyword><style face="normal" font="default" size="100%">inguinal region</style></keyword><keyword><style face="normal" font="default" size="100%">continence</style></keyword><keyword><style face="normal" font="default" size="100%">operation duration</style></keyword><keyword><style face="normal" font="default" size="100%">hospitalization</style></keyword><keyword><style face="normal" font="default" size="100%">transobturator tape</style></keyword><keyword><style face="normal" font="default" size="100%">follow up</style></keyword><keyword><style face="normal" font="default" size="100%">epidural anesthesia</style></keyword><keyword><style face="normal" font="default" size="100%">procedures</style></keyword><keyword><style face="normal" font="default" size="100%">incontinence</style></keyword><keyword><style face="normal" font="default" size="100%">questionnaire</style></keyword><keyword><style face="normal" font="default" size="100%">satisfaction</style></keyword><keyword><style face="normal" font="default" size="100%">urine retention</style></keyword><keyword><style face="normal" font="default" size="100%">urine</style></keyword><keyword><style face="normal" font="default" size="100%">catheterization</style></keyword><keyword><style face="normal" font="default" size="100%">urethral catheter</style></keyword><keyword><style face="normal" font="default" size="100%">female</style></keyword><keyword><style face="normal" font="default" size="100%">residual urine</style></keyword><keyword><style face="normal" font="default" size="100%">leg</style></keyword><keyword><style face="normal" font="default" size="100%">stress incontinence</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2015</style></year></dates><isbn><style face="normal" font="default" size="100%">1569-9056</style></isbn><abstract><style face="normal" font="default" size="100%">INTRODUCTION &amp; OBJECTIVES: Currently, it is unclear that how the mesh tension should be adjusted on the transobturator sling surgery (TSS) for improved continence. The aim of this study was to evaluate the effects of perioperative cough stress test on TSS. MATERIAL &amp; METHODS: Between March 2007 and December 2011, 206 women with SUI were enrolled in this study. Patients were randomly categorized to treatment with traditional TSS (96) or TSS with cough stress test (110). The procedures were performed under spinal or epidural anesthesia. Follow up visits were scheduled 7th day, 1st month and 1st year. The Incontinence Impact Questionnaire and the Urinary Distress Inventory were used to identify satisfaction level. At the end of 1st year, two groups were compared patient characteristics, operation time, duration of hospital stay, cure and complication rates. RESULTS: The cure rate was 84.37% (81/96) versus 83.63% (92/110) in traditional TSS and TSS with cough test groups, respectively (at the end of 1st year). Two groups were found to be similar in terms of operation time, duration of hospital stay and continence rate. The most common postoperative complaints were pain and voiding difficulty. Postoperatively ten patient (10/110, 9.09%) suffered voiding difficulties (250 ml residual urine) in TSS with cough stres test group Five patients were discharged with transurethral catheter. Whereas, in traditional TSS group two patients (2/96, 2.1%) had transient complication of voiding difficulty; two patient were treated with repeated catheterization for 1 week.(p&lt;0.05). Postoperative groin pain range was ( 7/96, 8%) versus (24/110, 22%) in traditional TSS and TSS with cough test groups, respectively.(p&lt;0.05) TSS with cough stress test group had higher complication rate like, retention of urine, necessitating to cut the tape, mesh erosion and pain in groin or leg. No patient had resistant voiding difficulty or prolonged urinary retention (&gt; 1 week) in traditional TSS group. CONCLUSIONS: We believe that perioperative cough stress test leads to overtreatment of stress urinary incontinence when the complication rates were considered.</style></abstract><notes><style face="normal" font="default" size="100%">L71831297&#xD;2015-04-10</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.embase.com/search/results?subaction=viewrecord&amp;id=L71831297&amp;from=export</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2165</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2165</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Kılınçarslan, M. G.</style></author><author><style face="normal" font="default" size="100%">Şahin, E. M.</style></author><author><style face="normal" font="default" size="100%">Korkmazer, B.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Family Medicine, Çanakkale Onsekiz Mart University Faculty of Medicine, Canakkale, Turkey goktugmk@gmail.com.&#xD;Family Medicine, Çanakkale Onsekiz Mart University Faculty of Medicine, Canakkale, Turkey.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Prevalence and associated factors of inappropriate repeat test</style></title><secondary-title><style face="normal" font="default" size="100%">Postgrad Med J</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Postgrad Med J</style></full-title></periodical><pages><style face="normal" font="default" size="100%">596-600</style></pages><volume><style face="normal" font="default" size="100%">95</style></volume><number><style face="normal" font="default" size="100%">1129</style></number><keywords><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Causality</style></keyword><keyword><style face="normal" font="default" size="100%">*Clinical Laboratory Services/economics/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">*Clinical Laboratory Techniques/methods/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Costs and Cost Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Cross-Sectional Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">*Medical Overuse/economics/prevention &amp; control/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Tertiary Care Centers/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Time Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Turkey</style></keyword><keyword><style face="normal" font="default" size="100%">Unnecessary Procedures/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">health services overuse</style></keyword><keyword><style face="normal" font="default" size="100%">logistic regression</style></keyword><keyword><style face="normal" font="default" size="100%">tertiary hospital</style></keyword><keyword><style face="normal" font="default" size="100%">unnecessary procedures</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style face="normal" font="default" size="100%">Nov</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0032-5473</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: The rate of laboratory test utilisation has been increasing unsustainably. Evaluating inappropriately repeated laboratory tests is promising because objective criteria are available to measure the rates while causes can be manipulated easily. In this study, we aimed to evaluate the prevalence, associated factors and financial burden of inappropriate repeat tests. METHODS: A cross-sectional study was conducted on the results of 26 types of laboratory tests recorded in a laboratory database of a tertiary hospital between 1 July 2014 and 30 June 2017. Minimum retest intervals were determined from the literature for each type of tests. If the time interval between the two tests was shorter than the minimum retest interval, then the later test was accepted an inappropriate repeat test. Binary logistic regression was performed after univariate analyses. RESULTS: Of a total of 673 794 tests, 109 370 (16.2%) were inappropriate repeat tests. Male gender, being ≥65 years old, being an inpatient, high-volume test and surgical clinic as the test-requesting clinic were associated with inappropriate repeat tests. Also, it was determined that US$66 761.3 had been wasted on inappropriate repeat tests for 3 years. DISCUSSION: There are several factors that increase the rate of inappropriate repeat tests. They should be considered during health policy making or planning interventions to reduce inappropriate repeat tests.</style></abstract><notes><style face="normal" font="default" size="100%">1469-0756&#xD;Kılınçarslan, Mehmet Göktuğ&#xD;Orcid: 0000-0003-4197-1914&#xD;Şahin, Erkan Melih&#xD;Korkmazer, Başak&#xD;Journal Article&#xD;England&#xD;Postgrad Med J. 2019 Nov;95(1129):596-600. doi: 10.1136/postgradmedj-2019-136696. Epub 2019 Jul 24.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://pmj.bmj.com/content/95/1129/596</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1136/postgradmedj-2019-136696</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2166</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2166</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Kumar, Neeta</style></author><author><style face="normal" font="default" size="100%">Sayed, Shahin</style></author><author><style face="normal" font="default" size="100%">Moloo, Zahir</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Educational needs and causes of false diagnosis of atypical squamous cells of unknown significance at a university hospital</style></title><secondary-title><style face="normal" font="default" size="100%">African Journal of Reproductive Health</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">African Journal of Reproductive Health</style></full-title></periodical><keywords><keyword><style face="normal" font="default" size="100%">Cells</style></keyword><keyword><style face="normal" font="default" size="100%">Health Services Needs and Demand</style></keyword><keyword><style face="normal" font="default" size="100%">Candida</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2011</style></year><pub-dates><date><style face="normal" font="default" size="100%">2011/00</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">2131-3606</style></isbn><abstract><style face="normal" font="default" size="100%">The entity of atypical squamous cells of undetermined significance (ASCUS) in The Bethesda System 2001 for reporting cervical cytology is characterized by equivocal diagnosis, poor reproducibility and debatable management. This retrospective study was done to analyse the causes of false ASCUS if any and identify the educational needs as part of quality assurance programme. Cervical smears of all ASCUS cases reported over the one-year period were reviewed by the Cytopathologist. Relevant clinical data was retrieved. ASCUS was the most common type of abnormality representing 43.0 % cases among 294 abnormal smears reported during study period. 16.0% cases were found to be non ASCUS on review. The main four causes of over use of ASCUS diagnosis were poor quality smears and cellular atypia associated with Candida infection, atrophy and squamous metaplasia. Educational measures are being undertaken to avoid over diagnosis and improve the patient management (Afr J Reprod Health 2011; 15[1]: 111-114).</style></abstract><label><style face="normal" font="default" size="100%">Included by Morty</style></label><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ajol.info/index.php/ajrh/article/view/67865/55959</style></url><url><style face="normal" font="default" size="100%">http://www.bioline.org.br/pdf?rh11015</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2167</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2167</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Lalude, O. O.</style></author><author><style face="normal" font="default" size="100%">Gutarra, M. F.</style></author><author><style face="normal" font="default" size="100%">Pollono, E. N.</style></author><author><style face="normal" font="default" size="100%">Lee, S.</style></author><author><style face="normal" font="default" size="100%">Tarwater, P. M.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Division of Cardiology, Department of Internal Medicine, Emory University, Atlanta, GA, 30322, USA, olalude@emory.edu.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Inappropriate utilization of SPECT myocardial perfusion imaging on the USA-Mexico border</style></title><secondary-title><style face="normal" font="default" size="100%">J Nucl Cardiol</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">J Nucl Cardiol</style></full-title></periodical><pages><style face="normal" font="default" size="100%">544-52</style></pages><volume><style face="normal" font="default" size="100%">21</style></volume><number><style face="normal" font="default" size="100%">3</style></number><keywords><keyword><style face="normal" font="default" size="100%">Age Distribution</style></keyword><keyword><style face="normal" font="default" size="100%">Cardiology/standards</style></keyword><keyword><style face="normal" font="default" size="100%">Coronary Artery Disease/*diagnostic imaging/epidemiology/ethnology</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Guideline Adherence/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Hispanic Americans/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Medically Underserved Area</style></keyword><keyword><style face="normal" font="default" size="100%">Mexico/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Myocardial Perfusion Imaging/*standards/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Practice Guidelines as Topic</style></keyword><keyword><style face="normal" font="default" size="100%">Practice Patterns, Physicians&apos;/standards/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Prevalence</style></keyword><keyword><style face="normal" font="default" size="100%">Sex Distribution</style></keyword><keyword><style face="normal" font="default" size="100%">Tomography, Emission-Computed, Single-Photon/*standards/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">United States/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Unnecessary Procedures/standards/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Utilization Review</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jun</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1071-3581</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: The American College of Cardiology/American Society of Nuclear Cardiology published revised appropriate use criteria (AUC) for SPECT MPI in 2009. We assessed adherence to these guidelines and factors associated with inappropriate utilization at the University Medical Center. METHODS: The AUC was applied retrospectively to 420 SPECT MPI studies. Two-sample t test, Fisher&apos;s exact test, and multivariable logistic regression models were used for analysis. RESULTS: There were 322 appropriate (86%) and 54 (14%) inappropriate studies. The odds of having an inappropriate test increased with younger age (P &lt; .001) and female gender (P &lt; .001). Subjects with diabetes (P = .007) and chest pain (P &lt; .001) were less likely to have an inappropriate test. Academic outpatients were three times more likely to have an inappropriate study (P = .123), while community PCPs were 5.6 times (P = .011) and community cardiologists eight times more likely to order inappropriate tests (P = .031). CONCLUSIONS: Inappropriate SPECT MPI in low risk younger women is an important issue on the USA-Mexico border. Initiatives to reduce inappropriate SPECT MPI should focus on a few indications and evaluation of cardiovascular symptoms in younger age women in outpatient/community practices.</style></abstract><notes><style face="normal" font="default" size="100%">1532-6551&#xD;Lalude, Omosalewa O&#xD;Gutarra, Mell F&#xD;Pollono, Eduardo N&#xD;Lee, Soyoung&#xD;Tarwater, Patrick M&#xD;Journal Article&#xD;United States&#xD;J Nucl Cardiol. 2014 Jun;21(3):544-52. doi: 10.1007/s12350-014-9881-9. Epub 2014 Mar 14.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://link.springer.com/article/10.1007/s12350-014-9881-9</style></url><url><style face="normal" font="default" size="100%">https://link.springer.com/content/pdf/10.1007/s12350-014-9881-9.pdf</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1007/s12350-014-9881-9</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2168</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2168</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Landman, K. Z.</style></author><author><style face="normal" font="default" size="100%">Jean, S. E.</style></author><author><style face="normal" font="default" size="100%">Existe, A.</style></author><author><style face="normal" font="default" size="100%">Akom, E. E.</style></author><author><style face="normal" font="default" size="100%">Chang, M. A.</style></author><author><style face="normal" font="default" size="100%">Lemoine, J. F.</style></author><author><style face="normal" font="default" size="100%">Mace, K. E.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, US Centers for Disease Control and Prevention, Atlanta, GA, USA. klandman@gmail.com.&#xD;Population Services International/Organisation Haïtienne de Marketing Social pour la Santé, Port-au-Prince, Haiti. sejean@ohmasshaiti.org.&#xD;Laboratoire National de Santé Publique/Ministère de la Santé Publique et de la Population (MSPP), Port-au-Prince, Haiti. alexandre.existe@gmail.com.&#xD;Population Services International/Organisation Haïtienne de Marketing Social pour la Santé, Port-au-Prince, Haiti. eniko.akom@gmail.com.&#xD;Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, US Centers for Disease Control and Prevention, Atlanta, GA, USA. mchang@cdc.gov.&#xD;Programme National de Contrôle de la Malaria/MSPP, Port-au-Prince, Haiti. jflemoine@mspp.gouv.ht.&#xD;Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, US Centers for Disease Control and Prevention, Atlanta, GA, USA. kmace@cdc.gov.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Evaluation of case management of uncomplicated malaria in Haiti: a national health facility survey, 2012</style></title><secondary-title><style face="normal" font="default" size="100%">Malar J</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Malar J</style></full-title></periodical><pages><style face="normal" font="default" size="100%">394</style></pages><volume><style face="normal" font="default" size="100%">14</style></volume><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Aged, 80 and over</style></keyword><keyword><style face="normal" font="default" size="100%">*Case Management</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Child, Preschool</style></keyword><keyword><style face="normal" font="default" size="100%">Cross-Sectional Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Fever/*diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">Haiti</style></keyword><keyword><style face="normal" font="default" size="100%">Health Facilities</style></keyword><keyword><style face="normal" font="default" size="100%">*Health Services Research</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Infant</style></keyword><keyword><style face="normal" font="default" size="100%">Malaria/*diagnosis/*drug therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Pregnancy</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style face="normal" font="default" size="100%">Oct 9</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1475-2875</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: Malaria is a public health concern in Haiti, although there are limited data on its burden and case management. National malaria guidelines updated in 2012 recommend treatment with chloroquine and primaquine. In December 2012, a nationally-representative cross-sectional survey of health facilities (HFs) was conducted to determine malaria prevalence among febrile outpatients and malaria case management quality at baseline before scale-up of diagnostics and case management training. METHODS: Among all 833 HFs nationwide, 30 were selected randomly, in proportion to total HFs per region, for 2-day evaluations. Survey teams inventoried HF material and human resources. Outpatients of all ages were screened for temperature &gt;37.5 °C or history of fever; those without severe symptoms were consented and enrolled. Providers evaluated and treated enrolled patients according to HF standards; the survey teams documented provider-ordered diagnostic tests and treatment decisions. Facility-based test results [microscopy and malaria rapid diagnostic tests (RDTs)] were collected from HF laboratories. Blood smears for gold-standard microscopy, and dried blood spots for polymerase chain reaction (PCR) were obtained. RESULTS: Malaria diagnostic capacity, defined as completing a test for an enrolled patient or having adequate resources for RDTs or microscopy, was present in 11 (37 %) HFs. Among 459 outpatients screened, 257 (56 %) were febrile, of which 193 (75 %) were eligible, and 153 (80 %) were enrolled. Among 39 patients with facility-level malaria test results available on the survey day, 11 (28 %) were positive, of whom 6 (55 %) were treated with an anti-malarial. Twenty-seven (95 %) of the 28 patients testing negative were not treated with an anti-malarial. Of 114 patients without test results available, 35 (31 %) were presumptively treated for malaria. Altogether, 42 patients were treated with an anti-malarial, one (2 %) according to Haiti&apos;s 2012 guidelines. Of 140 gold-standard smears, none were positive, although one patient tested positive by PCR, a more sensitive technique. The national prevalence of malaria among febrile outpatients is estimated to be 0.5 % (95 % confidence interval 0-1.7 %). CONCLUSIONS: Malaria is an uncommon cause of fever in Haitian outpatients, and limited, often inaccurate, diagnostic capacity at baseline contributes to over diagnosis. Scale-up of diagnostics and training on new guidelines should improve malaria diagnosis and treatment in Haiti.</style></abstract><label><style face="normal" font="default" size="100%">Included by Eman</style></label><notes><style face="normal" font="default" size="100%">1475-2875&#xD;Landman, Keren Z&#xD;Jean, Samuel E&#xD;Existe, Alexandre&#xD;Akom, Eniko E&#xD;Chang, Michelle A&#xD;Lemoine, Jean Frantz&#xD;Mace, Kimberly E&#xD;Journal Article&#xD;Malar J. 2015 Oct 9;14:394. doi: 10.1186/s12936-015-0901-2.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599749/pdf/12936_2015_Article_901.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC4599749</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1186/s12936-015-0901-2</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2169</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2169</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Lasry, A.</style></author><author><style face="normal" font="default" size="100%">Kalou, M. B.</style></author><author><style face="normal" font="default" size="100%">Young, P. R.</style></author><author><style face="normal" font="default" size="100%">Rurangirwa, J.</style></author><author><style face="normal" font="default" size="100%">Parekh, B.</style></author><author><style face="normal" font="default" size="100%">Behel, S.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">A. Lasry, Division of Global HIV and TB, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, United States</style></auth-address><titles><title><style face="normal" font="default" size="100%">Cost implications of HIV retesting for verification in Africa</style></title><secondary-title><style face="normal" font="default" size="100%">PLoS ONE</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">PLoS ONE</style></full-title></periodical><volume><style face="normal" font="default" size="100%">14</style></volume><number><style face="normal" font="default" size="100%">7</style></number><keywords><keyword><style face="normal" font="default" size="100%">Africa</style></keyword><keyword><style face="normal" font="default" size="100%">antiretroviral therapy</style></keyword><keyword><style face="normal" font="default" size="100%">article</style></keyword><keyword><style face="normal" font="default" size="100%">cost control</style></keyword><keyword><style face="normal" font="default" size="100%">diagnostic error</style></keyword><keyword><style face="normal" font="default" size="100%">drug cost</style></keyword><keyword><style face="normal" font="default" size="100%">Human immunodeficiency virus infection</style></keyword><keyword><style face="normal" font="default" size="100%">low income country</style></keyword><keyword><style face="normal" font="default" size="100%">middle income country</style></keyword><keyword><style face="normal" font="default" size="100%">sensitivity analysis</style></keyword><keyword><style face="normal" font="default" size="100%">unnecessary procedure</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2019</style></year></dates><isbn><style face="normal" font="default" size="100%">1932-6203</style></isbn><abstract><style face="normal" font="default" size="100%">Introduction HIV misdiagnosis leads to severe individual and public health consequences. Retesting for verification of all HIV-positive cases prior to antiretroviral therapy initiation can reduce HIV misdiagnosis, yet this practice has not been not widely implemented. Methods We evaluated and compared the cost of retesting for verification of HIV seropositivity (retesting) to the cost of antiretroviral treatment (ART) for misdiagnosed cases in the absence of retesting (no retesting), from the perspective of the health care system. We estimated the number of misdiagnosed cases based on a review of misdiagnosis rates, and the number of positives persons needing ART initiation by 2020. We presented the total and per person costs of retesting as compared to no retesting, over a ten-year horizon, across 50 countries in Africa grouped by income level. We conducted univariate sensitivity analysis on all model input parameters, and threshold analysis to evaluate the parameter values where the total costs of retesting and the costs no retesting are equivalent. Cost data were adjusted to 2017 United States Dollars. Results and discussion The estimated number of misdiagnoses, in the absence of retesting was 156,117, 52,720 and 29,884 for lower-income countries (LICs), lower-middle income countries (LMICs), and upper middle-income countries (UMICs), respectively, totaling 240,463 for Africa. Under the retesting scenario, costs per person initially diagnosed were: $40, $21, and $42, for LICs, LMICs, and UMICs, respectively. When retesting for verification is implemented, the savings in unnecessary ART were $125, $43, and $75 per person initially diagnosed, for LICs, LMICs, and UMICs, respectively. Over the ten-year horizon, the total costs under the retesting scenario, over all country income levels, was $475 million, and was $1.192 billion under the no retesting scenario, representing total estimated savings of $717 million in HIV treatment costs averted. Conclusions Results show that to reduce HIV misdiagnosis, countries in Africa should implement the WHO&apos;s recommendation of retesting for verification prior to ART initiation, as part of a comprehensive quality assurance program for HIV testing services.</style></abstract><notes><style face="normal" font="default" size="100%">L2002368731&#xD;2019-08-09&#xD;2020-08-26</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.embase.com/search/results?subaction=viewrecord&amp;id=L2002368731&amp;from=export</style></url><url><style face="normal" font="default" size="100%">http://dx.doi.org/10.1371/journal.pone.0218936</style></url><url><style face="normal" font="default" size="100%">https://storage.googleapis.com/plos-corpus-prod/10.1371/journal.pone.0218936/1/pone.0218936.pdf?X-Goog-Algorithm=GOOG4-RSA-SHA256&amp;X-Goog-Credential=wombat-sa%40plos-prod.iam.gserviceaccount.com%2F20210602%2Fauto%2Fstorage%2Fgoog4_request&amp;X-Goog-Date=20210602T011515Z&amp;X-Goog-Expires=86400&amp;X-Goog-SignedHeaders=host&amp;X-Goog-Signature=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</style></url></related-urls></urls><custom5><style face="normal" font="default" size="100%">31260467</style></custom5><electronic-resource-num><style face="normal" font="default" size="100%">10.1371/journal.pone.0218936</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2170</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2170</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Lee, W. S.</style></author><author><style face="normal" font="default" size="100%">Zainuddin, H.</style></author><author><style face="normal" font="default" size="100%">Boey, C. C.</style></author><author><style face="normal" font="default" size="100%">Chai, P. F.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Way Seah Lee, Christopher CM Boey, Pei Fan Chai, Department of Paediatrics, University Malaya Medical Centre, 50603 Kuala Lumpur, Malaysia.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Appropriateness, endoscopic findings and contributive yield of pediatric gastrointestinal endoscopy</style></title><secondary-title><style face="normal" font="default" size="100%">World J Gastroenterol</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">World J Gastroenterol</style></full-title></periodical><pages><style face="normal" font="default" size="100%">9077-83</style></pages><volume><style face="normal" font="default" size="100%">19</style></volume><number><style face="normal" font="default" size="100%">47</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Age Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Child, Preschool</style></keyword><keyword><style face="normal" font="default" size="100%">Colonoscopy</style></keyword><keyword><style face="normal" font="default" size="100%">*Endoscopy, Gastrointestinal/adverse effects</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Gastrointestinal Diseases/*pathology/therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Infant</style></keyword><keyword><style face="normal" font="default" size="100%">Malaysia</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">*Patient Selection</style></keyword><keyword><style face="normal" font="default" size="100%">Predictive Value of Tests</style></keyword><keyword><style face="normal" font="default" size="100%">Prognosis</style></keyword><keyword><style face="normal" font="default" size="100%">Retrospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Unnecessary Procedures</style></keyword><keyword><style face="normal" font="default" size="100%">American Society for Gastrointestinal Endoscopy</style></keyword><keyword><style face="normal" font="default" size="100%">Contributive yield</style></keyword><keyword><style face="normal" font="default" size="100%">Esophagogastroduodenoscopy</style></keyword><keyword><style face="normal" font="default" size="100%">North American Society for Pediatric Gastroenterology, Hepatology and Nutrition</style></keyword><keyword><style face="normal" font="default" size="100%">Pediatric gastrointestinal endoscopy</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2013</style></year><pub-dates><date><style face="normal" font="default" size="100%">Dec 21</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1007-9327 (Print)&#xD;1007-9327</style></isbn><abstract><style face="normal" font="default" size="100%">AIM: To determine the predictability of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) and American Society for Gastrointestinal Endoscopy (ASGE) guideline with regard to appropriate endoscopic practice in children, positive endoscopic findings and contributive yield in clinical practice. METHODS: This was a descriptive, retrospective analysis, conducted at the Department of Paediatrics, University Malaya Medical Centre, Malaysia. All children who had esophagogastroduodenoscopy (EGD) and colonoscopy from January 2008 to June 2011 were included. An endoscopy was considered appropriate when its indication complied with the NASPGHAN and ASGE guideline. All endoscopic findings were classified as either positive (presence of any endoscopic or histologic abnormality) or negative (no or minor abnormality, normal histology); effecting a positive contributive (a change in therapeutic decisions or prognostic consequences) or non-contributive yield (no therapeutic or prognostic consequences). RESULTS: Overall, 76% of the 345 procedures (231 EGD alone, 26 colonoscopy alone, 44 combined EGD and colonoscopy) performed in 301 children (median age 7.0 years, range 3 months to 18 years) had a positive endoscopic finding. Based on the NASPGHAN and ASGE guideline, 99.7% of the procedures performed were considered as appropriate. The only inappropriate procedure (0.3%) was in a child who had EGD for assessment of the healing of gastric ulcer following therapy in the absence of any symptoms. The overall positive contributive yield for a change in diagnosis and/or management was 44%. The presence of a positive endoscopic finding was more likely to effect a change in the therapeutic plan than an alteration of the initial diagnosis. A total of 20 (5.8%) adverse events were noted, most were minor and none was fatal. CONCLUSION: The NASPGHAN and ASGE guideline is more likely to predict a positive endoscopic finding but is less sensitive to effect a change in the initial clinical diagnosis or the subsequent therapeutic plan.</style></abstract><label><style face="normal" font="default" size="100%">Included by Hannah</style></label><notes><style face="normal" font="default" size="100%">2219-2840&#xD;Lee, Way Seah&#xD;Zainuddin, Hafizah&#xD;Boey, Christopher C M&#xD;Chai, Pei Fan&#xD;Journal Article&#xD;World J Gastroenterol. 2013 Dec 21;19(47):9077-83. doi: 10.3748/wjg.v19.i47.9077.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3870562/pdf/WJG-19-9077.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC3870562</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.3748/wjg.v19.i47.9077</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2171</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2171</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Leiva, B.</style></author><author><style face="normal" font="default" size="100%">Lebbad, M.</style></author><author><style face="normal" font="default" size="100%">Winiecka-Krusnell, J.</style></author><author><style face="normal" font="default" size="100%">Altamirano, I.</style></author><author><style face="normal" font="default" size="100%">Tellez, A.</style></author><author><style face="normal" font="default" size="100%">Linder, E.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Microbiology and Tumorbiology Center, Karolinska Institute, Stockholm, Sweden. byron.leiva@smi.ki.se</style></auth-address><titles><title><style face="normal" font="default" size="100%">Overdiagnosis of Entamoeba histolytica and Entamoeba dispar in Nicaragua: a microscopic, triage parasite panel and PCR study</style></title><secondary-title><style face="normal" font="default" size="100%">Arch Med Res</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Arch Med Res</style></full-title></periodical><pages><style face="normal" font="default" size="100%">529-34</style></pages><volume><style face="normal" font="default" size="100%">37</style></volume><number><style face="normal" font="default" size="100%">4</style></number><keywords><keyword><style face="normal" font="default" size="100%">Animals</style></keyword><keyword><style face="normal" font="default" size="100%">Diagnostic Errors</style></keyword><keyword><style face="normal" font="default" size="100%">Entamoeba/*cytology/*genetics/isolation &amp; purification</style></keyword><keyword><style face="normal" font="default" size="100%">Entamoebiasis/*diagnosis/*parasitology</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Microscopy</style></keyword><keyword><style face="normal" font="default" size="100%">Nicaragua</style></keyword><keyword><style face="normal" font="default" size="100%">Polymerase Chain Reaction</style></keyword><keyword><style face="normal" font="default" size="100%">Triage</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2006</style></year><pub-dates><date><style face="normal" font="default" size="100%">May</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0188-4409 (Print)&#xD;0188-4409</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: Based on stool microscopy, an E. histolytica/E. dispar prevalence of 18.6% was found in León, Nicaragua about 10 years ago. Since then, new non-microscopic methods have been developed to discriminate between pathogenic E. histolytica and nonpathogenic E. dispar. The main objectives of the present study were to evaluate the true prevalence of E. histolytica among individuals with diarrhea and to assess the diagnostic procedures carried out at the health center level. METHODS: A descriptive study was carried out on patients with diarrhea. Parasite detection was performed by conventional microscopy on native preparations or concentrated and stained specimens, Triage Parasite Panel and by PCR for both E. histolytica and E. dispar. RESULTS: In 134 individuals with diarrhea, the prevalence of intestinal parasites was 69% as detected by direct stool examination. E. histolytica/E. dispar was found in eight (6%) of the samples, but the health centers reported 24%. In the Triage Parasite Panel only one case of E. histolytica/E. dispar was found. Analysis by PCR showed E. dispar in ten (7.5%) and E. histolytica in two cases (1.5%). The detection of intestinal coccidia and Dientamoeba fragilis required additional staining methods. CONCLUSIONS: PCR results showed that E. histolytica is a rare finding in patients with diarrhea. At the health centers, E. histolytica, E. histolytica/E. dispar were clearly overdiagnosed, with the consequence of overtreatment.</style></abstract><label><style face="normal" font="default" size="100%">Included by Thanya</style></label><notes><style face="normal" font="default" size="100%">Leiva, Byron&#xD;Lebbad, Marianne&#xD;Winiecka-Krusnell, Jadwiga&#xD;Altamirano, Isabel&#xD;Tellez, Aleyda&#xD;Linder, Ewert&#xD;Journal Article&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Arch Med Res. 2006 May;37(4):529-34. doi: 10.1016/j.arcmed.2005.10.009.</style></notes><urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1016/j.arcmed.2005.10.009</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2172</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2172</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Lepe-Zúñiga, J.</style></author><author><style face="normal" font="default" size="100%">Pascual, R. E.</style></author><author><style face="normal" font="default" size="100%">Jiménez-Ruiz, M. F.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Secretaría de Salud del Estado de Chiapas, Centro Regional de Alta Especialidad, Hospital de Especialidades Pediátricas, Chiapas, México. joselepe36@Hotmail.com.</style></auth-address><titles><title><style face="normal" font="default" size="100%">[Hemophagocytic syndrome at a pediatric specialty hospital. Underdiagnosis and overdiagnosis]</style></title><secondary-title><style face="normal" font="default" size="100%">Rev Alerg Mex</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Rev Alerg Mex</style></full-title></periodical><pages><style face="normal" font="default" size="100%">316-328</style></pages><volume><style face="normal" font="default" size="100%">67</style></volume><number><style face="normal" font="default" size="100%">4</style></number><keywords><keyword><style face="normal" font="default" size="100%">*Hemophagocytic lymphohistiocytosis</style></keyword><keyword><style face="normal" font="default" size="100%">*Hemophagocytic syndrome</style></keyword><keyword><style face="normal" font="default" size="100%">*Immune chaos</style></keyword><keyword><style face="normal" font="default" size="100%">*Macrophage activation syndrome</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2020</style></year><pub-dates><date><style face="normal" font="default" size="100%">Oct-Dec</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0002-5151 (Print)&#xD;0002-5151</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: The hemophagocytic syndrome is a serious complication of several systemic illnesses. OBJECTIVE: To define the characteristics of the hemophagocytic syndrome at a pediatric specialty hospital in Tuxtla Gutiérrez, Chiapas, Mexico; incidences, underdiagnosis and overdiagnosis, associated conditions, treatment, and prognosis were included. METHODS: 214 cases of probable hemophagocytic syndrome that were seen between January 2011 and May 2019 were analyzed. 26 patients diagnosed with hemophagocytic syndrome and 188 cases with suspicion of this entity and/or ferritin &gt; 500 ug/L were included. The cases that met four or more criteria of the HFS (Histiocyte Society, 2004) were included in this study. RESULTS: Thirty-five cases were validated (fourteen were previously diagnosed, nine had suspicion, and twelve had ferritin &gt; 500 μg/L). Neither twelve out of 26 of the cases that were previously diagnosed (46.2 % overdiagnosed). Of the 35 validated cases, 21 hadn’t been diagnosed (60 % underdiagnosed) met the diagnostic criteria of the HFS. The annual occurrence was of 2.0/1000 egresses. The Epstein-Barr virus was involved in 42 % of the cases. The overall mortality was of 80 %. CONCLUSIONS: Hemophagocytic syndrome had been significantly underdiagnosed and overdiagnosed at the analyzed hospital. The clinical features allow early suspicion, diagnosis, and treatment. Specific and non-specific illnesses that were associated to hemophagocytic syndrome were identified.</style></abstract><label><style face="normal" font="default" size="100%">Included by Hannah</style></label><notes><style face="normal" font="default" size="100%">Lepe-Zúñiga, José&#xD;Pascual, Rosa Eira&#xD;Jiménez-Ruiz, María Fernanda&#xD;English Abstract&#xD;Journal Article&#xD;Mexico&#xD;Rev Alerg Mex. 2020 Oct-Dec;67(4):316-328. doi: 10.29262/ram.v67i4.759.</style></notes><urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.29262/ram.v67i4.759</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2173</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2173</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Leslie, T.</style></author><author><style face="normal" font="default" size="100%">Mikhail, A.</style></author><author><style face="normal" font="default" size="100%">Mayan, I.</style></author><author><style face="normal" font="default" size="100%">Anwar, M.</style></author><author><style face="normal" font="default" size="100%">Bakhtash, S.</style></author><author><style face="normal" font="default" size="100%">Nader, M.</style></author><author><style face="normal" font="default" size="100%">Chandler, C.</style></author><author><style face="normal" font="default" size="100%">Whitty, C. J.</style></author><author><style face="normal" font="default" size="100%">Rowland, M.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK. toby.leslie@lshtm.ac.uk</style></auth-address><titles><title><style face="normal" font="default" size="100%">Overdiagnosis and mistreatment of malaria among febrile patients at primary healthcare level in Afghanistan: observational study</style></title><secondary-title><style face="normal" font="default" size="100%">Bmj</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Bmj</style></full-title></periodical><pages><style face="normal" font="default" size="100%">e4389</style></pages><volume><style face="normal" font="default" size="100%">345</style></volume><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Afghanistan/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Ambulatory Care Facilities/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Animals</style></keyword><keyword><style face="normal" font="default" size="100%">Anti-Bacterial Agents/*therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Antimalarials/*therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Child, Preschool</style></keyword><keyword><style face="normal" font="default" size="100%">Diagnostic Errors/adverse effects/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Drug Combinations</style></keyword><keyword><style face="normal" font="default" size="100%">Drug Prescriptions/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Drug Utilization/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Fever/diagnosis/drug therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Guideline Adherence</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Infant</style></keyword><keyword><style face="normal" font="default" size="100%">Logistic Models</style></keyword><keyword><style face="normal" font="default" size="100%">Malaria/*diagnosis/drug therapy/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Microscopy/standards</style></keyword><keyword><style face="normal" font="default" size="100%">Plasmodium falciparum/isolation &amp; purification</style></keyword><keyword><style face="normal" font="default" size="100%">Plasmodium vivax/isolation &amp; purification</style></keyword><keyword><style face="normal" font="default" size="100%">Primary Health Care/organization &amp; administration/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Prospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Sensitivity and Specificity</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2012</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jul 24</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0959-8138 (Print)&#xD;0959-8138</style></isbn><abstract><style face="normal" font="default" size="100%">OBJECTIVE: To assess the accuracy of malaria diagnosis and treatment at primary level clinics in Afghanistan. DESIGN: Prospective observational study. SETTING: 22 clinics in two Afghan provinces, one in the north (adjoining Tajikistan) and one in the east (adjoining Pakistan); areas with seasonal transmission of Plasmodium vivax and Plasmodium falciparum. PARTICIPANTS: 2357 patients of all ages enrolled if clinicians suspected malaria. INTERVENTIONS: Established (&gt;5 years) microscopy (12 clinics in east Afghanistan), newly established microscopy (five clinics in north Afghanistan), and no laboratory (five clinics in north Afghanistan). All clinics used the national malaria treatment guidelines. MAIN OUTCOME MEASURES: Proportion of patients positive and negative for malaria who received a malaria drug; sensitivity and specificity of clinic based diagnosis; prescriber&apos;s response to the result of the clinic slide; and proportion of patients positive and negative for malaria who were prescribed antibiotics. Outcomes were measured against a double read reference blood slide. RESULTS: In health centres using clinical diagnosis, although 413 of 414 patients were negative by the reference slide, 412 (99%) received a malaria drug and 47 (11%) received an antibiotic. In clinics using new microscopy, 37% (75/202) of patients who were negative by the reference slide received a malaria drug and 60% (103/202) received an antibiotic. In clinics using established microscopy, 50.8% (645/1269) of patients who were negative by the reference slide received a malaria drug and 27.0% (342/1269) received an antibiotic. Among the patients who tested positive for malaria, 94% (443/472) correctly received a malaria drug but only 1 of 6 cases of falciparum malaria was detected and appropriately treated. The specificity of established and new microscopy was 72.9% and 79.9%, respectively. In response to negative clinic slide results, malaria drugs were prescribed to 270/905 (28.8%) and 32/154 (21%) and antibiotics to 347/930 (37.3%) and 99/154 (64%) patients in established and new microscopy arms, respectively. Nurses were less likely to misprescribe than doctors. CONCLUSIONS: Despite a much lower incidence of malaria in Afghanistan than in Africa, fever was substantially misdiagnosed as malaria in this south Asian setting. Inaccuracy was attributable to false positive laboratory diagnoses of malaria and the clinicians&apos; disregard of negative slide results. Rare but potentially fatal cases of falciparum malaria were not detected, emphasising the potential role of rapid diagnostic tests. Microscopy increased the proportion of patients treated with antibiotics producing a trade-off between overtreatment with malaria drugs and probable overtreatment with antibiotics.</style></abstract><label><style face="normal" font="default" size="100%">Included by Loai</style></label><notes><style face="normal" font="default" size="100%">1756-1833&#xD;Leslie, Toby&#xD;Mikhail, Amy&#xD;Mayan, Ismail&#xD;Anwar, Mohammed&#xD;Bakhtash, Sayed&#xD;Nader, Mohammed&#xD;Chandler, Clare&#xD;Whitty, Christopher J M&#xD;Rowland, Mark&#xD;Journal Article&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;BMJ. 2012 Jul 24;345:e4389. doi: 10.1136/bmj.e4389.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.bmj.com/content/bmj/345/bmj.e4389.full.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC3404186 www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; and no other relationships or activities that could appear to have influenced the submitted work.</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1136/bmj.e4389</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2174</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2174</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Leslie, T.</style></author><author><style face="normal" font="default" size="100%">Rowland, M.</style></author><author><style face="normal" font="default" size="100%">Mikhail, A.</style></author><author><style face="normal" font="default" size="100%">Cundill, B.</style></author><author><style face="normal" font="default" size="100%">Willey, B.</style></author><author><style face="normal" font="default" size="100%">Alokozai, A.</style></author><author><style face="normal" font="default" size="100%">Mayan, I.</style></author><author><style face="normal" font="default" size="100%">Hasanzai, A.</style></author><author><style face="normal" font="default" size="100%">Baktash, S. H.</style></author><author><style face="normal" font="default" size="100%">Mohammed, N.</style></author><author><style face="normal" font="default" size="100%">Wood, M.</style></author><author><style face="normal" font="default" size="100%">Rahimi, H. U.</style></author><author><style face="normal" font="default" size="100%">Laurent, B.</style></author><author><style face="normal" font="default" size="100%">Buhler, C.</style></author><author><style face="normal" font="default" size="100%">Whitty, C. J. M.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">London School of Hygiene &amp; Tropical Medicine, London, WC1H 7HT, UK. toby.leslie1@gmail.com.&#xD;Health Protection and Research Organisation, Kabul, Afghanistan. toby.leslie1@gmail.com.&#xD;London School of Hygiene &amp; Tropical Medicine, London, WC1H 7HT, UK.&#xD;Health Protection and Research Organisation, Kabul, Afghanistan.&#xD;HealthNet-TPO, Kabul, Afghanistan.&#xD;Merlin, Kunduz, Afghanistan.&#xD;OR Diagnostics, Paris, France.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Use of malaria rapid diagnostic tests by community health workers in Afghanistan: cluster randomised trial</style></title><secondary-title><style face="normal" font="default" size="100%">BMC Med</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">BMC Med</style></full-title></periodical><pages><style face="normal" font="default" size="100%">124</style></pages><volume><style face="normal" font="default" size="100%">15</style></volume><number><style face="normal" font="default" size="100%">1</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Afghanistan</style></keyword><keyword><style face="normal" font="default" size="100%">Antimalarials/administration &amp; dosage/therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Artemisinins/therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Child, Preschool</style></keyword><keyword><style face="normal" font="default" size="100%">Chloroquine/therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">*Community Health Workers</style></keyword><keyword><style face="normal" font="default" size="100%">Diagnostic Tests, Routine</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Infant</style></keyword><keyword><style face="normal" font="default" size="100%">Infant, Newborn</style></keyword><keyword><style face="normal" font="default" size="100%">Malaria/*diagnosis/drug therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Malaria, Falciparum/drug therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Plasmodium vivax</style></keyword><keyword><style face="normal" font="default" size="100%">Trimethoprim, Sulfamethoxazole Drug Combination/therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">*Afghanistan</style></keyword><keyword><style face="normal" font="default" size="100%">*Cluster randomised trial</style></keyword><keyword><style face="normal" font="default" size="100%">*Community health worker</style></keyword><keyword><style face="normal" font="default" size="100%">*Malaria</style></keyword><keyword><style face="normal" font="default" size="100%">*Rapid diagnostic test</style></keyword><keyword><style face="normal" font="default" size="100%">Institutional Review Board, Ministry of Public Health, Kabul, Afghanistan (number</style></keyword><keyword><style face="normal" font="default" size="100%">98182) and the Research Ethics Committee of the London School of Hygiene &amp; Tropical</style></keyword><keyword><style face="normal" font="default" size="100%">Medicine (ref 5911). Patients gave written informed consent to participate in the</style></keyword><keyword><style face="normal" font="default" size="100%">study at enrolment. Community health workers gave written informed consent to</style></keyword><keyword><style face="normal" font="default" size="100%">participate following protocol training. COMPETING INTERESTS: The authors declare</style></keyword><keyword><style face="normal" font="default" size="100%">that they have no competing interests. PUBLISHER’S NOTE: Springer Nature remains</style></keyword><keyword><style face="normal" font="default" size="100%">neutral with regard to jurisdictional claims in published maps and institutional</style></keyword><keyword><style face="normal" font="default" size="100%">affiliations.</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jul 7</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1741-7015</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: The World Health Organisation (WHO) recommends parasitological diagnosis of malaria before treatment, but use of malaria rapid diagnostic tests (mRDTs) by community health workers (CHWs) has not been fully tested within health services in south and central Asia. mRDTs could allow CHWs to diagnose malaria accurately, improving treatment of febrile illness. METHODS: A cluster randomised trial in community health services was undertaken in Afghanistan. The primary outcome was the proportion of suspected malaria cases correctly treated for polymerase chain reaction (PCR)-confirmed malaria and PCR negative cases receiving no antimalarial drugs measured at the level of the patient. CHWs from 22 clusters (clinics) received standard training on clinical diagnosis and treatment of malaria; 11 clusters randomised to the intervention arm received additional training and were provided with mRDTs. CHWs enrolled cases of suspected malaria, and the mRDT results and treatments were compared to blind-read PCR diagnosis. RESULTS: In total, 256 CHWs enrolled 2400 patients with 2154 (89.8%) evaluated. In the intervention arm, 75.3% (828/1099) were treated appropriately vs. 17.5% (185/1055) in the control arm (cluster adjusted risk ratio: 3.72, 95% confidence interval 2.40-5.77; p &lt; 0.001). In the control arm, 85.9% (164/191) with confirmed Plasmodium vivax received chloroquine compared to 45.1% (70/155) in the intervention arm (p &lt; 0.001). Overuse of chloroquine in the control arm resulted in 87.6% (813/928) of those with no malaria (PCR negative) being treated vs. 10.0% (95/947) in the intervention arm, p &lt; 0.001. In the intervention arm, 71.4% (30/42) of patients with P. falciparum did not receive artemisinin-based combination therapy, partly because operational sensitivity of the RDTs was low (53.2%, 38.1-67.9). There was high concordance between recorded RDT result and CHW prescription decisions: 826/950 (87.0%) with a negative test were not prescribed an antimalarial. Co-trimoxazole was prescribed to 62.7% of malaria negative patients in the intervention arm and 15.0% in the control arm. CONCLUSIONS: While introducing mRDT reduced overuse of antimalarials, this action came with risks that need to be considered before use at scale: an appreciable proportion of malaria cases will be missed by those using current mRDTs. Higher sensitivity tests could be used to detect all cases. Overtreatment with antimalarial drugs in the control arm was replaced with increased antibiotic prescription in the intervention arm, resulting in a probable overuse of antibiotics. TRIAL REGISTRATION: ClinicalTrials.gov, NCT01403350 . Prospectively registered.</style></abstract><notes><style face="normal" font="default" size="100%">1741-7015&#xD;Leslie, Toby&#xD;Rowland, Mark&#xD;Mikhail, Amy&#xD;Cundill, Bonnie&#xD;Willey, Barbara&#xD;Alokozai, Asif&#xD;Mayan, Ismail&#xD;Hasanzai, Anwar&#xD;Baktash, Sayed Habibullah&#xD;Mohammed, Nader&#xD;Wood, Molly&#xD;Rahimi, Habib-U-Rahman&#xD;Laurent, Baptiste&#xD;Buhler, Cyril&#xD;Whitty, Christopher J M&#xD;Journal Article&#xD;Randomized Controlled Trial&#xD;BMC Med. 2017 Jul 7;15(1):124. doi: 10.1186/s12916-017-0891-8.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5501368/pdf/12916_2017_Article_891.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC5501368</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1186/s12916-017-0891-8</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2175</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2175</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Li, M.</style></author><author><style face="normal" font="default" size="100%">Brito, J. P.</style></author><author><style face="normal" font="default" size="100%">Vaccarella, S.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France.&#xD;Knowledge and Evaluation Research Unit in Endocrinology, Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, Minnesota, USA.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Long-Term Declines of Thyroid Cancer Mortality: An International Age-Period-Cohort Analysis</style></title><secondary-title><style face="normal" font="default" size="100%">Thyroid</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Thyroid</style></full-title></periodical><pages><style face="normal" font="default" size="100%">838-846</style></pages><volume><style face="normal" font="default" size="100%">30</style></volume><number><style face="normal" font="default" size="100%">6</style></number><keywords><keyword><style face="normal" font="default" size="100%">*age–period–cohort</style></keyword><keyword><style face="normal" font="default" size="100%">*mortality</style></keyword><keyword><style face="normal" font="default" size="100%">*thyroid cancer</style></keyword><keyword><style face="normal" font="default" size="100%">*trends</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2020</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jun</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1050-7256</style></isbn><abstract><style face="normal" font="default" size="100%">Background: Thyroid cancer (TC) incidence rates have been increasing in many countries, predominantly due to overdiagnosis. It is, however, not yet clear whether a true increase in exposure to risk factors might have also contributed to the TC epidemic. We assessed the TC mortality trends, which should not be affected by overdiagnosis, to disentangle the specific contribution of period and cohort effects. Methods: We analyzed long-term mortality data in 24 countries from 5 continents using age-period-cohort (APC) models. Nonidentifiability of the APC models was circumvented by integrating evidence of a consistent relationship between age and TC mortality, allowing to estimate period and cohort linear effects. Results: Substantial heterogeneity existed in the historical TC mortality rates across countries, but long-term rates declined over time in most of the countries, converging around a value of 0.5/100,000. The shape of the age-specific curves was consistently similar across countries and periods, resembling straight lines on the log-log scale, with the slopes ranging between 4.0 and 6.0. Both period and cohort effects showed long-term declines in most countries for both genders. In some countries, such as the United States, Canada, and Australia, substantial long-term declines by period were visible until the 1980s and 1990s, but then stabilized or increased slightly. Declining cohort effects were also seen in almost all countries, and were particularly pronounced in women from Switzerland, whereas stable cohort effects were recorded in South Africa. Although there were some indications of possible increasing risks of deaths among the youngest generations in some countries for both men and women, changes are too recent to be treated as unequivocal and estimates suffered from large statistical variability due to small numbers of deaths. Conclusions: Global long-term declines in TC mortality have been accompanied by downward trends in both period and cohort effects. Our results suggest lack of evidence of a possible major contribution of &quot;real&quot; risk factors in TC mortality, and indirectly confirm the main role of overdiagnosis in the epidemic of TC incidence.</style></abstract><label><style face="normal" font="default" size="100%">Included by Loai</style></label><notes><style face="normal" font="default" size="100%">1557-9077&#xD;Li, Mengmeng&#xD;Brito, Juan P&#xD;Vaccarella, Salvatore&#xD;Journal Article&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Thyroid. 2020 Jun;30(6):838-846. doi: 10.1089/thy.2019.0684. Epub 2020 Mar 2.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.liebertpub.com/doi/pdfplus/10.1089/thy.2019.0684</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1089/thy.2019.0684</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2176</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2176</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Li, M.</style></author><author><style face="normal" font="default" size="100%">Zheng, R.</style></author><author><style face="normal" font="default" size="100%">Dal Maso, L.</style></author><author><style face="normal" font="default" size="100%">Zhang, S.</style></author><author><style face="normal" font="default" size="100%">Wei, W.</style></author><author><style face="normal" font="default" size="100%">Vaccarella, S.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Cancer Prevention, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon 69372, France.&#xD;National Cancer Center/ Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.&#xD;Cancer Epidemiology Unit, Centro di Riferimento Oncologico di Aviano, Istituto di Ricovero e Cura a Carattere Scientifico, Aviano, Italy.&#xD;Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon 69372, France. Electronic address: vaccarellas@iarc.fr.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Mapping overdiagnosis of thyroid cancer in China</style></title><secondary-title><style face="normal" font="default" size="100%">Lancet Diabetes Endocrinol</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Lancet Diabetes Endocrinol</style></full-title></periodical><pages><style face="normal" font="default" size="100%">330-332</style></pages><volume><style face="normal" font="default" size="100%">9</style></volume><number><style face="normal" font="default" size="100%">6</style></number><dates><year><style face="normal" font="default" size="100%">2021</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jun</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">2213-8587</style></isbn><notes><style face="normal" font="default" size="100%">2213-8595&#xD;Li, Mengmeng&#xD;Zheng, Rongshou&#xD;Dal Maso, Luigino&#xD;Zhang, Siwei&#xD;Wei, Wenqiang&#xD;Vaccarella, Salvatore&#xD;Letter&#xD;England&#xD;Lancet Diabetes Endocrinol. 2021 Jun;9(6):330-332. doi: 10.1016/S2213-8587(21)00083-8. Epub 2021 Apr 20.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.sciencedirect.com/science/article/abs/pii/S2213858721000838?via%3Dihub</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1016/s2213-8587(21)00083-8</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2177</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2177</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Li, R.</style></author><author><style face="normal" font="default" size="100%">Wang, Y.</style></author><author><style face="normal" font="default" size="100%">Du, L.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Health Care and Prevention, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China.&#xD;Institute of Cancer and Basic Medicine (IBMC), Chinese Academy of Sciences, Hangzhou, China.</style></auth-address><titles><title><style face="normal" font="default" size="100%">A rapidly increasing trend of thyroid cancer incidence in selected East Asian countries: Joinpoint regression and age-period-cohort analyses</style></title><secondary-title><style face="normal" font="default" size="100%">Gland Surg</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Gland Surg</style></full-title></periodical><pages><style face="normal" font="default" size="100%">968-984</style></pages><volume><style face="normal" font="default" size="100%">9</style></volume><number><style face="normal" font="default" size="100%">4</style></number><keywords><keyword><style face="normal" font="default" size="100%">Joinpoint regression</style></keyword><keyword><style face="normal" font="default" size="100%">Thyroid cancer (TC)</style></keyword><keyword><style face="normal" font="default" size="100%">age-period-cohort model</style></keyword><keyword><style face="normal" font="default" size="100%">incidence</style></keyword><keyword><style face="normal" font="default" size="100%">mortality</style></keyword><keyword><style face="normal" font="default" size="100%">(available at http://dx.doi.org/10.21037/gs-20-97). The authors have no conflicts of</style></keyword><keyword><style face="normal" font="default" size="100%">interest to declare.</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2020</style></year><pub-dates><date><style face="normal" font="default" size="100%">Aug</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">2227-684X (Print)&#xD;2227-684x</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: This study described the incidence and mortality trends and analyzed age-period-cohort effects on incidences in China, Japan, and Korea. METHODS: Data were extracted from the Cancer Incidence in Five Continents series and the World Health Organization Cancer Mortality Database, and the age-standardized incidence and mortality rates by Segi&apos;s world population were calculated. Joinpoint regression analysis was used to evaluate the time trend of age-standardized incidence and mortality rates and the age-period-cohort model with intrinsic estimator was applied for estimating the effects of age, period, and cohort on thyroid cancer (TC) incidence in individuals between 20 and 84 years of age. RESULTS: An increasing trend in TC incidence rates was observed among males from China (10.3%), Japan (4.7%), and Korea (20.8%) and among females from China (9.4%), Japan (3.5%), and Korea (20.5%). TC incidence rates in females were much higher than those in males. A downward trend of TC mortality rates was observed, especially in both sexes of Japan and Chinese females. The slope of the age effect curve peaked at an earlier age in females than males in Japan and Korea. A strong period effect and remarkedly increasing rate ratios were observed in all regions and for both sexes. The cohort effect had a declining tendency on TC incidence in males and females in these areas. CONCLUSIONS: The rapidly upward incidence trend and strong period effect suggest that overdiagnosis caused by higher diagnostic intensity might be an explanation for the upward trend, and some environmental risk factor exposures are also not excluded. In addition, the discrepant trends of TC incidence and mortality reveal the need to identify the few high-risk patients who needed further treatment from those patients who may not need treatment.</style></abstract><notes><style face="normal" font="default" size="100%">2227-8575&#xD;Li, Runhua&#xD;Wang, Youqing&#xD;Du, Lingbin&#xD;Journal Article&#xD;Gland Surg. 2020 Aug;9(4):968-984. doi: 10.21037/gs-20-97.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475344/pdf/gs-09-04-968.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC7475344</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.21037/gs-20-97</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2178</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2178</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Li, W. Q.</style></author><author><style face="normal" font="default" size="100%">Li, R.</style></author><author><style face="normal" font="default" size="100%">Liu, P. F.</style></author><author><style face="normal" font="default" size="100%">Huang, Y. B.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Project Office(Li WQ), Department of Utralsonography(Li R), Tianjin Women&apos;s and Children&apos;s Health Center, Tianjin 300070, China; Department of Breast Imaging(Liu PF), Department of Epidemiology and Biostatistics(Huang YB), Cancer Institute and Hospital, Tianjin Medical University, Tianjin 300060, China.</style></auth-address><titles><title><style face="normal" font="default" size="100%">[Discussion of breast cancer screening model in China]</style></title><secondary-title><style face="normal" font="default" size="100%">Zhonghua Liu Xing Bing Xue Za Zhi</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Zhonghua Liu Xing Bing Xue Za Zhi</style></full-title></periodical><pages><style face="normal" font="default" size="100%">1039-43</style></pages><volume><style face="normal" font="default" size="100%">37</style></volume><number><style face="normal" font="default" size="100%">7</style></number><keywords><keyword><style face="normal" font="default" size="100%">Breast Neoplasms/*diagnostic imaging</style></keyword><keyword><style face="normal" font="default" size="100%">China</style></keyword><keyword><style face="normal" font="default" size="100%">Early Detection of Cancer/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">*Mammography/standards</style></keyword><keyword><style face="normal" font="default" size="100%">Mass Screening/*methods</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jul</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0254-6450 (Print)&#xD;0254-6450</style></isbn><abstract><style face="normal" font="default" size="100%">Cancer screening has been considered as double-edged sword with both advantages and disadvantages. For decades, there have been strong interests in screening strategies for the early detection of cancers to reduce the mortality, especially breast X-ray(mammography)screening. However, several evidences also suggested that the benefit of reduction of breast-cancer mortality with mammography might become a problem due to the repeat mammography, subsequent biopsies, and overdiagnosis. And different screening strategies with different models, different intervals, and different target populations also incurred debates. After systematical analysis and discussion, we suggested to focus on high-risk population, improve the accuracy of screening technique, conduct the informed consent of participants, and explore individual screening mode in the screening of breast cancer.</style></abstract><label><style face="normal" font="default" size="100%">Included by Ray</style></label><notes><style face="normal" font="default" size="100%">Li, W Q&#xD;Li, R&#xD;Liu, P F&#xD;Huang, Y B&#xD;Journal Article&#xD;China&#xD;Zhonghua Liu Xing Bing Xue Za Zhi. 2016 Jul;37(7):1039-43. doi: 10.3760/cma.j.issn.0254-6450.2016.07.026.</style></notes><urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.3760/cma.j.issn.0254-6450.2016.07.026</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2179</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2179</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Li, Zhang</style></author><author><style face="normal" font="default" size="100%">Weijie, S. U. N.</style></author><author><style face="normal" font="default" size="100%">Ying, G. A. O.</style></author><author><style face="normal" font="default" size="100%">Sainan, Z. H. U.</style></author><author><style face="normal" font="default" size="100%">Youyuan, Huang</style></author><author><style face="normal" font="default" size="100%">Yang, Zhang</style></author><author><style face="normal" font="default" size="100%">Huixia, Yang</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">One-step or two-step screening for thyroid diseases during early pregnancy: which is better?</style></title><secondary-title><style face="normal" font="default" size="100%">Chinese Journal of Perinatal Medicine</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Chinese Journal of Perinatal Medicine</style></full-title></periodical><pages><style face="normal" font="default" size="100%">182-187</style></pages><number><style face="normal" font="default" size="100%">12</style></number><dates><year><style face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style face="normal" font="default" size="100%">2016/00</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1007-9408</style></isbn><abstract><style face="normal" font="default" size="100%">Objective To investigate the appropriate screening method for thyroid diseases during early pregnancy.Methods We collected information of 4 044 pregnant women who attended to the Department of Obstetrics and Gynecology of Peking University First Hospital from September 1,2013 to September 30,2014 for antenatal care and underwent one step screening for thyroid diseases in first trimester,which meant blood test for thyroid stimulating hormone(TSH),free thyroxine(FT4) and thyroid peroxidase antibody(TPOAb) at the same time.Simulation analysis was performed on these 4 044 women with twostep screening (TSH first and then FT4 and TPOAb if TSH was abnormal).The incidence,missed diagnosis rate,costs of screening,and outcomes of the missed diagnosed cases of women with thyroid diseases were compared between one-step and two-step screening based on the cutoff value determined by American Thyroid Association (ATA) or our hospital (0.23-4.08 mU/L).The positivel rate of TPOAb was compared among the three groups classified according to TSH value (≥ 0.1-＜ 2.5 mU/L,≥ 2.5-＜ 4.08 mU/L and ≥ 4.08 mU/L).T-test,Chi-square test or Fisher&amp;#039;s exact test were applied for statistical analysis.Results When the cutoff value of TSH was set at ≥ 0.1-＜ 2.5 mU/L (ATA recommendation),7.9％ (320/4 044) of the women required medical treatment.It was significantly higher than 3.2％ (129/4 044),which was obtained when the normal reference value of TSH was set based on data from our hospital.The positive rates of TPOAb were 7.2％(214/2 976),13.9％(103/777) and 28.6％(55/192) for TSH ≥ 0.1-＜ 2.5,≥ 2.5-＜ 4.08 mU/L and ≥ 4.08 mU/L group,respectively.When we set the OR value for TOPAb as one in the TSH ≥ 0.1-＜ 2.5 mU/L group,the OR(95％C1)s of the other two groups were 1.972(1.537-2.532) and 5.181(3.679-7.297).If two-step screening protocol and ATA recommendations were applied,0.7％ (27/4 044) of women who needed treatment would be missed.However,312 480 yuan (RMB) would be saved compared with one-step screening (77.27 yuan per person).When the hospitalized reference value was applied,1.1％(45/4 044) of women would not be treated and 384 720 yuan would be saved (95.13 yuan per person) compared to one-step screening.For those missed diagnosed cases,no more adverse pregnant outcomes (all P＞0.05),including fetal distress,gestational diabetes mellitus,preterm birth,fetal growth restriction,oligohydroamnios,polyhydroanmios,fetal death,gestational hypertension with pre-eclampsia,placental abruptio and neonatal asphyxia were reported although no standard treatment had been provided,no matter ATA recommendation or unique reference in our hospital was adopted.Conclusions We recommend the two-step method for thyroid function screening during early pregnancy.For the purpose of cost-saving,reduction of missed diagnosis rate and avoidance of overtreatment,the management protocol should be individualized for those women with TSH value between 2.5 mU/L and the normal reference value of our hospital during pregnancy.</style></abstract><label><style face="normal" font="default" size="100%">Included by Loai</style></label><urls><related-urls><url><style face="normal" font="default" size="100%">http://dx.doi.org/10.3760/cma.j.issn.1007-9408.2016.03.006</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2180</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2180</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Lortet-Tieulent, J.</style></author><author><style face="normal" font="default" size="100%">Franceschi, S.</style></author><author><style face="normal" font="default" size="100%">Dal Maso, L.</style></author><author><style face="normal" font="default" size="100%">Vaccarella, S.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Infections and Cancer Epidemiology Group, International Agency for Research on Cancer, Lyon, France.&#xD;Cancer Epidemiology Unit, CRO Aviano National Cancer Institute IRCCS, Aviano, Italy.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Thyroid cancer &quot;epidemic&quot; also occurs in low- and middle-income countries</style></title><secondary-title><style face="normal" font="default" size="100%">Int J Cancer</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Int J Cancer</style></full-title></periodical><pages><style face="normal" font="default" size="100%">2082-2087</style></pages><volume><style face="normal" font="default" size="100%">144</style></volume><number><style face="normal" font="default" size="100%">9</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Diagnostic Imaging/methods</style></keyword><keyword><style face="normal" font="default" size="100%">Economic Status/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Incidence</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Medical Overuse/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Sex Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Thyroid Neoplasms/diagnosis/*epidemiology/*mortality</style></keyword><keyword><style face="normal" font="default" size="100%">Ultrasonography/methods</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword><keyword><style face="normal" font="default" size="100%">*epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">*incidence</style></keyword><keyword><style face="normal" font="default" size="100%">*medical overuse</style></keyword><keyword><style face="normal" font="default" size="100%">*mortality</style></keyword><keyword><style face="normal" font="default" size="100%">*thyroid neoplasm</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style face="normal" font="default" size="100%">May 1</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0020-7136 (Print)&#xD;0020-7136</style></isbn><abstract><style face="normal" font="default" size="100%">Thyroid cancer incidence varies greatly between and within high-income countries (HICs), and overdiagnosis likely plays a major role in these differences. Yet, little is known about the situation in low- and middle-income countries (LMICs). We compare up-to-date thyroid cancer incidence and mortality at national and subnational levels. 599,851 thyroid cancer cases in subjects aged 20-74 reported in Cancer Incidence in Five Continents volume XI from 55 countries with at least 0.5 million population, aged 20-74 years, covered by population-based cancer registration, and 22,179 deaths from the WHO Mortality Database for 36 of the selected countries, over 2008-2012, were included. Age-standardized rates were computed. National incidence rates varied 50-fold. Rates were 4 times higher among women than men, with similar patterns between countries. The highest rates (&gt;25 cases per 100,000 women) were observed in the Republic of Korea, Israel, Canada, the United States, Italy, France, and LMICs such as Turkey, Costa Rica, Brazil, and Ecuador. Incidence rates were low (&lt;8) in a few HICs (the Netherlands, the United Kingdom, and Denmark) and lowest (3-4) in some LMICs (such as Uganda and India). Within-country incidence rates varied up to 45-fold, with the largest differences recorded between rural and urban areas in Canada (HIC) and Brazil, India, and China (LMICs). National mortality rates were very low (&lt;2) in all countries and in both sexes, and highest in LMICs. The very high thyroid cancer incidence and low mortality rates in some LMICs also strongly suggest a major role of overdiagnosis in these countries.</style></abstract><notes><style face="normal" font="default" size="100%">1097-0215&#xD;Lortet-Tieulent, Joannie&#xD;Orcid: 0000-0002-8816-7475&#xD;Franceschi, Silvia&#xD;Dal Maso, Luigino&#xD;Orcid: 0000-0001-6163-200x&#xD;Vaccarella, Salvatore&#xD;Journal Article&#xD;Int J Cancer. 2019 May 1;144(9):2082-2087. doi: 10.1002/ijc.31884. Epub 2018 Nov 5.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587710/pdf/IJC-144-2082.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC6587710</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1002/ijc.31884</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2181</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2181</key></foreign-keys><ref-type name="Generic">13</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">M, Faramarzi</style></author><author><style face="normal" font="default" size="100%">S, Esmaeelzade</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">[Identification and prediction of overdiagnosis of dystocia]</style></title></titles><pages><style face="normal" font="default" size="100%">66-71</style></pages><volume><style face="normal" font="default" size="100%">7</style></volume><keywords><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Cesarean Section/statistics &amp;amp</style></keyword><keyword><style face="normal" font="default" size="100%">amp</style></keyword><keyword><style face="normal" font="default" size="100%">numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Labor, Obstetric</style></keyword><keyword><style face="normal" font="default" size="100%">Oxytocin</style></keyword><keyword><style face="normal" font="default" size="100%">Parity</style></keyword><keyword><style face="normal" font="default" size="100%">Fetal Macrosomia</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2005</style></year><pub-dates><date><style face="normal" font="default" size="100%">2005/00</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1562-4765</style></isbn><abstract><style face="normal" font="default" size="100%">The Failure progress of labor is the second indication for cesarean delivery after repeat section. It is generally agreed that dystocia leading ro cesarean delivery is overdiagnosed in the world. Variability in the criteria for diagnosis is major determinant of the increase in cesarean deliveries for dystocia. This study was identified dystocia with comparison with the criteria obstetrics standards and determined the cause&amp;#039;s effects of incorrect diagnosis. A descriptive analytic case control study was performed on 1212 women who experienced cesarean delivery in Yahyanegad hospital of Babol a city in North of Iran during 2004. We compared criteria of diagnosis of dystocia among 248 women whom were operated with dystocia with criteria that were proposed by American college of obstetricians and gynecologist. Also, we compared 118 women with correct diagnosis with 130 women with incorrect diagnosis to identify causes of incorrect diagnosis. Statistical test chi [2], t-Test and multiple logistic regressions were used to analysis of data. Dystocia was diagnosed during latent phase, active phase and second stage respectively:%64.9,%29.8 and%5.3. The strongest predictor of incorrect diagnosis of dystocia was the lack of administration of oxytocine. Other independent risk factors for failure of labor to progress, using a multivariable analysis, were: performing of cesarean in morning [OR=2.8%95 CI 2.1 -3.5], performing of cesarean in afternoon [OR = 2.6%95 CI 1.3-3], nulliparity [OR=2.1%95 CI 1.7- 3.2], incorrect clinical estimation of fetal macrosomia [OR= 2.3%95 CI 1.5-2.9].%50 accuracy of failure of labor progress according to obstetrics standards implies that there is overdiagnosis in the dystocia. This study proposes that obstetricans should be managed conservatively protract dilatation in the patients to prevent of incorrect diagnosed dystocia cesarean. Active management of labor with accurate administration of oxytocine and amniotomy is another strategy that may be help to decrease cesarean with diagnostic dystocia</style></abstract><urls><related-urls><url><style face="normal" font="default" size="100%">https://pesquisa.bvsalud.org/gim/resource/en/emr-71863</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2182</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2182</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Mackinney-Novelo, I.</style></author><author><style face="normal" font="default" size="100%">Barahona-Garrido, J.</style></author><author><style face="normal" font="default" size="100%">Castillo-Albarran, F.</style></author><author><style face="normal" font="default" size="100%">Santiago-Hernández, J. J.</style></author><author><style face="normal" font="default" size="100%">Méndez-Sánchez, N.</style></author><author><style face="normal" font="default" size="100%">Uribe, M.</style></author><author><style face="normal" font="default" size="100%">Chávez-Tapia, N.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Obesity and Digestive Diseases Unit, Medica Sur Clinic &amp; Foundation, Mexico City, Mexico.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Clinical course and management of acute hepatitis A infection in adults</style></title><secondary-title><style face="normal" font="default" size="100%">Ann Hepatol</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Ann Hepatol</style></full-title></periodical><pages><style face="normal" font="default" size="100%">652-7</style></pages><volume><style face="normal" font="default" size="100%">11</style></volume><number><style face="normal" font="default" size="100%">5</style></number><keywords><keyword><style face="normal" font="default" size="100%">Acute Disease</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Anti-Bacterial Agents/therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Antiviral Agents/*therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Biomarkers/blood</style></keyword><keyword><style face="normal" font="default" size="100%">Disease Progression</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Guatemala/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Hepatitis A/blood/diagnosis/*drug therapy/mortality</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Liver Failure, Acute/drug therapy/mortality/virology</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mexico/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Predictive Value of Tests</style></keyword><keyword><style face="normal" font="default" size="100%">Retrospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Assessment</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Time Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Treatment Outcome</style></keyword><keyword><style face="normal" font="default" size="100%">Unnecessary Procedures</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2012</style></year><pub-dates><date><style face="normal" font="default" size="100%">Sep-Oct</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1665-2681 (Print)&#xD;1665-2681</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: Hepatitis A is the most common type of viral hepatitis in Mexico. The change of hepatitis A epidemiology in Mexico from high to intermediate endemicity leads to increasing susceptible adults for severe illness. OBJECTIVE: To describe the clinical characteristics and hospital outcome of adult patients with acute hepatitis A infection, and determine risk factor for mortality. MATERIAL AND METHODS: This is a retrospective observational, multicentre study in Mexico City and in Guatemala City. All inhospital patients were followed until discharge or death. Risk factors for death/acute liver failure were identified. RESULTS: Forty seven patients were analyzed, sixty percent were male, the prodrome phase was from 3 to 30 days. The three most common symptoms were fever, malaise and jaundice, with 87%, 74% and 62% respectively. The incidence of patients who were treated with antibiotics before hospital admission was up to 34%. Unnecessary imaging studies and out of guidelines drugs were used. Presence of encephalopathy, leukocytes &gt; 19,000/mL, blood urea nitrogen &gt; 36 mg/dL, creatinine &gt; 2 mg/dL, albumin &lt; 2.5 mg/dL and total bilirubin &gt; 9.6 mg/dL, are predictors of mortality. Serum creatinine &gt; 2 mg/dL has the best sensibility and specificity for predicting fulminant hepatitis/death. CONCLUSION: Acute hepatitis A infection in adults is associated some unnecessary diagnostic and therapeutic approach. Could be associated with fulminant hepatitis, and a creatinine value &gt; 2 mg/dL is the best predictor for fulminant hepatitis and death.</style></abstract><label><style face="normal" font="default" size="100%">Included by Morty</style></label><notes><style face="normal" font="default" size="100%">Mackinney-Novelo, Ileana&#xD;Barahona-Garrido, Josué&#xD;Castillo-Albarran, Fátima&#xD;Santiago-Hernández, Jean J&#xD;Méndez-Sánchez, Nahum&#xD;Uribe, Misael&#xD;Chávez-Tapia, Norberto&#xD;Journal Article&#xD;Multicenter Study&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Mexico&#xD;Ann Hepatol. 2012 Sep-Oct;11(5):652-7.</style></notes><urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2183</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2183</key></foreign-keys><ref-type name="Generic">13</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Maha Mohammed, Al Bayati</style></author><author><style face="normal" font="default" size="100%">Fadia Jassim, Al Izzi</style></author><author><style face="normal" font="default" size="100%">Rihab, Abdel Lateef</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Diagnosis of premature rupture of fetal membranes by identification of vaginal fluid urea and creatinine</style></title></titles><pages><style face="normal" font="default" size="100%">537-542</style></pages><volume><style face="normal" font="default" size="100%">14</style></volume><keywords><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Women</style></keyword><keyword><style face="normal" font="default" size="100%">Amniotic Fluid</style></keyword><keyword><style face="normal" font="default" size="100%">Urea</style></keyword><keyword><style face="normal" font="default" size="100%">Creatinine</style></keyword><keyword><style face="normal" font="default" size="100%">Pregnant Women</style></keyword><keyword><style face="normal" font="default" size="100%">Ultrasonography</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style face="normal" font="default" size="100%">2015/00</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1608-8360</style></isbn><abstract><style face="normal" font="default" size="100%">Background: Premature rupture of fetal membrane is one of the most common and controversial problem facing the obstetric clinician. Its Correct diagnosis has great importance because failure of diagnosis can lead to unwanted obstetric complications or over diagnosis can lead to unnecessary intervention&#xD;Objective: To evaluate the reliability of vaginal fluid urea and creatinine for the diagnosis of premature rupture of membrane&#xD;Patients and Methods: This study had been conducted in AL-Yarmouk Teaching Hospital, Department of Obstetrics and Gynecology. In this study, 105 pregnant women presented between 24-41 weeks of gestation were included, three groups were considered in this cohort, thirty five pregnant women with confirmed premature rupture of membrane [group A], thirty five pregnant women with suspected premature rupture of membranes[group B],and thirty five healthy pregnant women considered as control group [group C]. All patients underwent speculum examination for amniotic fluid pooling, nitrazine paper test, measurement of urea and creatinine in vaginal wash fluid sample, ultrasonographic examination for gestational age determination and amniotic fluid index calculation, and then the patients were followed up until delivery&#xD;Result: There was significant differences in the mean vaginal wash fluid urea and creatinine concentrations among the three groups [P &amp;lt; 0.001], being higher in group A than the other two groups. The gestational age at delivery and time interval between sampling and delivery was significantly shorter among patients in group A than group B and group C&#xD;Conclusion: Vaginal wash fluid urea and creatinine determination for the diagnosis of premature rupture of membrane in our study reported a comparable result in the sensitivity and specificity to other worldwide results</style></abstract><urls><related-urls><url><style face="normal" font="default" size="100%">https://pesquisa.bvsalud.org/gim/resource/en/emr-177715</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2184</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2184</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Mamova, A.</style></author><author><style face="normal" font="default" size="100%">Mikolasova, G.</style></author><author><style face="normal" font="default" size="100%">Krčméry, V.</style></author><author><style face="normal" font="default" size="100%">Mulera, M.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">PhD programme of St. Elisabeth University, Bratislava, Slovakia.&#xD;St. Ladislav Bathyani Clinic, Eldoret, Kenya.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Misdiagnosing of malaria as RTI decreased after introduction of RDTs in rural areas of Kenya</style></title><secondary-title><style face="normal" font="default" size="100%">Neuro Endocrinol Lett</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Neuro Endocrinol Lett</style></full-title></periodical><pages><style face="normal" font="default" size="100%">27-29</style></pages><volume><style face="normal" font="default" size="100%">38</style></volume><number><style face="normal" font="default" size="100%">Suppl1</style></number><keywords><keyword><style face="normal" font="default" size="100%">Diagnostic Errors/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">*Diagnostic Tests, Routine</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Incidence</style></keyword><keyword><style face="normal" font="default" size="100%">Kenya/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Malaria/*diagnosis/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">*Point-of-Care Testing</style></keyword><keyword><style face="normal" font="default" size="100%">Respiratory Tract Infections/*diagnosis/epidemiology</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style face="normal" font="default" size="100%">Nov</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0172-780X (Print)&#xD;0172-780x</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: Clinical presentation of malaria is highly variable and can be mistaken for number of other diseases, including respiratory tract diseases, which are associated with significant morbidity and mortality. However, presumptive management of fever as malaria can result in significant overdiagnosis, even in high-risk areas. Quality microscopy services for the diagnosis of malaria are not widely available in rural areas of Sub-Saharan Africa as well as in substandard conditions of low-income settings and the accuracy of microscopy is usually poor. MATERIAL AND METHODS: The aim of the study was to determine how introduction of RDTs influenced diagnostics of malaria in high risk area of Eldoret, Kenya. Documentation of every patient was screened for data of current disease and diagnostic tools used. In patients with suspected malaria, either microscopy, or RDT or both were done to confirm the diagnosis. RESULTS: Initially, incidence of malaria was very high, about 50-70% of all visits in OPD due to any infectious condition. In 2010, when rapid diagnostic tests became available in Eldoret, decrease in incidence of malaria from 49% (2010) to 29% (2011) and further to 5.3% (2016) was noted. At the same time, increased incidence of upper and especially lower respiratory tract infections was noted. CONCLUSION: Results suggest that upper and lower respiratory tract infections were formerly diagnosed and treated as malaria. Other contributing factors, such as improvement of infrastructure and malaria preventive and treatment programs also play a role in decreasing malaria incidence in rural areas of Kenya, however, RDTs play a key role in proper diagnostics of malaria.</style></abstract><label><style face="normal" font="default" size="100%">Included by Ray</style></label><notes><style face="normal" font="default" size="100%">Mamova, Alexandra&#xD;Mikolasova, Gertruda&#xD;Krčméry, Vladimír&#xD;Mulera, Michaela&#xD;Journal Article&#xD;Sweden&#xD;Neuro Endocrinol Lett. 2017 Nov;38(Suppl1):27-29.</style></notes><urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">https://europepmc.org/article/med/29200251</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2185</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2185</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Manguin, S.</style></author><author><style face="normal" font="default" size="100%">Foumane, V.</style></author><author><style face="normal" font="default" size="100%">Besnard, P.</style></author><author><style face="normal" font="default" size="100%">Fortes, F.</style></author><author><style face="normal" font="default" size="100%">Carnevale, P.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Institut de Recherche pour le Développement France (IRD), Laboratoire d&apos;Immuno-Physiopathologie Moléculaire Comparée, UMR-MD3, Montpellier, France. Electronic address: sylvie.manguin@ird.fr.&#xD;Organisation de Coordination pour la lutte contre les Endémies en Afrique Centrale (OCEAC), Yaoundé, Cameroon. Electronic address: vfoumane@yahoo.fr.&#xD;SUBSEA7, SONAMET Malaria Control Programme, Lobito, Angola. Electronic address: patrick.besnard@subsea7.com.&#xD;National Malaria Control Programme, Luanda, Angola. Electronic address: filomenofortes@gmail.com.&#xD;Portiragnes, France. Electronic address: pjcarnevale2001@yahoo.fr.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Malaria overdiagnosis and subsequent overconsumption of antimalarial drugs in Angola: Consequences and effects on human health</style></title><secondary-title><style face="normal" font="default" size="100%">Acta Trop</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Acta Trop</style></full-title></periodical><pages><style face="normal" font="default" size="100%">58-63</style></pages><volume><style face="normal" font="default" size="100%">171</style></volume><keywords><keyword><style face="normal" font="default" size="100%">Angola/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Antimalarials/administration &amp; dosage/*therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Artemether, Lumefantrine Drug Combination</style></keyword><keyword><style face="normal" font="default" size="100%">Artemisinins/administration &amp; dosage/*therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Child, Preschool</style></keyword><keyword><style face="normal" font="default" size="100%">Drug Combinations</style></keyword><keyword><style face="normal" font="default" size="100%">Drug Utilization</style></keyword><keyword><style face="normal" font="default" size="100%">Ethanolamines/administration &amp; dosage/*therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Fluorenes/administration &amp; dosage/*therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Malaria/*diagnosis/*drug therapy/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Medical Overuse</style></keyword><keyword><style face="normal" font="default" size="100%">Reproducibility of Results</style></keyword><keyword><style face="normal" font="default" size="100%">Seasons</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Angola</style></keyword><keyword><style face="normal" font="default" size="100%">Antimalarial drugs</style></keyword><keyword><style face="normal" font="default" size="100%">Malaria cases</style></keyword><keyword><style face="normal" font="default" size="100%">Overdiagnosis</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jul</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0001-706x</style></isbn><abstract><style face="normal" font="default" size="100%">Microscopic blood smear examinations done in health centers of Angola demonstrated a large overdiagnosis of malaria cases with an average rate of errors as high as 85%. Overall 83% of patients who received Coartem(®) had an inappropriate treatment. Overestimated malaria diagnosis was noticed even when specific symptoms were part of the clinical observation, antimalarial treatments being subsequently given. Then, malaria overdiagnosis has three main consequences, (i) the lack of data reliability is of great concern, impeding epidemiological records and evaluation of the actual influence of operations as scheduled by the National Malaria Control Programme; (ii) the large misuse of antimalarial drug can increase the selective pressure for resistant strain and can make a false consideration of drug resistant P. falciparum crisis; and (iii) the need of strengthening national health centers in term of human, with training in microscopy, and equipment resources to improve malaria diagnosis with a large scale use of rapid diagnostic tests associated with thick blood smears, backed up by a &quot;quality control&quot; developed by the national health authorities. Monitoring of malaria cases was done in three Angolan health centers of Alto Liro (Lobito town) and neighbor villages of Cambambi and Asseque (Benguéla Province) to evaluate the real burden of malaria. Carriers of Plasmodium among patients of newly-borne to 14 years old, with or without fever, were analyzed and compared to presumptive malaria cases diagnosed in these health centers. Presumptive malaria cases were diagnosed six times more than the positive thick blood smears done on the same children. In Alto Liro health center, the percentage of diagnosis error reached 98%, while in Cambambi and Asseque it was of 79% and 78% respectively. The percentage of confirmed malaria cases was significantly higher during the dry (20.2%) than the rainy (13.2%) season. These observations in three peripheral health centers confirmed what has already been noticed in other malaria endemic regions, and highlight the need for an accurate evaluation of the Malaria control programme implemented in Angola.</style></abstract><notes><style face="normal" font="default" size="100%">1873-6254&#xD;Manguin, Sylvie&#xD;Foumane, Vincent&#xD;Besnard, Patrick&#xD;Fortes, Filomeno&#xD;Carnevale, Pierre&#xD;Journal Article&#xD;Netherlands&#xD;Acta Trop. 2017 Jul;171:58-63. doi: 10.1016/j.actatropica.2017.03.022. Epub 2017 Mar 27.</style></notes><urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1016/j.actatropica.2017.03.022</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2186</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2186</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Marques, Elvira Ferreira</style></author><author><style face="normal" font="default" size="100%">Medeiros, Maria Luiza Leite de</style></author><author><style face="normal" font="default" size="100%">Souza, Juliana Alves de</style></author><author><style face="normal" font="default" size="100%">Mendonça, Maira Coltrone</style></author><author><style face="normal" font="default" size="100%">Bitencourt, Almir Galvão Vieira</style></author><author><style face="normal" font="default" size="100%">Chojniak, Rubens</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Indicações de ressonância magnética das mamas em um centro de referência em oncologia</style></title><secondary-title><style face="normal" font="default" size="100%">Radiol. bras</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Radiol. bras</style></full-title></periodical><pages><style face="normal" font="default" size="100%">363-366</style></pages><volume><style face="normal" font="default" size="100%">44</style></volume><number><style face="normal" font="default" size="100%">6</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Breast Neoplasms</style></keyword><keyword><style face="normal" font="default" size="100%">Early Detection of Cancer</style></keyword><keyword><style face="normal" font="default" size="100%">Magnetic Resonance Imaging</style></keyword><keyword><style face="normal" font="default" size="100%">Mammography</style></keyword><keyword><style face="normal" font="default" size="100%">Ultrasonography, Mammary</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2011</style></year><pub-dates><date><style face="normal" font="default" size="100%">2011/12</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0100-3984</style></isbn><abstract><style face="normal" font="default" size="100%">OBJETIVO: Avaliar e discutir as indicações de ressonância magnética das mamas em um centro de referência oncológico. MATERIAIS E MÉTODOS: Estudo retrospectivo, aprovado pelo Comitê de Ética e Pesquisa da instituição, conduzido através da revisão de prontuários e laudos médicos. Foram incluídos todos os exames de ressonância magnética das mamas realizados no período de julho de 2008 a julho de 2009 (n = 529). RESULTADOS: A idade média das pacientes foi de 49 anos, variando de 17 a 86 anos. História familiar de câncer de mama e/ou ovário esteve presente em 162 pacientes (30,6 por cento). As indicações mais comuns de ressonância magnética das mamas foram esclarecimento de achados inconclusivos na mamografia e/ou ultrassom (48,8 por cento), avaliação de recorrência tumoral/cicatriz cirúrgica (15,1 por cento), estadiamento/planejamento cirúrgico (11,7 por cento) e rastreamento de pacientes de alto risco (8,5 por cento). CONCLUSÃO: Apesar de achados inconclusivos nos exames convencionais serem a indicação mais comum de ressonância magnética das mamas, não há evidências que justifiquem esta conduta na literatura. Em razão da sua alta sensibilidade e percentual de falso-positivos, este exame deve ser adequadamente indicado, para evitar a realização de procedimentos desnecessários. Se bem indicada, a ressonância magnética pode contribuir para o processo de tomada de decisão e constitui uma ferramenta fundamental na avaliação de lesões mamárias.&#xD;OBJECTIVE: To evaluate and discuss the indications for breast magnetic resonance imaging in an oncology reference center. MATERIALS AND METHODS: Retrospective study approved by the Committee for Ethics in Research of the institution and developed through a review of patients&amp;#039; records and clinical reports. All the breast magnetic resonance studies performed in the period from July 2008 to July 2009 (n = 529) were included. RESULTS: Mean patients&amp;#039; age was 49 years, ranging from 17 to 86 years. Family history of breast and/or ovarian cancer was present in 162 patients (30.6 percent). Most common indications for breast magnetic resonance imaging included inconclusive mammographic/sonographic findings (48.8 percent), evaluation of tumor recurrence/surgical scar after breast surgery (15.1 percent), disease staging/surgical planning (11.7 percent) and screening in high-risk patients (8.5 percent). CONCLUSION: In spite of inconclusive findings at conventional imaging studies being the most common indication for breast magnetic resonance imaging, there is no evidence in the literature supporting such a conduct. Because of its high sensitivity and high rate of false positive results, magnetic resonance imaging should be appropriately indicated in order to avoid unnecessary procedures. Once such method is appropriately indicated, it may contribute in the decision making process, constituting an essential tool in the assessment of breast lesions.</style></abstract><label><style face="normal" font="default" size="100%">Included by Ray</style></label><urls><related-urls><url><style face="normal" font="default" size="100%">http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S0100-39842011000600007</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2187</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2187</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Martin-Weng-Chin, H.</style></author><author><style face="normal" font="default" size="100%">Ng,</style></author><author><style face="normal" font="default" size="100%">Seow-Siang, L. O. H.</style></author><author><style face="normal" font="default" size="100%">Arul, Earnest</style></author><author><style face="normal" font="default" size="100%">Gervais-Khin-Lin, Wansaicheong</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Effectiveness of an algorithm in reducing the number of unnecessary ultrasound scans for deep vein thrombosis: an evaluation report</style></title><secondary-title><style face="normal" font="default" size="100%">Singapore medical journal</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Singapore medical journal</style></full-title></periodical><pages><style face="normal" font="default" size="100%">595-598</style></pages><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Aged, 80 and over</style></keyword><keyword><style face="normal" font="default" size="100%">Algorithms</style></keyword><keyword><style face="normal" font="default" size="100%">Biomarkers</style></keyword><keyword><style face="normal" font="default" size="100%">Metabolism</style></keyword><keyword><style face="normal" font="default" size="100%">Cost-Benefit Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Emergencies</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Fibrin Fibrinogen Degradation Products</style></keyword><keyword><style face="normal" font="default" size="100%">Health Status Indicators</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">ROC Curve</style></keyword><keyword><style face="normal" font="default" size="100%">Sensitivity and Specificity</style></keyword><keyword><style face="normal" font="default" size="100%">Singapore</style></keyword><keyword><style face="normal" font="default" size="100%">Ultrasonography</style></keyword><keyword><style face="normal" font="default" size="100%">Unnecessary Procedures</style></keyword><keyword><style face="normal" font="default" size="100%">Economics</style></keyword><keyword><style face="normal" font="default" size="100%">Venous Thrombosis</style></keyword><keyword><style face="normal" font="default" size="100%">Diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">Diagnostic Imaging</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2012</style></year><pub-dates><date><style face="normal" font="default" size="100%">2012/00</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0037-5675</style></isbn><abstract><style face="normal" font="default" size="100%">&amp;amp;lt;p&amp;amp;gt;&amp;amp;lt;b&amp;amp;gt;INTRODUCTION&amp;amp;lt;/b&amp;amp;gt;Patients with suspected deep vein thrombosis (DVT) pose a diagnostic dilemma to the Emergency Department (ED) clinician. This study aimed to implement a known algorithm incorporating the modified Wells criteria and D-dimer testing to guide the ED clinician, thus reducing unnecessary ultrasound scans (USS).&amp;amp;lt;/p&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;&amp;amp;lt;b&amp;amp;gt;METHODS&amp;amp;lt;/b&amp;amp;gt;Patients who presented to the ED between August 2008 and April 2009 with suspected DVT underwent Wells scoring. Those with scores &amp;amp;lt; 2 were deemed unlikely to have DVT and underwent D-dimer testing first. Patients with scores &amp;amp;ge; 2 were regarded as likely to have DVT and underwent urgent USS. USS findings were tabulated as positive or negative/indeterminate for DVT. The latter group was followed up for one year to check whether DVT was missed during the initial USS.&amp;amp;lt;/p&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;&amp;amp;lt;b&amp;amp;gt;RESULTS&amp;amp;lt;/b&amp;amp;gt;75 patients presented with suspected DVT and underwent USS. Of these, 14 results were positive and 61 were negative. 37 patients had Wells scores &amp;amp;lt; 2, with three (8.1%) having DVT. Another 38 patients had Wells scores &amp;amp;ge; 2, with 11 (28.9%) having DVT. D-dimer testing was performed on 27 of the 75 patients. Those with DVT had higher average values compared to those without DVT (1.305 vs. 0.595 &amp;amp;micro;g/ml). The majority of patients with raised D-dimer values had cellulitis, although three also had DVT (with values &amp;amp;ge; 0.99 &amp;amp;micro;g/ml).&amp;amp;lt;/p&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;&amp;amp;lt;b&amp;amp;gt;CONCLUSION&amp;amp;lt;/b&amp;amp;gt;We managed to reduce the number of unnecessary USS and increase the pick-up rate of DVT. A cut-off score &amp;amp;ge; 2 in our algorithm is suitable for use in the ED setting.&amp;amp;lt;/p&amp;amp;gt;</style></abstract><urls><related-urls><url><style face="normal" font="default" size="100%">http://dx.doi.org/</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2188</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2188</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Martinez, C. A.</style></author><author><style face="normal" font="default" size="100%">Vietto, V.</style></author><author><style face="normal" font="default" size="100%">Terrasa, S. A.</style></author><author><style face="normal" font="default" size="100%">Vicens, J.</style></author><author><style face="normal" font="default" size="100%">Kopitowski, K. S.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Hospital Italiano de Buenos Aires. cintia.a.martinez@gmail.com.</style></auth-address><titles><title><style face="normal" font="default" size="100%">[Prostate specific antigen utilization trends in an academic hospital in Argentina.]</style></title><secondary-title><style face="normal" font="default" size="100%">Rev Fac Cien Med Univ Nac Cordoba</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Rev Fac Cien Med Univ Nac Cordoba</style></full-title></periodical><pages><style face="normal" font="default" size="100%">283-241</style></pages><volume><style face="normal" font="default" size="100%">76</style></volume><number><style face="normal" font="default" size="100%">4</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Age Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Argentina</style></keyword><keyword><style face="normal" font="default" size="100%">Early Detection of Cancer</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Prostate-Specific Antigen/*blood</style></keyword><keyword><style face="normal" font="default" size="100%">Prostatic Neoplasms/*diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">Spatio-Temporal Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">*prostatic neoplasms</style></keyword><keyword><style face="normal" font="default" size="100%">*mass screening</style></keyword><keyword><style face="normal" font="default" size="100%">*prostate-specific antigen</style></keyword><keyword><style face="normal" font="default" size="100%">*medical overuse</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style face="normal" font="default" size="100%">Dec 4</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0014-6722</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: Although prostate cancer (PC) screening with prostate-specific antigen (PSA) determination could decrease mortality, concerns about the potential risk of overdiagnosis led to recommendations against this preventive practice. The objective of this study was to describe the trend in PSA determinations in men between 40 and 79 years old, affiliated to a Health Maintenance Organization (HMO) of an academic hospital in the city of Buenos Aires, Argentina, and its association with the recommendations stated by the U.S. Preventive Task Force (USPSTF) and the Instituto Nacional del Cáncer in Argentina. METHODS: We analyzed a time series of aggregated data. We calculated the annual age-standardized rates of accumulated determinations of PSA for every 100 affiliates without a personal history of PC. Additionally, we compared trends by age groups every 10 years. We used Joinpoint and MS Excel programs. RESULTS: Between 2006 and 2011 there was a growing trend in the number of PSA determinations, with an annual average of + 1.2% (95% CI, -1.0 to +3.5). Between 2011 and 2015, the number of determinations began to decrease, with a percentage annual average of -4.1% (-6.9 to -1.1). CONCLUSION: We found a gradual decrease in PSA utilization in men between 40 and 79 years old after the 2012 USPSTF recommendation against prostate cancer screening.</style></abstract><notes><style face="normal" font="default" size="100%">1853-0605&#xD;Martinez, Cintia Ayelen&#xD;Vietto, Valeria&#xD;Terrasa, Sergio Adrián&#xD;Vicens, Jimena&#xD;Kopitowski, Karin Silvana&#xD;Journal Article&#xD;Argentina&#xD;Rev Fac Cien Med Univ Nac Cordoba. 2019 Dec 4;76(4):283-241. doi: 10.31053/1853.0605.v76.n4.25185.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://revistas.unc.edu.ar/index.php/med/article/download/25185/28406</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.31053/1853.0605.v76.n4.25185</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2189</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2189</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Masanja, I.</style></author><author><style face="normal" font="default" size="100%">Selemani, M.</style></author><author><style face="normal" font="default" size="100%">Amuri, B.</style></author><author><style face="normal" font="default" size="100%">Kajungu, D.</style></author><author><style face="normal" font="default" size="100%">Khatib, R.</style></author><author><style face="normal" font="default" size="100%">Skarbinski, J.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">I. Masanja, Ifakara Health Institute, Dar es Salaam, Tanzania</style></auth-address><titles><title><style face="normal" font="default" size="100%">Increased use of malaria diagnostic tests improves targeting of anti-malarial treatment in rural Tanzania: Implications for a national roll out of malaria rapid diagnostic tests</style></title><secondary-title><style face="normal" font="default" size="100%">American Journal of Tropical Medicine and Hygiene</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">American Journal of Tropical Medicine and Hygiene</style></full-title></periodical><pages><style face="normal" font="default" size="100%">194</style></pages><volume><style face="normal" font="default" size="100%">85</style></volume><number><style face="normal" font="default" size="100%">6</style></number><keywords><keyword><style face="normal" font="default" size="100%">artemisinin</style></keyword><keyword><style face="normal" font="default" size="100%">diagnostic test</style></keyword><keyword><style face="normal" font="default" size="100%">malaria</style></keyword><keyword><style face="normal" font="default" size="100%">tropical medicine</style></keyword><keyword><style face="normal" font="default" size="100%">society</style></keyword><keyword><style face="normal" font="default" size="100%">hygiene</style></keyword><keyword><style face="normal" font="default" size="100%">Tanzania</style></keyword><keyword><style face="normal" font="default" size="100%">patient</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">health care facility</style></keyword><keyword><style face="normal" font="default" size="100%">blood</style></keyword><keyword><style face="normal" font="default" size="100%">health</style></keyword><keyword><style face="normal" font="default" size="100%">season</style></keyword><keyword><style face="normal" font="default" size="100%">therapy</style></keyword><keyword><style face="normal" font="default" size="100%">case management</style></keyword><keyword><style face="normal" font="default" size="100%">parasitemia</style></keyword><keyword><style face="normal" font="default" size="100%">fever</style></keyword><keyword><style face="normal" font="default" size="100%">consultation</style></keyword><keyword><style face="normal" font="default" size="100%">diseases</style></keyword><keyword><style face="normal" font="default" size="100%">World Health Organization</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2011</style></year></dates><isbn><style face="normal" font="default" size="100%">0002-9637</style></isbn><abstract><style face="normal" font="default" size="100%">The World Health Organization recommends diagnostic confrmation of all uncomplicated malaria cases. Tanzania is implementing a phased roll-out of malaria rapid diagnostic tests (mRDTs) in all levels of health care facilities as one strategy to increase parasitological malaria diagnosis. We evaluated artemisinin combination therapy (ACT) prescribing patterns in febrile patients with and without uncomplicated malaria in two areas with high and low levels of mRDT implementation (mRDT area and non-mRDT area, respectively). We conducted repeat cross sectional health facility surveys in two areas with health and demographic surveillance systems during both high and low malaria transmission seasons in 2010. We collected clinical information and a reference blood slide on all patients presenting for an initial illness consultation. Uncomplicated malaria was defned as fever and asexual P. falciparum parasitemia on a reference blood slide. We included 1,247 febrile patients in the analysis. In the mRDT area, 65% (95% confdence interval (95% CI): 52-76) of febrile patients received a diagnostic test compared to 50% (95% CI: 39-61) of patients in the non-mRDT area (p&lt;0.001). In the mRDT area, 79% (95% CI: 66-88) of patients with uncomplicated malaria received recommended treatment with ACT compared to 67% (95% CI: 54-78) of patients in the non-mRDT area (p=0.11). Overtreatment with an ACT of patients without slide confrmed uncomplicated malaria was signifcantly less common in the mRDT area (23%; 95% CI: 17-30) compared to the non-mRDT area (35%; 95% CI: 29-43) (p=0.01). In conclusion, routine implementation of mRDTs resulted in increased diagnostic test use and reduced overtreatment with ACTs in one area in Tanzania. The national rollout of mRDTs will have to be monitored to assess whether these changes in case management practices will be replicated in other areas.</style></abstract><label><style face="normal" font="default" size="100%">Included by Ray</style></label><notes><style face="normal" font="default" size="100%">L71042803&#xD;2013-04-30</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.embase.com/search/results?subaction=viewrecord&amp;id=L71042803&amp;from=export</style></url><url><style face="normal" font="default" size="100%">http://www.ajtmh.org/content/85/6_Suppl/151.full.pdf+html</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2190</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2190</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Masanja, I. M.</style></author><author><style face="normal" font="default" size="100%">Selemani, M.</style></author><author><style face="normal" font="default" size="100%">Amuri, B.</style></author><author><style face="normal" font="default" size="100%">Kajungu, D.</style></author><author><style face="normal" font="default" size="100%">Khatib, R.</style></author><author><style face="normal" font="default" size="100%">Kachur, S. P.</style></author><author><style face="normal" font="default" size="100%">Skarbinski, J.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">INESS programme, Ifakara Health Institute, PO Box 78373, Dar es Salaam, Tanzania. imasanja@ihi.or.tz</style></auth-address><titles><title><style face="normal" font="default" size="100%">Increased use of malaria rapid diagnostic tests improves targeting of anti-malarial treatment in rural Tanzania: implications for nationwide rollout of malaria rapid diagnostic tests</style></title><secondary-title><style face="normal" font="default" size="100%">Malar J</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Malar J</style></full-title></periodical><pages><style face="normal" font="default" size="100%">221</style></pages><volume><style face="normal" font="default" size="100%">11</style></volume><keywords><keyword><style face="normal" font="default" size="100%">Antimalarials/*therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Artemisinins/therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Child, Preschool</style></keyword><keyword><style face="normal" font="default" size="100%">Cross-Sectional Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Diagnostic Tests, Routine/*methods/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Drug Therapy, Combination/methods</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Infant</style></keyword><keyword><style face="normal" font="default" size="100%">Infant, Newborn</style></keyword><keyword><style face="normal" font="default" size="100%">Lactones/therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Malaria/*diagnosis/*drug therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Rural Population</style></keyword><keyword><style face="normal" font="default" size="100%">Tanzania</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2012</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jul 2</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1475-2875</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: The World Health Organization recommends parasitological confirmation of all malaria cases. Tanzania is implementing a phased rollout of malaria rapid diagnostic tests (RDTs) for routine use in all levels of care as one strategy to increase parasitological confirmation of malaria diagnosis. This study was carried out to evaluated artemisinin combination therapy (ACT) prescribing patterns in febrile patients with and without uncomplicated malaria in one pre-RDT implementation and one post-RDT implementation area. METHODS: A cross-sectional health facility surveys was conducted during high and low malaria transmission seasons in 2010 in both areas. Clinical information and a reference blood film on all patients presenting for an initial illness consultation were collected. Malaria was defined as a history of fever in the past 48 h and microscopically confirmed parasitaemia. Routine diagnostic testing was defined as RDT or microscopy ordered by the health worker and performed at the health facility as part of the health worker-patient consultation. Correct diagnostic testing was defined as febrile patient tested with RDT or microscopy. Over-testing was defined as a non-febrile patient tested with RDT or microscopy. Correct treatment was defined as patient with malaria prescribed ACT. Over-treatment was defined as patient without malaria prescribed ACT. RESULTS: A total of 1,247 febrile patients (627 from pre-implementation area and 620 from post-implementation area) were included in the analysis. In the post-RDT implementation area, 80.9% (95% CI, 68.2-89.3) of patients with malaria received recommended treatment with ACT compared to 70.3% (95% CI, 54.7-82.2) of patients in the pre-RDT implementation area. Correct treatment was significantly higher in the post-implementation area during high transmission season (85.9% (95% CI, 72.0-93.6) compared to 58.3% (95% CI, 39.4-75.1) in pre-implementation area (p = 0.01). Over-treatment with ACT of patients without malaria was less common in the post-RDT implementation area (20.9%; 95% CI, 14.7-28.8) compared to the pre-RDT implementation area (45.8%; 95% CI, 37.2-54.6) (p &lt; 0.01) in high transmission. The odds of overtreatment was significantly lower in post- RDT area (adjusted Odds Ratio (OR: 95% CI) 0.57(0.36-0.89); and much higher with clinical diagnosis adjusted OR (95% CI) 2.24(1.37-3.67) CONCLUSION: Implementation of RDTs increased use of RDTs for parasitological confirmation and reduced over-treatment with ACT during high malaria transmission season in one area in Tanzania. Continued monitoring of the national RDT rollout will be needed to assess whether these changes in case management practices will be replicated in other areas and sustained over time. Additional measures (such as refresher trainings, closer supervisions, etc.) may be needed to improve ACT targeting during low transmission seasons.</style></abstract><label><style face="normal" font="default" size="100%">Included by Ray</style></label><notes><style face="normal" font="default" size="100%">1475-2875&#xD;Masanja, Irene M&#xD;Selemani, Majige&#xD;Amuri, Baraka&#xD;Kajungu, Dan&#xD;Khatib, Rashid&#xD;Kachur, S Patrick&#xD;Skarbinski, Jacek&#xD;Journal Article&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Malar J. 2012 Jul 2;11:221. doi: 10.1186/1475-2875-11-221.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3471012/pdf/1475-2875-11-221.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC3471012</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1186/1475-2875-11-221</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2191</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2191</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Masika, P. M.</style></author><author><style face="normal" font="default" size="100%">Semarundu, W. J.</style></author><author><style face="normal" font="default" size="100%">Urassa, R.</style></author><author><style face="normal" font="default" size="100%">Mosha, J.</style></author><author><style face="normal" font="default" size="100%">Chandramohan, D.</style></author><author><style face="normal" font="default" size="100%">Gosling, R. D.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">R.D. Gosling, Disease Control and Vector Biology Unit, London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, United Kingdom</style></auth-address><titles><title><style face="normal" font="default" size="100%">Over-diagnosis of malaria is not a lost cause</style></title><secondary-title><style face="normal" font="default" size="100%">Malaria Journal</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Malaria Journal</style></full-title></periodical><volume><style face="normal" font="default" size="100%">5</style></volume><keywords><keyword><style face="normal" font="default" size="100%">Africa</style></keyword><keyword><style face="normal" font="default" size="100%">article</style></keyword><keyword><style face="normal" font="default" size="100%">blood smear</style></keyword><keyword><style face="normal" font="default" size="100%">diagnostic error</style></keyword><keyword><style face="normal" font="default" size="100%">hospital patient</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">major clinical study</style></keyword><keyword><style face="normal" font="default" size="100%">malaria</style></keyword><keyword><style face="normal" font="default" size="100%">medical education</style></keyword><keyword><style face="normal" font="default" size="100%">outpatient</style></keyword><keyword><style face="normal" font="default" size="100%">overdiagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">Plasmodium</style></keyword><keyword><style face="normal" font="default" size="100%">public hospital</style></keyword><keyword><style face="normal" font="default" size="100%">rural area</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2006</style></year></dates><isbn><style face="normal" font="default" size="100%">1475-2875</style></isbn><abstract><style face="normal" font="default" size="100%">Background: Recent studies have highlighted the over-diagnosis of malaria in clinical settings in Africa. This study assessed the impact of a training programme implemented as part of an intervention trial on diagnostic behaviour of clinicians in a rural district hospital in a low-moderate malaria transmission setting. Methods: From the beginning of 2005, a randomized controlled trial (RCT) of intermittent preventive treatment for malaria in infants (IPTi) has been conducted at the study hospital. As part of the RCT, the study team offered laboratory quality assurance, and supervision and training of paediatric ward staff using information on malaria epidemiology in the community. Data on clinical and blood slide confirmed cases of malaria from 2001 to 2005 were extracted from the hospital records. Results: The proportion of blood slides positive for malaria parasites had decreased from 21% in 2001 to 7% in 2005 (p &lt; .01). The proportion of outpatient and inpatient cases diagnosed as malaria ranged between 34% and 28% from 2001 to 2004 and this decreased substantially to 17% after the introduction of the package of training and support in 2005 (p &lt; .01). There was no clear trend in the ratio of blood slide examined versus total diagnosis of malaria. Conclusion: It may be possible to change the diagnostic behaviour of clinicians by rigorous training using local malaria epidemiology data and supportive supervision. © 2006 Masika et al; licensee BioMed Central Ltd.</style></abstract><notes><style face="normal" font="default" size="100%">L44974633&#xD;2007-01-22</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.embase.com/search/results?subaction=viewrecord&amp;id=L44974633&amp;from=export</style></url><url><style face="normal" font="default" size="100%">http://dx.doi.org/10.1186/1475-2875-5-120</style></url><url><style face="normal" font="default" size="100%">https://malariajournal.biomedcentral.com/track/pdf/10.1186/1475-2875-5-120.pdf</style></url></related-urls></urls><custom5><style face="normal" font="default" size="100%">17166271</style></custom5><electronic-resource-num><style face="normal" font="default" size="100%">10.1186/1475-2875-5-120</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2192</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2192</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Mathew, I. E.</style></author><author><style face="normal" font="default" size="100%">Mathew, A.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Internal Medicine, Division of Endocrinology, University of Kentucky Medical Center, Lexington, Kentucky 40536.&#xD;Department of Internal Medicine, Division of Medical Oncology, University of Kentucky, Markey Cancer Center, Lexington, Kentucky 40536.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Rising Thyroid Cancer Incidence in Southern India: An Epidemic of Overdiagnosis?</style></title><secondary-title><style face="normal" font="default" size="100%">J Endocr Soc</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">J Endocr Soc</style></full-title></periodical><pages><style face="normal" font="default" size="100%">480-487</style></pages><volume><style face="normal" font="default" size="100%">1</style></volume><number><style face="normal" font="default" size="100%">5</style></number><keywords><keyword><style face="normal" font="default" size="100%">India</style></keyword><keyword><style face="normal" font="default" size="100%">Kerala</style></keyword><keyword><style face="normal" font="default" size="100%">epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">incidence</style></keyword><keyword><style face="normal" font="default" size="100%">overdiagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">thyroid</style></keyword><keyword><style face="normal" font="default" size="100%">thyroid cancer</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style face="normal" font="default" size="100%">May 1</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">2472-1972 (Print)&#xD;2472-1972</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: Thyroid cancer incidence is rising in high-income countries. This increase in disease burden is attributed to the phenomenon of overdiagnosis. OBJECTIVE: We aimed to investigate trends in thyroid cancer rates in India, focusing on the state of Kerala in southern India, which has reported a high incidence of the disease. DESIGN: Population-based study using data from the National Cancer Registry Program. PARTICIPANTS: We used data from the Population Based Cancer Registries for Thiruvananthapuram (capital of Kerala state), Delhi, Mumbai, Bangalore, and Chennai. We used data for three reporting periods from 2005 to 2014 (represented as 2006, 2009, and 2012). MAIN OUTCOME MEASURES: We reported the age-adjusted incidence rate (AARi) and mortality rate (AARm) per 100,000 women and the proportion of thyroid cancers diagnosed in females per 100 cancer cases. RESULTS: During 2006, the AARi for thyroid cancer in women in Thiruvananthapuram was 6.9 per 100,000, rising to 10 in 2009 and 13.3 in 2012. There was a 93% increase in incidence rates over less than a decade. The AARis in the other four cities were stable. In 2012, Thiruvananthapuram had at least a fourfold higher incidence compared with other regions. Thyroid was the primary site in one of every 10 cancers diagnosed in Thiruvananthapuram, and large numbers of patients were &lt;40 years of age. The AARm remained stable in all regions. CONCLUSION: We reported a high burden of thyroid cancer in Kerala, India, which is most likely due to overdiagnosis.</style></abstract><notes><style face="normal" font="default" size="100%">2472-1972&#xD;Mathew, Indu Elizabeth&#xD;Mathew, Aju&#xD;Journal Article&#xD;J Endocr Soc. 2017 Apr 4;1(5):480-487. doi: 10.1210/js.2017-00097. eCollection 2017 May 1.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686600/pdf/js-01-480.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC5686600</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1210/js.2017-00097</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2193</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2193</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Maung, K.</style></author><author><style face="normal" font="default" size="100%">Ohnmar, H.</style></author><author><style face="normal" font="default" size="100%">Than, W.</style></author><author><style face="normal" font="default" size="100%">Ramli, M.</style></author><author><style face="normal" font="default" size="100%">Najwa Hanim, M. R.</style></author><author><style face="normal" font="default" size="100%">Ali Sabri, R.</style></author><author><style face="normal" font="default" size="100%">Ahmad Zafri, A. B.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Psychiatry, Kulliyyah of Medicine, International Islamic University Malaysia, Bandar Indera Mahkota, 25200 Kuantan, Pahang, Malaysia.&#xD;Rehabilitation Unit, Department of Orthopaedics, University Kebangsaan Malaysia Medical Centre, Jalan Yacoob Latif, Bandar Tun Razak, Cheras, 56000, Kuala Lumpur, Malaysi.&#xD;Community Medicine Department, Mahsa University, Kuala Lumpur, Jalan Elmu, Off Jalan University, 59100, Kuala Lumpur, Malaysia.&#xD;Department of Psychiatry, Hospital Tengku Ampuan Afzan, HTAA Kuantan 25150, Kuantan, Pahang, Malaysia.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Assessment of documentation of DSM-IV-TR Criteria A for diagnosis of schizophrenia in psychiatric unit, tertiary hospital, Malaysia</style></title><secondary-title><style face="normal" font="default" size="100%">Clin Ter</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Clin Ter</style></full-title></periodical><pages><style face="normal" font="default" size="100%">87-90</style></pages><volume><style face="normal" font="default" size="100%">166</style></volume><number><style face="normal" font="default" size="100%">2</style></number><keywords><keyword><style face="normal" font="default" size="100%">Diagnostic Errors</style></keyword><keyword><style face="normal" font="default" size="100%">*Diagnostic and Statistical Manual of Mental Disorders</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Malaysia</style></keyword><keyword><style face="normal" font="default" size="100%">Retrospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Schizophrenia/*diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">Tertiary Care Centers</style></keyword><keyword><style face="normal" font="default" size="100%">Dsm-iv-tr</style></keyword><keyword><style face="normal" font="default" size="100%">Delusion</style></keyword><keyword><style face="normal" font="default" size="100%">Hallucination</style></keyword><keyword><style face="normal" font="default" size="100%">Over-diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">Psychopathology</style></keyword><keyword><style face="normal" font="default" size="100%">Schizophrenia</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2015</style></year></dates><isbn><style face="normal" font="default" size="100%">0009-9074</style></isbn><abstract><style face="normal" font="default" size="100%">OBJECTIVE: The purposes of this study were to investigate the documentation of the DSM-IV-TR- Criteria A in diagnoses of schizophrenia and to identify the symptoms associated with over diagnosis of schizophrenia. METHOD: This study involved a retrospective review and analysis of data from case notes. RESULTS: Data of 107 newly diagnosed patients with schizophrenia were keyed in and analyzed using SPSS v 19. The cases were then evaluated for the use of the DSM-IV-TR- Criteria A. Over diagnosis was noted in 37.39% of the patients. Disorganised behaviour (12.5%), affective flattening (12.5%), hallucination (16%) and non-bizarre delusion (18.3%) significantly contributed to the over-diagnosis of schizophrenia. Symptoms such as non-bizarre delusion and hallucination were the most commonly used in over-diagnosing schizophrenia and were statistically significant with p ≤0.05. CONCLUSIONS: There was a significant lack of DSM-IV-TR Criteria A among the data documented to diagnose schizophrenia and non-bizarre delusion and hallucination were the most commonly used in over-diagnosing schizophrenia. This key problem needs to be addressed. The reliability of a diagnosis is indispensable and achievable with the proper clinical application of DSM-IV-TR Criteria A. The DSM-IV-TR Criteria have been perceived to be useful and reliable and is most widely used throughout the world.</style></abstract><notes><style face="normal" font="default" size="100%">1972-6007&#xD;Maung, K&#xD;Ohnmar, H&#xD;Than, W&#xD;Ramli, M&#xD;Najwa Hanim, M R&#xD;Ali Sabri, R&#xD;Ahmad Zafri, A B&#xD;Journal Article&#xD;Italy&#xD;Clin Ter. 2015;166(2):87-90. doi: 10.7417/CT.2015.1823.</style></notes><urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.7417/ct.2015.1823</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2194</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2194</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Mbacham, W. F.</style></author><author><style face="normal" font="default" size="100%">Mangham-Jefferies, L.</style></author><author><style face="normal" font="default" size="100%">Cundill, B.</style></author><author><style face="normal" font="default" size="100%">Achonduh, O. A.</style></author><author><style face="normal" font="default" size="100%">Chandler, C. I.</style></author><author><style face="normal" font="default" size="100%">Ambebila, J. N.</style></author><author><style face="normal" font="default" size="100%">Nkwescheu, A.</style></author><author><style face="normal" font="default" size="100%">Forsah-Achu, D.</style></author><author><style face="normal" font="default" size="100%">Ndiforchu, V.</style></author><author><style face="normal" font="default" size="100%">Tchekountouo, O.</style></author><author><style face="normal" font="default" size="100%">Akindeh-Nji, M.</style></author><author><style face="normal" font="default" size="100%">Ongolo-Zogo, P.</style></author><author><style face="normal" font="default" size="100%">Wiseman, V.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Laboratory for Public Health Research Biotechnologies, University of Yaoundé I, Yaoundé, Cameroon.&#xD;Department of Global Health and Development, London School of Hygiene &amp; Tropical Medicine, London, UK.&#xD;Department of Infectious Disease Epidemiology, London School of Hygiene &amp; Tropical Medicine, London, UK.&#xD;Division of Health Operational Research, Ministry of Public Health Cameroon, Yaoundé, Cameroon.&#xD;National Malaria Control Programme, Ministry of Public Health Cameroon, Yaoundé, Cameroon.&#xD;Regional Delegation, Ministry of Public Health, Bamenda, Cameroon.&#xD;Malaria Unit, Ministry of Public Health, Bamenda, Cameroon.&#xD;Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon; Center for Best Practices in Health, Yaoundé, Cameroon.&#xD;Department of Global Health and Development, London School of Hygiene &amp; Tropical Medicine, London, UK; School of Public Health and Community Medicine, University of New South Wales, Kensington, NSW, Australia. Electronic address: virginia.wiseman@lshtm.ac.uk.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Basic or enhanced clinician training to improve adherence to malaria treatment guidelines: a cluster-randomised trial in two areas of Cameroon</style></title><secondary-title><style face="normal" font="default" size="100%">Lancet Glob Health</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Lancet Glob Health</style></full-title></periodical><pages><style face="normal" font="default" size="100%">e346-58</style></pages><volume><style face="normal" font="default" size="100%">2</style></volume><number><style face="normal" font="default" size="100%">6</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Antimalarials/*therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Cameroon</style></keyword><keyword><style face="normal" font="default" size="100%">Clinical Competence</style></keyword><keyword><style face="normal" font="default" size="100%">Cluster Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Delivery of Health Care/*standards</style></keyword><keyword><style face="normal" font="default" size="100%">Education, Medical, Continuing/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Fever/drug therapy</style></keyword><keyword><style face="normal" font="default" size="100%">*Guideline Adherence</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Malaria/*drug therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Medication Adherence/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jun</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">2214-109x</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: The scale-up of malaria rapid diagnostic tests (RDTs) is intended to improve case management of fever and targeting of artemisinin-based combination therapy. Habitual presumptive treatment has hampered these intentions, suggesting a need for strategies to support behaviour change. We aimed to assess the introduction of RDTs when packaged with basic or enhanced clinician training interventions in Cameroon. METHODS: We did a three-arm, stratified, cluster-randomised trial at 46 public and mission health facilities at two study sites in Cameroon to compare three approaches to malaria diagnosis. Facilities were randomly assigned by a computer program in a 9:19:19 ratio to current practice with microscopy (widely available, used as a control group); RDTs with a basic (1 day) clinician training intervention; or RDTs with an enhanced (3 days) clinician training intervention. Patients (or their carers) and fieldworkers who administered surveys to obtain outcome data were masked to study group assignment. The primary outcome was the proportion of patients treated in accordance with WHO malaria treatment guidelines, which is a composite indicator of whether patients were tested for malaria and given appropriate treatment consistent with the test result. All analyses were by intention to treat. This study is registered at ClinicalTrials.gov, number NCT01350752. FINDINGS: The study took place between June 7 and Dec 14, 2011. The analysis included 681 patients from nine facilities in the control group, 1632 patients from 18 facilities in the basic-training group, and 1669 from 19 facilities in the enhanced-training group. The proportion of patients treated in accordance with malaria guidelines did not improve with either intervention; the adjusted risk ratio (RR) for basic training compared with control was 1·04 (95% CI 0·53-2·07; p=0·90), and for enhanced training compared with control was 1·17 (0·61-2·25; p=0·62). Inappropriate use of antimalarial drugs after a negative test was reduced from 84% (201/239) in the control group to 52% (413/796) in the basic-training group (unadjusted RR 0·63, 0·28-1·43; p=0·25) and to 31% (232/759) in the enhanced-training group (0·29, 0·11-0·77; p=0·02). INTERPRETATION: Enhanced clinician training, designed to translate knowledge into prescribing practice and improve quality of care, has the potential to halve overtreatment in public and mission health facilities in Cameroon. Basic training is unlikely to be sufficient to support the behaviour change required for the introduction of RDTs.</style></abstract><label><style face="normal" font="default" size="100%">Included by Hannah</style></label><notes><style face="normal" font="default" size="100%">2214-109x&#xD;Mbacham, Wilfred F&#xD;Mangham-Jefferies, Lindsay&#xD;Cundill, Bonnie&#xD;Achonduh, Olivia A&#xD;Chandler, Clare I R&#xD;Ambebila, Joel N&#xD;Nkwescheu, Armand&#xD;Forsah-Achu, Dorothy&#xD;Ndiforchu, Victor&#xD;Tchekountouo, Odile&#xD;Akindeh-Nji, Mbuh&#xD;Ongolo-Zogo, Pierre&#xD;Wiseman, Virginia&#xD;Journal Article&#xD;Multicenter Study&#xD;Randomized Controlled Trial&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Lancet Glob Health. 2014 Jun;2(6):e346-58. doi: 10.1016/S2214-109X(14)70201-3. Epub 2014 Apr 25.</style></notes><urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1016/s2214-109x(14)70201-3</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2195</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2195</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Mbonye, A. K.</style></author><author><style face="normal" font="default" size="100%">Magnussen, P.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Community Health, Ministry of Health, Box 7272, Kampala, Uganda. vpadmn@infocom.co.ug</style></auth-address><titles><title><style face="normal" font="default" size="100%">Symptom-based diagnosis of malaria and its implication on antimalarial drug use in pregnancy in Central Uganda: results from a community trial</style></title><secondary-title><style face="normal" font="default" size="100%">Int J Adolesc Med Health</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Int J Adolesc Med Health</style></full-title></periodical><pages><style face="normal" font="default" size="100%">257-62</style></pages><volume><style face="normal" font="default" size="100%">22</style></volume><number><style face="normal" font="default" size="100%">2</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">*Antimalarials</style></keyword><keyword><style face="normal" font="default" size="100%">Chemoprevention</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Drug Combinations</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Inappropriate Prescribing</style></keyword><keyword><style face="normal" font="default" size="100%">Malaria, Falciparum/drug therapy/*prevention &amp; control</style></keyword><keyword><style face="normal" font="default" size="100%">Mass Screening/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Pregnancy</style></keyword><keyword><style face="normal" font="default" size="100%">Pregnancy Complications, Infectious/drug therapy/parasitology/*prevention &amp; control</style></keyword><keyword><style face="normal" font="default" size="100%">*Pyrimethamine</style></keyword><keyword><style face="normal" font="default" size="100%">Sensitivity and Specificity</style></keyword><keyword><style face="normal" font="default" size="100%">*Sulfadoxine</style></keyword><keyword><style face="normal" font="default" size="100%">Uganda</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2010</style></year><pub-dates><date><style face="normal" font="default" size="100%">Apr-Jun</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0334-0139 (Print)&#xD;0334-0139</style></isbn><abstract><style face="normal" font="default" size="100%">Diagnosis of malaria based on the symptomatic approach has been associated with over-treatment. We sought to assess the magnitude of antimalarial drug use in pregnancy in order to contribute to the debate of introducing effective diagnostic tools for malaria. METHODS: Data on malaria morbidity and treatment seeking practices were collected from pregnant women as part of a community intervention study testing new approaches to deliver intermittent preventive treatment of malaria in pregnancy in Mukono district, central Uganda. RESULTS: A high proportion of pregnant women, 261/667 (39.1%) at the health units reported having fever; and of these 124/559 (22.2%) had positive smears for Plasmodium faciliparum. The symptom-based approach had a low sensitivity of 26.4%, leading to many pregnant women with malaria undiagnosed. Similarly, a high proportion of pregnant women, 145/383 (37.9%) with negative blood smears for P. falciparum received antimalarial drugs in addition to intermittent preventive treatment (IPTp) with sulfadoxine-pyrimethamine (SP). CONCLUSION: The results call for urgent strategies to identify effective diagnostic tools for malaria in pregnancy and to assess the negative effects of the over-use of antimalarial drugs in pregnancy.</style></abstract><label><style face="normal" font="default" size="100%">Included by Loai</style></label><notes><style face="normal" font="default" size="100%">Mbonye, Anthony K&#xD;Magnussen, Pascal&#xD;Journal Article&#xD;Multicenter Study&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Germany&#xD;Int J Adolesc Med Health. 2010 Apr-Jun;22(2):257-62. doi: 10.1515/ijamh.2010.22.2.257.</style></notes><urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1515/ijamh.2010.22.2.257</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2196</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2196</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Mbonye, A. K.</style></author><author><style face="normal" font="default" size="100%">Magnussen, P.</style></author><author><style face="normal" font="default" size="100%">Lal, S.</style></author><author><style face="normal" font="default" size="100%">Hansen, K. S.</style></author><author><style face="normal" font="default" size="100%">Cundill, B.</style></author><author><style face="normal" font="default" size="100%">Chandler, C.</style></author><author><style face="normal" font="default" size="100%">Clarke, S. E.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">A.K. Mbonye, Ministry of Health, Kampala, Uganda</style></auth-address><titles><title><style face="normal" font="default" size="100%">A cluster randomized trial introducing rapid diagnostic tests into registered drug shops in Uganda: Impact on appropriate treatment of malaria</style></title><secondary-title><style face="normal" font="default" size="100%">American Journal of Tropical Medicine and Hygiene</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">American Journal of Tropical Medicine and Hygiene</style></full-title></periodical><pages><style face="normal" font="default" size="100%">383</style></pages><volume><style face="normal" font="default" size="100%">89</style></volume><number><style face="normal" font="default" size="100%">5</style></number><keywords><keyword><style face="normal" font="default" size="100%">antimalarial agent</style></keyword><keyword><style face="normal" font="default" size="100%">artesunate</style></keyword><keyword><style face="normal" font="default" size="100%">Uganda</style></keyword><keyword><style face="normal" font="default" size="100%">malaria</style></keyword><keyword><style face="normal" font="default" size="100%">society</style></keyword><keyword><style face="normal" font="default" size="100%">tropical medicine</style></keyword><keyword><style face="normal" font="default" size="100%">hygiene</style></keyword><keyword><style face="normal" font="default" size="100%">diagnostic test</style></keyword><keyword><style face="normal" font="default" size="100%">diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">community</style></keyword><keyword><style face="normal" font="default" size="100%">cost effectiveness analysis</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">arm</style></keyword><keyword><style face="normal" font="default" size="100%">microscopy</style></keyword><keyword><style face="normal" font="default" size="100%">Africa</style></keyword><keyword><style face="normal" font="default" size="100%">blood</style></keyword><keyword><style face="normal" font="default" size="100%">drug marketing</style></keyword><keyword><style face="normal" font="default" size="100%">fever</style></keyword><keyword><style face="normal" font="default" size="100%">purchasing</style></keyword><keyword><style face="normal" font="default" size="100%">health</style></keyword><keyword><style face="normal" font="default" size="100%">organization and management</style></keyword><keyword><style face="normal" font="default" size="100%">World Health Organization</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2013</style></year></dates><isbn><style face="normal" font="default" size="100%">0002-9637</style></isbn><abstract><style face="normal" font="default" size="100%">WHO recommends universal access to malaria diagnosis, encompassing all treatment providers, including the private sector. Diagnosis reduces inappropriate treatment practices, such as overdiagnosis of malaria and overtreatment with antimalarial drugs. Rapid diagnostic tests (mRDTs) may provide a simple means of confirming malaria diagnosis in drug shops. As yet, there is little evidence of the impact of diagnostic testing on antimalarial drug sales and referral practices by drug shops in Africa. A cluster-randomised trial to evaluate the impact and cost-effectiveness of using mRDTs, compared with presumptive treatment, has been conducted in registered drug shops in Mukono District, Uganda since October 2010. The trial aimed to evaluate the impact of mRDT testing on the proportion of drug shop clients who receive appropriate ACT treatment (consistent with parasitological status defined by microscopy on a research slide). A total of 65 drug shops were randomised to receive training either in use of mRDTs or presumptive diagnosis of malaria. All drug shop vendors (DSVs) were trained on the national malaria treatment guidelines, use of rectal artesunate pre-referral treatment, and when to refer. Supporting interventions included activities to raise community awareness emphasising that not all fevers are malaria and to test blood before receiving or purchasing an ACT. DSVs received close support supervision for first 2 months of implementation. Introduction of mRDTs in drug shops was acceptable to DSVs, the community and health staff. Adherence to mRDT results by DSVs was high with 92% of treatment decisions being consistent with mRDT test results, reducing sales of ACTs by approximately 40%, compared to drug shops in the control arm (presumptive diagnosis). Overall, appropriate treatment in drug shops using mRDTs was significantly higher than in drugs shops using presumptive diagnosis (70.1% versus 33.5%, P=0.0001). In conclusion, introducing mRDTs in drug shops was feasible and acceptable; and had a substantial impact on appropriate treatment of malaria.</style></abstract><label><style face="normal" font="default" size="100%">Included by Loai</style></label><notes><style face="normal" font="default" size="100%">L71313094&#xD;2014-02-07</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.embase.com/search/results?subaction=viewrecord&amp;id=L71313094&amp;from=export</style></url><url><style face="normal" font="default" size="100%">http://www.ajtmh.org/content/89/5_Suppl_1/380.full.pdf+html</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2197</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2197</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Mbonye, A. K.</style></author><author><style face="normal" font="default" size="100%">Magnussen, P.</style></author><author><style face="normal" font="default" size="100%">Lal, S.</style></author><author><style face="normal" font="default" size="100%">Hansen, K. S.</style></author><author><style face="normal" font="default" size="100%">Cundill, B.</style></author><author><style face="normal" font="default" size="100%">Chandler, C.</style></author><author><style face="normal" font="default" size="100%">Clarke, S. E.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Ministry of Health, Box 7272, Kampala, Uganda; School of Public Health, College of Health Sciences, Makerere University, Kampala, Uganda.&#xD;Centre for Medical Parasitology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.&#xD;Department of Disease Control, London School of Hygiene and Tropical Medicine, London, United Kingdom.&#xD;Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London, United Kingdom.&#xD;Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom.</style></auth-address><titles><title><style face="normal" font="default" size="100%">A Cluster Randomised Trial Introducing Rapid Diagnostic Tests into Registered Drug Shops in Uganda: Impact on Appropriate Treatment of Malaria</style></title><secondary-title><style face="normal" font="default" size="100%">PLoS One</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">PLoS ONE</style></full-title></periodical><pages><style face="normal" font="default" size="100%">e0129545</style></pages><volume><style face="normal" font="default" size="100%">10</style></volume><number><style face="normal" font="default" size="100%">7</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Antimalarials/economics/*therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Child, Preschool</style></keyword><keyword><style face="normal" font="default" size="100%">Cluster Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Diagnostic Tests, Routine/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Infant</style></keyword><keyword><style face="normal" font="default" size="100%">Malaria/*diagnosis/*drug therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Treatment Outcome</style></keyword><keyword><style face="normal" font="default" size="100%">Uganda</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2015</style></year></dates><isbn><style face="normal" font="default" size="100%">1932-6203</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: Inappropriate treatment of malaria is widely reported particularly in areas where there is poor access to health facilities and self-treatment of fevers with anti-malarial drugs bought in shops is the most common form of care-seeking. The main objective of the study was to examine the impact of introducing rapid diagnostic tests for malaria (mRDTs) in registered drug shops in Uganda, with the aim to increase appropriate treatment of malaria with artemisinin-based combination therapy (ACT) in patients seeking treatment for fever in drug shops. METHODS: A cluster-randomized trial of introducing mRDTs in registered drug shops was implemented in 20 geographical clusters of drug shops in Mukono district, central Uganda. Ten clusters were randomly allocated to the intervention (diagnostic confirmation of malaria by mRDT followed by ACT) and ten clusters to the control arm (presumptive treatment of fevers with ACT). Treatment decisions by providers were validated by microscopy on a reference blood slide collected at the time of consultation. The primary outcome was the proportion of febrile patients receiving appropriate treatment with ACT defined as: malaria patients with microscopically-confirmed presence of parasites in a peripheral blood smear receiving ACT or rectal artesunate, and patients with no malaria parasites not given ACT. FINDINGS: A total of 15,517 eligible patients (8672 intervention and 6845 control) received treatment for fever between January-December 2011. The proportion of febrile patients who received appropriate ACT treatment was 72·9% versus 33·7% in the control arm; a difference of 36·1% (95% CI: 21·3 - 50·9), p&lt;0·001. The majority of patients with fever in the intervention arm accepted to purchase an mRDT (97·8%), of whom 58·5% tested mRDT-positive. Drug shop vendors adhered to the mRDT results, reducing over-treatment of malaria by 72·6% (95% CI: 46·7- 98·4), p&lt;0·001) compared to drug shop vendors using presumptive diagnosis (control arm). CONCLUSION: Diagnostic testing with mRDTs compared to presumptive treatment of fevers implemented in registered drug shops substantially improved appropriate treatment of malaria with ACT. TRIAL REGISTRATION: ClinicalTrials.gov NCT01194557.</style></abstract><label><style face="normal" font="default" size="100%">Included by Loai</style></label><notes><style face="normal" font="default" size="100%">1932-6203&#xD;Mbonye, Anthony K&#xD;Magnussen, Pascal&#xD;Lal, Sham&#xD;Hansen, Kristian S&#xD;Cundill, Bonnie&#xD;Chandler, Clare&#xD;Clarke, Siân E&#xD;WT_/Wellcome Trust/United Kingdom&#xD;MR/N003810/1/MRC_/Medical Research Council/United Kingdom&#xD;Journal Article&#xD;Randomized Controlled Trial&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;PLoS One. 2015 Jul 22;10(7):e0129545. doi: 10.1371/journal.pone.0129545. eCollection 2015.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4511673/pdf/pone.0129545.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC4511673</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1371/journal.pone.0129545</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2198</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2198</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">McPherson, K.</style></author><author><style face="normal" font="default" size="100%">Al Waheidi, S.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Nuffield Department of Obstetrics and Gynaecology, University of Oxford, Oxford, UK. Electronic address: klim.mcpherson@obs-gyn.ox.ac.uk.&#xD;King&apos;s College London, London, UK.</style></auth-address><titles><title><style face="normal" font="default" size="100%">The overestimation and the inappropriate promotion of the benefits of mammographic screening in breast cancer research and interventions in the Gaza Strip</style></title><secondary-title><style face="normal" font="default" size="100%">Lancet</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Lancet</style></full-title></periodical><pages><style face="normal" font="default" size="100%">S21</style></pages><volume><style face="normal" font="default" size="100%">391 Suppl 2</style></volume><dates><year><style face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style face="normal" font="default" size="100%">Feb 21</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0140-6736</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: There has been extensive debate about whether mammographic screening has done more good than harm. Recent reviews showed that women who undergo mammographic screening are more likely to have a tumour that was an overdiagnosis and therefore would not cause them problems. In the Gaza Strip, a strong forum of people advocate an increase in mammographic screening, and the aim of this study was to establish the evidence for this view. METHODS: Research papers that have focused on breast screening in the Gaza Strip or elsewhere in the occupied Palestinian territory were reviewed. Published educational material, including brochures, booklets, and short videos on mammographic screening, were also reviewed. A thematic analysis was done to document the opinions of authors on the effect of mammography. FINDINGS: 11 studies and 20 sets of educational material were identified. Results of six cross-sectional studies showed that about 70% of Palestinian women had never had a mammogram, whereas data from one study showed that 90% of women in the Gaza Strip were willing to undergo diagnostic mammography, but around 30% of them were willing to undergo mammographic screening. Some investigators argued that mammographic screening programmes would improve survival by more than 20% in the Gaza Strip. The authors of two retrospective cohort studies concluded that Palestinian women have low survival rates because of the poor availability of mammography. Only three study groups mentioned harmful effects of mammographic screening. All educational materials had clear information on the benefits of mammographic screening but minimal information on its harms. INTERPRETATION: Research in the Gaza Strip overestimated the reduction in breast cancer mortality that can be attributable to mammographic screening, and this would encourage women to undergo screening without knowing that it could harm them. The content of breast cancer educational material was misleading. This study shows that the information and advice given to women in the Gaza Strip is one-sided. FUNDING: None.</style></abstract><notes><style face="normal" font="default" size="100%">1474-547x&#xD;McPherson, Klim&#xD;Al Waheidi, Shaymaa&#xD;Journal Article&#xD;England&#xD;Lancet. 2018 Feb 21;391 Suppl 2:S21. doi: 10.1016/S0140-6736(18)30387-8. Epub 2018 Feb 21.</style></notes><urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1016/s0140-6736(18)30387-8</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2199</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2199</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Mendonça, Dilton Rodrigues</style></author><author><style face="normal" font="default" size="100%">Aguiar, Carolina Villa Nova</style></author><author><style face="normal" font="default" size="100%">Lins-Kusterer, Liliane</style></author><author><style face="normal" font="default" size="100%">Correia, Luis Cláudio Lemos</style></author><author><style face="normal" font="default" size="100%">Vieira, Adriane Veloso Andrade</style></author><author><style face="normal" font="default" size="100%">Menezes, Marta Silva</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Implementation of the Choosing Wisely Campaign at a Medical Clinic Internship</style></title><secondary-title><style face="normal" font="default" size="100%">Rev. bras. educ. méd</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Rev. bras. educ. méd</style></full-title></periodical><pages><style face="normal" font="default" size="100%">e081-e081</style></pages><volume><style face="normal" font="default" size="100%">44</style></volume><number><style face="normal" font="default" size="100%">3</style></number><dates><year><style face="normal" font="default" size="100%">2020</style></year><pub-dates><date><style face="normal" font="default" size="100%">2020/00</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0100-5502</style></isbn><abstract><style face="normal" font="default" size="100%">Abstract: Objective: to evaluate the implementation of the Choosing Wisely (CW) campaign strategies at a medical clinic internship. Methods: This interventional study involved internship teachers and students, using online questionnaires on the SurveyMonkey platform, and face-to-face activities. Using the Delphi technique, teachers identified three unnecessary situations that commonly occur in practice. The recommendations were grouped by frequency and subject, adapted to the CW format. A Likert scale was used to classify the specialists&amp;#039; opinion aiming to obtain the final list of recommendations. Before the introduction of the CW campaign, we conducted an Objective Structured Clinical Examination (OSCE). Two groups of students were compared: one group that underwent the same OSCE evaluation before the implementation of the CW campaign (110), and another group that participated of all educational actions (n = 98). The CW campaign was implemented by developing educational actions using the recommendations during workshops, banners, and theoretical evaluation, in addition to an Objective Structured Clinical Examination (OSCE). Results: after grouping the recommendations, 24 items remained. The specialists selected eight recommendations by frequency, addressing unnecessary behaviors such as requesting multiple exams, overuse of non-hormonal anti-inflammatory drugs, the indication of digestive endoscopy in younger patients with dyspepsia, excessive chest X-rays in intensive care unit, prescribing antibiotic prophylaxis for longer than recommended, routine indication of allergic tests, inadequate initial screening for thyroid assessment, and spirometry in asymptomatic patients. The educational actions resulted in a process of awareness and discussion among the participants, evidenced by theoretical evaluation (&amp;amp;gt; 95%), as well as in the OSCE, where the level of successes was higher in the exposed group when compared to the nonexposed group (p = 0.001). Conclusion: the implementation of the CW campaign improved the clinical skills of medical clinic internship students and allowed positive discussions about cost-consciousness in health.&#xD;Resumo: Objetivo: avaliar a implementação de estratégias da campanha Choosing Wisely (CW) no internato de clínica médica. Métodos: Este estudo de intervenção envolveu professores e alunos do internato, por meio de questionários on-line na plataforma SurveyMonkey e atividades presenciais. Usando a técnica Delphi, os professores identificaram três situações desnecessárias que geralmente ocorrem na prática. As recomendações foram agrupadas por frequência e assunto e adaptadas ao formato CW. Utilizou-se uma escala Likert para classificar a opinião dos especialistas, obtendo-se a lista final de recomendações. Antes da introdução da campanha da CW, realizamos um Exame Clínico Objetivo Estruturado (OSCE). Foram comparados dois grupos de estudantes: um grupo que realizou a avaliação OSCE antes da implantação da campanha CW (110) e outro que participou de todas as ações educativas (n = 98). Implementamos a campanha da CW, desenvolvendo ações educativas usando as recomendações durante oficinas, banners e avaliação teórica, além de um Exame Clínico Objetivo Estruturado (OSCE). Resultados: após o agrupamento das recomendações, restaram 24 itens. Os especialistas selecionaram oito recomendações, abordando comportamentos desnecessários como solicitação de vários exames, uso excessivo de anti-inflamatórios não hormonais, indicação de endoscopia digestiva para pacientes mais jovens com dispepsia, excesso de radiografia de tórax em unidade de terapia intensiva, prescrição de profilaxia antibiótica por mais tempo do que o recomendado, indicação de rotina de testes alérgicos, triagem inicial inadequada para avaliação da tireóide e espirometria em pacientes assintomáticos. As ações educativas resultaram em conscientização e discussão entre os participantes, evidenciado por meio de avaliação teórica (&amp;amp;gt; 95%), bem como no OSCE, onde o nível de sucessos foi maior no grupo exposto quando comparado ao grupo não exposto (p = 0,001). Conclusão: a implementação da campanha CW melhorou as habilidades clínicas dos estudantes do internato em clínica médica e permitiu discussões positivas sobre custo-consciência em saúde.</style></abstract><urls><related-urls><url><style face="normal" font="default" size="100%">http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S0100-55022020000300212</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2200</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2200</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Mianji, F.</style></author><author><style face="normal" font="default" size="100%">Kirmayer, L. J.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Division of Social and Transcultural Psychiatry, Department of Psychiatry, McGill University, Montreal, Canada. fahimehmianji@gmail.com.&#xD;Culture and Mental Health Research Unit, Institute of Community and Family Psychiatry, 4333 Chemin de la Côte Ste-Catherine, Montreal, QC, H3T 1E4, Canada. fahimehmianji@gmail.com.&#xD;Division of Social and Transcultural Psychiatry, Department of Psychiatry, McGill University, Montreal, Canada.&#xD;Culture and Mental Health Research Unit, Institute of Community and Family Psychiatry, 4333 Chemin de la Côte Ste-Catherine, Montreal, QC, H3T 1E4, Canada.</style></auth-address><titles><title><style face="normal" font="default" size="100%">The Globalization of Biological Psychiatry and the Rise of Bipolar Spectrum Disorder in Iran</style></title><secondary-title><style face="normal" font="default" size="100%">Cult Med Psychiatry</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Cult Med Psychiatry</style></full-title></periodical><pages><style face="normal" font="default" size="100%">404-432</style></pages><volume><style face="normal" font="default" size="100%">44</style></volume><number><style face="normal" font="default" size="100%">3</style></number><keywords><keyword><style face="normal" font="default" size="100%">Antipsychotic Agents/adverse effects</style></keyword><keyword><style face="normal" font="default" size="100%">*Biological Psychiatry</style></keyword><keyword><style face="normal" font="default" size="100%">Bipolar Disorder/*diagnosis/*therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">*Internationality</style></keyword><keyword><style face="normal" font="default" size="100%">Iran</style></keyword><keyword><style face="normal" font="default" size="100%">Medicalization</style></keyword><keyword><style face="normal" font="default" size="100%">United States</style></keyword><keyword><style face="normal" font="default" size="100%">Bipolar spectrum disorder</style></keyword><keyword><style face="normal" font="default" size="100%">Global mental health</style></keyword><keyword><style face="normal" font="default" size="100%">Globalization of American psychiatry</style></keyword><keyword><style face="normal" font="default" size="100%">Iranian psychiatric system</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2020</style></year><pub-dates><date><style face="normal" font="default" size="100%">Sep</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0165-005x</style></isbn><abstract><style face="normal" font="default" size="100%">In recent years, psychiatry in Iran witnessed a dramatic increase in the use of the diagnosis of bipolar spectrum disorder (BSD). This qualitative study maps the journey of the BSD diagnosis from the West to Iran, examines the controversy surrounding the diagnosis and its treatment, and explores some of the structural factors that facilitate and maintain the widespread use of the BSD diagnosis in Iran and related practices of prescribing neuroleptic and mood stabilizers. The study methods include archival research and semi-structured interviews with 25 prominent Iranian psychiatrists in the field of mood disorders. Results show the importance of factors in addition to economics in driving changes in diagnostic fashion. Most psychiatrists interviewed reported what they viewed as an over-diagnosis of bipolar disorder and over-prescription of mood stabilizers and atypical antipsychotics among Iranian psychiatrists over the past decade. In addition to the influence of leading figures of American psychiatry, the dominance of Western psychiatric classifications and textbooks in Iran&apos;s psychiatry, and indirect intervention by pharmaceutical companies, local structural and political factors have played a significant role in the Iranian psychiatric system&apos;s embrace of the new concept of bipolarity. In Iran, the medicalization of social conflict has been embraced by government, families, and psychiatrists for cross-cutting purposes. These challenges and the continued controversy over the adoption of American psychiatric fads in a non-Western country like Iran point to the importance of elaborating a more ecosocial and cultural view of psychiatric practice to disentangle some of the complex trade-offs involved in adopting particular modes of diagnostic practice.</style></abstract><notes><style face="normal" font="default" size="100%">1573-076x&#xD;Mianji, Fahimeh&#xD;Kirmayer, Laurence J&#xD;Journal Article&#xD;Netherlands&#xD;Cult Med Psychiatry. 2020 Sep;44(3):404-432. doi: 10.1007/s11013-019-09665-2.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://link.springer.com/content/pdf/10.1007/s11013-019-09665-2.pdf</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1007/s11013-019-09665-2</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2201</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2201</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Mosha, J. F.</style></author><author><style face="normal" font="default" size="100%">Conteh, L.</style></author><author><style face="normal" font="default" size="100%">Tediosi, F.</style></author><author><style face="normal" font="default" size="100%">Gesase, S.</style></author><author><style face="normal" font="default" size="100%">Bruce, J.</style></author><author><style face="normal" font="default" size="100%">Chandramohan, D.</style></author><author><style face="normal" font="default" size="100%">Gosling, R.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">National Institute for Medical Research, Mwanza, Tanzania.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Cost implications of improving malaria diagnosis: findings from north-eastern Tanzania</style></title><secondary-title><style face="normal" font="default" size="100%">PLoS One</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">PLoS ONE</style></full-title></periodical><pages><style face="normal" font="default" size="100%">e8707</style></pages><volume><style face="normal" font="default" size="100%">5</style></volume><number><style face="normal" font="default" size="100%">1</style></number><keywords><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Child, Preschool</style></keyword><keyword><style face="normal" font="default" size="100%">Cohort Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Cost Savings</style></keyword><keyword><style face="normal" font="default" size="100%">Cross-Sectional Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Diagnostic Techniques and Procedures/*economics</style></keyword><keyword><style face="normal" font="default" size="100%">*Health Care Costs</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Infant</style></keyword><keyword><style face="normal" font="default" size="100%">Malaria/*diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">Tanzania</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2010</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jan 14</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1932-6203</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: Over diagnosis of malaria contributes to improper treatment, wastage of drugs and resistance to the few available drugs. This paper attempts to estimate the rates of over diagnosis of malaria among children attending dispensaries in rural Tanzania and examines the potential cost implications of improving the quality of diagnosis. METHODOLOGY/PRINCIPAL FINDINGS: The magnitude of over diagnosis of malaria was estimated by comparing the proportion of outpatient attendees of all ages clinically diagnosed as malaria to the proportion of attendees having a positive malaria rapid diagnostic test over a two month period. Pattern of causes of illness observed in a &lt;2 year old cohort of children over one year was compared to the pattern of causes of illness in &lt;5 year old children recorded in the routine health care system during the same period. Drug and diagnostic costs were modelled using local and international prices. Over diagnosis of malaria by the routine outpatient care system compared to RDT confirmed cases of malaria was highest among &lt;5 year old children in the low transmission site (RR 17.9, 95% CI 5.8-55.3) followed by the &gt;or=5 year age group in the lower transmission site (RR 14.0 95%CI 8.2-24.2). In the low transmission site the proportion of morbidity attributable to malaria was substantially lower in &lt;2 year old cohort compared to children seen at routine care system. (0.08% vs 28.2%; p&lt;0.001). A higher proportion of children were diagnosed with ARI in the &lt;2 year old cohort compared to children seen at the routine care system ( 42% vs 26%; p&lt;0.001). Using a RDT reduced overall drug and diagnostic costs by 10% in the high transmission site and by 15% in the low transmission site compared to total diagnostic and drug costs of treatment based on clinical judgment in routine health care system. IMPLICATIONS: The introduction of RDTs is likely to lead to financial savings. However, improving diagnosis to one disease may lead to over diagnosis of another illness. Quality improvement is complex but introducing RDTs for the diagnosis of malaria is a good start.</style></abstract><notes><style face="normal" font="default" size="100%">1932-6203&#xD;Mosha, Jacklin F&#xD;Conteh, Lesong&#xD;Tediosi, Fabrizio&#xD;Gesase, Samwel&#xD;Bruce, Jane&#xD;Chandramohan, Daniel&#xD;Gosling, Roly&#xD;Journal Article&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;PLoS One. 2010 Jan 14;5(1):e8707. doi: 10.1371/journal.pone.0008707.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806838/pdf/pone.0008707.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC2806838</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1371/journal.pone.0008707</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2202</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2202</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Mudawi, H. M.</style></author><author><style face="normal" font="default" size="100%">Mohammed Ali, S. E.</style></author><author><style face="normal" font="default" size="100%">Dabora, A. A.</style></author><author><style face="normal" font="default" size="100%">El Tahir, M. A.</style></author><author><style face="normal" font="default" size="100%">Suliman, S. H.</style></author><author><style face="normal" font="default" size="100%">Salim, O. E.</style></author><author><style face="normal" font="default" size="100%">Elsiddig, H. D.</style></author><author><style face="normal" font="default" size="100%">Ibrahim, S. Z.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Internal Medicine, Faculty of Medicine, University of Khartoum, Khartoum, Sudan. hmudawi@hotmail.com</style></auth-address><titles><title><style face="normal" font="default" size="100%">American Society for Gastrointestinal Endoscopy guidelines for appropriate use of colonoscopy: are they suitable for African patients?</style></title><secondary-title><style face="normal" font="default" size="100%">Trop Doct</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Trop Doct</style></full-title></periodical><pages><style face="normal" font="default" size="100%">165-7</style></pages><volume><style face="normal" font="default" size="100%">42</style></volume><number><style face="normal" font="default" size="100%">3</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Colonoscopy/standards/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Colorectal Neoplasms/diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">Cross-Sectional Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Endoscopy, Gastrointestinal/standards/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Gastrointestinal Diseases/diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">Hospitals, University/standards</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">*Practice Guidelines as Topic</style></keyword><keyword><style face="normal" font="default" size="100%">Prospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Referral and Consultation/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Societies, Medical/*standards</style></keyword><keyword><style face="normal" font="default" size="100%">Sudan</style></keyword><keyword><style face="normal" font="default" size="100%">Unnecessary Procedures/standards/statistics &amp; numerical data</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2012</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jul</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0049-4755</style></isbn><abstract><style face="normal" font="default" size="100%">This study investigates the appropriateness and diagnostic yield of colonoscopy referrals in an African setting using the American Society of Gastrointestinal Endoscopy guidelines: a prospective, descriptive, cross-sectional hospital-based study. A total of 311 patients were included in the study; 228 referrals (73.3%) were considered appropriate and clinically significant pathology was found in 157 patients, giving an overall diagnostic yield of 50.5%. Diagnostic yield in those with appropriate referrals was 58.8% and 27.7% (P = 0.004) in those with inappropriate referrals. In our setting these guidelines are useful in improving diagnostic yield and reducing the rate of inappropriate referrals for colonoscopy. However, patients above the age of 50 presenting with lower gastrointestinal symptoms should undergo a colonoscopy even if the indication was inappropriate, especially in countries which are not implementing colorectal cancer screening programmes for average risk patients.</style></abstract><notes><style face="normal" font="default" size="100%">1758-1133&#xD;Mudawi, H M Y&#xD;Mohammed Ali, S E A&#xD;Dabora, A A&#xD;El Tahir, M A&#xD;Suliman, S H&#xD;Salim, O E F H&#xD;Elsiddig, H D&#xD;Ibrahim, S Z&#xD;Journal Article&#xD;England&#xD;Trop Doct. 2012 Jul;42(3):165-7. doi: 10.1258/td.2012.120081. Epub 2012 May 14.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://journals.sagepub.com/doi/10.1258/td.2012.120081?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%3dpubmed</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1258/td.2012.120081</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2203</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2203</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Muntean, V.</style></author><author><style face="normal" font="default" size="100%">Mihailov, A.</style></author><author><style face="normal" font="default" size="100%">Iancu, C.</style></author><author><style face="normal" font="default" size="100%">Toganel, R.</style></author><author><style face="normal" font="default" size="100%">Fabian, O.</style></author><author><style face="normal" font="default" size="100%">Domsa, I.</style></author><author><style face="normal" font="default" size="100%">Muntean, M. V.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Railway Clinical Hospital; University of Medicine and Pharmacy Cluj-Napoca, Romania; E-mail: valentin.muntean@gmail.com;</style></auth-address><titles><title><style face="normal" font="default" size="100%">Staging laparoscopy in gastric cancer. Accuracy and impact on therapy</style></title><secondary-title><style face="normal" font="default" size="100%">J Gastrointestin Liver Dis</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">J Gastrointestin Liver Dis</style></full-title></periodical><pages><style face="normal" font="default" size="100%">189-95</style></pages><volume><style face="normal" font="default" size="100%">18</style></volume><number><style face="normal" font="default" size="100%">2</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adenocarcinoma/*secondary/surgery</style></keyword><keyword><style face="normal" font="default" size="100%">Cytodiagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">Endosonography</style></keyword><keyword><style face="normal" font="default" size="100%">Gastrectomy</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">*Laparoscopy</style></keyword><keyword><style face="normal" font="default" size="100%">Liver Neoplasms/*secondary</style></keyword><keyword><style face="normal" font="default" size="100%">Lymphatic Metastasis</style></keyword><keyword><style face="normal" font="default" size="100%">Magnetic Resonance Imaging</style></keyword><keyword><style face="normal" font="default" size="100%">Neoadjuvant Therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Neoplasm Staging/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Palliative Care</style></keyword><keyword><style face="normal" font="default" size="100%">Patient Selection</style></keyword><keyword><style face="normal" font="default" size="100%">Peritoneal Neoplasms/*secondary</style></keyword><keyword><style face="normal" font="default" size="100%">Positron-Emission Tomography</style></keyword><keyword><style face="normal" font="default" size="100%">Predictive Value of Tests</style></keyword><keyword><style face="normal" font="default" size="100%">Prospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Romania</style></keyword><keyword><style face="normal" font="default" size="100%">Sensitivity and Specificity</style></keyword><keyword><style face="normal" font="default" size="100%">Stomach Neoplasms/*pathology/surgery</style></keyword><keyword><style face="normal" font="default" size="100%">Tomography, X-Ray Computed</style></keyword><keyword><style face="normal" font="default" size="100%">Unnecessary Procedures</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2009</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jun</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1841-8724 (Print)&#xD;1841-8724</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: Surgical therapy remains the most effective treatment modality in gastric cancer. The importance of multimodal treatment for advanced gastric cancer has contributed to the development of more accurate preoperative staging strategies. We examined the diagnostic accuracy of staging laparoscopy (SL) for abdominal metastases and the predictive value of SL for tumor resectability. MATERIAL AND METHOD: This is a prospective, cohort, observational study of 98 patients with primary gastric adenocarcinoma admitted at a tertiary referral hospital over a three year period. Extended SL, laparoscopic ultrasonography and peritoneal cytology were performed in 45 patients with gastric cancer without distant metastases on pre-therapeutic imaging staging. Of the 45 patients, 17 (37.8%) had distant metastases on SL and were offered palliative therapy and/or supportive care. Open laparotomy and gastrectomy was performed in the patients without distant metastases or with uncertain resectability on SL. RESULTS: An unnecessary laparotomy was avoided in 17 (37.8%) patients. The overall SL sensitivity for distant metastases was 89%, specificity 100% and diagnostic accuracy 95.5%. The sensitivity for lymph node metastases was 54.5%, the specificity 100% and the diagnostic accuracy 64.3%. The SL positive predictive value for resectability was 96% and the negative predictive value was 50%. The morbidity of SL was 2.2% and the mortality 0. CONCLUSION: Staging laparoscopy is a safe and effective staging modality in patients with gastric carcinoma. It avoids unnecessary laparotomies in a significant number of patients and should be mandatory if neoadjuvant treatment is planned.</style></abstract><label><style face="normal" font="default" size="100%">Included by Morty</style></label><notes><style face="normal" font="default" size="100%">Muntean, Valentin&#xD;Mihailov, Anca&#xD;Iancu, Cornel&#xD;Toganel, Razvan&#xD;Fabian, Ovidiu&#xD;Domsa, Iacob&#xD;Muntean, Maximilian Vlad&#xD;Journal Article&#xD;Multicenter Study&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Romania&#xD;J Gastrointestin Liver Dis. 2009 Jun;18(2):189-95.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.jgld.ro/jgld/index.php/jgld/article/download/2009.2.10/1029</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2204</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2204</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Muntean, V.</style></author><author><style face="normal" font="default" size="100%">Oniu, T.</style></author><author><style face="normal" font="default" size="100%">Lungoci, C.</style></author><author><style face="normal" font="default" size="100%">Fabian, O.</style></author><author><style face="normal" font="default" size="100%">Munteanu, D.</style></author><author><style face="normal" font="default" size="100%">Molnar, G.</style></author><author><style face="normal" font="default" size="100%">Bintintan, V.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">CF Clinical Hospital, Republicii 18, 400015 Cluj-Napoca, Romania. valentin.muntean@gmail.com</style></auth-address><titles><title><style face="normal" font="default" size="100%">Staging laparoscopy in digestive cancers</style></title><secondary-title><style face="normal" font="default" size="100%">J Gastrointestin Liver Dis</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">J Gastrointestin Liver Dis</style></full-title></periodical><pages><style face="normal" font="default" size="100%">461-7</style></pages><volume><style face="normal" font="default" size="100%">18</style></volume><number><style face="normal" font="default" size="100%">4</style></number><keywords><keyword><style face="normal" font="default" size="100%">Digestive System Neoplasms/*diagnosis/diagnostic imaging/secondary/surgery</style></keyword><keyword><style face="normal" font="default" size="100%">*Endosonography</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">*Laparoscopy</style></keyword><keyword><style face="normal" font="default" size="100%">Liver Neoplasms/*diagnosis/diagnostic imaging/secondary/surgery</style></keyword><keyword><style face="normal" font="default" size="100%">Neoplasm Staging/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Patient Selection</style></keyword><keyword><style face="normal" font="default" size="100%">Peritoneal Lavage</style></keyword><keyword><style face="normal" font="default" size="100%">Predictive Value of Tests</style></keyword><keyword><style face="normal" font="default" size="100%">Prospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Romania</style></keyword><keyword><style face="normal" font="default" size="100%">Sensitivity and Specificity</style></keyword><keyword><style face="normal" font="default" size="100%">Unnecessary Procedures</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2009</style></year><pub-dates><date><style face="normal" font="default" size="100%">Dec</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1841-8724 (Print)&#xD;1841-8724</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND. Laparoscopy and laparoscopic ultrasonography may assist in the more accurate staging of digestive cancers. We assessed the diagnostic value of staging laparoscopy in patients with cancers of lower esophagus, stomach, liver, biliary tract, pancreas and colon. MATERIAL AND METHOD. Extended staging laparoscopy, laparoscopic ultrasonography and peritoneal cytology were performed in 165 patients with primary digestive cancers, admitted between January 2006 and December 2008 at three tertiary referral hospitals participating in the study. Staging laparoscopy was immediately followed by open surgery in 63 patients without distant metastases or with uncertain primary tumor resectability, and in 20 colorectal cancer patients with resectable hepatic metastases. The sensibility, sensitivity and diagnostic accuracy of staging laparoscopy for distant metastases and tumor resectability were assessed against the findings on open surgery and the final pathological report. RESULTS. An unnecessary laparotomy was avoided in 36 of the 99 patients (36.4%) without distant metastases on imaging pre-therapeutic staging. The staging laparoscopy sensitivity for distant metastases varied between 66% and 100% and the diagnostic accuracy between 87% for the lower esophageal cancer and 100% for the biliary tract tumors. The overall morbidity of staging laparoscopy was 2.5% and the mortality 0. CONCLUSION. Staging laparoscopy avoids unnecessary laparotomies and changes the therapeutic plan in a significant number of patients. It can be performed just before the planned surgery or as a separate diagnostic procedure. The laparoscopy indications in digestive cancers are changing fast, with ongoing new developments in cancer treatment and laparoscopic technology.</style></abstract><label><style face="normal" font="default" size="100%">Included by Morty</style></label><notes><style face="normal" font="default" size="100%">Muntean, Valentin&#xD;Oniu, Traian&#xD;Lungoci, Corneliu&#xD;Fabian, Ovidiu&#xD;Munteanu, Doru&#xD;Molnar, Geza&#xD;Bintintan, Vasile&#xD;Journal Article&#xD;Multicenter Study&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Romania&#xD;J Gastrointestin Liver Dis. 2009 Dec;18(4):461-7.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.jgld.ro/jgld/index.php/jgld/article/download/2009.4.8/1078</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2205</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2205</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Muro, F. J.</style></author><author><style face="normal" font="default" size="100%">Zamsaeur, N.</style></author><author><style face="normal" font="default" size="100%">Wangai, H.</style></author><author><style face="normal" font="default" size="100%">Mtove, G.</style></author><author><style face="normal" font="default" size="100%">Todd, J.</style></author><author><style face="normal" font="default" size="100%">Olomi, R.</style></author><author><style face="normal" font="default" size="100%">Reyburn, H.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">F.J. Muro, Kilimanjaro Christian Medical University College, Moshi, Tanzania</style></auth-address><titles><title><style face="normal" font="default" size="100%">The accuracy of non severe pneumonia diagnosis in tanzanian children: The validity of the respiratory rate</style></title><secondary-title><style face="normal" font="default" size="100%">American Journal of Tropical Medicine and Hygiene</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">American Journal of Tropical Medicine and Hygiene</style></full-title></periodical><pages><style face="normal" font="default" size="100%">168</style></pages><volume><style face="normal" font="default" size="100%">91</style></volume><number><style face="normal" font="default" size="100%">5</style></number><keywords><keyword><style face="normal" font="default" size="100%">antibiotic agent</style></keyword><keyword><style face="normal" font="default" size="100%">vaccine</style></keyword><keyword><style face="normal" font="default" size="100%">pneumonia</style></keyword><keyword><style face="normal" font="default" size="100%">diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">child</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">validity</style></keyword><keyword><style face="normal" font="default" size="100%">breathing rate</style></keyword><keyword><style face="normal" font="default" size="100%">society</style></keyword><keyword><style face="normal" font="default" size="100%">tropical medicine</style></keyword><keyword><style face="normal" font="default" size="100%">hygiene</style></keyword><keyword><style face="normal" font="default" size="100%">infant</style></keyword><keyword><style face="normal" font="default" size="100%">hospital</style></keyword><keyword><style face="normal" font="default" size="100%">reading</style></keyword><keyword><style face="normal" font="default" size="100%">groups by age</style></keyword><keyword><style face="normal" font="default" size="100%">dyspnea</style></keyword><keyword><style face="normal" font="default" size="100%">coughing</style></keyword><keyword><style face="normal" font="default" size="100%">antibiotic therapy</style></keyword><keyword><style face="normal" font="default" size="100%">diseases</style></keyword><keyword><style face="normal" font="default" size="100%">breathing</style></keyword><keyword><style face="normal" font="default" size="100%">childhood</style></keyword><keyword><style face="normal" font="default" size="100%">statistical model</style></keyword><keyword><style face="normal" font="default" size="100%">bacterial pneumonia</style></keyword><keyword><style face="normal" font="default" size="100%">outpatient department</style></keyword><keyword><style face="normal" font="default" size="100%">public health</style></keyword><keyword><style face="normal" font="default" size="100%">classification</style></keyword><keyword><style face="normal" font="default" size="100%">risk factor</style></keyword><keyword><style face="normal" font="default" size="100%">environment</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2014</style></year></dates><isbn><style face="normal" font="default" size="100%">0002-9637</style></isbn><abstract><style face="normal" font="default" size="100%">Integrated Management of Childhood Illness (IMCI) guidelines recommend antibiotic treatment to all children presenting with cough or difficult breathing and an increased respiratory rate for their age. However, many pneumonia diagnoses in resource poor settings are done on the bases of sub-optimal condition; the environment may not be conducive for counting respiratory rates. We conducted a study to determine if respiratory rate was likely to be transiently raised by a number of contextual factors in a busy clinic leading to overuse of antibiotics. Respiratory rates were recorded in children aged 2 - 59 months presenting with cough or difficulty breathing to one of the two busy outpatient clinics and then repeated at 10 minute intervals over 1 hour in a quiet setting. A total of 167 children were enrolled with a mean age of 7.1 (SD±2.9) months in infant and 27.6 (SD±2.8) months in the older age group. The mean respiratory rate declined from 37.5 breaths per minute (bpm) at clinic to 35.8 bpm initial reading at quiet room and 35.0 bpm final reading (p&lt;0.02). This resulted in 11(85%) being mis-classified with non severe pneumonia in infants and 2(13%) in older children. In a logistic model age group (infant or older child) was the only risk factor associated with over-diagnosis of non severe pneumonia. Over-diagnosis of non severe pneumonia in a busy clinic is significant and it tends to vary with age. Changing the respiratory rates cut-offs to higher threshold reduced the proportion of non-severe pneumonia mis-classification in infants. These findings have public health impact in managing these children as antibiotic over-use accelerates high levels of resistance. More studies of the accuracy and utility of respiratory rate as an indication for antibiotics are needed, especially as vaccines against bacterial pneumonia are introduced to many resource poor countries.</style></abstract><notes><style face="normal" font="default" size="100%">L71691787&#xD;2014-12-01</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.embase.com/search/results?subaction=viewrecord&amp;id=L71691787&amp;from=export</style></url><url><style face="normal" font="default" size="100%">http://www.ajtmh.org/content/91/5_Suppl_1/149.full.pdf+html</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2206</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2206</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Muwonge, R.</style></author><author><style face="normal" font="default" size="100%">Wesley, R. S.</style></author><author><style face="normal" font="default" size="100%">Nene, B. M.</style></author><author><style face="normal" font="default" size="100%">Shastri, S. S.</style></author><author><style face="normal" font="default" size="100%">Jayant, K.</style></author><author><style face="normal" font="default" size="100%">Malvi, S. G.</style></author><author><style face="normal" font="default" size="100%">Thara, S.</style></author><author><style face="normal" font="default" size="100%">Sankaranarayanan, R.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">R. Sankaranarayanan, Screening Group, Early Detection and Prevention Section, International Agency for Research on Cancer (WHO-IARC), 150 cours Albert Thomas, 69372 Lyon Cedex 08, France</style></auth-address><titles><title><style face="normal" font="default" size="100%">Evaluation of cytology and visual triage of human papillomavirus-positive women in cervical cancer prevention in India</style></title><secondary-title><style face="normal" font="default" size="100%">International Journal of Cancer</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">International Journal of Cancer</style></full-title></periodical><pages><style face="normal" font="default" size="100%">2902-2909</style></pages><volume><style face="normal" font="default" size="100%">134</style></volume><number><style face="normal" font="default" size="100%">12</style></number><keywords><keyword><style face="normal" font="default" size="100%">acetic acid</style></keyword><keyword><style face="normal" font="default" size="100%">adult</style></keyword><keyword><style face="normal" font="default" size="100%">article</style></keyword><keyword><style face="normal" font="default" size="100%">cancer grading</style></keyword><keyword><style face="normal" font="default" size="100%">cancer prevention</style></keyword><keyword><style face="normal" font="default" size="100%">clinical evaluation</style></keyword><keyword><style face="normal" font="default" size="100%">colposcopy</style></keyword><keyword><style face="normal" font="default" size="100%">controlled study</style></keyword><keyword><style face="normal" font="default" size="100%">cross-sectional study</style></keyword><keyword><style face="normal" font="default" size="100%">cytology</style></keyword><keyword><style face="normal" font="default" size="100%">emergency health service</style></keyword><keyword><style face="normal" font="default" size="100%">female</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">India</style></keyword><keyword><style face="normal" font="default" size="100%">major clinical study</style></keyword><keyword><style face="normal" font="default" size="100%">middle aged</style></keyword><keyword><style face="normal" font="default" size="100%">papillomavirus infection</style></keyword><keyword><style face="normal" font="default" size="100%">priority journal</style></keyword><keyword><style face="normal" font="default" size="100%">uterine cervix biopsy</style></keyword><keyword><style face="normal" font="default" size="100%">uterine cervix carcinoma in situ</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2014</style></year></dates><isbn><style face="normal" font="default" size="100%">1097-0215&#xD;0020-7136</style></isbn><abstract><style face="normal" font="default" size="100%">Although virtually all cervical cancers and most cervical intraepithelial neoplasia (CIN) are caused by persistent human papillomavirus (HPV) infection, only a small proportion of HPV-positive women have or will develop CIN. Triaging HPV-positive women has been suggested to reduce the false-positive rate and proportion of women referred for CIN confirmation and/or treatment. In two cross-sectional studies and one randomized trial in India, we evaluated the impact of using cytology or visual inspection with acetic acid (VIA) to triage HPV-positive women on the proportion of women who would be referred for CIN confirmation and on the detection rates of high-grade CIN. We present the numbers of HPV test-positive women found and the CIN detected among them. We further assess the proportions that would be referred for CIN confirmation with colposcopy/biopsy and CIN that would be detected if cytology triage or VIA triage were used. Using cytology triage at atypical squamous cells of undetermined significance threshold or VIA triage reduced referrals for colposcopy by about 62% and 59%, respectively (p-value = 0.012), but missed around 16% and 18%, respectively, of the high-grade CIN (p-value = 0.539) indicating similar performance of both triaging approaches. The choice of a triage test in different low- and middle-income countries (LMIC) would depend on the availability and affordability in the particular setting. Cytology triage may be considered in settings where adequate infrastructure exists, whereas VIA triage may be suitable in settings with limited or no cytology infrastructure. What&apos;s new? Information on appropriate and feasible methods for the triage of HPV-positive women is lacking for low- and middle-income countries, even though it could reduce overtreatment or unnecessary colposcopy referral. Here, the use of cytology or visual inspection with acetic acid (VIA) were investigated for HPV-positive triage in India. Cytology and VIA were found to reduce referrals for colposcopy by about 62% and 59%, respectively. However, they also missed 16% and 18% of high-grade cervical intraepithelial neoplasias. The similar performance of the two approaches suggests that availability and affordability could influence their use in different settings. © 2013 UICC.</style></abstract><notes><style face="normal" font="default" size="100%">L52897123&#xD;2013-12-05&#xD;2014-05-01</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.embase.com/search/results?subaction=viewrecord&amp;id=L52897123&amp;from=export</style></url><url><style face="normal" font="default" size="100%">http://dx.doi.org/10.1002/ijc.28627</style></url><url><style face="normal" font="default" size="100%">https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ijc.28627?download=true</style></url></related-urls></urls><custom5><style face="normal" font="default" size="100%">24272364</style></custom5><electronic-resource-num><style face="normal" font="default" size="100%">10.1002/ijc.28627</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2207</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2207</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Mwanziva, C.</style></author><author><style face="normal" font="default" size="100%">Manjurano, A.</style></author><author><style face="normal" font="default" size="100%">Mbugi, E.</style></author><author><style face="normal" font="default" size="100%">Mweya, C.</style></author><author><style face="normal" font="default" size="100%">Mkali, H.</style></author><author><style face="normal" font="default" size="100%">Kivuyo, M. P.</style></author><author><style face="normal" font="default" size="100%">Sanga, A.</style></author><author><style face="normal" font="default" size="100%">Ndaro, A.</style></author><author><style face="normal" font="default" size="100%">Chambo, W.</style></author><author><style face="normal" font="default" size="100%">Mkwizu, A.</style></author><author><style face="normal" font="default" size="100%">Kitau, J.</style></author><author><style face="normal" font="default" size="100%">Kavishe, R.</style></author><author><style face="normal" font="default" size="100%">Dolmans, W.</style></author><author><style face="normal" font="default" size="100%">Chilongola, J.</style></author><author><style face="normal" font="default" size="100%">Mosha, F. W.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Kilimanjaro Clinical Research Institute, Moshi, Tanzania. cmwanziva@yahoo.com</style></auth-address><titles><title><style face="normal" font="default" size="100%">Defining malaria burden from morbidity and mortality records, self treatment practices and serological data in Magugu, Babati District, northern Tanzania</style></title><secondary-title><style face="normal" font="default" size="100%">Tanzan J Health Res</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Tanzan J Health Res</style></full-title></periodical><pages><style face="normal" font="default" size="100%">97-105</style></pages><volume><style face="normal" font="default" size="100%">13</style></volume><number><style face="normal" font="default" size="100%">2</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Antimalarials/therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Child, Preschool</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Infant</style></keyword><keyword><style face="normal" font="default" size="100%">Malaria/diagnosis/drug therapy/*epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mosquito Nets/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Prevalence</style></keyword><keyword><style face="normal" font="default" size="100%">Prospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Retrospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Self Care</style></keyword><keyword><style face="normal" font="default" size="100%">Seroepidemiologic Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Tanzania/epidemiology</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2011</style></year><pub-dates><date><style face="normal" font="default" size="100%">Apr</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1821-6404 (Print)&#xD;1821-9241</style></isbn><abstract><style face="normal" font="default" size="100%">Malaria morbidity and mortality data from clinical records provide essential information towards defining disease burden in the area and for planning control strategies, but should be augmented with data on transmission intensity and serological data as measures for exposure to malaria. The objective of this study was to estimate the malaria burden based on serological data and prevalence of malaria, and compare it with existing self-treatment practices in Magugu in Babati District of northern Tanzania. Prospectively, 470 individuals were selected for the study. Both microscopy and Rapid Diagnostic Test (RDT) were used for malaria diagnosis. Seroprevalence of antibodies to merozoite surface proteins (MSP-1(19)) and apical membrane antigen (AMA-1) was performed and the entomological inoculation rate (EIR) was estimated. To complement this information, retrospective data on treatment history, prescriptions by physicians and use of bed nets were collected. Malaria prevalence in the area was 6.8% (32/470). Of 130 individuals treated with artemisinin combination therapy (ACT), 22.3% (29/130) were slide confirmed while 75.3% (98/130) of them were blood smear negative. Three of the slides confirmed individuals were not treated with ACT. Fever was reported in 38.2% of individuals, of whom 48.8% (88/180) were given ACT. Forty-two (32.3%) of those who received ACT had no history of fever. About half (51.1%) of those treated with ACT were children &lt; 10 years old. Immunoglobulin against MSP-119 was positive in 16.9% (74/437) while against AMA-1 was positive in 29.8% (130/436). Transmission intensity was estimated at &lt;0.2 infectious bites per person per year. The RDT was highly specific (96.3%) but with low sensitivity (15.6%). In conclusion, Magugu is a low endemic area. There is substantial over diagnosis, over treatment and self treatment in the community. The burden of malaria based on medical records is over estimated as was mostly presumptive. The low sensitivity of RDT reflects the low number of immune individuals as well as the low parasite density.</style></abstract><label><style face="normal" font="default" size="100%">Included by Ray</style></label><notes><style face="normal" font="default" size="100%">Mwanziva, Charles&#xD;Manjurano, Alphaxard&#xD;Mbugi, Erasto&#xD;Mweya, Clement&#xD;Mkali, Humphrey&#xD;Kivuyo, Maggie P&#xD;Sanga, Alex&#xD;Ndaro, Arnold&#xD;Chambo, William&#xD;Mkwizu, Abas&#xD;Kitau, Jovin&#xD;Kavishe, Reginald&#xD;Dolmans, Wil&#xD;Chilongola, Jaffu&#xD;Mosha, Franklin W&#xD;Journal Article&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Tanzania&#xD;Tanzan J Health Res. 2011 Apr;13(2):97-105. doi: 10.4314/thrb.v13i2.62980.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ajol.info/index.php/thrb/article/download/62980/54120</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.4314/thrb.v13i2.62980</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2208</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2208</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Mwanziva, C.</style></author><author><style face="normal" font="default" size="100%">Shekalaghe, S.</style></author><author><style face="normal" font="default" size="100%">Ndaro, A.</style></author><author><style face="normal" font="default" size="100%">Mengerink, B.</style></author><author><style face="normal" font="default" size="100%">Megiroo, S.</style></author><author><style face="normal" font="default" size="100%">Mosha, F.</style></author><author><style face="normal" font="default" size="100%">Sauerwein, R.</style></author><author><style face="normal" font="default" size="100%">Drakeley, C.</style></author><author><style face="normal" font="default" size="100%">Gosling, R.</style></author><author><style face="normal" font="default" size="100%">Bousema, T.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Medical Microbiology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. cmwanziva@yahoo.com</style></auth-address><titles><title><style face="normal" font="default" size="100%">Overuse of artemisinin-combination therapy in Mto wa Mbu (river of mosquitoes), an area misinterpreted as high endemic for malaria</style></title><secondary-title><style face="normal" font="default" size="100%">Malar J</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Malar J</style></full-title></periodical><pages><style face="normal" font="default" size="100%">232</style></pages><volume><style face="normal" font="default" size="100%">7</style></volume><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Age Distribution</style></keyword><keyword><style face="normal" font="default" size="100%">Animals</style></keyword><keyword><style face="normal" font="default" size="100%">Anopheles/parasitology</style></keyword><keyword><style face="normal" font="default" size="100%">Antibodies, Protozoan/blood</style></keyword><keyword><style face="normal" font="default" size="100%">Artemisinins/*administration &amp; dosage</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Child, Preschool</style></keyword><keyword><style face="normal" font="default" size="100%">Drug Therapy, Combination</style></keyword><keyword><style face="normal" font="default" size="100%">*Endemic Diseases</style></keyword><keyword><style face="normal" font="default" size="100%">Ethanolamines/*administration &amp; dosage</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Fluorenes/*administration &amp; dosage</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Infant</style></keyword><keyword><style face="normal" font="default" size="100%">Lumefantrine</style></keyword><keyword><style face="normal" font="default" size="100%">Malaria/*diagnosis/*drug therapy/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Parasitemia/*diagnosis/*drug therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Rain</style></keyword><keyword><style face="normal" font="default" size="100%">Rural Health Services</style></keyword><keyword><style face="normal" font="default" size="100%">Seroepidemiologic Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Tanzania/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2008</style></year><pub-dates><date><style face="normal" font="default" size="100%">Nov 5</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1475-2875</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: Adequate malaria diagnosis and treatment remain major difficulties in rural sub-Saharan Africa. These issues deserve renewed attention in the light of first-line treatment with expensive artemisinin-combination therapy (ACT) and changing patterns of transmission intensity. This study describes diagnostic and treatment practices in Mto wa Mbu, an area that used to be hyperendemic for malaria, but where no recent assessments of transmission intensity have been conducted. METHODS: Retrospective and prospective data were collected from the two major village health clinics. The diagnosis in prospectively collected data was confirmed by microscopy. The level of transmission intensity was determined by entomological assessment and by estimating sero-conversion rates using anti-malarial antibody responses. RESULTS: Malaria transmission intensity by serological assessment was equivalent to &lt; 1 infectious bites per person per year. Despite low transmission intensity, &gt; 40% of outpatients attending the clinics in 2006-2007 were diagnosed with malaria. Prospective data demonstrated a very high overdiagnosis of malaria. Microscopy was unreliable with &lt; 1% of slides regarded as malaria parasite-positive by clinic microscopists being confirmed by trained research microscopists. In addition, many &apos;slide negatives&apos; received anti-malarial treatment. As a result, 99.6% (248/249) of the individuals who were treated with ACT were in fact free of malaria parasites. CONCLUSION: Transmission intensity has dropped considerably in the area of Mto wa Mbu. Despite this, most fevers are still regarded and treated as malaria, thereby ignoring true causes of febrile illness and over-prescribing ACT. The discrepancy between the perceived and actual level of transmission intensity may be present in many areas in sub-Saharan Africa and calls for greater efforts in defining levels of transmission on a local scale to help rational drug-prescribing behaviour.</style></abstract><notes><style face="normal" font="default" size="100%">1475-2875&#xD;Mwanziva, Charles&#xD;Shekalaghe, Seif&#xD;Ndaro, Arnold&#xD;Mengerink, Bianca&#xD;Megiroo, Simon&#xD;Mosha, Frank&#xD;Sauerwein, Robert&#xD;Drakeley, Chris&#xD;Gosling, Roly&#xD;Bousema, Teun&#xD;078925/Wellcome Trust/United Kingdom&#xD;Journal Article&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Malar J. 2008 Nov 5;7:232. doi: 10.1186/1475-2875-7-232.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2588630/pdf/1475-2875-7-232.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC2588630</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1186/1475-2875-7-232</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2209</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2209</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Na, R.</style></author><author><style face="normal" font="default" size="100%">Ye, D.</style></author><author><style face="normal" font="default" size="100%">Qi, J.</style></author><author><style face="normal" font="default" size="100%">Liu, F.</style></author><author><style face="normal" font="default" size="100%">Helfand, B. T.</style></author><author><style face="normal" font="default" size="100%">Brendler, C. B.</style></author><author><style face="normal" font="default" size="100%">Conran, C. A.</style></author><author><style face="normal" font="default" size="100%">Packiam, V.</style></author><author><style face="normal" font="default" size="100%">Gong, J.</style></author><author><style face="normal" font="default" size="100%">Wu, Y.</style></author><author><style face="normal" font="default" size="100%">Zheng, S. L.</style></author><author><style face="normal" font="default" size="100%">Mo, Z.</style></author><author><style face="normal" font="default" size="100%">Ding, Q.</style></author><author><style face="normal" font="default" size="100%">Sun, Y.</style></author><author><style face="normal" font="default" size="100%">Xu, J.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Urology, Huashan Hospital, Fudan University, Shanghai, PR China.&#xD;Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, PR China.&#xD;Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, Illinois.&#xD;Department of Surgery, Pritzker School of Medicine, University of Chicago, Chicago, Illinois.&#xD;Fudan Universtiy Shanghai Medical College, Shanghai, PR China.&#xD;Department of Urology, Shanghai Cancer Center, Fudan University, Shanghai, PR China.&#xD;Department of Urology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, PR China.&#xD;Division of Urology, NorthShore University HealthSystem, Evanston, Illinois.&#xD;Center for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, Guangxi, PR China.&#xD;Department of Urology, Shanghai Changhai Hospital, The Second Military Medical University, Shanghai, PR China.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Prostate health index significantly reduced unnecessary prostate biopsies in patients with PSA 2-10 ng/mL and PSA &gt;10 ng/mL: Results from a Multicenter Study in China</style></title><secondary-title><style face="normal" font="default" size="100%">Prostate</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Prostate</style></full-title></periodical><pages><style face="normal" font="default" size="100%">1221-1229</style></pages><volume><style face="normal" font="default" size="100%">77</style></volume><number><style face="normal" font="default" size="100%">11</style></number><keywords><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Biomarkers/blood</style></keyword><keyword><style face="normal" font="default" size="100%">Biopsy/trends</style></keyword><keyword><style face="normal" font="default" size="100%">China/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Cohort Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Health Status</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Kallikreins/*blood</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Prospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Prostate/*pathology</style></keyword><keyword><style face="normal" font="default" size="100%">Prostate-Specific Antigen/*blood</style></keyword><keyword><style face="normal" font="default" size="100%">Unnecessary Procedures/*trends</style></keyword><keyword><style face="normal" font="default" size="100%">Chinese</style></keyword><keyword><style face="normal" font="default" size="100%">Prostate Health Index</style></keyword><keyword><style face="normal" font="default" size="100%">p2PSA</style></keyword><keyword><style face="normal" font="default" size="100%">prostate biopsy</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style face="normal" font="default" size="100%">Aug</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0270-4137</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: The performance of prostate health index (phi) in predicting prostate biopsy outcomes has been well established for patients with prostate-specific antigen (PSA) values between 2 and 10 ng/mL. However, the performance of phi remains unknown in patients with PSA &gt;10 ng/mL, the vast majority in Chinese biopsy patients. We aimed to assess the ability of phi to predict prostate cancer (PCa) and high-grade disease (Gleason Score ≥7) on biopsy in a Chinese population. METHODS: This is a prospective, observational, multi-center study of consecutive patients who underwent a transrectal ultrasound guided prostate biopsy at four hospitals in Shanghai, China from August 2013 to December 2014. RESULTS: In the cohort of 1538 patients, the detection rate of PCa was 40.2%. phi had a significantly better predictive performance for PCa than total PSA (tPSA). The areas under the receiver operating characteristic curve (AUC) were 0.90 and 0.79 for phi and tPSA, respectively, P &lt; 0.0001. A considerable proportion of patients in the cohort had PSAs &gt;10 ng/mL (N = 838, 54.5%). The detection rates of PCa were 35.9% and 57.7% in patients with tPSA 10.1-20 and 20.1-50 ng/mL, respectively. The AUCs of phi (0.79 and 0.89, for these two groups, respectively) were also significantly higher than tPSA (0.57 and 0.63, respectively), both P &lt; 0.0001. If a phi ≤35 was used as the cutoff, 599/1538 (39%) biopsies could have been avoided at a cost of missing small numbers of PCa patients: 49 (7.93%) PCa patients, including 18 (3.69%) high-grade tumors. CONCLUSIONS: Results from this study suggest that phi can be used to predict PCa and high-grade disease in Chinese men with high PSA levels (&gt;10 ng/mL).</style></abstract><label><style face="normal" font="default" size="100%">Included by Loai</style></label><notes><style face="normal" font="default" size="100%">1097-0045&#xD;Na, Rong&#xD;Ye, Dingwei&#xD;Qi, Jun&#xD;Liu, Fang&#xD;Helfand, Brian T&#xD;Brendler, Charles B&#xD;Conran, Carly A&#xD;Packiam, Vignesh&#xD;Gong, Jian&#xD;Wu, Yishuo&#xD;Zheng, Siqun L&#xD;Mo, Zengnan&#xD;Ding, Qiang&#xD;Sun, Yinghao&#xD;Xu, Jianfeng&#xD;Orcid: 0000-0002-9419-6627&#xD;Journal Article&#xD;Multicenter Study&#xD;Observational Study&#xD;United States&#xD;Prostate. 2017 Aug;77(11):1221-1229. doi: 10.1002/pros.23382. Epub 2017 Jun 30.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://onlinelibrary.wiley.com/doi/abs/10.1002/pros.23382</style></url><url><style face="normal" font="default" size="100%">https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pros.23382?download=true</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1002/pros.23382</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2210</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2210</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nagendra, L.</style></author><author><style face="normal" font="default" size="100%">Bhavani, N.</style></author><author><style face="normal" font="default" size="100%">Menon, V. U.</style></author><author><style face="normal" font="default" size="100%">Pavithran, P. V.</style></author><author><style face="normal" font="default" size="100%">Menon, A. S.</style></author><author><style face="normal" font="default" size="100%">Abraham, N.</style></author><author><style face="normal" font="default" size="100%">Nair, V.</style></author><author><style face="normal" font="default" size="100%">Kumar, H.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Endocrinology, K.S. Hegde Medical Academy, P.O. Nityanandanagar, Mangalore, Karnataka, 575018, India. drlakshminagendra@gmail.com.&#xD;Department of Endocrinology, Amrita Institute of Medical Sciences, Cochin, Kerala, India.</style></auth-address><titles><title><style face="normal" font="default" size="100%">FRAX-based osteoporosis treatment guidelines for resource-poor settings in India</style></title><secondary-title><style face="normal" font="default" size="100%">Arch Osteoporos</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Arch Osteoporos</style></full-title></periodical><pages><style face="normal" font="default" size="100%">69</style></pages><volume><style face="normal" font="default" size="100%">16</style></volume><number><style face="normal" font="default" size="100%">1</style></number><keywords><keyword><style face="normal" font="default" size="100%">Absorptiometry, Photon</style></keyword><keyword><style face="normal" font="default" size="100%">Bone Density</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">India/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">*Osteoporosis/diagnostic imaging/drug therapy/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">*Osteoporotic Fractures/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Assessment</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">*frax</style></keyword><keyword><style face="normal" font="default" size="100%">*Fracture probability</style></keyword><keyword><style face="normal" font="default" size="100%">*India</style></keyword><keyword><style face="normal" font="default" size="100%">*Intervention threshold</style></keyword><keyword><style face="normal" font="default" size="100%">*Osteoporosis</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2021</style></year><pub-dates><date><style face="normal" font="default" size="100%">Apr 14</style></date></pub-dates></dates><abstract><style face="normal" font="default" size="100%">Using the FRAX® model for India, thresholds for osteoporosis evaluation and treatment without bone mineral density measurement were derived and were validated in a cohort of 300 patients. We suggest the use of this newer age and ethnic-specific FRAX®-derived thresholds for management of osteoporosis in India. PURPOSE: Our study aimed to formulate population-specific intervention thresholds for treatment of osteoporosis in India which can be used even without dual X-ray absorptiometry (DXA). METHODS: Using the FRAX® model for India, thresholds for different age groups for men and women were calculated without bone mineral density (BMD) measurement. The lower assessment threshold (LAT) was based on the 10-year probability of a major osteoporosis fracture (MOF) or hip fracture (HF) equivalent to patients without clinical risk factors. The intervention threshold (IT) was based on the 10-year probability equivalent to patients with fracture. The upper assessment threshold (UAT) was set at 1.2 times the IT. Probability-based thresholds for no intervention (LAT), treatment initiation (UAT) and BMD assessment (between LAT and UAT) were derived. The thresholds were validated in a cohort of 300 patients who were referred for BMD testing. RESULTS: Graphs for age, gender, BMI and ethnic-specific LAT, IT and UAT for MOF and HF are derived. In the validation cohort, BMD testing to initiate/defer treatment was required in only 32.3% patients. The intervention thresholds derived without BMD testing were valid in 98.7% patients. Use of National Osteoporosis Foundation (NOF) guidelines would have resulted in overtreatment in 56/300 (18.6%) patients. CONCLUSION: We suggest the use of this newer age and ethnic-specific FRAX®-derived thresholds for management of osteoporosis. Adopting these cut-offs will ensure that those requiring osteoporosis treatment will not be denied of it just because of lack of a DXA machine and will also help avoid overtreatment.</style></abstract><label><style face="normal" font="default" size="100%">Included by Loai</style></label><notes><style face="normal" font="default" size="100%">1862-3514&#xD;Nagendra, Lakshmi&#xD;Orcid: 0000-0001-6865-5554&#xD;Bhavani, Nisha&#xD;Menon, V Usha&#xD;Pavithran, Praveen V&#xD;Menon, Arun S&#xD;Abraham, Nithya&#xD;Nair, Vasantha&#xD;Kumar, Harish&#xD;Journal Article&#xD;England&#xD;Arch Osteoporos. 2021 Apr 14;16(1):69. doi: 10.1007/s11657-021-00931-8.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://link.springer.com/article/10.1007%2Fs11657-021-00931-8</style></url><url><style face="normal" font="default" size="100%">https://link.springer.com/content/pdf/10.1007/s11657-021-00931-8.pdf</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1007/s11657-021-00931-8</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2211</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2211</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nana, S. U. N.</style></author><author><style face="normal" font="default" size="100%">Chang, L. I. U.</style></author><author><style face="normal" font="default" size="100%">Qiuxia, Feng</style></author><author><style face="normal" font="default" size="100%">Xisheng, L. I. U.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">CT imaging features of peritoneal metastasis of gastric cancer</style></title><secondary-title><style face="normal" font="default" size="100%">Chinese Journal of Digestive Surgery</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Chinese Journal of Digestive Surgery</style></full-title></periodical><pages><style face="normal" font="default" size="100%">1154-1159</style></pages><number><style face="normal" font="default" size="100%">12</style></number><dates><year><style face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style face="normal" font="default" size="100%">2017/00</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1673-9752</style></isbn><abstract><style face="normal" font="default" size="100%">Objective To summarize the CT imaging features of peritoneal metastasis of gastric cancer (GC).Methods The retrospective cross-sectional study was conducted.The clinicopathological data of 78 GC patients with peritoneal metastasis who were admitted to the First Affiliated Hospital of Nanjing Medical University from January 2013 to September 2016 were collected.All the patients underwent plain and enhanced scans of CT,and imaging data were converted to the multiplanar reformation (MPR) and maximum intensity projection (MIP).Observation indicators:(1) CT imaging features of primary lesion of GC;(2) CT diagnostic accurary and imaging features of GC with peritoneal metastasis;(3) CT imaging features of lymph nodes and other abdominal organ metastasis;(4) treatment and follow-up.Patients selected treatment plan according to results of laboratory and imaging examinations and patient&amp;#039;s will.Follow-up using outpatient examination,telephone interview and correspondence was performed to detect the treatment method and patients&amp;#039; prognosis up to December 2016.The survival time was from post-treatment to death or end of follow-up.Measurement data with skewed distribution were described as M (range).Results (1) CT imaging features of primary lesion of GC:primary tumor location of 78 patients:tumor located in the antrum,leather bottle stomach,gastric cardia,lesser curvature,gastric antrum and body and greater curvature were detected in 40,11,9,9,5 and 4 patients,respectively.All the 78 patients were in T4 stage,including 43 with T4a stage and 35 with T4b stage.(2) CT diagnostic accurary and imaging features of GC with peritoneal metastasis:of 78 patients,57 were found with peritoneal metastasis by CT examinations before chemotherapy,15 with peritoneal metastasis by exploratory laparotomy or open surgery and 6 with peritoneal metastasis by follow-up CT re-examinations after gastrectomy.Seventy-two patients were diagnosed as GC with peritoneal metastasis by CT scans,and final diagnosis,missed diagnosis and overdiagnosis were detected in 78,9 and 3 patients,respectively.The precision,sensitivity,specificity,positive and negative predictive values of CT diagnosis were respectively 98.7&amp;amp;#65285;,88.5&amp;amp;#65285;,99.6&amp;amp;#65285;,95.8&amp;amp;#65285; and 98.9&amp;amp;#65285;.Location and manifestation of 78 GC with peritoneal metastasis patients:&amp;amp;#9312; Peritoneal effusions:71 patients were accompanied with peritoneal effusions,including 21 with the slight peritoneal effusions and 50 with moderate and massive peritoneal effusions.&amp;amp;#9313; Greater omentum thickening:greater omnentum of 59 patients showed sheet,flocculent and nodular thickening,with a mass and cake-like change.&amp;amp;#9314; Peritoneal thickening:54 patients had peritoneal thickening,with the main of nodulelike and thick lines-like thickening;thickening occurred mainly in around the liver,peritoneal cavity and pelvic floor;11 patients were found with obvious left anterior renal fascia thickening.&amp;amp;#9315; Mesenteric thickening:46 patients were found with mesenteric thickening and edema,showing increased fat density with multi-node shadow.&amp;amp;#9316; Lesser omentum and hepatogastric ligament:18 patients were found with increased fat density of lesser omental bursa,showing striped and nodular shadow.&amp;amp;#9317; Transverse mesocolon:increased local fat density with striped-and nodular-like changes were seen in 15 patients after coronal and sagittal planes reconstruction,including 5 with local wall thickening of transverse colon.&amp;amp;#9318; Ovary:8 patients had ovarian metastases,including 6 with bilateral metastases and 2 with unilateral metastasis;diameter of metastatic tumor was 3-12 cm.&amp;amp;#9319; Intestinal canal:6 patients had local intestinal wall thickening,including 3 in small intestine and 3 in transverse colon,thickening tissues were mainly located in the mesentery,showing obvious intestinal wall enhancement.&amp;amp;#9320; Liver capsule node:2 patients showed multi-node abnormal enhanced lesions under liver capsule.(3) CT imaging features of lymph nodes an other abdominal organ metastasis:78 patients were accompanied with lymph nodes enlargement,including 41 in N2 stage and 37 in N3 stage;liver metastases were detected in 13 patients;5 had adrenal metastases,including 3 with bilateral metastases and 2 with unilateral metastasis;4 had lower GC invading the pancreatic head and body;2 had upper GC invading the liver and spleen;1 had leather bottle stomach invading the pancreatic head and neck,and inducing to obstruction of biliary tract.(4) Treatment and follow-up:of 78 patients,62 underwent systemic chemotherapy,6 underwent systemic chemotherapy and intraperitoneal hyperthermic perfusion chemotherapy,5 underwent systemic chemotherapy and local radiotherapy and 5 underwent palliative operations due to gastrointestinal tract obstruction or bleeding.Of 78 patients,69 were followed up for 15 months (range,3-21 months),and 9 lost to follow-up.The median survival time of 69 follow-up patients was 12 months (range,3-19 months).Conclusions CT imaging features of peritoneal metastasis of GC show specific sites of metastasis and performance.Combining with CT axial images and images of coronal and sagittal planes reconstruction,adjusting appropriate window width and level would be benefit to observe primary lesions of GC and peritoneal metastasis.</style></abstract><label><style face="normal" font="default" size="100%">Included by Eman</style></label><urls><related-urls><url><style face="normal" font="default" size="100%">http://dx.doi.org/10.3760/cma.j.issn.1673-9752.2017.11.016</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2212</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2212</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nankabirwa, J.</style></author><author><style face="normal" font="default" size="100%">Zurovac, D.</style></author><author><style face="normal" font="default" size="100%">Njogu, J. N.</style></author><author><style face="normal" font="default" size="100%">Rwakimari, J. B.</style></author><author><style face="normal" font="default" size="100%">Counihan, H.</style></author><author><style face="normal" font="default" size="100%">Snow, R. W.</style></author><author><style face="normal" font="default" size="100%">Tibenderana, J. K.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Malaria Consortium, Africa Regional Office, Kampala, Uganda. jnankabirwa@yahoo.co.uk</style></auth-address><titles><title><style face="normal" font="default" size="100%">Malaria misdiagnosis in Uganda--implications for policy change</style></title><secondary-title><style face="normal" font="default" size="100%">Malar J</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Malar J</style></full-title></periodical><pages><style face="normal" font="default" size="100%">66</style></pages><volume><style face="normal" font="default" size="100%">8</style></volume><keywords><keyword><style face="normal" font="default" size="100%">Animals</style></keyword><keyword><style face="normal" font="default" size="100%">Antimalarials/therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Child, Preschool</style></keyword><keyword><style face="normal" font="default" size="100%">Cross-Sectional Studies</style></keyword><keyword><style face="normal" font="default" size="100%">*Diagnostic Errors</style></keyword><keyword><style face="normal" font="default" size="100%">Diagnostic Tests, Routine/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Fever/drug therapy/*etiology</style></keyword><keyword><style face="normal" font="default" size="100%">Health Policy</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Infant</style></keyword><keyword><style face="normal" font="default" size="100%">Malaria/*diagnosis/drug therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Microscopy/methods</style></keyword><keyword><style face="normal" font="default" size="100%">Parasitemia/*diagnosis/drug therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Practice Guidelines as Topic</style></keyword><keyword><style face="normal" font="default" size="100%">Predictive Value of Tests</style></keyword><keyword><style face="normal" font="default" size="100%">Sensitivity and Specificity</style></keyword><keyword><style face="normal" font="default" size="100%">Uganda/epidemiology</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2009</style></year><pub-dates><date><style face="normal" font="default" size="100%">Apr 16</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1475-2875</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: In Uganda, like in many other countries traditionally viewed as harbouring very high malaria transmission, the norm has been to recommend that febrile episodes are diagnosed as malaria. In this study, the policy implications of such recommendations are revisited. METHODS: A cross-sectional survey was undertaken at outpatient departments of all health facilities in four Ugandan districts. The routine diagnostic practices were assessed for all patients during exit interviews and a research slide was obtained for later reading. Primary outcome measures were the accuracy of national recommendations and routine malaria diagnosis in comparison with the study definition of malaria (any parasitaemia on expert slide examination in patient with fever) stratified by age and intensity of malaria transmission. Secondary outcome measures were the use, interpretation and accuracy of routine malaria microscopy. RESULTS: 1,763 consultations undertaken by 233 health workers at 188 facilities were evaluated. The prevalence of malaria was 24.2% and ranged between 13.9% in patients &gt;or=5 years in medium-to-high transmission areas to 50.5% for children &lt;5 years in very high transmission areas. Overall, the sensitivity and negative predictive value (NPV) of routine malaria diagnosis were high (89.7% and 91.6% respectively) while the specificity and positive predictive value (PPV) were low (35.6% and 30.8% respectively). However, malaria was under-diagnosed in 39.9% of children less than five years of age in the very high transmission area. At 48 facilities with functional microscopy, the use of malaria slide examination was low (34.5%) without significant differences between age groups, or between patients for whom microscopy is recommended or not. 96.2% of patients with a routine positive slide result were treated for malaria but also 47.6% with a negative result. CONCLUSION: Current recommendations and associated clinical practices result in massive malaria over-diagnosis across all age groups and transmission areas in Uganda. Yet, under-diagnosis is also common in children &lt;5 years. The potential benefits of malaria microscopy are not realized. To address malaria misdiagnosis, Uganda&apos;s policy shift from presumptive to parasitological diagnosis should encompass introduction of malaria rapid diagnostic tests and substantial strengthening of malaria microscopy.</style></abstract><notes><style face="normal" font="default" size="100%">1475-2875&#xD;Nankabirwa, Joan&#xD;Zurovac, Dejan&#xD;Njogu, Julius N&#xD;Rwakimari, John B&#xD;Counihan, Helen&#xD;Snow, Robert W&#xD;Tibenderana, James K&#xD;079080/Wellcome Trust/United Kingdom&#xD;Journal Article&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Malar J. 2009 Apr 16;8:66. doi: 10.1186/1475-2875-8-66.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2671516/pdf/1475-2875-8-66.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC2671516</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1186/1475-2875-8-66</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2213</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2213</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nankabirwa, J.</style></author><author><style face="normal" font="default" size="100%">Zurovac, D.</style></author><author><style face="normal" font="default" size="100%">Njogu, J. N.</style></author><author><style face="normal" font="default" size="100%">Rwakimari, J. B.</style></author><author><style face="normal" font="default" size="100%">Counihan, H.</style></author><author><style face="normal" font="default" size="100%">Snow, R. W.</style></author><author><style face="normal" font="default" size="100%">Tibenderana, J. K.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">J. Nankabirwa, Malaria Consortium, Africa Regional Office, Sturrock Road, Kampala, Uganda</style></auth-address><titles><title><style face="normal" font="default" size="100%">Malaria misdiagnosis in Uganda implications for policy change</style></title><secondary-title><style face="normal" font="default" size="100%">Malaria Journal</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Malaria Journal</style></full-title></periodical><volume><style face="normal" font="default" size="100%">8</style></volume><number><style face="normal" font="default" size="100%">1</style></number><keywords><keyword><style face="normal" font="default" size="100%">article</style></keyword><keyword><style face="normal" font="default" size="100%">child</style></keyword><keyword><style face="normal" font="default" size="100%">comparative study</style></keyword><keyword><style face="normal" font="default" size="100%">consultation</style></keyword><keyword><style face="normal" font="default" size="100%">cross-sectional study</style></keyword><keyword><style face="normal" font="default" size="100%">diagnostic accuracy</style></keyword><keyword><style face="normal" font="default" size="100%">diagnostic error</style></keyword><keyword><style face="normal" font="default" size="100%">diagnostic value</style></keyword><keyword><style face="normal" font="default" size="100%">disease transmission</style></keyword><keyword><style face="normal" font="default" size="100%">functional assessment</style></keyword><keyword><style face="normal" font="default" size="100%">groups by age</style></keyword><keyword><style face="normal" font="default" size="100%">health care facility</style></keyword><keyword><style face="normal" font="default" size="100%">health care personnel</style></keyword><keyword><style face="normal" font="default" size="100%">health care policy</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">interview</style></keyword><keyword><style face="normal" font="default" size="100%">major clinical study</style></keyword><keyword><style face="normal" font="default" size="100%">malaria</style></keyword><keyword><style face="normal" font="default" size="100%">medical practice</style></keyword><keyword><style face="normal" font="default" size="100%">microscopy</style></keyword><keyword><style face="normal" font="default" size="100%">outcome assessment</style></keyword><keyword><style face="normal" font="default" size="100%">outpatient department</style></keyword><keyword><style face="normal" font="default" size="100%">preschool child</style></keyword><keyword><style face="normal" font="default" size="100%">prevalence</style></keyword><keyword><style face="normal" font="default" size="100%">sensitivity and specificity</style></keyword><keyword><style face="normal" font="default" size="100%">Uganda</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2009</style></year></dates><isbn><style face="normal" font="default" size="100%">1475-2875</style></isbn><abstract><style face="normal" font="default" size="100%">Background. In Uganda, like in many other countries traditionally viewed as harbouring very high malaria transmission, the norm has been to recommend that febrile episodes are diagnosed as malaria. In this study, the policy implications of such recommendations are revisited. Methods. A cross-sectional survey was undertaken at outpatient departments of all health facilities in four Ugandan districts. The routine diagnostic practices were assessed for all patients during exit interviews and a research slide was obtained for later reading. Primary outcome measures were the accuracy of national recommendations and routine malaria diagnosis in comparison with the study definition of malaria (any parasitaemia on expert slide examination in patient with fever) stratified by age and intensity of malaria transmission. Secondary outcome measures were the use, interpretation and accuracy of routine malaria microscopy. Results. 1,763 consultations undertaken by 233 health workers at 188 facilities were evaluated. The prevalence of malaria was 24.2% and ranged between 13.9% in patients &lt;5 years in medium-to-high transmission areas to 50.5% for children &lt;5 years in very high transmission areas. Overall, the sensitivity and negative predictive value (NPV) of routine malaria diagnosis were high (89.7% and 91.6% respectively) while the specificity and positive predictive value (PPV) were low (35.6% and 30.8% respectively). However, malaria was under-diagnosed in 39.9% of children less than five years of age in the very high transmission area. At 48 facilities with functional microscopy, the use of malaria slide examination was low (34.5%) without significant differences between age groups, or between patients for whom microscopy is recommended or not. 96.2% of patients with a routine positive slide result were treated for malaria but also 47.6% with a negative result. Conclusion. Current recommendations and associated clinical practices result in massive laria over-diagnosis across all age groups and transmission areas in Uganda. Yet, under-diagnosis is also common in children &lt;5 years. The potential benefits of malaria microscopy are not realized. To address malaria misdiagnosis, Uganda&apos;s policy shift from presumptive to parasitological diagnosis should encompass introduction of malaria rapid diagnostic tests and substantial strengthening of malaria microscopy.</style></abstract><notes><style face="normal" font="default" size="100%">L354535963&#xD;2009-05-12</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.embase.com/search/results?subaction=viewrecord&amp;id=L354535963&amp;from=export</style></url><url><style face="normal" font="default" size="100%">http://dx.doi.org/10.1186/1475-2875-8-66</style></url><url><style face="normal" font="default" size="100%">https://malariajournal.biomedcentral.com/track/pdf/10.1186/1475-2875-8-66.pdf</style></url></related-urls></urls><custom5><style face="normal" font="default" size="100%">19371426</style></custom5><electronic-resource-num><style face="normal" font="default" size="100%">10.1186/1475-2875-8-66</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2214</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2214</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nankabirwa, J. I.</style></author><author><style face="normal" font="default" size="100%">Zurovac, D.</style></author><author><style face="normal" font="default" size="100%">Njogu, J. N.</style></author><author><style face="normal" font="default" size="100%">Counihan, H. C.</style></author><author><style face="normal" font="default" size="100%">Snow, R. W.</style></author><author><style face="normal" font="default" size="100%">Tibenderana, J. K.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">J.I. Nankabirwa, Makarere University Kampala, Kampala, Uganda</style></auth-address><titles><title><style face="normal" font="default" size="100%">Malaria misdiagnosis in Uganda - Implications for policy change</style></title><secondary-title><style face="normal" font="default" size="100%">American Journal of Tropical Medicine and Hygiene</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">American Journal of Tropical Medicine and Hygiene</style></full-title></periodical><pages><style face="normal" font="default" size="100%">20</style></pages><volume><style face="normal" font="default" size="100%">81</style></volume><number><style face="normal" font="default" size="100%">5</style></number><keywords><keyword><style face="normal" font="default" size="100%">malaria</style></keyword><keyword><style face="normal" font="default" size="100%">society</style></keyword><keyword><style face="normal" font="default" size="100%">policy</style></keyword><keyword><style face="normal" font="default" size="100%">Uganda</style></keyword><keyword><style face="normal" font="default" size="100%">diagnostic error</style></keyword><keyword><style face="normal" font="default" size="100%">hygiene</style></keyword><keyword><style face="normal" font="default" size="100%">tropical medicine</style></keyword><keyword><style face="normal" font="default" size="100%">diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">child</style></keyword><keyword><style face="normal" font="default" size="100%">patient</style></keyword><keyword><style face="normal" font="default" size="100%">microscopy</style></keyword><keyword><style face="normal" font="default" size="100%">examination</style></keyword><keyword><style face="normal" font="default" size="100%">prevalence</style></keyword><keyword><style face="normal" font="default" size="100%">groups by age</style></keyword><keyword><style face="normal" font="default" size="100%">clinical practice</style></keyword><keyword><style face="normal" font="default" size="100%">diagnostic test</style></keyword><keyword><style face="normal" font="default" size="100%">health care facility</style></keyword><keyword><style face="normal" font="default" size="100%">reading</style></keyword><keyword><style face="normal" font="default" size="100%">parasitemia</style></keyword><keyword><style face="normal" font="default" size="100%">hospital patient</style></keyword><keyword><style face="normal" font="default" size="100%">fever</style></keyword><keyword><style face="normal" font="default" size="100%">consultation</style></keyword><keyword><style face="normal" font="default" size="100%">health care personnel</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2009</style></year></dates><isbn><style face="normal" font="default" size="100%">0002-9637</style></isbn><abstract><style face="normal" font="default" size="100%">In Uganda, like many other countries traditionally viewed as harboring very high malaria transmission, the recommendation is that febrile episodes are diagnosed as malaria. The policy implications of such recommendations are revisited in this study. A cross-sectional survey was undertaken at all health facilities in four Ugandan districts. Routine diagnostic and treatment practices were assessed and a research slide was obtained for later reading. Primary outcome measures were the accuracy of national recommendations and routine malaria diagnosis in comparison with the study definition of malaria (any parasitaemia on expert slide examination in patient with fever). Secondary outcome measures were the use, interpretation and accuracy of routine malaria microscopy. 1,763 consultations undertaken by 233 health workers at 188 facilities were evaluated. Malaria prevalence was 24.2% and ranged between 13.9% in patients ≥5 years in medium-to-high transmission areas to 50.5% for children &lt;5 years in very high transmission areas. The sensitivity and negative predictive value of routine malaria diagnosis were high (89.7% and 91.6% respectively) while specificity and positive predictive value (PPV) were low (35.6% and 30.8% respectively). However, malaria was under-diagnosed in 39.9% of the children less than five years of age in the very high transmission area. The use of malaria slide examination was low (34.5%) without significant differences between age groups. Although 96.2% of patients with positive slide result were treated for malaria, also 47.6% with a negative result were treated. In conclusion, current recommendations and associated clinical practices result in massive malaria over-diagnosis, yet, under-diagnosis is also common in children &lt;5 years. To address malaria misdiagnosis, a policy shift from presumptive to parasitological diagnosis encompassing introduction of malaria rapid diagnostic tests and strengthening of malaria microscopy.</style></abstract><notes><style face="normal" font="default" size="100%">L70336550&#xD;2011-02-04</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.embase.com/search/results?subaction=viewrecord&amp;id=L70336550&amp;from=export</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2215</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2215</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nascimento-Júnior, Valter Paz</style></author><author><style face="normal" font="default" size="100%">Camargos, Einstein Francisco</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Inappropriate requests for tumor markers in patients aged 50 years and older: lessons not learned</style></title><secondary-title><style face="normal" font="default" size="100%">Geriatr., Gerontol. Aging (Impr.)</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Geriatr., Gerontol. Aging (Impr.)</style></full-title></periodical><pages><style face="normal" font="default" size="100%">1-6</style></pages><volume><style face="normal" font="default" size="100%">15</style></volume><dates><year><style face="normal" font="default" size="100%">2021</style></year><pub-dates><date><style face="normal" font="default" size="100%">2021/00</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">2447-2115</style></isbn><abstract><style face="normal" font="default" size="100%">OBJECTIVE: To investigate, within a private health insurance, the ordering frequency and the costs related to inappropriate tumor markers test orders. METHODS: This study analyzed data regarding tumor markers requests within a private health insurance between 2010 and 2017. Patients included in this analysis were &amp;amp;#8805; 50 years old, had available medical records, and had at least 1 tumor markers tested within the study period. Tests were considered inappropriate when tumor markers were used in screening for neoplasms, ie, when there was no previous diagnosis. We evaluated data regarding age, sex, the ordering physician&amp;#039;s medical specialty, and test costs. RESULTS: Between 2010 and 2017, 1112 tumor markers tests were performed and increased from 52 to 262 per year. Our sample consisted mostly of women (69.50%) with a mean age of 59.40 (SD 8.20) years. Most orders were inappropriate (87.80%) and represented 79.40% of all expenses with tumor markers tests. Cardiology professionals were the medical specialty that requested the most tumor markers tests (23.90%), followed by internal medicine specialists (22.70%) and gynecologists (19.20%). CONCLUSIONS: We observed a high percentage of inappropriate test orders in the study period, resulting in elevated costs. Studies of this nature deserve the attention of health care managers, and interventions should be performed in order to reduce the inappropriate use of tumor markers tests in clinical practice.&#xD;OBJETIVO: investigar no âmbito de um plano de saúde privado a frequência de solicitação e os custos relacionados à solicitação inapropriada de marcadores tumorais. METODOLOGIA: Utilizou-se a base de dados de um plano de saúde privado entre os anos de 2010 a 2017. Foram incluídos na pesquisa, sujeitos com idade &amp;amp;#8805; 50 anos, que apresentavam prontuários médicos acessíveis e que havia realizado a dosagem de algum marcadores tumorais no período. Considerou-se como &amp;quot;exame inapropriado&amp;quot; quando o marcador tumoral foi utilizado como rastreio de neoplasia, ou seja, quando não havia o diagnóstico prévio. Foram avaliados os dados referentes à idade, sexo, especialidade do médico solicitante e informações sobre os custos desses exames. RESULTADOS: Foram realizados um total 1.112 testes no período, representando um aumento de 52 para 262 exames/ano. A amostra foi composta na maioria pelo sexo feminino (69,50%), com média de idade de 59,40 ± 8,20 anos. A maioria das solicitações foram inapropriadas (87,80%). Notou-se que a solicitação desses exames, impactaram cerca de 79,40% dos gastos totais do plano de saúde com marcadores tumorais. Os cardiologistas foram a especialidade que mais solicitaram marcadores tumorais em 23,90% das ocasiões, seguidos pelos especialistas em clínica médica (22,70%) e ginecologistas (19,20%). CONCLUSÕES: Observamos um alto percentual de pedidos de exames inadequados no período do estudo, resultando em custos elevados. Estudos dessa natureza merecem a atenção dos gestores de saúde e intervenções devem ser realizadas a fim de reduzir o uso inadequado de testes de marcador tumoral na prática clínica.</style></abstract><urls><related-urls><url><style face="normal" font="default" size="100%">https://ggaging.com/details/1664/en-US/solicitacao-inapropriada-de-marcadores-tumorais-em-pacientes-com-50-anos-ou-mais--licoes-nao-aprendidas</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2216</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2216</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Ndege, R.</style></author><author><style face="normal" font="default" size="100%">Ngome, O.</style></author><author><style face="normal" font="default" size="100%">Bani, F.</style></author><author><style face="normal" font="default" size="100%">Temba, Y.</style></author><author><style face="normal" font="default" size="100%">Wilson, H.</style></author><author><style face="normal" font="default" size="100%">Vanobberghen, F.</style></author><author><style face="normal" font="default" size="100%">Hella, J.</style></author><author><style face="normal" font="default" size="100%">Gingo, W.</style></author><author><style face="normal" font="default" size="100%">Sasamalo, M.</style></author><author><style face="normal" font="default" size="100%">Mnzava, D.</style></author><author><style face="normal" font="default" size="100%">Kimera, N.</style></author><author><style face="normal" font="default" size="100%">Hiza, H.</style></author><author><style face="normal" font="default" size="100%">Wigayi, J.</style></author><author><style face="normal" font="default" size="100%">Mapesi, H.</style></author><author><style face="normal" font="default" size="100%">Kato, I. B.</style></author><author><style face="normal" font="default" size="100%">Mhimbira, F.</style></author><author><style face="normal" font="default" size="100%">Reither, K.</style></author><author><style face="normal" font="default" size="100%">Battegay, M.</style></author><author><style face="normal" font="default" size="100%">Paris, D. H.</style></author><author><style face="normal" font="default" size="100%">Weisser, M.</style></author><author><style face="normal" font="default" size="100%">Rohacek, M.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Ifakara Health Institute, Ifakara, United Republic of Tanzania, Off Mlabani Passage, P. O Box 53, Ifakara, Tanzania. rndege@ihi.or.tz.&#xD;St Francis Referral Hospital, Ifakara, United Republic of Tanzania. rndege@ihi.or.tz.&#xD;Ifakara Health Institute, Ifakara, United Republic of Tanzania, Off Mlabani Passage, P. O Box 53, Ifakara, Tanzania.&#xD;Mwananyamala Regional Referral Hospital, Dar es salaam, United Republic of Tanzania.&#xD;St Francis Referral Hospital, Ifakara, United Republic of Tanzania.&#xD;Department of Medicine, Swiss Tropical and Public Health Institute, Basel, Switzerland.&#xD;Faculty of Medicine, University of Basel, Basel, Switzerland.&#xD;Division of Infectious Diseases, University Hospital Basel, Basel, Switzerland.&#xD;Ifakara Health Institute, Ifakara, United Republic of Tanzania, Off Mlabani Passage, P. O Box 53, Ifakara, Tanzania. mrohacek@ihi.or.tz.&#xD;St Francis Referral Hospital, Ifakara, United Republic of Tanzania. mrohacek@ihi.or.tz.&#xD;Department of Medicine, Swiss Tropical and Public Health Institute, Basel, Switzerland. mrohacek@ihi.or.tz.&#xD;Faculty of Medicine, University of Basel, Basel, Switzerland. mrohacek@ihi.or.tz.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Ultrasound in managing extrapulmonary tuberculosis: a randomized controlled two-center study</style></title><secondary-title><style face="normal" font="default" size="100%">BMC Infect Dis</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">BMC Infect Dis</style></full-title></periodical><pages><style face="normal" font="default" size="100%">349</style></pages><volume><style face="normal" font="default" size="100%">20</style></volume><number><style face="normal" font="default" size="100%">1</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Radiography</style></keyword><keyword><style face="normal" font="default" size="100%">Tanzania</style></keyword><keyword><style face="normal" font="default" size="100%">Tuberculosis/*diagnostic imaging</style></keyword><keyword><style face="normal" font="default" size="100%">Ultrasonography/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Extrapulmonary</style></keyword><keyword><style face="normal" font="default" size="100%">Fash</style></keyword><keyword><style face="normal" font="default" size="100%">Sonography</style></keyword><keyword><style face="normal" font="default" size="100%">Sub-Saharan Africa</style></keyword><keyword><style face="normal" font="default" size="100%">Tuberculosis</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2020</style></year><pub-dates><date><style face="normal" font="default" size="100%">May 15</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1471-2334</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: Patients with clinically suspected tuberculosis are often treated empirically, as diagnosis - especially of extrapulmonary tuberculosis - remains challenging. This leads to an overtreatment of tuberculosis and to underdiagnosis of possible differential diagnoses. METHODS: This open-label, parallel-group, superiority randomized controlled trial is done in a rural and an urban center in Tanzania. HIV-positive and -negative adults (≥18 years) with clinically suspected extrapulmonary tuberculosis are randomized in a 1:1 ratio to an intervention- or control group, stratified by center and HIV status. The intervention consists of a management algorithm including extended focused assessment of sonography for HIV and tuberculosis (eFASH) in combination with chest X-ray and microbiological tests. Treatment with anti-tuberculosis drugs is started, if eFASH is positive, chest X-ray suggests tuberculosis, or a microbiological result is positive for tuberculosis. Patients in the control group are managed according national guidelines. Treatment is started if microbiology is positive or empirically according to the treating physician. The primary outcome is the proportion of correctly managed patients at 6 months (i.e patients who were treated with anti-tuberculosis treatment and had definite or probable tuberculosis, and patients who were not treated with anti-tuberculosis treatment and did not have tuberculosis). Secondary outcomes are the proportion of symptom-free patients at two and 6 months, and time to death. The sample size is 650 patients. DISCUSSION: This study will determine, whether ultrasound in combination with other tests can increase the proportion of correctly managed patients with clinically suspected extrapulmonary tuberculosis, thus reducing overtreatment with anti-tuberculosis drugs. TRIAL REGISTRATION: PACTR, Registration number: PACTR201712002829221, registered December 1st 2017.</style></abstract><label><style face="normal" font="default" size="100%">Included by Hannah</style></label><notes><style face="normal" font="default" size="100%">1471-2334&#xD;Ndege, Robert&#xD;Ngome, Omary&#xD;Bani, Farida&#xD;Temba, Yvan&#xD;Wilson, Herieth&#xD;Vanobberghen, Fiona&#xD;Hella, Jerry&#xD;Gingo, Winfrid&#xD;Sasamalo, Mohamed&#xD;Mnzava, Dorcas&#xD;Kimera, Namvua&#xD;Hiza, Helen&#xD;Wigayi, John&#xD;Mapesi, Herry&#xD;Kato, Irene B&#xD;Mhimbira, Francis&#xD;Reither, Klaus&#xD;Battegay, Manuel&#xD;Paris, Daniel H&#xD;Weisser, Maja&#xD;Rohacek, Martin&#xD;N/A/Rudolf Geigy Foundation Basel, Switzerland/&#xD;N/A/Gottfried and Julia Bangerter-Rhyner Foundation, Basel, Switzerland/&#xD;Journal Article&#xD;Multicenter Study&#xD;Randomized Controlled Trial&#xD;BMC Infect Dis. 2020 May 15;20(1):349. doi: 10.1186/s12879-020-05073-9.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226714/pdf/12879_2020_Article_5073.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC7226714</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1186/s12879-020-05073-9</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2217</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2217</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Ndyomugyenyi, R.</style></author><author><style face="normal" font="default" size="100%">Magnussen, P.</style></author><author><style face="normal" font="default" size="100%">Lal, S.</style></author><author><style face="normal" font="default" size="100%">Hansen, K.</style></author><author><style face="normal" font="default" size="100%">Clarke, S. E.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Vector Control Division, Ministry of Health, Kampala, Uganda.&#xD;Centre for Medical Parasitology, Department for Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.&#xD;Department of Disease Control, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.&#xD;Department of Global Health and Development, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Appropriate targeting of artemisinin-based combination therapy by community health workers using malaria rapid diagnostic tests: findings from randomized trials in two contrasting areas of high and low malaria transmission in south-western Uganda</style></title><secondary-title><style face="normal" font="default" size="100%">Trop Med Int Health</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Trop Med Int Health</style></full-title></periodical><pages><style face="normal" font="default" size="100%">1157-70</style></pages><volume><style face="normal" font="default" size="100%">21</style></volume><number><style face="normal" font="default" size="100%">9</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Antimalarials/*therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Artemisinins/*therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Child, Preschool</style></keyword><keyword><style face="normal" font="default" size="100%">Clinical Decision-Making/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">*Community Health Workers</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Fever/diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Infant</style></keyword><keyword><style face="normal" font="default" size="100%">Malaria/diagnosis/*drug therapy/parasitology/transmission</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Parasitemia/diagnosis/drug therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Practice Guidelines as Topic/*standards</style></keyword><keyword><style face="normal" font="default" size="100%">Uganda</style></keyword><keyword><style face="normal" font="default" size="100%">*Ouganda</style></keyword><keyword><style face="normal" font="default" size="100%">*Rapid diagnostic test (RDT)</style></keyword><keyword><style face="normal" font="default" size="100%">*Uganda</style></keyword><keyword><style face="normal" font="default" size="100%">*agents de santé communautaire (ASC)</style></keyword><keyword><style face="normal" font="default" size="100%">*appropriately targeted treatment</style></keyword><keyword><style face="normal" font="default" size="100%">*artemisinin-based combination therapy (ACT)</style></keyword><keyword><style face="normal" font="default" size="100%">*combinaison thérapeutique à base d&apos;artémisinine (ACT)</style></keyword><keyword><style face="normal" font="default" size="100%">*community case management</style></keyword><keyword><style face="normal" font="default" size="100%">*community health workers (CHWs)</style></keyword><keyword><style face="normal" font="default" size="100%">*elección adecuada del tratamiento</style></keyword><keyword><style face="normal" font="default" size="100%">*manejo comunitario de casos</style></keyword><keyword><style face="normal" font="default" size="100%">*prise en charge communautaire des cas</style></keyword><keyword><style face="normal" font="default" size="100%">*prueba diagnóstica rápida (PDR)</style></keyword><keyword><style face="normal" font="default" size="100%">*terapia de combinación basada en la artemisinina (TCA)</style></keyword><keyword><style face="normal" font="default" size="100%">*test de diagnostic rapide (TDR)</style></keyword><keyword><style face="normal" font="default" size="100%">*trabajadores sanitarios comunitarios (TSC)</style></keyword><keyword><style face="normal" font="default" size="100%">*traitement ciblé approprié</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style face="normal" font="default" size="100%">Sep</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1360-2276 (Print)&#xD;1360-2276</style></isbn><abstract><style face="normal" font="default" size="100%">OBJECTIVE: To compare the impact of malaria rapid diagnostic tests (mRDTs), used by community health workers (CHWs), on the proportion of children &lt;5 years of age receiving appropriately targeted treatment with artemisinin-based combination therapy (ACT), vs. presumptive treatment. METHODS: Cluster-randomized trials were conducted in two contrasting areas of moderate-to-high and low malaria transmission in rural Uganda. Each trial examined the effectiveness of mRDTs in the management of malaria and targeting of ACTs by CHWs comparing two diagnostic approaches: (i) presumptive clinical diagnosis of malaria [control arm] and (ii) confirmatory diagnosis with mRDTs followed by ACT treatment for positive patients [intervention arm], with village as the unit of randomisation. Treatment decisions by CHWs were validated by microscopy on a reference blood slide collected at the time of consultation, to compare the proportion of children &lt;5 years receiving appropriately targeted ACT treatment, defined as patients with microscopically-confirmed presence of parasites in a peripheral blood smear receiving artemether-lumefantrine or rectal artesunate, and patients with no malaria parasites not given ACT. RESULTS: In the moderate-to-high transmission area, ACT treatment was appropriately targeted in 79.3% (520/656) of children seen by CHWs using mRDTs to diagnose malaria, vs. 30.8% (215/699) of children seen by CHWs using presumptive diagnosis (P &lt; 0.001). In the low transmission area, 90.1% (363/403) children seen by CHWs using mRDTs received appropriately targeted ACT treatment vs. 7.8% (64/817) seen by CHWs using presumptive diagnosis (P &lt; 0.001). Low mRDT sensitivity in children with low-density parasitaemia (&lt;200 parasites/μl) was identified as a potential concern. CONCLUSION: When equipped with mRDTs, ACT treatments delivered by CHWs are more accurately targeted to children with malaria parasites. mRDT use could play an important role in reducing overdiagnosis of malaria and improving fever case management within iCCM, in both moderate-to-high and low transmission areas. Nonetheless, missed treatments due to the low sensitivity of current mRDTs in patients with low parasite density are a concern. For community-based treatment in areas of low transmission and/or non-immune populations, presumptive treatment of all fevers as malaria may be advisable, until more sensitive diagnostic assays, suitable for routine use by CHWs in remote settings, become available.&#xD;Publisher: Abstract available from the publisher.&#xD;fre&#xD;spa</style></abstract><notes><style face="normal" font="default" size="100%">1365-3156&#xD;Ndyomugyenyi, Richard&#xD;Magnussen, Pascal&#xD;Lal, Sham&#xD;Hansen, Kristian&#xD;Clarke, Siân E&#xD;Wellcome Trust/United Kingdom&#xD;Comparative Study&#xD;Journal Article&#xD;Randomized Controlled Trial&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Trop Med Int Health. 2016 Sep;21(9):1157-70. doi: 10.1111/tmi.12748. Epub 2016 Aug 9.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5031222/pdf/TMI-21-1157.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC5031222</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1111/tmi.12748</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2218</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2218</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nguyen, M. H.</style></author><author><style face="normal" font="default" size="100%">Gammeltoft, T.</style></author><author><style face="normal" font="default" size="100%">Christoffersen, S. V.</style></author><author><style face="normal" font="default" size="100%">Tran, T. T.</style></author><author><style face="normal" font="default" size="100%">Rasch, V.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Institute for Population and Development Studies, General Office for Population and Family Planning, Ministry of Health, Hanoi, Vietnam. nguyenmy_huong@yahoo.com</style></auth-address><titles><title><style face="normal" font="default" size="100%">Reproductive tract infections in northern Vietnam: health providers&apos; diagnostic dilemmas</style></title><secondary-title><style face="normal" font="default" size="100%">Women Health</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Women Health</style></full-title></periodical><pages><style face="normal" font="default" size="100%">229-45</style></pages><volume><style face="normal" font="default" size="100%">49</style></volume><number><style face="normal" font="default" size="100%">2-3</style></number><keywords><keyword><style face="normal" font="default" size="100%">Abortion, Induced</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Attitude of Health Personnel</style></keyword><keyword><style face="normal" font="default" size="100%">*Clinical Competence</style></keyword><keyword><style face="normal" font="default" size="100%">Diagnosis, Differential</style></keyword><keyword><style face="normal" font="default" size="100%">Drug Prescriptions</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Focus Groups</style></keyword><keyword><style face="normal" font="default" size="100%">Genital Diseases, Female/*diagnosis/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Gynecology</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Infections/*diagnosis/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Medical Laboratory Personnel</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Midwifery</style></keyword><keyword><style face="normal" font="default" size="100%">Vietnam/epidemiology</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2009</style></year><pub-dates><date><style face="normal" font="default" size="100%">Mar-May</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0363-0242 (Print)&#xD;0363-0242</style></isbn><abstract><style face="normal" font="default" size="100%">Research was conducted on reproductive tract infections among women obtaining induced abortions at Ph[image omitted]-[image omitted] hospital in Haiphong City, a major maternity hospital in northern Vietnam. The research aimed to explore how clinicians and lab-technicians diagnose reproductive tract infections and the difficulties they experience in establishing exact diagnoses. A combination of both quantitative and qualitative research methodologies was employed. The quantitative research involved 748 abortion-seeking women; the qualitative research was conducted with 10 doctors and 10 lab-technicians providing reproductive health services. A marked tendency was observed among both clinicians and lab-technicians to overdiagnose reproductive tract infections and to prescribe antibiotics routinely. Social, cultural, and clinical factors associated with the tendency to overdiagnose reproductive tract infections included: inadequate training of health staff, lack of equipment, and cultural assumptions regarding the overwhelming prevalence of reproductive tract infections in Vietnamese women, especially among those who receive abortion services. Misconceptions of reproductive tract infections led to substantial over-diagnosis and unnecessary treatment of reproductive tract infections in this hospital. To enhance reproductive tract infection care, providers need to be sensitized to the social and medical consequences of their own cultural perceptions and to increase their awareness of the risks associated with overuse of antibiotics.</style></abstract><notes><style face="normal" font="default" size="100%">Nguyen, My Hu&apos;o&apos;ng&#xD;Gammeltoft, Tine&#xD;Christoffersen, Sarah Vigh&#xD;Tran, Thu Thuy&#xD;Rasch, Vibeke&#xD;Journal Article&#xD;United States&#xD;Women Health. 2009 Mar-May;49(2-3):229-45. doi: 10.1080/03630240902963630.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.tandfonline.com/doi/full/10.1080/03630240902963630</style></url><url><style face="normal" font="default" size="100%">https://www.tandfonline.com/doi/pdf/10.1080/03630240902963630?needAccess=true</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1080/03630240902963630</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2219</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2219</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nguyen Thi Thuy, Hanh</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Obstetric ultrasound scanning in urban Vietnam: Is it being over used?</style></title><secondary-title><style face="normal" font="default" size="100%">Journal of Practical Medicine</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Journal of Practical Medicine</style></full-title></periodical><pages><style face="normal" font="default" size="100%">34-37</style></pages><keywords><keyword><style face="normal" font="default" size="100%">Ultrasonography</style></keyword><keyword><style face="normal" font="default" size="100%">Epidemiology</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2005</style></year><pub-dates><date><style face="normal" font="default" size="100%">2005/00</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0866-7241</style></isbn><abstract><style face="normal" font="default" size="100%">The study was conducted at Hanoi Obstetrical and Gynecological Hospital, combining quantitative and qualitative research methods. Results: the study showed that there was a tendency for pregnant women to over-use ultrasound scanning. The reasons for this included women’s perceptions of the usefulness of ultrasound scanning, their serious worries for the fetus, as well as the effects of the market economy on this health service. Over-use of obstetrical ultrasound scanning was not only related to the perception, demands and psychology of pregnant women, but also to socio-economic changes associated with the economic reforms and the liberalization of the health care system.</style></abstract><urls><related-urls><url><style face="normal" font="default" size="100%">http://dx.doi.org/</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2220</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2220</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nguyen, T. H. N.</style></author><author><style face="normal" font="default" size="100%">Le, B. K.</style></author><author><style face="normal" font="default" size="100%">Nguyen, D. H.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">T.H.N. Nguyen, Internal Medicine Department, University of Medicine and Pharmacy at Ho Chi Minh City, Viet Nam</style></auth-address><titles><title><style face="normal" font="default" size="100%">Clinical characteristics of patients diagnosed with airflow obstruction by using fixed ratio and lower limit of normal of FEV1/FVC</style></title><secondary-title><style face="normal" font="default" size="100%">Respirology</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Respirology</style></full-title></periodical><pages><style face="normal" font="default" size="100%">102</style></pages><volume><style face="normal" font="default" size="100%">24</style></volume><keywords><keyword><style face="normal" font="default" size="100%">bronchodilating agent</style></keyword><keyword><style face="normal" font="default" size="100%">adult</style></keyword><keyword><style face="normal" font="default" size="100%">aged</style></keyword><keyword><style face="normal" font="default" size="100%">asthma</style></keyword><keyword><style face="normal" font="default" size="100%">chronic obstructive lung disease</style></keyword><keyword><style face="normal" font="default" size="100%">clinical feature</style></keyword><keyword><style face="normal" font="default" size="100%">complication</style></keyword><keyword><style face="normal" font="default" size="100%">conference abstract</style></keyword><keyword><style face="normal" font="default" size="100%">controlled study</style></keyword><keyword><style face="normal" font="default" size="100%">coughing</style></keyword><keyword><style face="normal" font="default" size="100%">diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">dyspnea</style></keyword><keyword><style face="normal" font="default" size="100%">female</style></keyword><keyword><style face="normal" font="default" size="100%">forced expiratory volume</style></keyword><keyword><style face="normal" font="default" size="100%">forced vital capacity</style></keyword><keyword><style face="normal" font="default" size="100%">fractional exhaled nitric oxide</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">lung function</style></keyword><keyword><style face="normal" font="default" size="100%">major clinical study</style></keyword><keyword><style face="normal" font="default" size="100%">male</style></keyword><keyword><style face="normal" font="default" size="100%">middle aged</style></keyword><keyword><style face="normal" font="default" size="100%">spirometry</style></keyword><keyword><style face="normal" font="default" size="100%">tuberculosis</style></keyword><keyword><style face="normal" font="default" size="100%">wheezing</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2019</style></year></dates><isbn><style face="normal" font="default" size="100%">1323-7799</style></isbn><abstract><style face="normal" font="default" size="100%">Background: The use of fixed ratio (FR) of FEV1/FVC &lt; 0.7 or lower limit of normal (LLN) as the diagnostic threshold for airflow obstruction is still controversial. Applying only FR criteria in elderly could lead to overdiagnosis and younger individuals could be underdiagnosed contrarily. Aims: To determine the prevalence and clinical features of individuals underdiagnosed or overdiagnosed with airflow obstruction when using FR versus LLN criteria. Methods: We enrolled 790 patients had respiratory symptoms (cough, wheezing, dyspnoea) for spirometry. Airway obstruction was defined by two criteria using the FEV1/FVC ratio: FR &lt; 0.7 (FR+) or ratio &lt; LLN (LLN+). Considering as underdiagnosis when FR- but LLN+ and overdiagnosis when FR+ but LLN-. Other parameters were also included: bronchodilator test (BrT+) (change of FEV1 &gt; 200ml and &gt; 12%), FeNO. Results: There were 155 (19.6%) patients had FR+/LLN+, 25 (3.1%) patients FR+/LLN- and 23 (2.9%) FR-/LLN+. In FR+/LLN- group (aged 63±11), patients diagnosed with asthma, COPD and tuberculosis sequela accounted for 36%, 32% and 12% respectively. In FR-/LLN+ group, asthma was the most common diagnosis with 78.3%, whereas tuberculosis sequela was only 4.3%. Cough and wheezing (70 - 80%) were the most frequent chief complaints in two group. Individuals in FR-/LLN+ group tended to have BrT+ (56.5% vs 6%) and increase of FeNO (39.1% vs 16%) more often than in FR +/LLN- group. Besides, 17.4 - 20% of patients in each group despite the LLN+ or FR+, the lung function was normalised after around 2 months - 2 years following up without specific treatment. Conclusions: When using only FR or LLN criteria, the airway obstruction could be underestimated or overestimated in a small number of patients. Younger patients were more likely to have FR-/LLN+ with common diagnosis of asthma and tend to have BrT+ as well as the increase of FeNO than in elderly who were more likely to have FR+/LLN-.</style></abstract><label><style face="normal" font="default" size="100%">Included by Loai</style></label><notes><style face="normal" font="default" size="100%">L631603836&#xD;2020-05-04</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.embase.com/search/results?subaction=viewrecord&amp;id=L631603836&amp;from=export</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2221</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2221</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Niu, X. K.</style></author><author><style face="normal" font="default" size="100%">Li, J.</style></author><author><style face="normal" font="default" size="100%">Das, S. K.</style></author><author><style face="normal" font="default" size="100%">Xiong, Y.</style></author><author><style face="normal" font="default" size="100%">Yang, C. B.</style></author><author><style face="normal" font="default" size="100%">Peng, T.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Radiology, Affiliated Hospital of Chengdu University, Chengdu, 610081, China.&#xD;Department of General Surgery, Affiliated Hospital of Chengdu University, No. 82 2nd North Section of Second Ring Road, Chengdu, Sichuan, 610081, China. niu051228@163.com.&#xD;Department of Intervention Radiology, Tenth People&apos;s Hospital of Tongji University, Shanghai, 200072, China.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Developing a nomogram based on multiparametric magnetic resonance imaging for forecasting high-grade prostate cancer to reduce unnecessary biopsies within the prostate-specific antigen gray zone</style></title><secondary-title><style face="normal" font="default" size="100%">BMC Med Imaging</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">BMC Med Imaging</style></full-title></periodical><pages><style face="normal" font="default" size="100%">11</style></pages><volume><style face="normal" font="default" size="100%">17</style></volume><number><style face="normal" font="default" size="100%">1</style></number><keywords><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">*Algorithms</style></keyword><keyword><style face="normal" font="default" size="100%">China/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Cohort Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Computer Simulation</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Image Interpretation, Computer-Assisted/methods</style></keyword><keyword><style face="normal" font="default" size="100%">Magnetic Resonance Imaging/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Models, Statistical</style></keyword><keyword><style face="normal" font="default" size="100%">Neoplasm Grading</style></keyword><keyword><style face="normal" font="default" size="100%">*Nomograms</style></keyword><keyword><style face="normal" font="default" size="100%">Prognosis</style></keyword><keyword><style face="normal" font="default" size="100%">*Proportional Hazards Models</style></keyword><keyword><style face="normal" font="default" size="100%">Prostate-Specific Antigen/*blood</style></keyword><keyword><style face="normal" font="default" size="100%">Prostatic Neoplasms/diagnostic imaging/*epidemiology/*pathology</style></keyword><keyword><style face="normal" font="default" size="100%">Reproducibility of Results</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Assessment/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Sensitivity and Specificity</style></keyword><keyword><style face="normal" font="default" size="100%">Unnecessary Procedures/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">*Magnetic Resonance Imaging</style></keyword><keyword><style face="normal" font="default" size="100%">*Nomogram</style></keyword><keyword><style face="normal" font="default" size="100%">*pi-rads</style></keyword><keyword><style face="normal" font="default" size="100%">*Prostate cancer</style></keyword><keyword><style face="normal" font="default" size="100%">*Prostate-specific antigen</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style face="normal" font="default" size="100%">Feb 1</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1471-2342</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: Since 1980s the application of Prostate specific antigen (PSA) brought the revolution in prostate cancer diagnosis. However, it is important to underline that PSA is not the ideal screening tool due to its low specificity, which leads to the possible biopsy for the patient without High-grade prostate cancer (HGPCa). Therefore, the aim of this study was to establish a predictive nomogram for HGPCa in patients with PSA 4-10 ng/ml based on Prostate Imaging Reporting and Data System version 2 (PI-RADS v2), MRI-based prostate volume (PV), MRI-based PV-adjusted Prostate Specific Antigen Density (adjusted-PSAD) and other traditional classical parameters. METHODS: Between January 2014 and September 2015, Of 151 men who were eligible for analysis were formed the training cohort. A prediction model for HGPCa was built by using backward logistic regression and was presented on a nomogram. The prediction model was evaluated by a validation cohort between October 2015 and October 2016 (n = 74). The relationship between the nomogram-based risk-score as well as other parameters with Gleason score (GS) was evaluated. All patients underwent 12-core systematic biopsy and at least one core targeted biopsy with transrectal ultrasonographic guidance. RESULTS: The multivariate analysis revealed that patient age, PI-RADS v2 score and adjusted-PSAD were independent predictors for HGPCa. Logistic regression (LR) model had a larger AUC as compared with other parameters alone. The most discriminative cutoff value for LR model was 0.36, the sensitivity, specificity, positive predictive value and negative predictive value were 87.3, 78.4, 76.3, and 90.4%, respectively and the diagnostic performance measures retained similar values in the validation cohort (AUC 0.82 [95% CI, 0.76-0.89]). For all patients with HGPCa (n = 50), adjusted-PSAD and nomogram-based risk-score were positively correlated with the GS of HGPCa in PSA gray zone (r = 0.455, P = 0.002 and r = 0.509, P = 0.001, respectively). CONCLUSION: The nomogram based on multiparametric magnetic resonance imaging (mp-MRI) for forecasting HGPCa is effective, which could reduce unnecessary prostate biopsies in patients with PSA 4-10 ng/ml and nomogram-based risk-score could provide a more robust parameter of assessing the aggressiveness of HGPCa in PSA gray zone.</style></abstract><label><style face="normal" font="default" size="100%">Included by Morty</style></label><notes><style face="normal" font="default" size="100%">1471-2342&#xD;Niu, Xiang-Ke&#xD;Li, Jun&#xD;Das, Susant Kumar&#xD;Xiong, Yan&#xD;Yang, Chao-Bing&#xD;Peng, Tao&#xD;Journal Article&#xD;BMC Med Imaging. 2017 Feb 1;17(1):11. doi: 10.1186/s12880-017-0184-x.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5286806/pdf/12880_2017_Article_184.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC5286806</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1186/s12880-017-0184-x</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2222</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2222</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Njuguna, J.</style></author><author><style face="normal" font="default" size="100%">Menge, D.</style></author><author><style face="normal" font="default" size="100%">Nzou, J.</style></author><author><style face="normal" font="default" size="100%">Chege, C.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Impact of an Intervention to Minimize Overdiagnosis of Malaria Cases in a Low Risk Kenyan sub-County</style></title><secondary-title><style face="normal" font="default" size="100%">J Health Care Poor Underserved</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">J Health Care Poor Underserved</style></full-title></periodical><pages><style face="normal" font="default" size="100%">802-10</style></pages><volume><style face="normal" font="default" size="100%">26</style></volume><number><style face="normal" font="default" size="100%">3</style></number><keywords><keyword><style face="normal" font="default" size="100%">Case Management</style></keyword><keyword><style face="normal" font="default" size="100%">Diagnostic Tests, Routine</style></keyword><keyword><style face="normal" font="default" size="100%">Health Personnel/*education</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Kenya</style></keyword><keyword><style face="normal" font="default" size="100%">Malaria/*diagnosis/therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Medical Overuse/*prevention &amp; control</style></keyword><keyword><style face="normal" font="default" size="100%">Program Evaluation</style></keyword><keyword><style face="normal" font="default" size="100%">Risk</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style face="normal" font="default" size="100%">Aug</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1049-2089</style></isbn><abstract><style face="normal" font="default" size="100%">INTRODUCTION: Overdiagnosis of malaria cases hampers malaria control in developing countries. Due to lack of diagnostics, febrile cases are treated using signs and symptoms. We evaluated an intervention to minimize overdiagnosis in Ijara sub-County, Kenya. METHODS: Health workers were trained on case management and rapid diagnostic tests provided in late 2011. Malaria outpatient morbidity was assessed a year before and after the intervention coupled with data on rapid diagnostic tests consumption. RESULTS: The number of diagnosed malaria cases decreased from 15,615 in 2011 to 1,892 in 2012. This represents an 87.8% decrease. There was a significant difference in number of diagnosed monthly malaria cases during the pre-intervention (Mean = 1,299, SD = 550.4) and post-intervention periods (Mean = 158, SD = 160.9, t (12.9) = 6.9, p =.000, two tailed). Mean monthly consumption of rapid diagnostic tests was 730, with 5.2% testing positive. CONCLUSION: This intervention reduced overdiagnosis and overtreatment of malaria cases.</style></abstract><notes><style face="normal" font="default" size="100%">1548-6869&#xD;Njuguna, John&#xD;Menge, Daniel&#xD;Nzou, Joseph&#xD;Chege, Charles&#xD;Evaluation Study&#xD;Journal Article&#xD;United States&#xD;J Health Care Poor Underserved. 2015 Aug;26(3):802-10. doi: 10.1353/hpu.2015.0101.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://muse.jhu.edu/article/590114</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1353/hpu.2015.0101</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2223</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2223</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nomhwange, T. I.</style></author><author><style face="normal" font="default" size="100%">Whitty, C. J.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Clinical Research Unit, London School of Hygiene &amp; Tropical Medicine, Keppel Street, London WC1E 7HT, UK.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Diagnosis of malaria in children&apos;s outpatient departments in Abuja, Nigeria</style></title><secondary-title><style face="normal" font="default" size="100%">Trop Doct</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Trop Doct</style></full-title></periodical><pages><style face="normal" font="default" size="100%">90-2</style></pages><volume><style face="normal" font="default" size="100%">39</style></volume><number><style face="normal" font="default" size="100%">2</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Animals</style></keyword><keyword><style face="normal" font="default" size="100%">Antimalarials/therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Child, Preschool</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Infant</style></keyword><keyword><style face="normal" font="default" size="100%">Infant, Newborn</style></keyword><keyword><style face="normal" font="default" size="100%">Malaria/*diagnosis/drug therapy/epidemiology/parasitology</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mothers</style></keyword><keyword><style face="normal" font="default" size="100%">Nigeria/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Outpatient Clinics, Hospital/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Population Surveillance/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">*Practice Patterns, Physicians&apos;</style></keyword><keyword><style face="normal" font="default" size="100%">Prescriptions</style></keyword><keyword><style face="normal" font="default" size="100%">Surveys and Questionnaires</style></keyword><keyword><style face="normal" font="default" size="100%">Treatment Outcome</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2009</style></year><pub-dates><date><style face="normal" font="default" size="100%">Apr</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0049-4755 (Print)&#xD;0049-4755</style></isbn><abstract><style face="normal" font="default" size="100%">Over-diagnosis of malaria has previously been described, especially in East Africa. Abuja is the capital of the most populous country in Africa. Over-prescription of artemisinin-based combination therapy (ACT) antimalarials in Nigeria on the scale reported from other countries will result in substantial unnecessary use of this class of drug. In a study of 1000 children seen in the outpatient paediatric clinics of four district hospitals in Abuja, 669 had history of fever, of whom 616 (92%) were diagnosed with malaria. Only 24 (3.8%) where confirmed by positive malaria slides. Of 82 malaria tests requested, 32 (40%) were not available when clinicians wrote their prescriptions. Of 256 children prescribed an ACT, 11 (4.4%) were test negative, eight (3.1%) test positive, in 11 (4.3%) the test was not available and the test was not requested for 219 (86%). The proportion of available negative slides for patients treated with an antimalarial was 23/26 (88%), which was similar to the 22/24 (91%) treated with an antimalarial who were test positive. Testing for malaria made almost no impact on ACT prescription or on all other antimalarials and antibiotics. Based on these findings there is high possibility of massive over prescription of antimalarials.</style></abstract><label><style face="normal" font="default" size="100%">Included by Loai</style></label><notes><style face="normal" font="default" size="100%">Nomhwange, Terna I&#xD;Whitty, Christopher J M&#xD;Journal Article&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Trop Doct. 2009 Apr;39(2):90-2. doi: 10.1258/td.2008.080200.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://journals.sagepub.com/doi/10.1258/td.2008.080200?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%3dpubmed</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1258/td.2008.080200</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2224</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2224</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nsutebu, E. F.</style></author><author><style face="normal" font="default" size="100%">Ndumbe, P. M.</style></author><author><style face="normal" font="default" size="100%">Koulla, S.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">TB Research and Development Programme, Nuffield Institute for Health, University of Leeds, 71-75 Clarendon Road, Leeds LS2 9PL, UK. hssefn@leeds.ac.uk</style></auth-address><titles><title><style face="normal" font="default" size="100%">The increase in occurrence of typhoid fever in Cameroon: overdiagnosis due to misuse of the Widal test?</style></title><secondary-title><style face="normal" font="default" size="100%">Trans R Soc Trop Med Hyg</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Trans R Soc Trop Med Hyg</style></full-title></periodical><pages><style face="normal" font="default" size="100%">64-7</style></pages><volume><style face="normal" font="default" size="100%">96</style></volume><number><style face="normal" font="default" size="100%">1</style></number><keywords><keyword><style face="normal" font="default" size="100%">Agglutination Tests/*standards/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Cameroon/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Clinical Laboratory Techniques/standards</style></keyword><keyword><style face="normal" font="default" size="100%">Diagnostic Errors</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Incidence</style></keyword><keyword><style face="normal" font="default" size="100%">Salmonella typhi/isolation &amp; purification</style></keyword><keyword><style face="normal" font="default" size="100%">Sensitivity and Specificity</style></keyword><keyword><style face="normal" font="default" size="100%">Typhoid Fever/diagnosis/*epidemiology</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2002</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jan-Feb</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0035-9203 (Print)&#xD;0035-9203</style></isbn><abstract><style face="normal" font="default" size="100%">This study investigates the cause of an apparent increase in occurrence of typhoid fever in Cameroon. The reasons explored include an overdiagnosis of the illness related to poor performance of the Widal test in laboratories and interpretation by prescribers. Questionnaires were used in 1996 to evaluate the use and interpretation of the Widal test, and checklists were used to assess its laboratory performance in 2 of the 10 provinces in Cameroon. The majority of prescribers from 20 health facilities (an average of 76% of the doctors and 61% of the nurses) could detect patients who truly had positive Widal tests and needed treatment. However, an average of 48% of the doctors and 84% of the nurses would treat patients who did not require treatment based on the Widal test result. Patients may therefore be treated unnecessarily. Most (88%) of the visited laboratories performed the Widal rapid slide agglutination test as opposed to the conventional tube agglutination test. About 14% of the laboratories that performed the rapid slide agglutination test had a score above average for each criterion evaluated. Misdiagnosis of typhoid fever leads to unnecessary expenditure and exposure of patients to the side-effects of antibiotics. In addition, misdiagnosis may result in delayed diagnosis and treatment of malaria, and other acute febrile illness.</style></abstract><notes><style face="normal" font="default" size="100%">Nsutebu, Emmanuel Fru&#xD;Ndumbe, Peter Martins&#xD;Koulla, Shiro&#xD;Journal Article&#xD;Multicenter Study&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Trans R Soc Trop Med Hyg. 2002 Jan-Feb;96(1):64-7. doi: 10.1016/s0035-9203(02)90243-9.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://academic.oup.com/trstmh/article-abstract/96/1/64/1871121?redirectedFrom=fulltext</style></url><url><style face="normal" font="default" size="100%">https://watermark.silverchair.com/96-1-64.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAArgwggK0BgkqhkiG9w0BBwagggKlMIICoQIBADCCApoGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMCcekgVXiXdrhEL2lAgEQgIICa1UlChnr7YMVKcYN_bEXM2aqHg1PW8jJBhhV54VfLbY3WWRmLYnnKyrI2_Msqs-9PTjm0KmaQT5mvWaLxH5MMhp87sS65WEnp_dNxGGmpQ-iBL6FK6kgKMqTGq4MC6lZR9m2Lpqo6xHdVgzrzHKI7k0brPC97dv91TmvKc3zOYF25Xmjw08VlZ6KIhFaV4iGKGIGxyq2I08azUNAe5Q9uZAUvt85_iKtvz_ikFFs_FNnP-UzYyrUbI_684taZhZuLuQ_1ur2h5NdEfrIVemXpfLWK6cxBsn0bxIqoIf54JX6hwomfU0M4xYbm0I_94xw29L_hmhbCC3h7rKzfhbfYjflp8QAy8v7EeevYVRO-cFkc8lt8UqUK9MnMi4sXBs6VYdS-p5uC7gQTxO_JDjSr0svVwNWsw2gta3oyo0ZO_lStiNBUJTgHOeSNbmt-voB0xB7sgFs9FJQmHIu3s9T0ZxDLG2YpyECImmUuKNrKNqb9idW5Lu4yO-VLf3LreD8ZmZUw1VHNhbI-wUX_GuoFgglAQ61IoJOWP0C6uS6Ow8QhUwZFc0HnU_lnvqnAk68KvPuJPoTDSdaXtIZjGMy0lJbAwtWGB73TQQGt8JTci0puhI0ln0Sr6mmyNsb22BEgrtvJHISDFe-XMGvRnBJ8NhnSm2DD8KmMREF1h7hnd07GY1qqIAJ3A1C1yRKyh4KCMPhXDqOX5FJs9VNnJfhANm6rvOhX8s995rDx58T5tWVlYd9KT_X-MP_mXMHZGaSr2F3smMHhlvw_5L9uL640n5UjT7DPPcl8Q6lHvkmv7W80aFWV3rr_Y6s7Lg</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1016/s0035-9203(02)90243-9</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2225</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2225</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nwokolo, E.</style></author><author><style face="normal" font="default" size="100%">Ujuju, C.</style></author><author><style face="normal" font="default" size="100%">Anyanti, J.</style></author><author><style face="normal" font="default" size="100%">Isiguzo, C.</style></author><author><style face="normal" font="default" size="100%">Udoye, I.</style></author><author><style face="normal" font="default" size="100%">BongosIkwue, E.</style></author><author><style face="normal" font="default" size="100%">Ezire, O.</style></author><author><style face="normal" font="default" size="100%">Raji, M.</style></author><author><style face="normal" font="default" size="100%">Oyibo, W. A.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Society for Family Health, Abuja, Nigeria.&#xD;ANDI Centre of Excellence for Malaria Diagnosis, College of Medicine, University of Lagos, Lagos, Nigeria.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Misuse of Artemisinin Combination Therapies by Clients of Medicine Retailers Suspected to Have Malaria Without Prior Parasitological Confirmation in Nigeria</style></title><secondary-title><style face="normal" font="default" size="100%">Int J Health Policy Manag</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Int J Health Policy Manag</style></full-title></periodical><pages><style face="normal" font="default" size="100%">542-548</style></pages><volume><style face="normal" font="default" size="100%">7</style></volume><number><style face="normal" font="default" size="100%">6</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Antimalarials/*therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Artemisinins/*therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Cross-Sectional Studies</style></keyword><keyword><style face="normal" font="default" size="100%">*Drug Misuse</style></keyword><keyword><style face="normal" font="default" size="100%">Drug Therapy, Combination</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Malaria/diagnosis/*drug therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Nigeria</style></keyword><keyword><style face="normal" font="default" size="100%">*Pharmacies</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword><keyword><style face="normal" font="default" size="100%">*ACT Misuse</style></keyword><keyword><style face="normal" font="default" size="100%">*Malaria Case Management in Africa</style></keyword><keyword><style face="normal" font="default" size="100%">*Presumptive Malaria Treatment</style></keyword><keyword><style face="normal" font="default" size="100%">*Private Medicine Vendors</style></keyword><keyword><style face="normal" font="default" size="100%">*Test Before Treatment</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jun 1</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">2322-5939</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: Prompt and effective case detection and treatment are vital components of the malaria case management strategy as malaria-endemic countries implement the testing, treating and tracking policy. The implementation of this policy in public and formal private sectors continue to receive great attention while the informal private retail sector (mostly the patent and propriety medicine vendors [PPMVs]) where about 60% of patients with fever in Nigeria seek treatment is yet to be fully integrated. The PPMVs sell artemisinin combination therapies (ACTs) without prior testing and are highly patronized. Without prior testing, malaria is likely to be over-treated. The need to expand access to diagnosis in the huge informal private health sector among PPMVs is currently being explored to ensure that clients that patronize retail drug stores are tested before sales of ACTs. METHODS: A cross-sectional multistage study was conducted among 1279 adult clients, 20 years and above, who purchased malaria medicines from 119 selected PPMVs in five administrative areas (States) of Nigeria, namely: Adamawa, Cross River, Enugu, Lagos and Kaduna, as well as the Federal Capital Territory, Abuja. Exit interviews using a standard case report questionnaire was conducted after the purchase of the antimalarial medicine and thick/thin blood smears from the clients&apos; finger-prick were prepared to confirm malaria by expert microscopy. RESULTS: Of the 1279 clients who purchased malaria medicines from the PPMV outlets, 107 (8.4%) were confirmed to have malaria parasites. The malaria prevalence in the various study areas ranged from 3.5% to 16%. A high proportion of clients in the various study sites who had no need for malaria medicines (84%-96.5%) purchased and used antimalarial medicines from the PPMVs. This indicated a high level of over-treatment and misuse of antimalarials. Common symptoms that are widely used as indicators for malaria such as, fever, headache, and tiredness were not significantly associated with malaria. Nausea/vomiting, poor appetite, chills, bitter taste in the mouth and dark urine were symptoms that were significantly associated with malaria among the adult clients (P&lt;.05) but not fever (P=.06). CONCLUSION: Misuse of ACTs following overtreatment of malaria based on clinical diagnosis occurs when suspected cases of malaria are not prior confirmed with a test. Non-testing before sales of malaria medicines by PPMVs will perpetuate ACT misuse with the patients not benefiting due to poor treatment outcomes, waste of medicines and financial loss from out-of-pocket payment for unneeded medicines.</style></abstract><notes><style face="normal" font="default" size="100%">2322-5939&#xD;Nwokolo, Ernest&#xD;Ujuju, Chinazo&#xD;Anyanti, Jennifer&#xD;Isiguzo, Chinwoke&#xD;Udoye, Ifeanyi&#xD;BongosIkwue, Elamei&#xD;Ezire, Onoriode&#xD;Raji, Mopelola&#xD;Oyibo, Wellington A&#xD;Journal Article&#xD;Int J Health Policy Manag. 2018 Jun 1;7(6):542-548. doi: 10.15171/ijhpm.2017.122.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015511/pdf/ijhpm-7-542.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC6015511</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.15171/ijhpm.2017.122</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2226</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2226</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Olcay, A.</style></author><author><style face="normal" font="default" size="100%">Emren, S. V.</style></author><author><style face="normal" font="default" size="100%">Babür Güler, G.</style></author><author><style face="normal" font="default" size="100%">Güler, E.</style></author><author><style face="normal" font="default" size="100%">Ertunç, V.</style></author><author><style face="normal" font="default" size="100%">Berilgen, R.</style></author><author><style face="normal" font="default" size="100%">Aslan, A.</style></author><author><style face="normal" font="default" size="100%">Şimşek, EÇ</style></author><author><style face="normal" font="default" size="100%">Gölcük Ş, E.</style></author><author><style face="normal" font="default" size="100%">Yalın, K.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Cardiology, İstanbul Aydın University Faculty of Medicine, İstanbul, Turkey. drayhanolcay@gmail.com.</style></auth-address><titles><title><style face="normal" font="default" size="100%">The opinion of Turkish cardiologists on current malpractice system and an alternative patient compensation system proposal: PCS study group</style></title><secondary-title><style face="normal" font="default" size="100%">Turk Kardiyol Dern Ars</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Turk Kardiyol Dern Ars</style></full-title></periodical><pages><style face="normal" font="default" size="100%">630-637</style></pages><volume><style face="normal" font="default" size="100%">45</style></volume><number><style face="normal" font="default" size="100%">7</style></number><keywords><keyword><style face="normal" font="default" size="100%">Cardiologists/legislation &amp; jurisprudence/*psychology</style></keyword><keyword><style face="normal" font="default" size="100%">Computed Tomography Angiography/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Coronary Angiography/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Cross-Sectional Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Defensive Medicine/legislation &amp; jurisprudence/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Malpractice/*legislation &amp; jurisprudence</style></keyword><keyword><style face="normal" font="default" size="100%">Radionuclide Imaging/methods/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Referral and Consultation/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Stents/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Surveys and Questionnaires</style></keyword><keyword><style face="normal" font="default" size="100%">Thallium</style></keyword><keyword><style face="normal" font="default" size="100%">Turkey</style></keyword><keyword><style face="normal" font="default" size="100%">Unnecessary Procedures/psychology/trends</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style face="normal" font="default" size="100%">Oct</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1016-5169</style></isbn><abstract><style face="normal" font="default" size="100%">OBJECTIVE: Cardiologists participate in the diagnosis and interventional treatment of numerous high-risk patients. The goal of this study was to investigate how the current malpractice system in Turkey influences cardiologists&apos; diagnostic and interventional behavior and to obtain their opinions about an alternative patient compensation system. METHODS: The present cross-sectional study assessed the practice of defensive medicine among cardiologists who are actively working in various types of workplace within the Turkish healthcare system. A 24-item questionnaire was distributed to cardiology residents, specialists, and academics in Turkey in print format, by electronic mail, or via cell phone message. RESULTS: A total of 253 cardiologists responded to the survey. Among them, 29 (11.6%) had been sued for malpractice claims in the past. Of the cardiologists who had been sued, 2 (6.9%) had been ordered to pay financial compensation, and 1 (3.4%) was given a sentence of imprisonment due to negligence. In all, 132 (52.8%) of the surveyed cardiologists reported that they had changed their practices due to fear of litigation, and 232 (92.8%) reported that they would prefer the new proposed patient compensation system to the current malpractice system. Among the cardiologists surveyed, 78.8% indicated that malpractice fear had affected their decision-making with regard to requesting computed tomography angiography or thallium scintigraphy, 71.6% for coronary angiography, 20% for stent implantation, and 83.2% for avoiding treating high-risk patients. CONCLUSION: The results of this survey demonstrated that cardiologists may request unnecessary tests and perform unneeded interventions due to the fear of malpractice litigation fear. Many also avoid high-risk patients and interventions. The majority indicated that they would prefer the proposed alternative patient compensation system to the current malpractice system.</style></abstract><label><style face="normal" font="default" size="100%">Included by Morty</style></label><notes><style face="normal" font="default" size="100%">1308-4488&#xD;Olcay, Ayhan&#xD;Emren, Sadık Volkan&#xD;Babür Güler, Gamze&#xD;Güler, Ekrem&#xD;Ertunç, Vedat&#xD;Berilgen, Rida&#xD;Aslan, Abdullah&#xD;Şimşek, Ersin Çağrı&#xD;Gölcük, Şükriye Ebru&#xD;Yalın, Kıvanç&#xD;Journal Article&#xD;Turkey&#xD;Turk Kardiyol Dern Ars. 2017 Oct;45(7):630-637. doi: 10.5543/tkda.2017.39455.</style></notes><urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.5543/tkda.2017.39455</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2227</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2227</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Orish, V. N.</style></author><author><style face="normal" font="default" size="100%">Ansong, J. Y.</style></author><author><style face="normal" font="default" size="100%">Onyeabor, O. S.</style></author><author><style face="normal" font="default" size="100%">Sanyaolu, A. O.</style></author><author><style face="normal" font="default" size="100%">Oyibo, W. A.</style></author><author><style face="normal" font="default" size="100%">Iriemenam, N. C.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Physician/Lecturer, Department of Internal Medicine, Effia-Nkwanta Regional Hospital Sekondi-Takoradi, Sekondi, Western Region, Ghana orishv@yahoo.com.&#xD;Physician, Department of Paediatrics, Effia-Nkwanta Regional Hospital Sekondi-Takoradi, Sekondi, Western Region, Ghana.&#xD;Physician, Department of Community Health and Preventive Medicine, The Satcher Health Leadership Institute, Morehouse School of Medicine, Atlanta, Georgia, USA.&#xD;Associate Professor of Microbiology, Department of Medical Microbiology &amp; Immunology, Saint James School of Medicine, Anguilla, British West Indies Associate Professor of Microbiology, ANDI Centre of Excellence for Malaria Diagnosis, WHO/TDR/FIND Malaria Specimen Bank Site, Department of Medical Microbiology and Parasitology, College of Medicine of the University of Lagos, Idi-araba, Lagos, Nigeria.&#xD;Professor of Parasitology, ANDI Centre of Excellence for Malaria Diagnosis, WHO/TDR/FIND Malaria Specimen Bank Site, Department of Medical Microbiology and Parasitology, College of Medicine of the University of Lagos, Idi-araba, Lagos, Nigeria.&#xD;Principal Investigator, ANDI Centre of Excellence for Malaria Diagnosis, WHO/TDR/FIND Malaria Specimen Bank Site, Department of Medical Microbiology and Parasitology, College of Medicine of the University of Lagos, Idi-araba, Lagos, Nigeria.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Overdiagnosis and overtreatment of malaria in children in a secondary healthcare centre in Sekondi-Takoradi, Ghana</style></title><secondary-title><style face="normal" font="default" size="100%">Trop Doct</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Trop Doct</style></full-title></periodical><pages><style face="normal" font="default" size="100%">191-198</style></pages><volume><style face="normal" font="default" size="100%">46</style></volume><number><style face="normal" font="default" size="100%">4</style></number><keywords><keyword><style face="normal" font="default" size="100%">Antimalarials/*therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Child, Preschool</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Fever/*etiology</style></keyword><keyword><style face="normal" font="default" size="100%">Ghana/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Hospitalization</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Inappropriate Prescribing/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Infant</style></keyword><keyword><style face="normal" font="default" size="100%">Infant, Newborn</style></keyword><keyword><style face="normal" font="default" size="100%">Malaria/diagnosis/*drug therapy/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Medical Overuse/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Prevalence</style></keyword><keyword><style face="normal" font="default" size="100%">Retrospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Secondary Care Centers</style></keyword><keyword><style face="normal" font="default" size="100%">Sex Distribution</style></keyword><keyword><style face="normal" font="default" size="100%">*Overdiagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">*children</style></keyword><keyword><style face="normal" font="default" size="100%">*healthcare</style></keyword><keyword><style face="normal" font="default" size="100%">*malaria</style></keyword><keyword><style face="normal" font="default" size="100%">*overtreatment</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style face="normal" font="default" size="100%">Oct</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0049-4755</style></isbn><abstract><style face="normal" font="default" size="100%">Overdiagnosis and overtreatment of malaria is a major problem in children in malaria-endemic countries. This retrospective study identified children who were admitted with fever and were treated with or without anti-malarial medications and discharged at the Paediatric Unit of the Effia-Nkwanta Regional Hospital. The medical records of all children were searched, retrieved and assessed. A total of 1160 records from children (age range, 0-12 years) were reviewed and evaluated. Of the total number, 21.3% had laboratory confirmed malaria, 38.4% were malaria negative, while 40.3% had no malaria tests performed. In addition, the results showed that 4.5% of the laboratory confirmed malaria positive cases were not given anti-malarial medication while 84.1% of the malaria negative cases were given these incorrectly. Furthermore, 78.2% of the children with no malaria tests were prescribed anti-malarial medication. The presumptive diagnosis of malaria should be abandoned and the installation of a functional laboratory services promoted.</style></abstract><notes><style face="normal" font="default" size="100%">1758-1133&#xD;Orish, Verner N&#xD;Ansong, Joseph Y&#xD;Onyeabor, Onyekachi S&#xD;Sanyaolu, Adekunle O&#xD;Oyibo, Wellington A&#xD;Iriemenam, Nnaemeka C&#xD;001/World Health Organization/International&#xD;Journal Article&#xD;England&#xD;Trop Doct. 2016 Oct;46(4):191-198. doi: 10.1177/0049475515622861. Epub 2016 Jan 5.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://journals.sagepub.com/doi/10.1177/0049475515622861?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%3dpubmed</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1177/0049475515622861</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2228</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2228</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Osei-Kwakye, K.</style></author><author><style face="normal" font="default" size="100%">Asante, K. P.</style></author><author><style face="normal" font="default" size="100%">Mahama, E.</style></author><author><style face="normal" font="default" size="100%">Apanga, S.</style></author><author><style face="normal" font="default" size="100%">Owusu, R.</style></author><author><style face="normal" font="default" size="100%">Kwara, E.</style></author><author><style face="normal" font="default" size="100%">Adjei, G.</style></author><author><style face="normal" font="default" size="100%">Abokyi, L.</style></author><author><style face="normal" font="default" size="100%">Yeetey, E.</style></author><author><style face="normal" font="default" size="100%">Dosoo, D. K.</style></author><author><style face="normal" font="default" size="100%">Punguyire, D.</style></author><author><style face="normal" font="default" size="100%">Owusu-Agyei, S.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Kintampo Health Research Centre, Ghana Health Service, Ministry of Health, Kintampo, Ghana.</style></auth-address><titles><title><style face="normal" font="default" size="100%">The benefits or otherwise of managing malaria cases with or without laboratory diagnosis: the experience in a district hospital in Ghana</style></title><secondary-title><style face="normal" font="default" size="100%">PLoS One</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">PLoS ONE</style></full-title></periodical><pages><style face="normal" font="default" size="100%">e58107</style></pages><volume><style face="normal" font="default" size="100%">8</style></volume><number><style face="normal" font="default" size="100%">3</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Antimalarials/economics/therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Child, Preschool</style></keyword><keyword><style face="normal" font="default" size="100%">Clinical Laboratory Techniques/economics/methods</style></keyword><keyword><style face="normal" font="default" size="100%">Cross-Sectional Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Ghana</style></keyword><keyword><style face="normal" font="default" size="100%">Health Care Costs</style></keyword><keyword><style face="normal" font="default" size="100%">Hospitals, District</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Infant</style></keyword><keyword><style face="normal" font="default" size="100%">Infant, Newborn</style></keyword><keyword><style face="normal" font="default" size="100%">Malaria/*diagnosis/*drug therapy/economics</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Sensitivity and Specificity</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2013</style></year></dates><isbn><style face="normal" font="default" size="100%">1932-6203</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: This study was conducted at the Kintampo Municipal Hospital in Ghana to determine whether there was any benefit (or otherwise) in basing the management of cases of suspected malaria solely on laboratory confirmation (microscopy or by RDT) as compared with presumptive diagnosis. METHOD: Children under five years who reported at the Out-Patient Department of the Hospital with axillary temperature ≥37.5°C or with a 48 hr history of fever were enrolled and had malaria microscopy and RDT performed. The attending clinician was blinded from laboratory results unless a request for these tests had been made earlier. Diagnosis of malaria was based on three main methods: presumptive or microscopy and/or RDT. Cost implication for adopting laboratory diagnosis or not was determined to inform malaria control programmes. RESULTS: In total, 936 children were enrolled in the study. Proportions of malaria diagnosed presumptively, by RDT and microscopy were 73.6% (689/936), 66.0% (618/936) and 43.2% (404/936) respectively. Over 50% (170/318) of the children who were RDT negative and 60% (321/532) who were microscopy negative were treated for malaria when presumptive diagnoses were used. Comparing the methods of diagnoses, the cost of malaria treatment could have been reduced by 24% and 46% in the RDT and microscopy groups respectively; the reduction was greater in the dry season (43% vs. 50%) compared with the wet season (20% vs. 45%) for the RDT and microscopy confirmed cases respectively. DISCUSSION/CONCLUSION: Over-diagnosis of malaria was prevalent in Kintampo during the period of the study. Though the use of RDT for diagnosis of malaria might have improved the quality of care for children, it appeared not to have a cost saving effect on the management of children with suspected malaria. Further research may be needed to confirm this.</style></abstract><notes><style face="normal" font="default" size="100%">1932-6203&#xD;Osei-Kwakye, Kingsley&#xD;Asante, Kwaku Poku&#xD;Mahama, Emmanuel&#xD;Apanga, Stephen&#xD;Owusu, Ruth&#xD;Kwara, Evans&#xD;Adjei, George&#xD;Abokyi, Livesy&#xD;Yeetey, Enuameh&#xD;Dosoo, David Kwame&#xD;Punguyire, Damien&#xD;Owusu-Agyei, Seth&#xD;Journal Article&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;PLoS One. 2013;8(3):e58107. doi: 10.1371/journal.pone.0058107. Epub 2013 Mar 7.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3591456/pdf/pone.0058107.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC3591456</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1371/journal.pone.0058107</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2229</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2229</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Ozbek, O. A.</style></author><author><style face="normal" font="default" size="100%">Oktem, I. M.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Dokuz Eylül Universitesi Tip Fakültesi, Tibbi Mikrobiyoloji Anabilim Dali, Izmir. alpay.ozbek@deu.edu.tr</style></auth-address><titles><title><style face="normal" font="default" size="100%">[Inappropriately ordered tests from hepatitis B vaccinated subjects]</style></title><secondary-title><style face="normal" font="default" size="100%">Mikrobiyol Bul</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Mikrobiyol Bul</style></full-title></periodical><pages><style face="normal" font="default" size="100%">285-90</style></pages><volume><style face="normal" font="default" size="100%">44</style></volume><number><style face="normal" font="default" size="100%">2</style></number><keywords><keyword><style face="normal" font="default" size="100%">Hepatitis B/*diagnosis/immunology/prevention &amp; control</style></keyword><keyword><style face="normal" font="default" size="100%">Hepatitis B Antibodies/blood</style></keyword><keyword><style face="normal" font="default" size="100%">Hepatitis B Core Antigens/immunology</style></keyword><keyword><style face="normal" font="default" size="100%">Hepatitis B Surface Antigens/blood/immunology</style></keyword><keyword><style face="normal" font="default" size="100%">Hepatitis B Vaccines/*administration &amp; dosage/immunology</style></keyword><keyword><style face="normal" font="default" size="100%">Hepatitis B e Antigens/blood/immunology</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Immunoglobulin M/blood</style></keyword><keyword><style face="normal" font="default" size="100%">Mass Screening/*economics/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Retrospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Turkey</style></keyword><keyword><style face="normal" font="default" size="100%">Unnecessary Procedures/*economics</style></keyword><keyword><style face="normal" font="default" size="100%">Vaccination/statistics &amp; numerical data</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2010</style></year><pub-dates><date><style face="normal" font="default" size="100%">Apr</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0374-9096 (Print)&#xD;0374-9096</style></isbn><abstract><style face="normal" font="default" size="100%">Laboratory testing for viral hepatitis B constitutes a vast burden regarding the cost and the workload for health care system for many countries including ours. There are several reports stating that the cost in question is not always necessary. As a consequence of larger scale vaccination programmes, an increase in unnecessary hepatitis B testing is expected in vaccinated individuals. The present retrospective study aims to determine the rate of inappropriately ordered tests from vaccinated individuals and to discuss the causes and possible solutions of this problem. Laboratory records of 56.349 subjects admitted to Dokuz Eylul University Hospital, Izmir, during 2007 and 2009, were evaluated retrospectively for hepatitis B serological test results. Unnecessary testing was defined as the requests for HBsAg, anti-HBc, anti-HBc IgM, HBeAg and anti-HBe tests from those who had positive anti-HBs and negative anti-HBc results. The cost burden was calculated by taking account the prices recommended by the Department of Social Security. The appropriateness of anti-HBs test orders were not taken into evaluation since specific clinical conditions (immune response disorders, HIV infection, chronic hemodialysis, newborns of HBsAg positive mothers, contact with HBsAg carriers) were not clarified. It was found that among the 17.869 samples tested for both anti-HBs and anti-HBc, 4402 (24.6%) were ordered from subjects who were vaccinated against hepatitis B virus (anti-HBs positive, anti-HBc negative status). Thus, 11.405 (12.9%) tests out of a total of 88.174 hepatitis B tests (HBsAg, anti-HBc, anti-HBc IgM, HBeAg, anti-HBe) were unnecessarily ordered. Social security services and/or individuals paid approximately 59.000 USD for these unnecessary tests in three years, leading to an economic loss of approximately 20.000 USD yearly. Providing appropriate feedback to clinicians and reflex test application (to order a test according to the results of previous tests in accordance to diagnostic test algorithms) were considered to be useful in prevention of the problem.</style></abstract><notes><style face="normal" font="default" size="100%">Ozbek, Ozgen Alpay&#xD;Oktem, Ibrahim Mehmet Ali&#xD;Journal Article&#xD;Turkey&#xD;Mikrobiyol Bul. 2010 Apr;44(2):285-90.</style></notes><urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2230</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2230</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Ozbek, O. A.</style></author><author><style face="normal" font="default" size="100%">Oktem, M. A.</style></author><author><style face="normal" font="default" size="100%">Dogan, G.</style></author><author><style face="normal" font="default" size="100%">Abacioglu, Y. H.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Dokuz Eylul University Faculty of Medicine, Department of Microbiology and Clinical Microbiology, Inciralti, Izmir, Turkey.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Application of hepatitis serology testing algorithms to assess inappropriate laboratory utilization</style></title><secondary-title><style face="normal" font="default" size="100%">J Eval Clin Pract</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">J Eval Clin Pract</style></full-title></periodical><pages><style face="normal" font="default" size="100%">519-23</style></pages><volume><style face="normal" font="default" size="100%">10</style></volume><number><style face="normal" font="default" size="100%">4</style></number><keywords><keyword><style face="normal" font="default" size="100%">*Algorithms</style></keyword><keyword><style face="normal" font="default" size="100%">Hematologic Tests/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Hepatitis, Viral, Human/blood/classification/*diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Laboratories, Hospital/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Turkey</style></keyword><keyword><style face="normal" font="default" size="100%">Unnecessary Procedures/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Utilization Review</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2004</style></year><pub-dates><date><style face="normal" font="default" size="100%">Nov</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1356-1294 (Print)&#xD;1356-1294</style></isbn><abstract><style face="normal" font="default" size="100%">RATIONALE, AIMS AND OBJECTIVES: Many studies pointed out inappropriate utilization of laboratory caused by excessive amounts of tests ordered by doctors. To prevent and to eliminate the ordering of unhelpful tests, introducing diagnostic algorithms, which are also a suitable practice for application to hepatitis serology, have been suggested. This study aimed to determine inappropriate test ordering rates with respect to the commonly approved algorithms for serological diagnosis of viral hepatitis. METHODS: To assess the number of inappropriate test orders, laboratory records of samples sent for hepatitis A, B, and D serology were reviewed and evaluated retrospectively with respect to algorithms for serological diagnosis of viral hepatitis. Orders including serological marker groups with inadequate clinical information to determine whether or not the order was inappropriate were excluded from the analysis. RESULTS: Application of diagnostic algorithms showed that 50% of anti-HAV IgM and anti-HAV total; 12.7% of anti-HBs, 12.7% of anti-HBc total, 78.5% of anti-HBc IgM, 87.3% of HBe Ag, 78.8% of anti-HBe, 58.7% of anti-HD total orders were made inappropriately. CONCLUSIONS: Our study provides information for inappropriate laboratory utilization for hepatitis serology testing and we suggest to use diagnostic algorithms applied by the serology laboratory to decrease the rate of unhelpful test orders.</style></abstract><notes><style face="normal" font="default" size="100%">Ozbek, Ozgen A&#xD;Oktem, Mehmet A&#xD;Dogan, Guliz&#xD;Abacioglu, Yusuf H&#xD;Journal Article&#xD;England&#xD;J Eval Clin Pract. 2004 Nov;10(4):519-23. doi: 10.1111/j.1365-2753.2003.00447.x.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-2753.2003.00447.x?sid=nlm%3Apubmed</style></url><url><style face="normal" font="default" size="100%">https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2753.2003.00447.x?download=true</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1111/j.1365-2753.2003.00447.x</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2231</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2231</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Panato, C.</style></author><author><style face="normal" font="default" size="100%">Vaccarella, S.</style></author><author><style face="normal" font="default" size="100%">Dal Maso, L.</style></author><author><style face="normal" font="default" size="100%">Basu, P.</style></author><author><style face="normal" font="default" size="100%">Franceschi, S.</style></author><author><style face="normal" font="default" size="100%">Serraino, D.</style></author><author><style face="normal" font="default" size="100%">Wang, K.</style></author><author><style face="normal" font="default" size="100%">Lei, F.</style></author><author><style face="normal" font="default" size="100%">Chen, Q.</style></author><author><style face="normal" font="default" size="100%">Huang, B.</style></author><author><style face="normal" font="default" size="100%">Mathew, A.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Cancer Epidemiology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.&#xD;International Agency for Research on Cancer, Lyon, France.&#xD;Scientific Directorate, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.&#xD;Department of Internal Medicine, Division of Medical Oncology, University of Kentucky, Lexington, KY, USA.&#xD;Department of Biostatistics, College of Public Health, University of Kentucky, Lexington, KY, USA.&#xD;Biostatistics and Bioinformatics Shared Facility, Markey Cancer Center, University of Kentucky, Lexington, KY, USA.&#xD;MOSC Medical College Kolenchery, Kerala, India.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Thyroid Cancer Incidence in India Between 2006 and 2014 and Impact of Overdiagnosis</style></title><secondary-title><style face="normal" font="default" size="100%">J Clin Endocrinol Metab</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">J Clin Endocrinol Metab</style></full-title></periodical><pages><style face="normal" font="default" size="100%">2507-14</style></pages><volume><style face="normal" font="default" size="100%">105</style></volume><number><style face="normal" font="default" size="100%">8</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Age Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Child, Preschool</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Geography</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Incidence</style></keyword><keyword><style face="normal" font="default" size="100%">India/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Infant</style></keyword><keyword><style face="normal" font="default" size="100%">Infant, Newborn</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mass Screening/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Medical Overuse/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Registries/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Sex Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Thyroid Neoplasms/*epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword><keyword><style face="normal" font="default" size="100%">*India</style></keyword><keyword><style face="normal" font="default" size="100%">*Thyroid cancer</style></keyword><keyword><style face="normal" font="default" size="100%">*incidence</style></keyword><keyword><style face="normal" font="default" size="100%">*overdiagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">*time trends</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2020</style></year><pub-dates><date><style face="normal" font="default" size="100%">Aug 1</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0021-972X (Print)&#xD;0021-972x</style></isbn><abstract><style face="normal" font="default" size="100%">CONTEXT/OBJECTIVE: Increases of thyroid cancer (TC) incidence emerged in the past several decades in several countries. This study aimed to estimate time trends of TC incidence in India and the proportion of TC cases potentially attributable to overdiagnosis by sex, age, and area. DESIGN: TC cases aged 0 to 74 years reported to Indian cancer registries during 2006 through 2014 were included. Age-standardized incidence rates (ASR) and TC overdiagnosis were estimated by sex, period, age, and area. RESULTS: Between 2006 to 2008 and 2012 to 2014, the ASRs for TC in India increased from 2.5 to 3.5/100,000 women (+37%) and from 1.0 to 1.3/100,000 men (+27%). However, up to a 10-fold difference was found among regions in both sexes. Highest ASRs emerged in Thiruvananthapuram (14.6/100,000 women and 4.1/100,000 men in 2012-2014), with 93% increase in women and 64% in men compared with 2006 to 2008. No evidence of overdiagnosis was found in Indian men. Conversely, overdiagnosis accounted for 51% of TC in Indian women: 74% in those aged &lt; 35 years, 50% at ages 35 to 54 years, and 30% at ages 55 to 64 years. In particular, 80% of TC overdiagnosis in women emerged in Thiruvananthapuram, whereas none or limited evidence of overdiagnosis emerged in Kamrup, Dibrugarh, Bhopal, or Sikkim. CONCLUSIONS: Relatively high and increasing TC ASRs emerged in Indian regions where better access to health care was reported. In India, as elsewhere, new strategies are needed to discourage opportunistic screening practice, particularly in young women, and to avoid unnecessary and expensive treatments. Present results may serve as a warning also for other transitioning countries.</style></abstract><label><style face="normal" font="default" size="100%">Included by Hannah</style></label><notes><style face="normal" font="default" size="100%">1945-7197&#xD;Panato, Chiara&#xD;Vaccarella, Salvatore&#xD;Dal Maso, Luigino&#xD;Basu, Partha&#xD;Franceschi, Silvia&#xD;Serraino, Diego&#xD;Wang, Kevin&#xD;Lei, Feitong&#xD;Chen, Quan&#xD;Huang, Bin&#xD;Mathew, Aju&#xD;P30 CA177558/CA/NCI NIH HHS/United States&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;J Clin Endocrinol Metab. 2020 Aug 1;105(8):2507-14. doi: 10.1210/clinem/dgaa192.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://academic.oup.com/jcem/article-abstract/105/8/2507/5820802?redirectedFrom=fulltext</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC7947989</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1210/clinem/dgaa192</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2232</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2232</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Parkes-Ratanshi, R.</style></author><author><style face="normal" font="default" size="100%">Kikonyogo, R.</style></author><author><style face="normal" font="default" size="100%">Hsieh, Y. H.</style></author><author><style face="normal" font="default" size="100%">Nakku-Joloba, E.</style></author><author><style face="normal" font="default" size="100%">Manabe, Y. C.</style></author><author><style face="normal" font="default" size="100%">Gaydos, C. A.</style></author><author><style face="normal" font="default" size="100%">Rompalo, A.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">1 Infectious Disease Institute, Makerere University College of Health Sciences, Kampala, Uganda.&#xD;2 Institute of Public Health, University of Cambridge, Cambridge, UK.&#xD;3 Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.&#xD;4 School of Public Health, Makerere University, Kampala, Uganda.&#xD;5 Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Point-of-care diagnostics: needs of African health care workers and their role combating global antimicrobial resistance</style></title><secondary-title><style face="normal" font="default" size="100%">Int J STD AIDS</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Int J STD AIDS</style></full-title></periodical><pages><style face="normal" font="default" size="100%">404-410</style></pages><volume><style face="normal" font="default" size="100%">30</style></volume><number><style face="normal" font="default" size="100%">4</style></number><keywords><keyword><style face="normal" font="default" size="100%">Anti-Bacterial Agents/*pharmacology</style></keyword><keyword><style face="normal" font="default" size="100%">*Drug Resistance, Bacterial</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">*Health Personnel</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Point-of-Care Systems/*organization &amp; administration</style></keyword><keyword><style face="normal" font="default" size="100%">Point-of-Care Testing/*organization &amp; administration</style></keyword><keyword><style face="normal" font="default" size="100%">Uganda</style></keyword><keyword><style face="normal" font="default" size="100%">*Africa</style></keyword><keyword><style face="normal" font="default" size="100%">*Point-of-care tests</style></keyword><keyword><style face="normal" font="default" size="100%">*sexually transmitted infections</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style face="normal" font="default" size="100%">Mar</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0956-4624 (Print)&#xD;0956-4624</style></isbn><abstract><style face="normal" font="default" size="100%">Point-of-care tests (POCTs) offer the opportunity for increased diagnostic capacity in resource-limited settings, where there is lack of electricity, technical capacity, reagents, and infrastructure. Understanding how POCTs are currently used and determining what health care workers (HCWs) need is key to development of appropriate tests. In 2016, we undertook an email survey of 7584 HCWs who had received training at the Infectious Diseases Institute, Uganda, in a wide variety of courses. HCWs were contacted up to three times and asked to complete the survey using Qualtrics software. Of 555 participants answering the survey (7.3% response rate), 62% completed. Ninety-one percent were from Uganda and 50.3% were male. The most commonly-used POCTs were pregnancy tests (74%), urine dipstick (71%), syphilis rapid test (66%), and Gram stain (41%). The majority (74%) practiced syndromic diagnosis for sexually transmitted infections/HIV. Lack of availability of POCTs, increased patient wait time, and lack of training were the leading barriers for POCT use. Increasing POCT availability and training could improve uptake of POCTs for sexually transmitted infections in Africa and decrease syndromic management. This could reduce overtreatment and slow the emergence of antibiotic resistance. This is the first published email survey of HCWs in Uganda; mechanisms to increase the response rate should be evaluated.</style></abstract><notes><style face="normal" font="default" size="100%">1758-1052&#xD;Parkes-Ratanshi, Rosalind&#xD;Orcid: 0000-0001-9297-1311&#xD;Kikonyogo, Ruth&#xD;Hsieh, Yu-Hsiang&#xD;Nakku-Joloba, Edith&#xD;Manabe, Yukari C&#xD;Gaydos, Charlotte A&#xD;Rompalo, Anne&#xD;U54 EB007958/EB/NIBIB NIH HHS/United States&#xD;UM1 AI068613/AI/NIAID NIH HHS/United States&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Int J STD AIDS. 2019 Mar;30(4):404-410. doi: 10.1177/0956462418807112. Epub 2019 Jan 9.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6693631/pdf/nihms-1019161.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC6693631</style></custom2><custom6><style face="normal" font="default" size="100%">NIHMS1019161</style></custom6><electronic-resource-num><style face="normal" font="default" size="100%">10.1177/0956462418807112</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2233</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2233</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Pathirana, T.</style></author><author><style face="normal" font="default" size="100%">Yu, M. W.</style></author><author><style face="normal" font="default" size="100%">Martiny, F.</style></author><author><style face="normal" font="default" size="100%">Rupasinghe, M.</style></author><author><style face="normal" font="default" size="100%">Kottahachchi, D.</style></author><author><style face="normal" font="default" size="100%">Wijewickrama, A.</style></author><author><style face="normal" font="default" size="100%">Copp, T.</style></author><author><style face="normal" font="default" size="100%">Kumar, R.</style></author><author><style face="normal" font="default" size="100%">Mendis, K.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">T. Pathirana</style></auth-address><titles><title><style face="normal" font="default" size="100%">Drivers and potential solutions for overdiagnosis: Perspectives from the low and middle income countries</style></title><secondary-title><style face="normal" font="default" size="100%">BMJ Evidence-Based Medicine</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">BMJ Evidence-Based Medicine</style></full-title></periodical><pages><style face="normal" font="default" size="100%">A6-A7</style></pages><volume><style face="normal" font="default" size="100%">24</style></volume><keywords><keyword><style face="normal" font="default" size="100%">antibiotic agent</style></keyword><keyword><style face="normal" font="default" size="100%">antivirus agent</style></keyword><keyword><style face="normal" font="default" size="100%">adult</style></keyword><keyword><style face="normal" font="default" size="100%">Asia</style></keyword><keyword><style face="normal" font="default" size="100%">awareness</style></keyword><keyword><style face="normal" font="default" size="100%">breast cancer</style></keyword><keyword><style face="normal" font="default" size="100%">cancer screening</style></keyword><keyword><style face="normal" font="default" size="100%">conference abstract</style></keyword><keyword><style face="normal" font="default" size="100%">controlled study</style></keyword><keyword><style face="normal" font="default" size="100%">developed country</style></keyword><keyword><style face="normal" font="default" size="100%">diabetes mellitus</style></keyword><keyword><style face="normal" font="default" size="100%">drug overdose</style></keyword><keyword><style face="normal" font="default" size="100%">epidemic</style></keyword><keyword><style face="normal" font="default" size="100%">expectation</style></keyword><keyword><style face="normal" font="default" size="100%">fear</style></keyword><keyword><style face="normal" font="default" size="100%">female</style></keyword><keyword><style face="normal" font="default" size="100%">follow up</style></keyword><keyword><style face="normal" font="default" size="100%">high income country</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">hypertension</style></keyword><keyword><style face="normal" font="default" size="100%">laboratory test</style></keyword><keyword><style face="normal" font="default" size="100%">law suit</style></keyword><keyword><style face="normal" font="default" size="100%">lifestyle modification</style></keyword><keyword><style face="normal" font="default" size="100%">medical education</style></keyword><keyword><style face="normal" font="default" size="100%">middle income country</style></keyword><keyword><style face="normal" font="default" size="100%">nuclear magnetic resonance imaging</style></keyword><keyword><style face="normal" font="default" size="100%">patient care</style></keyword><keyword><style face="normal" font="default" size="100%">practice guideline</style></keyword><keyword><style face="normal" font="default" size="100%">prescription</style></keyword><keyword><style face="normal" font="default" size="100%">primary medical care</style></keyword><keyword><style face="normal" font="default" size="100%">quality control</style></keyword><keyword><style face="normal" font="default" size="100%">remission</style></keyword><keyword><style face="normal" font="default" size="100%">shared decision making</style></keyword><keyword><style face="normal" font="default" size="100%">shopping</style></keyword><keyword><style face="normal" font="default" size="100%">skill</style></keyword><keyword><style face="normal" font="default" size="100%">tertiary health care</style></keyword><keyword><style face="normal" font="default" size="100%">uncertainty</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2019</style></year></dates><isbn><style face="normal" font="default" size="100%">2515-4478</style></isbn><abstract><style face="normal" font="default" size="100%">The issue of too much medicine and overdiagnosis has drawn considerable attention in the high-income countries. However, in the low-income and low-middle income countries (LMIC) where the problem is equally, if not more rampant, it has not come to attention. Although the undersupply and inaccessibility of healthcare remain major problems in most of these countries, the emerging issue of overdiagnosis threatens health systems, health financing and health equity, and cannot be neglected. Preventing Overdiagnosis Conference, first organized in 2013, has become a strong international platform which brings together a wide range of stake holders working on preventing overdiagnosis - although to date, the focus has been more on the developed countries. In 2019, with the conference being held for the first time in the Asia Pacific region, we aim to bring more attention to the key drivers of overdiagnosis and possible solutions in LMICs, which may be very different from high-income countries. In this workshop, we attempt to 1. Better understand the issue of over-diagnosis in LMICs 2. Identify and describe the possible drivers and potential solutions for overdiagnosis in LMIC. 3. Explore opportunities for collaborations with developed countries and other international stakeholders working on preventing overdiagnosis In the LMICs, patients&apos; expectations for a rapid recovery, doctor shopping, less onus with life-style modification and lack of follow-up in primary care, play a vital role in overtesting and overtreatment. Thus, the overarching cultural norms of &apos;more is better&apos;, &apos;quicker is better&apos; in a background of lack of knowledge and awareness about the negative effects of overdiagnosis only add to the epidemic of it. Compared to high-income countries, fear of litigation plays minimal (if any) role. The doctors who practice medicine primarily as a business commonly receive undeclared industry sponsored financial and other incentives for laboratory tests and treatment. These practices are invigorated by the lack of local evidence-based guidelines (e.g. breast cancer screening, prescribing antivirals/ antibiotics, cut-offs for hypertension, diabetes, ordering CT/ MRI) and quality control measures for laboratory results. The medical education system in the region is based on the western/ allopathic system with emphasis on secondary and tertiary care, which places too much emphasis on &apos;diagnosis/labelling&apos; and treatments. Most of the medical graduates have limited skills in primary care, and lack specific skills dealing with tolerance and uncertainty. To address these complex and multifaceted drivers we propose focused awareness campaigns for health professionals as well as the public. In addition, generating point of care evidence-based guidelines and introducing shared decision making to the patient management process will be novel but important strategies for our region. Ensuring comprehensive evaluation prior to introduction of new tests will help in reducing the negative effects of overdiagnosis, associated overtreatment and overuse. These strategies may support maintaining sustainability of resource poor health systems in the region.</style></abstract><label><style face="normal" font="default" size="100%">Included by Ray</style></label><notes><style face="normal" font="default" size="100%">L631349196&#xD;2020-04-07</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.embase.com/search/results?subaction=viewrecord&amp;id=L631349196&amp;from=export</style></url><url><style face="normal" font="default" size="100%">http://dx.doi.org/10.1136/bmjebm-2019-POD.13</style></url><url><style face="normal" font="default" size="100%">https://ebm.bmj.com/content/ebmed/24/Suppl_2/A6.2.full.pdf</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1136/bmjebm-2019-POD.13</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2234</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2234</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Patkar, S.</style></author><author><style face="normal" font="default" size="100%">Shinde, R. S.</style></author><author><style face="normal" font="default" size="100%">Kurunkar, S. R.</style></author><author><style face="normal" font="default" size="100%">Niyogi, D.</style></author><author><style face="normal" font="default" size="100%">Shetty, N. S.</style></author><author><style face="normal" font="default" size="100%">Ramadwar, M.</style></author><author><style face="normal" font="default" size="100%">Goel, M.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Surgical Oncology, Tata Memorial Hospital Tata Memorial Hospital, Mumbai, Maharashtra, India.&#xD;Department of Interventional Radiology, Tata Memorial Hospital Tata Memorial Hospital, Mumbai, Maharashtra, India.&#xD;Department of Pathology, Tata Memorial Hospital Tata Memorial Hospital, Mumbai, Maharashtra, India.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Radiological diagnosis alone risks overtreatment of benign disease in suspected gallbladder cancer: A word of caution in an era of radical surgery</style></title><secondary-title><style face="normal" font="default" size="100%">Indian J Cancer</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Indian J Cancer</style></full-title></periodical><pages><style face="normal" font="default" size="100%">681-684</style></pages><volume><style face="normal" font="default" size="100%">54</style></volume><number><style face="normal" font="default" size="100%">4</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">*Diagnostic Errors</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Frozen Sections</style></keyword><keyword><style face="normal" font="default" size="100%">Gallbladder Neoplasms/*diagnosis/pathology/surgery</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">India/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">*Medical Overuse</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Neoplasm Staging</style></keyword><keyword><style face="normal" font="default" size="100%">Neoplasms/*diagnosis/pathology/surgery</style></keyword><keyword><style face="normal" font="default" size="100%">Reoperation</style></keyword><keyword><style face="normal" font="default" size="100%">Retrospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Benign gallbladder disease</style></keyword><keyword><style face="normal" font="default" size="100%">gallbladder cancer</style></keyword><keyword><style face="normal" font="default" size="100%">radical surgery</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style face="normal" font="default" size="100%">Oct-Dec</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0019-509x</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: Incidental gallbladder cancer (iGBC) is on the rise world over. This may be a good scenario as we get to treat GBC in early stages. However, there is a practice of diagnosing patients based on clinicoradiological findings alone and subjecting them to a radical surgical procedure. This approach over-treats patient and has important implications for resource utilization. METHODS: We performed a retrospective analysis of 284 consecutive patients undergoing upfront surgery for suspected GBC from January 2010 to December 2016. The study cohort was divided into two groups, group A - benign (n = 138, 48.6%) and group B - malignant (n = 146, 51.4%). Both groups were compared with respect to demographic characteristics, tumor marker levels, clinicoradiological features, and perioperative outcomes. RESULTS: Approximately 48.6% patients with clinicoradiological suspicion of GBC turned out to be benign on final histology as confirmed on frozen section evaluation (FS). Only 2 patients who were reported benign on FS required revision surgery for malignancy in the final histopathology report. Demographic and clinicoradiological characteristics in both groups were comparable. However, there was a significant difference in blood loss, postoperative hospital stay, and complications between the two groups (P &lt; 0.005). CONCLUSION: Every other patient who presented to a tertiary cancer center with high index suspicion for malignancy, based on clinicoradiological findings, turned out to be benign on final histology. This emphasizes the fact that, as a norm, for radiologically suspected gallbladder malignancy, we need to have a confirmed histological diagnosis at least during surgery before proceeding to radical resection.</style></abstract><label><style face="normal" font="default" size="100%">Included by Ray</style></label><notes><style face="normal" font="default" size="100%">1998-4774&#xD;Patkar, Shraddha&#xD;Shinde, Rajesh S&#xD;Kurunkar, Sagar R&#xD;Niyogi, Devayani&#xD;Shetty, Nitin S&#xD;Ramadwar, Mukta&#xD;Goel, Mahesh&#xD;Journal Article&#xD;India&#xD;Indian J Cancer. 2017 Oct-Dec;54(4):681-684. doi: 10.4103/ijc.IJC_516_17.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.indianjcancer.com/article.asp?issn=0019-509X;year=2017;volume=54;issue=4;spage=681;epage=684;aulast=Patkar</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.4103/ijc.IJC_516_17</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2235</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2235</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Patra, A. K.</style></author><author><style face="normal" font="default" size="100%">Mallik, R. N.</style></author><author><style face="normal" font="default" size="100%">Dash, S.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Fine needle aspiration as a primary diagnostic procedure of breast lumps</style></title><secondary-title><style face="normal" font="default" size="100%">Indian J Pathol Microbiol</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Indian J Pathol Microbiol</style></full-title></periodical><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Biopsy, Needle</style></keyword><keyword><style face="normal" font="default" size="100%">Breast Diseases/pathology</style></keyword><keyword><style face="normal" font="default" size="100%">Breast Neoplasms/pathology</style></keyword><keyword><style face="normal" font="default" size="100%">Carcinoma/pathology</style></keyword><keyword><style face="normal" font="default" size="100%">Carcinoma, Intraductal, Noninfiltrating/pathology</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Fibrocystic Breast Disease/pathology</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Mastitis/pathology</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">1991</style></year><pub-dates><date><style face="normal" font="default" size="100%">1991/10</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0974-5130</style></isbn><abstract><style face="normal" font="default" size="100%">Two hundred and sixty-seven patients from the ages between 17 to 70 years with breast lumps attending the Cytology Clinic of the Out-patients Department and Cytology Section of the Department of Pathology, M.K.C.G. Medical College, Berhampur (Orissa), were subjected to Fine-Needle Aspiration Cytology (FNAC). Sixty-four patients were discarded from study because of non-availability of biopsy specimens and unsuitable smears. When cytological results were compared with those of histological sections, 100 per cent correct diagnosis was made in chronic mastitis and lobular carcinoma, 94.24 per cent in infiltrating duct carcinoma and 84.60 percent in duct papilloma and with the maximum over diagnosis to the tune of 14.75 per cent was found in fibro-adenoma. An overall correct diagnosis was made in 88.67 percent of cases by FNAC.</style></abstract><urls><related-urls><url><style face="normal" font="default" size="100%">http://imsear.searo.who.int/handle/123456789/73096</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2236</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2236</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Pema, A. K.</style></author><author><style face="normal" font="default" size="100%">Kiabilua, O.</style></author><author><style face="normal" font="default" size="100%">Pillay, T. S.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">1 Department of Chemical Pathology, Faculty of Health Sciences, University of Pretoria and National Health Laboratory Service, Tshwane Academic Division, Pretoria, South Africa.&#xD;2 Division of Chemical Pathology, University of Cape Town, Cape Town, South Africa.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Demand management by electronic gatekeeping of test requests does not influence requesting behaviour or save costs dramatically</style></title><secondary-title><style face="normal" font="default" size="100%">Ann Clin Biochem</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Ann Clin Biochem</style></full-title></periodical><pages><style face="normal" font="default" size="100%">244-253</style></pages><volume><style face="normal" font="default" size="100%">55</style></volume><number><style face="normal" font="default" size="100%">2</style></number><keywords><keyword><style face="normal" font="default" size="100%">Clinical Laboratory Techniques/*economics/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">*Cost Savings</style></keyword><keyword><style face="normal" font="default" size="100%">*Gatekeeping</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Medical Order Entry Systems/*organization &amp; administration</style></keyword><keyword><style face="normal" font="default" size="100%">Retrospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">South Africa</style></keyword><keyword><style face="normal" font="default" size="100%">Unnecessary Procedures</style></keyword><keyword><style face="normal" font="default" size="100%">Demand management</style></keyword><keyword><style face="normal" font="default" size="100%">cost-saving</style></keyword><keyword><style face="normal" font="default" size="100%">electronic gatekeeping</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style face="normal" font="default" size="100%">Mar</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0004-5632</style></isbn><abstract><style face="normal" font="default" size="100%">Background Healthcare budgets face constraints, and laboratories have developed strategies to adapt to the concomitant increase in workload. Some of the tests (7.4%) may be attributed to unnecessary repeat testing. Electronic gatekeeping has been implemented at selected laboratories in South Africa to limit unnecessary repeat testing. We performed a study of chemistry tests subjected to electronic gatekeeping to determine its effectiveness as a sustainable demand management tool. Methods A 22-month retrospective study of chemistry test requests at a Pretoria hospital was performed. Tests violating electronic gatekeeping rules were rejected upon registration before analysis, and cost-savings were estimated from electronic gatekeeping-held tests. The impact of electronic gatekeeping on the test requesting pattern of clinicians was derived from the percentage cost of electronic gatekeeping-held tests. Results The total savings generated from electronic gatekeeping test rejections amounted to $84,380. Greatest savings were generated from high-cost tests: glycated haemoglobin ($14,139), urea ($8661) and thyroid-stimulating hormone ($7514). The average number of electronic gatekeeping-held tests as a percentage of their total requested number over 22 months was 3.18%. Discussion The savings from electronic gatekeeping-held tests were not as dramatic as anticipated, but were modest and may have some impact in a cost-constrained setting. Electronic gatekeeping was concluded not to have a substantial effect on the clinician test requesting pattern, demonstrated by the largely unchanged monthly percentage of electronic gatekeeping-held tests. As a solitary demand management strategy, electronic gatekeeping does not appear to be as effective as anticipated or as demonstrated in other studies.</style></abstract><notes><style face="normal" font="default" size="100%">1758-1001&#xD;Pema, Aarti K&#xD;Kiabilua, Olivia&#xD;Pillay, Tahir S&#xD;Journal Article&#xD;Observational Study&#xD;England&#xD;Ann Clin Biochem. 2018 Mar;55(2):244-253. doi: 10.1177/0004563217707980. Epub 2017 Jun 29.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://journals.sagepub.com/doi/pdf/10.1177/0004563217707980</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1177/0004563217707980</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2237</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2237</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Peng, L. E. I.</style></author><author><style face="normal" font="default" size="100%">Zhuochun, W. U.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Analysis on Mechanism of Over-diagnosis and Over-treatment Problem Formation in Public Hospitals of China</style></title><secondary-title><style face="normal" font="default" size="100%">Chinese Health Economics</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Chinese Health Economics</style></full-title></periodical><pages><style face="normal" font="default" size="100%">9-11</style></pages><number><style face="normal" font="default" size="100%">12</style></number><dates><year><style face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style face="normal" font="default" size="100%">2014/00</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1003-0743</style></isbn><abstract><style face="normal" font="default" size="100%">According to the theoretical basis of using 5 gripper models of health system reform and high-value policy designing process, to define the over-diagnosis and over-treatment in the process of basic health care utilization in public hospitals of China, basing on the diagnostic framework of the internal and external environment, to explore the causes herein and discriminate the root, direct and intermediate factors that lead to the problem systematically, and identify the formation mechanism of the problem.</style></abstract><urls><related-urls><url><style face="normal" font="default" size="100%">http://dx.doi.org/10.7664/CHE20140502</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2238</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2238</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Pezeshki, M. Z.</style></author><author><style face="normal" font="default" size="100%">Janati, A.</style></author><author><style face="normal" font="default" size="100%">Arab-Zozani, M.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Social Determinants of Health Research Center, Department of Community and Family Medicine, Tabriz Medical School, Tabriz University of Medical Sciences, Tabriz, Iran.&#xD;Iranian Center of Excellence in Health Management, Department of Health Services Management, School of Management and Medical Informatics, Tabriz University of Medical Sciences, Tabriz, Iran.&#xD;Social Determinants of Health Research Center, Birjand University of Medical Sciences, Birjand, Iran.&#xD;Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Medical Overuse in the Iranian Healthcare System: A Systematic Scoping Review and Practical Recommendations for Decreasing Medical Overuse During Unexpected COVID-19 Pandemic Opportunity</style></title><secondary-title><style face="normal" font="default" size="100%">Risk Manag Healthc Policy</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Risk Manag Healthc Policy</style></full-title></periodical><pages><style face="normal" font="default" size="100%">1103-1110</style></pages><volume><style face="normal" font="default" size="100%">13</style></volume><keywords><keyword><style face="normal" font="default" size="100%">Covid-19</style></keyword><keyword><style face="normal" font="default" size="100%">Iran</style></keyword><keyword><style face="normal" font="default" size="100%">healthcare system</style></keyword><keyword><style face="normal" font="default" size="100%">medical overuse</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2020</style></year></dates><isbn><style face="normal" font="default" size="100%">1179-1594 (Print)&#xD;1179-1594</style></isbn><abstract><style face="normal" font="default" size="100%">PURPOSE: To perform an inclusive search for original studies that report medical overuse in the Iranian healthcare system and discovering the area of overuse. PATIENTS AND METHODS: A systematic search of the literature is conducted in bibliographic databases including PubMed, Embase, Scopus, Web of Sciences, Cochrane and Scientific Information Database using a comprehensive search strategy without time limit until the end of 2018, updated by 1 July 2020, accomplished by reference tracking, author contacting and expert consultation to identify studies on the overuse of medical care. RESULTS: We reviewed 4124 published articles based on predetermined inclusion criteria. The author&apos;s consensus included a total of 41 articles. Of these, 32 were in English and 9 in Farsi, published between 1975-2019. The result categorized into two distinct clinical areas: treatment (18 articles) and diagnostic (23 articles) services. Almost all of the studies only described the magnitude of unnecessary overuse. Unnecessary overuse of antibiotics, MRI, and CT-scan were the most reported topics. The ranges of their overuse proportion were as follows: antibiotic (31 to 97%); MRI (33 to 88%), and CT-scan (19 to 50%). CONCLUSION: Our review showed, even so, the magnitude of unnecessary overuse of medical services is high but there are only a few interventional studies in clinical and administrative level for finding effective methods for decreasing these unnecessary services. Researchers should be encouraged to conducting interventional studies. We suggest the ministry of health to use the golden opportunity of COVID-19 epidemic for designing Iran national policy and action plan for controlling and preventing unnecessary healthcare services and including a section for &quot;Interventional Research&quot; in the action plan.</style></abstract><notes><style face="normal" font="default" size="100%">1179-1594&#xD;Pezeshki, Mohammad Zakaria&#xD;Orcid: 0000-0003-1810-0467&#xD;Janati, Ali&#xD;Arab-Zozani, Morteza&#xD;Orcid: 0000-0001-7223-6707&#xD;Journal Article&#xD;Review&#xD;Risk Manag Healthc Policy. 2020 Aug 11;13:1103-1110. doi: 10.2147/RMHP.S262908. eCollection 2020.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.dovepress.com/getfile.php?fileID=60512</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC7429239</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.2147/rmhp.S262908</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2239</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2239</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Piram, M.</style></author><author><style face="normal" font="default" size="100%">Darce Bello, M.</style></author><author><style face="normal" font="default" size="100%">Merlin, E.</style></author><author><style face="normal" font="default" size="100%">Launay, E.</style></author><author><style face="normal" font="default" size="100%">Faye, A.</style></author><author><style face="normal" font="default" size="100%">Boralevi, F.</style></author><author><style face="normal" font="default" size="100%">Di Filippo, S.</style></author><author><style face="normal" font="default" size="100%">Bosdure, E.</style></author><author><style face="normal" font="default" size="100%">Armangaud, J. B.</style></author><author><style face="normal" font="default" size="100%">Tellier, S.</style></author><author><style face="normal" font="default" size="100%">Arnoux, A.</style></author><author><style face="normal" font="default" size="100%">Kone-Paut, I.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">M. Piram, CHU de Bicêtre-APHP, Le Kremlin Bicêtre, France</style></auth-address><titles><title><style face="normal" font="default" size="100%">Kawasaki disease in France (KAWANET): Incomplete forms are frequent and associated with a high frequency of cardiac complications</style></title><secondary-title><style face="normal" font="default" size="100%">Nephron</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Nephron</style></full-title></periodical><pages><style face="normal" font="default" size="100%">103</style></pages><volume><style face="normal" font="default" size="100%">129</style></volume><keywords><keyword><style face="normal" font="default" size="100%">acetylsalicylic acid</style></keyword><keyword><style face="normal" font="default" size="100%">endogenous compound</style></keyword><keyword><style face="normal" font="default" size="100%">human immunoglobulin</style></keyword><keyword><style face="normal" font="default" size="100%">steroid</style></keyword><keyword><style face="normal" font="default" size="100%">tumor necrosis factor</style></keyword><keyword><style face="normal" font="default" size="100%">Africa</style></keyword><keyword><style face="normal" font="default" size="100%">African Caribbean</style></keyword><keyword><style face="normal" font="default" size="100%">Caucasian</style></keyword><keyword><style face="normal" font="default" size="100%">cervical lymphadenopathy</style></keyword><keyword><style face="normal" font="default" size="100%">cheilitis</style></keyword><keyword><style face="normal" font="default" size="100%">child</style></keyword><keyword><style face="normal" font="default" size="100%">complication</style></keyword><keyword><style face="normal" font="default" size="100%">conference abstract</style></keyword><keyword><style face="normal" font="default" size="100%">congenital malformation</style></keyword><keyword><style face="normal" font="default" size="100%">conjunctivitis</style></keyword><keyword><style face="normal" font="default" size="100%">consensus</style></keyword><keyword><style face="normal" font="default" size="100%">controlled study</style></keyword><keyword><style face="normal" font="default" size="100%">coronary artery aneurysm</style></keyword><keyword><style face="normal" font="default" size="100%">coronary artery dilatation</style></keyword><keyword><style face="normal" font="default" size="100%">death</style></keyword><keyword><style face="normal" font="default" size="100%">desquamation</style></keyword><keyword><style face="normal" font="default" size="100%">diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">drug combination</style></keyword><keyword><style face="normal" font="default" size="100%">drug therapy</style></keyword><keyword><style face="normal" font="default" size="100%">erythema</style></keyword><keyword><style face="normal" font="default" size="100%">female</style></keyword><keyword><style face="normal" font="default" size="100%">fever</style></keyword><keyword><style face="normal" font="default" size="100%">France</style></keyword><keyword><style face="normal" font="default" size="100%">gender</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">limb</style></keyword><keyword><style face="normal" font="default" size="100%">major clinical study</style></keyword><keyword><style face="normal" font="default" size="100%">male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle East</style></keyword><keyword><style face="normal" font="default" size="100%">mucocutaneous lymph node syndrome</style></keyword><keyword><style face="normal" font="default" size="100%">Mycobacterium bovis BCG</style></keyword><keyword><style face="normal" font="default" size="100%">myocarditis</style></keyword><keyword><style face="normal" font="default" size="100%">nonhuman</style></keyword><keyword><style face="normal" font="default" size="100%">onset age</style></keyword><keyword><style face="normal" font="default" size="100%">pericarditis</style></keyword><keyword><style face="normal" font="default" size="100%">perineum</style></keyword><keyword><style face="normal" font="default" size="100%">preschool child</style></keyword><keyword><style face="normal" font="default" size="100%">raspberry</style></keyword><keyword><style face="normal" font="default" size="100%">tongue</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2015</style></year></dates><isbn><style face="normal" font="default" size="100%">2235-3186</style></isbn><abstract><style face="normal" font="default" size="100%">Objectives: Kawasaki disease (KD) is the main vasculitis affecting children before 5 years and the leading cause of acquired heart disease in childhood. Kawanet is a clinical and biological data repository aimed to define the epidemiological characteristics of KD in France. Kawanet will compare clinical characteristics between distinct ethnic backgrounds and will define risk factors for resistance to standard treatment (IVIG) and for cardiac complications. Methods: Targeted institutional physicians received information on a national registry for KD. All patients suspected with KD and seen since January 2011 were eligible to enter the study. An eCRF was implemented in a web database. IRB approval for data storage was obtained.The included patients without the AHA international criteria were reviewed by an experts&apos; committee. Results: 468 cases were entered by 84 physicians from 65 centers. The AHA classification gave: 280 complete (= 4 criteria), and 73 incomplete (= 3 criteria with coronary dilatation). An expert consensus classified 48 other patients (= 3 criteria but agreement for IVIg treatment) leading to 401 patients considered as KD (M229/F172). 45 patients were doubtful and 22 not classified for incomplete data. The median age at diagnosis for the Kawasaki was 3.1 y (2 m-14 y). Their ethnical backgrounds were: European Caucasian 67%, Eastern Caucasian or North African 15% afroCaribbean, 13%, Asian 4% and mixed ancestry 1%. The clinical symptoms were (%): conjunctivitis 84, cheilitis 82, diffuse exanthema 74, modification of the extremities 73, oral erythema 66, cervical adenopathy 52, raspberry tongue 49, seat erythema 26, perineal desquamation 18 and BCG erythema 5. The cardiac complications were: coronary dilatation 30%, pericarditis 15%, coronary aneurysm 4%, and myocarditis 3% (1 death). 392/401 (98%) patients received IVIG, 64 (21%) and 5 required, respectively, 2 and 3 courses. 11% required steroids, 93% received Aspirin and 1 Anti-TNF. The mean delay between fever onset and treatment was 6 days. The factors associated with the coronary abnormalities were: male gender (p = 0.01), young KD onset age (p = 0.03), and resistance to IVIG (p = 0.03). Conclusion: KD diagnosis remains challenging and overdiagnosis represents at least 10% of cases in this registry. Incomplete forms of KD account for 37% and are associated with coronary dilatation/aneurysm (34%; p &lt; 0.01) and a high rate of IVIG resistance. Unlike previous studies, our population is very mixed with 28% of children from the Middle East and Africa, in whom KD is still few reported.</style></abstract><label><style face="normal" font="default" size="100%">Included by Morty</style></label><notes><style face="normal" font="default" size="100%">L623780336&#xD;2018-09-11</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.embase.com/search/results?subaction=viewrecord&amp;id=L623780336&amp;from=export</style></url><url><style face="normal" font="default" size="100%">http://dx.doi.org/10.1159/000381120</style></url><url><style face="normal" font="default" size="100%">https://www.karger.com/Article/Pdf/381120</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1159/000381120</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2240</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2240</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Pizzanelli, Miguel</style></author><author><style face="normal" font="default" size="100%">Almenas, Marina</style></author><author><style face="normal" font="default" size="100%">Quirós, Robert</style></author><author><style face="normal" font="default" size="100%">Pineda, Carlos</style></author><author><style face="normal" font="default" size="100%">Cordero, Esteban</style></author><author><style face="normal" font="default" size="100%">Taureaux, Niurka</style></author><author><style face="normal" font="default" size="100%">Rojas, María de Lourdes</style></author><author><style face="normal" font="default" size="100%">Kopitowsk, Karin</style></author><author><style face="normal" font="default" size="100%">La Valle, Ricardo</style></author><author><style face="normal" font="default" size="100%">Nivelo, Mónica</style></author><author><style face="normal" font="default" size="100%">Menares, Verónica</style></author><author><style face="normal" font="default" size="100%">Piñero, Agustina</style></author><author><style face="normal" font="default" size="100%">Ortiz, Sonia</style></author><author><style face="normal" font="default" size="100%">Herrera, Rolando</style></author><author><style face="normal" font="default" size="100%">Taja, Alexis Correa</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Prevención Cuaternaria: Ética Médica, Evaluación y Eficiencia en los Sistemas de Salud</style></title><secondary-title><style face="normal" font="default" size="100%">Rev. bras. med. fam. comunidade</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Rev. bras. med. fam. comunidade</style></full-title></periodical><pages><style face="normal" font="default" size="100%">75-85</style></pages><volume><style face="normal" font="default" size="100%">11</style></volume><number><style face="normal" font="default" size="100%">Suplemento 2 - VI CUMBRE</style></number><keywords><keyword><style face="normal" font="default" size="100%">Bioethics</style></keyword><keyword><style face="normal" font="default" size="100%">Diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">Medicalization</style></keyword><keyword><style face="normal" font="default" size="100%">Physician-Patient Relations</style></keyword><keyword><style face="normal" font="default" size="100%">Quaternary Prevention</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style face="normal" font="default" size="100%">2016/10</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1809-5909</style></isbn><abstract><style face="normal" font="default" size="100%">La prevención Cuaternaria consiste en desarrollar cuidados de salud y de ejercer la medicina, priorizando los cuidados centrados en la persona. Su marco conceptual se sustenta en aspectos éticos y filosóficos centrales en el ejercicio de la medicina, en aspectos epistemológicos y de carácter social. Su objeto es proteger fundamentalmente a los pacientes, pero también a los integrantes del equipo de salud, de los excesos de la medicalización y de los excesos o prácticas innecesarias o dañinas. El presente artículo es el resultado de la síntesis de los documentos de trabajo, discusión y propuestas llevadas adelante por un amplio grupo de comprometidos profesionales de CIMF, con interés particular sobre la Prevención Cuaternaria. Los materiales se produjeron en forma colaborativa por medio de un largo y complejo proceso de trabajo a distancia, realizado durante los foros preparatorios de la VI Cumbre Iberoamericana de Medicina Familiar y Comunitaria. A estos materiales se sumaron los documentos de trabajo elaborados durante la misma cumbre en San José de Costa Rica, en el mes de abril de 2016. El cometido de este artículo es difundir el estado de desarrollo y de compromiso actual con este enfoque y el destacado impulso que ha tenido en Iberoamérica en los últimos cinco años. Por su relevancia, se pretende estimular una mayor difusión del concepto: la implementación de contenidos relacionados con él en la formación y en el nivel académico. A nivel político promover su consideración en la toma de decisión, en políticas de salud pública. Difundir a nivel poblacional y promover la elaboración de contenidos de calidad. Ofrecer pistas de reflexión y herramientas concretas para su aplicación.&#xD;Quaternary Prevention as main focus and practice, promotes changes in developing health care and practicing medicine, prioritizing the person centred care.Their conceptual framework is sustained on ethical and philosophical aspects essential to medicine practice, in epistemological aspects of social and others related to political nature. Its objective is to protect fundamentally the patients, but also the members of the health group from excessive medicalization and unnecessary and hurtful practices. The present article is the result of the synthesis of the work documents, discussion and proposals carried forward by a large group of committed professionals from CIMF, with particular interest in Quaternary Prevention. The materials were produced in collaboration through a complex long distance work process, done during preparatory forums of the VI Ibero-American Summit of Family And Community Medicine. The work documents made during the same summit in San JoseÌ of Costa Rica, in April 2016 were added to this material. The purpose of this document is to spread the state of development and current commitment to this approach and the outstanding initiative that it has had in Ibero America in the last five years. Due to its relevance, the intention is to stimulate greater dissemination of the concept; the implementation of content related to at in the training and academic levels. At a political level, to promote its consideration on decision making and public health issues so as to broadcast to demographic levels and promote the making of quality content. Finally to offer reflection clues to consider and concrete application tools.&#xD;A PrevencÌ§aÌo QuaternaÌria consiste em desenvolver cuidados de sauÌde e exercer a medicina priorizando o cuidado centrado na pessoa. Seu arcaboucÌ§o conceitual se sustenta em aspectos eÌticos e filosoÌficos fundamentais ao exerciÌcio da praÌtica meÌdica, tambeÌm em aspectos epistemoloÌgicos e de caraÌter social. O seu objetivo eÌ proteger os pacientes, mas tambeÌm os membros da equipe de sauÌde, dos excessos da medicalizacÌ§aÌo e das praÌticas excessivas ou desnecessaÌrias ou prejudiciais. Este artigo eÌ o resultado da siÌntese dos documentos de trabalho, discussaÌo e propostas levada a cabo por um numeroso grupo de profissionais comprometidos com a CIMF, com particular interesse na PrevencÌ§aÌo QuaternaÌria. Os materiais foram produzidos de forma colaborativa atraveÌs de um extenso e complexo processo de trabalho a distancia, realizado durante as reunioÌes preparatoÌrias da VI CuÌpula Ibero-Americana de Medicina de FamiÌlia e Comunidade. A estes materiais se somaram os documentos de trabalho preparados durante a mesma cuÌpula em San Jose, Costa Rica, em abril de 2016. O objetivo deste artigo eÌ o de difundir o estado de desenvolvimento e de compromisso atual com esta abordagem e o impulso notaÌvel que tem havido na Iberoamerica nos uÌltimos cinco anos. Por sua relevaÌncia, pretende-se estimular uma maior difusaÌo do conceito, bem como a implementacÌ§aÌo de conteuÌdos relacionados a ele na formacÌ§aÌo e em niÌvel acadeÌmico; a niÌvel poliÌtico, promover sua consideracÌ§aÌo na tomada de decisoÌes de poliÌticas puÌblicas de sauÌde; difundir a niÌvel da populacÌ§aÌo e promover o desenvolvimento de conteuÌdo de qualidade; oferecer pistas de reflexaÌo e ferramentas praÌticas para sua implementacÌ§aÌo.</style></abstract><label><style face="normal" font="default" size="100%">Included by Ray</style></label><urls><related-urls><url><style face="normal" font="default" size="100%">https://rbmfc.org.br/rbmfc/article/view/1388/786</style></url><url><style face="normal" font="default" size="100%">http://fi-admin.bvsalud.org/document/view/bw7nh</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2241</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2241</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Quanjer, P. H.</style></author><author><style face="normal" font="default" size="100%">Brazzale, D. J.</style></author><author><style face="normal" font="default" size="100%">Boros, P. W.</style></author><author><style face="normal" font="default" size="100%">Pretto, J. J.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Erasmus Medical Centre, Erasmus University, Rotterdam, The Netherlands.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Implications of adopting the Global Lungs Initiative 2012 all-age reference equations for spirometry</style></title><secondary-title><style face="normal" font="default" size="100%">Eur Respir J</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Eur Respir J</style></full-title></periodical><pages><style face="normal" font="default" size="100%">1046-54</style></pages><volume><style face="normal" font="default" size="100%">42</style></volume><number><style face="normal" font="default" size="100%">4</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Aged, 80 and over</style></keyword><keyword><style face="normal" font="default" size="100%">Airway Obstruction/diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">Australia</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Forced Expiratory Volume</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Lung/*physiology</style></keyword><keyword><style face="normal" font="default" size="100%">Lung Diseases/diagnosis/*physiopathology</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Nutrition Surveys</style></keyword><keyword><style face="normal" font="default" size="100%">Poland</style></keyword><keyword><style face="normal" font="default" size="100%">Prevalence</style></keyword><keyword><style face="normal" font="default" size="100%">Pulmonary Disease, Chronic Obstructive/diagnosis/physiopathology</style></keyword><keyword><style face="normal" font="default" size="100%">Pulmonary Medicine/methods/standards</style></keyword><keyword><style face="normal" font="default" size="100%">Reference Standards</style></keyword><keyword><style face="normal" font="default" size="100%">Reference Values</style></keyword><keyword><style face="normal" font="default" size="100%">Retrospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Spirometry/*methods/*standards</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2013</style></year><pub-dates><date><style face="normal" font="default" size="100%">Oct</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0903-1936</style></isbn><abstract><style face="normal" font="default" size="100%">The aim of this study was to determine the diagnostic and interpretative consequences of adopting the Global Lungs Initiative (GLI) 2012 spirometric prediction equations. We assessed spirometric records from 17 572 subjects (49.5% females), aged 18-85 years, from hospitals in Australia and Poland. We calculated predicted forced expiratory volume in 1 s (FEV1), forced expiratory volume (FVC), FEV1/FVC and lower limits of normal (LLN) using European Community for Steel and Coal (ECSC), National Health and Nutrition Examination Survey (NHANES) III and GLI 2012 equations. Obstruction was defined as FEV1/FVC&lt;LLN and a restrictive pattern as FEV1/FVC&gt;LLN and FVC&lt;LLN. Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage 2 and higher was defined as FEV1/FVC&lt;0.70 and FEV1 &lt;80% pred. GLI 2012 equations produce similar predicted values for FEV1 and FVC compared with NHANES, but produce larger values than ECSC. Differences in the LLN lead to an important increase in the prevalence rate of a low FVC compared to ECSC, and a significant decrease compared to NHANES prediction equations. Adopting GLI 2012 equations has small effects on the prevalence rate of airway obstruction. GOLD stages 2-4 lead to &gt;20% underdiagnosis of airway obstruction up to the age of 55 years and to 16-23% overdiagnosis in older subjects. GLI 2012 equations increase the prevalence of a &quot;restrictive spirometric pattern&quot; compared to ECSC but decrease it compared to NHANES.</style></abstract><notes><style face="normal" font="default" size="100%">1399-3003&#xD;Quanjer, Philip H&#xD;Brazzale, Danny J&#xD;Boros, Piotr W&#xD;Pretto, Jeffrey J&#xD;Journal Article&#xD;Multicenter Study&#xD;England&#xD;Eur Respir J. 2013 Oct;42(4):1046-54. doi: 10.1183/09031936.00195512. Epub 2013 Mar 21.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://erj.ersjournals.com/content/erj/42/4/1046.full.pdf</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1183/09031936.00195512</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2242</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2242</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Ramirez Fernández, Evelio</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Sobrediagnóstico de ambiasis en un laboratorio de urgencia de un área rural de Cuba</style></title><secondary-title><style face="normal" font="default" size="100%">Carta med. A.I.S. Boliv</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Carta med. A.I.S. Boliv</style></full-title></periodical><pages><style face="normal" font="default" size="100%">19-20</style></pages><volume><style face="normal" font="default" size="100%">14</style></volume><number><style face="normal" font="default" size="100%">1</style></number><keywords><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Acute Disease</style></keyword><keyword><style face="normal" font="default" size="100%">Diarrhea</style></keyword><keyword><style face="normal" font="default" size="100%">Hospital Departments</style></keyword><keyword><style face="normal" font="default" size="100%">Hospitals, Community</style></keyword><keyword><style face="normal" font="default" size="100%">Hospitals, District</style></keyword><keyword><style face="normal" font="default" size="100%">Hospitals, Rural</style></keyword><keyword><style face="normal" font="default" size="100%">Sampling Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Signs and Symptoms</style></keyword><keyword><style face="normal" font="default" size="100%">Amebiasis</style></keyword><keyword><style face="normal" font="default" size="100%">Cuba</style></keyword><keyword><style face="normal" font="default" size="100%">Intestinal Diseases, Parasitic</style></keyword><keyword><style face="normal" font="default" size="100%">Parasites</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">1999</style></year><pub-dates><date><style face="normal" font="default" size="100%">1999/00</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">XXXX-0156</style></isbn><abstract><style face="normal" font="default" size="100%">Seincientas cincuenta y dos muestras diarreícas observadas en el laboratorio de urgencias del Hospital Rural Eduardo Mesa Yuell, en Santiago de Cuba durante 1993, fueron preservadas en alcohol de polivinilo y fueron observadas por expertos en parasitología del Instituto Kouri (IPK). Los observadores locales responsabilizan a los parásitos con el 63 por ciento de todas las causas posibles de diarrea aguda, mientras los expertos solo le adjuntan el (12 por ciento) (p&amp;lt;0.001), además se diagnosticaron 261 casos de E. histólica más que los que realmente existen mientras que 113 casos de G.Lamblia y 81 de protozoos sin importancia médica menos que los hallados por los expertos. Se considera que la confusión de los protozoos produce un consumo indebido de imidazólicos en la comunidad, ocasionando diarrea persistente y ausencias reiteradas al trabajo y centros educacionales</style></abstract><urls><related-urls><url><style face="normal" font="default" size="100%">https://pesquisa.bvsalud.org/gim/resource/en/lil-254472</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2243</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2243</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Rao, B.</style></author><author><style face="normal" font="default" size="100%">Schellenberg, D.</style></author><author><style face="normal" font="default" size="100%">Ghani, A.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">B. Rao, Department of Infectious Disease Epidemiology, Imperial College London, United Kingdom</style></auth-address><titles><title><style face="normal" font="default" size="100%">Modelling health systems barriers to successful malaria management</style></title><secondary-title><style face="normal" font="default" size="100%">Malaria Journal</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Malaria Journal</style></full-title></periodical><pages><style face="normal" font="default" size="100%">S70</style></pages><volume><style face="normal" font="default" size="100%">11</style></volume><keywords><keyword><style face="normal" font="default" size="100%">antimalarial agent</style></keyword><keyword><style face="normal" font="default" size="100%">artemisinin</style></keyword><keyword><style face="normal" font="default" size="100%">malaria</style></keyword><keyword><style face="normal" font="default" size="100%">health care</style></keyword><keyword><style face="normal" font="default" size="100%">model</style></keyword><keyword><style face="normal" font="default" size="100%">case management</style></keyword><keyword><style face="normal" font="default" size="100%">decision tree</style></keyword><keyword><style face="normal" font="default" size="100%">community</style></keyword><keyword><style face="normal" font="default" size="100%">fever</style></keyword><keyword><style face="normal" font="default" size="100%">organization and management</style></keyword><keyword><style face="normal" font="default" size="100%">health</style></keyword><keyword><style face="normal" font="default" size="100%">policy</style></keyword><keyword><style face="normal" font="default" size="100%">health care facility</style></keyword><keyword><style face="normal" font="default" size="100%">control strategy</style></keyword><keyword><style face="normal" font="default" size="100%">drug bioavailability</style></keyword><keyword><style face="normal" font="default" size="100%">malaria control</style></keyword><keyword><style face="normal" font="default" size="100%">diagnostic test</style></keyword><keyword><style face="normal" font="default" size="100%">parameters</style></keyword><keyword><style face="normal" font="default" size="100%">therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Africa</style></keyword><keyword><style face="normal" font="default" size="100%">primary health care</style></keyword><keyword><style face="normal" font="default" size="100%">diseases</style></keyword><keyword><style face="normal" font="default" size="100%">infection</style></keyword><keyword><style face="normal" font="default" size="100%">diagnosis</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2012</style></year></dates><isbn><style face="normal" font="default" size="100%">1475-2875</style></isbn><abstract><style face="normal" font="default" size="100%">Background The success of national malaria control strategies is increasingly recognised to be limited by the capacity of the health system to deliver interventions at the required levels of coverage and quality[1]. It is critical to better understand how to deliver a proven intervention, such as Artemisinin Combination therapies (ACTs), most eff ectively through an existing system, and where the barriers are to achieving its predicted potential. Few models address the delivery of case management: the Piot model[2] or the “community eff ectiveness framework”[3] has been used to describe how a cascade of interacting health-systems barriers may sequentially reduce the eff ectiveness of treatment interventions.[4, 5] However the end-estimate of correct treatment is lower than estimates from health facility surveys.[1, 4-12] We investigated whether an alternative decision-tree approach may more closely estimate rates of appropriate treatment for malaria and also non-malarial febrile illness (NMFI). Methods We systematically reviewed the sequential process of and barriers to, malaria case management through primary health care in sub-Saharan Africa. We thus developed community eff ectiveness and decision tree models to case management in the public sector. Articles published since the rollout of ACTs were used to obtain a range of estimates for malaria management steps. Parameters were sampled from between these ranges of estimates and used to inform the two models. We then explored scenarios of lifting diff erent case management barriers. Results The decision analysis model more accurately reflected reported levels of appropriate management of fever (malarial and non-malarial) in the public sector (&gt;60% attendees), compared with a systems eff ectiveness approach (&lt;2%). Scenarios of perfect case management steps all improved correct fever management using both models, except in the case of perfect ACT stock; a decision tree approach predicted a 12% reduction in correct management of all cases compared with a 63% increase with the community eff ectiveness approach. Using the decision-tree model, increases in availability and rapid diagnostic tests (RDTs) improved overall management of fever upto 65% of all attendees, and reduced overtreatment of NMFI with unnecessary antimalarials by over 35%, but did not substantially improve appropriate treatment rates of malaria cases. The greatest impact on the proportion of malaria cases correctly treated resulted from improving ACT stock (over 65% increase from baseline), even without increased RDT use. Under conditions of perfect availability and use of RDTs, test adherence and drug availability appropriate treatment rates rose to over 85%. Conclusion The relationship between improving delivery through health systems and resulting impact on health outcomes of infectious diseases is not straightforward, however simple decision analysis models can provide insight into which aspects of delivering care are most likely to impact on care quality and treatment eff ectiveness. Unlike the community-eff ectiveness framework, the decision-tree approach accounts for clinical (non-RDT guided) treatment of malaria, under-diagnosis of malaria and unnecessary antimalarial use in NMFI cases, which are all of policy interest impacting on health outcomes and ongoing transmission. Further work into the amenability of health systems to change is required to explore the most cost-eff ective targets in expanding the delivery of antimalarials.</style></abstract><label><style face="normal" font="default" size="100%">Included by Thanya</style></label><notes><style face="normal" font="default" size="100%">L70908054&#xD;2012-11-01</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.embase.com/search/results?subaction=viewrecord&amp;id=L70908054&amp;from=export</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2244</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2244</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Raza, S. A.</style></author><author><style face="normal" font="default" size="100%">Javalkar, V.</style></author><author><style face="normal" font="default" size="100%">Dehkharghani, S.</style></author><author><style face="normal" font="default" size="100%">Kudrimoti, A.</style></author><author><style face="normal" font="default" size="100%">Saindane, A.</style></author><author><style face="normal" font="default" size="100%">Mullins, M.</style></author><author><style face="normal" font="default" size="100%">Nahab, F.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Neurology, Emory University, Atlanta, Georgia.&#xD;Department of Radiology, NYU Langone Medical Center, New York, New York.&#xD;LITS, Emory University, Atlanta, Georgia.&#xD;Department of Radiology and Imaging Sciences, Emory University, Atlanta, Georgia.&#xD;Department of Neurology, Emory University, Atlanta, Georgia. Electronic address: fnahab@emory.edu.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Utility of Repeat Cerebrovascular Imaging among Hospitalized Stroke Patients</style></title><secondary-title><style face="normal" font="default" size="100%">J Stroke Cerebrovasc Dis</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">J Stroke Cerebrovasc Dis</style></full-title></periodical><pages><style face="normal" font="default" size="100%">1588-1593</style></pages><volume><style face="normal" font="default" size="100%">26</style></volume><number><style face="normal" font="default" size="100%">7</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Cerebral Angiography/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Chi-Square Distribution</style></keyword><keyword><style face="normal" font="default" size="100%">*Computed Tomography Angiography</style></keyword><keyword><style face="normal" font="default" size="100%">Contrast Media/administration &amp; dosage</style></keyword><keyword><style face="normal" font="default" size="100%">Databases, Factual</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Georgia</style></keyword><keyword><style face="normal" font="default" size="100%">*Hospitalization</style></keyword><keyword><style face="normal" font="default" size="100%">Hospitals, University</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Inpatients</style></keyword><keyword><style face="normal" font="default" size="100%">Logistic Models</style></keyword><keyword><style face="normal" font="default" size="100%">*Magnetic Resonance Angiography</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Multivariate Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Odds Ratio</style></keyword><keyword><style face="normal" font="default" size="100%">Predictive Value of Tests</style></keyword><keyword><style face="normal" font="default" size="100%">Prognosis</style></keyword><keyword><style face="normal" font="default" size="100%">Retrospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Stroke/*diagnostic imaging/therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Time Factors</style></keyword><keyword><style face="normal" font="default" size="100%">*Unnecessary Procedures</style></keyword><keyword><style face="normal" font="default" size="100%">Stroke</style></keyword><keyword><style face="normal" font="default" size="100%">cerebrovascular imaging</style></keyword><keyword><style face="normal" font="default" size="100%">predictors</style></keyword><keyword><style face="normal" font="default" size="100%">repeat imaging</style></keyword><keyword><style face="normal" font="default" size="100%">utility</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jul</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1052-3057</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND AND PURPOSE: The purpose of this study is to evaluate the frequency and clinical utility of repeat cerebrovascular imaging with computed tomography angiography (CTA) of the head after contrast-enhanced magnetic resonance angiography (CE-MRA) of the head in acute stroke patients. MATERIALS AND METHODS: All stroke patients admitted to 2 academic medical centers from January 1, 2012 through December 31, 2014 were identified as part of prospective radiology database if they underwent CE-MRA of the head followed by subsequent CTA of the head within 7 days. Two vascular neurologists blinded to CTA results retrospectively reviewed medical records including documented indications for imaging studies and clinical changes in patients to determine necessity of CTA. RESULTS: Of 1355 acute stroke patients who underwent CE-MRA of the head, 195 (14%) patients underwent subsequent CTA of the head within 7 days, including 33 patients with nondiagnostic CE-MRA because of motion artifact. Of the remaining 162 (12%) patients, 69 (43%) were considered to have an unnecessary CTA of the head. Multivariable logistic regression analysis identified (1) absence of new neurologic examination changes [OR 7.29; 95% CI 1.92-27.63] and (2) same documented indication for both studies [OR 6.47; 95% CI 3.04-13.78] as significant predictors of an unnecessary CTA. Changes in clinical management after CTA were significantly more common in necessary CTAs compared with studies determined to be unnecessary (42% versus 7%, P &lt; .0001). CONCLUSION: The utility of repeat cerebrovascular imaging with CTA of the head following a diagnostic CE-MRA is low when there is no change in neurologic examination or when ordered for the same indication.</style></abstract><label><style face="normal" font="default" size="100%">Included by Eman</style></label><notes><style face="normal" font="default" size="100%">1532-8511&#xD;Raza, Syed Ali&#xD;Javalkar, Vijay&#xD;Dehkharghani, Seena&#xD;Kudrimoti, Archana&#xD;Saindane, Amit&#xD;Mullins, Mark&#xD;Nahab, Fadi&#xD;Evaluation Study&#xD;Journal Article&#xD;Multicenter Study&#xD;United States&#xD;J Stroke Cerebrovasc Dis. 2017 Jul;26(7):1588-1593. doi: 10.1016/j.jstrokecerebrovasdis.2017.02.029. Epub 2017 Mar 6.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.strokejournal.org/article/S1052-3057(17)30077-0/fulltext</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1016/j.jstrokecerebrovasdis.2017.02.029</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2245</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2245</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Rehmani, R.</style></author><author><style face="normal" font="default" size="100%">Amanullah, S.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Emergency Department, Aga Khan University Hospital, Karachi, Pakistan.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Analysis of blood tests in the emergency department of a tertiary care hospital</style></title><secondary-title><style face="normal" font="default" size="100%">Postgrad Med J</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Postgrad Med J</style></full-title></periodical><pages><style face="normal" font="default" size="100%">662-6</style></pages><volume><style face="normal" font="default" size="100%">75</style></volume><number><style face="normal" font="default" size="100%">889</style></number><keywords><keyword><style face="normal" font="default" size="100%">Blood Specimen Collection/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Cross-Sectional Studies</style></keyword><keyword><style face="normal" font="default" size="100%">*Emergency Service, Hospital</style></keyword><keyword><style face="normal" font="default" size="100%">Hematologic Tests/*standards</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Myocardial Infarction/diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">Pakistan</style></keyword><keyword><style face="normal" font="default" size="100%">Practice Guidelines as Topic</style></keyword><keyword><style face="normal" font="default" size="100%">Prospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">*Unnecessary Procedures</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">1999</style></year><pub-dates><date><style face="normal" font="default" size="100%">Nov</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0032-5473 (Print)&#xD;0032-5473</style></isbn><abstract><style face="normal" font="default" size="100%">There is ample evidence that many investigations sent from the accident and emergency department are inappropriate, thus affecting the quality of patient care. A study was designed to address this issue in the emergency department of a tertiary care hospital of a large city. A prospective cross-sectional study was carried out during the 3-month period 1 December 1996 to 28 February 1997. A set of guidelines was used to assess the appropriateness of different blood tests for the initial assessment of the patients presenting with common clinical conditions, although any investigation could be done if considered important for patient management. All other blood tests were considered inappropriate. A total of 6401 patients were seen in the emergency department and 14,300 blood tests were done on 3529 patients with diagnoses covered by the guidelines. Of these 62.2% were found to be inappropriate. Of the total 22,655 investigations done on all the 6401 patients seen, only 3.8% influenced the diagnosis, 3.0% influenced patient care in the emergency department, and 4.0% influenced the decision to admit or not. Amylase and arterial blood gases were found to be the most appropriate investigations. Analysis of reasons for unnecessary use of emergency tests suggested that improving supervision, decreasing the utilization of the emergency department as a phlebotomy service for the hospital, and abolition of routine blood tests would help to improve patient care.</style></abstract><notes><style face="normal" font="default" size="100%">1469-0756&#xD;Rehmani, R&#xD;Amanullah, S&#xD;Journal Article&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Postgrad Med J. 1999 Nov;75(889):662-6. doi: 10.1136/pgmj.75.889.662.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1741401/pdf/v075p00662.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC1741401</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1136/pgmj.75.889.662</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2246</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2246</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Reyburn, H.</style></author><author><style face="normal" font="default" size="100%">Mbakilwa, H.</style></author><author><style face="normal" font="default" size="100%">Mwangi, R.</style></author><author><style face="normal" font="default" size="100%">Mwerinde, O.</style></author><author><style face="normal" font="default" size="100%">Olomi, R.</style></author><author><style face="normal" font="default" size="100%">Drakeley, C.</style></author><author><style face="normal" font="default" size="100%">Whitty, C. J.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Infectious and Tropical Disease, London School of Hygiene and Tropical Medicine, London WCIE 7HT. hugh.reyburn@lshtm.ac.uk</style></auth-address><titles><title><style face="normal" font="default" size="100%">Rapid diagnostic tests compared with malaria microscopy for guiding outpatient treatment of febrile illness in Tanzania: randomised trial</style></title><secondary-title><style face="normal" font="default" size="100%">Bmj</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Bmj</style></full-title></periodical><pages><style face="normal" font="default" size="100%">403</style></pages><volume><style face="normal" font="default" size="100%">334</style></volume><number><style face="normal" font="default" size="100%">7590</style></number><keywords><keyword><style face="normal" font="default" size="100%">Anti-Bacterial Agents/therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Antimalarials/therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Fever/*parasitology</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Malaria, Falciparum/*diagnosis/drug therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Microscopy/*standards</style></keyword><keyword><style face="normal" font="default" size="100%">Parasitology/*standards</style></keyword><keyword><style face="normal" font="default" size="100%">Point-of-Care Systems/standards</style></keyword><keyword><style face="normal" font="default" size="100%">Reagent Strips/*standards</style></keyword><keyword><style face="normal" font="default" size="100%">Tanzania</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2007</style></year><pub-dates><date><style face="normal" font="default" size="100%">Feb 24</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0959-8138 (Print)&#xD;0959-8138</style></isbn><abstract><style face="normal" font="default" size="100%">OBJECTIVE: To compare rapid diagnostic tests (RDTs) for malaria with routine microscopy in guiding treatment decisions for febrile patients. DESIGN: Randomised trial. SETTING: Outpatient departments in northeast Tanzania at varying levels of malaria transmission. PARTICIPANTS: 2416 patients for whom a malaria test was requested. INTERVENTION: Staff received training on rapid diagnostic tests; patients sent for malaria tests were randomised to rapid diagnostic test or routine microscopy MAIN OUTCOME MEASURE: Proportion of patients with a negative test prescribed an antimalarial drug. RESULTS: Of 7589 outpatient consultations, 2425 (32%) had a malaria test requested. Of 1204 patients randomised to microscopy, 1030 (86%) tested negative for malaria; 523 (51%) of these were treated with an antimalarial drug. Of 1193 patients randomised to rapid diagnostic test, 1005 (84%) tested negative; 540 (54%) of these were treated for malaria (odds ratio 1.13, 95% confidence interval 0.95 to 1.34; P=0.18). Children aged under 5 with negative rapid diagnostic tests were more likely to be prescribed an antimalarial drug than were those with negative slides (P=0.003). Patients with a negative test by any method were more likely to be prescribed an antibiotic (odds ratio 6.42, 4.72 to 8.75; P&lt;0.001). More than 90% of prescriptions for antimalarial drugs in low-moderate transmission settings were for patients for whom a test requested by a clinician was negative for malaria. CONCLUSIONS: Although many cases of malaria are missed outside the formal sector, within it malaria is massively over-diagnosed. This threatens the sustainability of deployment of artemisinin combination treatment, and treatable bacterial diseases are likely to be missed. Use of rapid diagnostic tests, with basic training for clinical staff, did not in itself lead to any reduction in over-treatment for malaria. Interventions to improve clinicians&apos; management of febrile illness are essential but will not be easy. TRIAL REGISTRATION: Clinical trials NCT00146796 [ClinicalTrials.gov].</style></abstract><notes><style face="normal" font="default" size="100%">1756-1833&#xD;Reyburn, Hugh&#xD;Mbakilwa, Hilda&#xD;Mwangi, Rose&#xD;Mwerinde, Ombeni&#xD;Olomi, Raimos&#xD;Drakeley, Chris&#xD;Whitty, Christopher J M&#xD;Comparative Study&#xD;Journal Article&#xD;Multicenter Study&#xD;Randomized Controlled Trial&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;BMJ. 2007 Feb 24;334(7590):403. doi: 10.1136/bmj.39073.496829.AE. Epub 2007 Jan 26.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1804187/pdf/bmj-334-7590-res-00403-el.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC1804187</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1136/bmj.39073.496829.AE</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2247</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2247</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Reyburn, H.</style></author><author><style face="normal" font="default" size="100%">Mbatia, R.</style></author><author><style face="normal" font="default" size="100%">Drakeley, C.</style></author><author><style face="normal" font="default" size="100%">Carneiro, I.</style></author><author><style face="normal" font="default" size="100%">Mwakasungula, E.</style></author><author><style face="normal" font="default" size="100%">Mwerinde, O.</style></author><author><style face="normal" font="default" size="100%">Saganda, K.</style></author><author><style face="normal" font="default" size="100%">Shao, J.</style></author><author><style face="normal" font="default" size="100%">Kitua, A.</style></author><author><style face="normal" font="default" size="100%">Olomi, R.</style></author><author><style face="normal" font="default" size="100%">Greenwood, B. M.</style></author><author><style face="normal" font="default" size="100%">Whitty, C. J.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">London School of Hygiene and Tropical Medicine, London WCIE 7HT. hugh.reyburn@lshtm.ac.uk</style></auth-address><titles><title><style face="normal" font="default" size="100%">Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: a prospective study</style></title><secondary-title><style face="normal" font="default" size="100%">Bmj</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Bmj</style></full-title></periodical><pages><style face="normal" font="default" size="100%">1212</style></pages><volume><style face="normal" font="default" size="100%">329</style></volume><number><style face="normal" font="default" size="100%">7476</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Child, Preschool</style></keyword><keyword><style face="normal" font="default" size="100%">*Diagnostic Errors</style></keyword><keyword><style face="normal" font="default" size="100%">Fever/*etiology</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Infant</style></keyword><keyword><style face="normal" font="default" size="100%">Infant, Newborn</style></keyword><keyword><style face="normal" font="default" size="100%">Malaria, Falciparum/*diagnosis/mortality</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Prospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Regression Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Tanzania/epidemiology</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2004</style></year><pub-dates><date><style face="normal" font="default" size="100%">Nov 20</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0959-8138 (Print)&#xD;0959-8138</style></isbn><abstract><style face="normal" font="default" size="100%">OBJECTIVE: To study the diagnosis and outcomes in people admitted to hospital with a diagnosis of severe malaria in areas with differing intensities of malaria transmission. DESIGN: Prospective observational study of children and adults over the course a year. SETTING: 10 hospitals in north east Tanzania. PARTICIPANTS: 17,313 patients were admitted to hospital; of these 4474 (2851 children aged under 5 years) fulfilled criteria for severe disease. MAIN OUTCOME MEASURE: Details of the treatment given and outcome. Altitudes of residence (a proxy for transmission intensity) measured with a global positioning system. RESULTS: Blood film microscopy showed that 2062 (46.1%) of people treated for malaria had Plasmodium falciparum (slide positive). The proportion of slide positive cases fell with increasing age and increasing altitude of residence. Among 1086 patients aged &gt; or = 5 years who lived above 600 metres, only 338 (31.1%) were slide positive, while in children &lt; 5 years living in areas of intense transmission (&lt; 600 metres) most (958/1392, 68.8%) were slide positive. Among 2375 people who were slide negative, 1571 (66.1%) were not treated with antibiotics and of those, 120 (7.6%) died. The case fatality in slide negative patients was higher (292/2412, 12.1%) than for slide positive patients (142/2062, 6.9%) (P &lt; 0.001). Respiratory distress and altered consciousness were the strongest predictors of mortality in slide positive and slide negative patients and in adults as well as children. CONCLUSIONS: In Tanzania, malaria is commonly overdiagnosed in people presenting with severe febrile illness, especially in those living in areas with low to moderate transmission and in adults. This is associated with a failure to treat alternative causes of severe infection. Diagnosis needs to be improved and syndromic treatment considered. Routine hospital data may overestimate mortality from malaria by over twofold.</style></abstract><label><style face="normal" font="default" size="100%">Included by Ray</style></label><notes><style face="normal" font="default" size="100%">1756-1833&#xD;Reyburn, Hugh&#xD;Mbatia, Redepmta&#xD;Drakeley, Chris&#xD;Carneiro, Ilona&#xD;Mwakasungula, Emmanuel&#xD;Mwerinde, Ombeni&#xD;Saganda, Kapalala&#xD;Shao, John&#xD;Kitua, Andrew&#xD;Olomi, Raimos&#xD;Greenwood, Brian M&#xD;Whitty, Christopher J M&#xD;Journal Article&#xD;Multicenter Study&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;BMJ. 2004 Nov 20;329(7476):1212. doi: 10.1136/bmj.38251.658229.55. Epub 2004 Nov 12.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC529364/pdf/bmj32901212.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC529364</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1136/bmj.38251.658229.55</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2248</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2248</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Rodríguez Martínez, C. E.</style></author><author><style face="normal" font="default" size="100%">Sossa Briceño, M. P.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Facultad de Medicina, Universidad El Bosque, Bogotá, Colombia. carlos_rodriguez2671@yahoo.com</style></auth-address><titles><title><style face="normal" font="default" size="100%">[Cost-effectiveness of chest x-rays in infants with clinically suspected viral bronchiolitis in Colombia]</style></title><secondary-title><style face="normal" font="default" size="100%">Rev Panam Salud Publica</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Rev Panam Salud Publica</style></full-title></periodical><pages><style face="normal" font="default" size="100%">153-61</style></pages><volume><style face="normal" font="default" size="100%">29</style></volume><number><style face="normal" font="default" size="100%">3</style></number><keywords><keyword><style face="normal" font="default" size="100%">Bronchiolitis, Viral/*diagnosis/diagnostic imaging/economics</style></keyword><keyword><style face="normal" font="default" size="100%">Colombia</style></keyword><keyword><style face="normal" font="default" size="100%">Cost-Benefit Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Costs and Cost Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">*Decision Support Techniques</style></keyword><keyword><style face="normal" font="default" size="100%">Decision Trees</style></keyword><keyword><style face="normal" font="default" size="100%">Health Care Costs/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Infant</style></keyword><keyword><style face="normal" font="default" size="100%">Insurance, Health, Reimbursement/economics</style></keyword><keyword><style face="normal" font="default" size="100%">Pneumonia/economics</style></keyword><keyword><style face="normal" font="default" size="100%">Radiography, Thoracic/*economics/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Sensitivity and Specificity</style></keyword><keyword><style face="normal" font="default" size="100%">Unnecessary Procedures/*economics</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2011</style></year><pub-dates><date><style face="normal" font="default" size="100%">Mar</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1020-4989</style></isbn><abstract><style face="normal" font="default" size="100%">OBJECTIVE: Estimate the cost-effectiveness of not taking chest x-rays of any infant with clinically suspected viral bronchiolitis versus routinely taking them of all such patients, the most common practice today in Colombia. METHODS: A cost-effectiveness study was conducted, comparing strategies of taking chest x-rays of all infants with clinically suspected viral bronchiolitis and not x-raying any of these infants. The principal outcome was the proportion of correct diagnoses. The time horizon was the clinical course of the bronchiolitis. The perspective was that of the third-party payer, and the costs were obtained from the rates in effect in a clinic in Bogotá. Deterministic and probabilistic sensitivity analyses were performed. RESULTS: The strategy of not taking a chest x-ray of any patient prevailed over that of routinely taking one in all cases, with an average cost of US$ 111.00 and a correct diagnosis rate of 0.8020, versus the respective values of US$ 129.00 and 0.7873 for the strategy of routinely x-raying all of these patients. The most influential variable was pneumonia-related hospital costs. In the probabilistic sensitivity analysis, the strategy of not x-raying any infant prevailed in 61.1% of the simulations. CONCLUSIONS: The results suggest that not taking routine chest x-rays of infants with clinically suspected viral bronchiolitis is a cost-effective strategy compared with the common practice of taking them in all cases, since the former yields a greater proportion of correct diagnoses at a lower average cost per patient. Nevertheless, new studies will be needed that have more representative samples from all of the health facilities and include the strategy of taking chest x-rays only of patients with predictors of radiologic abnormalities.</style></abstract><label><style face="normal" font="default" size="100%">Included by Hannah</style></label><notes><style face="normal" font="default" size="100%">1680-5348&#xD;Rodríguez Martínez, Carlos E&#xD;Sossa Briceño, Mónica P&#xD;Journal Article&#xD;Review&#xD;United States&#xD;Rev Panam Salud Publica. 2011 Mar;29(3):153-61.</style></notes><urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2249</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2249</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Rodulfo, H.</style></author><author><style face="normal" font="default" size="100%">Ahmar, B.</style></author><author><style face="normal" font="default" size="100%">Rodríguez, M. E.</style></author><author><style face="normal" font="default" size="100%">Mora, L.</style></author><author><style face="normal" font="default" size="100%">De Donato, M.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Laboratorio de Genética Molecular, Instituto de Investigaciones en Biomedicina y Ciencias Aplicadas &quot;Dra. Susan Tai&quot;, Universidad de Oriente, Núcleo de Sucre, Cumaná, Venezuela.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Nested PCR reveals elevated over-diagnosis of E. histolytica in Barcelona, Venezuela</style></title><secondary-title><style face="normal" font="default" size="100%">Invest Clin</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Invest Clin</style></full-title></periodical><pages><style face="normal" font="default" size="100%">365-77</style></pages><volume><style face="normal" font="default" size="100%">53</style></volume><number><style face="normal" font="default" size="100%">4</style></number><keywords><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Child, Preschool</style></keyword><keyword><style face="normal" font="default" size="100%">Entamoeba histolytica/*genetics/*isolation &amp; purification</style></keyword><keyword><style face="normal" font="default" size="100%">Entamoebiasis/*diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">Feces/*parasitology</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Infant</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">*Polymerase Chain Reaction</style></keyword><keyword><style face="normal" font="default" size="100%">Venezuela</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2012</style></year><pub-dates><date><style face="normal" font="default" size="100%">Dec</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0535-5133 (Print)&#xD;0535-5133</style></isbn><abstract><style face="normal" font="default" size="100%">The aim of this study was to identify the presence of Entamoeba histolytica and E. dispar by nested PCR in children attending the &quot;Dr. Luis Razetti&quot; Hospital, Barcelona, Anzoátegui State. Of the 1,141 fecal samples coproparasitologically evaluated by conventional microscopy, 150 were diagnosed positive for E. histolytica in 0-10 year-old-children, of both sexes. The signs, symptoms and a full coproparasitological report were obtained from all of these and nested PCR was performed to identify E. histolytica and E. dispar. The conventional microscopy results showed a diagnostic frequency of E. histolytica in 13.2% of the cases, of which 79.3% were positive only for this pathogen. However, nested PCR showed that of these, only 28% (42/150) were actually infected by Entamoeba spp., revealing a high over-diagnosis of E. histolytica. We also identified 9.3% E. histolytica, 4% E. dispar and 4.7% mixed infections. Diarrhea was the most common symptom, followed by abdominal pain and fever. Bloody stools were statistically associated with E. histolytica, but were also found for E. dispar infections. This study demonstrates that molecular techniques complementary to conventional methods enable the correct identification of Entamoeba spp., thus contributing to an improved epidemiological assessment of these parasites and implementation of the appropriate treatment.</style></abstract><label><style face="normal" font="default" size="100%">Included by Thanya</style></label><notes><style face="normal" font="default" size="100%">Rodulfo, Hectorina&#xD;Ahmar, Beatriz&#xD;Rodríguez, María E&#xD;Mora, Leonor&#xD;De Donato, Marcos&#xD;Journal Article&#xD;Venezuela&#xD;Invest Clin. 2012 Dec;53(4):365-77.</style></notes><urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2250</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2250</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Rodulfo, H.</style></author><author><style face="normal" font="default" size="100%">De Donato, M.</style></author><author><style face="normal" font="default" size="100%">Rodriguez, M. E.</style></author><author><style face="normal" font="default" size="100%">Ahmar, B.</style></author><author><style face="normal" font="default" size="100%">Mora, L.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">H. Rodulfo, IIBCA, Universidad de Oriente, Cumana, Venezuela</style></auth-address><titles><title><style face="normal" font="default" size="100%">Common diagnostic methods for entamoeba species lead to over-diagnosis of the pathogenic entamoeba histolytica, in populations of Eastern Venezuela</style></title><secondary-title><style face="normal" font="default" size="100%">American Journal of Tropical Medicine and Hygiene</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">American Journal of Tropical Medicine and Hygiene</style></full-title></periodical><pages><style face="normal" font="default" size="100%">96</style></pages><volume><style face="normal" font="default" size="100%">83</style></volume><number><style face="normal" font="default" size="100%">5</style></number><keywords><keyword><style face="normal" font="default" size="100%">sodium chloride</style></keyword><keyword><style face="normal" font="default" size="100%">lugol</style></keyword><keyword><style face="normal" font="default" size="100%">Entamoeba histolytica</style></keyword><keyword><style face="normal" font="default" size="100%">society</style></keyword><keyword><style face="normal" font="default" size="100%">species</style></keyword><keyword><style face="normal" font="default" size="100%">tropical medicine</style></keyword><keyword><style face="normal" font="default" size="100%">diagnostic procedure</style></keyword><keyword><style face="normal" font="default" size="100%">diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">Venezuela</style></keyword><keyword><style face="normal" font="default" size="100%">population</style></keyword><keyword><style face="normal" font="default" size="100%">Entamoeba</style></keyword><keyword><style face="normal" font="default" size="100%">hygiene</style></keyword><keyword><style face="normal" font="default" size="100%">amebiasis</style></keyword><keyword><style face="normal" font="default" size="100%">prevalence</style></keyword><keyword><style face="normal" font="default" size="100%">trophozoite</style></keyword><keyword><style face="normal" font="default" size="100%">genus</style></keyword><keyword><style face="normal" font="default" size="100%">infection</style></keyword><keyword><style face="normal" font="default" size="100%">morphology</style></keyword><keyword><style face="normal" font="default" size="100%">multiplex polymerase chain reaction</style></keyword><keyword><style face="normal" font="default" size="100%">clinical laboratory</style></keyword><keyword><style face="normal" font="default" size="100%">cyst</style></keyword><keyword><style face="normal" font="default" size="100%">microscopy</style></keyword><keyword><style face="normal" font="default" size="100%">diarrhea</style></keyword><keyword><style face="normal" font="default" size="100%">child</style></keyword><keyword><style face="normal" font="default" size="100%">coinfection</style></keyword><keyword><style face="normal" font="default" size="100%">parasite</style></keyword><keyword><style face="normal" font="default" size="100%">World Health Organization</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2010</style></year></dates><isbn><style face="normal" font="default" size="100%">0002-9637</style></isbn><abstract><style face="normal" font="default" size="100%">In Venezuela, since 1990, infection frequencies are reported from 6.8 to 42% throughout the country. Between 2005 and 2008, 124,142 diarrhea cases were reported in children, 7,366 of these were reported as amebiasis, with Capital District, Zulia, Anzoategui and Sucre states showing highest prevalences. Even tough WHO since 1997 have recommended to differentiate the pathogenic species Entamoeba histolytica from the other non pathogenic species of the genus, in order to rationalize the treatment, few places carry out such differentiation. In Venezuela, the main diagnostic method is based on the microscopic observation of the trophozoites and cysts, which has a proven sensitibity of about 60% and cannot differenciate among E. histolytica, E. dispar and E. moshkovskii because of their identical morphology, except in cases where hematophagous trophozoites are seen. To study the real prevalence of these species in the states of Sucre and Anzoategui, we have diagnosed 1,045 fecal samples from symptomatic and asymptomatic individuals using nested-multiplex PCR for the detection of E. histolytica, E. dispar and E. moshkovskii. These samples were previously diagnosed by clinical laboratories using microscopic observation in saline physiologic solution and Lugol. The results show variations in the prevalence from 11 to 20% for the complex E. histolytica/E. dispar using microscopy, while PCR detected infection in symptomatic and asymptomatic individuals with 3.3% of cases being diagnosed as E. histolytica, 3.8% as E. dispar and 0.6% of mixed infections. E. moshkovskii has not been detected so far in these populations. These results make evident the over-diagnosis of amebiasis by conventional diagnostic methods and the lack of differentiation among the species of the genus, indicating the treatment in many more cases than really needed, which can lead to parasite resistance to common drugs to treat amebiasis.</style></abstract><notes><style face="normal" font="default" size="100%">L70442329&#xD;2011-09-13</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.embase.com/search/results?subaction=viewrecord&amp;id=L70442329&amp;from=export</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2251</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2251</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Salgado, María Victoria</style></author><author><style face="normal" font="default" size="100%">Kopitowski, Karin</style></author><author><style face="normal" font="default" size="100%">Barani, Mariela</style></author><author><style face="normal" font="default" size="100%">Vietto, Valeria</style></author><author><style face="normal" font="default" size="100%">Terrasa, Sergio</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Sobreuso de mamografía para rastreo en un hospital académico de Buenos Aires</style></title><secondary-title><style face="normal" font="default" size="100%">Rev. argent. salud publica</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Rev. argent. salud publica</style></full-title></periodical><pages><style face="normal" font="default" size="100%">7-11</style></pages><volume><style face="normal" font="default" size="100%">7</style></volume><number><style face="normal" font="default" size="100%">27</style></number><keywords><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Breast Neoplasms</style></keyword><keyword><style face="normal" font="default" size="100%">Health Services Misuse</style></keyword><keyword><style face="normal" font="default" size="100%">Mammography</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style face="normal" font="default" size="100%">2016/06</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1852-8724</style></isbn><abstract><style face="normal" font="default" size="100%">INTRODUCCIÓN: el rastreo de cáncer de mama en lapoblación general asintomática no está recomendado en mujeresmenores de 40 años y es controvertido en las de 40 a 49 años. Eluso inadecuado de mamografía con fines de rastreo (sobreuso) y suconsecuencia, el sobrediagnóstico, pueden conducir a tratamientosagresivos. OBJETIVO: Reportar la proporción de mamografíasinapropiadamente realizadas en mujeres menores de 50 añosafiliadas a un plan de salud de un proveedor de medicina prepaga.MÉTODOS: Se efectuó un estudio observacional de corte transversal.Se identificó a las mujeres de 18-39 y de 40-49 años afiliadas al plande salud del Hospital Italiano de Buenos Aires que se habían realizadoal menos una mamografía en 2012. Se revisaron las historiasclínicas de 200 pacientes en cada grupo de edad para determinarsi la mamografía había sido solicitada para rastreo de cáncer demama. RESULTADOS: Durante 2012, 1 533 mujeres de 18-39 añosse realizaron una mamografía. En 96 de las 200 historias revisadas,esta prueba había sido solicitada con fines de rastreo (48%; IC 95%:40,9-55,2%). Entre las mujeres de 40-49 años, 4 432 tenían unamamografía efectuada ese año. Se revisaron 199 historias clínicas;en 105 casos, el estudio había sido solicitado con fines de rastreo(52,8%; IC 95%: 45,6-59,9%). No se realizó ningún diagnóstico decáncer de mama como consecuencia de esta estrategia de rastreo.CONCLUSIONES: La alta proporción de sobreuso de mamografíapara rastreo es especialmente preocupante entre las mujeres másjóvenes y revela la dificultad que los médicos pueden tener paraadoptar las guías de práctica clínica más actualizadas.&#xD;INTRODUCTION: breast cancer screening in the generalasymptomatic population is not recommended in women youngerthan 40 years old, and it is controversial among women aged 40 to49 years. Overuse of screening mammography and its consequence,overdiagnosis, can lead to aggressive treatments. OBJECTIVE: To reportthe proportion of mammograms that were performed for breast cancerscreening among women younger than 50 years old enrolled in aprivate Health Insurance Plan in Buenos Aires, Argentina. METHODS:A cross-sectional observational study was performed. Among womenaged 18 to 39 and 40 to 49 years old enrolled in a private health plan(Hospital Italiano de Buenos Aires), those with a mammogram conductedin 2012 were identified. Of them, 200 in each age group wererandomly selected. Their medical charts were reviewed to determine ifthe mammography had been performed for breast cancer screeningpurposes. RESULTS: During 2012, 1533 women aged 18 to 39 years oldhad a mammogram conducted. Of them, 200 charts were reviewed, 96of which were determined to have a screening mammography (overuseproportion: 48%; 95% CI: 40.9-55.2%). Among women aged 40 to49, 4 432 had a mammography performed during 2012. The chartsof 199 of these women were reviewed. The mammogram had beenconducted for screening purposes in 105 cases (overuse proportion:52.8%; 95% CI: 45.6-59.9%). There was no diagnosis of breast canceras a result of these screening mammograms. CONCLUSIONS: Thishigh overuse of screening mammography is particularly concerningamong the younger women and highlights the difficulty physiciansmay have to adopt the most updated guidelines.</style></abstract><urls><related-urls><url><style face="normal" font="default" size="100%">rasp.msal.gov.ar/rasp/articulos/volumen27/7-11.pdf</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2252</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2252</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Samarakoon, Y.</style></author><author><style face="normal" font="default" size="100%">Gunawardena, N.</style></author><author><style face="normal" font="default" size="100%">Pathirana, A.</style></author><author><style face="normal" font="default" size="100%">Hewage, S.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">National Cancer Control Programme, No.555, Public Health Building Complex, Elvitigala Mawatha, Colombo, 5, Sri Lanka.&#xD;World Health Organization Country Office for Sri Lanka, No. 5, Anderson road, Colombo, 5, Sri Lanka.&#xD;Department of surgery, Faculty of Medical Sciences, University of Sri Jayewardenepura, Sri Jayewardenepura, Sri Lanka.&#xD;National Cancer Control Programme, No.555, Public Health Building Complex, Elvitigala Mawatha, Colombo, 5, Sri Lanka. sumuduavanthi@gmail.com.</style></auth-address><titles><title><style face="normal" font="default" size="100%">&quot;Appropriateness of colonoscopy according to EPAGE II in a low resource setting: a cross sectional study from Sri Lanka&quot;</style></title><secondary-title><style face="normal" font="default" size="100%">BMC Gastroenterol</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">BMC Gastroenterol</style></full-title></periodical><pages><style face="normal" font="default" size="100%">72</style></pages><volume><style face="normal" font="default" size="100%">18</style></volume><number><style face="normal" font="default" size="100%">1</style></number><keywords><keyword><style face="normal" font="default" size="100%">Abdominal Pain/etiology</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Colonoscopy/economics/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Colorectal Neoplasms/*diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">Cross-Sectional Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Developing Countries/*economics</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Gastrointestinal Hemorrhage/etiology</style></keyword><keyword><style face="normal" font="default" size="100%">Health Resources/*economics</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Medical Audit</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Rectal Diseases/etiology</style></keyword><keyword><style face="normal" font="default" size="100%">Sri Lanka</style></keyword><keyword><style face="normal" font="default" size="100%">Unnecessary Procedures/economics/*statistics &amp; numerical data</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style face="normal" font="default" size="100%">May 29</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1471-230x</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: Due to finite resources, the clinical decision to subject a patient to colonoscopy needs to be based on the evidence, regardless of its availability, affordability and safety. This study assessed the appropriateness of colonoscopies conducted in selected study settings in Sri Lanka. In the absence of local guidelines, audit was based on European Panel on Appropriateness of Gastrointestinal Endoscopy II (EPAGE II) criteria. METHODS: This cross-sectional study assessed consecutive patients who underwent colonoscopy between June to August 2015 at four main hospitals in Sri Lanka. Interviewer administered questionnaire and secondary data were collected by trained health staff. Indications were assessed according to EPAGE II criteria. RESULTS: Out of 325 patients, male female proportions were 57.2 and 42.8%. Mean (SD) age was 54.9 (12.1) years. Colonoscopies were appropriate in 61.2% (95% CI 55.8-66.3), uncertain in 28.6% (95% CI 23.9-33.7) and inappropriate in 10.2% (95% CI 7.3-13.9). Colonoscopy to evaluate abdominal pain has highest percentage of inappropriateness of 10.0%. However, 9.5% of these colonoscopies revealed Colo-Rectal Cancer (CRC), reflecting differences in the profile of local CRC patients. Colonoscopies with appropriate or uncertain indications are three times more likely to have a relevant finding than inappropriate indications (42.5% vs. 18.2%; OR 3.32, 95% CI 1.33-8.3; P = 0.008). CONCLUSIONS: Majority of colonoscopies are appropriate. However, it cannot be neglected that every one in ten patients undergo inappropriate colonoscopy. Proportion of inappropriateness was highest for the indication of chronic abdominal pain, of which, 9.5% of patients were diagnosed with CRC. This may reflect the different profile of local CRC patients in terms of symptom manifestation and other characteristics. In conclusion, the authors recommend formulation of national guidelines for colonoscopy indications based on current best evidence and local patient profile. Use of such prepared local guidelines will improve the efficient use of finite resources.</style></abstract><notes><style face="normal" font="default" size="100%">1471-230x&#xD;Samarakoon, Yasara&#xD;Gunawardena, Nalika&#xD;Pathirana, Aloka&#xD;Hewage, Sumudu&#xD;Orcid: 0000-0001-8079-4338&#xD;001/World Health Organization/International&#xD;2015/025./Medical Research Institute Sri Lanka/&#xD;Journal Article&#xD;BMC Gastroenterol. 2018 May 29;18(1):72. doi: 10.1186/s12876-018-0798-7.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975517/pdf/12876_2018_Article_798.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC5975517 PUBLISHER’S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1186/s12876-018-0798-7</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2253</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2253</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Sanchez, J.</style></author><author><style face="normal" font="default" size="100%">Volquez, C.</style></author><author><style face="normal" font="default" size="100%">Totten, P. A.</style></author><author><style face="normal" font="default" size="100%">Campos, P. E.</style></author><author><style face="normal" font="default" size="100%">Ryan, C.</style></author><author><style face="normal" font="default" size="100%">Catlin, M.</style></author><author><style face="normal" font="default" size="100%">Hasbun, J.</style></author><author><style face="normal" font="default" size="100%">Rosado De Quiñones, M.</style></author><author><style face="normal" font="default" size="100%">Sanchez, C.</style></author><author><style face="normal" font="default" size="100%">De Lister, M. B.</style></author><author><style face="normal" font="default" size="100%">Weiss, J. B.</style></author><author><style face="normal" font="default" size="100%">Ashley, R.</style></author><author><style face="normal" font="default" size="100%">Holmes, K. K.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Universidad Peruana Cayetano Heredia School of Public Health and Administration, Lima, Peru.</style></auth-address><titles><title><style face="normal" font="default" size="100%">The etiology and management of genital ulcers in the Dominican Republic and Peru</style></title><secondary-title><style face="normal" font="default" size="100%">Sex Transm Dis</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Sex Transm Dis</style></full-title></periodical><pages><style face="normal" font="default" size="100%">559-67</style></pages><volume><style face="normal" font="default" size="100%">29</style></volume><number><style face="normal" font="default" size="100%">10</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Anti-Bacterial Agents/therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Chancroid/*complications/diagnosis/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">DNA, Bacterial/analysis</style></keyword><keyword><style face="normal" font="default" size="100%">DNA, Viral/analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Dominican Republic/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Genital Diseases, Male/epidemiology/*etiology/*therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Herpes Genitalis/*complications/diagnosis/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Peru/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Polymerase Chain Reaction</style></keyword><keyword><style face="normal" font="default" size="100%">Prevalence</style></keyword><keyword><style face="normal" font="default" size="100%">Sensitivity and Specificity</style></keyword><keyword><style face="normal" font="default" size="100%">Syphilis/*complications/diagnosis/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Ulcer/epidemiology/*etiology/*therapy</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2002</style></year><pub-dates><date><style face="normal" font="default" size="100%">Oct</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0148-5717 (Print)&#xD;0148-5717</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: Clinical diagnosis of genital ulcers is difficult, and diagnostic tests are least available in settings where rates of disease are highest. The World Health Organization (WHO) has developed protocols for the syndromic management of genital ulcers in resource-poor settings. However, because risk factors, patterns and causes of disease, and antimicrobial susceptibilities differ from region to region and over time, they must be adapted to local situations. GOAL: The goal of this study was to determine etiologic factors, evaluate syndromic management, and compare polymerase chain reaction (PCR) testing with other diagnostic alternatives for genital ulcers among patients attending sexually transmitted disease clinics in the Dominican Republic and Peru. STUDY DESIGN: Eighty-one men with genital ulcers in the Dominican Republic and 63 in Peru underwent identical interviews and identical multiplex PCR (M-PCR) tests of genital lesion specimens for etiologic diagnoses. Algorithms for managing genital ulcers were developed. RESULTS: In the Dominican Republic, 5% were M-PCR-positive for, 26% for, and 43% for herpes simplex virus (HSV); in Peru, 10%, 5%, and 43%, respectively, were positive. The WHO algorithm for treating syphilis and chancroid had a sensitivity of 100%, a positive predictive value (PPV) of 24%, and an overtreatment rate of 76%. A modified algorithm for treating only those without vesicular lesions had 88% sensitivity and a 27% PPV, and the overtreatment rate was reduced to 58%. CONCLUSION: HSV caused 43% of genital ulcers in these populations. The modified algorithm had lower sensitivity but a reduced overtreatment rate. M-PCR testing was more sensitive than standard tests and more specific and sensitive than clinical diagnosis.</style></abstract><notes><style face="normal" font="default" size="100%">Sanchez, Jorge&#xD;Volquez, Claudio&#xD;Totten, Patricia A&#xD;Campos, Pablo E&#xD;Ryan, Caroline&#xD;Catlin, Mary&#xD;Hasbun, Julia&#xD;Rosado De Quiñones, Margarita&#xD;Sanchez, Cesar&#xD;De Lister, Martha Butler&#xD;Weiss, Judith B&#xD;Ashley, Rhoda&#xD;Holmes, King K&#xD;Comparative Study&#xD;Journal Article&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Sex Transm Dis. 2002 Oct;29(10):559-67. doi: 10.1097/00007435-200210000-00001.</style></notes><urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1097/00007435-200210000-00001</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2254</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2254</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Santillán-Fragoso, W. J.</style></author><author><style face="normal" font="default" size="100%">Sánchez-Ávila, E.</style></author><author><style face="normal" font="default" size="100%">Paz-García, A.</style></author><author><style face="normal" font="default" size="100%">Hernández-López, A.</style></author><author><style face="normal" font="default" size="100%">Enríquez-Peregrino, K. G.</style></author><author><style face="normal" font="default" size="100%">Lagunas-Alvarado, M. G.</style></author><author><style face="normal" font="default" size="100%">Ramírez-del Pilar, R.</style></author><author><style face="normal" font="default" size="100%">López-González, D. S.</style></author><author><style face="normal" font="default" size="100%">Copca-Nieto, D. V.</style></author><author><style face="normal" font="default" size="100%">Lagunas-Alvarado, M.</style></author><author><style face="normal" font="default" size="100%">López y López, L. R.</style></author><author><style face="normal" font="default" size="100%">Medina-Carrillo, O.</style></author><author><style face="normal" font="default" size="100%">Álvarez-López, J. A.</style></author><author><style face="normal" font="default" size="100%">Terán-González, J. O.</style></author><author><style face="normal" font="default" size="100%">Castro, D.</style></author><author><style face="normal" font="default" size="100%">Franchis, L. J.</style></author><author><style face="normal" font="default" size="100%">Reyes-Jiménez, A. E.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Control glucémico intensivo y sobretratamiento en pacientes mayores de 60 años con diabetes mellitus</style></title><secondary-title><style face="normal" font="default" size="100%">Med. interna Méx</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Med. interna Méx</style></full-title></periodical><pages><style face="normal" font="default" size="100%">185-194</style></pages><volume><style face="normal" font="default" size="100%">33</style></volume><number><style face="normal" font="default" size="100%">2</style></number><dates><year><style face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style face="normal" font="default" size="100%">2017/04</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0186-4866</style></isbn><abstract><style face="normal" font="default" size="100%">Resumen ANTECEDENTES: existe incremento de la prevalência de diabetes mellitus 2 y del envejecimiento. Así, los riesgos asociados con control glucémico intensivo en esta población vulnerable se incrementan. Por ello, debe considerarse la posibilidad de un sobretratamiento en estos pacientes. OBJETIVO: determinar la prevalencia de control glucémico intensivo y sobretratamiento en pacientes con diabetes mellitus tipo 2 mayores de 60 años. MATERIAL Y MÉTODO: estudio retrospectivo, transversal, observacional y analítico. De 2013 a 2015 se evaluaron pacientes mayores de 60 años de edad con diabetes mellitus tipo 2, hemoglobina glucosilada (HbAlc) &amp;amp;lt;7% y administración de hipoglucemiantes. Los pacientes se clasificaron en control glucémico intensivo (HbAlc 6.6-7%) y sobretratamiento (HbAlc &amp;amp;lt;6.5%). Los porcentajes de ambos grupos y sus complicaciones cardiovasculares y no cardiovasculares asociadas se compararon utilizando una prueba Z. RESULTADOS: se incluyeron 13,229 pacientes con diabetes mellitus tipo 2 mayores de 60 años; en 2013, fueron 4,381, 16% (n=701) en control glucémico intensivo y 6% (n=256) en sobretratamiento; en 2014 fueron 4,383, 16% (n=697) en control glucémico intensivo y 6% (n=252) en sobretratamiento; en 2015 fueron 4,465, 16% (n=708) en control glucémico intensivo y 6% (n=260) con sobretratamiento. El control glucémico intensivo causó 5, 3 y 1% de complicaciones durante 2013, 2014 y 2015, respectivamente. En el grupo con sobretratamiento el porcentaje de complicaciones fue de 4% en 2013 y de 6% en 2015. Se obtuvo un valor Z de -2.90 (p&amp;amp;lt;0.05), mostrando mayor número en sobretratamiento. CONCLUSIONES: de la población estudiada, 16% estaba en control glucémico intensivo y 6% en sobretratamiento, con incremento significativo de complicaciones en el grupo con sobretratamiento, la hipoglucemia fue la más frecuente.&#xD;BACKGROUND: Due to increasing prevalence of type 2 diabetes mellitus (T2DM) and the overall aging of the population, the number of elderly patients with T2DM is continuously growing. Given the risks associated with intensive glycemic control of those patients, the possibility of overtreatment must be considered. OBJECTIVE: To determine the prevalence of intensive glycemic control and overtreatment in individuals &amp;amp;gt;60 years with T2DM. MATERIAL AND METHOD: An observational, cross-sectional, retrospective and analytical study was done from 2013 to 2015. Individuals &amp;amp;gt;60 years old with T2DM, glycated hemoglobin (HbA1c) &amp;amp;lt;7%, and use of hypoglycemic agents were included. Patients were divided into two groups: intensive glycemic control (HbA1c 6.6-7%) and overtreatment (HbA1c &amp;amp;lt;6.5%). Cardiovascular and non-cardiovascular complications associated with treatment were compared by Z-test. RESULTS: There were included 13,229 patients older than 60 years with T2DM; 4,381 in 2013, 16% (n=701) was classified as intensive glycemic control and 6% (n=256) as overtreatment; 4,383 in 2014, 16% (n=697) as intensive glycemic control and 6% (n=252) as over-treatment; 4,465 in 2015, 16% (n=708) as intensive glycemic control and 6% (n=260) as overtreatment. By this period, adverse outcomes were reported in 5%, 3% and 1% during 2013, 2014 and 2015, respectively; referring to intensive glycemic control group. Likewise, adverse outcomes were reported in 4% and 6% during 2013 and 2015, respectively; referring to overtreatment group. A value of Z-test -2.90 (p&amp;amp;lt;0.05) was obtained, which was increased in overtreatment group. CONCLUSIONS: All data collected during the study highlights a significant increase of cardiovascular and non-cardiovascular adverse outcomes in patients with strict glycemic management, being hypoglycemia the most frequent; 16% are in intensive glycemic control and 6% in overtreatment.</style></abstract><urls><related-urls><url><style face="normal" font="default" size="100%">http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;amp;pid=S0186-48662017000200185</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2255</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2255</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Sator, L.</style></author><author><style face="normal" font="default" size="100%">Horner, A.</style></author><author><style face="normal" font="default" size="100%">Studnicka, M.</style></author><author><style face="normal" font="default" size="100%">Lamprecht, B.</style></author><author><style face="normal" font="default" size="100%">Kaiser, B.</style></author><author><style face="normal" font="default" size="100%">McBurnie, M. A.</style></author><author><style face="normal" font="default" size="100%">Buist, A. S.</style></author><author><style face="normal" font="default" size="100%">Gnatiuc, L.</style></author><author><style face="normal" font="default" size="100%">Mannino, D. M.</style></author><author><style face="normal" font="default" size="100%">Janson, C.</style></author><author><style face="normal" font="default" size="100%">Bateman, E. D.</style></author><author><style face="normal" font="default" size="100%">Burney, P.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Pulmonary Medicine, Paracelsus Medical University, Salzburg, Austria.&#xD;Department of Pulmonology, Kepler University Hospital, Linz, Austria; Faculty of Medicine, Johannes-Kepler-University, Linz, Austria; Institute of General Practice, Family Medicine and Preventive Medicine, Paracelsus Medical University, Salzburg, Austria. Electronic address: andreas.horner@kepleruniklinikum.at.&#xD;Department of Pulmonology, Kepler University Hospital, Linz, Austria; Faculty of Medicine, Johannes-Kepler-University, Linz, Austria.&#xD;Department of Pulmonology, Kepler University Hospital, Linz, Austria.&#xD;Center for Health Research, Kaiser Permanente Northwest, Portland, OR.&#xD;Oregon Health and Science University, Portland, OR.&#xD;Respiratory Epidemiology and Public Health Group, Imperial College, London, London, United Kingdom.&#xD;Department of Preventive Medicine and Environmental Health, College of Public Health, University of Kentucky, Lexington, KY.&#xD;Department of Medical Sciences, Uppsala University, Uppsala, Sweden.&#xD;Division of Pulmonology, Department of Medicine, University of Cape Town, Cape Town, South Africa.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Overdiagnosis of COPD in Subjects With Unobstructed Spirometry: A BOLD Analysis</style></title><secondary-title><style face="normal" font="default" size="100%">Chest</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Chest</style></full-title></periodical><pages><style face="normal" font="default" size="100%">277-288</style></pages><volume><style face="normal" font="default" size="100%">156</style></volume><number><style face="normal" font="default" size="100%">2</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Cross-Sectional Studies</style></keyword><keyword><style face="normal" font="default" size="100%">False Positive Reactions</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Forced Expiratory Volume</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">*Medical Overuse</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Prevalence</style></keyword><keyword><style face="normal" font="default" size="100%">Pulmonary Disease, Chronic Obstructive/*diagnosis/epidemiology/physiopathology</style></keyword><keyword><style face="normal" font="default" size="100%">Spirometry</style></keyword><keyword><style face="normal" font="default" size="100%">Surveys and Questionnaires</style></keyword><keyword><style face="normal" font="default" size="100%">Vital Capacity</style></keyword><keyword><style face="normal" font="default" size="100%">*copd</style></keyword><keyword><style face="normal" font="default" size="100%">*false positive diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">*misdiagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">*overdiagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">*overtreatment</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style face="normal" font="default" size="100%">Aug</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0012-3692</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: There are several reports on underdiagnosis of COPD, while little is known about COPD overdiagnosis and overtreatment. We describe the overdiagnosis and the prevalence of spirometrically defined false positive COPD, as well as their relationship with overtreatment across 23 population samples in 20 countries participating in the BOLD Study between 2003 and 2012. METHODS: A false positive diagnosis of COPD was considered when participants reported a doctor&apos;s diagnosis of COPD, but postbronchodilator spirometry was unobstructed (FEV(1)/FVC &gt; LLN). Additional analyses were performed using the fixed ratio criterion (FEV(1)/FVC &lt; 0.7). RESULTS: Among 16,177 participants, 919 (5.7%) reported a previous medical diagnosis of COPD. Postbronchodilator spirometry was unobstructed in 569 subjects (61.9%): false positive COPD. A similar rate of overdiagnosis was seen when using the fixed ratio criterion (55.3%). In a subgroup analysis excluding participants who reported a diagnosis of &quot;chronic bronchitis&quot; or &quot;emphysema&quot; (n = 220), 37.7% had no airflow limitation. The site-specific prevalence of false positive COPD varied greatly, from 1.9% in low- to middle-income countries to 4.9% in high-income countries. In multivariate analysis, overdiagnosis was more common among women, and was associated with higher education; former and current smoking; the presence of wheeze, cough, and phlegm; and concomitant medical diagnosis of asthma or heart disease. Among the subjects with false positive COPD, 45.7% reported current use of respiratory medication. Excluding patients with reported asthma, 34.4% of those with normal spirometry still used a respiratory medication. CONCLUSIONS: False positive COPD is frequent. This might expose nonobstructed subjects to possible adverse effects of respiratory medication.</style></abstract><notes><style face="normal" font="default" size="100%">1931-3543&#xD;Sator, Lea&#xD;Horner, Andreas&#xD;Studnicka, Michael&#xD;Lamprecht, Bernd&#xD;Kaiser, Bernhard&#xD;McBurnie, Mary Ann&#xD;Buist, A Sonia&#xD;Gnatiuc, Luisa&#xD;Mannino, David M&#xD;Janson, Christer&#xD;Bateman, Eric D&#xD;Burney, Peter&#xD;BOLD Collaborative Research Group&#xD;MC_UU_00017/2/MRC_/Medical Research Council/United Kingdom&#xD;085790/Z/08/Z/WT_/Wellcome Trust/United Kingdom&#xD;Journal Article&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Chest. 2019 Aug;156(2):277-288. doi: 10.1016/j.chest.2019.01.015. Epub 2019 Jan 31.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://spiral.imperial.ac.uk/handle/10044/1/68548</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1016/j.chest.2019.01.015</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2256</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2256</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Savitha, M. R.</style></author><author><style face="normal" font="default" size="100%">Khanagavi, Jagadish B.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Redefining the World Health Organization algorithm for diagnosis of pneumonia with simple additional markers</style></title><secondary-title><style face="normal" font="default" size="100%">Indian J Pediatr</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Indian J Pediatr</style></full-title></periodical><keywords><keyword><style face="normal" font="default" size="100%">Algorithms</style></keyword><keyword><style face="normal" font="default" size="100%">Asthma/diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">Biomarkers</style></keyword><keyword><style face="normal" font="default" size="100%">Bronchodilator Agents/therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Child, Preschool</style></keyword><keyword><style face="normal" font="default" size="100%">Cough/etiology</style></keyword><keyword><style face="normal" font="default" size="100%">Emergency Service, Hospital</style></keyword><keyword><style face="normal" font="default" size="100%">Fever/diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">Guidelines as Topic</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Infant</style></keyword><keyword><style face="normal" font="default" size="100%">Pneumonia/complications</style></keyword><keyword><style face="normal" font="default" size="100%">Prospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Respiratory Sounds/etiology</style></keyword><keyword><style face="normal" font="default" size="100%">Sleep Wake Disorders</style></keyword><keyword><style face="normal" font="default" size="100%">World Health Organization</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2008</style></year><pub-dates><date><style face="normal" font="default" size="100%">2008/06</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0973-7693</style></isbn><abstract><style face="normal" font="default" size="100%">OBJECTIVES: WHO to examine the value of additional markers like history of previous respiratory distress and response to bronchodilator (BD) to redefine these guidelines. METHODS: Fifty (50) patients were analysed for presence of fever. Those who were febrile were put on antipyretic to look for resolution of tachypnea. Those who showed persistent tachypnea and those who were afebrile were analyzed for history of previous respiratory distress. Those who gave a positive history were challenged with BD. The association of persistent tachypnea and pulmonary infiltrates was recorded. RESULTS: Persistence of tachypnea after BD therapy was associated with pulmonary infiltrate in 7/8 (87.5%) whereas tachypnea persisted in 9/30 (30%) of those without infiltrates (p &amp;amp;lt; 0.001). The proposed algorithm brings down the overuse of antibiotics from 78.9% to 26.3% (p &amp;amp;lt;0.001) and also brings down the underuse of bronchodilators from 78.9% to 21.1 %(p&amp;amp;lt;0.001). CONCLUSION: Adding simple markers like history of previous respiratory distress and response to BD therapy to the existing WHO guidelines it is possible to reliably differentiate pneumonia from acute exacerbation of asthma.</style></abstract><label><style face="normal" font="default" size="100%">Included by Loai</style></label><urls><related-urls><url><style face="normal" font="default" size="100%">http://imsear.searo.who.int/handle/123456789/81268</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2257</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2257</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Sawasdivorn, S.</style></author><author><style face="normal" font="default" size="100%">Vibulvattanakit, S.</style></author><author><style face="normal" font="default" size="100%">Sasavatpakdee, M.</style></author><author><style face="normal" font="default" size="100%">Iamsirithavorn, S.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">S. Sawasdivorn, Paediatric Department, Sawanpracharak Medical Center, Bangkok, Thailand</style></auth-address><titles><title><style face="normal" font="default" size="100%">Efficacy of clinical diagnosis of dengue fever in paediatric age groups as determined by WHO case definition 1997 in Thailand</style></title><secondary-title><style face="normal" font="default" size="100%">Dengue Bulletin</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Dengue Bulletin</style></full-title></periodical><pages><style face="normal" font="default" size="100%">56-64</style></pages><volume><style face="normal" font="default" size="100%">25</style></volume><keywords><keyword><style face="normal" font="default" size="100%">adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">article</style></keyword><keyword><style face="normal" font="default" size="100%">child</style></keyword><keyword><style face="normal" font="default" size="100%">clinical feature</style></keyword><keyword><style face="normal" font="default" size="100%">controlled study</style></keyword><keyword><style face="normal" font="default" size="100%">dengue</style></keyword><keyword><style face="normal" font="default" size="100%">enzyme linked immunosorbent assay</style></keyword><keyword><style face="normal" font="default" size="100%">female</style></keyword><keyword><style face="normal" font="default" size="100%">fever</style></keyword><keyword><style face="normal" font="default" size="100%">hospital admission</style></keyword><keyword><style face="normal" font="default" size="100%">hospital discharge</style></keyword><keyword><style face="normal" font="default" size="100%">hospitalization</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">laboratory test</style></keyword><keyword><style face="normal" font="default" size="100%">leukopenia</style></keyword><keyword><style face="normal" font="default" size="100%">major clinical study</style></keyword><keyword><style face="normal" font="default" size="100%">male</style></keyword><keyword><style face="normal" font="default" size="100%">medical record</style></keyword><keyword><style face="normal" font="default" size="100%">pediatric hospital</style></keyword><keyword><style face="normal" font="default" size="100%">pediatrician</style></keyword><keyword><style face="normal" font="default" size="100%">physical examination</style></keyword><keyword><style face="normal" font="default" size="100%">polymerase chain reaction</style></keyword><keyword><style face="normal" font="default" size="100%">prevalence</style></keyword><keyword><style face="normal" font="default" size="100%">risk assessment</style></keyword><keyword><style face="normal" font="default" size="100%">sensitivity and specificity</style></keyword><keyword><style face="normal" font="default" size="100%">symptomatology</style></keyword><keyword><style face="normal" font="default" size="100%">Thailand</style></keyword><keyword><style face="normal" font="default" size="100%">tourniquet</style></keyword><keyword><style face="normal" font="default" size="100%">World Health Organization</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2001</style></year></dates><isbn><style face="normal" font="default" size="100%">1020-895X</style></isbn><abstract><style face="normal" font="default" size="100%">A descriptive cross-sectional study was undertaken at the Paediatrics department of the Sawanpracharak Medical Centre, Bangkok, from September 1998 to September 1999. Patients admitted with a tentative diagnosis of dengue infection were followed througout their hospital stay. Daily records were kept of the patient&apos;s symptoms, their physical examination findings and laboratory data. Clinical diagnosis of DF/DHF/DSS or other febrile illness was made by paeditricians at the time of discharge based on the WHO 1997 case definition. During the study, 176 patients, aged 1-13 years, were recruited based on initial admission diagnosis. At the end of hospitalization, 71 patients (40%) were diagnosed as having DF by their paeditricians. Based on LISA and/or PCR, only 45 were confirmed to have DF. In the study of our population, the sensitivity, PPV and NPV according to the WHO 1997 DF case definition were 100%, 21.21%, 63.38% and 100% respectively. The four leading clinical manifestations in the sample of 45 confirmed cases included: fever 100%, positive tourniquet test 86.67%, headeache 80.48% and leukopenia 62.22%. By using fever with two other clinical manifestations, only fever with positive tourniquet test and leukopenia differentiated DF from other febrile illness (p=0.042) and had the highest predictive value (PPV = 72.72%). It was also found that fever with positive tourniquet, or fever with leukopenia with one other clinical manifestations, has a higher chance of more PPV than fever combined with just any two clinical manifestations. The study brought out the fact that WHO case definition for DF has very high sensitivity but runs the risk of over-diagnosis to the extents of 36.62% (PPV = 63.38%) To reduce this risk, the study found that the combination of fever with positive tourniquet and leukopenia was the best (PPV = 72.72%). The (PPV = 72.72%-61.53%) was better than fever with any two clinical manifestations (PPV = 64.2%-40.00%).</style></abstract><label><style face="normal" font="default" size="100%">Included by Thanya</style></label><notes><style face="normal" font="default" size="100%">L36322063&#xD;2003-03-26</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.embase.com/search/results?subaction=viewrecord&amp;id=L36322063&amp;from=export</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2258</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2258</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Schmulson, M. J.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Laboratorio de Hígado, Páncreas y Motilidad, Departamento de Medicina Experimental, Facultad de Medicina, Universidad Nacional Autónoma de México. maxjulio@avantel.net</style></auth-address><titles><title><style face="normal" font="default" size="100%">[Limited diagnostic testing can decrease the direct economic impact of irritable bowel syndrome]</style></title><secondary-title><style face="normal" font="default" size="100%">Rev Med Chil</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Rev Med Chil</style></full-title></periodical><pages><style face="normal" font="default" size="100%">1398-405</style></pages><volume><style face="normal" font="default" size="100%">136</style></volume><number><style face="normal" font="default" size="100%">11</style></number><keywords><keyword><style face="normal" font="default" size="100%">Consensus</style></keyword><keyword><style face="normal" font="default" size="100%">Diagnostic Techniques, Digestive System/economics</style></keyword><keyword><style face="normal" font="default" size="100%">Direct Service Costs/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Health Expenditures/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Irritable Bowel Syndrome/diagnosis/*economics</style></keyword><keyword><style face="normal" font="default" size="100%">Mexico</style></keyword><keyword><style face="normal" font="default" size="100%">Practice Guidelines as Topic</style></keyword><keyword><style face="normal" font="default" size="100%">Unnecessary Procedures/economics</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2008</style></year><pub-dates><date><style face="normal" font="default" size="100%">Nov</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0034-9887 (Print)&#xD;0034-9887</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: The economic impact of irritable bowel syndrome (IBS) in Mexico in terms of excessive diagnostic testing can be considerably reduced if the recommendations of the Latin American Consensus (LATAM) for IBS are followed. AIM: To estimate the economic impact of IBS in terms of excessive diagnostic testing. MATERIAL AND METHODS: Based on a previously published study, the costs of diagnostic testing for IBS were compared to the theoretical costs according to the recommendations of the consensus. These costs were compared to estimate the economic impact of excessive diagnostic testing. A cost-minimization analysis was also done. RESULTS: For the lowest socioeconomic level in academic medicine, the excessive diagnostic testing had an approximate cost of U.S. $21.38, compared to U.S. $1.72 if the LATAM Consensus recommendations would have been followed, representing a saving of 92.0%. The cost for the highest socioeconomic level in academic medicine was U.S. $1080.36 versus U.S. $103.60 (a saving of 90.4%) and for private medicine, the costs were U.S. $3121.60 versus U.S. $159.90 (a saving of 94.9%) if the recommendations would have been followed. CONCLUSIONS: Limited diagnostic testing recommended by the LATAM Consensus for IBS can significantly decrease the economic impact of this disease in Mexico</style></abstract><notes><style face="normal" font="default" size="100%">Schmulson, Max J&#xD;Comparative Study&#xD;English Abstract&#xD;Journal Article&#xD;Chile&#xD;Rev Med Chil. 2008 Nov;136(11):1398-405. doi: 10.4067/s0034-98872008001100005.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scielo.cl/pdf/rmc/v136n11/art05.pdf</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.4067/s0034-98872008001100005</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2259</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2259</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Schmulson, Max J.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">El escrutinio diagnóstico limitado puede disminuir el impacto económico directo del síndrome de intestino irritable (SII)</style></title><secondary-title><style face="normal" font="default" size="100%">Rev. méd. Chile</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Rev. méd. Chile</style></full-title></periodical><pages><style face="normal" font="default" size="100%">1398-1405</style></pages><volume><style face="normal" font="default" size="100%">136</style></volume><number><style face="normal" font="default" size="100%">11</style></number><keywords><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Direct Service Costs/statistics &amp;amp</style></keyword><keyword><style face="normal" font="default" size="100%">amp</style></keyword><keyword><style face="normal" font="default" size="100%">numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Health Expenditures/statistics &amp;amp</style></keyword><keyword><style face="normal" font="default" size="100%">amp</style></keyword><keyword><style face="normal" font="default" size="100%">numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Irritable Bowel Syndrome/economics</style></keyword><keyword><style face="normal" font="default" size="100%">Consensus</style></keyword><keyword><style face="normal" font="default" size="100%">Diagnostic Techniques, Digestive System/economics</style></keyword><keyword><style face="normal" font="default" size="100%">Irritable Bowel Syndrome/diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">Mexico</style></keyword><keyword><style face="normal" font="default" size="100%">Practice Guidelines as Topic</style></keyword><keyword><style face="normal" font="default" size="100%">Unnecessary Procedures/economics</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2008</style></year><pub-dates><date><style face="normal" font="default" size="100%">2008/11</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0034-9887</style></isbn><abstract><style face="normal" font="default" size="100%">Background: The economic impact of irritable bowel syndrome (IBS) in México in terms of excessive diagnostic testing can be considerably reduced if the recommendations of the Latín American Consensus (LATAM) for IBS are followed. Aim: To estímate the economic impact of IBS in terms of excessive diagnostic testing. Material and Methods: Based on a previously published study the costs of diagnostic testing for IBS were compared to the theoretical costs according to the recommendations of the consensus. These costs were compared to estímate the economic impact of excessive diagnostic testing. A cost-minimization analysis was also done. Results: For the lowest socioeconomic level in academic medicine, the excessive diagnostic testing had an approximate cost of US$21.38, compared to US$1.72 if the LATAM Consensus recommendations would have been followed, representing a saving of 92.0 percent. The cost for the highest socioeconomic level in academic medicine was US$1080.36 versus US$103.60 (a saving of 90.4 percent) and for prívate medicine, the costs were US$3121.60 versus US$159.90 (a saving of 94.9 percent) if the recommendations would have been followed. Conclusions: Limited diagnostic testing recommended by the LATAM Consensus for IBS can significantly decrease the economic impact of this disease in México.</style></abstract><label><style face="normal" font="default" size="100%">Included by Hannah</style></label><urls><related-urls><url><style face="normal" font="default" size="100%">http://www.scielo.cl/scielo.php?script=sci_arttext&amp;amp;pid=S0034-98872008001100005</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2260</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2260</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Seigneurin, A.</style></author><author><style face="normal" font="default" size="100%">Labarère, J.</style></author><author><style face="normal" font="default" size="100%">Duffy, S. W.</style></author><author><style face="normal" font="default" size="100%">Colonna, M.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">A. Seigneurin, Unité d&apos;évaluation médicale, Pavillon Taillefer, Centre Hospitalier Universitaire de Grenoble, Cs 10217, Grenoble Cedex 9, France</style></auth-address><titles><title><style face="normal" font="default" size="100%">Overdiagnosis associated with breast cancer screening: A simulation study to compare lead-time adjustment methods</style></title><secondary-title><style face="normal" font="default" size="100%">Cancer Epidemiology</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Cancer Epidemiology</style></full-title></periodical><pages><style face="normal" font="default" size="100%">1128-1135</style></pages><volume><style face="normal" font="default" size="100%">39</style></volume><number><style face="normal" font="default" size="100%">6</style></number><keywords><keyword><style face="normal" font="default" size="100%">epidermal growth factor receptor</style></keyword><keyword><style face="normal" font="default" size="100%">adenosquamous carcinoma</style></keyword><keyword><style face="normal" font="default" size="100%">adult</style></keyword><keyword><style face="normal" font="default" size="100%">advanced cancer</style></keyword><keyword><style face="normal" font="default" size="100%">aged</style></keyword><keyword><style face="normal" font="default" size="100%">article</style></keyword><keyword><style face="normal" font="default" size="100%">Asian</style></keyword><keyword><style face="normal" font="default" size="100%">cancer patient</style></keyword><keyword><style face="normal" font="default" size="100%">Caucasian</style></keyword><keyword><style face="normal" font="default" size="100%">clinical article</style></keyword><keyword><style face="normal" font="default" size="100%">exon</style></keyword><keyword><style face="normal" font="default" size="100%">female</style></keyword><keyword><style face="normal" font="default" size="100%">gene deletion</style></keyword><keyword><style face="normal" font="default" size="100%">gene mutation</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">immunohistochemistry</style></keyword><keyword><style face="normal" font="default" size="100%">large cell carcinoma</style></keyword><keyword><style face="normal" font="default" size="100%">Lebanese</style></keyword><keyword><style face="normal" font="default" size="100%">lung adenocarcinoma</style></keyword><keyword><style face="normal" font="default" size="100%">male</style></keyword><keyword><style face="normal" font="default" size="100%">metastasis</style></keyword><keyword><style face="normal" font="default" size="100%">Middle East</style></keyword><keyword><style face="normal" font="default" size="100%">non small cell lung cancer</style></keyword><keyword><style face="normal" font="default" size="100%">prevalence</style></keyword><keyword><style face="normal" font="default" size="100%">priority journal</style></keyword><keyword><style face="normal" font="default" size="100%">real time echography</style></keyword><keyword><style face="normal" font="default" size="100%">smoking</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2015</style></year></dates><isbn><style face="normal" font="default" size="100%">1877-783X&#xD;1877-7821</style></isbn><abstract><style face="normal" font="default" size="100%">Objective: Estimating overdiagnosis associated with breast cancer screening may use annual incidence rates of cancer. We simulated populations invited to screening programmes to assess two lead-time adjustment methods. Methods: Overdiagnosis estimates were computed using the compensatory drop method, which considered the decrease in incidence of cancers among older age groups no longer offered screening, and the method based on the decrease in incidence of late-stage cancers. Results: The true value of overdiagnosis was 0% in all the data sets simulated. The compensatory drop method yielded an overdiagnosis estimate of -0.1% (95% credibility interval -0.5% to 0.5%) when participation rates among the population and risk of cancers were constant. However, if participation rates increased with calendar year as well as risk of cancer with birth cohorts, the overdiagnosis estimated was 11.0% (10.5-11.6%). Using the method based on the incidence of early- and late-stage cancers, overdiagnosis estimates were 8.9% (8.5-9.3%) and 17.6% (17.4-17.9%) when participation rates and risks of cancer were constant or increased with time, respectively. Conclusion: Adjustment for lead time based on the compensatory drop method is accurate only when participation rates and risks of cancer remain constant, whereas the adjustment method based on the incidence of early- and late-stage cancers results in overestimating overdiagnosis regardless of stability of participation rates and breast cancer risk.</style></abstract><label><style face="normal" font="default" size="100%">Included by Morty</style></label><notes><style face="normal" font="default" size="100%">L605868572&#xD;2015-09-08&#xD;2015-12-31</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.embase.com/search/results?subaction=viewrecord&amp;id=L605868572&amp;from=export</style></url><url><style face="normal" font="default" size="100%">http://dx.doi.org/10.1016/j.canep.2015.08.013</style></url></related-urls></urls><custom5><style face="normal" font="default" size="100%">26341587</style></custom5><electronic-resource-num><style face="normal" font="default" size="100%">10.1016/j.canep.2015.08.013</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2261</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2261</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Sevy Court, J.</style></author><author><style face="normal" font="default" size="100%">Machado Molina, D.</style></author><author><style face="normal" font="default" size="100%">Armas Pérez, L.</style></author><author><style face="normal" font="default" size="100%">Peralta Pérez, M.</style></author><author><style face="normal" font="default" size="100%">Carreras Corzo, L.</style></author><author><style face="normal" font="default" size="100%">Sánchez de la Osa, R.</style></author><author><style face="normal" font="default" size="100%">Rosas Valladares, C.</style></author><author><style face="normal" font="default" size="100%">González Ochoa, E.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Hospital Universitario Neumológico Benéfico Jurídico, La Habana, Cuba.</style></auth-address><titles><title><style face="normal" font="default" size="100%">[An alternative for improving the diagnosis of smear-negative tuberculosis and other bronchopulmonary disorders in Cuba]</style></title><secondary-title><style face="normal" font="default" size="100%">Arch Bronconeumol</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Arch Bronconeumol</style></full-title></periodical><pages><style face="normal" font="default" size="100%">604-10</style></pages><volume><style face="normal" font="default" size="100%">44</style></volume><number><style face="normal" font="default" size="100%">11</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Ambulatory Care Facilities/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">*Bacteriological Techniques</style></keyword><keyword><style face="normal" font="default" size="100%">Bronchial Diseases/diagnosis/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Child, Preschool</style></keyword><keyword><style face="normal" font="default" size="100%">Coloring Agents</style></keyword><keyword><style face="normal" font="default" size="100%">Cuba/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Government Programs/*organization &amp; administration/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Hospitals/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Infant</style></keyword><keyword><style face="normal" font="default" size="100%">Infection Control/*organization &amp; administration/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Lung Diseases/diagnosis/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Mycobacterium tuberculosis/growth &amp; development/isolation &amp; purification</style></keyword><keyword><style face="normal" font="default" size="100%">Program Evaluation</style></keyword><keyword><style face="normal" font="default" size="100%">Sputum/microbiology</style></keyword><keyword><style face="normal" font="default" size="100%">Tuberculosis/*diagnosis/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Urban Population/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2008</style></year><pub-dates><date><style face="normal" font="default" size="100%">Nov</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0300-2896 (Print)&#xD;0300-2896</style></isbn><abstract><style face="normal" font="default" size="100%">OBJECTIVE: The diagnosis of tuberculosis in patients with negative acid-fast bacillus smears poses a challenge to both clinicians and public health authorities. In an attempt to aid diagnosis in such cases, an expert committee was established in Ciudad de La Habana, Cuba in 1995. The aim of this study was to describe the progress of the committee&apos;s work and the corresponding results for the period 1996 through 2003. PATIENTS AND METHODS: For each patient studied by the commission, we analyzed the following data: patient&apos;s residence and referring center, tentative diagnosis proposed by the attending physician, history of antibiotic treatment, and final diagnosis made by the commission. RESULTS: Of the 1703 patients studied, 84.8% were from La Habana, 48.4% were 55 years or older, and 63.8% were men. Between 2001 and 2003, 11.3% of patients were already on antituberculosis treatment when their case was studied by the commission. The corresponding percentage for 1996 through 2000 was 16.9% (P=.001). Active tuberculosis was confirmed in 43.1% of a total of 918 patients with full test results during the period 1996 through 2000 and in 52.2% of a total of 619 patients (52.2%) during the period 2001 through 2003 (P&lt; .001). Of 344 patients with suspected pulmonary tuberculosis and negative acid-fast bacillus smears between 2001 and 2003, 128 (37.2%) were diagnosed with active tuberculosis. CONCLUSIONS: These findings indicate that the work of the commission is viable, sustainable, and useful for preventing overdiagnosis and inappropriate treatment, and that it also serves an educational purpose.</style></abstract><notes><style face="normal" font="default" size="100%">Sevy Court, José&#xD;Machado Molina, Delfina&#xD;Armas Pérez, Luisa&#xD;Peralta Pérez, Mariana&#xD;Carreras Corzo, Libertad&#xD;Sánchez de la Osa, Reinaldo&#xD;Rosas Valladares, Carmen&#xD;González Ochoa, Edilberto&#xD;English Abstract&#xD;Journal Article&#xD;Spain&#xD;Arch Bronconeumol. 2008 Nov;44(11):604-10.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.sciencedirect.com/science/article/abs/pii/S0300289608750221?via%3Dihub</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2262</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2262</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Shah, D.</style></author><author><style face="normal" font="default" size="100%">Sachdev, H. P.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Evaluation of the WHO/UNICEF algorithm for integrated management of childhood illness between the age of two months to five years</style></title><secondary-title><style face="normal" font="default" size="100%">Indian Pediatr</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Indian Pediatr</style></full-title></periodical><keywords><keyword><style face="normal" font="default" size="100%">Child Health Services/organization &amp;amp</style></keyword><keyword><style face="normal" font="default" size="100%">amp</style></keyword><keyword><style face="normal" font="default" size="100%">administration</style></keyword><keyword><style face="normal" font="default" size="100%">Child, Preschool</style></keyword><keyword><style face="normal" font="default" size="100%">Community Health Services/organization &amp;amp</style></keyword><keyword><style face="normal" font="default" size="100%">amp</style></keyword><keyword><style face="normal" font="default" size="100%">administration</style></keyword><keyword><style face="normal" font="default" size="100%">Evaluation Studies as Topic</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Infant</style></keyword><keyword><style face="normal" font="default" size="100%">Infant, Newborn</style></keyword><keyword><style face="normal" font="default" size="100%">Pediatrics</style></keyword><keyword><style face="normal" font="default" size="100%">United Nations</style></keyword><keyword><style face="normal" font="default" size="100%">World Health Organization</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">1999</style></year><pub-dates><date><style face="normal" font="default" size="100%">1999/08</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0974-7559</style></isbn><abstract><style face="normal" font="default" size="100%">OBJECTIVE: To evaluate the utility of the &amp;quot;WHO/UNICEF algorithm for integrated management of childhood illness (IMCI) between the age of 2 months to 5 years. DESIGN: Prospective observational. SETTING: The Outpatient Department and Emergency Room of a medical college hospital. METHODS: 203 children presenting to Outpatient Department (n=101) or Emergency Room (n=102) were assessed and classified as per &amp;#039;IMCI&amp;#039; algorithm and treatment required was identified. A detailed evaluation with all relevant investigations was also done for these subjects. The final diagnoses made and therapies instituted on this basis served as &amp;#039;gold standard&amp;#039;. The diagnostic and therapeutic agreements between the &amp;#039;gold standard&amp;#039; and the IMCI and vertical (on the basis of primary presenting complaint) algorithms were computed. RESULTS: More than one illness was present in 135 (66.5%) of subjects as per &amp;#039;gold standard&amp;#039;. The mean (SD) numbers of morbidities as per the gold standard and IMCI- low and high malaria risks were 2.1 (1.1), 1.8 (1.0) and 2.2 (1.1), respectively. Subjects having any referral criteria as per IMCI module had a greater co-existence of illnesses (mean 2.6 vs. 1.6 illnesses per child, respectively). The referral criteria proved useful in predicting hospitalization and a combination of hospitalization and observation; their sensitivity and specificity were 81% and 69% and 74% and 85%, respectively. IMCI algorithms covered majority (92%) of the recorded illnesses. A total agreement with IMCI (malaria low risk) was found in 129 (64%) cases while in 43 (22%) cases, there was partial agreement. Corresponding figures for vertical (split IMCI) program were 93 (46%; p&amp;amp;lt;0.001) and 41 (25%). The difference was primarily due to underdiagnoses (30%). Diagnostic discordance of IMCI algorithm and gold standard was evident for the cough category due to underdiagnosis of bronchial asthma and bronchiolitis and an overdiagnosis of pneumonia whereas the discordance for fever was due to an overdiagnosis of malaria. Identical results were found for broad treatment categories. The IMCI algorithm had a provision for preventive services of immunization (16.3% possibility of availing missed opportunities) and feeding advice. CONCLUSIONS: There is a sound scientific basis for adopting the IMCI approach since: (i) co-existence of morbidities is frequent; (ii) severe illness is assessed with good sensitivity and specificity; and (iii) the IMCI algorithm is diagnostically and therapeutically superior to the vertical disease specific algorithms. The generic IMCI algorithm needs adaptation to reflect the regional morbidity profile.</style></abstract><label><style face="normal" font="default" size="100%">Included by Eman</style></label><urls><related-urls><url><style face="normal" font="default" size="100%">http://imsear.searo.who.int/handle/123456789/6306</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2263</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2263</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Shuyi, Wang</style></author><author><style face="normal" font="default" size="100%">Weiwei, Z. H. U.</style></author><author><style face="normal" font="default" size="100%">Huixia, Yang</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Relationship between fasting plasma glucose in early pregnancy and diagnosis of gestational diabetes mellitus</style></title><secondary-title><style face="normal" font="default" size="100%">Chinese Journal of Perinatal Medicine</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Chinese Journal of Perinatal Medicine</style></full-title></periodical><pages><style face="normal" font="default" size="100%">45-50</style></pages><number><style face="normal" font="default" size="100%">12</style></number><dates><year><style face="normal" font="default" size="100%">2013</style></year><pub-dates><date><style face="normal" font="default" size="100%">2013/00</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1007-9408</style></isbn><abstract><style face="normal" font="default" size="100%">Objective To investigate the relationship between fasting plasma glucose (FPG) in early pregnancy and diagnosis of gestational diabetes mellitus (GDM) and to confirm the rationality of the new standard for GDM diagnosis in early pregnancy set by the International Association of Diabetes and Pregnancy Study Groups (IADPSG).Methods Clinical materials of 2761 pregnant women without diabetes mellitus,who accepted prenatal cares in Peking University First Hospital from April 1,2011 to December 31,2011,were collected and analyzed.The difference between FPG levels of GDM and non-GDM women was compared.According to the early pregnancy FPG level,the subjects were divided into group A (FPG＜5.1 mmol/L,n=2431) and B (FPG≥5.1 mmol/L,n=330).The incidence of GDM and pregnant outcomes of the two groups were compared with t or Chi-square test.Relationship between FPG and GDM was analyzed by Logistic regression and receiver operating characteristic curve.Results (1) Among the 2761 subjects,515 were diagnosed as GDM (18.7％) and the early pregnancy FPG level in GDM group was significantly higher than that in non-GDM group [(4.84±0.46) mmol/L vs (4.57 ± 0.35) mmol/L,t =11.924,P =0.000].In early pregnancy,the risk of GDM increased by 7.984-fold (OR=8.984,95％CI:6.605-12.220) with every 1 mmol/L increase of the FPG level.(2) The diagnostic rate of GDM during mid-and last-trimester in group A (15.2％,370/2431) was lower than that of group B (43.9％,145/330),x2 =123.976,P =0.000.(3) Receiver operating characteristic curve analysis of FPG in early pregnancy and diagnosis of GDM:The largest area under the curve was 0.718 (95％ CI:0.690-0.747).The sensitivity and specificity were 0.600 and 0.612,or 0.735 and 0.726 respectively,when 4.795 mmol/L or 4.785 mmol/L were set as the cut-off value.(4) Among the 1208 cases delivered,GDM was diagnosed in 227 cases.The cesarean section rate (54.2％,123/227) of GDM women was higher than that (39.2％,385/981) of non-GDM women (x2 =16.884,P=0.000).There were no differences in the incidences of macrosomia,neonatal hyperbilirubinemia,low birthweight infant,premature delivery,fetal growth restriction and preeclampsia between GDM and non-GDM group (all P＞0.05).The incidence of premature birth in GDM women with FPG＜ 5.1 mmol/L was lower (5.8％,10/173) than that (14.8％,8/54) of women with FPG≥5.1 mmol/L (x2=4.601,P＜0.05).The incidence of cesarean section,insulin administration,macrosomia and preeclampsia increased from low FPG group to high FPG group,however there was no statistical significances.Conclusions Diagnosing GDM with FPG≥5.1 mmol/L in early pregnancy is not recommended as over diagnosis might happen.But this cut-off value might indicate that the patient are at risk of GDM,and this population should not be ignored.</style></abstract><urls><related-urls><url><style face="normal" font="default" size="100%">http://dx.doi.org/10.3760/cma.j.issn.1007-9408.2013.01.012</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2264</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2264</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Sibai, A. M.</style></author><author><style face="normal" font="default" size="100%">Tohme, R. A.</style></author><author><style face="normal" font="default" size="100%">Saade, G. A.</style></author><author><style face="normal" font="default" size="100%">Ghanem, G.</style></author><author><style face="normal" font="default" size="100%">Alam, S.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Epidemiology &amp; Population Health, Faculty of Health Sciences, American University of Beirut, PO Box: 11-0236, Riad El Solh 1107 2020 Beirut, Lebanon.</style></auth-address><titles><title><style face="normal" font="default" size="100%">The appropriateness of use of coronary angiography in Lebanon: implications for health policy</style></title><secondary-title><style face="normal" font="default" size="100%">Health Policy Plan</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Health Policy Plan</style></full-title></periodical><pages><style face="normal" font="default" size="100%">210-7</style></pages><volume><style face="normal" font="default" size="100%">23</style></volume><number><style face="normal" font="default" size="100%">3</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Coronary Angiography/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">*Health Policy</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Interviews as Topic</style></keyword><keyword><style face="normal" font="default" size="100%">Lebanon</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Registries</style></keyword><keyword><style face="normal" font="default" size="100%">*Unnecessary Procedures</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2008</style></year><pub-dates><date><style face="normal" font="default" size="100%">May</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0268-1080 (Print)&#xD;0268-1080</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: Lebanon, characterized by a free-market health care system, has one of the highest reported per capita rates of cardiac catheterization facilities and coronary angiographies in the world. The aim of this study is to evaluate the appropriateness of performance of coronary angiography procedures in Lebanon. METHODS: Data derived from the 2004 Lebanese Interventional Coronary Registry (LICOR) included 5418 patients aged 30 years and older who had not undergone prior percutaneous coronary intervention or coronary artery bypass grafting. Appropriateness was evaluated based on the Class I indications of the ACC/AHA guidelines for coronary angiography. FINDINGS: The overall rate of appropriate procedures was 54.7% (95% CI 53.3-56.0%). Appropriateness varied significantly by gender and across administrative regions. Compared with females, males were more likely to be referred appropriately for coronary angiography (OR = 1.28, 95% CI = 1.15-1.44). Appropriateness was lowest (OR = 0.89, 95% CI = 0.71-1.12) in the region where the per capita density of cardiac catheterization labs increased by six-fold in the latter 2 years. The majority of the patients (84.3%) were not evaluated by any of the non-invasive tests prior to angiography, with only 10.8%, 4% and 1.5% of the patients referred for an exercise stress test, stress echocardiography and thallium stress tests, respectively. DISCUSSION: Findings indicate a high rate of procedures conducted without appropriate indications and a low utilization rate of pre-interventional non-invasive testing. This may be attributed to three factors: a surplus of catheterization facilities in certain regions, the insignificant cost gradient between non-invasive testing and coronary angiography, and the wide case-based reimbursement of coronary angiography, unlike non-invasive testing, by public insurance schemes.</style></abstract><notes><style face="normal" font="default" size="100%">Sibai, Abla M&#xD;Tohme, Rania A&#xD;Saade, Georges A&#xD;Ghanem, Georges&#xD;Alam, Samir&#xD;Lebanese Interventional Coronary Registry Working Group (LICOR)&#xD;Journal Article&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Health Policy Plan. 2008 May;23(3):210-7. doi: 10.1093/heapol/czn005. Epub 2008 Mar 20.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://watermark.silverchair.com/czn005.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAq8wggKrBgkqhkiG9w0BBwagggKcMIICmAIBADCCApEGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMvIIx3VR5xvHlERTRAgEQgIICYmv3Uv0tqplJyt-i5-cF4IR1O33ZOisqS4twJ1G1EdsN4BFA2F9KjT0muCJs50NQGYkh4ZuL2zSkosZXAHEKouJYpMbk_S_lu2JiEXXl1ERJ7PC56MVBnH7iNQsSBP1NcHZcIt2JFatDUixZuB6chS94uFoTbHR0gKcRSRY1HTWxYizBY1IDIt54uvZg3bqXIXk6UTRk36Wwo-Ev_K0A8GbZa5Q-eySgWkiZzHe0tK_14FDHxpshiPsd1iC2bpsUUN6a2553FhtD_RBT-nTy-HeryghziKgxZt5kchgKY_GLXdXmUvPRi1vdYvNyFiDswQ7xewrOKsRc8ghT22EdH3Y_vPVF_2jv-wDfg-ddSYR2AYeyzDMZpYvjo6YlVBGTET4EqBsiDZmEc9H6ye9cO6zmQQW1mdEAmac1NEqDVqKLc5h7WZHPYSGN12KdJOVZtRr48pbSKiyQY3baA6nJNJZ9j0lyUbqEE8DK_7tkq6d4GurTxEESdjumk1ckobieLT3s6w2UOg3--_FaAPenzEyJR7ZJ0wJ7EU5rSW9TTL-8-AHYcMSvHiDJabwanBlHqNrBloGlEwtX8YDqSfhgp_UH8lFLpqiYBLxx1kZklvaALk2w33RjLAKQrUS9MD86YfLWxX8e7Nb8auSlKoRJgyyBNtKDlKo99xG_bE4RDAtJgqNCp4qqu0Uvqypr_AV4-f4WrRkIF5no3LyHT8lHkCB65geXLVGQrX9hOLxC8fshqK4kHlxp7MjWFgzPl7zoCgHl8BijatDn8ZCUuSS44R_xC9yGSGm-Amxjh-RHO7qpGyc</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1093/heapol/czn005</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2265</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2265</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Sievers, A. C.</style></author><author><style face="normal" font="default" size="100%">Lewey, J.</style></author><author><style face="normal" font="default" size="100%">Musafiri, P.</style></author><author><style face="normal" font="default" size="100%">Franke, M. F.</style></author><author><style face="normal" font="default" size="100%">Bucyibaruta, B. J.</style></author><author><style face="normal" font="default" size="100%">Stulac, S. N.</style></author><author><style face="normal" font="default" size="100%">Rich, M. L.</style></author><author><style face="normal" font="default" size="100%">Karema, C.</style></author><author><style face="normal" font="default" size="100%">Daily, J. P.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Brigham and Women&apos;s Hospital, Harvard Medical School, Boston, MA, USA.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Reduced paediatric hospitalizations for malaria and febrile illness patterns following implementation of a community-based malaria control programme in rural Rwanda</style></title><secondary-title><style face="normal" font="default" size="100%">World Hosp Health Serv</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">World Hosp Health Serv</style></full-title></periodical><pages><style face="normal" font="default" size="100%">28-35</style></pages><volume><style face="normal" font="default" size="100%">44</style></volume><number><style face="normal" font="default" size="100%">4</style></number><dates><year><style face="normal" font="default" size="100%">2008</style></year></dates><isbn><style face="normal" font="default" size="100%">1029-0540 (Print)&#xD;1029-0540</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: Malaria control is currently receiving significant international commitment. As part of this commitment, Rwanda has undertaken a two-pronged approach to combating malaria via mass distribution of long-lasting insecticidal-treated nets and distribution of antimalarial medications by community health workers. This study attempted to measure the impact of these interventions on paediatric hospitalizations for malaria and on laboratory markers of disease severity. METHODS: A retrospective analysis of hospital records pre- and post-community-based malaria control interventions at a district hospital in rural Rwanda was performed. The interventions took place in August 2006 in the region served by the hospital and consisted of mass insecticide treated net distribution and community health workers antimalarial medication disbursement. The study periods consisted of the December-February high transmission seasons pre- and post-rollout. The record review examined a total of 551 paediatric admissions to identify 1) laboratory-confirmed malaria, defined by thick smear examination, 2) suspected malaria, defined as fever and symptoms consistent with malaria in the absence of an alternate cause, and 3) all-cause admissions. To define the impact of the intervention on clinical markers of malaria disease, trends in admission peripheral parasitaemia and haemoglobin were analyzed. To define accuracy of clinical diagnoses, trends in proportions of malaria admissions which were microscopy-confirmed before and after the intervention were examined. Finally, to assess overall management of febrile illnesses antibiotic use was described. RESULTS: Of the 551 total admissions, 268 (48.6%) and 437 (79.3%) were attributable to laboratory confirmed and suspected malaria, respectively. The absolute number of admissions due to suspected malaria was smaller during the post-intervention period (N = 150) relative to the pre-intervention period (N = 287), in spite of an increase in the absolute number of hospitalizations due to other causes during the post-intervention period. The percentage of suspected malaria admissions that were laboratory-confirmed was greater during the pre-intervention period (80.4%) relative to the post-intervention period (48.1%, prevalence ratio [PR]: 1.67; 95% CI: 1.39-2.02; chi-squared p-value &lt; 0.0001). Among children admitted with laboratory-confirmed malaria, the risk of high parasitaemia was higher during the pre-intervention period relative to the post-intervention period (age-adjusted PR: 1.62; 95% CI: 1.11-2.38; chi-squared p-value = 0.004), and the risk of severe anaemia was more than twofold greater during the prei-ntervention period (age-adjusted PR: 2.47; 95% CI: 0.84-7.24; chi-squared p-value = 0.08). Antibiotic use was common, with 70.7% of all children with clinical malaria and 86.4% of children with slide-negative malaria receiving antibacterial therapy. CONCLUSION: This study suggests that both admissions for malaria and laboratory markers of clinical disease among children may be rapidly reduced following community-based malaria control efforts. Additionally, this study highlights the problem of over-diagnosis and over-treatment of malaria in malaria-endemic regions, especially as malaria prevalence falls. More accurate diagnosis and management of febrile illnesses is critically needed both now and as fever aetiologies change with further reductions in malaria.</style></abstract><notes><style face="normal" font="default" size="100%">Sievers, Amy C&#xD;Lewey, Jenifer&#xD;Musafiri, Placide&#xD;Franke, Molly F&#xD;Bucyibaruta, Blaise J&#xD;Stulac, Sara N&#xD;Rich, Michael L&#xD;Karema, Corine&#xD;Daily, Johanna P&#xD;Journal Article&#xD;England&#xD;World Hosp Health Serv. 2008;44(4):28-35.</style></notes><urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2266</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2266</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Sievers, A. C.</style></author><author><style face="normal" font="default" size="100%">Lewey, J.</style></author><author><style face="normal" font="default" size="100%">Musafiri, P.</style></author><author><style face="normal" font="default" size="100%">Franke, M. F.</style></author><author><style face="normal" font="default" size="100%">Bucyibaruta, B. J.</style></author><author><style face="normal" font="default" size="100%">Stulac, S. N.</style></author><author><style face="normal" font="default" size="100%">Rich, M. L.</style></author><author><style face="normal" font="default" size="100%">Karema, C.</style></author><author><style face="normal" font="default" size="100%">Daily, J. P.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Brigham and Women&apos;s Hospital, Harvard Medical School, Boston, MA, USA. asievers@partners.org</style></auth-address><titles><title><style face="normal" font="default" size="100%">Reduced paediatric hospitalizations for malaria and febrile illness patterns following implementation of community-based malaria control programme in rural Rwanda</style></title><secondary-title><style face="normal" font="default" size="100%">Malar J</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Malar J</style></full-title></periodical><pages><style face="normal" font="default" size="100%">167</style></pages><volume><style face="normal" font="default" size="100%">7</style></volume><keywords><keyword><style face="normal" font="default" size="100%">Anemia/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Antimalarials/therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Child, Preschool</style></keyword><keyword><style face="normal" font="default" size="100%">Communicable Disease Control/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Hospitalization/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Infant</style></keyword><keyword><style face="normal" font="default" size="100%">Infant, Newborn</style></keyword><keyword><style face="normal" font="default" size="100%">Malaria/drug therapy/*epidemiology/*prevention &amp; control</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mosquito Control/methods</style></keyword><keyword><style face="normal" font="default" size="100%">Parasitemia/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Protective Devices/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Retrospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Rural Population</style></keyword><keyword><style face="normal" font="default" size="100%">Rwanda/epidemiology</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2008</style></year><pub-dates><date><style face="normal" font="default" size="100%">Aug 27</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1475-2875</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: Malaria control is currently receiving significant international commitment. As part of this commitment, Rwanda has undertaken a two-pronged approach to combating malaria via mass distribution of long-lasting insecticidal-treated nets and distribution of antimalarial medications by community health workers. This study attempted to measure the impact of these interventions on paediatric hospitalizations for malaria and on laboratory markers of disease severity. METHODS: A retrospective analysis of hospital records pre- and post-community-based malaria control interventions at a district hospital in rural Rwanda was performed. The interventions took place in August 2006 in the region served by the hospital and consisted of mass insecticide treated net distribution and community health workers antimalarial medication disbursement. The study periods consisted of the December-February high transmission seasons pre- and post-rollout. The record review examined a total of 551 paediatric admissions to identify 1) laboratory-confirmed malaria, defined by thick smear examination, 2) suspected malaria, defined as fever and symptoms consistent with malaria in the absence of an alternate cause, and 3) all-cause admissions. To define the impact of the intervention on clinical markers of malaria disease, trends in admission peripheral parasitaemia and haemoglobin were analyzed. To define accuracy of clinical diagnoses, trends in proportions of malaria admissions which were microscopy-confirmed before and after the intervention were examined. Finally, to assess overall management of febrile illnesses antibiotic use was described. RESULTS: Of the 551 total admissions, 268 (48.6%) and 437 (79.3%) were attributable to laboratory-confirmed and suspected malaria, respectively. The absolute number of admissions due to suspected malaria was smaller during the post-intervention period (N = 150) relative to the pre-intervention period (N = 287), in spite of an increase in the absolute number of hospitalizations due to other causes during the post-intervention period. The percentage of suspected malaria admissions that were laboratory-confirmed was greater during the pre-intervention period (80.4%) relative to the post-intervention period (48.1%, prevalence ratio [PR]: 1.67; 95% CI: 1.39 - 2.02; chi-squared p-value &lt; 0.0001). Among children admitted with laboratory-confirmed malaria, the risk of high parasitaemia was higher during the pre-intervention period relative to the post-intervention period (age-adjusted PR: 1.62; 95% CI: 1.11 - 2.38; chi-squared p-value = 0.004), and the risk of severe anaemia was more than twofold greater during the pre-intervention period (age-adjusted PR: 2.47; 95% CI: 0.84 - 7.24; chi-squared p-value = 0.08). Antibiotic use was common, with 70.7% of all children with clinical malaria and 86.4% of children with slide-negative malaria receiving antibacterial therapy. CONCLUSION: This study suggests that both admissions for malaria and laboratory markers of clinical disease among children may be rapidly reduced following community-based malaria control efforts. Additionally, this study highlights the problem of over-diagnosis and over-treatment of malaria in malaria-endemic regions, especially as malaria prevalence falls. More accurate diagnosis and management of febrile illnesses is critically needed both now and as fever aetiologies change with further reductions in malaria.</style></abstract><label><style face="normal" font="default" size="100%">Included by Loai</style></label><notes><style face="normal" font="default" size="100%">1475-2875&#xD;Sievers, Amy C&#xD;Lewey, Jenifer&#xD;Musafiri, Placide&#xD;Franke, Molly F&#xD;Bucyibaruta, Blaise J&#xD;Stulac, Sara N&#xD;Rich, Michael L&#xD;Karema, Corine&#xD;Daily, Johanna P&#xD;Journal Article&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Malar J. 2008 Aug 27;7:167. doi: 10.1186/1475-2875-7-167.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2557016/pdf/1475-2875-7-167.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC2557016</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1186/1475-2875-7-167</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2267</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2267</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Silva, Henrique Soares</style></author><author><style face="normal" font="default" size="100%">Oliveira, Fernanda Kelly Fraga</style></author><author><style face="normal" font="default" size="100%">Prado, Lourivania Oliveira Melo</style></author><author><style face="normal" font="default" size="100%">Almeida-Santos, Marcos</style></author><author><style face="normal" font="default" size="100%">Reis, Francisco Prado</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Abdominal Computed Tomography in the Emergency Room: Overuse of Medical Technologies and the Depreciation of Clinical Diagnosis</style></title><secondary-title><style face="normal" font="default" size="100%">Rev. bras. educ. méd</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Rev. bras. educ. méd</style></full-title></periodical><pages><style face="normal" font="default" size="100%">498-504</style></pages><volume><style face="normal" font="default" size="100%">43</style></volume><number><style face="normal" font="default" size="100%">1,supl.1</style></number><dates><year><style face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style face="normal" font="default" size="100%">2019/00</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0100-5502</style></isbn><abstract><style face="normal" font="default" size="100%">ABSTRACT The number of computed tomography (CT) examinations performed in urgent care has been increasing since its introduction in the emergency room (ER). This has led to a substantial increase in hospital costs and patient&amp;#039;s exposure to ionizing radiation, which has led to the need for more judicious use of CT in the ER. The aim of this study is to show the difference between clinical (pre-CT), tomographic (post-CT) and definitive diagnoses in patients with abdominal CT in the ER. This is a cross-sectional study, with retrospective data collection through electronic medical records. A total of 834 patients with acute abdominal pain (AAP) lasting less than 7 days, submitted to abdominal computed tomography between January 1, 2016 and December 31, 2017 were selected. Clinical, tomographic and final diagnoses were recorded and submitted to a concordance analysis by calculating the Kappa coefficient, considering p &amp;amp;lt;0.05 as significant. CT scans were considered unnecessary when the clinical diagnosis was concordant when both final and post-CT diagnosis were also concordant. The most frequent diagnoses were nonspecific abdominal pain (NSAP), obstructive uropathy (OU) and appendicitis (AP), corresponding to 73.6%, 58.5% and 61.3% of all diagnoses, respectively. Data analysis showed a moderate Concordance for NSAP (kappa: 0.41, p ¬&amp;amp;lt;0.001) and for OU (kappa: 0.46, p &amp;amp;lt;0.001) and excellent for AP (kappa:0.87, p &amp;amp;lt;0.001). In total, 52.6% of computed tomography were considered unnecessary for NSAP, 82.4% for OU and 91.7% for AP. It was concluded that there are high rates of CT that may be considered unnecessary for the diagnosis of the main emergency conditions, especially appendicitis. The study warns to the exaggerated use of CT in the ER and raise discussions over the possible causes, such as lack of confidence in the clinical diagnosis, fear of diagnostic errors and fear of malpractice lawsuits, of which possible solutions may be more effective when applied since the medical education basis.&#xD;RESUMO O número de tomografias computadorizadas (TC) realizadas de urgência tem aumentado cada vez mais desde a introdução desse recurso nos pronto-atendimentos (PA). Isso levou ao aumento substancial dos custos hospitalares e da exposição dos pacientes à radiação ionizante, o que tem despertado a necessidade do uso mais criterioso da TC no PA. O objetivo deste estudo é mostrar a relação entre os diagnósticos clínico, tomográfico e definitivo em pacientes com dor abdominal aguda não traumática como forma de evidenciar situações nas quais o uso da TC de abdome no PA possa ser considerado dispensável. Trata-se de um estudo transversal, com coleta retrospectiva de dados em prontuário eletrônico. Foram selecionados 834 prontuários de pacientes com dor abdominal aguda (DAA) com menos de sete dias de duração até o atendimento inicial, submetidos à TC de abdome de urgência entre 1º de janeiro de 2016 e 31 de dezembro de 2017. Os diagnósticos clínicos (pré-TC), tomográficos (pós-TC) e finais foram registrados e submetidos à análise de concordância por meio do cálculo do coeficiente Kappa (K), adotando-se p &amp;amp;lt; 0,05 como significativo. As TC foram avaliadas como desnecessárias quando o diagnóstico clínico foi concordante com as situações em que o diagnóstico final e pós-TC foram também o mesmo. Os diagnósticos mais frequentes foram dor abdominal inespecífica (DAI), uropatia obstrutiva (UO) e apendicite (AP), que correspondem a 73,6% de todos os diagnósticos clínicos, 58,5% dos diagnósticos pós-TC e 61,3% dos diagnósticos finais. Os resultados mostraram concordância moderada para DAI (Kappa = 0,41; p &amp;amp;lt; 0,001) e para UO (Kappa = 0,46; p &amp;amp;lt; 0,001) e excelente para AP (Kappa = 0,87; p &amp;amp;lt; 0,001). Foram consideradas desnecessárias 52,6% das TC realizadas em pacientes com diagnóstico de DAI, 82,4% dos pacientes com UO e 91,7% daqueles com diagnóstico final de AP. Conclui-se que há altas taxas de TC que podem ser entendidas como desnecessárias para o diagnóstico das principais condições de urgência encontradas, especialmente AP. O estudo alerta para a utilização exagerada da TC no PA e faz uma reflexão sobre possíveis causas, como falta de confiança no diagnóstico clínico, medo de erros médicos e processos judiciais, cujas soluções possíveis podem ser mais eficazes se adotadas ainda na base da formação médica.</style></abstract><urls><related-urls><url><style face="normal" font="default" size="100%">http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S0100-55022019000500498</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2268</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2268</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Simsek, A.</style></author><author><style face="normal" font="default" size="100%">Kirecci, S. L.</style></author><author><style face="normal" font="default" size="100%">Bayar, G.</style></author><author><style face="normal" font="default" size="100%">Horasanli, K.</style></author><author><style face="normal" font="default" size="100%">Ozgor, F.</style></author><author><style face="normal" font="default" size="100%">Gurbuz, Z. G.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">A. Simsek, Bakirkoy Sadi Konuk Research and Training Hospital, Department of Urology, Tevfik Saglam Cad. NO:11 Bakirkoy, Zuhuratbaba, Istanbul, Turkey</style></auth-address><titles><title><style face="normal" font="default" size="100%">Evaluation of per-operative cough stress test during transobturator mid-urethral sling surgery</style></title><secondary-title><style face="normal" font="default" size="100%">Archivio Italiano di Urologia e Andrologia</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Archivio Italiano di Urologia e Andrologia</style></full-title></periodical><pages><style face="normal" font="default" size="100%">222-225</style></pages><volume><style face="normal" font="default" size="100%">89</style></volume><number><style face="normal" font="default" size="100%">3</style></number><keywords><keyword><style face="normal" font="default" size="100%">transobturator tape</style></keyword><keyword><style face="normal" font="default" size="100%">adult</style></keyword><keyword><style face="normal" font="default" size="100%">article</style></keyword><keyword><style face="normal" font="default" size="100%">bladder catheterization</style></keyword><keyword><style face="normal" font="default" size="100%">controlled study</style></keyword><keyword><style face="normal" font="default" size="100%">cough stress test</style></keyword><keyword><style face="normal" font="default" size="100%">erosion</style></keyword><keyword><style face="normal" font="default" size="100%">female</style></keyword><keyword><style face="normal" font="default" size="100%">function test</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">inguinal pain</style></keyword><keyword><style face="normal" font="default" size="100%">leg pain</style></keyword><keyword><style face="normal" font="default" size="100%">length of stay</style></keyword><keyword><style face="normal" font="default" size="100%">major clinical study</style></keyword><keyword><style face="normal" font="default" size="100%">operation duration</style></keyword><keyword><style face="normal" font="default" size="100%">patient satisfaction</style></keyword><keyword><style face="normal" font="default" size="100%">peroperative care</style></keyword><keyword><style face="normal" font="default" size="100%">postoperative complication</style></keyword><keyword><style face="normal" font="default" size="100%">postoperative pain</style></keyword><keyword><style face="normal" font="default" size="100%">prospective study</style></keyword><keyword><style face="normal" font="default" size="100%">quality of life</style></keyword><keyword><style face="normal" font="default" size="100%">randomized controlled trial</style></keyword><keyword><style face="normal" font="default" size="100%">stress incontinence</style></keyword><keyword><style face="normal" font="default" size="100%">tension</style></keyword><keyword><style face="normal" font="default" size="100%">transobturator tape procedure</style></keyword><keyword><style face="normal" font="default" size="100%">urine retention</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2017</style></year></dates><isbn><style face="normal" font="default" size="100%">2282-4197&#xD;1124-3562</style></isbn><abstract><style face="normal" font="default" size="100%">This study has been presented in EAU 2015 Meeting in Madrid. Purpose: Currently, it is unclear how the mesh tension should be adjusted on the transobturator tape surgery (TOT) for improving continence. The aim of this study was to evaluate the effects of per-operative cough stress test on TOT. Materials and methods: Between March 2007 and December 2011, 206 women with SUI were enrolled in this study. Patients were randomly categorized to treatment with TOT (96) or TOT with cough stress test (110). The IIQ-7 and the UDI-6 were used to identify satisfaction level. At the end of 1st year, two groups were compared patient characteristics, operation time, duration of hospital stay, cure and complication rates. Results: The cure rate was 84.37% 81/96) versus 83.63% (92/110) in TOT and TOT with cough test groups, respectively. Postoperatively ten patient (10/110, 9.09%) suffered voiding difficulties (&gt; 250 ml residual urine) in TOT with cough stress test group. Five patients were discharged with transurethral catheter, whereas, in traditional TOT group, two patients (2/96, 2.1%) had transient postoperative voiding difficulty and two patients were treated with repeated catheterization for 1 week (p &lt; 0.05). Postoperative groin pain was present in 7/96 (8%) versus 24/110 (22%) in TOT and TOT with cough test groups, respectively (p &lt; 0.05). TOT with cough stress test group had an higher rate of complications like, retention of urine, necessitating to cut the tape, mesh erosion and pain in groin or leg. No patient had resistant voiding difficulty or prolonged urinary retention (&gt; 1 week) in traditional TOT group. Conclusions: We believe that per-operative cough stress test leads to overtreatment of stress urinary incontinence when the complication rates were considered.</style></abstract><notes><style face="normal" font="default" size="100%">L619708911&#xD;2017-12-19&#xD;2017-12-28</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.embase.com/search/results?subaction=viewrecord&amp;id=L619708911&amp;from=export</style></url><url><style face="normal" font="default" size="100%">http://dx.doi.org/10.4081/aiua.2017.3.222</style></url><url><style face="normal" font="default" size="100%">https://www.pagepressjournals.org/index.php/aiua/article/download/aiua.2017.3.222/6729</style></url></related-urls></urls><custom5><style face="normal" font="default" size="100%">28969408</style></custom5><electronic-resource-num><style face="normal" font="default" size="100%">10.4081/aiua.2017.3.222</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2269</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2269</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Skarbinski, J.</style></author><author><style face="normal" font="default" size="100%">Ouma, P. O.</style></author><author><style face="normal" font="default" size="100%">Causer, L. M.</style></author><author><style face="normal" font="default" size="100%">Kariuki, S. K.</style></author><author><style face="normal" font="default" size="100%">Barnwell, J. W.</style></author><author><style face="normal" font="default" size="100%">Alaii, J. A.</style></author><author><style face="normal" font="default" size="100%">de Oliveira, A. M.</style></author><author><style face="normal" font="default" size="100%">Zurovac, D.</style></author><author><style face="normal" font="default" size="100%">Larson, B. A.</style></author><author><style face="normal" font="default" size="100%">Snow, R. W.</style></author><author><style face="normal" font="default" size="100%">Rowe, A. K.</style></author><author><style face="normal" font="default" size="100%">Laserson, K. F.</style></author><author><style face="normal" font="default" size="100%">Akhwale, W. S.</style></author><author><style face="normal" font="default" size="100%">Slutsker, L.</style></author><author><style face="normal" font="default" size="100%">Hamel, M. J.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Malaria Branch, US Centers for Disease Control and Prevention, Atlanta, Georgia 30341-3724, USA. jskarbinski@cdc.gov</style></auth-address><titles><title><style face="normal" font="default" size="100%">Effect of malaria rapid diagnostic tests on the management of uncomplicated malaria with artemether-lumefantrine in Kenya: a cluster randomized trial</style></title><secondary-title><style face="normal" font="default" size="100%">Am J Trop Med Hyg</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Am J Trop Med Hyg</style></full-title></periodical><pages><style face="normal" font="default" size="100%">919-26</style></pages><volume><style face="normal" font="default" size="100%">80</style></volume><number><style face="normal" font="default" size="100%">6</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Antimalarials/administration &amp; dosage/*therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Artemether, Lumefantrine Drug Combination</style></keyword><keyword><style face="normal" font="default" size="100%">Artemisinins/administration &amp; dosage/*therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Drug Combinations</style></keyword><keyword><style face="normal" font="default" size="100%">Ethanolamines/administration &amp; dosage/*therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Fluorenes/administration &amp; dosage/*therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Kenya/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Malaria/*diagnosis/*drug therapy/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">*Reagent Kits, Diagnostic/economics</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2009</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jun</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0002-9637</style></isbn><abstract><style face="normal" font="default" size="100%">Shortly after Kenya introduced artemether-lumefantrine (AL) for first-line treatment of uncomplicated malaria, we conducted a pre-post cluster randomized controlled trial to assess the effect of providing malaria rapid diagnostic tests (RDTs) on recommended treatment (patients with malaria prescribed AL) and overtreatment (patients without malaria prescribed AL) in outpatients &gt;/= 5 years old. Sixty health facilities were randomized to receive either RDTs plus training, guidelines, and supervision (TGS) or TGS alone. Of 1,540 patients included in the analysis, 7% had uncomplicated malaria. The provision of RDTs coupled with TGS emphasizing AL use only after laboratory confirmation of malaria reduced recommended treatment by 63%-points (P = 0.04), because diagnostic test use did not change (-2%-points), but health workers significantly reduced presumptive treatment with AL for patients with a clinical diagnosis of malaria who did not undergo testing (-36%-points; P = 0.03). Health workers generally adhered to RDT results when prescribing AL: 88% of RDT-positive and 9% of RDT-negative patients were treated with AL, respectively. Overtreatment was low in both arms and was not significantly reduced by the provision of RDTs (-12%-points, P = 0.30). RDTs could potentially improve malaria case management, but we urgently need to develop more effective strategies for implementing guidelines before large scale implementation.</style></abstract><label><style face="normal" font="default" size="100%">Included by Loai</style></label><notes><style face="normal" font="default" size="100%">1476-1645&#xD;Skarbinski, Jacek&#xD;Ouma, Peter O&#xD;Causer, Louise M&#xD;Kariuki, Simon K&#xD;Barnwell, John W&#xD;Alaii, Jane A&#xD;de Oliveira, Alexandre Macedo&#xD;Zurovac, Dejan&#xD;Larson, Bruce A&#xD;Snow, Robert W&#xD;Rowe, Alexander K&#xD;Laserson, Kayla F&#xD;Akhwale, Willis S&#xD;Slutsker, Laurence&#xD;Hamel, Mary J&#xD;079080/Wellcome Trust/United Kingdom&#xD;GH99-005/GH/CGH CDC HHS/United States&#xD;Journal Article&#xD;Randomized Controlled Trial&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, P.H.S.&#xD;United States&#xD;Am J Trop Med Hyg. 2009 Jun;80(6):919-26.</style></notes><urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2270</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2270</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">A. Elgayoum SM</style></author><author><style face="normal" font="default" size="100%">El-Feki Ael, K.</style></author><author><style face="normal" font="default" size="100%">Mahgoub, B. A.</style></author><author><style face="normal" font="default" size="100%">El-Rayah el, A.</style></author><author><style face="normal" font="default" size="100%">Giha, H. A.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Faculty of Science, Department of Zoology, University of Khartoum, P.O. Box 321, Khartoum, Sudan 11111.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Malaria overdiagnosis and burden of malaria misdiagnosis in the suburbs of central Sudan: special emphasis on artemisinin-based combination therapy era</style></title><secondary-title><style face="normal" font="default" size="100%">Diagn Microbiol Infect Dis</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Diagn Microbiol Infect Dis</style></full-title></periodical><pages><style face="normal" font="default" size="100%">20-6</style></pages><volume><style face="normal" font="default" size="100%">64</style></volume><number><style face="normal" font="default" size="100%">1</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Antimalarials/economics/*therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Artemisinins/economics/*therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Blood/parasitology</style></keyword><keyword><style face="normal" font="default" size="100%">Diagnostic Errors/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Drug Therapy, Combination</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">*Health Services Research</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Lactones/economics/*therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Malaria/*diagnosis/drug therapy/economics</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Microscopy</style></keyword><keyword><style face="normal" font="default" size="100%">Retrospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Sudan</style></keyword><keyword><style face="normal" font="default" size="100%">Urban Population</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2009</style></year><pub-dates><date><style face="normal" font="default" size="100%">May</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0732-8893</style></isbn><abstract><style face="normal" font="default" size="100%">Accuracy of diagnosis is central for malaria control. Although microscopy is gold standard in malaria diagnosis, its reliability is largely dependent on user skill. In this study, we evaluated practitioners&apos; clinical and microscopists&apos; technical skills in diagnosis of malaria in central Sudan. In a retrospective study, 3203 blood smears from 95 peripheral health facilities (each represented by a general practitioner [GP] and general microscopist [GM]) were reexamined by expert microscopist. Furthermore, in a prospective study, 410 patients had their malaria diagnosis rechecked by rapid diagnostic test for validation of the microscopic diagnosis. Results showed that the rate of false-positive diagnosis of malaria was 75.6% and false-negative diagnosis was 0.01%. The study disclosed poor skills of the GPs and GMs in malaria diagnosis because 43% of the GPs and 44% of the GMs failed to make a single true-positive malaria diagnosis. The false-positive malaria diagnosis showed bias toward adult females. Economically, the calculated cost of diagnosis and treatment of malaria in Sudan in year 2000 is US$100 million, whereas the calculated cost of true malaria is approximately US$14 million. In conclusion, malaria overdiagnosis was widely recognized in central Sudan, with high economic burden during the era of artemisinin-based combination therapy. Finally, different scenarios were suggested for improvement of malaria diagnosis.</style></abstract><notes><style face="normal" font="default" size="100%">1879-0070&#xD;A-Elgayoum, Salwa M E&#xD;El-Feki, Abd El-Karim Ahmed&#xD;Mahgoub, Babiker Ahmed&#xD;El-Rayah, El-Amin&#xD;Giha, Hayder A&#xD;Journal Article&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Diagn Microbiol Infect Dis. 2009 May;64(1):20-6. doi: 10.1016/j.diagmicrobio.2009.01.029.</style></notes><urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1016/j.diagmicrobio.2009.01.029</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2271</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2271</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Smith, J. E.</style></author><author><style face="normal" font="default" size="100%">Midwinter, M.</style></author><author><style face="normal" font="default" size="100%">Lambert, A. W.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Academic Department of Military Emergency Medicine, Royal Centre for Defence Medicine, Birmingham, UK. jasonesmith@doctors.org.uk</style></auth-address><titles><title><style face="normal" font="default" size="100%">Avoiding cavity surgery in penetrating torso trauma: the role of the computed tomography scan</style></title><secondary-title><style face="normal" font="default" size="100%">Ann R Coll Surg Engl</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Ann R Coll Surg Engl</style></full-title></periodical><pages><style face="normal" font="default" size="100%">486-8</style></pages><volume><style face="normal" font="default" size="100%">92</style></volume><number><style face="normal" font="default" size="100%">6</style></number><keywords><keyword><style face="normal" font="default" size="100%">Afghan Campaign 2001-</style></keyword><keyword><style face="normal" font="default" size="100%">Decision Making</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">*Military Personnel</style></keyword><keyword><style face="normal" font="default" size="100%">Thoracic Injuries/*diagnostic imaging/surgery</style></keyword><keyword><style face="normal" font="default" size="100%">*Tomography, X-Ray Computed</style></keyword><keyword><style face="normal" font="default" size="100%">Unnecessary Procedures</style></keyword><keyword><style face="normal" font="default" size="100%">Wounds, Gunshot/diagnostic imaging/surgery</style></keyword><keyword><style face="normal" font="default" size="100%">Wounds, Penetrating/*diagnostic imaging/surgery</style></keyword><keyword><style face="normal" font="default" size="100%">Wounds, Stab/diagnostic imaging/surgery</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2010</style></year><pub-dates><date><style face="normal" font="default" size="100%">Sep</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0035-8843 (Print)&#xD;0035-8843</style></isbn><abstract><style face="normal" font="default" size="100%">INTRODUCTION: Surgical decision-making in torso trauma is complex. This paper looks at the role of the computed tomography (CT) scan in this decision-making process. PATIENTS AND METHODS: Patients with significant torso trauma (high velocity gunshot wound [HVGSW], blast, stab) admitted to a military role 2 (enhanced) hospital facility during a 7-week period of Operation HERRICK 9 (Afghanistan, October to November 2008) are reported. The management of those patients undergoing a CT scan as part of the decision-making process at the time of admission is discussed. RESULTS: Twenty eight patients with significant torso trauma were admitted to the facility during the study period; HVGSW (n = 15), blast (n = 9), stab (n = 4). Thirteen patients underwent a CT scan as part of the surgical decision-making process; HVGSW (n = 5), blast (n = 8). Imaging confirmed torso integrity in 12 patients, one of whom subsequently had a laparotomy for vascular control for on-table haemorrhage during lower limb surgery. One patient had a confirmed thoraco-abdominal injury, which was treated conservatively with tube thoracostomy and &apos;active observation&apos;. CONCLUSIONS: A CT scan formed part of the surgical decision-making process in about half of the patients admitted with significant torso trauma, and helped prevent unnecessary laparotomy in this forward military environment. Those patients with a blast injury were more likely to undergo CT scanning than those where the mechanism of injury was a HVGSW.</style></abstract><notes><style face="normal" font="default" size="100%">1478-7083&#xD;Smith, J E&#xD;Midwinter, M&#xD;Lambert, A W&#xD;Journal Article&#xD;Ann R Coll Surg Engl. 2010 Sep;92(6):486-8. doi: 10.1308/003588410X12699663903511. Epub 2010 Jun 1.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3182790/pdf/rcse9206-486.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC3182790</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1308/003588410x12699663903511</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2272</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2272</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Soares, Danielle de Sousa</style></author><author><style face="normal" font="default" size="100%">Brandão, Roberta Ribeiro Marques</style></author><author><style face="normal" font="default" size="100%">Mourão, Mirla Rossana Nogueira</style></author><author><style face="normal" font="default" size="100%">Azevedo, Vera Lucia Fernandes de</style></author><author><style face="normal" font="default" size="100%">Figueiredo, Alexandre Vieira</style></author><author><style face="normal" font="default" size="100%">Trindade, Eliomar Santana</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Relevância de exames de rotina em pacientes de baixo risco submetidos a cirurgias de pequeno e médio porte</style></title><secondary-title><style face="normal" font="default" size="100%">Rev. bras. anestesiol</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Rev. bras. anestesiol</style></full-title></periodical><pages><style face="normal" font="default" size="100%">197-201</style></pages><volume><style face="normal" font="default" size="100%">63</style></volume><number><style face="normal" font="default" size="100%">2</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Child, Preschool</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Infant</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Diagnostic Tests, Routine</style></keyword><keyword><style face="normal" font="default" size="100%">Elective Surgical Procedures</style></keyword><keyword><style face="normal" font="default" size="100%">Minor Surgical Procedures</style></keyword><keyword><style face="normal" font="default" size="100%">Preoperative Care</style></keyword><keyword><style face="normal" font="default" size="100%">Cross-Sectional Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Prospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Assessment</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2013</style></year><pub-dates><date><style face="normal" font="default" size="100%">2013/04</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0034-7094</style></isbn><abstract><style face="normal" font="default" size="100%">JUSTIFICATIVA E OBJETIVOS: A avaliação pré-operatória tem como objetivos diminuir a morbimortalidade do paciente cirúrgico, o custo do atendimento perioperatório e a ansiedade pré-operatória. A partir da avaliação clínica deve-se definir a necessidade de exames complementares e estratégias para reduzir o risco anestésico-cirúrgico. O objetivo deste trabalho foi avaliar o benefício de exames de rotina pré-operatório de pacientes de baixo risco em cirurgias de pequeno e médio porte. MÉTODOS: Trata-se de um estudo descritivo, transversal, com 800 pacientes atendidos no consultório de avaliação pré-anestésica do Hospital Santo Antonio, Salvador, BA. Foram incluídos pacientes de 1 a 45 anos, estado físico ASA I, que seriam submetidos a cirurgias eletivas de pequeno e médio porte. Avaliaram-se alterações no hemograma, coagulograma, eletrocardiograma, RX de tórax, glicemia, função renal e dosagem de sódio e potássio e as eventuais mudanças de conduta que ocorreram decorrentes dessas alterações. RESULTADOS: Dos 800 pacientes avaliados, 97,5% fizeram hemograma, 89% coagulograma, 74,1% eletrocardiograma, 62% RX de tórax, 68% glicemia de jejum, 55,7% dosagens séricas de ureia e creatinina e 10,1% dosagens de sódio e potássio séricos. Desses 700 pacientes, 68 (9,71%) apresentaram alteração nos exames pré-operatórios de rotina e apenas 10 (14,7%) dos considerados alterados tiveram conduta pré-operatória modificada, ou seja, solicitação de novos exames, interconsulta ou adiamento do procedimento. Nenhuma das cirurgias foi suspensa. CONCLUSÃO: Observou-se que excessivos exames complementares são solicitados no pré-operatório, mesmo em pacientes jovens, de baixo risco cirúrgico, com pouca ou nenhuma interferência na conduta perioperatória. Exames aboratoriais padronizados não são bons instrumentos de screening de doenças, além de gerar gastos elevados e desnecessários.&#xD;BACKGROUND AND OBJECTIVES: Preoperative tests aim to reduce morbidity and mortality of surgical patients, cost of perioperative care, and preoperative anxiety. Clinical evaluation allows defining the need for additional tests and strategies to reduce the surgical-anesthetic risk. The aim of this study was to evaluate the benefit of routine preoperative testing of low-risk patients undergoing minor and medium surgical procedures. METHODS: A descriptive cross-sectional study of 800 patients seen at the preanesthetic assessment department of Hospital Santo Antonio, Salvador, BA. Patients with physical status ASA I, aged 1-45 years and scheduled to undergo elective minor and medium surgeries were include in the study. We evaluated changes in blood count, coagulation profile, electrocardiogram, chest X-ray, blood sugar, kidney function, sodium and potassium levels, and eventual change in clinical approach occurring due to these changes. RESULTS: Of 800 patients evaluated, a blood count was performed in 97.5%, coagulation in 89%t, electrocardiogram in 74.1%, chest X-ray in 62%, fasting glucose in 68%, serum urea and creatinine in 55.7%, and plasma levels of sodium and potassium in 10.1%. Of these 700 patients, 68 (9.71%) showed changes in preoperative routine tests and only 10 (14.7%) of the patients with abnormal tests had a preoperative modified approach (i.e., new tests ordered, referral to a specialist or surgery postponement). No surgery was suspended. CONCLUSION: We found that preoperative additional tests are excessively ordered, even for young patients with low surgical risk, with little or no interference in perioperative management. Laboratory tests, besides generating high and unnecessary costs, are not good standardized screening instruments for diseases.&#xD;OBJETIVOS Y JUSTIFICATIVA: La evaluación preoperatoria tiene el objetivo de disminuir la morbimortalidad del paciente quirúrgico, el coste de la atención perioperatoria y la ansiedad preoperatoria. A partir de la evaluación clínica debemos definir la necesidad de exámenes complementarios y de estrategias para reducir el riesgo anestésico-quirúrgico. El objetivo de este trabajo fue el de evaluar el beneficio de exámenes de rutina preoperatorio de pacientes de bajo riesgo en las cirugías menores. MÉTODOS: Se trata de un estudio descriptivo, transversal con 700 pacientes atendidos en la consulta de evaluación preanestésica del Hospital Santo Antonio, Salvador, BA. Fueron incluidos pacientes de 1 a 45 años, estado físico ASA I, que serían sometidos a cirugías electivas menores. Se evaluaron las alteraciones en el hemograma, el coagulograma, el electrocardiograma, RX de tórax, glucemia, función renal y dosificación de sodio y potasio, y los eventuales cambios de conducta que se suscitaron provenientes de esas alteraciones. RESULTADOS: De los 800 pacientes evaluados un 97,5% realizaron hemograma, 89% coagulograma, 74,1% electrocardiograma, 62% RX de tórax, 68% glucemia en ayunas, 55,7% dosificaciones séricas de urea y creatinina y un 10,1% dosificaciones de sodio y potasio séricos. De esos 800 pacientes, 68 (9,71%) tuvieron alteración en los exámenes preoperatorios de rutina y solo 10 (14,7%) de los considerados alterados tuvieron una conducta preoperatoria modificada, o sea, una solicitación de nuevos exámenes, interconsulta o la postergación del procedimiento. Ninguna de las cirugías se suspendió. CONCLUSIONES: Observamos que los excesivos exámenes complementarios se solicitaban en el preoperatorio, aunque fuese en los pacientes jóvenes y de bajo riesgo quirúrgico, con poca o ninguna interferencia en el conducta perioperatoria. Los exámenes laboratoriales estándares no son buenos instrumentos de screening de enfermedades y pueden generar gastos elevados e innecesarios.</style></abstract><label><style face="normal" font="default" size="100%">Included by Ray</style></label><urls><related-urls><url><style face="normal" font="default" size="100%">http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S0034-70942013000200007</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2273</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2273</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Soares, S. C. M.</style></author><author><style face="normal" font="default" size="100%">de Camargo Cancela, M.</style></author><author><style face="normal" font="default" size="100%">Migowski, A.</style></author><author><style face="normal" font="default" size="100%">de Souza, D. L. B.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Graduate Program in Collective Health, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil.&#xD;Population Research Division, Brazilian National Cancer Institute (INCA), Rio de Janeiro, Brazil.&#xD;Cancer Early Detection Division, Brazilian National Cancer Institute (INCA), National Institute of Cardiology (INC), Rio de Janeiro, Brazil.&#xD;Collective Health Department, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil. dysouz@yahoo.com.br.&#xD;Present Address: Universidade Federal do Rio Grande do Norte / Federal University of Rio Grande do Norte. Programa de Pós-Graduação em Saúde Coletiva / Graduate Program in Collective Health, Avenida Senador Salgado Filho 1787, CEP: 59010-000 Lagoa Nova, Natal, RN, Brazil. dysouz@yahoo.com.br.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Digital rectal examination and its associated factors in the early detection of prostate cancer: a cross-sectional population-based study</style></title><secondary-title><style face="normal" font="default" size="100%">BMC Public Health</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">BMC Public Health</style></full-title></periodical><pages><style face="normal" font="default" size="100%">1573</style></pages><volume><style face="normal" font="default" size="100%">19</style></volume><number><style face="normal" font="default" size="100%">1</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Aged, 80 and over</style></keyword><keyword><style face="normal" font="default" size="100%">Brazil</style></keyword><keyword><style face="normal" font="default" size="100%">Cross-Sectional Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Digital Rectal Examination/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Early Detection of Cancer/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Insurance, Health/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Prostatic Neoplasms/*diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">Digital rectal examination</style></keyword><keyword><style face="normal" font="default" size="100%">Excessive use of health products and services</style></keyword><keyword><style face="normal" font="default" size="100%">Prostate neoplasms</style></keyword><keyword><style face="normal" font="default" size="100%">Public Health,mass screening</style></keyword><keyword><style face="normal" font="default" size="100%">Cancer early detection</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style face="normal" font="default" size="100%">Nov 27</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1471-2458</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: Digital rectal examination (DRE) is one of the most common strategies for prostate cancer early detection. However, the use for screening purposes has a controversial benefit and potential harms can occur due to false-positive results, overdiagnosis and overtreatment. The objective of this study is to calculate the prevalence and identify factors associated with the receipt of DRE in Brazilian men. METHODS: We selected men older than 40 from a nationwide population-based survey (13,625 individuals) excluding those with prostate cancer diagnosis. Information was extracted from the most recent database of the Brazilian National Health Survey (PNS 2013). Statistical analysis was carried out to calculate incidence rate ratios, with 95% confidence intervals and p values, through multivariate analysis with Poisson regression and robust variance. RESULTS: Men having private health insurance (63.3%; CI = 60.5-66.0) presented higher prevalence of DRE than those in the public health system (41.6%; CI = 39.8-43.4). The results show a positive association between DRE and men having private health insurance, aged 60-69, living with a spouse, never smokers, and living in urban areas. Among public health services users, this positive association was observed among men aged 70-79, living with a spouse, having bad/very bad health self-perception, abstainers, ex-smokers, with undergraduate studies, presenting four or more comorbidities, and residing in urban areas. CONCLUSIONS: Prostate cancer screening with DRE is quite frequent in Brazil, specially among men with private health plans and better access to health services, healthier lifestyle and at more advanced ages, characteristics which increase the risk of overdiagnosis and overtreatment.</style></abstract><label><style face="normal" font="default" size="100%">Included by Thanya</style></label><notes><style face="normal" font="default" size="100%">1471-2458&#xD;Soares, Samara Carollyne Mafra&#xD;de Camargo Cancela, Marianna&#xD;Migowski, Arn&#xD;de Souza, Dyego Leandro Bezerra&#xD;Orcid: 0000-0001-8426-3120&#xD;Journal Article&#xD;BMC Public Health. 2019 Nov 27;19(1):1573. doi: 10.1186/s12889-019-7946-z.</style></notes><urls></urls><custom2><style face="normal" font="default" size="100%">PMC6881979</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1186/s12889-019-7946-z</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2274</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2274</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Sodhi, K. S.</style></author><author><style face="normal" font="default" size="100%">Krishna, S.</style></author><author><style face="normal" font="default" size="100%">Saxena, A. K.</style></author><author><style face="normal" font="default" size="100%">Sinha, A.</style></author><author><style face="normal" font="default" size="100%">Khandelwal, N.</style></author><author><style face="normal" font="default" size="100%">Lee, E. Y.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Departments of Radiodiagnosis and Imaging, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India. Electronic address: sodhiks@gmail.com.&#xD;Departments of Radiodiagnosis and Imaging, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.&#xD;Departments of Radiology and Medicine, Pulmonary Division, Boston Children&apos;s Hospital and Harvard Medical School, 300 Longwood Ave. Boston, MA 02115, United States.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Clinical application of &apos;Justification&apos; and &apos;Optimization&apos; principle of ALARA in pediatric CT imaging: &quot;How many children can be protected from unnecessary radiation?&quot;</style></title><secondary-title><style face="normal" font="default" size="100%">Eur J Radiol</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Eur J Radiol</style></full-title></periodical><pages><style face="normal" font="default" size="100%">1752-7</style></pages><volume><style face="normal" font="default" size="100%">84</style></volume><number><style face="normal" font="default" size="100%">9</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Child, Preschool</style></keyword><keyword><style face="normal" font="default" size="100%">Developing Countries</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Hospitals, Pediatric/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">India</style></keyword><keyword><style face="normal" font="default" size="100%">Infant</style></keyword><keyword><style face="normal" font="default" size="100%">Infant, Newborn</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Medical Overuse/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Prospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">*Radiation Dosage</style></keyword><keyword><style face="normal" font="default" size="100%">Radiation Injuries/*prevention &amp; control</style></keyword><keyword><style face="normal" font="default" size="100%">Tomography, X-Ray Computed/methods/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">CT imaging</style></keyword><keyword><style face="normal" font="default" size="100%">Justification</style></keyword><keyword><style face="normal" font="default" size="100%">Optimization</style></keyword><keyword><style face="normal" font="default" size="100%">Pediatric patients</style></keyword><keyword><style face="normal" font="default" size="100%">Radiation</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style face="normal" font="default" size="100%">Sep</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0720-048x</style></isbn><abstract><style face="normal" font="default" size="100%">RATIONALE AND OBJECTIVES: Practice of ALARA (as low as reasonably achievable) principle in the developed world is currently well established. However, there is striking lack of published data regarding such experience in the developing countries. Therefore, the goal of this study is to prospectively evaluate CT request forms to assess how many children could be protected from harmful radiation exposure if &apos;Justification&apos; and &apos;Optimization&apos; principles of ALARA are applied before obtaining CT imaging in a developing country. This can save children from potential radiation risks including development of brain cancer and leukemia. MATERIAL AND METHODS: Consecutive CT request forms over a six month study period (May 16, 2013 to November 15, 2013) in a tertiary pediatric children&apos;s hospital in India were prospectively reviewed by two pediatric radiologists before obtaining CT imaging. First, &apos;Justification&apos; of CT was evaluated and then &apos;Optimization&apos; was applied for evaluation of appropriateness of the requested CT studies. The number (and percentage) of CT studies avoided by applying &apos;Justification&apos; and &apos;Optimization&apos; principle of ALARA were calculated. The difference in number of declined and optimized CT requests between CT requests from inpatient and outpatient departments was compared using Chi-Square test. RESULTS: A total of 1302 consecutive CT request forms were received during the study period. Some of the request forms (n=86; 6.61%) had requests for more than one (multiple) anatomical regions, hence, a total of 1392 different anatomical CT requests were received. Based on evaluation of the CT request forms for &apos;Justification&apos; and &apos;Optimization&apos; principle of ALARA by pediatric radiology reviewers, 111 individual anatomic part CT requests from 105 pediatric patients were avoided. Therefore, 8.06% (105 out of 1302 pediatric patients) were protected from unnecessary or additional radiation exposure.The rates of declined or optimized CT requests from inpatient department was significantly higher than that from outpatient departments (p&lt;0.05). CONCLUSIONS: A substantial number of pediatric patients, particularly coming from outpatient departments, can be protected from unnecessary or additional radiation exposure from CT imaging when &apos;Justification&apos; and &apos;Optimization&apos; principle of ALARA are applied before obtaining CT imaging in a developing country.</style></abstract><notes><style face="normal" font="default" size="100%">1872-7727&#xD;Sodhi, Kushaljit S&#xD;Krishna, Satheesh&#xD;Saxena, Akshay K&#xD;Sinha, Anindita&#xD;Khandelwal, Niranjan&#xD;Lee, Edward Y&#xD;Journal Article&#xD;Ireland&#xD;Eur J Radiol. 2015 Sep;84(9):1752-7. doi: 10.1016/j.ejrad.2015.05.030. Epub 2015 May 27.</style></notes><urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1016/j.ejrad.2015.05.030</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2275</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2275</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Solis-Pazmino, P.</style></author><author><style face="normal" font="default" size="100%">Salazar-Vega, J.</style></author><author><style face="normal" font="default" size="100%">Lincango-Naranjo, E.</style></author><author><style face="normal" font="default" size="100%">Garcia, C.</style></author><author><style face="normal" font="default" size="100%">Koupermann, G. J.</style></author><author><style face="normal" font="default" size="100%">Ortiz-Prado, E.</style></author><author><style face="normal" font="default" size="100%">Ledesma, T.</style></author><author><style face="normal" font="default" size="100%">Rojas, T.</style></author><author><style face="normal" font="default" size="100%">Alvarado-Mafla, B.</style></author><author><style face="normal" font="default" size="100%">Carcamo, C.</style></author><author><style face="normal" font="default" size="100%">Ponce, O. J.</style></author><author><style face="normal" font="default" size="100%">Brito, J. P.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Otolaryngology Head and Neck Department, Stanford University, Palo Alto, California, USA.&#xD;Knowledge and Evaluation Research Unit, Mayo Clinic, Rochester, MN, USA.&#xD;CaTaLiNa (Thyroid Cancer in LatinAmerica), Quito, Ecuador.&#xD;Endocrinology Department, Hospital de Especialidades Eugenio Espejo, Quito, Ecuador.&#xD;One Health Research Group, Universidad de las Americas, Quito, Ecuador, 170137, Quito, Ecuador.&#xD;Universidad Central del Ecuador, Medical School, Quito, Ecuador.&#xD;Surgery Department, Hospital de Especialidades Eugenio Espejo, Quito, Ecuador.&#xD;Molecular Biology Department, Hospital de Especialidades Eugenio Espejo, Quito, Ecuador.&#xD;One Health Research Group, Universidad de las Americas, Quito, Ecuador, 170137, Quito, Ecuador. e.ortizprado@gmail.com.&#xD;Universidad San Francisco de Quito, Quito, Ecuador.&#xD;School of Public Health and Administration, Universidad Peruana Cayetano Heredia, Lima, Peru.&#xD;Unidad de Conocimiento y Evidencia, Universidad Peruana Cayetano Heredia, Lima, Peru.&#xD;Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic, Rochester, MN, USA.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Thyroid cancer overdiagnosis and overtreatment: a cross- sectional study at a thyroid cancer referral center in Ecuador</style></title><secondary-title><style face="normal" font="default" size="100%">BMC Cancer</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">BMC Cancer</style></full-title></periodical><pages><style face="normal" font="default" size="100%">42</style></pages><volume><style face="normal" font="default" size="100%">21</style></volume><number><style face="normal" font="default" size="100%">1</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adenocarcinoma, Follicular/diagnosis/epidemiology/*therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Carcinoma, Papillary/diagnosis/epidemiology/*therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Combined Modality Therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Cross-Sectional Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Ecuador/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Follow-Up Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Incidence</style></keyword><keyword><style face="normal" font="default" size="100%">Iodine Radioisotopes/*therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Medical Overuse/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Prognosis</style></keyword><keyword><style face="normal" font="default" size="100%">Referral and Consultation</style></keyword><keyword><style face="normal" font="default" size="100%">Thyroid Neoplasms/diagnosis/epidemiology/*therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Thyroidectomy/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Ecuador</style></keyword><keyword><style face="normal" font="default" size="100%">Histopathology</style></keyword><keyword><style face="normal" font="default" size="100%">Latin-America</style></keyword><keyword><style face="normal" font="default" size="100%">Outcome</style></keyword><keyword><style face="normal" font="default" size="100%">Surgical</style></keyword><keyword><style face="normal" font="default" size="100%">Thyroid Cancer</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2021</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jan 8</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1471-2407</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: In contrast to the rapid increase in thyroid cancer incidence, the mortality has remained low and stable over the last decades. In Ecuador, however, thyroid cancer mortality has increased. The objective of this study is to determine possible drivers of high rates of thyroid cancer mortality, through a cross-sectional analysis of all patients attending a thyroid cancer referral center in Ecuador. METHODS: From June 2014 to December 2017, a cross-sectional study was conducted at the Hospital de Especialidades Eugenio Espejo, a regional reference public hospital for endocrine neoplasia in adults in Quito, Ecuador. We identified the mechanism of detection, histopathology and treatment modalities from a patient interview and review of clinical records. RESULTS: Among 452 patients, 74.8% were young adults and 94.2% (426) were female. 13.7% had a family history of thyroid cancer, and patients&apos; median tumor size was 2 cm. The incidental finding was 54.2% whereas 45.8% was non-incidental. Thyroid cancer histology reported that 93.3% had papillary thyroid cancer (PTC), 2.7% follicular, 1.5% Hurtle cells, 1.6% medullary, 0.7% poor differentiated, and 0.2% anaplastic carcinoma. The mean MACIS (metastasis, age, completeness, invasion, and size) score was 4.95 (CI 4.15-5.95) with 76.2% of the thyroid cancer patients having MACIS score less than or equal to 6. The very low and low risk of recurrence was 18.1% (79) and 62% (271) respectively. An analysis of 319 patients with non-metastatic thyroid cancer showed that 10.7% (34) of patients had surgical complications. Moreover, around 62.5% (80 from 128 patients with thyroglobulin laboratory results) of TC patients had a stimulated-thyroglobulin value equal or higher than 2 ng/ml. Overall, a poor surgical outcome was present in 35.1% (112) patients. Out of 436 patients with differentiated thyroid carcinoma, 86% (375) received radioactive iodine. CONCLUSION: Thyroid cancer histological characteristics and method of diagnosis are like those described in other reports without any evidence of the high frequency of aggressive thyroid cancer histology. However, we observed evidence of overtreatment and poor surgical outcomes that demand additional studies to understand their association with thyroid cancer mortality in Ecuador.</style></abstract><label><style face="normal" font="default" size="100%">Included by Hannah</style></label><notes><style face="normal" font="default" size="100%">1471-2407&#xD;Solis-Pazmino, Paola&#xD;Salazar-Vega, Jorge&#xD;Lincango-Naranjo, Eddy&#xD;Garcia, Cristhian&#xD;Koupermann, Gabriela Jaramillo&#xD;Ortiz-Prado, Esteban&#xD;Orcid: 0000-0002-1895-7498&#xD;Ledesma, Tannya&#xD;Rojas, Tatiana&#xD;Alvarado-Mafla, Benjamin&#xD;Carcamo, Cesar&#xD;Ponce, Oscar J&#xD;Brito, Juan P&#xD;Journal Article&#xD;BMC Cancer. 2021 Jan 8;21(1):42. doi: 10.1186/s12885-020-07735-y.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791844/pdf/12885_2020_Article_7735.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC7791844</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1186/s12885-020-07735-y</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2276</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2276</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Sonkar, S. C.</style></author><author><style face="normal" font="default" size="100%">Wasnik, K.</style></author><author><style face="normal" font="default" size="100%">Kumar, A.</style></author><author><style face="normal" font="default" size="100%">Mittal, P.</style></author><author><style face="normal" font="default" size="100%">Saluja, D.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Dr. B. R. Ambedkar Center for Biomedical Research, University of Delhi, Delhi, 110007, India.&#xD;Department of Obstetrics &amp; Gynecology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, 110029, India.&#xD;Dr. B. R. Ambedkar Center for Biomedical Research, University of Delhi, Delhi, 110007, India. dsalujach59@gmail.com.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Comparative analysis of syndromic and PCR-based diagnostic assay reveals misdiagnosis/ overtreatment for trichomoniasis based on subjective judgment in symptomatic patients</style></title><secondary-title><style face="normal" font="default" size="100%">Infect Dis Poverty</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Infect Dis Poverty</style></full-title></periodical><pages><style face="normal" font="default" size="100%">42</style></pages><volume><style face="normal" font="default" size="100%">5</style></volume><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Diagnostic Errors/psychology</style></keyword><keyword><style face="normal" font="default" size="100%">*Diagnostic Techniques and Procedures/psychology/standards</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Judgment</style></keyword><keyword><style face="normal" font="default" size="100%">Medical Overuse</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Polymerase Chain Reaction/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Pregnancy</style></keyword><keyword><style face="normal" font="default" size="100%">Trichomonas Infections/*diagnosis/*drug therapy/psychology</style></keyword><keyword><style face="normal" font="default" size="100%">Trichomonas vaginalis/classification/drug effects/genetics/isolation &amp; purification</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Misdiagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">Overtreatment</style></keyword><keyword><style face="normal" font="default" size="100%">PCR based diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">Syndromic case management</style></keyword><keyword><style face="normal" font="default" size="100%">Trichomoniasis</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style face="normal" font="default" size="100%">May 5</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">2049-9957</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: Trichomoniasis, a sexually transmitted disease (STD), is caused by Trichomonas vaginalis in both men and women. Screening of trichomoniasis is problematic in resource challenged settings as currently available, inexpensive diagnostic methods are of low sensitivity and/or specificity. In India, National AIDS Control organization (NACO) recommended syndromic case management (SCM) for treatment. The objective of the present study was to compare the utility of the NACO-NACP III Algorithms for STI/RTI treatment used by clinicians with PCR based diagnosis. METHODS: Patients visiting Department of Obstetrics &amp; Gynecology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi from January 2011 to June 2014 were enrolled in the study to compare the diagnostic efficiency of PCR-based assays against SCM. Based on SCM, patients (n = 820) were treated with antibiotics using pre-packed STI/RTI kits (sexually transmitted infection/reproductive tract infection; procured by National AIDS Control/State AIDS Control Society (NACO/SACS), Ministry of Health and Family Welfare, Govt of India.) under National AIDS Control Programme (NACP III) for syndromic case management (SCM). Ectocervical dry swab samples were also obtained from these patients and out of that 634 samples were tested by PCR. Total genomic DNA was extracted from these samples and used as template for PCR amplification using pfoB, gyrA and orf1 gene specific primers for diagnosis of T. vaginalis (TV), Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) respectively. RESULTS: Out of 6000 patients who visited OPD, 820 (14 %) female patients reported vaginal discharge and were recommended antibiotic treatment for one or more pathogens namely, TV, CT, NG and Candida or for co-infection. On the basis of signs &amp; symptoms and NACO guidelines, the following distribution of various infections was observed: TV (46 %), CT (20 %), coinfection with TV and CT (12 %), coinfection with CT and NG (11 %), coinfection with TV, CT and Candida (7 %) and coinfection with TV and NG (2 %). Others were infected with NG alone (1 %), coinfected with TV and Candida (0.4 %) and 0.3 % were coinfected with CT, NG and Candida. Based on PCR method, 110 (17 %) women tested positive for one or more of these three pathogens while 524 (83 %) women were negative for any of these three pathogens but could be positive for other STIs not tested in this study. Since all the patients (634) were given antibiotics, we estimate that the over-treatment was 85 % while 524 (83 %) patients were also misdiagnosed by SCM. CONCLUSIONS: The over-treatment and inaccurate diagnosis of pathogens due to subjective judgment based on syndromic approach in symptomatic women is a large economic wastage and may also contribute towards increased resistance. The misdiagnosed patients will also serve as a reservoir for transmission of pathogens to their sexual partner.</style></abstract><notes><style face="normal" font="default" size="100%">2049-9957&#xD;Sonkar, Subash Chandra&#xD;Wasnik, Kirti&#xD;Kumar, Anita&#xD;Mittal, Pratima&#xD;Saluja, Daman&#xD;Comparative Study&#xD;Journal Article&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Infect Dis Poverty. 2016 May 5;5:42. doi: 10.1186/s40249-016-0133-x.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4857337/pdf/40249_2016_Article_133.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC4857337</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1186/s40249-016-0133-x</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2277</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2277</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Steinhardt, L. C.</style></author><author><style face="normal" font="default" size="100%">Chinkhumba, J.</style></author><author><style face="normal" font="default" size="100%">Wolkon, A.</style></author><author><style face="normal" font="default" size="100%">Luka, M.</style></author><author><style face="normal" font="default" size="100%">Luhanga, M.</style></author><author><style face="normal" font="default" size="100%">Sande, J.</style></author><author><style face="normal" font="default" size="100%">Oyugi, J.</style></author><author><style face="normal" font="default" size="100%">Ali, D.</style></author><author><style face="normal" font="default" size="100%">Mathanga, D.</style></author><author><style face="normal" font="default" size="100%">Skarbinski, J.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Malaria Branch, Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, GA, USA. LSteinhardt@cdc.gov.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Patient-, health worker-, and health facility-level determinants of correct malaria case management at publicly funded health facilities in Malawi: results from a nationally representative health facility survey</style></title><secondary-title><style face="normal" font="default" size="100%">Malar J</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Malar J</style></full-title></periodical><pages><style face="normal" font="default" size="100%">64</style></pages><volume><style face="normal" font="default" size="100%">13</style></volume><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Aged, 80 and over</style></keyword><keyword><style face="normal" font="default" size="100%">*Case Management</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Child, Preschool</style></keyword><keyword><style face="normal" font="default" size="100%">Data Collection</style></keyword><keyword><style face="normal" font="default" size="100%">Diagnostic Tests, Routine/methods/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">*Health Facilities</style></keyword><keyword><style face="normal" font="default" size="100%">*Health Personnel</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Infant</style></keyword><keyword><style face="normal" font="default" size="100%">Malaria/*diagnosis/*drug therapy/prevention &amp; control</style></keyword><keyword><style face="normal" font="default" size="100%">Malawi</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">*Medication Adherence</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Point-of-Care Systems</style></keyword><keyword><style face="normal" font="default" size="100%">Public Sector</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style face="normal" font="default" size="100%">Feb 20</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1475-2875</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: Prompt and effective case management is needed to reduce malaria morbidity and mortality. However, malaria diagnosis and treatment is a multistep process that remains problematic in many settings, resulting in missed opportunities for effective treatment as well as overtreatment of patients without malaria. METHODS: Prior to the widespread roll-out of malaria rapid diagnostic tests (RDTs) in late 2011, a national, cross-sectional, complex-sample, health facility survey was conducted in Malawi to assess patient-, health worker-, and health facility-level factors associated with malaria case management quality using multivariate Poisson regression models. RESULTS: Among the 2,019 patients surveyed, 34% had confirmed malaria defined as presence of fever and parasitaemia on a reference blood smear. Sixty-seven per cent of patients with confirmed malaria were correctly prescribed the first-line anti-malarial, with most cases of incorrect treatment due to missed diagnosis; 31% of patients without confirmed malaria were overtreated with an anti-malarial. More than one-quarter of patients were not assessed for fever or history of fever by health workers. The most important determinants of correct malaria case management were patient-level clinical symptoms, such as spontaneous complaint of fever to health workers, which increased both correct treatment and overtreatment by 72 and 210%, respectively (p&lt;0.0001). Complaint of cough was associated with a 27% decreased likelihood of correct malaria treatment (p=0.001). Lower-level cadres of health workers were more likely to prescribe anti-malarials for patients, increasing the likelihood of both correct treatment and overtreatment, but no other health worker or health facility-level factors were significantly associated with case management quality. CONCLUSIONS: Introduction of RDTs holds potential to improve malaria case management in Malawi, but health workers must systematically assess all patients for fever, and then test and treat accordingly, otherwise, malaria control programmes might miss an opportunity to dramatically improve malaria case management, despite better diagnostic tools.</style></abstract><notes><style face="normal" font="default" size="100%">1475-2875&#xD;Steinhardt, Laura C&#xD;Chinkhumba, Jobiba&#xD;Wolkon, Adam&#xD;Luka, Madalitso&#xD;Luhanga, Misheck&#xD;Sande, John&#xD;Oyugi, Jessica&#xD;Ali, Doreen&#xD;Mathanga, Don&#xD;Skarbinski, Jacek&#xD;Journal Article&#xD;Research Support, U.S. Gov&apos;t, P.H.S.&#xD;Malar J. 2014 Feb 20;13:64. doi: 10.1186/1475-2875-13-64.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3938135/pdf/1475-2875-13-64.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC3938135</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1186/1475-2875-13-64</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2278</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2278</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Tachi, K.</style></author><author><style face="normal" font="default" size="100%">Nkrumah, K. N.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Medicine, Korle-Bu Teaching Hospital, Korle-Bu, Ghana. kennethtachi@yahoo.com</style></auth-address><titles><title><style face="normal" font="default" size="100%">Appropriateness and diagnostic yield of referrals for oesophagogastroduodenoscopy at the Korle Bu Teaching Hospital</style></title><secondary-title><style face="normal" font="default" size="100%">West Afr J Med</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">West Afr J Med</style></full-title></periodical><pages><style face="normal" font="default" size="100%">158-63</style></pages><volume><style face="normal" font="default" size="100%">30</style></volume><number><style face="normal" font="default" size="100%">3</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Endoscopy, Gastrointestinal/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Gastrointestinal Diseases/diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">Ghana</style></keyword><keyword><style face="normal" font="default" size="100%">Hospitals, University</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Practice Guidelines as Topic</style></keyword><keyword><style face="normal" font="default" size="100%">Practice Patterns, Physicians&apos;/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Predictive Value of Tests</style></keyword><keyword><style face="normal" font="default" size="100%">Referral and Consultation/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Unnecessary Procedures/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">*Utilization Review</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2011</style></year><pub-dates><date><style face="normal" font="default" size="100%">May-Jun</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0189-160X (Print)&#xD;0189-160x</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: Increasing endoscopy workload in open-access services necessitates adoption of appropriateness criteria to check abuse and improve yield. OBJECTIVE: To assess the appropriateness of referrals for oesophagogastroduodenoscopy (OGD) and its relationship to yield at Korle-Bu Teaching Hospital (KBTH), Accra. METHODS: Referrals, signs, and symptoms of 375 consecutive patients for diagnostic oesophagogastroduodenoscopy were evaluated over four months. Indications were categorized as appropriate or inappropriate using the American Society of Gastrointestinal Endoscopy (ASGE) guidelines and endoscopic findings (yield) categorized as positive or negative. The relationship between these was analyzed and the diagnostic accuracy of the guidelines determined. RESULTS: There were 209 (55.7%) females, and 316 (84.3%) open-access procedures. Mean age was 46±17 years. Dyspepsia, 272 (72.5%) and epigastric tenderness, 192 (41.4 %) were the commonest symptom and sign respectively. Only 133 (35.5%) reported alarm symptoms. Appropriate referrals constituted 221(58.9%). Inappropriate referral rate was similar for endoscopists and non-endoscopists. Positive yield was 62.7%. Male sex, age &gt; 45 years, haematemesis, persistent vomiting, gastroenterologists&apos; referrals and epigastric tenderness were the best predictors of positive yield. Gastritis, 121 (32.3%), duodenal ulcer, 48 (12.5%) and oesophagitis, 36 (9.6%) were the leading endoscopy diagnoses. Carcinomas were reported only after 45 years and 18 (81.8%) of the cases had alarm symptoms. CONCLUSIONS: Inappropriate referral for OGD rate is high in Accra. Yield is improved by adherence to the ASGE guidelines but its accuracy as a screening tool for OGD at Korle- Bu Teaching Hospital is too low to recommend it for adoption.</style></abstract><label><style face="normal" font="default" size="100%">Included by Ray</style></label><notes><style face="normal" font="default" size="100%">Tachi, K&#xD;Nkrumah, K N&#xD;Journal Article&#xD;Nigeria&#xD;West Afr J Med. 2011 May-Jun;30(3):158-63.</style></notes><urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2279</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2279</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Tambe, J.</style></author><author><style face="normal" font="default" size="100%">Mbuagbaw, L.</style></author><author><style face="normal" font="default" size="100%">Nguefack-Tsague, G.</style></author><author><style face="normal" font="default" size="100%">Foyet, J.</style></author><author><style face="normal" font="default" size="100%">Ongolo-Zogo, P.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Post-Graduate School for Life Sciences, Health and Environment, The University of Yaoundé I, Yaoundé, Cameroon.&#xD;Centre for the Development of Best Practices in Health (CDBPH), Yaoundé Central Hospital, Yaoundé, Cameroon.&#xD;Division of Radiology, University of Buea, Buea, Cameroon.&#xD;Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Canada.&#xD;Biostatistics Unit, Father Sean O&apos;Sullivan Research Centre, St. Joseph&apos;s Healthcare, Hamilton, Canada.&#xD;Biostatistics Unit, Department of Public Health, Faculty of Medicine and Biomedical Sciences, The University of Yaoundé I, Yaoundé, Cameroon.&#xD;Deido Radiology and Ultrasonography Centre, Douala, Cameroon.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Multidetector computed tomography utilization in an urban sub-Saharan Africa setting: user characteristics, indications and appropriateness</style></title><secondary-title><style face="normal" font="default" size="100%">Pan Afr Med J</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Pan Afr Med J</style></full-title></periodical><pages><style face="normal" font="default" size="100%">42</style></pages><volume><style face="normal" font="default" size="100%">37</style></volume><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Age Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Aged, 80 and over</style></keyword><keyword><style face="normal" font="default" size="100%">Cameroon</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Child, Preschool</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Infant</style></keyword><keyword><style face="normal" font="default" size="100%">Insurance, Health/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Multidetector Computed Tomography/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Surveys and Questionnaires</style></keyword><keyword><style face="normal" font="default" size="100%">Unnecessary Procedures/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Wounds and Injuries/*diagnostic imaging</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Multidetector computed tomography</style></keyword><keyword><style face="normal" font="default" size="100%">appropriateness</style></keyword><keyword><style face="normal" font="default" size="100%">utilization</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2020</style></year></dates><abstract><style face="normal" font="default" size="100%">INTRODUCTION: multidetector computed tomography (MDCT) is a widely used cross-sectional imaging modality despite increasing concerns about radiation exposure and overuse. The aim of this study was to describe the socio-demographic characteristics of MDCT users in an urban city in Cameroon and to assess the clinical indications for appropriateness. METHODS: we conducted a survey of MDCT users and collected data on demographic attributes and socialization patterns, clinical indications for MDCT and time to obtain MDCT. MDCT appropriateness was assessed using the American College of Radiologists Appropriateness Criteria®. Frequencies, percentages, odds ratios and 95% confidence intervals were used to summarize the data. RESULTS: with a response rate of 79%, 511 MDCT users were surveyed. The mean (standard deviation) age was 45(19) years and male to female sex ratio 1:1. Seventy-eight percent (95% confidence interval [CI]: 74-83%) of respondents reported not having any health insurance. Head scans accounted for 52% (95%CI: 47-56%) of all scans with trauma (19% [95%CI: 15-22%]), low back pain (18% [95%CI: 14-21%]) and suspected stroke (10% [95%CI: 7-13%]) being the most frequent indications. Sixteen percent (95%CI: 13-20%) of the scans were judged to be inappropriate. Predictors of MDCT appropriateness after multivariable logistic regression modeling were age (aOR=0.97; P=0.009; 95%CI=0.94-0.99), health insurance ownership (aOR=0.40; P=0.034; 95%CI=0.18-0.94) and being referred by non-specialist physicians (aOR=0.20; P&lt;0.001; 95%CI=0.09-0.47). CONCLUSION: people from all social strata use MDCT, mostly appropriately and especially for head scans after trauma in this urban setting. However, the proportion of inappropriate studies was considerable suggesting the need for control measures.</style></abstract><label><style face="normal" font="default" size="100%">Included by Ray</style></label><notes><style face="normal" font="default" size="100%">1937-8688&#xD;Tambe, Joshua&#xD;Mbuagbaw, Lawrence&#xD;Nguefack-Tsague, Georges&#xD;Foyet, Joseph&#xD;Ongolo-Zogo, Pierre&#xD;Journal Article&#xD;Pan Afr Med J. 2020 Sep 9;37:42. doi: 10.11604/pamj.2020.37.42.21176. eCollection 2020.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648473/pdf/PAMJ-37-42.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC7648473</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.11604/pamj.2020.37.42.21176</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2280</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2280</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Tan, Y. M.</style></author><author><style face="normal" font="default" size="100%">Goh, K. L.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Division of Gastroenterology, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Appropriateness of colonoscopy in a university hospital</style></title><secondary-title><style face="normal" font="default" size="100%">Med J Malaysia</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Med J Malaysia</style></full-title></periodical><pages><style face="normal" font="default" size="100%">34-8</style></pages><volume><style face="normal" font="default" size="100%">59</style></volume><number><style face="normal" font="default" size="100%">1</style></number><keywords><keyword><style face="normal" font="default" size="100%">Colonoscopy/*standards/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Gastroenterology/*standards/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Hospitals, University</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Malaysia</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Practice Guidelines as Topic</style></keyword><keyword><style face="normal" font="default" size="100%">Referral and Consultation/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Retrospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Unnecessary Procedures/statistics &amp; numerical data</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2004</style></year><pub-dates><date><style face="normal" font="default" size="100%">Mar</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0300-5283 (Print)&#xD;0300-5283</style></isbn><abstract><style face="normal" font="default" size="100%">An open access endoscopy system allows for the direct scheduling of endoscopies by non-gastroenterologist physicians without prior gastroenterology consultation. The aim of our study was to examine our practice of open access endoscopy by evaluating the appropriateness of referrals for colonoscopy and to determine whether there were differences depending on the specialty of the referring clinician. The indication for colonoscopy was assessed in 499 consecutive outpatients referred for colonoscopy at University Hospital, Kuala Lumpur over a 12-month period. The American Society of Gastrointestinal Endoscopy (ASGE) guidelines were used to determine the appropriateness of referrals. 80.6% of colonoscopies requested by the gastroenterologist were performed for accepted indications compared to 50.6% of referrals by the primary care physician (p&lt;0.001) and 67.0% of referrals by the surgeon (p=0.006). The rate of colonoscopies generally not indicated was 2.1% for the gastroenterologist, 25.0% for the internist (p=0.002) and 7.5% for the surgeon (p=0.04). The rate of indications not listed in the ASGE guidelines was significantly lower for requests made by gastroenterologists (17.3%) than those requested by primary care physicians (44.2%; p&lt;0.001). Patients who have had prior consultation with the gastroenterologist were significantly more likely to undergo colonoscopy for appropriate indications than among patients who were referred through an open access system. The rate of inappropriate indications for colonoscopy was also significantly lower when the gastroenterologist made the referral. A substantial proportion of colonoscopies (25.4%) was performed for indications not listed in the ASGE guidelines.</style></abstract><notes><style face="normal" font="default" size="100%">Tan, Y M&#xD;Goh, K L&#xD;Journal Article&#xD;Malaysia&#xD;Med J Malaysia. 2004 Mar;59(1):34-8.</style></notes><urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2281</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2281</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Tawiah, T.</style></author><author><style face="normal" font="default" size="100%">Hansen, K. S.</style></author><author><style face="normal" font="default" size="100%">Baiden, F.</style></author><author><style face="normal" font="default" size="100%">Bruce, J.</style></author><author><style face="normal" font="default" size="100%">Tivura, M.</style></author><author><style face="normal" font="default" size="100%">Delimini, R.</style></author><author><style face="normal" font="default" size="100%">Amengo-Etego, S.</style></author><author><style face="normal" font="default" size="100%">Chandramohan, D.</style></author><author><style face="normal" font="default" size="100%">Owusu-Agyei, S.</style></author><author><style face="normal" font="default" size="100%">Webster, J.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Kintampo Health Research Centre, Kintampo, Brong Ahafo Region, Ghana.&#xD;Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London, United Kingdom.&#xD;Section of Health Services Research, Department of Public Health, University of Copenhagen, Copenhagen, Denmark.&#xD;Epidemiology Unit, Ensign College of Public Health, Kpong, Eastern Region, Ghana.&#xD;Department for Disease Control, London School of Hygiene and Tropical Medicine, London, United Kingdom.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Cost-Effectiveness Analysis of Test-Based versus Presumptive Treatment of Uncomplicated Malaria in Children under Five Years in an Area of High Transmission in Central Ghana</style></title><secondary-title><style face="normal" font="default" size="100%">PLoS One</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">PLoS ONE</style></full-title></periodical><pages><style face="normal" font="default" size="100%">e0164055</style></pages><volume><style face="normal" font="default" size="100%">11</style></volume><number><style face="normal" font="default" size="100%">10</style></number><dates><year><style face="normal" font="default" size="100%">2016</style></year></dates><isbn><style face="normal" font="default" size="100%">1932-6203</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: The presumptive approach of confirming malaria in health facilities leads to over-diagnosis of malaria, over use of anti-malaria drugs and the risk of drug resistance development. WHO recommends parasitological confirmation before treatment with artemisinin-based combination therapy (ACT) in all suspected malaria patients. The use of malaria rapid diagnostic tests (mRDTs) would make it possible for prescribers to diagnose malaria at point-of-care and better target the use of antimalarials. Therefore, a cost-effectiveness analysis was performed on the introduction of mRDTs for management of malaria in under-five children in a high transmission area in Ghana where presumptive diagnosis was the norm in public health centres. METHODS: A cluster-randomised controlled trial where thirty-two health centres were randomised into test-based diagnosis of malaria using mRDTs (intervention) or clinical judgement (control) was used to measure the effect of mRDTs on appropriate treatment: &apos;a child with a positive reference diagnosis prescribed a course of ACT or a child with a negative reference diagnosis not given an ACT&apos;. Cost data was collected from five purposively selected health centres and used to estimate the health sector costs of performing an mRDT and treat children for malaria and other common febrile illnesses. Costs of training healthcare personnel and supervision in the study period were also collected. A sample of caregivers to children participating in the trial was interviewed about household cost incurred on transport, drugs, fees, and special food during a period of one week after the health centre visit as well as days unable to work. A decision model approach was used to calculate the incremental cost-effectiveness ratios (ICERs). Univariate and multivariate sensitivity analyses were applied to assess the robustness of ICERs. RESULTS: The availability of mRDTs for malaria diagnosis resulted in fewer ACT treatments compared to the clinical judgement approach (73% versus 81%) and more children appropriately treated (70% versus 57%). The introduction of mRDT-based diagnosis would cost the Ministry of Health US$18.6 per extra appropriately treated child under five compared to clinical judgement while the ICER from a societal perspective was lower at US$11.0 per appropriately treated child. ICERs were sensitive to a decrease in adherence to negative mRDTs, malaria positivity rate and specificity of the mRDT. CONCLUSION: The introduction of mRDTs is likely to be considered cost-effective in this high transmission setting as this intervention increased the number of appropriately treated children at low cost. TRIAL REGISTRATION: ClinicalTrials.gov NCT00832754.</style></abstract><notes><style face="normal" font="default" size="100%">1932-6203&#xD;Tawiah, Theresa&#xD;Hansen, Kristian Schultz&#xD;Baiden, Frank&#xD;Bruce, Jane&#xD;Tivura, Mathilda&#xD;Delimini, Rupert&#xD;Amengo-Etego, Seeba&#xD;Chandramohan, Daniel&#xD;Owusu-Agyei, Seth&#xD;Webster, Jayne&#xD;Journal Article&#xD;PLoS One. 2016 Oct 3;11(10):e0164055. doi: 10.1371/journal.pone.0164055. eCollection 2016.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047443/pdf/pone.0164055.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC5047443</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1371/journal.pone.0164055</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2282</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2282</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Tesser, Charles Dalcanale</style></author><author><style face="normal" font="default" size="100%">Ávila, Thiago Luiz de Campos</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Por que reconsiderar a indicação do rastreamento do câncer de mama?</style></title><secondary-title><style face="normal" font="default" size="100%">Cad. Saúde Pública (Online)</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Cad. Saúde Pública (Online)</style></full-title></periodical><pages><style face="normal" font="default" size="100%">e00095914-e00095914</style></pages><volume><style face="normal" font="default" size="100%">32</style></volume><number><style face="normal" font="default" size="100%">5</style></number><keywords><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Breast Neoplasms/diagnostic imaging</style></keyword><keyword><style face="normal" font="default" size="100%">Mammography</style></keyword><keyword><style face="normal" font="default" size="100%">Early Detection of Cancer</style></keyword><keyword><style face="normal" font="default" size="100%">Brazil/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Breast Neoplasms/mortality</style></keyword><keyword><style face="normal" font="default" size="100%">Breast Neoplasms/prevention &amp;amp</style></keyword><keyword><style face="normal" font="default" size="100%">amp</style></keyword><keyword><style face="normal" font="default" size="100%">control</style></keyword><keyword><style face="normal" font="default" size="100%">Mass Screening</style></keyword><keyword><style face="normal" font="default" size="100%">Decision Making</style></keyword><keyword><style face="normal" font="default" size="100%">Secondary Prevention</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style face="normal" font="default" size="100%">2016/00</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1678-4464</style></isbn><abstract><style face="normal" font="default" size="100%">Resumo: O objetivo deste artigo foi discutir a recomendação do rastreamento mamográfico do câncer de mama e suas bases técnicas. A primeira parte tece considerações sobre critérios de decisão, que devem ser coerentes com evidências científicas de alta qualidade. A segunda discute o sobrediagnóstico, o maior dano do rastreamento, e seu significado questionador do modelo da história natural da doença. A terceira parte sintetiza estudos sobre eficácia, efetividade e danos do rastreamento, mostrando que os últimos (principalmente sobrediagnósticos e falsos positivos) são significativos e tornam a balança entre danos e benefícios duvidosa. Conclui-se que a recomendação de rastreamento mamográfico deve ser reconsiderada pelas autoridades sanitárias brasileiras em qualquer idade.&#xD;Abstract: The aim of this article was to discuss the recommendation of mammogram screening for breast cancer and its technical basis. The first part discusses criteria for the decision, which should be consistent with high-quality scientific evidence. The second part discusses over-diagnosis (the greatest harm of screening) and its meaning in questioning the natural history of disease model. The third part summarizes studies on the efficacy, effectiveness, and harms of screening, showing that the latter (especially over-diagnosis and false-positives) are significant, shedding doubt on the balance between harms and benefits. In conclusion, the recommendation of mammogram screening at any age should be reconsidered by Brazilian health authorities.&#xD;Resumen: El objetivo de este artículo fue discutir la recomendación del rastreo mamográfico del cáncer de mama y sus bases técnicas. La primera parte abarca consideraciones sobre criterios de decisión, que deben ser coherentes con evidencias científicas de alta calidad. La segunda parte discute sobre el diagnóstico, el mayor daño del rastreo, y su significado como cuestionador del modelo de la historia natural de la enfermedad. La tercera parte sintetiza estudios sobre eficacia, efectividad y daños del rastreo, mostrando que los últimos (principalmente sobre diagnósticos y falsos-positivos) son significativos y hacen que el equilibrio entre daños y beneficios sea dudoso. Se concluye que la recomendación de rastreo mamográfico debe ser reconsiderada por las autoridades sanitarias brasileñas en cualquier edad.</style></abstract><urls><related-urls><url><style face="normal" font="default" size="100%">http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S0102-311X2016000500706</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2283</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2283</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Timire, C.</style></author><author><style face="normal" font="default" size="100%">Sandy, C.</style></author><author><style face="normal" font="default" size="100%">Ngwenya, M.</style></author><author><style face="normal" font="default" size="100%">Woznitza, N.</style></author><author><style face="normal" font="default" size="100%">Kumar, A. M. V.</style></author><author><style face="normal" font="default" size="100%">Takarinda, K. C.</style></author><author><style face="normal" font="default" size="100%">Sengai, T.</style></author><author><style face="normal" font="default" size="100%">Harries, A. D.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Ministry of Health and Child Care, National AIDS &amp; TB Programme, Harare, Zimbabwe.&#xD;International Union Against Tuberculosis and Lung Disease (The Union), Harare, Zimbabwe.&#xD;The Union, Paris, France.&#xD;World Health Organization, Harare Country Office, Zimbabwe.&#xD;Homerton University Hospital &amp; Canterbury Christ Church University, London, UK.&#xD;The Union, South East-Asia Office, New Delhi, India.&#xD;Yenepoya Medical College, Yenepoya (deemed University), Mangaluru, India.&#xD;Family AIDS Caring Trust (FACT), Mutare, Zimbabwe.&#xD;London School of Hygiene &amp; Tropical Medicine, London, UK.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Targeted active screening for tuberculosis in Zimbabwe: are field digital chest X-ray ratings reliable?</style></title><secondary-title><style face="normal" font="default" size="100%">Public Health Action</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Public Health Action</style></full-title></periodical><pages><style face="normal" font="default" size="100%">96-101</style></pages><volume><style face="normal" font="default" size="100%">9</style></volume><number><style face="normal" font="default" size="100%">3</style></number><keywords><keyword><style face="normal" font="default" size="100%">Cxr</style></keyword><keyword><style face="normal" font="default" size="100%">Sort-it</style></keyword><keyword><style face="normal" font="default" size="100%">diagnostic accuracy</style></keyword><keyword><style face="normal" font="default" size="100%">high-risk group</style></keyword><keyword><style face="normal" font="default" size="100%">inter-observer variability</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style face="normal" font="default" size="100%">Sep 21</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">2220-8372 (Print)&#xD;2220-8372</style></isbn><abstract><style face="normal" font="default" size="100%">SETTING: Fifteen purposively selected districts in Zimbabwe in which targeted active screening for tuberculosis (Tas4TB) was conducted among TB high-risk groups (HRGs). There were 230 patients started on TB treatment on the basis of chest X-ray (CXR) results without corresponding bacteriological confirmation. OBJECTIVES: To determine 1) the percentage of agreements in digital CXR ratings by medical officers against final ratings by radiologist(s), 2) inter-rater agreement in CXR ratings between medical officers and radiologists, and 3) number (and proportion) of patients belonging to HRGs who were over-treated during Tas4TB. DESIGN: This was a cross-sectional study using programme data. RESULTS: A total of 168 patients had their CXRs rated by two independent radiologists. Discordances among the radiologists were resolved by a third index radiologist, who provided the final rating. κ scores were 0.01 (field ratings vs. Radiologist A); 0.02 (field ratings vs. Radiologist B); 0.74 (Radiologists A vs. B). The percentage agreement for field and final radiologist rating was 70% (95%CI 64-78). Around 29% (95%CI 23-36) of the patients were potentially over-treated during Tas4TB. CONCLUSION: Over a quarter of patients with presumptive TB are potentially over-treated during Tas4TB. Over-treatment is highest among those with previous contact with TB patients. Trainings of radiographers and medical officers may improve CXR ratings.</style></abstract><label><style face="normal" font="default" size="100%">Included by Loai</style></label><notes><style face="normal" font="default" size="100%">2220-8372&#xD;Timire, C&#xD;Sandy, C&#xD;Ngwenya, M&#xD;Woznitza, N&#xD;Kumar, A M V&#xD;Takarinda, K C&#xD;Sengai, T&#xD;Harries, A D&#xD;001/WHO_/World Health Organization/International&#xD;D43 TW009539/TW/FIC NIH HHS/United States&#xD;Journal Article&#xD;Public Health Action. 2019 Sep 21;9(3):96-101. doi: 10.5588/pha.19.0003.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827497/pdf/i2220-8372-9-3-96.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC6827497</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.5588/pha.19.0003</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2284</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2284</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Torres-Castro, I.</style></author><author><style face="normal" font="default" size="100%">Hendauss-Waked, H.</style></author><author><style face="normal" font="default" size="100%">Baena-Rivero, A.</style></author><author><style face="normal" font="default" size="100%">Granados-Gómez, C. E.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Colsanitas, Bogotá, Colombia. tocais@yahoo.com</style></auth-address><titles><title><style face="normal" font="default" size="100%">[Lipid profile frequency and relevancy as an initial test for peripheral vertigo]</style></title><secondary-title><style face="normal" font="default" size="100%">Rev Salud Publica (Bogota)</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Rev Salud Publica (Bogota)</style></full-title></periodical><pages><style face="normal" font="default" size="100%">796-803</style></pages><volume><style face="normal" font="default" size="100%">13</style></volume><number><style face="normal" font="default" size="100%">5</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Aged, 80 and over</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Colombia/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Comorbidity</style></keyword><keyword><style face="normal" font="default" size="100%">Cost-Benefit Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Cross-Sectional Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Diagnostic Tests, Routine/economics/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Dyslipidemias/blood/diagnosis/economics/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">General Practice</style></keyword><keyword><style face="normal" font="default" size="100%">Hospitals, University/economics</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Lipids/*blood</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Medicine</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Outpatient Clinics, Hospital/economics</style></keyword><keyword><style face="normal" font="default" size="100%">Practice Patterns, Physicians&apos;/economics/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Retrospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Unnecessary Procedures/economics/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Vertigo/*blood/economics/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2011</style></year><pub-dates><date><style face="normal" font="default" size="100%">Oct</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0124-0064 (Print)&#xD;0124-0064</style></isbn><abstract><style face="normal" font="default" size="100%">OBJECTIVE: Determining the prevalence of requesting lipid profile as a first-line diagnostic method in patients having a clinical impression of peripheral vertigo and also determining such request&apos;s cost- benefit ratio. METHODS: This was a retrospective cross-sectional study of 201 clinical charts regarding patients diagnosed as having peripheral vertigo at the Teletón teaching hospital&apos;s outpatient services in Chía between January 2005 and July 2008. Clinical charts drawn up by both general practitioners and medical specialists at first-time visit were compiled and analyzed. RESULTS: The patients were aged 6 to 87 years old; 36 % were males and 64 % females. Lipid profile was requested for 76 % of the patients as initial diagnostic method; it was found that 80 % of the results revealed no abnormality. CONCLUSION: Although a high prevalence regarding a request for lipid profile first-line study was found for patients having peripheral vertigo, there was no scientific evidence supporting such requirement. Ordering this kind of study not only increases unnecessary costs concerning diagnostic methods but also involves unjustified treatment. Feedback is needed for both doctors and first attention staff to ensure that this type of practice becomes changed.</style></abstract><notes><style face="normal" font="default" size="100%">Torres-Castro, Isidro&#xD;Hendauss-Waked, Hassan&#xD;Baena-Rivero, Antonio&#xD;Granados-Gómez, Carlos E&#xD;Journal Article&#xD;Colombia&#xD;Rev Salud Publica (Bogota). 2011 Oct;13(5):796-803. doi: 10.1590/s0124-00642011000500008.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://scielosp.org/article/ssm/content/raw/?resource_ssm_path=/media/assets/rsap/v13n5/v13n5a08.pdf</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1590/s0124-00642011000500008</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2285</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2285</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Torres-Castro, Isidro</style></author><author><style face="normal" font="default" size="100%">Hendauss-Waked, Hassan</style></author><author><style face="normal" font="default" size="100%">Baena-Rivero, Antonio</style></author><author><style face="normal" font="default" size="100%">Granados-Gómez, Carlos E.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Frecuencia y pertinencia del perfil lipídico como examen inicial en vértigo periférico</style></title><secondary-title><style face="normal" font="default" size="100%">Rev. salud pública</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Rev. salud pública</style></full-title></periodical><pages><style face="normal" font="default" size="100%">796-803</style></pages><volume><style face="normal" font="default" size="100%">13</style></volume><number><style face="normal" font="default" size="100%">5</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Aged, 80 and over</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Diagnostic Tests, Routine</style></keyword><keyword><style face="normal" font="default" size="100%">Lipids/blood</style></keyword><keyword><style face="normal" font="default" size="100%">Practice Patterns, Physicians&amp;amp</style></keyword><keyword><style face="normal" font="default" size="100%">apos</style></keyword><keyword><style face="normal" font="default" size="100%">Unnecessary Procedures</style></keyword><keyword><style face="normal" font="default" size="100%">Vertigo/blood</style></keyword><keyword><style face="normal" font="default" size="100%">Comorbidity</style></keyword><keyword><style face="normal" font="default" size="100%">Cost-Benefit Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Cross-Sectional Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Colombia/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Diagnostic Tests, Routine/economics</style></keyword><keyword><style face="normal" font="default" size="100%">Dyslipidemias/blood</style></keyword><keyword><style face="normal" font="default" size="100%">Dyslipidemias/diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">Dyslipidemias/economics</style></keyword><keyword><style face="normal" font="default" size="100%">Dyslipidemias/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">General Practice</style></keyword><keyword><style face="normal" font="default" size="100%">Hospitals, University/economics</style></keyword><keyword><style face="normal" font="default" size="100%">Medicine</style></keyword><keyword><style face="normal" font="default" size="100%">Outpatient Clinics, Hospital/economics</style></keyword><keyword><style face="normal" font="default" size="100%">Practice Patterns, Physicians&amp;amp</style></keyword><keyword><style face="normal" font="default" size="100%">apos</style></keyword><keyword><style face="normal" font="default" size="100%">/economics</style></keyword><keyword><style face="normal" font="default" size="100%">Retrospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Unnecessary Procedures/economics</style></keyword><keyword><style face="normal" font="default" size="100%">Vertigo/economics</style></keyword><keyword><style face="normal" font="default" size="100%">Vertigo/epidemiology</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2011</style></year><pub-dates><date><style face="normal" font="default" size="100%">2011/10</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0124-0064</style></isbn><abstract><style face="normal" font="default" size="100%">Objetivos Determinar la prevalencia de la solicitud del perfil lipídico como ayuda diagnóstica de primera línea en pacientes con impresión clínica de vértigo periférico, así como un análisis de la relación costo-beneficio de dicha solicitud. Métodos Estudio de tipo corte transversal retrospectivo. Revisión de 201 historias de pacientes atendidos en la consulta externa tanto de especialistas como de médicos generales de la Clínica Universitaria Teletón y Casa chía, con diagnóstico de vértigo periférico, en el periodo comprendido entre enero de 2005 y julio de 2008. Resultados Las edades de los pacientes oscilaron entre 6 y 87 años, el 36 % de sexo masculino y el 64 % femenino. El perfil lipídico fue solicitado como prueba diagnóstica inicial para el manejo de vértigo a un 76 % de los pacientes. Los perfiles lipídicos hallados fueron normales en el 80 % de los pacientes a quienes se les solicitó. Se presenta el análisis de la relación costo-beneficio de esta prueba. Conclusiones Existe una alta prevalencia de solicitud de perfil lipídico como estudio de primera línea en el abordaje de pacientes con vértigo periférico, aunque no existe evidencia que avale esta solicitud, se requiere retroalimentación al cuerpo médico tanto de atención primaria como especialistas.&#xD;Objective Determining the prevalence of requesting lipid profile as a first-line diagnostic method in patients having a clinical impression of peripheral vertigo and also determining such request&amp;#039;s cost- benefit ratio. Methods This was a retrospective cross-sectional study of 201 clinical charts regarding patients diagnosed as having peripheral vertigo at the Teletón teaching hospital&amp;#039;s outpatient services in Chía between January 2005 and July 2008. Clinical charts drawn up by both general practitioners and medical specialists at first-time visit were compiled and analyzed Results The patients were aged 6 to 87 years old; 36 % were males and 64 % females. Lipid profile was requested for 76 % of the patients as initial diagnostic method; it was found that 80 % of the results revealed no abnormality. Conclusion Although a high prevalence regarding a request for lipid profile first-line study was found for patients having peripheral vertigo, there was no scientific evidence supporting such requirement. Ordering this kind of study not only increases unnecessary costs concerning diagnostic methods but also involves unjustified treatment. Feedback is needed for both doctors and first attention staff to ensure that this type of practice becomes changed.</style></abstract><urls><related-urls><url><style face="normal" font="default" size="100%">http://www.scielosp.org/scielo.php?script=sci_arttext&amp;amp;pid=S0124-00642011000500008</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2286</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2286</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Torres-Ruiz, M. F.</style></author><author><style face="normal" font="default" size="100%">Cárdenas-Lailson, L. E.</style></author><author><style face="normal" font="default" size="100%">Quiróz-Villegas, M. E.</style></author><author><style face="normal" font="default" size="100%">Bravo-León, J.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Servicio de Cirugía General del Hospital General Dr. Manuel Gea González, México, DF, Mexico. dratorresruiz@gmail.com.&#xD;Servicio de Cirugía General del Hospital General Dr. Manuel Gea González, México, DF, Mexico.</style></auth-address><titles><title><style face="normal" font="default" size="100%">[A standard questionnaire to reduce the routine battery of preoperative tests for elective surgery]</style></title><secondary-title><style face="normal" font="default" size="100%">Cir Cir</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Cir Cir</style></full-title></periodical><pages><style face="normal" font="default" size="100%">517-27</style></pages><volume><style face="normal" font="default" size="100%">82</style></volume><number><style face="normal" font="default" size="100%">5</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Aged, 80 and over</style></keyword><keyword><style face="normal" font="default" size="100%">Confidence Intervals</style></keyword><keyword><style face="normal" font="default" size="100%">Cost Savings</style></keyword><keyword><style face="normal" font="default" size="100%">Diagnosis-Related Groups</style></keyword><keyword><style face="normal" font="default" size="100%">*Diagnostic Tests, Routine/economics/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">*Elective Surgical Procedures/economics</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Medical History Taking</style></keyword><keyword><style face="normal" font="default" size="100%">Mexico</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Predictive Value of Tests</style></keyword><keyword><style face="normal" font="default" size="100%">Preoperative Care/economics/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Prospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Sensitivity and Specificity</style></keyword><keyword><style face="normal" font="default" size="100%">*Surveys and Questionnaires</style></keyword><keyword><style face="normal" font="default" size="100%">*Unnecessary Procedures/economics</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Preoperative test</style></keyword><keyword><style face="normal" font="default" size="100%">cirugía electiva</style></keyword><keyword><style face="normal" font="default" size="100%">cuestionario</style></keyword><keyword><style face="normal" font="default" size="100%">elective surgery</style></keyword><keyword><style face="normal" font="default" size="100%">estandarizado</style></keyword><keyword><style face="normal" font="default" size="100%">estudios preoperatorios</style></keyword><keyword><style face="normal" font="default" size="100%">questionnaire</style></keyword><keyword><style face="normal" font="default" size="100%">standardization</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style face="normal" font="default" size="100%">Sep-Oct</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0009-7411</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: Preoperative medical testing in the United States is estimated at $3,000,000 USD per year. In an attempt to reduce this cost, some key points have been described with the purpose of promoting appropriate preoperative measurements with an adequate costObjective: To evaluate the utility of a preoperative standardized questionnaire in adult patients prior to elective surgery to detect which patients could be operated without laboratory testing. METHOD: An observational, prospective and analytic study was carried out. The questionnaire has been applied to 176 patients, all adults scheduled for elective surgery from April 2011 to March 2012. RESULTS: There were 57.4% females and 42.6% males. Ages varied between 18 and 85 years old, with a median of 46 years; 40.3% of the patients were &gt; 50 years old and 59.7% were &lt; 50 years old. The negative predictive value of the questionnaire is 95.88% (CI 95.34-96.42%). CONCLUSION: This questionnaire is a useful instrument to determinate the necessity of preoperative laboratory testing in young, clinical healthy and elective surgery patients in a general hospital.</style></abstract><label><style face="normal" font="default" size="100%">Included by Loai</style></label><notes><style face="normal" font="default" size="100%">2444-054x&#xD;Torres-Ruiz, María Fernanda&#xD;Cárdenas-Lailson, Luis Eduardo&#xD;Quiróz-Villegas, Martha Esthela&#xD;Bravo-León, Jesús&#xD;Journal Article&#xD;Observational Study&#xD;Mexico&#xD;Cir Cir. 2014 Sep-Oct;82(5):517-27.</style></notes><urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2287</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2287</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Vaccarella, S.</style></author><author><style face="normal" font="default" size="100%">Lortet-Tieulent, J.</style></author><author><style face="normal" font="default" size="100%">Colombet, M.</style></author><author><style face="normal" font="default" size="100%">Davies, L.</style></author><author><style face="normal" font="default" size="100%">Stiller, C. A.</style></author><author><style face="normal" font="default" size="100%">Schüz, J.</style></author><author><style face="normal" font="default" size="100%">Togawa, K.</style></author><author><style face="normal" font="default" size="100%">Bray, F.</style></author><author><style face="normal" font="default" size="100%">Franceschi, S.</style></author><author><style face="normal" font="default" size="100%">Dal Maso, L.</style></author><author><style face="normal" font="default" size="100%">Steliarova-Foucher, E.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Section of Cancer Surveillance, International Agency for Research on Cancer (IARC), Lyon, France. Electronic address: vaccarella@iarc.fr.&#xD;Section of Cancer Surveillance, International Agency for Research on Cancer (IARC), Lyon, France.&#xD;VA Outcomes Group, Department of Veterans Affairs Medical Center, White River Junction, VT, USA; Dartmouth Institute for Health Policy and Clinical Outcomes, Lebanon, NH, USA.&#xD;National Cancer Registration and Analysis Service, Public Health England, Oxford, UK.&#xD;Section of Environment and Radiation, International Agency for Research on Cancer (IARC), Lyon, France.&#xD;Cancer Epidemiology Unit, Centro di Riferimento Oncologico di Aviano, IRCCS, Aviano, Italy.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Global patterns and trends in incidence and mortality of thyroid cancer in children and adolescents: a population-based study</style></title><secondary-title><style face="normal" font="default" size="100%">Lancet Diabetes Endocrinol</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Lancet Diabetes Endocrinol</style></full-title></periodical><pages><style face="normal" font="default" size="100%">144-152</style></pages><volume><style face="normal" font="default" size="100%">9</style></volume><number><style face="normal" font="default" size="100%">3</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Age of Onset</style></keyword><keyword><style face="normal" font="default" size="100%">Cause of Death/trends</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Child Mortality</style></keyword><keyword><style face="normal" font="default" size="100%">Child, Preschool</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Global Health/statistics &amp; numerical data/*trends</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Incidence</style></keyword><keyword><style face="normal" font="default" size="100%">Infant</style></keyword><keyword><style face="normal" font="default" size="100%">Infant, Newborn</style></keyword><keyword><style face="normal" font="default" size="100%">Life Expectancy/trends</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Medical Overuse/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Thyroid Neoplasms/diagnosis/*epidemiology/*mortality</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2021</style></year><pub-dates><date><style face="normal" font="default" size="100%">Mar</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">2213-8587</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: There has been a considerable increase in thyroid cancer incidence among adults in several countries in the past three decades, attributed primarily to overdiagnosis. We aimed to assess global patterns and trends in incidence and mortality of thyroid cancer in children and adolescents, in view of the increased incidence among adults. METHODS: We did a population-based study of the observed incidence (in 49 countries and territories) and mortality (in 27 countries) of thyroid cancer in children and adolescents aged 0-19 years using data from the International Incidence of Childhood Cancer Volume 3 study database, the WHO mortality database, and the cancer incidence in five continents database (CI5plus; for adult data [age 20-74 years]). We analysed temporal trends in incidence rates, including absolute changes in rates, and the strength of the correlation between incidence rates in children and adolescents and in adults. We calculated the average annual number of thyroid cancer deaths and the age-standardised mortality rates for children and adolescents. FINDINGS: Age-standardised incidence rates of thyroid cancer among children and adolescents aged 0-19 years ranged from 0·4 (in Uganda and Kenya) to 13·4 (in Belarus) cancers per 1 million person-years in 2008-12. The variability in the incidence rates was mostly accounted for by the papillary tumour subtype. Incidence rates were almost always higher in girls than in boys and increased with age in both sexes. Rapid increases in incidence between 1998-2002 and 2008-12 were observed in almost all countries. Country-specific incidence rates in children and adolescents were strongly correlated (r&gt;0·8) with rates in adults, as were the temporal changes in the respective incidence rates (r&gt;0·6). Thyroid cancer deaths in those aged younger than 20 years were less than 0·1 per 10 million person-years in each country. INTERPRETATION: The pattern of thyroid cancer incidence in children and adolescents mirrors the pattern seen in adults, suggesting a major role for overdiagnosis, which, in turn, can lead to overtreatment, lifelong medical care, and side effects that can negatively affect quality of life. We suggest that the existing recommendation against screening for thyroid cancer in the asymptomatic adult population who are free from specific risk factors should be extended to explicitly recommend against screening for thyroid cancer in similar populations of children and adolescents. FUNDING: International Agency for Research on Cancer and the Union for International Cancer Control; French Institut National du Cancer; Italian Association of Cancer Research; and Italian Ministry of Health.</style></abstract><label><style face="normal" font="default" size="100%">Included by Eman</style></label><notes><style face="normal" font="default" size="100%">2213-8595&#xD;Vaccarella, Salvatore&#xD;Lortet-Tieulent, Joannie&#xD;Colombet, Murielle&#xD;Davies, Louise&#xD;Stiller, Charles A&#xD;Schüz, Joachim&#xD;Togawa, Kayo&#xD;Bray, Freddie&#xD;Franceschi, Silvia&#xD;Dal Maso, Luigino&#xD;Steliarova-Foucher, Eva&#xD;IICC-3 contributors&#xD;Journal Article&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Lancet Diabetes Endocrinol. 2021 Mar;9(3):144-152. doi: 10.1016/S2213-8587(20)30401-0. Epub 2021 Jan 19.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.thelancet.com/journals/landia/article/PIIS2213-8587(20)30401-0/fulltext</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1016/s2213-8587(20)30401-0</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2288</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2288</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Vakili, M.</style></author><author><style face="normal" font="default" size="100%">Shirani, S.</style></author><author><style face="normal" font="default" size="100%">Paknejad, O.</style></author><author><style face="normal" font="default" size="100%">Yousefshahi, F.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Internal Medicine, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran. manzarvakili940@gmail.com.&#xD;Department of Cardiology, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran. yousefshahi@tums.ac.ir.&#xD;Department of Internal Medicine, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran. opaknjd@tums.ac.ir.&#xD;Women Hospital, Tehran University of Medical Sciences, Tehran, Iran. yousefshahi@tums.ac.ir.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Acute Respiratory Distress Syndrome diagnosis after coronary artery bypass: comparison between diagnostic criteria and clinical picture</style></title><secondary-title><style face="normal" font="default" size="100%">Acta Med Iran</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Acta Med Iran</style></full-title></periodical><pages><style face="normal" font="default" size="100%">51-6</style></pages><volume><style face="normal" font="default" size="100%">53</style></volume><number><style face="normal" font="default" size="100%">1</style></number><keywords><keyword><style face="normal" font="default" size="100%">Blood Gas Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Coronary Artery Bypass/*adverse effects</style></keyword><keyword><style face="normal" font="default" size="100%">Coronary Artery Disease/*surgery</style></keyword><keyword><style face="normal" font="default" size="100%">Diagnosis, Differential</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Follow-Up Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Intensive Care Units</style></keyword><keyword><style face="normal" font="default" size="100%">Iran</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Postoperative Complications</style></keyword><keyword><style face="normal" font="default" size="100%">Prospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Respiratory Distress Syndrome/*diagnosis/etiology</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2015</style></year></dates><isbn><style face="normal" font="default" size="100%">0044-6025</style></isbn><abstract><style face="normal" font="default" size="100%">Acute Respiratory Distress Syndrome (ARDS) is a potential complication of cardiac surgery, given that patients undergoing CABG frequently have hypoxemia and pulmonary dysfunction during initial hours after surgery. Thus, ARDS criteria in these patients are more likely to be positive while these criteria may not match the patient`s clinical picture. We aimed to investigate frequency of rapid onset hypoxemia in Pressure of Arterial Oxygen to Fractional Inspired Oxygen Concentration (PaO2/FiO2) less than 200 and diffuse pulmonary infiltrates as two diagnostic criteria forwards and compared these criteria with the clinical picture of the patients after Coronary Artery Bypass Graft (CABG) in this study. The study was prospective case series which carried out in about six months. All patients admitted to intensive care unit of Tehran Heart Center, who had undergone CABG on cardiopulmonary pump (CPB) recruited in the study. After considering inclusion criteria, age, sex, duration of intubation, arterial blood gas and chest radiography, on 24 hours and 48 hours after admission to the ICU were recorded. Then, patients with rapid onset of hypoxemia (PaO2/FiO2≤200mmHg) and diffuse pulmonary infiltrates and without sign or symptoms of obvious heart failure (probable positive ARDS cases) criteria were recorded and comparison between these probable positive cases with clinician`s clinical diagnosis (blinded to the study) was performed. In this study, a total of 300 patients after on-pump coronary artery bypass surgery were included. Postoperatively, 2 (0.66 %) in the 24 hours and 4 (1.33%) patients in 48 hours after surgery were positive for the two ARDS criteria according to the checklists, but; nobody had saved persistently ARDS criteria persistently during 48 hours after surgery. At the same time, clinician did not report any case of ARDS among 300 patients. In this study patients with ARDS criteria had no significant differences in age (P.value=0.937) and sex (P.value=0.533). Duration of intubation in patients with ARDS (14.26 ± 4.25 hours) in the first 48 hours was higher but not statistically different from the group without ARDS (11.60 ± 5.45 hours) (P.value=0.236). ARDS diagnosis based on rapid onset of hypoxemia (PaO2/FiO2≤200 mmHg) and diffuse pulmonary infiltrates and without signs or symptoms of obvious heart failure criteria in patients undergoing CABG could lead to overdiagnosis or misdiagnosis in less than 24 hours follow up. We recommend following patients for more than 24 hours and revise the current ARDS criteria for CABG patients.</style></abstract><label><style face="normal" font="default" size="100%">Included by Morty</style></label><notes><style face="normal" font="default" size="100%">1735-9694&#xD;Vakili, Manzar&#xD;Shirani, Shapour&#xD;Paknejad, Omalbanin&#xD;Yousefshahi, Fardin&#xD;Comparative Study&#xD;Journal Article&#xD;Iran&#xD;Acta Med Iran. 2015;53(1):51-6.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://acta.tums.ac.ir/index.php/acta/article/download/4936/4287</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2289</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2289</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">van Bogaert, L. J.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Pathology, National Health Laboratory Service, University of Limpopo, Polokwane, Limpopo Province, South Africa.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Influence of knowledge of human immunodeficiency virus serostatus on accuracy of cervical cytologic diagnosis</style></title><secondary-title><style face="normal" font="default" size="100%">Cancer Cytopathol</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Cancer Cytopathol</style></full-title></periodical><pages><style face="normal" font="default" size="100%">909-13</style></pages><volume><style face="normal" font="default" size="100%">122</style></volume><number><style face="normal" font="default" size="100%">12</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Carcinoma, Squamous Cell/*diagnosis/virology</style></keyword><keyword><style face="normal" font="default" size="100%">Cervical Intraepithelial Neoplasia/*diagnosis/virology</style></keyword><keyword><style face="normal" font="default" size="100%">Cytodiagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">Electrosurgery</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Follow-Up Studies</style></keyword><keyword><style face="normal" font="default" size="100%">HIV/*pathogenicity</style></keyword><keyword><style face="normal" font="default" size="100%">HIV Seropositivity/*diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Incidence</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Neoplasm Staging</style></keyword><keyword><style face="normal" font="default" size="100%">Prognosis</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">South Africa/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Uterine Cervical Neoplasms/*diagnosis/virology</style></keyword><keyword><style face="normal" font="default" size="100%">Vaginal Smears</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword><keyword><style face="normal" font="default" size="100%">accuracy</style></keyword><keyword><style face="normal" font="default" size="100%">cervical screening</style></keyword><keyword><style face="normal" font="default" size="100%">human immunodeficiency virus (HIV)</style></keyword><keyword><style face="normal" font="default" size="100%">loop electrosurgical excision procedure (LEEP)</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style face="normal" font="default" size="100%">Dec</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1934-662x</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: Women who are infected with the human immunodeficiency virus (HIV) are at high risk of human papillomavirus-persistent infections. Invasive cervical cancer is listed among the illnesses associated with the acquired immunodeficiency syndrome. The objective of the current study was to investigate whether, in South Africa, the accuracy of abnormal cytology confirmed by a histological diagnosis using loop electrosurgical excision procedure (LEEP) is affected by knowledge of the woman&apos;s HIV serostatus. METHODS: Of 7648 biopsy specimens, 941 were LEEPs indicated by a cytology report of low-grade squamous intraepithelial lesion or high-grade squamous intraepithelial lesion. A total of 618 specimens (65.7%) were from HIV-uninfected women and 323 specimens (34.3%) were from HIV-infected women. Those women with an unknown pre-LEEP cytological diagnosis were excluded from the study. RESULTS: The total prevalence of HIV infection among the 7648 patients was 18.6%, reflecting its prevalence in the general population of women aged 15 to 49 years. The rate of HIV infection among 3462 women with invasive cervical cancer was 10.7%. The overall prevalence of preinvasive lesions was 73.9% in HIV-infected women compared with 50.3% in women not infected with HIV (P&lt;.0001). The concordance and discordance rates between cytology and histology were similar in uninfected and infected women (P =.93 and P =.18, respectively). Among HIV-infected women, 79.1% of discordant results were due to cytological overdiagnosis; among HIV-negative women, 86.5% of discordant results were due to underdiagnosis (P&lt;.0001). CONCLUSIONS: It appears that the finding of a higher prevalence of preinvasive lesions combined with the knowledge of a patient&apos;s HIV-positive serostatus prompts more cytological overdiagnosis, thereby resulting in avoidable LEEP interventions.</style></abstract><notes><style face="normal" font="default" size="100%">1934-6638&#xD;van Bogaert, Louis-Jacques&#xD;Journal Article&#xD;United States&#xD;Cancer Cytopathol. 2014 Dec;122(12):909-13. doi: 10.1002/cncy.21487. Epub 2014 Sep 29.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://acsjournals.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncy.21487?download=true</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1002/cncy.21487</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2290</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2290</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Van Dillen, J.</style></author><author><style face="normal" font="default" size="100%">De Jager, A. J.</style></author><author><style face="normal" font="default" size="100%">De Jong, I.</style></author><author><style face="normal" font="default" size="100%">Wendte, J. F.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Overdiagnosis of malaria in hospitalized patients in Namibia</style></title><secondary-title><style face="normal" font="default" size="100%">Trop Doct</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Trop Doct</style></full-title></periodical><pages><style face="normal" font="default" size="100%">185-6</style></pages><volume><style face="normal" font="default" size="100%">37</style></volume><number><style face="normal" font="default" size="100%">3</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Animals</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Child, Preschool</style></keyword><keyword><style face="normal" font="default" size="100%">*Diagnostic Errors</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">*Hospitalization</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Malaria/*diagnosis/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">*Medical Audit</style></keyword><keyword><style face="normal" font="default" size="100%">Namibia/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Rural Population</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2007</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jul</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0049-4755 (Print)&#xD;0049-4755</style></isbn><label><style face="normal" font="default" size="100%">Included by Ray</style></label><notes><style face="normal" font="default" size="100%">Van Dillen, J&#xD;De Jager, A J&#xD;De Jong, I&#xD;Wendte, J F&#xD;Letter&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Trop Doct. 2007 Jul;37(3):185-6. doi: 10.1258/004947507781524845.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://journals.sagepub.com/doi/10.1258/004947507781524845?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%3dpubmed</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1258/004947507781524845</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2291</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2291</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Vassilakos, P.</style></author><author><style face="normal" font="default" size="100%">Wisniak, A.</style></author><author><style face="normal" font="default" size="100%">Catarino, R.</style></author><author><style face="normal" font="default" size="100%">Tincho Foguem, E.</style></author><author><style face="normal" font="default" size="100%">Balli, C.</style></author><author><style face="normal" font="default" size="100%">Saiji, E.</style></author><author><style face="normal" font="default" size="100%">Tille, J. C.</style></author><author><style face="normal" font="default" size="100%">Kenfack, B.</style></author><author><style face="normal" font="default" size="100%">Petignat, P.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Pediatrics, Gynecology and Obstetrics, Geneva University Hospitals, Geneva, Switzerland.&#xD;Geneva Foundation for Medical Education and Research, Geneva, Switzerland.&#xD;Department of Pediatrics, Gynecology and Obstetrics, Geneva University Hospitals, Geneva, Switzerland ania.wisniak@hcuge.ch.&#xD;Department of Biomedical Sciences, University of Dschang Faculty of Sciences, Dschang, Cameroon.&#xD;Division of Clinical Pathology, Diagnostic Department, Geneva University Hospitals, Geneva, Switzerland.</style></auth-address><titles><title><style face="normal" font="default" size="100%">A cross-sectional study exploring triage of human papillomavirus (HPV)-positive women by visual assessment, manual and computer-interpreted cytology, and HPV-16/18-45 genotyping in Cameroon</style></title><secondary-title><style face="normal" font="default" size="100%">Int J Gynecol Cancer</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Int J Gynecol Cancer</style></full-title></periodical><keywords><keyword><style face="normal" font="default" size="100%">cervical cancer</style></keyword><keyword><style face="normal" font="default" size="100%">pathology</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2021</style></year><pub-dates><date><style face="normal" font="default" size="100%">Apr 8</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1048-891x</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: High-risk human papillomavirus (HPV)-positive women require triage to identify those at higher risk of cervical intraepithelial neoplasia grade 2 or worse (CIN2+). We aimed to compare visual assessment of the cervix, manual cytology and automated cytology as triage tests to screen HPV-positive women, and to assess over-treatment rates after visual assessment and over-referral rates to colposcopy after cytology. METHODS: The present cross-sectional study is nested in a large prospective screening trial in Cameroon. Evaluations of the tests have been conducted individually and in combination with HPV-16/HPV-18/45 genotyping. For the evaluation of over-treatment and colposcopic over-referral, we simulated two screening scenarios: (1) one-visit scenario (test-triage-and-treatment); and (2) two-visit scenario (test-triage-and-colposcopy). RESULTS: 1582 women with a median age of 40 years (IQR 35-45) performed self-sampling for HPV testing, of which 294 (18.6%) were HPV-positive, and 12.2% had CIN2+. Sensitivities for CIN2+ detection were 77.1% for visual assessment, 80.0% for manual cytology, and 84.8% for automated cytology. Sensitivity of combined tests was higher compared with single tests. The highest sensitivity was obtained by the combination of genotyping and automated cytology (91.2%). In the one-visit scenario, the over-treatment rate was 83.9% in referred women, with a ratio of 6.2 treated women per CIN2+. In the two-visit scenario, the lowest over-referral rate would have been under manual cytology (45.0%), with a ratio of 1.8 referred women per CIN2+. Single and combined triage strategies by automated cytology gave rise to over-referral rates of 69.2% and 76.7%, respectively, and a ratio of 3.2 and 4.3 referred women per CIN2+, respectively. DISCUSSION: Triage of HPV-positive women using a combination of genotyping and automated cytology for CIN2+ detection may provide public benefits in low- and middle-income countries.</style></abstract><label><style face="normal" font="default" size="100%">Included by Hannah</style></label><notes><style face="normal" font="default" size="100%">1525-1438&#xD;Vassilakos, Pierre&#xD;Wisniak, Ania&#xD;Orcid: 0000-0002-3942-2134&#xD;Catarino, Rosa&#xD;Tincho Foguem, Eveline&#xD;Balli, Christine&#xD;Saiji, Essia&#xD;Tille, Jean-Christophe&#xD;Kenfack, Bruno&#xD;Petignat, Patrick&#xD;Journal Article&#xD;England&#xD;Int J Gynecol Cancer. 2021 Apr 8:ijgc-2020-002302. doi: 10.1136/ijgc-2020-002302.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://ijgc.bmj.com/content/ijgc/early/2021/04/07/ijgc-2020-002302.full.pdf</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1136/ijgc-2020-002302</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2292</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2292</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Veedu, J. S.</style></author><author><style face="normal" font="default" size="100%">Veedu, E. S.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">J.S. Veedu, Department of Internal Medicine, University of Kentucky, Lexington, KY, United States</style></auth-address><titles><title><style face="normal" font="default" size="100%">Overdiagnosis of thyroid cancer: A problem of greater access to healthcare</style></title><secondary-title><style face="normal" font="default" size="100%">Anticancer Research</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Anticancer Research</style></full-title></periodical><pages><style face="normal" font="default" size="100%">5836</style></pages><volume><style face="normal" font="default" size="100%">39</style></volume><number><style face="normal" font="default" size="100%">10</style></number><keywords><keyword><style face="normal" font="default" size="100%">adult</style></keyword><keyword><style face="normal" font="default" size="100%">cancer registry</style></keyword><keyword><style face="normal" font="default" size="100%">conference abstract</style></keyword><keyword><style face="normal" font="default" size="100%">controlled study</style></keyword><keyword><style face="normal" font="default" size="100%">developing country</style></keyword><keyword><style face="normal" font="default" size="100%">differentiated thyroid cancer</style></keyword><keyword><style face="normal" font="default" size="100%">educational status</style></keyword><keyword><style face="normal" font="default" size="100%">female</style></keyword><keyword><style face="normal" font="default" size="100%">government</style></keyword><keyword><style face="normal" font="default" size="100%">groups by age</style></keyword><keyword><style face="normal" font="default" size="100%">health care access</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">incidence</style></keyword><keyword><style face="normal" font="default" size="100%">Kerala</style></keyword><keyword><style face="normal" font="default" size="100%">male</style></keyword><keyword><style face="normal" font="default" size="100%">mortality rate</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2019</style></year></dates><isbn><style face="normal" font="default" size="100%">1791-7530</style></isbn><abstract><style face="normal" font="default" size="100%">Background: Access to cancer care is a major problem worldwide, leading to poor outcomes. However, overdiagnosis due to improved access is an ignored phenomenon. The incidence of differentiated thyroid cancer, especially papillary, has been rising worldwide, including India. A large proportion of this is attributed to the phenomenon of overdiagnosis. Materials and Methods: We analyzed the incident rate of thyroid cancers using data from Population Based Cancer Registries compiled by the National Cancer Registry Program of the Government of India from 14 regions which reported data from 2004/05 to 2013/14. Results: There was a relative increase of 62% and 48% in incidence rate of thyroid cancer in women and men, respectively. The relative increase was highest in age groups &lt;30 years (121%) and 30-44 years (107%), and similarly in men of age group &lt;45 years. In Kerala state in India, there was a 93% increase in incidence over a decade. The incidence was four-fold higher there compared with other regions, but the mortality rate remained stable, suggesting overdiagnosis as the most plausible etiology. Conclusion: The dramatic rise in incidence of thyroid cancer in India is likely due to overdiagnosis. Overdiagnosis was a problem in developed nations but with changing epidemiology and greater access to care, this phenomenon is also occurring in developing countries. India is seeing a mushrooming of diagnostic laboratories and imaging modalities. Kerala with its high socioeconomic and educational status has healthcare access and quality of a developed region. This is probably the driver for the high incidence of thyroid cancer in the state. Access to healthcare can be a double-edged sword.</style></abstract><label><style face="normal" font="default" size="100%">Included by Thanya</style></label><notes><style face="normal" font="default" size="100%">L629806649&#xD;2019-11-14</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.embase.com/search/results?subaction=viewrecord&amp;id=L629806649&amp;from=export</style></url><url><style face="normal" font="default" size="100%">http://dx.doi.org/10.21873/anticanres.13787</style></url><url><style face="normal" font="default" size="100%">https://ar.iiarjournals.org/content/anticanres/39/10/5831.full.pdf</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.21873/anticanres.13787</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2293</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2293</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Velicković, J. V.</style></author><author><style face="normal" font="default" size="100%">Hajdarević, S. A.</style></author><author><style face="normal" font="default" size="100%">Palibrk, I. G.</style></author><author><style face="normal" font="default" size="100%">Janić, N. R.</style></author><author><style face="normal" font="default" size="100%">Djukanović, M.</style></author><author><style face="normal" font="default" size="100%">Miljković, B.</style></author><author><style face="normal" font="default" size="100%">Velicković, D. M.</style></author><author><style face="normal" font="default" size="100%">Bumbasirević, V.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Routine chest radiographs in the surgical intensive care unit: can we change clinical habits with no proven benefit?</style></title><secondary-title><style face="normal" font="default" size="100%">Acta Chir Iugosl</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Acta Chir Iugosl</style></full-title></periodical><pages><style face="normal" font="default" size="100%">39-44</style></pages><volume><style face="normal" font="default" size="100%">60</style></volume><number><style face="normal" font="default" size="100%">3</style></number><keywords><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Critical Care/methods/standards</style></keyword><keyword><style face="normal" font="default" size="100%">Digestive System Surgical Procedures</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">*Intensive Care Units</style></keyword><keyword><style face="normal" font="default" size="100%">Length of Stay</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Postoperative Period</style></keyword><keyword><style face="normal" font="default" size="100%">Prospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Radiography, Thoracic/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Serbia</style></keyword><keyword><style face="normal" font="default" size="100%">*Unnecessary Procedures</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2013</style></year></dates><isbn><style face="normal" font="default" size="100%">0354-950X (Print)&#xD;0354-950x</style></isbn><abstract><style face="normal" font="default" size="100%">Daily routine chest radiographs (CR) are commonly performed in surgical ICU. Unnecessary CR increase costs and expose the staff and the patients to radiation risk. The goal of our study was to estimate the value of daily routine CR in the ICU and to determine the correlation between CR and physical findings in surgical ICU patients. Prospective observational study was conducted during period of two months at the ICU department at the Clinic for Digestive Surgery, Clinical Center of Serbia, Belgrade. It included 97 consecutive patients who underwent digestive surgery and stayed at the ICU for at least two days. During their ICU stay, CRs were obtained as a clinical routine or to monitor lung pathology. Patients were followed daily, and CRs (as the proportion of positive findings) were compared with physical examination and clinical presentation. A total of 717 CRs were obtained, median number per patient was 4.0 (2.0-7.0). Proportion of positive findings was significantly higher comparing to auscultation until the sixth day of ICU stay. There was no difference in CR findings from day to day after the sixth day. Therapeutic efficacy of CRs was low as only 56 (7.8%) resulted in a change of patient management. We conclude that daily routine CRs are justified in the first six days of ICU stay, and after that time they show no advantages over clinical examination.</style></abstract><label><style face="normal" font="default" size="100%">Included by Loai</style></label><notes><style face="normal" font="default" size="100%">Velicković, Jelena V&#xD;Hajdarević, Sanela A&#xD;Palibrk, Ivan G&#xD;Janić, Natasa R&#xD;Djukanović, Marija&#xD;Miljković, Bojana&#xD;Velicković, Dejan M&#xD;Bumbasirević, Vesna&#xD;Journal Article&#xD;Observational Study&#xD;Serbia&#xD;Acta Chir Iugosl. 2013;60(3):39-44. doi: 10.2298/aci1303039v.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">http://www.doiserbia.nb.rs/img/doi/0354-950X/2013/0354-950X1303039V.pdf</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.2298/aci1303039v</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2294</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2294</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Ventura-Alfaro, Carmelita E.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Errores de medición en la interpretación mamográfica por radiólogos</style></title><secondary-title><style face="normal" font="default" size="100%">Rev. salud pública</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Rev. salud pública</style></full-title></periodical><pages><style face="normal" font="default" size="100%">518-522</style></pages><volume><style face="normal" font="default" size="100%">20</style></volume><number><style face="normal" font="default" size="100%">4</style></number><keywords><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Breast Neoplasms/diagnostic imaging</style></keyword><keyword><style face="normal" font="default" size="100%">Mammography/instrumentation</style></keyword><keyword><style face="normal" font="default" size="100%">Image Interpretation, Computer-Assisted</style></keyword><keyword><style face="normal" font="default" size="100%">Diagnostic Errors/trends</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style face="normal" font="default" size="100%">2018/08</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0124-0064</style></isbn><abstract><style face="normal" font="default" size="100%">RESUMEN La detección oportuna de cáncer de mama se realiza mediante mamografía; sin embargo, se debe prestar atención a la calidad de la misma para su realización e interpretación. A pesar de recientes mejoras en el control de calidad de la mamografía, la interpretación todavía depende de cada lector; por lo que se pueden cometer errores en la interpretación mamográfica y éstos pueden producir biopsias no necesarias y/o sobre-diagnóstico, reportándose consecuencias físicas, económicas y psicológicas sostenidas; debido a que la interpretación obedece a la habilidad perceptiva y cognitiva del médico radiólogo. Sin embargo, se requiere de un amplio conocimiento de los posibles errores que puede haber en la interpretación de mamografías, y la forma en que pueden minimizarse, prevenirse y/o corregirse con el fin de ofrecer a la paciente la mayor seguridad posible.(AU)&#xD;ABSTRACT The timely detection of breast cancer is achieved through mammography; however, the quality of the procedure should be addressed for proper performance and interpretation. Despite recent improvements in quality assurance in mammography, interpretation still depends on each reader; therefore, errors can be made when interpreting screening mammograms, leading to unnecessary biopsies and/or overdiagnosis, with sustained physical, economic and psychological consequences. Since interpretation is related to the perceptive and cognitive ability of the radiologist, it is necessary to have extensive knowledge about the possible errors that may occur during interpretation, as well as of the way how they can be reduced, prevented and/or corrected to provide the patient with the highest possible level of safety.(AU)</style></abstract><label><style face="normal" font="default" size="100%">Included by Eman</style></label><urls><related-urls><url><style face="normal" font="default" size="100%">http://www.scielo.org.co/scielo.php?script=sci_arttext&amp;amp;pid=S0124-00642018000400518</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2295</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2295</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Veronese, F. V.</style></author><author><style face="normal" font="default" size="100%">Gomes, E. C.</style></author><author><style face="normal" font="default" size="100%">Chanan, J.</style></author><author><style face="normal" font="default" size="100%">Carraro, M. A.</style></author><author><style face="normal" font="default" size="100%">Camargo, E. G.</style></author><author><style face="normal" font="default" size="100%">Soares, A. A.</style></author><author><style face="normal" font="default" size="100%">Thomé, F. S.</style></author><author><style face="normal" font="default" size="100%">Silveiro, S. P.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Performance of CKD-EPI equation to estimate glomerular filtration rate as compared to MDRD equation in South Brazilian individuals in each stage of renal function</style></title><secondary-title><style face="normal" font="default" size="100%">Clin Chem Lab Med</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Clin Chem Lab Med</style></full-title></periodical><pages><style face="normal" font="default" size="100%">1747-54</style></pages><volume><style face="normal" font="default" size="100%">52</style></volume><number><style face="normal" font="default" size="100%">12</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Aged, 80 and over</style></keyword><keyword><style face="normal" font="default" size="100%">*Algorithms</style></keyword><keyword><style face="normal" font="default" size="100%">Brazil</style></keyword><keyword><style face="normal" font="default" size="100%">Chromium Radioisotopes/chemistry</style></keyword><keyword><style face="normal" font="default" size="100%">Creatinine/blood</style></keyword><keyword><style face="normal" font="default" size="100%">Cross-Sectional Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Glomerular Filtration Rate/*physiology</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Logistic Models</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Odds Ratio</style></keyword><keyword><style face="normal" font="default" size="100%">Renal Insufficiency, Chronic/*physiopathology</style></keyword><keyword><style face="normal" font="default" size="100%">Severity of Illness Index</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style face="normal" font="default" size="100%">Dec</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1434-6621</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation seems to correct the overdiagnosis of chronic kidney disease (CKD) provided by Modification of Diet in Renal Disease (MDRD) equation. However, this point has not been tested in some ethnic groups. This study investigated the performance of MDRD and CKD-EPI equations in South Brazilian individuals. METHODS: This cross-sectional study included 354 individuals including healthy volunteers, diabetic and non-diabetic individuals with or without CKD. Glomerular filtration rate (GFR) was measured by the 51Cr-EDTA single-injection method (51Cr-GFR). Accuracy (P30), bias, and Bland-Altman agreement plots were evaluated. RESULTS: In the group as a whole, 51Cr-GFR was 87±37 (6-187), CKD-EPI eGFR, 82±30 (6-152), and MDRD eGFR, 77±28 (6-156) mL/min/1.73 m2 (p&lt;0.001 for all comparisons). Analyzing the subset of individuals with 51Cr-GFR &lt;60 mL/min/1.73 m2, P30 values were, respectively, 76% and 84% for MDRD and for CKD-EPI (p&lt;0.001) while for 51Cr-GFR ≥60 mL/min/1.73 m2, P30 values were 57.5% for both equations (p=1.000). For MDRD and CKD-EPI, mean bias were negative for GFRs &lt;60 (-11 vs. -12, p=0.221) and positive for values &gt;60 (16 vs. 9, p&lt;0.001). In multivariate analysis, absolute bias was unfavorably influenced by measured GFR &gt;60 (for MDRD) and being diabetic or younger (for CKD-EPI). CONCLUSIONS: CKD-EPI reduces GFR underestimation in individuals with GFRs &gt;60, but still presents a quite low accuracy at this GFR range. Moreover, it tends to overestimate GFR in subjects with GFRs &lt;60 mL/min/1.73 m2. CKD stages 1 and 2, diabetes and young age had a negative influence on the performance of the equations.</style></abstract><label><style face="normal" font="default" size="100%">Included by Loai</style></label><notes><style face="normal" font="default" size="100%">1437-4331&#xD;Veronese, Francisco Veríssimo&#xD;Gomes, Eduardo C&#xD;Chanan, Joana&#xD;Carraro, Maicon A&#xD;Camargo, Eduardo G&#xD;Soares, Ariana A&#xD;Thomé, Fernando S&#xD;Silveiro, Sandra P&#xD;Comparative Study&#xD;Journal Article&#xD;Germany&#xD;Clin Chem Lab Med. 2014 Dec;52(12):1747-54. doi: 10.1515/cclm-2014-0052.</style></notes><urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1515/cclm-2014-0052</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2296</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2296</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Visser, T.</style></author><author><style face="normal" font="default" size="100%">Bruxvoort, K.</style></author><author><style face="normal" font="default" size="100%">Maloney, K.</style></author><author><style face="normal" font="default" size="100%">Leslie, T.</style></author><author><style face="normal" font="default" size="100%">Barat, L. M.</style></author><author><style face="normal" font="default" size="100%">Allan, R.</style></author><author><style face="normal" font="default" size="100%">Ansah, E. K.</style></author><author><style face="normal" font="default" size="100%">Anyanti, J.</style></author><author><style face="normal" font="default" size="100%">Boulton, I.</style></author><author><style face="normal" font="default" size="100%">Clarke, S. E.</style></author><author><style face="normal" font="default" size="100%">Cohen, J. L.</style></author><author><style face="normal" font="default" size="100%">Cohen, J. M.</style></author><author><style face="normal" font="default" size="100%">Cutherell, A.</style></author><author><style face="normal" font="default" size="100%">Dolkart, C.</style></author><author><style face="normal" font="default" size="100%">Eves, K.</style></author><author><style face="normal" font="default" size="100%">Fink, G.</style></author><author><style face="normal" font="default" size="100%">Goodman, C.</style></author><author><style face="normal" font="default" size="100%">Hutchinson, E.</style></author><author><style face="normal" font="default" size="100%">Lal, S.</style></author><author><style face="normal" font="default" size="100%">Mbonye, A.</style></author><author><style face="normal" font="default" size="100%">Onwujekwe, O.</style></author><author><style face="normal" font="default" size="100%">Petty, N.</style></author><author><style face="normal" font="default" size="100%">Pontarollo, J.</style></author><author><style face="normal" font="default" size="100%">Poyer, S.</style></author><author><style face="normal" font="default" size="100%">Schellenberg, D.</style></author><author><style face="normal" font="default" size="100%">Streat, E.</style></author><author><style face="normal" font="default" size="100%">Ward, A.</style></author><author><style face="normal" font="default" size="100%">Wiseman, V.</style></author><author><style face="normal" font="default" size="100%">Whitty, C. J.</style></author><author><style face="normal" font="default" size="100%">Yeung, S.</style></author><author><style face="normal" font="default" size="100%">Cunningham, J.</style></author><author><style face="normal" font="default" size="100%">Chandler, C. I.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Clinton Health Access Initiative, Boston, Massachusetts, United States of America.&#xD;Department of Global Health and Development, London School of Hygiene &amp; Tropical Medicine, London, United Kingdom.&#xD;Bill and Melinda Gates Foundation, Seattle, Washington, United States of America.&#xD;US President&apos;s Malaria Initiative, United States Agency for International Development, Washington DC, United States of America.&#xD;Mentor Initiative, West Sussex, United Kingdom.&#xD;Research &amp; Development Division, Ghana Health Service, Accra, Ghana.&#xD;Society for Family Health, Abuja, Nigeria.&#xD;TropMed Pharma Consulting, Lower Shiplake, Oxfordshire, United Kingdom.&#xD;Department of Disease Control, London School of Hygiene &amp; Tropical Medicine, London, United Kingdom.&#xD;Harvard T.H. Chan School of Public Health, Boston, United States of America.&#xD;Population Services International, Nairobi, Kenya.&#xD;Ministry of Health, Kampala, Uganda.&#xD;University of Enugu, Agbani, Enugu State, Nigeria.&#xD;Malaria Consortium, London, United Kingdom.&#xD;School of Public Health and Community Medicine, University of New South Wales, UNSW, Sydney, Australia.&#xD;Department of Clinical Research, London School of Hygiene &amp; Tropical Medicine, London, United Kingdom.&#xD;Global Malaria Program, World Health Organization, Geneva, Switzerland.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Introducing malaria rapid diagnostic tests in private medicine retail outlets: A systematic literature review</style></title><secondary-title><style face="normal" font="default" size="100%">PLoS One</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">PLoS ONE</style></full-title></periodical><pages><style face="normal" font="default" size="100%">e0173093</style></pages><volume><style face="normal" font="default" size="100%">12</style></volume><number><style face="normal" font="default" size="100%">3</style></number><keywords><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Malaria/*diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">*Private Sector</style></keyword><keyword><style face="normal" font="default" size="100%">*Reagent Kits, Diagnostic</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2017</style></year></dates><isbn><style face="normal" font="default" size="100%">1932-6203</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: Many patients with malaria-like symptoms seek treatment in private medicine retail outlets (PMR) that distribute malaria medicines but do not traditionally provide diagnostic services, potentially leading to overtreatment with antimalarial drugs. To achieve universal access to prompt parasite-based diagnosis, many malaria-endemic countries are considering scaling up malaria rapid diagnostic tests (RDTs) in these outlets, an intervention that may require legislative changes and major investments in supporting programs and infrastructures. This review identifies studies that introduced malaria RDTs in PMRs and examines study outcomes and success factors to inform scale up decisions. METHODS: Published and unpublished studies that introduced malaria RDTs in PMRs were systematically identified and reviewed. Literature published before November 2016 was searched in six electronic databases, and unpublished studies were identified through personal contacts and stakeholder meetings. Outcomes were extracted from publications or provided by principal investigators. RESULTS: Six published and six unpublished studies were found. Most studies took place in sub-Saharan Africa and were small-scale pilots of RDT introduction in drug shops or pharmacies. None of the studies assessed large-scale implementation in PMRs. RDT uptake varied widely from 8%-100%. Provision of artemisinin-based combination therapy (ACT) for patients testing positive ranged from 30%-99%, and was more than 85% in five studies. Of those testing negative, provision of antimalarials varied from 2%-83% and was less than 20% in eight studies. Longer provider training, lower RDT retail prices and frequent supervision appeared to have a positive effect on RDT uptake and provider adherence to test results. Performance of RDTs by PMR vendors was generally good, but disposal of medical waste and referral of patients to public facilities were common challenges. CONCLUSIONS: Expanding services of PMRs to include malaria diagnostic services may hold great promise to improve malaria case management and curb overtreatment with antimalarials. However, doing so will require careful planning, investment and additional research to develop and sustain effective training, supervision, waste-management, referral and surveillance programs beyond the public sector.</style></abstract><label><style face="normal" font="default" size="100%">Included by Ray</style></label><notes><style face="normal" font="default" size="100%">1932-6203&#xD;Visser, Theodoor&#xD;Bruxvoort, Katia&#xD;Maloney, Kathleen&#xD;Leslie, Toby&#xD;Barat, Lawrence M&#xD;Allan, Richard&#xD;Ansah, Evelyn K&#xD;Anyanti, Jennifer&#xD;Boulton, Ian&#xD;Clarke, Siân E&#xD;Cohen, Jessica L&#xD;Cohen, Justin M&#xD;Cutherell, Andrea&#xD;Dolkart, Caitlin&#xD;Eves, Katie&#xD;Fink, Günther&#xD;Goodman, Catherine&#xD;Hutchinson, Eleanor&#xD;Lal, Sham&#xD;Mbonye, Anthony&#xD;Onwujekwe, Obinna&#xD;Petty, Nora&#xD;Pontarollo, Julie&#xD;Poyer, Stephen&#xD;Schellenberg, David&#xD;Streat, Elizabeth&#xD;Ward, Abigail&#xD;Wiseman, Virginia&#xD;Whitty, Christopher J M&#xD;Yeung, Shunmay&#xD;Cunningham, Jane&#xD;Chandler, Clare I R&#xD;001/World Health Organization/International&#xD;MR/N003810/1/Medical Research Council/United Kingdom&#xD;Journal Article&#xD;Review&#xD;Systematic Review&#xD;PLoS One. 2017 Mar 2;12(3):e0173093. doi: 10.1371/journal.pone.0173093. eCollection 2017.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333947/pdf/pone.0173093.pdf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC5333947 professional, or personal competing interest. One of the authors (IB) is employed by a commercial company, TropMed Pharma Consulting, but that does not alter our adherence to PLOS ONE policies on sharing data and materials.</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1371/journal.pone.0173093</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2297</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2297</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Voloshina, E. P.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">[The reactivation of pulmonary tuberculosis in persons in registry groups III and VII and those removed from dispensary observation]</style></title><secondary-title><style face="normal" font="default" size="100%">Probl Tuberk</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Probl Tuberk</style></full-title></periodical><pages><style face="normal" font="default" size="100%">53-5</style></pages><number><style face="normal" font="default" size="100%">12</style></number><keywords><keyword><style face="normal" font="default" size="100%">Diagnostic Errors</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Recurrence</style></keyword><keyword><style face="normal" font="default" size="100%">Registries/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Retrospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Tuberculosis, Pulmonary/diagnosis/*epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">USSR/epidemiology</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">1989</style></year></dates><isbn><style face="normal" font="default" size="100%">0032-9533 (Print)&#xD;0032-9533</style></isbn><abstract><style face="normal" font="default" size="100%">Clinicoroentgenological findings on 3262 patients registered in groups III and VII of the dispensary observation were studied for a period of 12 years and 425 cases of tuberculosis relapses were analyzed. On the basis of the data it was suggested to divide tuberculosis relapses into real reactivation (65.6 per cent) and pseudoreactivation (26.4 per cent). Pseudoreactivation of tuberculosis in 46.4 and 42.0 per cent of the patients was diagnosed because of mistakes of roentgenologists and phthisiologists, respectively. Diagnosis of tuberculosis pseudoreactivation in 11.6 per cent of the patients was associated with diagnostic difficulties. 8 per cent of the pseudoreactivations interpreted as relapses referred to overdiagnosis of tuberculosis activity. Therefore, real reactivation of pulmonary tuberculosis was only in 2/3 of the patients.</style></abstract><label><style face="normal" font="default" size="100%">Included by Morty</style></label><notes><style face="normal" font="default" size="100%">8 per cent of the pseudoreactivations interpreted as relapses referred to overdiagnosis of tuberculosis activity.&#xD;Voloshina, E P&#xD;English Abstract&#xD;Journal Article&#xD;Russia (Federation)&#xD;Probl Tuberk. 1989;(12):53-5.</style></notes><urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2298</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2298</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Wang, Yujie</style></author><author><style face="normal" font="default" size="100%">Álvarez, Gonzalo</style></author><author><style face="normal" font="default" size="100%">Salinas, Rodrigo</style></author><author><style face="normal" font="default" size="100%">Ramírez, Gloria</style></author><author><style face="normal" font="default" size="100%">Catalán, Mónica</style></author><author><style face="normal" font="default" size="100%">Díaz, Cristian</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Análisis del cumplimiento de la Guía Clínica del AUGE en pacientes con accidente cerebrovascular isquémico: la utilización de tecnología sanitaria de diagnóstico para prevención secundaria en un hospital público</style></title><secondary-title><style face="normal" font="default" size="100%">Rev. méd. Chile</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Rev. méd. Chile</style></full-title></periodical><pages><style face="normal" font="default" size="100%">697-703</style></pages><volume><style face="normal" font="default" size="100%">139</style></volume><number><style face="normal" font="default" size="100%">6</style></number><keywords><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Guideline Adherence</style></keyword><keyword><style face="normal" font="default" size="100%">Hospitals, Public/statistics &amp;amp</style></keyword><keyword><style face="normal" font="default" size="100%">amp</style></keyword><keyword><style face="normal" font="default" size="100%">numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Stroke/diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">Acute Disease</style></keyword><keyword><style face="normal" font="default" size="100%">Chile/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Data Interpretation, Statistical</style></keyword><keyword><style face="normal" font="default" size="100%">Stroke/complications</style></keyword><keyword><style face="normal" font="default" size="100%">Stroke/mortality</style></keyword><keyword><style face="normal" font="default" size="100%">Stroke/therapy</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2011</style></year><pub-dates><date><style face="normal" font="default" size="100%">2011/06</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0034-9887</style></isbn><abstract><style face="normal" font="default" size="100%">Background: Acute ischemic stroke in adults was given an Explicit Guarantee of diagnosis and treatment (GES) with Clinical Guidelines in 2007 as part of the on-going Chilean National Health Reform. Aim: To evaluate the adherence to official guidelines with regard to the use of diagnostic methods for patients with acute ischemic stroke during their stay in a public hospital. Patients and Methods: The study included a review of the medical records of 101 patients aged 70 ±13 years (49 males and 52 females) diagnosed with acute ischemic stroke and discharged within August and September of 2008 and 2009 from a public hospital. Three trained ob-servers independently determined the degree of dependency of patients at discharge using the Modified Rankin score. The completion of recommended diagnostic tests (electrocardiogram, carotid Doppler ultrasound and echocardiogram) as well as their overuse was evaluated. Results: Ten patients died before discharge, 38 percent were discharged with and 52 percent were discharged without disabilities. Nineteen percent of patients with a Modified Rankin score of two or less (corresponding to a slight disability) had a complete diagnostic workup, compared with 87 percent of patients with a score of 3 to 5 (moderate to severe disability). In 27 percent of the patients, there was an overuse of diagnostic tests. No association between the diagnostic test use adequacy and year of discharge was observed. Conclusions: There exists a disparity between the recommended diagnostic testing and the actual tests completed among patients with acute ischemic stroke.</style></abstract><label><style face="normal" font="default" size="100%">Included by Loai</style></label><urls><related-urls><url><style face="normal" font="default" size="100%">http://www.scielo.cl/scielo.php?script=sci_arttext&amp;amp;pid=S0034-98872011000600001</style></url><url><style face="normal" font="default" size="100%">https://www.scielo.cl/pdf/rmc/v139n6/art01.pdf</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2299</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2299</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Weiping, Teng</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">&amp;quot;We are facing a challenge of &amp;quot;&amp;quot;overdiagnosis&amp;quot;&amp;quot; of the thyroid cancer&amp;quot</style></title><secondary-title><style face="normal" font="default" size="100%">Chinese Journal of Endocrinology and Metabolism</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Chinese Journal of Endocrinology and Metabolism</style></full-title></periodical><pages><style face="normal" font="default" size="100%">531-532</style></pages><number><style face="normal" font="default" size="100%">12</style></number><dates><year><style face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style face="normal" font="default" size="100%">2016/00</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1000-6699</style></isbn><abstract><style face="normal" font="default" size="100%">[Summary] The incidence of thyroid cancer in China is increasing rapidly, at an annual percentage change (APC)of 20. 1%, while the APC of mortality of thyroid cancer is only 1. 6%, which is defined asoverdiagnosis by the experts of tumor field. This tendency is due to the over-screening for thyroid nodules and cancers with high resolution of B ultrasound equipments. The prevalence of latent thyroid cancer is 11. 5% in human-being as found by the autopsy. However, the prognosis of the majority of patients is good. The clinical doctors and health-care department of government in China should take actions to deal with the tendency of over-screening andoverdiagnosisfor thyroid nodules and cancers.</style></abstract><label><style face="normal" font="default" size="100%">Included by Ray</style></label><urls><related-urls><url><style face="normal" font="default" size="100%">http://dx.doi.org/10.3760/cma.j.issn.1000-6699.2016.07.001</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2300</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2300</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Wilson, L. G.</style></author><author><style face="normal" font="default" size="100%">Young, D.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Psychiatry, Hunan Medical College, Second Affiliated Hospital, Changsha, People&apos;s Republic of China.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Diagnosis of severely ill inpatients in China. A collaborative project using the structured clinical interview for DSM-III (SCID)</style></title><secondary-title><style face="normal" font="default" size="100%">J Nerv Ment Dis</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">J Nerv Ment Dis</style></full-title></periodical><pages><style face="normal" font="default" size="100%">585-92</style></pages><volume><style face="normal" font="default" size="100%">176</style></volume><number><style face="normal" font="default" size="100%">10</style></number><keywords><keyword><style face="normal" font="default" size="100%">Bipolar Disorder/diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">China/ethnology</style></keyword><keyword><style face="normal" font="default" size="100%">*Cross-Cultural Comparison</style></keyword><keyword><style face="normal" font="default" size="100%">Follow-Up Studies</style></keyword><keyword><style face="normal" font="default" size="100%">*Hospitalization</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Manuals as Topic</style></keyword><keyword><style face="normal" font="default" size="100%">Mental Disorders/*diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">Psychiatric Status Rating Scales</style></keyword><keyword><style face="normal" font="default" size="100%">Psychotic Disorders/diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">Schizophrenia/diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">United States</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">1988</style></year><pub-dates><date><style face="normal" font="default" size="100%">Oct</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0022-3018 (Print)&#xD;0022-3018</style></isbn><abstract><style face="normal" font="default" size="100%">The purpose of this project was to investigate any differences in diagnostic practice between Chinese psychiatry and Western psychiatry with regard to severe psychiatric illness among Chinese inpatients. Specifically, the project aimed to look at differences between the Chinese diagnostic system and DSM-III. This study stemmed partly from a desire to investigate the supposed &quot;overdiagnosis&quot; of schizophrenia in China relative to the West. A second objective was to use a structured interview format to obtain clinical data for DSM-III and to decide whether a translated version of such an interview offered promise for future transcultural psychiatric research. Forty-two inpatients on a psychiatric ward in China were interviewed by an American psychiatrist assisted by a Chinese faculty translator and a diagnosis was made using the Structured Clinical Interview for DSM-III. A Chinese professor of psychiatry who was blind to the structured interview results interviewed each patient independently and assigned a diagnosis within the current Chinese system. Follow-up data was obtained on 69% of the patients after 16 months to check for stability of diagnosis. Results of the study pointed to less diagnostic disagreement than previous work had predicted. On cases where there was disagreement, DSM-III diagnoses tended toward affective disorders or atypical forms of psychosis while the Chinese diagnosis tended towards schizophrenia.(ABSTRACT TRUNCATED AT 250 WORDS)</style></abstract><notes><style face="normal" font="default" size="100%">Wilson, L G&#xD;Young, D&#xD;Comparative Study&#xD;Journal Article&#xD;United States&#xD;J Nerv Ment Dis. 1988 Oct;176(10):585-92.</style></notes><urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2301</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2301</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Xavier, T.</style></author><author><style face="normal" font="default" size="100%">Vasan, A.</style></author><author><style face="normal" font="default" size="100%">S, V.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Karnataka Janaarogya Chaluvali, PushpaniketanaNilaya, 3rd Floor, 1st cross, 4th Main, Sampangiramanagara, Bangalore-560 027 Karnataka, India,. teenakuzhively@gmail.com.&#xD;Karnataka Janaarogya Chaluvali, PushpaniketanaNilaya, 3rd Floor, 1st cross, 4th Main, Sampangiramanagara, Bangalore-560 027 Karnataka, India,. akhila.punch@gmail.com.&#xD;Karnataka Janaarogya Chaluvali, PushpaniketanaNilaya, 3rd Floor, 1st cross, 4th Main, Sampangiramanagara, Bangalore-560 027 Karnataka, India,. vijayalter75@gmail.com.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Instilling fear makes good business sense: unwarranted hysterectomies in Karnataka</style></title><secondary-title><style face="normal" font="default" size="100%">Indian J Med Ethics</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Indian J Med Ethics</style></full-title></periodical><pages><style face="normal" font="default" size="100%">49-55</style></pages><volume><style face="normal" font="default" size="100%">2</style></volume><number><style face="normal" font="default" size="100%">1</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Ethics, Business</style></keyword><keyword><style face="normal" font="default" size="100%">*Ethics, Medical</style></keyword><keyword><style face="normal" font="default" size="100%">*Fear</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Hospitals, Private/*ethics</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Hysterectomy/*ethics/psychology</style></keyword><keyword><style face="normal" font="default" size="100%">India</style></keyword><keyword><style face="normal" font="default" size="100%">*Motivation</style></keyword><keyword><style face="normal" font="default" size="100%">Neoplasms/*psychology/surgery</style></keyword><keyword><style face="normal" font="default" size="100%">Unnecessary Procedures/*ethics</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jan-Mar</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0974-8466</style></isbn><abstract><style face="normal" font="default" size="100%">This paper uses data from two fact-finding exercises in two districts of Karnataka to trace how government and private doctors alike pushed women to undergo hysterectomies. The doctors provided grossly unscientific information to poor Dalit women to instil a fear of &quot;cancer&quot; in their minds to wilfully mislead them to undergo hysterectomies, following which many suffered complications and died. The paper examines a review, made by two separate panels of experts, of women&apos;s medical records from private hospitals to illustrate that a large proportion of the hysterectomies performed were medically unwarranted; that private doctors were using highly suspect diagnostic criteria, based on a single ultrasound scan, to perform the hysterectomies and had not sent even a single sample for histopathology; and that the medical records were incomplete, erroneous and, in several instances, manipulated. The paper describes how a combination of patriarchal bias, professional unscrupulousness and pro-private healthcare policies posed a serious threat to the survival and well-being of women in Karnataka.</style></abstract><label><style face="normal" font="default" size="100%">Included by Ray</style></label><notes><style face="normal" font="default" size="100%">0975-5691&#xD;Xavier, Teena&#xD;Vasan, Akhila&#xD;S, Vijayakumar&#xD;Journal Article&#xD;India&#xD;Indian J Med Ethics. 2017 Jan-Mar;2(1):49-55. doi: 10.20529/IJME.2017.010. Epub 2016 Oct 26.</style></notes><urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.20529/ijme.2017.010</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2302</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2302</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Xia, T. A. O.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Analysis of Diagnostic Differences between Colposcopy Beginner and Pathologic Report in Cervical Disease</style></title><secondary-title><style face="normal" font="default" size="100%">Journal of Practical Obstetrics and Gynecology</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Journal of Practical Obstetrics and Gynecology</style></full-title></periodical><pages><style face="normal" font="default" size="100%">198-202</style></pages><number><style face="normal" font="default" size="100%">12</style></number><dates><year><style face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style face="normal" font="default" size="100%">2017/00</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1003-6946</style></isbn><abstract><style face="normal" font="default" size="100%">Objective:To evaluate the consistency of colposcopy diagnosis performed by a single examiner with pathologic diagnosis and to analyze the factors related with colposcopy over-and under diagnosis.Methods:A retrospective study was performed.The initial 200 cases diagnosed by a single colposcopy beginner at Peking University first Hospital out-patient clinic from March 2015 to October 2015 were included in this study.The consistency rate and bias rate of colposcopy diagnosis versus pathologic diagnosis as well as the causes of such differences were analyzed.Results:Of 174 cases with pathologic diagnosis,the consistency rate was 59.2％.The underdiagnosis rate and overdiagnosis rate were 18.4％ and 22.4％ separately.Of HSIL underdiagnosis group,the rate of TCT NILM was 78.6％ which was higher than 18.1％ in HSIL consistency group,P ＜ 0.05.Re-evaluation of the colposcopy pictures revealed that acetowhite epithelium were present in all 14 cased of HSIL underdiagnosis group.The rate of post-menopausal women was higher in HSIL underdiagnosis group than in HSIL consistency group(21.4％ vs 0％),P ＜0.05.The medium numbers of biopsy were higher in HSIL consistency group when compared with HSIL underdiagnosis group,P ＜0.05.The medium numbers of biopsy was higher in overdiagnosis group when compared with consistency group,P ＜ 0.05.Conclusions:Underdiagnosis of colposcopy was related with TCT-overdependent,insufficient understanding of acetowhite epithelium and post-menopausal women.Increasing biopsy numbers may improve the consistency rate of colposcopy and pathologic diagnosis.However,the increasing numbers of biopsy often results from overdiagnosis.</style></abstract><urls><related-urls><url><style face="normal" font="default" size="100%">http://dx.doi.org/</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2303</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2303</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Xiaoguang, S. H. I.</style></author><author><style face="normal" font="default" size="100%">Wenqing, Yang</style></author><author><style face="normal" font="default" size="100%">Weiping, Teng</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">&amp;quot;&amp;quot;&amp;quot;Overdiagnosis&amp;quot;&amp;quot; and &amp;quot;&amp;quot;overtreatment&amp;quot;&amp;quot; in thyroid cancer&amp;quot</style></title><secondary-title><style face="normal" font="default" size="100%">Chinese Journal of Endocrinology and Metabolism</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Chinese Journal of Endocrinology and Metabolism</style></full-title></periodical><pages><style face="normal" font="default" size="100%">443-447</style></pages><number><style face="normal" font="default" size="100%">12</style></number><dates><year><style face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style face="normal" font="default" size="100%">2016/00</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1000-6699</style></isbn><abstract><style face="normal" font="default" size="100%">The incidence of thyroid cancer in South Korea increased 15 times over the past twenty years, that made South Korea became a country of the highest reported incidence in thyroid cancer all over the world. But the mortality of thyroid cancer was stable and unchanged. The incidence of thyroid cancer in our country was growing at an annual percentage change of 20. 1%. It is a generally accepted that the sharply increased incidence is attributed tooverdiagnosis. Here we introduced the definition of overdiagnosis of cancer and the current understanding in tumor field. The corresponding strategy in our country was proposed.</style></abstract><label><style face="normal" font="default" size="100%">Included by Ray</style></label><urls><related-urls><url><style face="normal" font="default" size="100%">http://dx.doi.org/10.3760/cma.j.issn.1000-6699.2016.06.002</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2304</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2304</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Xie, M.</style></author><author><style face="normal" font="default" size="100%">Cui, L.</style></author><author><style face="normal" font="default" size="100%">Liu, J.</style></author><author><style face="normal" font="default" size="100%">Wang, W.</style></author><author><style face="normal" font="default" size="100%">Li, J.</style></author><author><style face="normal" font="default" size="100%">Xiao, W.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Pulmonary and Critical Care Medicine, Qilu Hospital, Shandong University, Jinan, People&apos;s Republic of China.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Impacts of Different Spirometry Reference Equations and Diagnostic Criteria on the Frequency of Airway Obstruction in Adult People of North China</style></title><secondary-title><style face="normal" font="default" size="100%">Int J Chron Obstruct Pulmon Dis</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Int J Chron Obstruct Pulmon Dis</style></full-title></periodical><pages><style face="normal" font="default" size="100%">651-659</style></pages><volume><style face="normal" font="default" size="100%">15</style></volume><keywords><keyword><style face="normal" font="default" size="100%">*copd</style></keyword><keyword><style face="normal" font="default" size="100%">*lln</style></keyword><keyword><style face="normal" font="default" size="100%">*airflow limitation</style></keyword><keyword><style face="normal" font="default" size="100%">*lung function</style></keyword><keyword><style face="normal" font="default" size="100%">*reference equations</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2020</style></year></dates><isbn><style face="normal" font="default" size="100%">1176-9106 (Print)&#xD;1176-9106</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND AND OBJECTIVE: The reference equations and diagnostic criteria play a critical role in the interpretation of pulmonary function tests (PFTs). The aim was to investigate the impacts of different reference equations and diagnostic criteria on the frequency of airway obstruction in adult people of a large teaching hospital of North China. METHODS: The spirometry data of all adult people who underwent PFTs in Qilu hospital from April 2012 to November 2015 were collected. Two spirometry reference equations, namely, Zhongshan-2011 and Global Lung Function Initiative 2012 (GLI-2012) were compared. The frequency of airway obstruction using different spirometry prediction equations and diagnostic criteria including forced expiratory volume in 1 s (FEV1)/forced vital capacity (FVC) &lt;92% of predicted value and FEV1/FVC &lt;lower limits of normal (LLN) were investigated. RESULTS: A total of 57,888 subjects were recruited with a mean age of 55.5 ± 13.72. There were significant differences in LLN and predicted value between the GLI-2012 and Zhongshan-2011. The average age of those who had an LLN of FEV1/FVC below 0.7 was 66.59 ± 6.05 years using GLI-2012, which was significantly lower than that in Zhongshan-2011 (77.46±2.63, P&lt;0.001). Using FEV1/FVC&lt;LLN as diagnostic criteria, Zhongshan-2011 identifies more obstructive subjects than GLI-2012 in each age group. In 45-59 or 60-80 age group, more participants were defined as obstructive using FEV1/FVC&lt;92%pred than FEV1/FVC&lt;LLN (both P&lt;0.001). CONCLUSION: Zhongshan-2011 identifies more airway obstruction than GLI-2012 in adult people of North China. Compared to FEV1/FVC&lt;LLN, FEV1/FVC&lt;92%pred may lead to overdiagnosis of airway obstruction in elderly people.</style></abstract><notes><style face="normal" font="default" size="100%">1178-2005&#xD;Xie, Mengshuang&#xD;Orcid: 0000-0002-3132-5890&#xD;Cui, Liwei&#xD;Orcid: 0000-0003-4356-209x&#xD;Liu, Jinhuan&#xD;Wang, Wei&#xD;Orcid: 0000-0002-0488-4654&#xD;Li, Jun&#xD;Xiao, Wei&#xD;Journal Article&#xD;Int J Chron Obstruct Pulmon Dis. 2020 Mar 27;15:651-659. doi: 10.2147/COPD.S232863. eCollection 2020.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.dovepress.com/getfile.php?fileID=57087</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC7112747</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.2147/copd.S232863</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2305</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2305</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Xu, Y.</style></author><author><style face="normal" font="default" size="100%">Zhao, W.</style></author><author><style face="normal" font="default" size="100%">Wang, W.</style></author><author><style face="normal" font="default" size="100%">Bi, Y.</style></author><author><style face="normal" font="default" size="100%">Li, J.</style></author><author><style face="normal" font="default" size="100%">Mi, S.</style></author><author><style face="normal" font="default" size="100%">Xu, M.</style></author><author><style face="normal" font="default" size="100%">Lu, J.</style></author><author><style face="normal" font="default" size="100%">Wang, T.</style></author><author><style face="normal" font="default" size="100%">Li, M.</style></author><author><style face="normal" font="default" size="100%">Wang, Z.</style></author><author><style face="normal" font="default" size="100%">Jiang, Y.</style></author><author><style face="normal" font="default" size="100%">Wang, L.</style></author><author><style face="normal" font="default" size="100%">Wang, L.</style></author><author><style face="normal" font="default" size="100%">Dai, M.</style></author><author><style face="normal" font="default" size="100%">Zhang, D.</style></author><author><style face="normal" font="default" size="100%">Lai, S.</style></author><author><style face="normal" font="default" size="100%">Ning, G.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">State Key Laboratory of Medical Genomics, Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health, the National Clinical Research Center for Metabolic Diseases, and Shanghai Clinical Center for Endocrine and Metabolic Diseases, Rui-Jin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China.&#xD;Chinese Center for Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.&#xD;National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.&#xD;Department of Food Science, College of Applied Art and Science, Beijing Union University, Beijing, China.&#xD;Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Plasma glucose and hemoglobin A1c for the detection of diabetes in Chinese adults</style></title><secondary-title><style face="normal" font="default" size="100%">J Diabetes</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">J Diabetes</style></full-title></periodical><pages><style face="normal" font="default" size="100%">378-86</style></pages><volume><style face="normal" font="default" size="100%">8</style></volume><number><style face="normal" font="default" size="100%">3</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Blood Glucose/*analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Cardiovascular Diseases/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">China</style></keyword><keyword><style face="normal" font="default" size="100%">Cross-Sectional Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Diabetes Mellitus/*diagnosis/metabolism</style></keyword><keyword><style face="normal" font="default" size="100%">Fasting/physiology</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Glucose Tolerance Test</style></keyword><keyword><style face="normal" font="default" size="100%">Glycated Hemoglobin A/*analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Prevalence</style></keyword><keyword><style face="normal" font="default" size="100%">HA1c</style></keyword><keyword><style face="normal" font="default" size="100%">HbA1c</style></keyword><keyword><style face="normal" font="default" size="100%">diabetes</style></keyword><keyword><style face="normal" font="default" size="100%">plasma glucose</style></keyword><keyword><style face="normal" font="default" size="100%">糖尿病</style></keyword><keyword><style face="normal" font="default" size="100%">血糖</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style face="normal" font="default" size="100%">May</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1753-0407</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: The aim of the present study was to evaluate the performance of plasma glucose (PG) and HbA1c for the detection of diabetes in the general population in China. METHODS: A cross-sectional analysis was conducted in a nationally representative sample of 98,658 Chinese adults aged ≥18 years. Fasting plasma glucose and HbA1c levels were measured in all participants after at least a 10-h overnight fast. An oral glucose tolerance test (OGTT) was conducted among participants without a self-reported history of diagnosed diabetes. RESULTS: An HbA1c ≥6.5% could identify 4.57% of Chinese adults as having newly detected diabetes, followed by fasting PG (FPG) and 2-h PG at 4.52% and 3.50%, respectively. Approximately 1.95% of the total population was detected by HbA1c but not by FPG or 2-h PG. However, FPG plus HbA1c could identify most (85.2%) diabetic individuals identified by any of the three tests (i.e., FPG, 2-h PG, and HbA1c). Levels of most cardiovascular risk factors, such as body mass index, waist circumference, and cholesterol, were higher in diabetes detected by HbA1c alone than in diabetes identified by the OGTT. CONCLUSIONS: Although HbA1c ≥6.5% has been recommended by the American Diabetes Association as one of the diagnostic tests for diabetes, caution should be used to avoid potential overdiagnosis when interpreting diabetes identified by elevated HbA1c alone.</style></abstract><label><style face="normal" font="default" size="100%">Included by Eman</style></label><notes><style face="normal" font="default" size="100%">1753-0407&#xD;Xu, Yu&#xD;Zhao, Wenhua&#xD;Wang, Weiqing&#xD;Bi, Yufang&#xD;Li, Jianhong&#xD;Mi, Shengquan&#xD;Xu, Min&#xD;Lu, Jieli&#xD;Wang, Tiange&#xD;Li, Mian&#xD;Wang, Zhuoqun&#xD;Jiang, Yong&#xD;Wang, Limin&#xD;Wang, Linhong&#xD;Dai, Meng&#xD;Zhang, Di&#xD;Lai, Shenghan&#xD;Ning, Guang&#xD;2010 China Noncommunicable Disease Surveillance Group&#xD;Journal Article&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Australia&#xD;J Diabetes. 2016 May;8(3):378-86. doi: 10.1111/1753-0407.12305. Epub 2015 Jul 30.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/1753-0407.12305?download=true</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1111/1753-0407.12305</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2306</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2306</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Yeonsook, Moon</style></author><author><style face="normal" font="default" size="100%">Mi-Hyang, K. I. M.</style></author><author><style face="normal" font="default" size="100%">Hye-Ryoun, K. I. M.</style></author><author><style face="normal" font="default" size="100%">Jeong-Yeal, A. H. N.</style></author><author><style face="normal" font="default" size="100%">Jungwon, H. U. H.</style></author><author><style face="normal" font="default" size="100%">Ji-Young, H. U. H.</style></author><author><style face="normal" font="default" size="100%">Jae-Ho, H. A. N.</style></author><author><style face="normal" font="default" size="100%">Joon-Seong, Park</style></author><author><style face="normal" font="default" size="100%">Sung-Ran, C. H. O.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">The 2016 WHO versus 2008 WHO Criteria for the Diagnosis of Chronic Myelomonocytic Leukemia</style></title><secondary-title><style face="normal" font="default" size="100%">Annals of Laboratory Medicine</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Annals of Laboratory Medicine</style></full-title></periodical><pages><style face="normal" font="default" size="100%">481-483</style></pages><keywords><keyword><style face="normal" font="default" size="100%">Bone Marrow</style></keyword><keyword><style face="normal" font="default" size="100%">Classification</style></keyword><keyword><style face="normal" font="default" size="100%">Diagnosis</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Leukemia, Myelomonocytic, Chronic</style></keyword><keyword><style face="normal" font="default" size="100%">Leukocytes</style></keyword><keyword><style face="normal" font="default" size="100%">Medical Records</style></keyword><keyword><style face="normal" font="default" size="100%">Monocytes</style></keyword><keyword><style face="normal" font="default" size="100%">Platelet Count</style></keyword><keyword><style face="normal" font="default" size="100%">Retrospective Studies</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style face="normal" font="default" size="100%">2018/00</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">2234-3806</style></isbn><abstract><style face="normal" font="default" size="100%">The 2016 WHO diagnostic criteria for chronic myelomonocytic leukemia (CMML) require both absolute and relative monocytosis (≥1×10⁹/L and ≥10% of white blood cell counts) in peripheral blood. Moreover, myeloproliferative neoplasm (MPN) features in bone marrow and/or MPN-associated mutations tend to support MPN with monocytosis rather than CMML. We assessed the impact of the 2016 WHO criteria on CMML diagnosis, compared with the 2008 WHO criteria, through a retrospective review of the medical records of 38 CMML patients diagnosed according to the 2008 WHO classification. Application of the 2016 WHO criteria resulted in the exclusion of three (8%) patients who did not fulfill the relative monocytosis criterion and eight (21%) patients with an MPN-associated mutation. These 11 patients formed the 2016 WHO others group; the remaining 27 formed the 2016 WHO CMML group. The significant difference in the platelet count and monocyte percentage between the two groups indicated that the 2016 WHO criteria lead to a more homogenous and improved definition of CMML compared with the 2008 WHO criteria, which may have led to over-diagnosis of CMML. More widespread use of molecular tests and more sophisticated clinical and morphological evaluations are necessary to diagnose CMML accurately.</style></abstract><label><style face="normal" font="default" size="100%">Included by Loai</style></label><urls><related-urls><url><style face="normal" font="default" size="100%">http://dx.doi.org/10.3343/alm.2018.38.5.481</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2307</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2307</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Yilmaz, F. M.</style></author><author><style face="normal" font="default" size="100%">Kahveci, R.</style></author><author><style face="normal" font="default" size="100%">Aksoy, A.</style></author><author><style face="normal" font="default" size="100%">Kucuk, E. Ö</style></author><author><style face="normal" font="default" size="100%">Akin, T.</style></author><author><style face="normal" font="default" size="100%">Mathew, J. L.</style></author><author><style face="normal" font="default" size="100%">Meads, C.</style></author><author><style face="normal" font="default" size="100%">Zengin, N.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Impact of laboratory test use strategies in a Turkish hospital</style></title><secondary-title><style face="normal" font="default" size="100%">PLoS ONE</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">PLoS ONE</style></full-title></periodical><volume><style face="normal" font="default" size="100%">11</style></volume><number><style face="normal" font="default" size="100%">4</style></number><keywords><keyword><style face="normal" font="default" size="100%">chloride</style></keyword><keyword><style face="normal" font="default" size="100%">folic acid</style></keyword><keyword><style face="normal" font="default" size="100%">prostate specific antigen</style></keyword><keyword><style face="normal" font="default" size="100%">article</style></keyword><keyword><style face="normal" font="default" size="100%">cost control</style></keyword><keyword><style face="normal" font="default" size="100%">hepatitis</style></keyword><keyword><style face="normal" font="default" size="100%">HIV test</style></keyword><keyword><style face="normal" font="default" size="100%">hospital information system</style></keyword><keyword><style face="normal" font="default" size="100%">hospital management</style></keyword><keyword><style face="normal" font="default" size="100%">laboratory test</style></keyword><keyword><style face="normal" font="default" size="100%">Turkey (republic)</style></keyword><keyword><style face="normal" font="default" size="100%">unnecessary procedure</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2016</style></year></dates><isbn><style face="normal" font="default" size="100%">1932-6203</style></isbn><abstract><style face="normal" font="default" size="100%">Objectives Eliminating unnecessary laboratory tests is a good way to reduce costs while maintain patient safety. The aim of this study was to define and process strategies to rationalize laboratory use in Ankara Numune Training and Research Hospital (ANH) and calculate potential savings in costs. Methods A collaborative plan was defined by hospital managers; joint meetings with ANHTA and laboratory professors were set; the joint committee invited relevant staff for input, and a laboratory efficiency committee was created. Literature was reviewed systematically to identify strategies used to improve laboratory efficiency. Strategies that would be applicable in local settings were identified for implementation, processed, and the impact on clinical use and costs assessed for 12 months. Results Laboratory use in ANH differed enormously among clinics. Major use was identified in internal medicine. The mean number of tests per patient was 15.8. Unnecessary testing for chloride, folic acid, free prostate specific antigen, hepatitis and HIV testing were observed. Test panel use was pinpointed as the main cause of overuse of the laboratory and the Hospital Information System test ordering page was reorganized. A significant decrease (between 12.6-85.0%) was observed for the tests that were taken to an alternative page on the computer screen. The one year study saving was equivalent to 371,183 US dollars. Conclusion Hospital-based committees including laboratory professionals and clinicians can define hospital based problems and led to a standardized approach to test use that can help clinicians reduce laboratory costs through appropriate use of laboratory tests.</style></abstract><notes><style face="normal" font="default" size="100%">L609927052&#xD;2016-04-27&#xD;2016-05-02</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.embase.com/search/results?subaction=viewrecord&amp;id=L609927052&amp;from=export</style></url><url><style face="normal" font="default" size="100%">http://dx.doi.org/10.1371/journal.pone.0153693</style></url><url><style face="normal" font="default" size="100%">https://storage.googleapis.com/plos-corpus-prod/10.1371/journal.pone.0153693/1/pone.0153693.pdf?X-Goog-Algorithm=GOOG4-RSA-SHA256&amp;X-Goog-Credential=wombat-sa%40plos-prod.iam.gserviceaccount.com%2F20210531%2Fauto%2Fstorage%2Fgoog4_request&amp;X-Goog-Date=20210531T122814Z&amp;X-Goog-Expires=86400&amp;X-Goog-SignedHeaders=host&amp;X-Goog-Signature=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</style></url></related-urls></urls><custom5><style face="normal" font="default" size="100%">27077653</style></custom5><electronic-resource-num><style face="normal" font="default" size="100%">10.1371/journal.pone.0153693</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2308</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2308</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Yıldırım, A.</style></author><author><style face="normal" font="default" size="100%">Gokosmanoglu, F.</style></author><author><style face="normal" font="default" size="100%">Onmez, A.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">A. Onmez, Duzce Universitesi Tıp Fakultesi, İç Hastalıkları, Konuralp Yerleşkesi, Duzce, Turkey</style></auth-address><titles><title><style face="normal" font="default" size="100%">Determination of cut-off values and sensitivities of tests for the diagnosis of subclinical cushing’s syndrome in functional investigation of adrenal incidentalomas</style></title><secondary-title><style face="normal" font="default" size="100%">Annals of Clinical and Analytical Medicine</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Annals of Clinical and Analytical Medicine</style></full-title></periodical><pages><style face="normal" font="default" size="100%">417-420</style></pages><volume><style face="normal" font="default" size="100%">10</style></volume><number><style face="normal" font="default" size="100%">4</style></number><keywords><keyword><style face="normal" font="default" size="100%">corticotropin</style></keyword><keyword><style face="normal" font="default" size="100%">dexamethasone</style></keyword><keyword><style face="normal" font="default" size="100%">hydrocortisone</style></keyword><keyword><style face="normal" font="default" size="100%">prasterone</style></keyword><keyword><style face="normal" font="default" size="100%">adrenal incidentaloma</style></keyword><keyword><style face="normal" font="default" size="100%">adult</style></keyword><keyword><style face="normal" font="default" size="100%">age</style></keyword><keyword><style face="normal" font="default" size="100%">article</style></keyword><keyword><style face="normal" font="default" size="100%">biochemical analysis</style></keyword><keyword><style face="normal" font="default" size="100%">cancer patient</style></keyword><keyword><style face="normal" font="default" size="100%">comorbidity</style></keyword><keyword><style face="normal" font="default" size="100%">comparative study</style></keyword><keyword><style face="normal" font="default" size="100%">controlled study</style></keyword><keyword><style face="normal" font="default" size="100%">Cushing syndrome</style></keyword><keyword><style face="normal" font="default" size="100%">dexamethasone suppression test</style></keyword><keyword><style face="normal" font="default" size="100%">diagnostic value</style></keyword><keyword><style face="normal" font="default" size="100%">disease association</style></keyword><keyword><style face="normal" font="default" size="100%">female</style></keyword><keyword><style face="normal" font="default" size="100%">follow up</style></keyword><keyword><style face="normal" font="default" size="100%">gender</style></keyword><keyword><style face="normal" font="default" size="100%">hormone determination</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">hydrocortisone blood level</style></keyword><keyword><style face="normal" font="default" size="100%">major clinical study</style></keyword><keyword><style face="normal" font="default" size="100%">male</style></keyword><keyword><style face="normal" font="default" size="100%">middle aged</style></keyword><keyword><style face="normal" font="default" size="100%">reference value</style></keyword><keyword><style face="normal" font="default" size="100%">retrospective study</style></keyword><keyword><style face="normal" font="default" size="100%">saliva level</style></keyword><keyword><style face="normal" font="default" size="100%">sensitivity and specificity</style></keyword><keyword><style face="normal" font="default" size="100%">subclinical cushing syndrome</style></keyword><keyword><style face="normal" font="default" size="100%">tumor volume</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2019</style></year></dates><isbn><style face="normal" font="default" size="100%">2667-663X</style></isbn><abstract><style face="normal" font="default" size="100%">Aim: The aim of our study was to determine the sensitivities of tests used in the diagnosis of subclinical Cushing’s syndrome (SCS) in patients with adrenal incidentalomas using clinical findings and other biochemical parameters. Material and Method: One hundred and twenty-nine patients with adrenal incidentalomas who were followed up by our endocrinology clinic were included in the study. Patients were divided into 4 groups according to the 1-mg DST results and these groups were compared in terms of age, gender, hormonal parameters, and comorbidities associated with Cushing’s syndrome. The cut-off value of salivary cortisol level for the diagnosis of SCS was calculated by ROC curve analysis. Result: If the cut-off values of plasma cortisol levels after the 1-mg DST were considered ≥1,8 µg/dL, ≥3 µg/dL, and ≥5µg/dL, the detection rates of SCS were respectively 22,4%, 1,4%, and 3,8%. When the cut-off value of plasma cortisol levels after the 1-mg DST was considered ≥1,8µg/dL, the sensitivity, specificity, and cut-off value of salivary cortisol levels were calculated as 68%, 57%, and 0.195 µg/dL by ROC curve analysis. Discussion: As the adrenal mass size and patient age increased, cortisol suppression decreased according to the 1-mg DST. As the cut-off value of plasma cortisol level used in the 1-mg DST decreased, the incidence of SCS increased significantly. This leads to overdiagnosis of SCS in asymptomatic patients with adrenal incidentalomas. New cut-off values should be determined for salivary cortisol level according to different populations.</style></abstract><notes><style face="normal" font="default" size="100%">L2002326597&#xD;2019-08-14&#xD;2019-08-22</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.embase.com/search/results?subaction=viewrecord&amp;id=L2002326597&amp;from=export</style></url><url><style face="normal" font="default" size="100%">http://dx.doi.org/10.4328/ACAM.5988</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.4328/ACAM.5988</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2309</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2309</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Yubei, Huang</style></author><author><style face="normal" font="default" size="100%">Lei, Yang</style></author><author><style face="normal" font="default" size="100%">Fengju, Song</style></author><author><style face="normal" font="default" size="100%">Kexin, Chen</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Overdiagnosis in mammography screening for breast cancer</style></title><secondary-title><style face="normal" font="default" size="100%">Chinese Journal of Epidemiology</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Chinese Journal of Epidemiology</style></full-title></periodical><pages><style face="normal" font="default" size="100%">1574-1578</style></pages><number><style face="normal" font="default" size="100%">12</style></number><dates><year><style face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style face="normal" font="default" size="100%">2017/00</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0254-6450</style></isbn><abstract><style face="normal" font="default" size="100%">Screening has been always considered as a double-edged sword. Cancer screening could save lives in some cases, however, in other cases, it might also turn people into overdiagnosis. Overdiagnosis is the diagnosis of cancer that will never cause symptoms or death during a patient&amp;#039;s lifetime. Therefore, overdiagnosis might lead to unnecessary treatments and lifetime surveillance, and then increase economic burden and psychological burden. In this review, we focus on how to correctly evaluate the overdiagnosis rate, and how to avoid or reduce the harms caused by overdiagnosis in the future according to the reasons associated with overdiagnosis. After systematically reviewing the previous studies, we will try to identify the potential reasons associated with overdiagnosis in breast cancer screening with mammography, address how to correctly evaluate the overdiagnosis rate, and finally provide some suggestions to reduce the overdiagnosis.</style></abstract><urls><related-urls><url><style face="normal" font="default" size="100%">http://dx.doi.org/10.3760/cma.j.issn.0254-6450.2017.11.027</style></url></related-urls></urls></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2310</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2310</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Zhang, H.</style></author><author><style face="normal" font="default" size="100%">Song, Y.</style></author><author><style face="normal" font="default" size="100%">Zhang, X.</style></author><author><style face="normal" font="default" size="100%">Hu, J.</style></author><author><style face="normal" font="default" size="100%">Yuan, S.</style></author><author><style face="normal" font="default" size="100%">Ma, J.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China.&#xD;Department of Clinical Laboratory, Shanghai Xuhui Central Hospital, Shanghai, China.&#xD;Department of Information Service, Shanghai Xuhui Central Hospital, Shanghai, China.&#xD;Department of Respiratory Medicine, Shanghai Xuhui Central Hospital, Shanghai, China.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Extent and cost of inappropriate use of tumour markers in patients with pulmonary disease: a multicentre retrospective study in Shanghai, China</style></title><secondary-title><style face="normal" font="default" size="100%">BMJ Open</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">BMJ Open</style></full-title></periodical><pages><style face="normal" font="default" size="100%">e019051</style></pages><volume><style face="normal" font="default" size="100%">8</style></volume><number><style face="normal" font="default" size="100%">2</style></number><keywords><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Aged, 80 and over</style></keyword><keyword><style face="normal" font="default" size="100%">Area Under Curve</style></keyword><keyword><style face="normal" font="default" size="100%">Biomarkers, Tumor/*analysis</style></keyword><keyword><style face="normal" font="default" size="100%">China</style></keyword><keyword><style face="normal" font="default" size="100%">Cost-Benefit Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Linear Models</style></keyword><keyword><style face="normal" font="default" size="100%">Lung Neoplasms/diagnosis/*economics</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Practice Guidelines as Topic</style></keyword><keyword><style face="normal" font="default" size="100%">Pulmonary Disease, Chronic Obstructive/diagnosis/*economics</style></keyword><keyword><style face="normal" font="default" size="100%">Retrospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Unnecessary Procedures/*economics/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">*cost</style></keyword><keyword><style face="normal" font="default" size="100%">*inappropriate request</style></keyword><keyword><style face="normal" font="default" size="100%">*overuse of medical services</style></keyword><keyword><style face="normal" font="default" size="100%">*pulmonary disease</style></keyword><keyword><style face="normal" font="default" size="100%">*tumor marker</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style face="normal" font="default" size="100%">Feb 28</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">2044-6055</style></isbn><abstract><style face="normal" font="default" size="100%">OBJECTIVES: The currently implemented healthcare reform in China requires substantial capital investment. Although overtreatment results in serious waste, inappropriate laboratory use is widespread, and overuse of tumour markers (TMs) has attracted increasing attention. DESIGN: Retrospective study. SETTING: The respiratory, thoracic surgery and oncology departments of three hospitals in Shanghai from 2014 to 2015. PARTICIPANTS: Patients with chronic obstructive pulmonary disease (COPD) and primary bronchogenic lung cancer (PLC). Based on clinical guidelines and physician experience, the criteria of suitability of TM examinations were determined, and the number, cost and proportion of inappropriate TM requests were analysed. RESULTS: The area under the receiver operating characteristic curve for carcinoembryonic antigen+cytokeratin fragment 21-1+squamous cell carcinoma antigen+neuron-specific enolase in patients with COPD and PLC was 0.813, in accordance with the cost-effectiveness principle, indicating good clinical and health economics values. In the 2706 patients, 12 496-16 956 (58.27%-79.06%) of TM requests were inappropriate. Furthermore, the involved expense was 650 200-1 014 156 yuan, accounting for 7.69%-12.00% of examination expenses and 1.35%-2.11% of hospitalisation costs. CONCLUSIONS: We found that the inappropriate use of TMs was widespread for patients with pulmonary disease. Clinicians should use TMs strictly according to the guidelines to effectively manage laboratory resources and control costs.</style></abstract><notes><style face="normal" font="default" size="100%">2044-6055&#xD;Zhang, Haichen&#xD;Song, Yunxiao&#xD;Zhang, Xiong&#xD;Hu, Jun&#xD;Yuan, Suwei&#xD;Ma, Jin&#xD;Orcid: 0000-0001-9000-589x&#xD;Journal Article&#xD;Multicenter Study&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;BMJ Open. 2018 Feb 28;8(2):e019051. doi: 10.1136/bmjopen-2017-019051.</style></notes><urls></urls><custom2><style face="normal" font="default" size="100%">PMC5855297</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1136/bmjopen-2017-019051</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2311</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2311</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Zhao, J.</style></author><author><style face="normal" font="default" size="100%">Liu, S.</style></author><author><style face="normal" font="default" size="100%">Gao, D.</style></author><author><style face="normal" font="default" size="100%">Ding, S.</style></author><author><style face="normal" font="default" size="100%">Niu, Z.</style></author><author><style face="normal" font="default" size="100%">Zhang, H.</style></author><author><style face="normal" font="default" size="100%">Huang, Z.</style></author><author><style face="normal" font="default" size="100%">Qiu, J.</style></author><author><style face="normal" font="default" size="100%">Li, Q.</style></author><author><style face="normal" font="default" size="100%">Li, N.</style></author><author><style face="normal" font="default" size="100%">Xie, F.</style></author><author><style face="normal" font="default" size="100%">Cui, J.</style></author><author><style face="normal" font="default" size="100%">Lu, J.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Urology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, People&apos;s Republic of China.&#xD;Department of Urology, Shandong Provincial Hospital Affiliated to Shandong University (East Branch), Jinan, People&apos;s Republic of China.&#xD;Department of Urology, Lanling People&apos;s Hospital, Lanling, People&apos;s Republic of China.&#xD;Department of Urology, Dongying People&apos;s Hospital, Dongying, People&apos;s Republic of China.&#xD;Department of Urology, Yucheng People&apos;s Hospital, Yucheng, People&apos;s Republic of China.&#xD;Department of Urology, Guangrao County Hospital of traditional Chinese Medicine, Guangrao, People&apos;s Republic of China.&#xD;Department of Urology, Weihai Municipal Hospital, Weihai, People&apos;s Republic of China.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Risk assessment models to evaluate the necessity of prostate biopsies in North Chinese patients with 4-50 ng/mL PSA</style></title><secondary-title><style face="normal" font="default" size="100%">Oncotarget</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Oncotarget</style></full-title></periodical><pages><style face="normal" font="default" size="100%">9935-9946</style></pages><volume><style face="normal" font="default" size="100%">8</style></volume><number><style face="normal" font="default" size="100%">6</style></number><keywords><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Area Under Curve</style></keyword><keyword><style face="normal" font="default" size="100%">Chi-Square Distribution</style></keyword><keyword><style face="normal" font="default" size="100%">China</style></keyword><keyword><style face="normal" font="default" size="100%">Clinical Decision-Making</style></keyword><keyword><style face="normal" font="default" size="100%">*Decision Support Techniques</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">*Image-Guided Biopsy</style></keyword><keyword><style face="normal" font="default" size="100%">Kallikreins/*blood</style></keyword><keyword><style face="normal" font="default" size="100%">Logistic Models</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Multivariate Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Nomograms</style></keyword><keyword><style face="normal" font="default" size="100%">Odds Ratio</style></keyword><keyword><style face="normal" font="default" size="100%">Patient Selection</style></keyword><keyword><style face="normal" font="default" size="100%">Predictive Value of Tests</style></keyword><keyword><style face="normal" font="default" size="100%">Prognosis</style></keyword><keyword><style face="normal" font="default" size="100%">Prospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Prostate-Specific Antigen/*blood</style></keyword><keyword><style face="normal" font="default" size="100%">Prostatic Neoplasms/*blood/*pathology</style></keyword><keyword><style face="normal" font="default" size="100%">ROC Curve</style></keyword><keyword><style face="normal" font="default" size="100%">Reproducibility of Results</style></keyword><keyword><style face="normal" font="default" size="100%">Retrospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Assessment</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">*Unnecessary Procedures</style></keyword><keyword><style face="normal" font="default" size="100%">Watchful Waiting</style></keyword><keyword><style face="normal" font="default" size="100%">North China</style></keyword><keyword><style face="normal" font="default" size="100%">Psa</style></keyword><keyword><style face="normal" font="default" size="100%">biopsy</style></keyword><keyword><style face="normal" font="default" size="100%">prostate cancer</style></keyword><keyword><style face="normal" font="default" size="100%">risk assessment model</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style face="normal" font="default" size="100%">Feb 7</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1949-2553</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: Prostate-specific antigen (PSA) is widely used for prostate cancer screening, but low specificity results in high false positive rates of prostate biopsies. OBJECTIVE: To develop new risk assessment models to overcome the diagnostic limitation of PSA and reduce unnecessary prostate biopsies in North Chinese patients with 4-50 ng/mL PSA. METHODS: A total of 702 patients in seven hospitals with 4-10 and 10-50 ng/mL PSA, respectively, who had undergone transrectal ultrasound-guided prostate biopsies, were assessed. Analysis-modeling stage for several clinical indexes related to prostate cancer and renal function was carried out. Multiple logistic regression analyses were used to develop new risk assessment models of prostate cancer for both PSA level ranges 4-10 and 10-50 ng/mL. External validation stage of the new models was performed to assess the necessity of biopsy. RESULTS: The new models for both PSA ranges performed significantly better than PSA for detecting prostate cancers. Both models showed higher areas under the curves (0.937 and 0.873, respectively) compared with PSA alone (0.624 and 0.595), at pre-determined cut-off values of 0.1067 and 0.6183, respectively. Patients above the cut-off values were recommended for immediate biopsy, while the others were actively observed. External validation of the models showed significantly increased detection rates for prostate cancer (4-10 ng/mL group, 39.29% vs 17.79%, p=0.006; 10-50 ng/mL group, 71.83% vs 50.0%, p=0.015). CONCLUSIONS: We developed risk assessment models for North Chinese patients with 4-50 ng/mL PSA to reduce unnecessary prostate biopsies and increase the detection rate of prostate cancer.</style></abstract><label><style face="normal" font="default" size="100%">Included by Morty</style></label><notes><style face="normal" font="default" size="100%">1949-2553&#xD;Zhao, Jing&#xD;Liu, Shuai&#xD;Gao, Dexuan&#xD;Ding, Sentai&#xD;Niu, Zhihong&#xD;Zhang, Hui&#xD;Huang, Zhilong&#xD;Qiu, Juhui&#xD;Li, Qing&#xD;Li, Ning&#xD;Xie, Fang&#xD;Cui, Jilei&#xD;Lu, Jiaju&#xD;Journal Article&#xD;Multicenter Study&#xD;Validation Study&#xD;Oncotarget. 2017 Feb 7;8(6):9935-9946. doi: 10.18632/oncotarget.14214.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.oncotarget.com/article/14214/pdf/</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC5354782</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.18632/oncotarget.14214</style></electronic-resource-num></record><record><database name="Search results.enl" path="C:\Users\Conno\Downloads\Search results.enl">Search results.enl</database><source-app name="EndNote" version="20.0">EndNote</source-app><rec-number>2312</rec-number><foreign-keys><key app="EN" db-id="0adr29zf29zvtyes553ptrpuz9vdvraxdsed">2312</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Znaor, A.</style></author><author><style face="normal" font="default" size="100%">Laversanne, M.</style></author><author><style face="normal" font="default" size="100%">Bray, F.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Less overdiagnosis of kidney cancer? an age-period-cohort analysis of incidence trends in 16 populations worldwide</style></title><secondary-title><style face="normal" font="default" size="100%">Int J Cancer</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Int J Cancer</style></full-title></periodical><pages><style face="normal" font="default" size="100%">925-932</style></pages><volume><style face="normal" font="default" size="100%">141</style></volume><number><style face="normal" font="default" size="100%">5</style></number><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Cohort Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Incidence</style></keyword><keyword><style face="normal" font="default" size="100%">Kidney Neoplasms/*epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Medical Overuse</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Prevalence</style></keyword><keyword><style face="normal" font="default" size="100%">*age-period-cohort analysis</style></keyword><keyword><style face="normal" font="default" size="100%">*incidence trends</style></keyword><keyword><style face="normal" font="default" size="100%">*kidney cancer</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style face="normal" font="default" size="100%">Sep 1</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0020-7136</style></isbn><abstract><style face="normal" font="default" size="100%">The increasing rates of kidney cancer incidence, reported in many populations globally, have been attributed both to increasing exposures to environmental risk factors, as well as increasing levels of incidental diagnosis due to widespread use of imaging. To better understand these trends, we examine long-term cancer registry data worldwide, focusing on the roles of birth cohort and calendar period, proxies for changes in risk factor prevalence and detection practice respectively. We used an augmented version of the Cancer Incidence in Five Continents series to analyze kidney cancer incidence rates 1978-2007 in 16 geographically representative populations worldwide by sex for ages 30-74, using age-period-cohort (APC) analysis. The full APC model provided the best fit to the data in most studied populations. While kidney cancer incidence rates have been increasing in successive generations born from the early twentieth century in most countries, equivalent period-specific rises were observed from the late-1970s, although these have subsequently stabilized in certain European countries (the Czech Republic, Lithuania, Finland, Spain) as well as Japan from the mid-1990s, and from the mid-2000s, in Colombia, Costa Rica and Australia. Our results indicate that the effects of both birth cohort and calendar period contribute to the international kidney cancer incidence trends. While cohort-specific increases may partly reflect the rising trends in obesity prevalence and the need for more effective primary prevention policies, the attenuations in period-specific increases (observed in 8 of the 16 populations) highlight a possible change in imaging practices that could lead to mitigation of overdiagnosis and overtreatment.</style></abstract><notes><style face="normal" font="default" size="100%">1097-0215&#xD;Znaor, Ariana&#xD;Orcid: 0000-0002-5849-4782&#xD;Laversanne, Mathieu&#xD;Bray, Freddie&#xD;Journal Article&#xD;United States&#xD;Int J Cancer. 2017 Sep 1;141(5):925-932. doi: 10.1002/ijc.30799. Epub 2017 Jun 7.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ijc.30799?download=true</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1002/ijc.30799</style></electronic-resource-num></record></records></xml>